1	JACC	NN	O	jacc	_	0	SENT_1	[p1l192t81r259b96],
2	:	:	O	:	_	0	SENT_1	[p1l192t81r259b96],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_1	[p1l276t81r498b96],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_1	[p1l516t81r708b96],
5	VOL	NNP	O	VOL	dep	4	SENT_1	[p1l1712t81r1765b96],
6	.	.	O	.	_	0	SENT_1	[p1l1712t81r1765b96],

1	6	CD	NUMBER	6	dobj	21	SENT_2	[p1l1782t81r1801b98],
2	,	,	O	,	_	0	SENT_2	[p1l1782t81r1801b98],
3	No	UH	O	no	dep	1	SENT_2	[p1l1819t81r1858b96],
4	,	,	O	,	_	0	SENT_2	[p1l1819t81r1858b96],
5	2	CD	NUMBER	2	nsubj	21	SENT_2	[p1l1876t81r1894b98],
6	,	,	O	,	_	0	SENT_2	[p1l1876t81r1894b98],
7	2013	CD	DATE	2013	dep	13	SENT_2	[p1l1911t81r1966b96],
8	©	CD	DATE	©	num	9	SENT_2	[p1l193t113r206b127],
9	2013	CD	DATE	2013	dep	7	SENT_2	[p1l223t113r278b127],
10	BY	NNP	O	BY	dep	13	SENT_2	[p1l296t112r322b127],
11	THE	DT	O	the	det	13	SENT_2	[p1l338t112r381b127],
12	AMERICAN	NNP	MISC	AMERICAN	nn	13	SENT_2	[p1l398t112r523b127],
13	COLLEGE	NNP	O	COLLEGE	dep	5	SENT_2	[p1l541t112r647b127],
14	OF	IN	O	of	_	0	SENT_2	[p1l664t112r692b127],
15	CARDIOLOGY	NNP	O	CARDIOLOGY	nn	17	SENT_2	[p1l709t112r868b127],
16	FOUNDATION	NNP	O	FOUNDATION	nn	17	SENT_2	[p1l886t112r1046b127],
17	lSSN1936-8798	NN	O	lssn1936-8798	prep_of	13	SENT_2	[p1l1674t111r1967b129],
18	/	:	O	/	punct	19	SENT_2	[p1l1674t111r1967b129],
19	$	$	MONEY	$	dep	17	SENT_2	[p1l1674t111r1967b129],
20	36.00	CD	MONEY	36.00	num	19	SENT_2	[p1l1674t111r1967b129],
21	PUBLISHED	VBN	O	publish	_	0	SENT_2	[p1l193t142r327b157],
22	BY	IN	O	by	_	0	SENT_2	[p1l345t142r370b157],
23	ELSEVIER	NNP	O	ELSEVIER	nn	25	SENT_2	[p1l388t142r497b157],
24	INC.	NNP	O	INC.	nn	25	SENT_2	[p1l515t142r562b157],
25	http://dx.doi.org/10,1016/j.jcin.2012.09.013	NN	O	http://dx.doi.org/10,1016/j.jcin.2012.09.013	prep_by	21	SENT_2	[p1l1396t142r1966b161],

1	High-Dose	JJ	MISC	high-dose	amod	2	SENT_3	[p1l195t236r512b305],
2	Atorvastatin	NN	MISC	atorvastatin	_	0	SENT_3	[p1l539t236r920b294],
3	on	IN	O	on	dep	2	SENT_3	[p1l951t252r1024b294],
4	the	DT	O	the	det	6	SENT_3	[p1l1053t236r1154b294],
5	Pharmacodynamic	JJ	O	pharmacodynamic	amod	6	SENT_3	[p1l1185t236r1765b305],
6	Effects	NNS	O	effect	nsubj	12	SENT_3	[p1l195t337r410b396],
7	of	IN	O	of	_	0	SENT_3	[p1l438t337r499b396],
8	Double-Dose	NNP	O	Double-Dose	nn	9	SENT_3	[p1l528t338r920b396],
9	Clopidogrel	NNP	O	Clopidogrel	prep_of	6	SENT_3	[p1l948t337r1303b407],
10	in	IN	O	in	_	0	SENT_3	[p1l1335t338r1388b395],
11	Patients	NNPS	O	Patients	prep_in	9	SENT_3	[p1l1421t338r1678b396],
12	Undergoing	VBG	O	undergo	pcomp	3	SENT_3	[p1l195t440r555b509],
13	Percutaneous	JJ	O	percutaneous	amod	15	SENT_3	[p1l584t440r1015b498],
14	Coronary	JJ	O	coronary	amod	15	SENT_3	[p1l1043t439r1329b509],
15	Interventions	NNS	O	intervention	dobj	12	SENT_3	[p1l1358t440r1769b498],

1	The	DT	O	the	det	2	SENT_4	[p1l192t563r265b595],
2	ACHIDO	NNP	O	ACHIDO	_	0	SENT_4	[p1l282t563r444b596],
3	(	CD	NUMBER	(	num	2	SENT_4	[p1l462t563r729b603],
4	Atorvastatin	NNP	O	Atorvastatin	nn	8	SENT_4	[p1l462t563r729b603],
5	and	CC	O	and	_	0	SENT_4	[p1l748t563r819b595],
6	Clopidogrel	NNP	O	Clopidogrel	nn	8	SENT_4	[p1l837t563r1065b603],
7	Hlgh	NNP	O	Hlgh	nn	8	SENT_4	[p1l1085t563r1174b603],
8	Dose	NNP	O	Dose	dep	2	SENT_4	[p1l1194t563r1299b595],
9	in	IN	O	in	_	0	SENT_4	[p1l1318t563r1350b595],
10	stable	JJ	O	stable	amod	11	SENT_4	[p1l1368t563r1493b596],
11	patients	NNS	O	patient	prep_in	8	SENT_4	[p1l1512t563r1676b603],
12	with	IN	O	with	_	0	SENT_4	[p1l192t618r278b651],
13	residual	JJ	O	residual	amod	16	SENT_4	[p1l298t618r454b651],
14	high	JJ	O	high	amod	16	SENT_4	[p1l474t618r557b659],
15	platelet	NN	O	platelet	nn	16	SENT_4	[p1l577t619r731b659],
16	activity	NN	O	activity	prep_with	11	SENT_4	[p1l748t618r913b659],
17	)	CD	NUMBER	)	num	18	SENT_4	[p1l748t618r913b659],
18	Study	NN	O	study	dep	2	SENT_4	[p1l932t618r1048b659],

1	Mario	NNP	PERSON	Mario	nn	2	SENT_5	[p1l192t720r289b751],
2	Leoncini	NNP	PERSON	Leoncini	_	0	SENT_5	[p1l302t720r446b758],
3	,	,	O	,	_	0	SENT_5	[p1l302t720r446b758],
4	MD	NNP	O	MD	appos	2	SENT_5	[p1l458t720r552b758],
5	,	,	O	,	_	0	SENT_5	[p1l458t720r552b758],
6	*	CD	NUMBER	*	num	8	SENT_5	[p1l458t720r552b758],
7	Anna	NNP	PERSON	Anna	nn	8	SENT_5	[p1l563t719r651b751],
8	Toso	NNP	PERSON	Toso	appos	2	SENT_5	[p1l661t719r749b758],
9	,	,	O	,	_	0	SENT_5	[p1l661t719r749b758],
10	MD	NNP	O	MD	appos	2	SENT_5	[p1l762t720r855b758],
11	,	,	O	,	_	0	SENT_5	[p1l762t720r855b758],
12	*	NNP	O	*	nn	14	SENT_5	[p1l762t720r855b758],
13	Mauro	NNP	PERSON	Mauro	nn	14	SENT_5	[p1l866t720r973b751],
14	Maioli	NNP	PERSON	Maioli	appos	2	SENT_5	[p1l985t720r1096b758],
15	,	,	O	,	_	0	SENT_5	[p1l985t720r1096b758],
16	MD	NNP	O	MD	appos	2	SENT_5	[p1l1108t720r1202b758],
17	,	,	O	,	_	0	SENT_5	[p1l1108t720r1202b758],
18	*	NNP	O	*	nn	20	SENT_5	[p1l1108t720r1202b758],
19	Dominick	NNP	PERSON	Dominick	nn	20	SENT_5	[p1l1214t720r1402b760],
20	Angiolillo	NNP	PERSON	Angiolillo	appos	2	SENT_5	[p1l1415t719r1577b762],
21	,	,	O	,	_	0	SENT_5	[p1l1415t719r1577b762],
22	MD	NNP	O	MD	appos	2	SENT_5	[p1l1589t720r1669b758],
23	,	,	O	,	_	0	SENT_5	[p1l1589t720r1669b758],
24	PHD	NNP	O	PHD	appos	2	SENT_5	[p1l1683t720r1790b758],
25	,	,	O	,	_	0	SENT_5	[p1l1683t720r1790b758],
26	”	CD	NUMBER	”	appos	2	SENT_5	[p1l1683t720r1790b758],
27	I	PRP	O	I	nsubj	28	SENT_5	[p1l1683t720r1790b758],
28	’	VBP	O	’	rcmod	26	SENT_5	[p1l1683t720r1790b758],
29	Betti	NNP	PERSON	Betti	nn	30	SENT_5	[p1l193t771r268b802],
30	Giusti	NNP	PERSON	Giusti	dobj	28	SENT_5	[p1l281t771r383b809],
31	,	,	O	,	_	0	SENT_5	[p1l281t771r383b809],
32	PHD	NNP	O	PHD	appos	30	SENT_5	[p1l397t771r504b809],
33	,	,	O	,	_	0	SENT_5	[p1l397t771r504b809],
34	:	:	O	:	_	0	SENT_5	[p1l397t771r504b809],
35	II	CD	NUMBER	ii	num	37	SENT_5	[p1l397t771r504b809],
36	Rossella	NNP	PERSON	Rossella	nn	37	SENT_5	[p1l517t771r640b802],
37	Marcucci	NNP	PERSON	Marcucci	dep	26	SENT_5	[p1l650t771r802b809],
38	,	,	O	,	_	0	SENT_5	[p1l650t771r802b809],
39	MD	NNP	O	MD	appos	37	SENT_5	[p1l815t771r915b809],
40	,	,	O	,	_	0	SENT_5	[p1l815t771r915b809],
41	III	NNP	O	III	nn	43	SENT_5	[p1l815t771r915b809],
42	Rosanna	NNP	PERSON	Rosanna	nn	43	SENT_5	[p1l928t771r1061b802],
43	Abbate	NNP	PERSON	Abbate	appos	37	SENT_5	[p1l1071t770r1192b809],
44	,	,	O	,	_	0	SENT_5	[p1l1071t770r1192b809],
45	MD	NNP	O	MD	appos	37	SENT_5	[p1l1205t771r1305b809],
46	,	,	O	,	_	0	SENT_5	[p1l1205t771r1305b809],
47	Il	NNP	O	Il	appos	37	SENT_5	[p1l1205t771r1305b809],
48	:	:	O	:	_	0	SENT_5	[p1l1205t771r1305b809],
49	Francesco	NNP	PERSON	Francesco	nn	50	SENT_5	[p1l1317t771r1468b802],
50	Bellandi	NNP	PERSON	Bellandi	dep	26	SENT_5	[p1l1481t771r1615b809],
51	,	,	O	,	_	0	SENT_5	[p1l1481t771r1615b809],
52	MD	NNP	O	MD	appos	50	SENT_5	[p1l1627t771r1712b802],
53	*	CD	NUMBER	*	num	52	SENT_5	[p1l1627t771r1712b802],

1	Pmto	NNP	O	Pmto	_	0	SENT_6	[p1l193t859r280b888],
2	and	CC	O	and	_	0	SENT_6	[p1l295t859r358b888],
3	Florence	NNP	LOCATION	Florence	conj_and	1	SENT_6	[p1l368t858r506b893],
4	,	,	O	,	_	0	SENT_6	[p1l368t858r506b893],
5	Italy	NNP	LOCATION	Italy	appos	1	SENT_6	[p1l523t859r608b900],
6	;	:	O	;	_	0	SENT_6	[p1l523t859r608b900],
7	andfacksonville	NN	O	andfacksonville	dep	1	SENT_6	[p1l623t858r887b896],
8	,	,	O	,	_	0	SENT_6	[p1l623t858r887b896],
9	Florida	NNP	LOCATION	Florida	appos	7	SENT_6	[p1l905t858r1023b888],

1	Objectives	NNS	O	objective	nsubj	7	SENT_7	[p1l193t991r367b1024],
2	The	DT	O	the	det	3	SENT_7	[p1l387t990r444b1018],
3	goal	NN	O	goal	dep	1	SENT_7	[p1l459t990r524b1026],
4	of	IN	O	of	_	0	SENT_7	[p1l540t990r572b1018],
5	this	DT	O	this	det	6	SENT_7	[p1l583t990r638b1018],
6	study	NN	O	study	prep_of	1	SENT_7	[p1l653t990r739b1026],
7	was	VBD	O	be	_	0	SENT_7	[p1l752t999r810b1018],
8	to	TO	O	to	aux	9	SENT_7	[p1l825t995r856b1018],
9	investigate	VB	O	investigate	xcomp	7	SENT_7	[p1l872t992r1041b1026],
10	the	DT	O	the	det	11	SENT_7	[p1l1055t990r1106b1018],
11	impact	NN	O	impact	dobj	9	SENT_7	[p1l1122t992r1227b1025],
12	of	IN	O	of	_	0	SENT_7	[p1l1242t990r1274b1018],
13	high-dose	JJ	O	high-dose	amod	14	SENT_7	[p1l1287t990r1442b1026],
14	atorvastatin	NN	O	atorvastatin	prep_of	11	SENT_7	[p1l1456t992r1640b1018],
15	on	IN	O	on	_	0	SENT_7	[p1l1656t999r1694b1018],
16	the	DT	O	the	det	19	SENT_7	[p1l1709t990r1759b1018],
17	pharmacodynamic	JJ	O	pharmacodynamic	amod	19	SENT_7	[p1l194t1040r485b1076],
18	(	NN	O	(	nn	19	SENT_7	[p1l500t1041r562b1073],
19	PD	NN	O	pd	prep_on	14	SENT_7	[p1l500t1041r562b1073],
20	)	CD	NUMBER	)	num	21	SENT_7	[p1l500t1041r562b1073],
21	effects	NNS	O	effect	dep	35	SENT_7	[p1l578t1040r679b1068],
22	of	IN	O	of	_	0	SENT_7	[p1l694t1040r726b1068],
23	double-dose	JJ	O	double-dose	amod	24	SENT_7	[p1l738t1040r934b1068],
24	clopidogrel	NN	O	clopidogrel	prep_of	21	SENT_7	[p1l949t1040r1124b1076],
25	in	IN	O	in	_	0	SENT_7	[p1l1141t1042r1166b1068],
26	statin-naive	JJ	O	statin-naive	amod	27	SENT_7	[p1l1183t1042r1363b1068],
27	patients	NNS	O	patient	prep_in	24	SENT_7	[p1l1379t1042r1503b1075],
28	with	IN	O	with	_	0	SENT_7	[p1l1518t1040r1584b1068],
29	stable	JJ	O	stable	amod	31	SENT_7	[p1l1600t1040r1692b1068],
30	coronary	JJ	O	coronary	amod	31	SENT_7	[p1l1707t1049r1787b1068, p1l194t1098r260b1125],
31	artery	NN	O	artery	prep_with	27	SENT_7	[p1l274t1094r364b1125],
32	disease	NN	O	disease	dep	35	SENT_7	[p1l378t1090r491b1118],
33	(	CD	NUMBER	(	num	32	SENT_7	[p1l507t1091r594b1122],
34	CAD	NN	O	cad	nn	35	SENT_7	[p1l507t1091r594b1122],
35	)	NN	O	)	dep	11	SENT_7	[p1l507t1091r594b1122],
36	and	CC	O	and	_	0	SENT_7	[p1l610t1090r666b1118],
37	high-on-treatment	JJ	O	high-on-treatment	amod	42	SENT_7	[p1l683t1090r973b1125],
38	platelet	NN	O	platelet	nn	42	SENT_7	[p1l989t1090r1105b1125],
39	reactivity	NN	O	reactivity	nn	42	SENT_7	[p1l1121t1091r1262b1125],
40	(	CD	NUMBER	(	num	42	SENT_7	[p1l1277t1091r1377b1122],
41	HTPR	NN	O	htpr	nn	42	SENT_7	[p1l1277t1091r1377b1122],
42	)	NN	O	)	dep	11	SENT_7	[p1l1277t1091r1377b1122],
43	while	IN	O	while	mark	44	SENT_7	[p1l1393t1090r1476b1117],
44	on	IN	O	on	dep	11	SENT_7	[p1l1491t1098r1528b1118],
45	standard-dose	JJ	O	standard-dose	amod	46	SENT_7	[p1l1545t1090r1768b1118],
46	clopidogrel	NN	O	clopidogrel	pobj	44	SENT_7	[p1l193t1139r368b1175],
47	before	IN	O	before	_	0	SENT_7	[p1l386t1139r485b1167],
48	percutaneous	JJ	O	percutaneous	amod	50	SENT_7	[p1l501t1143r713b1174],
49	coronary	JJ	O	coronary	amod	50	SENT_7	[p1l728t1147r866b1175],
50	intervention	NN	O	intervention	prep_before	9	SENT_7	[p1l881t1141r1070b1167],
51	(	CD	NUMBER	(	num	53	SENT_7	[p1l1087t1140r1163b1171],
52	PCI	NN	O	pcus	nn	53	SENT_7	[p1l1087t1140r1163b1171],
53	)	NN	O	)	dep	50	SENT_7	[p1l1087t1140r1163b1171],
54	.	.	O	.	_	0	SENT_7	[p1l1087t1140r1163b1171],

1	Background	NN	O	background	nn	2	SENT_8	[p1l194t1221r391b1254],
2	Patients	NNS	O	patient	nsubj	5	SENT_8	[p1l414t1222r536b1248],
3	with	IN	O	with	_	0	SENT_8	[p1l551t1220r617b1248],
4	HTPR	NN	O	htpr	prep_with	2	SENT_8	[p1l635t1222r715b1247],
5	are	VBP	O	be	_	0	SENT_8	[p1l729t1228r776b1248],
6	at	IN	O	at	_	0	SENT_8	[p1l791t1225r819b1248],
7	increased	VBN	O	increase	amod	8	SENT_8	[p1l835t1220r981b1248],
8	risk	NN	O	risk	prep_at	5	SENT_8	[p1l998t1220r1049b1248],
9	of	IN	O	of	_	0	SENT_8	[p1l1063t1220r1094b1248],
10	adverse	JJ	O	adverse	amod	12	SENT_8	[p1l1107t1220r1226b1248],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_8	[p1l1241t1220r1465b1248],
12	events	NNS	O	event	prep_of	8	SENT_8	[p1l1479t1225r1580b1248],
13	after	IN	O	after	_	0	SENT_8	[p1l1595t1220r1666b1248],
14	PCI	NN	O	pcus	prep_after	12	SENT_8	[p1l1681t1221r1736b1248],
15	.	.	O	.	_	0	SENT_8	[p1l1681t1221r1736b1248],

1	High-dose	JJ	O	high-dose	amod	2	SENT_9	[p1l195t1270r353b1305],
2	statins	NNS	O	statin	nsubj	3	SENT_9	[p1l368t1271r467b1297],
3	improve	VBP	O	improve	_	0	SENT_9	[p1l483t1271r611b1304],
4	prognosis	NN	O	prognosis	dobj	3	SENT_9	[p1l627t1271r778b1305],
5	in	IN	O	in	_	0	SENT_9	[p1l794t1271r819b1297],
6	high-risk	JJ	O	high-risk	amod	7	SENT_9	[p1l837t1270r971b1305],
7	patients	NNS	O	patient	prep_in	4	SENT_9	[p1l985t1271r1109b1304],
8	by	IN	O	by	_	0	SENT_9	[p1l1125t1270r1162b1305],
9	lipid	NN	O	lipid	prep_by	3	SENT_9	[p1l1177t1270r1254b1304],
10	-	:	O	-	_	0	SENT_9	[p1l1177t1270r1254b1304],
11	and	CC	O	and	_	0	SENT_9	[p1l1268t1270r1325b1297],
12	nonlipid-related	JJ	O	nonlipid-related	amod	13	SENT_9	[p1l1342t1270r1590b1304],
13	mechanisms	NNS	O	mechanism	prep_by	3	SENT_9	[p1l1608t1270r1808b1302],
14	,	,	O	,	_	0	SENT_9	[p1l1608t1270r1808b1302],
15	including	VBG	O	include	_	0	SENT_9	[p1l194t1320r337b1355],
16	antithrombotic	JJ	O	antithrombotic	amod	17	SENT_9	[p1l353t1320r588b1347],
17	effects	NNS	O	effect	prep_including	3	SENT_9	[p1l603t1319r712b1347],
18	.	.	O	.	_	0	SENT_9	[p1l603t1319r712b1347],

1	Methods	NNS	O	method	dep	9	SENT_10	[p1l194t1402r338b1429],
2	The	DT	O	the	det	3	SENT_10	[p1l357t1401r415b1429],
3	ACHIDO	NNP	O	ACHIDO	dep	1	SENT_10	[p1l429t1402r556b1429],
4	(	CD	NUMBER	(	num	3	SENT_10	[p1l572t1401r770b1433],
5	Atorvastatin	NNP	O	Atorvastatin	nn	8	SENT_10	[p1l572t1401r770b1433],
6	and	CC	O	and	_	0	SENT_10	[p1l786t1401r842b1429],
7	Clopidogrel	NNP	O	Clopidogrel	nn	8	SENT_10	[p1l858t1401r1038b1436],
8	Hlgh	NNP	O	Hlgh	dep	9	SENT_10	[p1l1056t1401r1126b1436],
9	DOse	NN	O	dose	dep	22	SENT_10	[p1l1144t1402r1225b1429],
10	in	IN	O	in	_	0	SENT_10	[p1l1240t1402r1265b1428],
11	stable	JJ	O	stable	amod	12	SENT_10	[p1l1282t1401r1373b1429],
12	patients	NNS	O	patient	prep_in	9	SENT_10	[p1l1389t1402r1513b1436],
13	with	IN	O	with	_	0	SENT_10	[p1l1528t1401r1594b1429],
14	residual	JJ	O	residual	amod	17	SENT_10	[p1l1611t1401r1730b1429],
15	high	JJ	O	high	amod	17	SENT_10	[p1l1747t1401r1814b1436],
16	platelet	NN	O	platelet	nn	17	SENT_10	[p1l194t1451r311b1486],
17	activity	NN	O	activity	prep_with	12	SENT_10	[p1l325t1452r445b1487],
18	)	CD	NUMBER	)	num	19	SENT_10	[p1l325t1452r445b1487],
19	study	NN	O	study	nsubjpass	22	SENT_10	[p1l461t1451r547b1487],
20	was	VBD	O	be	auxpass	22	SENT_10	[p1l560t1460r618b1479],
21	a	DT	O	a	dep	22	SENT_10	[p1l633t1460r648b1479],
22	randomized	VBN	O	randomize	ccomp	58	SENT_10	[p1l665t1451r849b1479],
23	PD	NN	O	pd	nn	24	SENT_10	[p1l867t1453r908b1479],
24	study	NN	O	study	dobj	22	SENT_10	[p1l923t1451r1008b1487],
25	of	IN	O	of	_	0	SENT_10	[p1l1022t1451r1054b1479],
26	high-dose	JJ	O	high-dose	amod	27	SENT_10	[p1l1067t1451r1222b1487],
27	(	NN	O	(	prep_of	24	SENT_10	[p1l1238t1452r1284b1483],
28	80	CD	NUMBER	80	num	31	SENT_10	[p1l1238t1452r1284b1483],
29	mg	NN	O	mg	nn	31	SENT_10	[p1l1300t1452r1358b1487],
30	)	NN	O	)	nn	31	SENT_10	[p1l1300t1452r1358b1487],
31	atorvastatin	NN	O	atorvastatin	dep	40	SENT_10	[p1l1374t1453r1557b1479],
32	in	IN	O	in	_	0	SENT_10	[p1l1574t1453r1599b1479],
33	addition	NN	O	addition	_	0	SENT_10	[p1l1615t1451r1743b1479],
34	to	TO	O	to	_	0	SENT_10	[p1l1759t1456r1790b1479],
35	double-dose	JJ	O	double-dose	amod	36	SENT_10	[p1l193t1502r389b1530],
36	(	NN	O	(	prep_in_addition_to	31	SENT_10	[p1l405t1503r470b1534],
37	150	CD	NUMBER	150	num	38	SENT_10	[p1l405t1503r470b1534],
38	mg	NN	O	mg	dep	40	SENT_10	[p1l486t1503r544b1537],
39	)	NN	O	)	nn	40	SENT_10	[p1l486t1503r544b1537],
40	clopidogrel	NN	O	clopidogrel	dep	24	SENT_10	[p1l560t1502r735b1537],
41	(	CD	NUMBER	(	num	43	SENT_10	[p1l753t1503r945b1534],
42	atorvastatin	NN	O	atorvastatin	nn	43	SENT_10	[p1l753t1503r945b1534],
43	group	NN	O	group	dep	40	SENT_10	[p1l962t1510r1063b1537],
44	,	,	O	,	_	0	SENT_10	[p1l962t1510r1063b1537],
45	n	NN	O	n	nsubj	58	SENT_10	[p1l1079t1510r1095b1529],
46	=	JJ	O	=	amod	45	SENT_10	[p1l1114t1512r1136b1521],
47	38	CD	NUMBER	38	number	48	SENT_10	[p1l1155t1503r1200b1534],
48	)	CD	NUMBER	)	dep	46	SENT_10	[p1l1155t1503r1200b1534],
49	versus	CC	O	versus	prep	48	SENT_10	[p1l1215t1510r1313b1530],
50	double-dose	JJ	O	double-dose	amod	51	SENT_10	[p1l1328t1502r1524b1530],
51	clopidogrel	NN	O	clopidogrel	dep	49	SENT_10	[p1l1539t1502r1714b1537],
52	alone	RB	O	alone	advmod	45	SENT_10	[p1l1730t1502r1815b1530],
53	(	RB	O	(	advmod	55	SENT_10	[p1l194t1553r312b1584],
54	control	JJ	O	control	amod	55	SENT_10	[p1l194t1553r312b1584],
55	group	NN	O	group	dep	45	SENT_10	[p1l329t1561r430b1587],
56	,	,	O	,	_	0	SENT_10	[p1l329t1561r430b1587],
57	n	NN	O	n	appos	45	SENT_10	[p1l446t1561r462b1580],
58	=	JJ	O	=	_	0	SENT_10	[p1l481t1563r504b1572],
59	38	CD	NUMBER	38	num	60	SENT_10	[p1l522t1553r567b1584],
60	)	NN	O	)	dobj	58	SENT_10	[p1l522t1553r567b1584],
61	in	IN	O	in	_	0	SENT_10	[p1l584t1554r609b1580],
62	patients	NNS	O	patient	prep_in	60	SENT_10	[p1l626t1554r750b1587],
63	with	IN	O	with	_	0	SENT_10	[p1l765t1553r831b1580],
64	HTPR	NN	O	htpr	prep_with	58	SENT_10	[p1l849t1554r936b1580],
65	.	.	O	.	_	0	SENT_10	[p1l849t1554r936b1580],

1	HTPR	NN	ORGANIZATION	htpr	nsubj	9	SENT_11	[p1l952t1554r1032b1580],
2	was	VBD	O	be	auxpass	3	SENT_11	[p1l1046t1561r1105b1580],
3	deﬁned	VBN	O	deﬁned	rcmod	1	SENT_11	[p1l1120t1552r1236b1580],
4	as	IN	O	as	_	0	SENT_11	[p1l1252t1561r1283b1580],
5	P2Y	NN	O	p2y	nn	8	SENT_11	[p1l1299t1554r1384b1588],
6	,2	CD	NUMBER	,2	num	8	SENT_11	[p1l1299t1554r1384b1588],
7	reaction	NN	O	reaction	nn	8	SENT_11	[p1l1401t1554r1524b1580],
8	units	NNS	O	unit	prep_as	3	SENT_11	[p1l1542t1554r1615b1580],
9	(	VBP	O	(	_	0	SENT_11	[p1l1631t1553r1713b1584],
10	PRU	NNP	ORGANIZATION	PRU	dobj	9	SENT_11	[p1l1631t1553r1713b1584],
11	)	CD	NUMBER	)	number	12	SENT_11	[p1l1631t1553r1713b1584],
12	2235	CD	DATE	2235	npadvmod	9	SENT_11	[p1l1730t1554r1814b1580],
13	by	IN	O	by	_	0	SENT_11	[p1l194t1602r231b1638],
14	the	DT	O	the	det	17	SENT_11	[p1l244t1602r294b1630],
15	VerifyNow	NNP	O	VerifyNow	nn	17	SENT_11	[p1l308t1602r470b1638],
16	P2Y12	NN	O	p2y12	nn	17	SENT_11	[p1l485t1603r579b1630],
17	assay	NN	O	assay	prep_by	9	SENT_11	[p1l594t1610r683b1638],
18	.	.	O	.	_	0	SENT_11	[p1l594t1610r683b1638],

1	Platelet	NN	O	platelet	nn	2	SENT_12	[p1l699t1602r814b1630],
2	reactivity	NN	O	reactivity	nsubjpass	4	SENT_12	[p1l830t1604r971b1638],
3	was	VBD	O	be	auxpass	4	SENT_12	[p1l984t1610r1043b1630],
4	evaluated	VBN	O	evaluate	_	0	SENT_12	[p1l1058t1602r1209b1630],
5	immediately	RB	O	immediately	advmod	4	SENT_12	[p1l1226t1602r1420b1638],
6	before	IN	O	before	_	0	SENT_12	[p1l1435t1602r1534b1630],
7	PCI	NN	O	pcus	prep_before	4	SENT_12	[p1l1550t1603r1596b1630],
8	and	CC	O	and	_	0	SENT_12	[p1l1612t1602r1669b1630],
9	at	IN	O	at	quantmod	10	SENT_12	[p1l1685t1606r1713b1630],
10	10	CD	NUMBER	10	num	13	SENT_12	[p1l1730t1604r1764b1630],
11	and	CC	O	and	_	0	SENT_12	[p1l193t1652r250b1680],
12	30	CD	DURATION	30	num	13	SENT_12	[p1l266t1654r302b1680],
13	days	NNS	NUMBER	day	prep_before	4	SENT_12	[p1l317t1652r394b1688],
14	.	.	O	.	_	0	SENT_12	[p1l317t1652r394b1688],

1	Results	NNS	O	result	nn	2	SENT_13	[p1l194t1735r318b1762],
2	Patients	NNS	O	patient	nsubj	6	SENT_13	[p1l340t1735r462b1762],
3	randomized	VBN	O	randomize	partmod	2	SENT_13	[p1l478t1734r662b1762],
4	to	TO	O	to	_	0	SENT_13	[p1l676t1738r708b1762],
5	atorvastatin	NN	O	atorvastatin	prep_to	3	SENT_13	[p1l722t1735r905b1762],
6	had	VBD	O	have	_	0	SENT_13	[p1l921t1734r977b1762],
7	lower	JJR	O	lower	dobj	6	SENT_13	[p1l993t1734r1078b1762],
8	PRU	NNP	O	PRU	nsubj	9	SENT_13	[p1l1093t1735r1152b1762],
9	values	VBZ	O	value	rcmod	7	SENT_13	[p1l1167t1734r1264b1762],
10	(	CD	NUMBER	(	number	11	SENT_13	[p1l1280t1735r1340b1766],
11	188	CD	NUMBER	188	dobj	9	SENT_13	[p1l1280t1735r1340b1766],
12	:	:	O	:	_	0	SENT_13	[p1l1356t1737r1378b1760],
13	48	CD	NUMBER	48	dep	11	SENT_13	[p1l1393t1736r1429b1762],
14	vs.	CC	O	vs.	prep	13	SENT_13	[p1l1441t1742r1477b1762],
15	223	CD	NUMBER	223	dep	14	SENT_13	[p1l1489t1736r1540b1762],
16	:	:	O	:	_	0	SENT_13	[p1l1557t1737r1580b1760],
17	53	CD	NUMBER	53	num	20	SENT_13	[p1l1596t1736r1629b1762],
18	PRU	NNP	ORGANIZATION	PRU	nn	20	SENT_13	[p1l1644t1735r1708b1766],
19	,	,	O	,	_	0	SENT_13	[p1l1644t1735r1708b1766],
20	p	NN	O	p	nsubj	30	SENT_13	[p1l1722t1742r1740b1769],
21	<	JJR	O	<	dep	30	SENT_13	[p1l1754t1738r1779b1760],
22	0.01	CD	NUMBER	0.01	dep	30	SENT_13	[p1l193t1786r264b1816],
23	;	:	O	;	_	0	SENT_13	[p1l193t1786r264b1816],
24	primary	JJ	O	primary	amod	26	SENT_13	[p1l280t1785r399b1819],
25	endpoint	NN	O	endpoint	nn	26	SENT_13	[p1l413t1784r565b1819],
26	)	NN	O	)	dep	22	SENT_13	[p1l413t1784r565b1819],
27	and	CC	O	and	_	0	SENT_13	[p1l581t1784r637b1812],
28	HTPR	NN	O	htpr	nn	29	SENT_13	[p1l655t1785r735b1811],
29	rates	NNS	O	rate	dep	22	SENT_13	[p1l750t1788r823b1811],
30	(	VBP	O	(	parataxis	9	SENT_13	[p1l839t1785r915b1816],
31	16	CD	PERCENT	16	num	32	SENT_13	[p1l839t1785r915b1816],
32	%	NN	PERCENT	%	nsubj	38	SENT_13	[p1l839t1785r915b1816],
33	vs.	CC	O	vs.	prep	32	SENT_13	[p1l929t1792r967b1811],
34	42	CD	PERCENT	42	num	35	SENT_13	[p1l982t1786r1056b1816],
35	%	NN	PERCENT	%	dep	33	SENT_13	[p1l982t1786r1056b1816],
36	,	,	O	,	_	0	SENT_13	[p1l982t1786r1056b1816],
37	p	NN	O	p	appos	35	SENT_13	[p1l1072t1792r1090b1819],
38	<	JJR	O	<	xcomp	30	SENT_13	[p1l1106t1788r1132b1809],
39	0.01	CD	NUMBER	0.01	num	40	SENT_13	[p1l1148t1785r1221b1816],
40	)	NN	O	)	nsubj	30	SENT_13	[p1l1148t1785r1221b1816],
41	at	IN	O	at	_	0	SENT_13	[p1l1237t1788r1265b1812],
42	30	CD	DURATION	30	num	43	SENT_13	[p1l1280t1786r1316b1812],
43	days	NNS	NUMBER	day	prep_at	6	SENT_13	[p1l1331t1784r1400b1819],
44	than	IN	O	than	_	0	SENT_13	[p1l1414t1784r1484b1811],
45	patients	NNS	O	patient	prep_than	43	SENT_13	[p1l1501t1785r1625b1819],
46	in	IN	O	in	_	0	SENT_13	[p1l1640t1785r1666b1811],
47	the	DT	O	the	det	49	SENT_13	[p1l1681t1784r1731b1811],
48	control	NN	O	control	nn	49	SENT_13	[p1l1746t1792r1814b1811, p1l192t1833r243b1861],
49	group	NN	O	group	prep_in	45	SENT_13	[p1l260t1841r361b1868],
50	.	.	O	.	_	0	SENT_13	[p1l260t1841r361b1868],

1	Statin	NN	O	statin	nn	2	SENT_14	[p1l376t1834r463b1861],
2	treatment	NN	O	treatment	dep	7	SENT_14	[p1l479t1837r635b1861],
3	(	CD	NUMBER	(	num	4	SENT_14	[p1l650t1833r735b1865],
4	odds	NNS	O	odds	dep	2	SENT_14	[p1l650t1833r735b1865],
5	ratio	NN	O	ratio	dep	7	SENT_14	[p1l751t1835r820b1861],
6	[	CD	NUMBER	[	num	5	SENT_14	[p1l836t1834r907b1864],
7	OR	NN	O	or	dep	38	SENT_14	[p1l836t1834r907b1864],
8	]	CD	NUMBER	]	dep	7	SENT_14	[p1l836t1834r907b1864],
9	:	:	O	:	_	0	SENT_14	[p1l836t1834r907b1864],
10	3.8	CD	NUMBER	3.8	dep	7	SENT_14	[p1l922t1835r974b1865],
11	,	,	O	,	_	0	SENT_14	[p1l922t1835r974b1865],
12	p	NN	O	p	appos	10	SENT_14	[p1l990t1841r1007b1868],
13	=	JJ	O	=	amod	19	SENT_14	[p1l1025t1843r1048b1852],
14	0.011	CD	NUMBER	0.011	num	15	SENT_14	[p1l1066t1834r1167b1865],
15	)	NN	O	)	tmod	13	SENT_14	[p1l1066t1834r1167b1865],
16	,	,	O	,	_	0	SENT_14	[p1l1066t1834r1167b1865],
17	baseline	NN	O	baseline	nn	18	SENT_14	[p1l1183t1833r1309b1861],
18	PRU	NNP	O	PRU	appos	15	SENT_14	[p1l1326t1834r1385b1861],
19	<	JJR	O	<	dep	12	SENT_14	[p1l1403t1835r1488b1861],
20	298	CD	NUMBER	298	num	22	SENT_14	[p1l1403t1835r1488b1861],
21	(	NN	O	(	nn	22	SENT_14	[p1l1504t1834r1565b1865],
22	OR	NN	O	or	dep	12	SENT_14	[p1l1504t1834r1565b1865],
23	:	:	O	:	_	0	SENT_14	[p1l1504t1834r1565b1865],
24	10.7	CD	NUMBER	10.7	dep	7	SENT_14	[p1l1582t1835r1650b1865],
25	,	,	O	,	_	0	SENT_14	[p1l1582t1835r1650b1865],
26	p	NN	O	p	appos	24	SENT_14	[p1l1666t1841r1684b1868],
27	=	JJ	O	=	amod	26	SENT_14	[p1l1702t1843r1725b1852],
28	0.0001	CD	NUMBER	0.0001	num	29	SENT_14	[p1l193t1883r313b1914],
29	)	NN	O	)	tmod	27	SENT_14	[p1l193t1883r313b1914],
30	,	,	O	,	_	0	SENT_14	[p1l193t1883r313b1914],
31	noncarrier	JJ	O	noncarrier	amod	32	SENT_14	[p1l329t1884r488b1910],
32	status	NN	O	status	appos	29	SENT_14	[p1l502t1887r593b1910],
33	of	IN	O	of	_	0	SENT_14	[p1l608t1882r640b1910],
34	CYP2C19	NN	O	cyp2c19	nn	35	SENT_14	[p1l652t1883r819b1910],
35	*	NN	O	*	prep_of	7	SENT_14	[p1l652t1883r819b1910],
36	2	CD	NUMBER	2	num	38	SENT_14	[p1l652t1883r819b1910],
37	loss	NN	O	loss	nn	38	SENT_14	[p1l835t1882r1075b1910],
38	—	NN	O	—	dep	44	SENT_14	[p1l835t1882r1075b1910],
39	of	IN	O	of	_	0	SENT_14	[p1l835t1882r1075b1910],
40	—	CD	NUMBER	—	num	42	SENT_14	[p1l835t1882r1075b1910],
41	function	NN	O	function	nn	42	SENT_14	[p1l835t1882r1075b1910],
42	allele	NN	O	allele	prep_of	38	SENT_14	[p1l1091t1882r1171b1910],
43	(	CD	NUMBER	(	num	44	SENT_14	[p1l1187t1883r1248b1914],
44	OR	NN	O	or	dep	46	SENT_14	[p1l1187t1883r1248b1914],
45	:	:	O	:	_	0	SENT_14	[p1l1187t1883r1248b1914],
46	2.9	CD	NUMBER	2.9	_	0	SENT_14	[p1l1263t1884r1315b1914],
47	,	,	O	,	_	0	SENT_14	[p1l1263t1884r1315b1914],
48	p	NN	O	p	appos	46	SENT_14	[p1l1331t1890r1348b1917],
49	=	JJ	O	=	amod	48	SENT_14	[p1l1366t1893r1389b1901],
50	0.043	CD	NUMBER	0.043	num	51	SENT_14	[p1l1407t1883r1508b1914],
51	)	NN	O	)	tmod	49	SENT_14	[p1l1407t1883r1508b1914],
52	,	,	O	,	_	0	SENT_14	[p1l1407t1883r1508b1914],
53	and	CC	O	and	_	0	SENT_14	[p1l1523t1882r1579b1910],
54	age	NN	O	age	nn	56	SENT_14	[p1l1595t1890r1651b1917],
55	(	CD	NUMBER	(	num	56	SENT_14	[p1l1666t1883r1727b1914],
56	OR	NN	O	or	tmod	49	SENT_14	[p1l1666t1883r1727b1914],
57	:	:	O	:	_	0	SENT_14	[p1l1666t1883r1727b1914],
58	0.94	CD	NUMBER	0.94	dep	48	SENT_14	[p1l1742t1884r1813b1914],
59	,	,	O	,	_	0	SENT_14	[p1l1742t1884r1813b1914],
60	p	NN	O	p	appos	58	SENT_14	[p1l194t1940r212b1966],
61	=	JJ	O	=	amod	63	SENT_14	[p1l230t1942r253b1951],
62	0.032	CD	NUMBER	0.032	num	63	SENT_14	[p1l271t1932r363b1963],
63	)	NN	O	)	nsubjpass	67	SENT_14	[p1l271t1932r363b1963],
64	were	VBD	O	be	auxpass	67	SENT_14	[p1l378t1939r454b1959],
65	variables	NNS	O	variable	attr	67	SENT_14	[p1l468t1931r605b1959],
66	signiﬁcantly	RB	O	signiﬁcantly	advmod	67	SENT_14	[p1l620t1931r807b1967],
67	associated	VBN	O	associate	rcmod	60	SENT_14	[p1l821t1931r982b1959],
68	with	IN	O	with	_	0	SENT_14	[p1l997t1931r1064b1959],
69	optimal	JJ	O	optimal	amod	70	SENT_14	[p1l1080t1931r1197b1966],
70	PD	NN	O	pd	prep_with	67	SENT_14	[p1l1215t1933r1256b1959],
71	response	NN	O	response	nn	73	SENT_14	[p1l1272t1939r1411b1966],
72	(	CD	NUMBER	(	num	73	SENT_14	[p1l1427t1932r1497b1963],
73	PRU	NNP	O	PRU	tmod	67	SENT_14	[p1l1427t1932r1497b1963],
74	<	JJR	O	<	amod	73	SENT_14	[p1l1515t1932r1609b1963],
75	235	CD	NUMBER	235	num	76	SENT_14	[p1l1515t1932r1609b1963],
76	)	NN	O	)	npadvmod	77	SENT_14	[p1l1515t1932r1609b1963],
77	at	IN	O	at	advmod	79	SENT_14	[p1l1625t1936r1654b1959],
78	30	CD	DURATION	30	num	79	SENT_14	[p1l1669t1933r1704b1959],
79	days	NNS	NUMBER	day	tmod	67	SENT_14	[p1l1719t1931r1796b1967],
80	.	.	O	.	_	0	SENT_14	[p1l1719t1931r1796b1967],

1	No	DT	O	no	det	2	SENT_15	[p1l194t1983r236b2009],
2	correlations	NNS	O	correlation	nsubjpass	4	SENT_15	[p1l251t1981r433b2009],
3	were	VBD	O	be	auxpass	4	SENT_15	[p1l448t1989r524b2009],
4	found	VBN	O	find	_	0	SENT_15	[p1l537t1981r629b2009],
5	between	IN	O	between	_	0	SENT_15	[p1l646t1981r780b2009],
6	PRU	NNP	O	PRU	prep_between	4	SENT_15	[p1l797t1983r857b2009],
7	and	CC	O	and	_	0	SENT_15	[p1l873t1981r929b2009],
8	lipid	NN	O	lipid	nn	9	SENT_15	[p1l947t1981r1011b2016],
9	fractions	NNS	O	fraction	prep_between	4	SENT_15	[p1l1026t1981r1168b2009],
10	.	.	O	.	_	0	SENT_15	[p1l1026t1981r1168b2009],

1	Conclusions	NNS	MISC	conclusion	nn	3	SENT_16	[p1l193t2064r394b2091],
2	High-dose	JJ	MISC	high-dose	amod	3	SENT_16	[p1l416t2063r575b2099],
3	atorvastatin	NN	O	atorvastatin	nsubj	5	SENT_16	[p1l589t2065r773b2091],
4	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_16	[p1l789t2063r976b2099],
5	improved	VBD	O	improve	_	0	SENT_16	[p1l991t2063r1138b2098],
6	the	DT	O	the	det	8	SENT_16	[p1l1154t2063r1204b2091],
7	PD	NN	O	pd	nn	8	SENT_16	[p1l1220t2064r1261b2091],
8	effects	NNS	O	effect	dobj	5	SENT_16	[p1l1276t2063r1377b2091],
9	of	IN	O	of	_	0	SENT_16	[p1l1392t2063r1424b2091],
10	doub	NN	O	doub	nn	11	SENT_16	[p1l1436t2063r1632b2091],
11	|	NN	O	|	prep_of	8	SENT_16	[p1l1436t2063r1632b2091],
12	e	SYM	O	e	dep	15	SENT_16	[p1l1436t2063r1632b2091],
13	—	CD	NUMBER	—	num	15	SENT_16	[p1l1436t2063r1632b2091],
14	dose	NN	O	dose	nn	15	SENT_16	[p1l1436t2063r1632b2091],
15	clopidogrel	NN	O	clopidogrel	dep	8	SENT_16	[p1l1647t2063r1733b2098, p1l193t2114r292b2149],
16	in	IN	O	in	_	0	SENT_16	[p1l309t2115r334b2141],
17	our	PRP$	O	we	poss	20	SENT_16	[p1l350t2122r402b2142],
18	stable	JJ	O	stable	amod	20	SENT_16	[p1l417t2114r508b2142],
19	CAD	NN	O	cad	nn	20	SENT_16	[p1l523t2115r590b2142],
20	patients	NNS	O	patient	prep_in	15	SENT_16	[p1l606t2115r730b2149],
21	with	IN	O	with	_	0	SENT_16	[p1l745t2114r811b2142],
22	HTPR	NN	O	htpr	prep_with	5	SENT_16	[p1l829t2115r908b2141],
23	undergoing	VBG	O	undergo	partmod	22	SENT_16	[p1l924t2114r1105b2149],
24	PCI	NNP	O	PCI	dobj	23	SENT_16	[p1l1123t2115r1168b2142],
25	(	CD	NUMBER	(	num	24	SENT_16	[p1l1185t2114r1383b2146],
26	Atorvastatin	NNP	O	Atorvastatin	nn	30	SENT_16	[p1l1185t2114r1383b2146],
27	and	CC	O	and	_	0	SENT_16	[p1l1399t2114r1456b2142],
28	Clopidogrel	NNP	O	Clopidogrel	nn	30	SENT_16	[p1l1472t2114r1652b2149],
29	Hlgh	NNP	O	Hlgh	nn	30	SENT_16	[p1l1669t2114r1740b2149],
30	DOse	NN	O	dose	tmod	23	SENT_16	[p1l194t2165r275b2191],
31	in	IN	O	in	_	0	SENT_16	[p1l291t2165r316b2191],
32	stable	JJ	O	stable	amod	33	SENT_16	[p1l332t2164r424b2191],
33	patients	NNS	O	patient	prep_in	30	SENT_16	[p1l440t2165r564b2198],
34	with	IN	O	with	_	0	SENT_16	[p1l578t2164r645b2191],
35	residual	JJ	O	residual	amod	38	SENT_16	[p1l662t2164r781b2191],
36	high	JJ	O	high	amod	38	SENT_16	[p1l798t2164r865b2199],
37	platelet	NN	O	platelet	nn	38	SENT_16	[p1l882t2164r998b2198],
38	activity	NN	O	activity	prep_with	33	SENT_16	[p1l1013t2165r1124b2199],
39	[	CD	NUMBER	[	num	40	SENT_16	[p1l1140t2165r1294b2196],
40	ACHIDO	NNP	O	ACHIDO	dep	38	SENT_16	[p1l1140t2165r1294b2196],
41	]	CD	NUMBER	]	num	40	SENT_16	[p1l1140t2165r1294b2196],
42	;	:	O	;	_	0	SENT_16	[p1l1140t2165r1294b2196],
43	NCT01335048	CD	NUMBER	nct01335048	num	44	SENT_16	[p1l1310t2164r1544b2195],
44	)	NN	O	)	dep	30	SENT_16	[p1l1310t2164r1544b2195],
45	.	.	O	.	_	0	SENT_16	[p1l1310t2164r1544b2195],

1	(	NN	O	(	nn	2	SENT_17	[p1l1587t2164r1607b2195],
2	J	NN	O	j	nsubj	5	SENT_17	[p1l1587t2164r1607b2195],
3	Am	VBP	O	be	cop	5	SENT_17	[p1l1622t2165r1673b2191],
4	Coll	NNP	PERSON	Coll	nn	5	SENT_17	[p1l1689t2164r1746b2191],
5	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_17	[p1l193t2213r301b2241],
6	lntv	NN	O	lntv	dep	5	SENT_17	[p1l318t2215r376b2241],
7	2013	CD	DATE	2013	num	6	SENT_17	[p1l390t2214r628b2246],
8	;	:	O	;	_	0	SENT_17	[p1l390t2214r628b2246],
9	6:169	CD	NUMBER	6:169	number	10	SENT_17	[p1l390t2214r628b2246],
10	—	CD	NUMBER	—	dep	5	SENT_17	[p1l390t2214r628b2246],
11	79	CD	NUMBER	79	num	12	SENT_17	[p1l390t2214r628b2246],
12	)	NN	O	)	dep	10	SENT_17	[p1l390t2214r628b2246],
13	©	CD	NUMBER	©	num	14	SENT_17	[p1l644t2216r667b2240],
14	2013	CD	DATE	2013	dep	5	SENT_17	[p1l682t2215r755b2241],
15	by	IN	O	by	dep	14	SENT_17	[p1l773t2213r809b2249],
16	the	DT	O	the	det	18	SENT_17	[p1l822t2213r873b2241],
17	American	NNP	ORGANIZATION	American	nn	18	SENT_17	[p1l887t2215r1034b2241],
18	College	NNP	ORGANIZATION	College	pobj	15	SENT_17	[p1l1050t2213r1166b2249],
19	of	IN	ORGANIZATION	of	dep	14	SENT_17	[p1l1181t2213r1213b2241],
20	Cardiology	NNP	ORGANIZATION	Cardiology	nn	21	SENT_17	[p1l1225t2213r1394b2249],
21	Foundation	NNP	ORGANIZATION	Foundation	pobj	19	SENT_17	[p1l1409t2213r1586b2241],

1	From	IN	O	from	_	0	SENT_18	[p1l193t2367r257b2389],
2	the	DT	O	the	det	4	SENT_18	[p1l265t2367r301b2389],
3	*	CD	NUMBER	*	num	4	SENT_18	[p1l310t2367r419b2389],
4	Division	NN	O	division	prep_from	10	SENT_18	[p1l310t2367r419b2389],
5	of	IN	O	of	_	0	SENT_18	[p1l427t2367r454b2389],
6	Cardiology	NNP	O	Cardiology	prep_of	4	SENT_18	[p1l459t2367r594b2397],
7	,	,	O	,	_	0	SENT_18	[p1l459t2367r594b2397],
8	Misericordia	NNP	PERSON	Misericordia	nsubj	10	SENT_18	[p1l602t2367r751b2389],
9	e	LS	O	e	dep	10	SENT_18	[p1l759t2376r770b2389],
10	Dolce	NNP	ORGANIZATION	Dolce	_	0	SENT_18	[p1l779t2367r848b2389],
11	Hospital	NNP	ORGANIZATION	Hospital	npadvmod	10	SENT_18	[p1l856t2367r964b2397],
12	,	,	O	,	_	0	SENT_18	[p1l856t2367r964b2397],
13	Prato	NNP	PERSON	Prato	appos	11	SENT_18	[p1l973t2367r1042b2394],
14	,	,	O	,	_	0	SENT_18	[p1l973t2367r1042b2394],
15	Italy	NNP	LOCATION	Italy	appos	13	SENT_18	[p1l1051t2367r1110b2397],
16	;	:	O	;	_	0	SENT_18	[p1l1051t2367r1110b2397],
17	'	''	O	'	_	0	SENT_18	[p1l1119t2367r1233b2393],
18	I	PRP	O	I	npadvmod	11	SENT_18	[p1l1119t2367r1233b2393],
19	'	''	O	'	_	0	SENT_18	[p1l1119t2367r1233b2393],
20	Division	NN	O	division	npadvmod	18	SENT_18	[p1l1119t2367r1233b2393],
21	of	IN	O	of	_	0	SENT_18	[p1l1241t2367r1267b2389],
22	Cardiology	NNP	O	Cardiology	nn	24	SENT_18	[p1l1272t2367r1408b2397],
23	,	,	O	,	_	0	SENT_18	[p1l1272t2367r1408b2397],
24	Department	NNP	ORGANIZATION	Department	prep_of	18	SENT_18	[p1l1417t2367r1560b2397],
25	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l1568t2367r1594b2389],
26	Medicine	NNP	ORGANIZATION	Medicine	nn	28	SENT_18	[p1l1598t2367r1716b2394],
27	,	,	O	,	_	0	SENT_18	[p1l1598t2367r1716b2394],
28	University	NNP	ORGANIZATION	University	prep_of	11	SENT_18	[p1l192t2404r313b2433],
29	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l324t2404r351b2426],
30	Florida	NNP	ORGANIZATION	Florida	nn	31	SENT_18	[p1l359t2404r443b2426],
31	College	NNP	ORGANIZATION	College	prep_of	10	SENT_18	[p1l455t2404r544b2433],
32	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l556t2404r583b2426],
33	Medicine	NNP	ORGANIZATION	Medicine	prep_of	10	SENT_18	[p1l590t2404r708b2430],
34	,	,	O	,	_	0	SENT_18	[p1l590t2404r708b2430],
35	Jacksonville	NNP	LOCATION	Jacksonville	conj_and	10	SENT_18	[p1l718t2404r863b2432],
36	,	,	O	,	_	0	SENT_18	[p1l718t2404r863b2432],
37	Florida	NNP	LOCATION	Florida	appos	35	SENT_18	[p1l877t2404r967b2430],
38	;	:	O	;	_	0	SENT_18	[p1l877t2404r967b2430],
39	and	CC	O	and	_	0	SENT_18	[p1l980t2404r1022b2426],
40	the	DT	O	the	det	41	SENT_18	[p1l1034t2404r1070b2426],
41	#Department	NN	O	#department	conj_and	10	SENT_18	[p1l1083t2404r1241b2433],
42	of	IN	O	of	_	0	SENT_18	[p1l1252t2404r1279b2426],
43	Medical	NNP	O	Medical	prep_of	41	SENT_18	[p1l1286t2404r1382b2426],
44	and	CC	O	and	_	0	SENT_18	[p1l1394t2404r1436b2426],
45	Surgical	NNP	O	Surgical	nn	47	SENT_18	[p1l1450t2404r1542b2433],
46	Critical	JJ	O	critical	amod	47	SENT_18	[p1l1555t2404r1642b2426],
47	Care	NN	O	care	conj_and	43	SENT_18	[p1l1654t2404r1716b2430],
48	,	,	O	,	_	0	SENT_18	[p1l1654t2404r1716b2430],
49	University	NNP	ORGANIZATION	University	dobj	10	SENT_18	[p1l192t2440r313b2469],
50	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l321t2440r348b2462],
51	Florence	NNP	ORGANIZATION	Florence	prep_of	49	SENT_18	[p1l353t2439r683b2462],
52	.	.	O	.	_	0	SENT_18	[p1l353t2439r683b2462],

1	—	NN	O	—	_	0	SENT_19	[p1l353t2439r683b2462],
2	.	.	O	.	_	0	SENT_19	[p1l353t2439r683b2462],

1	Atherothrombotic	JJ	ORGANIZATION	atherothrombotic	amod	2	SENT_20	[p1l353t2439r683b2462],
2	Diseases	NNS	ORGANIZATION	disease	_	0	SENT_20	[p1l692t2440r791b2462],
3	Center	NNP	ORGANIZATION	Center	dep	2	SENT_20	[p1l801t2440r887b2466],
4	,	,	O	,	_	0	SENT_20	[p1l801t2440r887b2466],
5	Careggi	NNP	LOCATION	Careggi	nn	6	SENT_20	[p1l898t2440r989b2469],
6	Hospital	NNP	LOCATION	Hospital	appos	3	SENT_20	[p1l998t2440r1106b2469],
7	,	,	O	,	_	0	SENT_20	[p1l998t2440r1106b2469],
8	Florence	NNP	LOCATION	Florence	appos	3	SENT_20	[p1l1116t2440r1223b2466],
9	,	,	O	,	_	0	SENT_20	[p1l1116t2440r1223b2466],
10	Italy	NNP	LOCATION	Italy	appos	3	SENT_20	[p1l1233t2440r1291b2469],
11	.	.	O	.	_	0	SENT_20	[p1l1233t2440r1291b2469],

1	This	DT	O	this	det	2	SENT_21	[p1l1301t2439r1354b2462],
2	study	NN	O	study	nsubjpass	4	SENT_21	[p1l1365t2440r1427b2469],
3	was	VBD	O	be	auxpass	4	SENT_21	[p1l1433t2448r1476b2462],
4	supported	VBN	O	support	_	0	SENT_21	[p1l1486t2440r1601b2469],
5	by	IN	O	by	_	0	SENT_21	[p1l1610t2440r1638b2469],
6	grants	NNS	O	grant	agent	4	SENT_21	[p1l1646t2445r1716b2469],
7	from	IN	O	from	_	0	SENT_21	[p1l192t2476r249b2498],
8	the	DT	O	the	det	9	SENT_21	[p1l259t2476r295b2498],
9	Ministry	NNP	ORGANIZATION	Ministry	prep_from	6	SENT_21	[p1l304t2476r407b2505],
10	of	IN	ORGANIZATION	of	_	0	SENT_21	[p1l416t2476r443b2498],
11	Health	NNP	ORGANIZATION	Health	prep_of	9	SENT_21	[p1l449t2476r530b2498],
12	to	TO	O	to	_	0	SENT_21	[p1l540t2482r562b2498],
13	young	JJ	O	young	amod	14	SENT_21	[p1l572t2484r644b2505],
14	investigators	NNS	O	investigator	prep_to	4	SENT_21	[p1l653t2477r798b2505],
15	GR	NN	O	gr	dep	14	SENT_21	[p1l809t2476r853b2498],
16	2009 1605547	CD	NUMBER	2009 1605547	num	15	SENT_21	[p1l931t2476r1030b2498],[p1l861t2477r919b2498],
17	and	CC	O	and	_	0	SENT_21	[p1l1041t2476r1083b2498],
18	from	IN	O	from	dep	14	SENT_21	[p1l1092t2476r1149b2498],
19	Ente	NNP	ORGANIZATION	Ente	nn	24	SENT_21	[p1l1159t2476r1215b2498],
20	Cassa	NNP	ORGANIZATION	Cassa	nn	24	SENT_21	[p1l1225t2476r1292b2498],
21	di	FW	ORGANIZATION	di	nn	24	SENT_21	[p1l1302t2476r1323b2498],
22	Risparmio	NNP	ORGANIZATION	Risparmio	nn	24	SENT_21	[p1l1334t2476r1454b2505],
23	di	FW	ORGANIZATION	di	nn	24	SENT_21	[p1l1464t2476r1486b2498],
24	Firenze	NNP	ORGANIZATION	Firenze	pobj	18	SENT_21	[p1l1496t2476r1583b2498],
25	to	TO	O	to	_	0	SENT_21	[p1l1593t2481r1615b2498],
26	Fiorgen	NNP	ORGANIZATION	Fiorgen	nn	27	SENT_21	[p1l1626t2476r1717b2505],
27	Foundation	NNP	ORGANIZATION	Foundation	prep_to	24	SENT_21	[p1l193t2511r335b2533],
28	.	.	O	.	_	0	SENT_21	[p1l193t2511r335b2533],

1	Dr.	NNP	O	Dr.	nn	2	SENT_22	[p1l344t2512r382b2533],
2	Angiolillo	NNP	PERSON	Angiolillo	nsubj	4	SENT_22	[p1l390t2511r508b2541],
3	has	VBZ	O	have	aux	4	SENT_22	[p1l516t2511r553b2533],
4	received	VBN	O	receive	_	0	SENT_22	[p1l561t2511r655b2533],
5	honoraria	NN	O	honorarium	dobj	4	SENT_22	[p1l663t2511r775b2533],
6	for	IN	O	for	mark	7	SENT_22	[p1l782t2511r815b2533],
7	lectures	VBZ	O	lecture	advcl	4	SENT_22	[p1l822t2511r909b2533],
8	from	IN	O	from	_	0	SENT_22	[p1l917t2511r974b2533],
9	Bristol	NNP	LOCATION	Bristol	prep_from	7	SENT_22	[p1l981t2511r1144b2541],
10	.	.	O	.	_	0	SENT_22	[p1l981t2511r1144b2541],

1	—	NN	O	—	_	0	SENT_23	[p1l981t2511r1144b2541],
2	.	.	O	.	_	0	SENT_23	[p1l981t2511r1144b2541],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_24	[p1l981t2511r1144b2541],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_24	[p1l1153t2511r1241b2541],
3	,	,	O	,	_	0	SENT_24	[p1l1153t2511r1241b2541],
4	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	conj_and	2	SENT_24	[p1l1250t2511r1430b2538],
5	,	,	O	,	_	0	SENT_24	[p1l1250t2511r1430b2538],
6	Eli	NNP	ORGANIZATION	Eli	nn	9	SENT_24	[p1l1439t2511r1473b2533],
7	Lilly	NNP	ORGANIZATION	Lilly	nn	9	SENT_24	[p1l1481t2511r1536b2541],
8	Sc	NNP	ORGANIZATION	Sc	nn	9	SENT_24	[p1l1543t2512r1568b2534],
9	Co.	NNP	ORGANIZATION	Co.	conj_and	2	SENT_24	[p1l1574t2511r1622b2538],
10	,	,	O	,	_	0	SENT_24	[p1l1574t2511r1622b2538],
11	Daiichi	NNP	ORGANIZATION	Daiichi	nn	12	SENT_24	[p1l1631t2511r1717b2533],
12	Sankyo	NNP	ORGANIZATION	Sankyo	conj_and	2	SENT_24	[p1l194t2547r284b2577],
13	,	,	O	,	_	0	SENT_24	[p1l194t2547r284b2577],
14	Astrazeneca	NNP	ORGANIZATION	Astrazeneca	conj_and	2	SENT_24	[p1l293t2547r449b2574],
15	,	,	O	,	_	0	SENT_24	[p1l293t2547r449b2574],
16	and	CC	O	and	_	0	SENT_24	[p1l460t2547r501b2569],
17	Abbott	NNP	PERSON	Abbott	conj_and	2	SENT_24	[p1l510t2547r594b2569],
18	Vascular	JJ	PERSON	vascular	amod	2	SENT_24	[p1l603t2547r709b2574],
19	;	:	O	;	_	0	SENT_24	[p1l603t2547r709b2574],
20	consulting	NN	O	consulting	nn	21	SENT_24	[p1l720t2547r840b2577],
21	fees	NNS	O	fee	dep	2	SENT_24	[p1l849t2547r892b2569],
22	from	IN	O	from	_	0	SENT_24	[p1l902t2547r958b2569],
23	Bristol-Myers	NNP	O	Bristol-Myers	nn	24	SENT_24	[p1l968t2547r1131b2577],
24	Squibb	NNP	O	Squibb	prep_from	21	SENT_24	[p1l1142t2547r1229b2577],
25	,	,	O	,	_	0	SENT_24	[p1l1142t2547r1229b2577],
26	Sanoﬁ	NNP	LOCATION	Sanoﬁ	appos	24	SENT_24	[p1l1241t2547r1421b2574],
27	.	.	O	.	_	0	SENT_24	[p1l1241t2547r1421b2574],

1	—	NN	O	—	_	0	SENT_25	[p1l1241t2547r1421b2574],
2	.	.	O	.	_	0	SENT_25	[p1l1241t2547r1421b2574],

1	Aventis	NNP	ORGANIZATION	Aventis	_	0	SENT_26	[p1l1241t2547r1421b2574],
2	,	,	O	,	_	0	SENT_26	[p1l1241t2547r1421b2574],
3	Eli	NNP	ORGANIZATION	Eli	nn	6	SENT_26	[p1l1432t2547r1466b2569],
4	Lilly	NNP	ORGANIZATION	Lilly	nn	6	SENT_26	[p1l1475t2547r1530b2577],
5	Sc	NNP	ORGANIZATION	Sc	nn	6	SENT_26	[p1l1539t2548r1564b2570],
6	Co.	NNP	ORGANIZATION	Co.	appos	1	SENT_26	[p1l1572t2547r1620b2574],
7	,	,	O	,	_	0	SENT_26	[p1l1572t2547r1620b2574],
8	Daiichi	NNP	ORGANIZATION	Daiichi	nn	9	SENT_26	[p1l1631t2547r1717b2569],
9	Sankyo	NNP	ORGANIZATION	Sankyo	appos	1	SENT_26	[p1l194t2584r284b2613],
10	,	,	O	,	_	0	SENT_26	[p1l194t2584r284b2613],
11	The	DT	ORGANIZATION	the	det	13	SENT_26	[p1l303t2583r351b2606],
12	Medicines	NNP	ORGANIZATION	Medicines	nn	13	SENT_26	[p1l370t2584r492b2606],
13	Company	NNP	ORGANIZATION	Company	appos	1	SENT_26	[p1l512t2584r632b2613],
14	,	,	O	,	_	0	SENT_26	[p1l512t2584r632b2613],
15	Portola	NNP	LOCATION	Portola	nn	24	SENT_26	[p1l653t2584r744b2610],
16	,	,	O	,	_	0	SENT_26	[p1l653t2584r744b2610],
17	Novartis	NNP	ORGANIZATION	Novartis	appos	24	SENT_26	[p1l764t2584r870b2610],
18	,	,	O	,	_	0	SENT_26	[p1l764t2584r870b2610],
19	Medicure	NNP	O	Medicure	appos	24	SENT_26	[p1l890t2584r1009b2610],
20	,	,	O	,	_	0	SENT_26	[p1l890t2584r1009b2610],
21	Accumetrics	NNP	O	Accumetrics	appos	24	SENT_26	[p1l1029t2583r1181b2610],
22	,	,	O	,	_	0	SENT_26	[p1l1029t2583r1181b2610],
23	Arena	NNP	ORGANIZATION	Arena	appos	24	SENT_26	[p1l1200t2583r1273b2606],
24	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	appos	1	SENT_26	[p1l1292t2584r1487b2610],
25	,	,	O	,	_	0	SENT_26	[p1l1292t2584r1487b2610],
26	Abbott	NNP	ORGANIZATION	Abbott	nn	27	SENT_26	[p1l1507t2583r1592b2606],
27	Vascular	NNP	ORGANIZATION	Vascular	appos	1	SENT_26	[p1l1610t2584r1716b2610],
28	,	,	O	,	_	0	SENT_26	[p1l1610t2584r1716b2610],
29	Astrazeneca	NNP	ORGANIZATION	Astrazeneca	appos	1	SENT_26	[p1l192t2619r347b2646],
30	,	,	O	,	_	0	SENT_26	[p1l192t2619r347b2646],
31	Merck	NNP	ORGANIZATION	Merck	nn	33	SENT_26	[p1l358t2619r437b2641],
32	8c	NNP	ORGANIZATION	8c	nn	33	SENT_26	[p1l446t2620r472b2642],
33	Co.	NNP	ORGANIZATION	Co.	appos	1	SENT_26	[p1l480t2619r529b2646],
34	,	,	O	,	_	0	SENT_26	[p1l480t2619r529b2646],
35	and	CC	O	and	_	0	SENT_26	[p1l541t2619r583b2641],
36	Evolva	NN	LOCATION	evolva	dep	41	SENT_26	[p1l594t2619r679b2646],
37	;	:	O	;	_	0	SENT_26	[p1l594t2619r679b2646],
38	and	CC	O	and	_	0	SENT_26	[p1l691t2619r733b2641],
39	research	NN	O	research	nn	40	SENT_26	[p1l743t2619r838b2641],
40	grants	NNS	O	grant	dep	41	SENT_26	[p1l848t2625r919b2649],
41	from	IN	O	from	conj_and	1	SENT_26	[p1l930t2619r986b2641],
42	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	nn	47	SENT_26	[p1l997t2619r1209b2646],
43	,	,	O	,	_	0	SENT_26	[p1l997t2619r1209b2646],
44	Otsuka	NNP	PERSON	Otsuka	appos	47	SENT_26	[p1l1222t2619r1312b2646],
45	,	,	O	,	_	0	SENT_26	[p1l1222t2619r1312b2646],
46	Eli	NNP	ORGANIZATION	Eli	appos	47	SENT_26	[p1l1324t2619r1358b2641],
47	Lilly	NNP	ORGANIZATION	Lilly	pobj	41	SENT_26	[p1l1369t2619r1424b2649],
48	8	CD	NUMBER	8	num	47	SENT_26	[p1l1433t2620r1459b2642],
49	:	:	O	:	_	0	SENT_26	[p1l1433t2620r1459b2642],
50	Co.	NNP	ORGANIZATION	Co.	dep	47	SENT_26	[p1l1468t2619r1516b2646],
51	,	,	O	,	_	0	SENT_26	[p1l1468t2619r1516b2646],
52	Daiichi	NNP	ORGANIZATION	Daiichi	nn	53	SENT_26	[p1l1528t2619r1614b2641],
53	Sankyo	NNP	ORGANIZATION	Sankyo	appos	50	SENT_26	[p1l1626t2619r1716b2649],
54	,	,	O	,	_	0	SENT_26	[p1l1626t2619r1716b2649],

1	170	CD	NUMBER	170	num	2	SENT_27	[p1l11t2802r111b2844],
2	Leoncini	NNP	O	Leoncini	_	0	SENT_27	[p1l317t2803r522b2844],
3	et	FW	O	et	nn	4	SENT_27	[p1l545t2804r594b2844],
4	al.	FW	O	al.	dep	2	SENT_27	[p1l611t2803r666b2844],
5	.	.	O	.	_	0	SENT_27	[p1l611t2803r666b2844],

1	High-Dose	JJ	O	high-dose	amod	2	SENT_28	[p1l317t2881r569b2932],
2	Atorvastatin	NN	O	atorvastatin	_	0	SENT_28	[p1l588t2881r893b2922],
3	and	CC	O	and	_	0	SENT_28	[p1l915t2881r1006b2922],
4	Platelet	NN	O	platelet	nn	5	SENT_28	[p1l1031t2881r1222b2922],
5	Reactivity	NN	O	reactivity	conj_and	2	SENT_28	[p1l1245t2881r1489b2932],

1	The	DT	O	the	dep	100	SENT_29	[p1l7t3085r140b3149],
2	long	JJ	O	long	dep	100	SENT_29	[p1l173t3086r488b3171],
3	—	NN	O	—	dep	100	SENT_29	[p1l173t3086r488b3171],
4	term	NN	O	term	dep	100	SENT_29	[p1l173t3086r488b3171],
5	prognostic	JJ	O	prognostic	dep	100	SENT_29	[p1l520t3089r846b3171],
6	beneﬁts	NNS	O	beneﬁts	dep	100	SENT_29	[p1l876t3086r1117b3149],
7	of	IN	O	of	dep	100	SENT_29	[p1l1152t3086r1225b3149],
8	3	CD	NUMBER	3	dep	100	SENT_29	[p1l1247t3086r1882b3171],
9	—	NN	O	—	dep	100	SENT_29	[p1l1247t3086r1882b3171],
10	hydroxy	NN	O	hydroxy	dep	100	SENT_29	[p1l1247t3086r1882b3171],
11	—	CD	NUMBER	—	dep	100	SENT_29	[p1l1247t3086r1882b3171],
12	3	CD	NUMBER	3	dep	100	SENT_29	[p1l1247t3086r1882b3171],
13	—	NN	O	—	dep	100	SENT_29	[p1l1247t3086r1882b3171],
14	rnethyl	NN	O	rnethyl	dep	100	SENT_29	[p1l1247t3086r1882b3171],
15	glutaryl	NN	O	glutaryl	dep	100	SENT_29	[p1l1913t3086r2037b3171, p1l10t3186r145b3271],
16	coenzyme	NN	O	coenzyme	dep	100	SENT_29	[p1l179t3211r486b3271],
17	A	NN	O	a	dep	100	SENT_29	[p1l518t3185r582b3248],
18	reductase	NN	O	reductase	dep	100	SENT_29	[p1l614t3186r899b3249],
19	inhibitors	NNS	O	inhibitor	dep	100	SENT_29	[p1l934t3186r1228b3249],
20	in	IN	O	in	dep	100	SENT_29	[p1l1263t3189r1324b3248],
21	high-risk	JJ	O	high-risk	dep	100	SENT_29	[p1l1358t3186r1645b3271],
22	patients	NNS	O	patient	dep	100	SENT_29	[p1l1673t3189r1914b3271],
23	are	VBP	O	be	dep	100	SENT_29	[p1l1951t3211r2039b3249],
24	well	RB	O	well	dep	100	SENT_29	[p1l7t3286r135b3349],
25	established	VBN	O	establish	dep	100	SENT_29	[p1l181t3286r531b3363],
26	,	,	O	,	_	0	SENT_29	[p1l181t3286r531b3363],
27	and	CC	O	and	dep	100	SENT_29	[p1l581t3286r696b3349],
28	their	PRP$	O	they	dep	100	SENT_29	[p1l741t3286r886b3349],
29	use	NN	O	use	dep	100	SENT_29	[p1l930t3311r1029b3349],
30	is	VBZ	O	be	dep	100	SENT_29	[p1l1075t3289r1120b3349],
31	strongly	RB	O	strongly	dep	100	SENT_29	[p1l1169t3286r1418b3371],
32	recommended	VBN	O	recommend	dep	100	SENT_29	[p1l1460t3286r1908b3349],
33	for	IN	O	for	dep	100	SENT_29	[p1l1953t3286r2042b3349],
34	secondary	JJ	O	secondary	dep	100	SENT_29	[p1l11t3386r318b3471],
35	prevention	NN	O	prevention	dep	100	SENT_29	[p1l356t3389r687b3471],
36	in	IN	O	in	dep	100	SENT_29	[p1l730t3389r791b3448],
37	patients	NNS	O	patient	dep	100	SENT_29	[p1l832t3389r1073b3471],
38	with	IN	O	with	dep	100	SENT_29	[p1l1114t3386r1258b3449],
39	coronary	JJ	O	coronary	dep	100	SENT_29	[p1l1301t3410r1572b3471],
40	artery	NN	O	artery	dep	100	SENT_29	[p1l1613t3403r1789b3471],
41	disease	NN	O	disease	dep	100	SENT_29	[p1l1829t3386r2039b3449],
42	(	CD	NUMBER	(	dep	100	SENT_29	[p1l13t3484r241b3562],
43	CAD	NN	O	cad	dep	100	SENT_29	[p1l13t3484r241b3562],
44	)	CD	NUMBER	)	dep	100	SENT_29	[p1l13t3484r241b3562],
45	"	``	O	"	dep	100	SENT_29	[p1l268t3484r367b3562],
46	W	NN	O	w	dep	100	SENT_29	[p1l268t3484r367b3562],
47	H	NN	O	h	dep	100	SENT_29	[p1l268t3484r367b3562],
48	+	CC	O	+	dep	100	SENT_29	[p1l268t3484r367b3562],
49	The	DT	O	the	dep	100	SENT_29	[p1l390t3485r523b3549],
50	clinical	JJ	O	clinical	dep	100	SENT_29	[p1l546t3486r758b3549],
51	beneﬁt	NN	O	beneﬁt	dep	100	SENT_29	[p1l776t3486r993b3549],
52	of	IN	O	of	dep	100	SENT_29	[p1l1013t3486r1086b3549],
53	statins	NNS	O	statin	dep	100	SENT_29	[p1l1097t3489r1288b3549],
54	is	VBZ	O	be	dep	100	SENT_29	[p1l1311t3489r1355b3549],
55	attributed	VBN	O	attribute	dep	100	SENT_29	[p1l1379t3486r1680b3549],
56	to	TO	O	to	dep	100	SENT_29	[p1l1700t3502r1761b3549],
57	multiple	JJ	O	multiple	dep	100	SENT_29	[p1l1784t3486r2039b3571],
58	mechanisms	NNS	O	mechanism	dep	100	SENT_29	[p1l11t3586r392b3649],
59	that	WDT	O	that	dep	100	SENT_29	[p1l442t3586r566b3649],
60	go	VBP	O	go	dep	100	SENT_29	[p1l612t3611r688b3671],
61	beyond	IN	O	beyond	dep	100	SENT_29	[p1l736t3586r966b3671],
62	their	PRP$	O	they	dep	100	SENT_29	[p1l1013t3586r1158b3649],
63	lipid	NN	O	lipid	dep	100	SENT_29	[p1l1204t3586r1644b3671],
64	—	NN	O	—	dep	100	SENT_29	[p1l1204t3586r1644b3671],
65	lowering	VBG	O	lower	dep	100	SENT_29	[p1l1204t3586r1644b3671],
66	effects	NNS	O	effect	dep	100	SENT_29	[p1l1692t3586r1875b3649],
67	and	CC	O	and	dep	100	SENT_29	[p1l1926t3586r2041b3649],
68	include	VBP	O	include	dep	100	SENT_29	[p1l10t3686r233b3749],
69	antithrombotic	JJ	O	antithrombotic	dep	100	SENT_29	[p1l282t3686r746b3749],
70	properties	NNS	O	property	dep	100	SENT_29	[p1l792t3689r1097b3771],
71	`	``	O	`	_	0	SENT_29	[p1l1149t3684r1248b3762],
72	H	NN	O	h	dep	100	SENT_29	[p1l1149t3684r1248b3762],
73	+	CC	O	+	dep	100	SENT_29	[p1l1149t3684r1248b3762],
74	In	IN	O	in	dep	100	SENT_29	[p1l1299t3687r1370b3748],
75	fact	NN	O	fact	dep	100	SENT_29	[p1l1417t3686r1543b3763],
76	,	,	O	,	_	0	SENT_29	[p1l1417t3686r1543b3763],
77	statins	NNS	O	statin	dep	100	SENT_29	[p1l1595t3689r1786b3749],
78	inhibit	VBP	O	inhibit	dep	100	SENT_29	[p1l1835t3686r2041b3749],
79	adenosine	NN	O	adenosine	dep	100	SENT_29	[p2l11t15r316b78],
80	diphosphate	NN	O	diphosphate	dep	100	SENT_29	[p2l360t15r738b100],
81	(	CD	NUMBER	(	dep	100	SENT_29	[p2l784t13r1000b91],
82	ADP	NN	O	adp	dep	100	SENT_29	[p2l784t13r1000b91],
83	)	NN	O	)	dep	100	SENT_29	[p2l784t13r1000b91],
84	and	CC	O	and	dep	100	SENT_29	[p2l1047t15r1162b78],
85	thrombin	NN	O	thrombin	dep	100	SENT_29	[p2l1203t15r1776b78],
86	—	NN	O	—	dep	100	SENT_29	[p2l1203t15r1776b78],
87	induced	VBD	O	induce	dep	100	SENT_29	[p2l1203t15r1776b78],
88	platelet	NN	O	platelet	dep	100	SENT_29	[p2l1816t15r2042b100],
89	aggregation	NN	O	aggregation	dep	100	SENT_29	[p2l11t118r370b200],
90	in	IN	O	in	dep	100	SENT_29	[p2l388t118r449b177],
91	both	CC	O	both	dep	100	SENT_29	[p2l464t115r610b178],
92	healthy	JJ	O	healthy	dep	100	SENT_29	[p2l628t115r857b200],
93	subjects	NNS	O	subject	dep	100	SENT_29	[p2l872t115r1107b200],
94	and	CC	O	and	dep	100	SENT_29	[p2l1127t115r1242b178],
95	patients	NNS	O	patient	dep	100	SENT_29	[p2l1257t118r1498b200],
96	with	IN	O	with	dep	100	SENT_29	[p2l1513t116r1657b178],
97	CAD	NN	O	cad	dep	100	SENT_29	[p2l1676t114r1857b178],
98	(	CD	NUMBER	(	dep	100	SENT_29	[p2l1879t113r2036b192],
99	3,4	CD	NUMBER	3,4	dep	100	SENT_29	[p2l1879t113r2036b192],
100	)	NN	O	)	_	0	SENT_29	[p2l1879t113r2036b192],
101	.	.	O	.	_	0	SENT_29	[p2l1879t113r2036b192],

1	Although	IN	O	although	mark	30	SENT_30	[p2l8t214r312b300],
2	a	DT	O	a	det	7	SENT_30	[p2l345t240r378b278],
3	pharmacodynamic	JJ	O	pharmacodynamic	amod	7	SENT_30	[p2l408t215r983b300],
4	(	NN	O	(	nn	7	SENT_30	[p2l1017t213r1173b291],
5	PD	NN	O	pd	nn	7	SENT_30	[p2l1017t213r1173b291],
6	)	CD	NUMBER	)	num	7	SENT_30	[p2l1017t213r1173b291],
7	interaction	NN	O	interaction	nsubj	30	SENT_30	[p2l1209t218r1539b278],
8	between	IN	O	between	_	0	SENT_30	[p2l1569t216r1829b278],
9	clopidogrel	NN	O	clopidogrel	nn	12	SENT_30	[p2l1862t215r2037b300, p2l11t315r205b400],
10	and	CC	O	and	_	0	SENT_30	[p2l237t315r352b378],
11	cytochrome	NN	O	cytochrome	nn	12	SENT_30	[p2l383t315r745b400],
12	CYP3A4	NN	O	cyp3a4	prep_between	7	SENT_30	[p2l779t314r1076b378],
13	-	:	O	-	_	0	SENT_30	[p2l1084t315r1502b378],
14	metabolized	VBN	O	metabolize	partmod	12	SENT_30	[p2l1084t315r1502b378],
15	statins	NNS	O	statin	nsubjpass	18	SENT_30	[p2l1535t318r1726b378],
16	has	VBZ	O	have	aux	18	SENT_30	[p2l1760t315r1860b378],
17	been	VBN	O	be	auxpass	18	SENT_30	[p2l1892t315r2040b378],
18	described	VBN	O	describe	ccomp	14	SENT_30	[p2l11t415r300b478],
19	in	IN	O	in	_	0	SENT_30	[p2l326t418r387b477],
20	the	DT	O	the	det	22	SENT_30	[p2l414t415r513b478],
21	acute	JJ	O	acute	amod	22	SENT_30	[p2l542t432r700b478],
22	phase	NN	O	phase	prep_in	18	SENT_30	[p2l727t415r902b500],
23	of	IN	O	of	_	0	SENT_30	[p2l931t415r1003b478],
24	clopidogrel	NN	O	clopidogrel	nn	25	SENT_30	[p2l1020t415r1362b500],
25	treatment	NN	O	treatment	prep_of	22	SENT_30	[p2l1388t431r1691b478],
26	with	IN	O	with	_	0	SENT_30	[p2l1713t415r1857b478],
27	standard	JJ	O	standard	amod	29	SENT_30	[p2l1885t432r2037b478, p2l11t515r151b578],
28	loading-dose	JJ	O	loading-dose	amod	29	SENT_30	[p2l182t515r582b600],
29	regimens	NNS	O	regimen	prep_with	18	SENT_30	[p2l617t518r897b600],
30	(	VBP	O	(	advcl	36	SENT_30	[p2l935t513r1093b592],
31	5,6	CD	NUMBER	5,6	number	32	SENT_30	[p2l935t513r1093b592],
32	)	CD	NUMBER	)	dobj	30	SENT_30	[p2l935t513r1093b592],
33	,	,	O	,	_	0	SENT_30	[p2l935t513r1093b592],
34	most	JJS	O	most	amod	35	SENT_30	[p2l1130t532r1285b578],
35	studies	NNS	O	study	nsubj	36	SENT_30	[p2l1318t515r1525b578],
36	show	VBP	O	show	_	0	SENT_30	[p2l1562t515r1726b578],
37	a	DT	O	a	det	38	SENT_30	[p2l1758t540r1791b578],
38	lack	NN	O	lack	dobj	36	SENT_30	[p2l1822t515r1949b578],
39	of	IN	O	of	_	0	SENT_30	[p2l1979t515r2052b578],
40	interaction	NN	O	interaction	prep_of	38	SENT_30	[p2l10t618r341b678],
41	that	WDT	O	that	nsubjpass	45	SENT_30	[p2l376t616r500b678],
42	has	VBZ	O	have	aux	45	SENT_30	[p2l535t615r635b678],
43	been	VBN	O	be	auxpass	45	SENT_30	[p2l671t615r819b678],
44	consistently	RB	O	consistently	advmod	45	SENT_30	[p2l856t615r1217b700],
45	shown	VBN	O	show	rcmod	38	SENT_30	[p2l1251t615r1454b678],
46	when	WRB	O	when	advmod	57	SENT_30	[p2l1486t615r1661b678],
47	using	VBG	O	use	csubj	57	SENT_30	[p2l1696t618r1864b700],
48	high	JJ	O	high	amod	51	SENT_30	[p2l1898t615r2040b700],
49	clopidogrel	NN	O	clopidogrel	nn	51	SENT_30	[p2l11t715r353b800],
50	dosing	NN	O	dosing	nn	51	SENT_30	[p2l385t715r591b800],
51	regimens	NNS	O	regimen	dobj	47	SENT_30	[p2l621t718r901b800],
52	as	RB	O	as	_	0	SENT_30	[p2l936t740r993b778],
53	well	RB	O	well	_	0	SENT_30	[p2l1023t715r1152b778],
54	as	IN	O	as	_	0	SENT_30	[p2l1184t740r1241b778],
55	once	RB	DATE	once	advmod	56	SENT_30	[p2l1276t740r1419b778],
56	patients	NNS	O	patient	dobj	47	SENT_30	[p2l1451t718r1691b800],
57	are	VBP	O	be	advcl	45	SENT_30	[p2l1726t739r1815b778],
58	in	IN	O	in	_	0	SENT_30	[p2l1848t718r1909b777],
59	the	DT	O	the	prep_in	57	SENT_30	[p2l1941t715r2039b778],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_31	[p2l8t887r445b938],
2	and	CC	O	and	_	0	SENT_31	[p2l10t981r121b1031],
3	Acronyms	NNS	O	acronym	conj_and	1	SENT_31	[p2l149t981r463b1043],

1	ADP	NN	O	adp	_	0	SENT_32	[p2l8t1116r113b1154],
2	=	JJ	O	=	amod	4	SENT_32	[p2l138t1128r172b1146],
3	adenosine	NN	O	adenosine	nn	4	SENT_32	[p2l197t1115r445b1154],
4	diphosphate	NN	O	diphosphate	dep	1	SENT_32	[p2l9t1195r307b1244],

1	BASE	NN	O	base	nsubj	2	SENT_33	[p2l11t1454r143b1494],
2	=	JJ	O	=	_	0	SENT_33	[p2l169t1467r203b1485],
3	iso-thrombin	NN	O	iso-thrombin	nn	4	SENT_33	[p2l230t1454r528b1494],
4	receptor	NN	O	receptor	dobj	2	SENT_33	[p2l11t1536r215b1583],
5	activating	VBG	O	activate	partmod	4	SENT_33	[p2l235t1535r481b1584],
6	peptide	NN	O	peptide	nn	8	SENT_33	[p2l501t1535r681b1583],
7	reaction	NN	O	reaction	nn	8	SENT_33	[p2l11t1615r208b1655],
8	unit	NN	O	unit	dobj	5	SENT_33	[p2l232t1615r322b1655],

1	CAD	NN	O	cad	_	0	SENT_34	[p2l10t1722r114b1761],
2	=	JJ	O	=	amod	5	SENT_34	[p2l140t1734r174b1752],
3	coronary	JJ	O	coronary	amod	5	SENT_34	[p2l200t1731r411b1770],
4	artery	NN	O	artery	nn	5	SENT_34	[p2l431t1723r573b1770],
5	disease	NN	O	disease	dep	1	SENT_34	[p2l9t1802r195b1841],

1	CI	NN	O	ci	_	0	SENT_35	[p2l10t1907r57b1946],
2	=	JJ	O	=	amod	4	SENT_35	[p2l85t1920r119b1938],
3	confidence	NN	O	confidence	nn	4	SENT_35	[p2l145t1907r411b1947],
4	interval	NN	O	interval	dep	1	SENT_35	[p2l433t1907r612b1947],

1	CK-MB	NN	O	ck-mb	_	0	SENT_36	[p2l10t2013r176b2052],
2	=	JJ	O	=	amod	4	SENT_36	[p2l202t2026r236b2043],
3	creatine	NN	O	creatine	nn	4	SENT_36	[p2l262t2013r462b2053],
4	kinase	NN	O	kinase	dep	1	SENT_36	[p2l484t2013r642b2053],
5	MB	NN	O	mb	nn	6	SENT_36	[p2l11t2094r92b2132],
6	fraction	NN	O	fraction	dep	1	SENT_36	[p2l112t2093r299b2133],

1	HTPR	NN	O	htpr	_	0	SENT_37	[p2l11t2200r143b2238],
2	=	JJ	O	=	amod	5	SENT_37	[p2l169t2212r203b2230],
3	high-on-treatment	JJ	O	high-on-treatment	amod	5	SENT_37	[p2l230t2199r662b2248],
4	platelet	NN	O	platelet	nn	5	SENT_37	[p2l11t2280r196b2328],
5	reactivity	NN	O	reactivity	dep	1	SENT_37	[p2l219t2280r447b2328],

1	IPA	NN	O	ipa	nsubj	2	SENT_38	[p2l12t2387r93b2426],
2	=	JJ	O	=	_	0	SENT_38	[p2l118t2400r153b2417],
3	percent	NN	O	percent	nn	9	SENT_38	[p2l180t2388r364b2435],
4	P2Y12	NN	O	p2y12	nn	9	SENT_38	[p2l386t2387r533b2438],
5	inhibition	NN	O	inhibition	nn	9	SENT_38	[p2l11t2467r232b2506],
6	iso-TRAP	NN	O	iso-trap	nn	9	SENT_38	[p2l11t2573r227b2612],
7	=	JJ	O	=	amod	9	SENT_38	[p2l252t2586r287b2603],
8	iso-thrombin	NN	O	iso-thrombin	nn	9	SENT_38	[p2l314t2573r611b2612],
9	receptor	NN	O	receptor	dobj	2	SENT_38	[p2l11t2655r215b2702],
10	activating	VBG	O	activate	partmod	9	SENT_38	[p2l235t2653r481b2702],
11	peptide	NN	O	peptide	nn	12	SENT_38	[p2l501t2653r681b2702],
12	OR	NN	O	or	dobj	10	SENT_38	[p2l10t2760r79b2799],
13	=	JJ	O	=	amod	15	SENT_38	[p2l105t2772r139b2790],
14	odds	NNS	O	odds	nn	15	SENT_38	[p2l164t2760r279b2799],
15	ratio	NN	O	ratio	dep	12	SENT_38	[p2l301t2759r411b2799],

1	PCI	NN	O	pcus	nn	6	SENT_39	[p2l11t2866r91b2905],
2	=	JJ	O	=	amod	6	SENT_39	[p2l119t2879r153b2896],
3	percutaneous	JJ	O	percutaneous	amod	6	SENT_39	[p2l181t2867r511b2914],
4	coronary	JJ	O	coronary	amod	6	SENT_39	[p2l9t2955r220b2994],
5	intervention	NN	O	intervention	nn	6	SENT_39	[p2l242t2946r531b2985],
6	PD	NN	O	pd	_	0	SENT_39	[p2l11t3053r77b3091],
7	=	JJ	O	=	amod	13	SENT_39	[p2l103t3065r137b3083],
8	pharmacodynamic	JJ	O	pharmacodynamic	amod	13	SENT_39	[p2l164t3052r606b3101],
9	PRU	NN	O	pru	nn	13	SENT_39	[p2l11t3159r112b3198],
10	=	JJ	O	=	amod	13	SENT_39	[p2l139t3171r173b3189],
11	PZY12	NN	O	pzy12	nn	13	SENT_39	[p2l201t3158r347b3210],
12	reaction	NN	O	reaction	nn	13	SENT_39	[p2l370t3158r567b3198],
13	units	NNS	O	unit	dep	6	SENT_39	[p2l590t3158r708b3198],
14	ULN	NN	O	uln	dep	13	SENT_39	[p2l11t3265r105b3304],
15	=	JJ	O	=	amod	17	SENT_39	[p2l132t3277r167b3295],
16	upper	JJ	O	upper	amod	17	SENT_39	[p2l193t3274r328b3313],
17	limit	NN	O	limit	dep	6	SENT_39	[p2l349t3264r454b3304],
18	of	IN	O	of	_	0	SENT_39	[p2l475t3264r522b3304],
19	normal	JJ	O	normal	amod	21	SENT_39	[p2l541t3265r703b3304],
20	maintenance	NN	O	maintenance	nn	21	SENT_39	[p2l934t819r1337b879],
21	phase	NN	O	phase	prep_of	17	SENT_39	[p2l1387t816r1566b902],
22	of	IN	O	of	_	0	SENT_39	[p2l1618t816r1692b879],
23	treatment	NN	O	treatment	prep_of	21	SENT_39	[p2l1731t832r2042b879],
24	(	CD	NUMBER	(	dep	6	SENT_39	[p2l936t916r1152b994],
25	7-11	CD	NUMBER	7-11	num	26	SENT_39	[p2l936t916r1152b994],
26	)	NN	O	)	dep	24	SENT_39	[p2l936t916r1152b994],
27	.	.	O	.	_	0	SENT_39	[p2l936t916r1152b994],

1	Moreover	RB	O	moreover	advmod	5	SENT_40	[p2l1188t919r1512b995],
2	,	,	O	,	_	0	SENT_40	[p2l1188t919r1512b995],
3	PD	NN	O	pd	nn	4	SENT_40	[p2l1548t919r1659b980],
4	studies	NNS	O	study	nsubj	5	SENT_40	[p2l1695t918r1901b981],
5	appear	VBP	O	appear	_	0	SENT_40	[p2l1937t943r2037b1003, p2l932t1044r1066b1105],
6	to	TO	O	to	aux	7	SENT_40	[p2l1083t1036r1145b1083],
7	show	VB	O	show	xcomp	5	SENT_40	[p2l1168t1020r1332b1083],
8	some	DT	O	some	det	9	SENT_40	[p2l1350t1045r1511b1083],
9	synergy	NN	O	synergy	dobj	7	SENT_40	[p2l1533t1044r1766b1105],
10	between	IN	O	between	_	0	SENT_40	[p2l1780t1020r2040b1083],
11	clopidogrel	NN	O	clopidogrel	prep_between	9	SENT_40	[p2l934t1121r1276b1207],
12	and	CC	O	and	_	0	SENT_40	[p2l1320t1121r1435b1184],
13	atorvastatin	NN	O	atorvastatin	dobj	7	SENT_40	[p2l1479t1124r1833b1184],
14	(	CD	NUMBER	(	number	15	SENT_40	[p2l1879t1119r2036b1198],
15	3,4	CD	NUMBER	3,4	num	16	SENT_40	[p2l1879t1119r2036b1198],
16	)	NN	O	)	dep	13	SENT_40	[p2l1879t1119r2036b1198],
17	.	.	O	.	_	0	SENT_40	[p2l1879t1119r2036b1198],

1	Atorvastatin	NNP	O	Atorvastatin	nn	2	SENT_41	[p2l931t1222r1315b1286],
2	effects	NNS	O	effect	nsubj	3	SENT_41	[p2l1337t1223r1521b1286],
3	seem	VBP	O	seem	_	0	SENT_41	[p2l1545t1248r1700b1286],
4	to	TO	O	to	aux	6	SENT_41	[p2l1723t1240r1784b1286],
5	be	VB	O	be	cop	6	SENT_41	[p2l1805t1223r1878b1286],
6	dose	NN	O	dose	xcomp	3	SENT_41	[p2l1902t1223r2039b1286],
7	related	JJ	O	related	amod	6	SENT_41	[p2l933t1478r1141b1541],
8	and	CC	O	and	_	0	SENT_41	[p2l1168t1478r1283b1541],
9	additive	JJ	O	additive	amod	6	SENT_41	[p2l1311t1478r1551b1541],
10	to	TO	O	to	_	0	SENT_41	[p2l1578t1494r1640b1541],
11	that	DT	O	that	prep_to	6	SENT_41	[p2l1668t1478r1792b1541],
12	exerted	VBN	O	exert	partmod	11	SENT_41	[p2l1819t1478r2040b1541],
13	by	IN	O	by	_	0	SENT_41	[p2l931t1580r1010b1665],
14	clopidogrel	NN	O	clopidogrel	agent	12	SENT_41	[p2l1032t1580r1374b1665],
15	|	CD	NUMBER	|	num	14	SENT_41	[p2l1401t1578r1500b1656],
16	v	LS	O	v	prep	14	SENT_41	[p2l1401t1578r1500b1656],
17	$	$	MONEY	$	dep	16	SENT_41	[p2l1401t1578r1500b1656],
18	+	CC	MONEY	+	cc	17	SENT_41	[p2l1401t1578r1500b1656],

1	See	VB	O	see	_	0	SENT_42	[p2l1258t1792r1377b1844],
2	page	NN	O	page	dobj	1	SENT_42	[p2l1407t1800r1558b1856],
3	180	CD	NUMBER	180	num	2	SENT_42	[p2l1587t1792r1712b1844],

1	High	JJ	O	high	nsubjpass	12	SENT_43	[p2l1019t1997r1186b2081],
2	on	IN	O	on	_	0	SENT_43	[p2l1209t2013r1622b2059],
3	—	NN	O	—	nn	5	SENT_43	[p2l1209t2013r1622b2059],
4	treatment	NN	O	treatment	nn	5	SENT_43	[p2l1209t2013r1622b2059],
5	platelet	NN	O	platelet	prep_on	1	SENT_43	[p2l1641t1997r1867b2082],
6	reactivity	NN	O	reactivity	nn	9	SENT_43	[p2l1886t2021r2037b2059, p2l933t2101r1090b2183],
7	(	CD	NUMBER	(	num	9	SENT_43	[p2l1121t2096r1393b2175],
8	HTPR	NN	O	htpr	nn	9	SENT_43	[p2l1121t2096r1393b2175],
9	)	NN	O	)	dep	5	SENT_43	[p2l1121t2096r1393b2175],
10	has	VBZ	O	have	aux	12	SENT_43	[p2l1428t2098r1529b2161],
11	been	VBN	O	be	auxpass	12	SENT_43	[p2l1560t2098r1709b2161],
12	shown	VBN	O	show	_	0	SENT_43	[p2l1742t2098r1946b2161],
13	to	TO	O	to	aux	18	SENT_43	[p2l1977t2114r2038b2161],
14	be	VB	O	be	cop	18	SENT_43	[p2l931t2200r1005b2263],
15	an	DT	O	a	det	18	SENT_43	[p2l1047t2225r1120b2263],
16	independent	JJ	O	independent	amod	18	SENT_43	[p2l1160t2200r1549b2285],
17	risk	NN	O	risk	nn	18	SENT_43	[p2l1587t2200r1702b2263],
18	factor	NN	O	factor	xcomp	12	SENT_43	[p2l1737t2200r1914b2263],
19	for	IN	O	for	_	0	SENT_43	[p2l1952t2200r2041b2263],
20	recurrent	JJ	O	recurrent	amod	22	SENT_43	[p2l933t2318r1213b2364],
21	ischernic	JJ	O	ischernic	amod	22	SENT_43	[p2l1247t2302r1516b2365],
22	events	NNS	O	event	prep_for	18	SENT_43	[p2l1553t2318r1758b2378],
23	,	,	O	,	_	0	SENT_43	[p2l1553t2318r1758b2378],
24	particularly	RB	O	particularly	advmod	12	SENT_43	[p2l1796t2305r2037b2388, p2l932t2404r1065b2489],
25	in	IN	O	in	_	0	SENT_43	[p2l1090t2407r1155b2466],
26	patients	NNS	O	patient	prep_in	12	SENT_43	[p2l1185t2407r1450b2489],
27	undergoing	VBG	O	undergo	partmod	26	SENT_43	[p2l1482t2404r1870b2489],
28	percutaneous	JJ	O	percutaneous	amod	30	SENT_43	[p2l1900t2429r2037b2489, p2l934t2522r1266b2569],
29	coronary	JJ	O	coronary	amod	30	SENT_43	[p2l1303t2530r1598b2590],
30	intervention	NN	O	intervention	dobj	27	SENT_43	[p2l1629t2509r2040b2569],
31	(	CD	NUMBER	(	num	32	SENT_43	[p2l936t2605r1128b2684],
32	PCI	NN	O	pcus	dep	30	SENT_43	[p2l936t2605r1128b2684],
33	)	CD	NUMBER	)	number	34	SENT_43	[p2l936t2605r1128b2684],
34	(	CD	NUMBER	(	dep	32	SENT_43	[p2l1181t2605r1320b2684],
35	12	CD	NUMBER	12	num	36	SENT_43	[p2l1181t2605r1320b2684],
36	)	NN	O	)	dep	34	SENT_43	[p2l1181t2605r1320b2684],
37	.	.	O	.	_	0	SENT_43	[p2l1181t2605r1320b2684],

1	Double	JJ	O	double	amod	3	SENT_44	[p2l1367t2607r1601b2670],
2	maintenance	NN	O	maintenance	nn	3	SENT_44	[p2l1646t2610r2039b2670],
3	doses	NNS	O	dose	nsubj	10	SENT_44	[p2l934t2709r1098b2772],
4	of	IN	O	of	_	0	SENT_44	[p2l1127t2709r1200b2772],
5	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_44	[p2l1217t2709r1559b2794],
6	may	MD	O	may	aux	10	SENT_44	[p2l1586t2734r1720b2794],
7	be	VB	O	be	cop	10	SENT_44	[p2l1742t2709r1815b2772],
8	a	DT	O	a	det	10	SENT_44	[p2l1845t2734r1878b2772],
9	possible	JJ	O	possible	amod	10	SENT_44	[p2l1903t2734r2037b2794, p2l935t2811r1069b2874],
10	strategy	NN	O	strategy	_	0	SENT_44	[p2l1107t2827r1346b2896],
11	to	TO	O	to	aux	12	SENT_44	[p2l1378t2827r1439b2874],
12	overcome	VB	O	overcome	infmod	10	SENT_44	[p2l1478t2835r1774b2874],
13	HTPR	NN	O	htpr	nn	14	SENT_44	[p2l1812t2809r2043b2873],
14	(	NN	O	(	dobj	12	SENT_44	[p2l936t2911r1191b2989],
15	13-15	CD	NUMBER	13-15	num	16	SENT_44	[p2l936t2911r1191b2989],
16	)	NN	O	)	dep	14	SENT_44	[p2l936t2911r1191b2989],
17	.	.	O	.	_	0	SENT_44	[p2l936t2911r1191b2989],

1	However	RB	O	however	advmod	22	SENT_45	[p2l1238t2914r1539b2989],
2	,	,	O	,	_	0	SENT_45	[p2l1238t2914r1539b2989],
3	the	DT	O	the	det	4	SENT_45	[p2l1584t2913r1682b2975],
4	impact	NN	O	impact	nsubjpass	22	SENT_45	[p2l1724t2916r1938b2997],
5	of	IN	O	of	_	0	SENT_45	[p2l1979t2913r2051b2975],
6	this	DT	O	this	det	7	SENT_45	[p2l933t3014r1044b3077],
7	treatment	NN	O	treatment	prep_of	4	SENT_45	[p2l1074t3030r1392b3091],
8	,	,	O	,	_	0	SENT_45	[p2l1074t3030r1392b3091],
9	when	WRB	O	when	advmod	10	SENT_45	[p2l1420t3014r1595b3077],
10	used	VBN	O	use	dep	4	SENT_45	[p2l1623t3014r1765b3077],
11	in	IN	O	in	_	0	SENT_45	[p2l1793t3017r1854b3077],
12	association	NN	O	association	prep_in	10	SENT_45	[p2l1885t3039r2037b3077, p2l934t3119r1140b3179],
13	with	IN	O	with	_	0	SENT_45	[p2l1162t3116r1305b3179],
14	high	JJ	O	high	amod	17	SENT_45	[p2l1330t3116r1641b3201],
15	—	NN	O	—	nn	17	SENT_45	[p2l1330t3116r1641b3201],
16	dose	NN	O	dose	nn	17	SENT_45	[p2l1330t3116r1641b3201],
17	atorvastatin	NN	O	atorvastatin	prep_with	10	SENT_45	[p2l1668t3119r2037b3193],
18	,	,	O	,	_	0	SENT_45	[p2l1668t3119r2037b3193],
19	has	VBZ	O	have	aux	22	SENT_45	[p2l933t3218r1034b3281],
20	not	RB	O	not	neg	22	SENT_45	[p2l1063t3234r1168b3281],
21	been	VBN	O	be	auxpass	22	SENT_45	[p2l1192t3218r1340b3281],
22	explored	VBN	O	explore	_	0	SENT_45	[p2l1368t3218r1645b3303],
23	.	.	O	.	_	0	SENT_45	[p2l1368t3218r1645b3303],

1	The	DT	O	the	det	2	SENT_46	[p2l1673t3216r1806b3281],
2	aim	NN	O	aim	nsubj	9	SENT_46	[p2l1836t3221r1951b3281],
3	of	IN	O	of	_	0	SENT_46	[p2l1979t3218r2052b3281],
4	this	DT	O	this	det	8	SENT_46	[p2l933t3318r1044b3380],
5	prospective	JJ	O	prospective	amod	8	SENT_46	[p2l1076t3321r1438b3403],
6	,	,	O	,	_	0	SENT_46	[p2l1076t3321r1438b3403],
7	randomized	JJ	O	randomized	amod	8	SENT_46	[p2l1473t3318r1844b3380],
8	study	NN	O	study	prep_of	2	SENT_46	[p2l1877t3318r2044b3402],
9	was	VBD	O	be	_	0	SENT_46	[p2l7t3443r123b3481],
10	to	TO	O	to	aux	11	SENT_46	[p2l150t3434r211b3480],
11	evaluate	VB	O	evaluate	xcomp	9	SENT_46	[p2l239t3418r483b3481],
12	the	DT	O	the	det	13	SENT_46	[p2l510t3418r608b3480],
13	effects	NNS	O	effect	dobj	11	SENT_46	[p2l635t3418r818b3481],
14	of	IN	O	of	prep	13	SENT_46	[p2l847t3418r919b3480],
15	high	JJ	O	high	amod	18	SENT_46	[p2l933t3418r1244b3502],
16	—	NN	O	—	nn	18	SENT_46	[p2l933t3418r1244b3502],
17	dose	NN	O	dose	nn	18	SENT_46	[p2l933t3418r1244b3502],
18	(	NN	O	(	dep	14	SENT_46	[p2l1274t3416r1372b3494],
19	80	CD	NUMBER	80	num	20	SENT_46	[p2l1274t3416r1372b3494],
20	mg	NN	O	mg	dep	18	SENT_46	[p2l1400t3418r1530b3502],
21	/	:	O	/	punct	18	SENT_46	[p2l1400t3418r1530b3502],
22	day	NN	DURATION	day	nn	24	SENT_46	[p2l1529t3416r1656b3502],
23	)	CD	NUMBER	)	num	24	SENT_46	[p2l1529t3416r1656b3502],
24	atorvastatin	NN	O	atorvastatin	dep	18	SENT_46	[p2l1687t3421r2040b3481],
25	on	IN	O	on	_	0	SENT_46	[p2l11t3543r91b3580],
26	PD	NN	O	pd	nn	27	SENT_46	[p2l136t3519r248b3580],
27	profiles	NNS	O	profile	prep_on	24	SENT_46	[p2l294t3518r519b3603],
28	of	IN	O	of	_	0	SENT_46	[p2l567t3518r639b3580],
29	double	JJ	O	double	amod	35	SENT_46	[p2l674t3518r1052b3581],
30	—	JJ	O	—	amod	35	SENT_46	[p2l674t3518r1052b3581],
31	dose	NN	O	dose	nn	35	SENT_46	[p2l674t3518r1052b3581],
32	clopidogrel	NN	O	clopidogrel	nn	35	SENT_46	[p2l1099t3518r1442b3603],
33	(	NN	O	(	nn	35	SENT_46	[p2l1488t3516r1626b3594],
34	150	CD	NUMBER	150	num	35	SENT_46	[p2l1488t3516r1626b3594],
35	mg	NN	O	mg	prep_of	24	SENT_46	[p2l1673t3518r1803b3602],
36	/	:	O	/	punct	18	SENT_46	[p2l1673t3518r1803b3602],
37	day	NN	DURATION	day	dep	18	SENT_46	[p2l1802t3516r1930b3602],
38	)	CD	NUMBER	)	dep	37	SENT_46	[p2l1802t3516r1930b3602],
39	in	IN	O	in	_	0	SENT_46	[p2l1979t3521r2040b3580],
40	statin	NN	O	statin	nn	43	SENT_46	[p2l11t3621r368b3681],
41	—	NN	O	—	nn	43	SENT_46	[p2l11t3621r368b3681],
42	naive	JJ	O	naive	amod	43	SENT_46	[p2l11t3621r368b3681],
43	patients	NNS	O	patient	prep_in	38	SENT_46	[p2l400t3621r641b3702],
44	with	IN	O	with	_	0	SENT_46	[p2l672t3618r816b3681],
45	stable	JJ	O	stable	amod	46	SENT_46	[p2l850t3618r1022b3681],
46	CAD	NN	O	cad	prep_with	11	SENT_46	[p2l1058t3617r1239b3681],
47	and	CC	O	and	_	0	SENT_46	[p2l1275t3618r1390b3680],
48	HTPR	NN	O	htpr	conj_and	46	SENT_46	[p2l1423t3616r1654b3680],
49	undergoing	VBG	O	undergo	xcomp	11	SENT_46	[p2l1683t3618r2042b3702],
50	PCI	NN	O	pcus	dobj	49	SENT_46	[p2l10t3719r160b3782],
51	.	.	O	.	_	0	SENT_46	[p2l10t3719r160b3782],

1	Methods	NNS	O	method	_	0	SENT_47	[p3l13t134r360b194],

1	Population	NNP	O	Population	_	0	SENT_48	[p3l13t327r368b397],
2	and	CC	O	and	_	0	SENT_48	[p3l398t327r518b383],
3	study	NN	O	study	nn	4	SENT_48	[p3l549t327r730b399],
4	protocol	NN	O	protocol	conj_and	1	SENT_48	[p3l758t327r1051b397],
5	.	.	O	.	_	0	SENT_48	[p3l758t327r1051b397],

1	The	DT	O	the	det	2	SENT_49	[p3l1095t319r1235b383],
2	ACHIDO	NNP	O	ACHIDO	_	0	SENT_49	[p3l1260t319r1625b383],
3	(	CD	NUMBER	(	num	6	SENT_49	[p3l1657t319r2037b397],
4	Atorvasta	NNP	O	Atorvasta	nn	6	SENT_49	[p3l1657t319r2037b397],
5	—	CD	NUMBER	—	num	6	SENT_49	[p3l1657t319r2037b397],
6	tin	NN	O	tin	dep	2	SENT_49	[p3l10t424r102b483],
7	and	CC	O	and	_	0	SENT_49	[p3l147t421r268b483],
8	Clopidogrel	NNP	O	Clopidogrel	nn	10	SENT_49	[p3l314t421r717b505],
9	Hlgh	NNP	O	Hlgh	nn	10	SENT_49	[p3l761t421r948b505],
10	DOse	NN	O	dose	dep	2	SENT_49	[p3l992t421r1192b483],
11	in	IN	O	in	dep	2	SENT_49	[p3l1237t424r1302b482],
12	stable	JJ	O	stable	amod	13	SENT_49	[p3l1347t421r1536b483],
13	patients	NNS	O	patient	pobj	11	SENT_49	[p3l1580t424r1844b505],
14	with	IN	O	with	dep	2	SENT_49	[p3l1886t421r2040b483],

1	The	DT	O	the	det	3	SENT_50	[p3l7t686r105b732],
2	Medicines	NNP	ORGANIZATION	Medicines	nn	3	SENT_50	[p3l140t687r386b732],
3	Company	NNP	ORGANIZATION	Company	_	0	SENT_50	[p3l423t687r668b747],
4	,	,	O	,	_	0	SENT_50	[p3l423t687r668b747],
5	Portola	NNP	LOCATION	Portola	nn	9	SENT_50	[p3l705t688r890b741],
6	,	,	O	,	_	0	SENT_50	[p3l705t688r890b741],
7	Accumetrics	NNP	O	Accumetrics	appos	9	SENT_50	[p3l926t687r1234b741],
8	,	,	O	,	_	0	SENT_50	[p3l926t687r1234b741],
9	Schering	NNP	ORGANIZATION	Schering	appos	3	SENT_50	[p3l1274t687r1688b747],
10	.	.	O	.	_	0	SENT_50	[p3l1274t687r1688b747],

1	—	NN	O	—	_	0	SENT_51	[p3l1274t687r1688b747],
2	.	.	O	.	_	0	SENT_51	[p3l1274t687r1688b747],

1	Plough	NNP	O	Plough	_	0	SENT_52	[p3l1274t687r1688b747],
2	,	,	O	,	_	0	SENT_52	[p3l1274t687r1688b747],
3	Astrazeneca	NNP	ORGANIZATION	Astrazeneca	nn	7	SENT_52	[p3l1724t687r2039b741],
4	,	,	O	,	_	0	SENT_52	[p3l1724t687r2039b741],
5	Eisai	NNP	ORGANIZATION	Eisai	appos	7	SENT_52	[p3l10t761r139b814],
6	,	,	O	,	_	0	SENT_52	[p3l10t761r139b814],
7	Bristol	NNP	LOCATION	Bristol	appos	1	SENT_52	[p3l165t761r496b820],
8	.	.	O	.	_	0	SENT_52	[p3l165t761r496b820],

1	—	NN	O	—	_	0	SENT_53	[p3l165t761r496b820],
2	.	.	O	.	_	0	SENT_53	[p3l165t761r496b820],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_54	[p3l165t761r496b820],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_54	[p3l524t761r701b820],
3	,	,	O	,	_	0	SENT_54	[p3l524t761r701b820],
4	and	CC	O	and	_	0	SENT_54	[p3l728t761r813b805],
5	Sanoﬁ	NNP	PERSON	Sanoﬁ	conj_and	2	SENT_54	[p3l839t760r1204b805],
6	.	.	O	.	_	0	SENT_54	[p3l839t760r1204b805],

1	—	NN	O	—	_	0	SENT_55	[p3l839t760r1204b805],
2	.	.	O	.	_	0	SENT_55	[p3l839t760r1204b805],

1	Aventis	NNP	O	Aventis	_	0	SENT_56	[p3l839t760r1204b805],
2	.	.	O	.	_	0	SENT_56	[p3l839t760r1204b805],

1	Dr.	NNP	O	Dr.	nn	2	SENT_57	[p3l1231t761r1310b805],
2	Marcucci	NNP	PERSON	Marcucci	nsubj	4	SENT_57	[p3l1336t761r1557b805],
3	has	VBZ	O	have	aux	4	SENT_57	[p3l1581t761r1656b805],
4	received	VBN	O	receive	_	0	SENT_57	[p3l1682t761r1873b805],
5	honoraria	NN	O	honorarium	dobj	4	SENT_57	[p3l1897t761r2039b805, p3l9t836r115b878],
6	for	IN	O	for	mark	7	SENT_57	[p3l132t834r199b878],
7	lectures	VBZ	O	lecture	advcl	4	SENT_57	[p3l216t834r394b878],
8	from	IN	O	from	_	0	SENT_57	[p3l413t834r527b878],
9	Daiichi	NNP	ORGANIZATION	Daiichi	nn	10	SENT_57	[p3l545t834r721b878],
10	Sankyo	NNP	ORGANIZATION	Sankyo	prep_from	7	SENT_57	[p3l741t834r924b893],
11	,	,	O	,	_	0	SENT_57	[p3l741t834r924b893],
12	Eli	NNP	ORGANIZATION	Eli	nn	13	SENT_57	[p3l945t834r1014b877],
13	Lilly	NNP	ORGANIZATION	Lilly	appos	10	SENT_57	[p3l1033t834r1144b893],
14	8	CD	NUMBER	8	dep	13	SENT_57	[p3l1161t835r1212b878],
15	!	.	O	!	_	0	SENT_57	[p3l1161t835r1212b878],

1	,	,	O	,	_	0	SENT_58	[p3l1161t835r1212b878],
2	Co.	NNP	ORGANIZATION	Co.	_	0	SENT_58	[p3l1227t834r1325b887],
3	,	,	O	,	_	0	SENT_58	[p3l1227t834r1325b887],
4	and	CC	O	and	_	0	SENT_58	[p3l1346t834r1431b878],
5	Merck	NNP	ORGANIZATION	Merck	nn	6	SENT_58	[p3l1448t834r1607b878],
6	Sharp	NNP	ORGANIZATION	Sharp	conj_and	2	SENT_58	[p3l1625t834r1760b893],
7	&	CC	ORGANIZATION	&	_	0	SENT_58	[p3l1780t835r1831b878],
8	Dohme	NNP	ORGANIZATION	Dohme	conj_and	2	SENT_58	[p3l1845t834r2037b878],
9	.	.	O	.	_	0	SENT_58	[p3l1845t834r2037b878],

1	Dr.	NNP	O	Dr.	nn	2	SENT_59	[p3l9t907r88b951],
2	Abbate	NNP	PERSON	Abbate	nsubj	4	SENT_59	[p3l118t906r290b951],
3	has	VBZ	O	have	aux	4	SENT_59	[p3l320t907r395b951],
4	received	VBN	O	receive	_	0	SENT_59	[p3l425t907r617b951],
5	consulting	VBG	O	consult	xcomp	4	SENT_59	[p3l646t907r891b966],
6	fees	NNS	O	fee	dobj	5	SENT_59	[p3l919t907r1006b951],
7	from	IN	O	from	_	0	SENT_59	[p3l1036t907r1150b951],
8	Eli	NNP	ORGANIZATION	Eli	nn	11	SENT_59	[p3l1180t907r1249b950],
9	Lilly	NNP	ORGANIZATION	Lilly	nn	11	SENT_59	[p3l1279t907r1390b966],
10	86	CD	ORGANIZATION	86	num	11	SENT_59	[p3l1417t908r1469b951],
11	Co.	NNP	ORGANIZATION	Co.	prep_from	5	SENT_59	[p3l1494t907r1592b960],
12	;	:	O	;	_	0	SENT_59	[p3l1494t907r1592b960],
13	lecture	NN	O	lecture	nn	14	SENT_59	[p3l1622t907r1780b951],
14	fees	NNS	O	fee	prep_from	5	SENT_59	[p3l1809t907r1896b951],
15	from	IN	O	from	_	0	SENT_59	[p3l1927t907r2040b951],
16	Instrumentation	NNP	ORGANIZATION	Instrumentation	nn	17	SENT_59	[p3l9t980r396b1024],
17	Laboratory	NNP	ORGANIZATION	Laboratory	prep_from	14	SENT_59	[p3l416t980r679b1039],
18	and	CC	O	and	_	0	SENT_59	[p3l697t980r782b1024],
19	Sigma	NNP	O	Sigma	nn	20	SENT_59	[p3l804t980r950b1039],
20	Tau	NNP	O	Tau	conj_and	17	SENT_59	[p3l966t979r1076b1033],
21	;	:	O	;	_	0	SENT_59	[p3l966t979r1076b1033],
22	and	CC	O	and	_	0	SENT_59	[p3l1099t980r1184b1024],
23	research	NN	O	research	nn	25	SENT_59	[p3l1202t980r1394b1024],
24	grant	NN	O	grant	nn	25	SENT_59	[p3l1413t991r1537b1039],
25	funding	NN	O	funding	conj_and	11	SENT_59	[p3l1555t980r1741b1039],
26	from	IN	O	from	_	0	SENT_59	[p3l1759t980r1873b1024],
27	Bayer	NNP	ORGANIZATION	Bayer	prep_from	5	SENT_59	[p3l1893t980r2039b1039],
28	,	,	O	,	_	0	SENT_59	[p3l1893t980r2039b1039],

1	JACC	NN	O	jacc	_	0	SENT_60	[p3l384t1056r531b1087],
2	:	:	O	:	_	0	SENT_60	[p3l384t1056r531b1087],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_60	[p3l567t1056r1057b1087],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_60	[p3l1094t1056r1544b1092],
5	,	,	O	,	_	0	SENT_60	[p3l1094t1056r1544b1092],
6	VOL	NNP	O	VOL	appos	4	SENT_60	[p3l1579t1056r1699b1087],
7	.	.	O	.	_	0	SENT_60	[p3l1579t1056r1699b1087],

1	6	CD	NUMBER	6	_	0	SENT_61	[p3l1735t1057r1778b1092],
2	,	,	O	,	_	0	SENT_61	[p3l1735t1057r1778b1092],
3	NO.	NNP	O	NO.	appos	1	SENT_61	[p3l1816t1056r1904b1087],
4	2	CD	NUMBER	2	num	3	SENT_61	[p3l1940t1057r1982b1092],
5	,	,	O	,	_	0	SENT_61	[p3l1940t1057r1982b1092],
6	2013	CD	DATE	2013	num	3	SENT_61	[p3l2019t1057r2141b1087],
7	FEBRUARY	NNP	DATE	FEBRUARY	dep	1	SENT_61	[p3l1483t1120r1757b1150],
8	2013:169	CD	DATE	2013:169	num	7	SENT_61	[p3l1792t1120r2142b1150],
9	—	CD	NUMBER	—	number	10	SENT_61	[p3l1792t1120r2142b1150],
10	79	CD	NUMBER	79	dep	7	SENT_61	[p3l1792t1120r2142b1150],

1	residual	JJ	O	residual	amod	4	SENT_62	[p3l51t1309r319b1374],
2	high	JJ	O	high	amod	4	SENT_62	[p3l373t1309r529b1397],
3	platelet	NN	O	platelet	nn	4	SENT_62	[p3l583t1309r839b1397],
4	activity	NN	O	activity	nsubj	9	SENT_62	[p3l893t1307r1165b1397],
5	)	CD	NUMBER	)	num	6	SENT_62	[p3l893t1307r1165b1397],
6	study	NN	O	study	dep	4	SENT_62	[p3l1225t1309r1410b1397],
7	was	VBD	O	be	cop	9	SENT_62	[p3l1458t1335r1585b1374],
8	a	DT	O	a	det	9	SENT_62	[p3l1642t1335r1676b1374],
9	prospective	JJ	O	prospective	_	0	SENT_62	[p3l1729t1312r2139b1397],
10	,	,	O	,	_	0	SENT_62	[p3l1729t1312r2139b1397],
11	randomized	VBN	O	randomize	partmod	9	SENT_62	[p3l51t1414r483b1493],
12	,	,	O	,	_	0	SENT_62	[p3l51t1414r483b1493],
13	active-control	NN	O	active-control	nn	16	SENT_62	[p3l525t1414r1023b1493],
14	,	,	O	,	_	0	SENT_62	[p3l525t1414r1023b1493],
15	PD	NN	O	pd	dep	16	SENT_62	[p3l1063t1415r1181b1478],
16	trial	NN	O	trial	dobj	11	SENT_62	[p3l1220t1414r1375b1478],
17	.	.	O	.	_	0	SENT_62	[p3l1220t1414r1375b1478],

1	From	IN	O	from	_	0	SENT_63	[p3l1417t1415r1609b1478],
2	April	NNP	DATE	April	prep_from	14	SENT_63	[p3l1644t1412r1829b1501],
3	2011	CD	DATE	2011	num	2	SENT_63	[p3l1863t1417r2031b1479],
4	to	TO	O	to	_	0	SENT_63	[p3l2073t1431r2140b1478],
5	December	NNP	DATE	December	prep_to	2	SENT_63	[p3l51t1519r411b1584],
6	2011	CD	DATE	2011	num	5	SENT_63	[p3l439t1522r631b1598],
7	,	,	O	,	_	0	SENT_63	[p3l439t1522r631b1598],
8	all	DT	O	all	det	11	SENT_63	[p3l667t1519r745b1584],
9	consecutive	JJ	O	consecutive	amod	11	SENT_63	[p3l776t1522r1171b1584],
10	statin-naive	JJ	O	statin-naive	amod	11	SENT_63	[p3l1205t1522r1610b1584],
11	patients	NNS	O	patient	nsubj	14	SENT_63	[p3l1641t1522r1913b1607],
12	(	IN	O	(	dep	13	SENT_63	[p3l1949t1517r2039b1598],
13	N	NN	O	n	amod	11	SENT_63	[p3l1949t1517r2039b1598],
14	=	JJ	O	=	_	0	SENT_63	[p3l2081t1544r2133b1564],
15	209	CD	NUMBER	209	num	16	SENT_63	[p3l49t1622r203b1703],
16	)	NN	O	)	dobj	14	SENT_63	[p3l49t1622r203b1703],
17	with	IN	O	with	_	0	SENT_63	[p3l240t1624r399b1689],
18	angiographically	RB	O	angiographically	advmod	19	SENT_63	[p3l437t1624r1009b1712],
19	documented	VBN	O	document	amod	20	SENT_63	[p3l1043t1624r1473b1689],
20	CAD	NN	O	cad	prep_with	16	SENT_63	[p3l1511t1623r1705b1689],
21	undergoing	VBG	O	undergo	partmod	20	SENT_63	[p3l1743t1624r2143b1711],
22	PCI	NN	O	pcus	dobj	21	SENT_63	[p3l51t1730r196b1794],
23	with	IN	O	with	_	0	SENT_63	[p3l223t1730r382b1794],
24	stent	NN	O	stent	nn	25	SENT_63	[p3l412t1746r579b1794],
25	implantation	NN	O	implantation	prep_with	22	SENT_63	[p3l606t1730r1054b1817],
26	at	IN	O	at	_	0	SENT_63	[p3l1084t1746r1146b1794],
27	the	DT	O	the	det	28	SENT_63	[p3l1173t1730r1281b1794],
28	Division	NN	O	division	prep_at	21	SENT_63	[p3l1311t1731r1607b1794],
29	of	IN	O	of	_	0	SENT_63	[p3l1637t1730r1715b1794],
30	Cardiology	NNP	O	Cardiology	nn	32	SENT_63	[p3l1734t1730r2138b1817],
31	,	,	O	,	_	0	SENT_63	[p3l1734t1730r2138b1817],
32	Misericordia	NNP	PERSON	Misericordia	prep_of	28	SENT_63	[p3l49t1834r494b1898],
33	e	LS	O	e	dep	36	SENT_63	[p3l532t1859r564b1898],
34	Dolce	NNP	ORGANIZATION	Dolce	nn	36	SENT_63	[p3l603t1834r808b1898],
35	Hospital	NNP	ORGANIZATION	Hospital	nn	36	SENT_63	[p3l848t1834r1150b1921],
36	(	NNP	O	(	dep	32	SENT_63	[p3l1190t1832r1423b1913],
37	Prato	NNP	PERSON	Prato	nn	39	SENT_63	[p3l1190t1832r1423b1913],
38	,	,	O	,	_	0	SENT_63	[p3l1190t1832r1423b1913],
39	Italy	NNP	LOCATION	Italy	npadvmod	36	SENT_63	[p3l1463t1832r1643b1921],
40	)	CD	NUMBER	)	num	39	SENT_63	[p3l1463t1832r1643b1921],
41	were	VBD	O	be	auxpass	42	SENT_63	[p3l1682t1859r1845b1899],
42	considered	VBN	O	consider	rcmod	39	SENT_63	[p3l1885t1834r2139b1898, p3l52t1939r198b2004],
43	for	IN	O	for	_	0	SENT_63	[p3l236t1939r334b2004],
44	enrollment	NN	O	enrollment	prep_for	36	SENT_63	[p3l372t1939r753b2004],
45	in	IN	O	in	_	0	SENT_63	[p3l790t1942r857b2003],
46	the	DT	O	the	det	48	SENT_63	[p3l896t1939r1004b2004],
47	present	JJ	DATE	present	amod	48	SENT_63	[p3l1042t1956r1296b2026],
48	study	NN	O	study	prep_in	36	SENT_63	[p3l1334t1939r1534b2026],
49	.	.	O	.	_	0	SENT_63	[p3l1334t1939r1534b2026],

1	Per	IN	O	per	_	0	SENT_64	[p3l1578t1940r1696b2004],
2	our	PRP$	O	we	poss	4	SENT_64	[p3l1734t1964r1849b2004],
3	institutional	JJ	O	institutional	amod	4	SENT_64	[p3l1886t1942r2139b2004, p3l51t2044r249b2109],
4	protocol	NN	O	protocol	prep_per	15	SENT_64	[p3l296t2044r604b2132],
5	,	,	O	,	_	0	SENT_64	[p3l296t2044r604b2132],
6	all	DT	O	all	det	8	SENT_64	[p3l657t2044r735b2109],
7	stable	JJ	O	stable	amod	8	SENT_64	[p3l784t2044r978b2109],
8	patients	NNS	O	patient	appos	4	SENT_64	[p3l1026t2047r1298b2132],
9	scheduled	VBN	O	schedule	partmod	8	SENT_64	[p3l1350t2044r1691b2109],
10	to	TO	O	to	aux	11	SENT_64	[p3l1739t2061r1806b2109],
11	undergo	VB	O	undergo	xcomp	9	SENT_64	[p3l1855t2044r2140b2131],
12	elective	JJ	O	elective	amod	13	SENT_64	[p3l52t2151r281b2215],
13	angiography	NN	O	angiography	dobj	11	SENT_64	[p3l323t2151r719b2238],
14	are	VBP	O	be	auxpass	15	SENT_64	[p3l756t2176r848b2215],
15	prescribed	VBN	O	prescribe	_	0	SENT_64	[p3l887t2151r1213b2238],
16	with	IN	O	with	prep	15	SENT_64	[p3l1248t2151r1396b2215],
17	aspirin	NN	O	aspirin	nn	18	SENT_64	[p3l1438t2154r1648b2238],
18	(	NN	O	(	dep	16	SENT_64	[p3l1690t2149r1832b2229],
19	100	CD	NUMBER	100	num	20	SENT_64	[p3l1690t2149r1832b2229],
20	mg	NN	O	mg	dep	18	SENT_64	[p3l1874t2150r2008b2238],
21	/	:	O	/	punct	18	SENT_64	[p3l1874t2150r2008b2238],
22	day	NN	DURATION	day	dep	18	SENT_64	[p3l2007t2149r2138b2238],
23	)	CD	NUMBER	)	num	22	SENT_64	[p3l2007t2149r2138b2238],
24	and	CC	O	and	_	0	SENT_64	[p3l52t2256r177b2320],
25	clopidogrel	NN	O	clopidogrel	nn	26	SENT_64	[p3l209t2256r596b2343],
26	(	NN	O	(	dep	18	SENT_64	[p3l629t2254r781b2334],
27	600	CD	NUMBER	600	num	30	SENT_64	[p3l629t2254r781b2334],
28	mg	NN	O	mg	nn	30	SENT_64	[p3l815t2281r925b2343],
29	loading	NN	O	loading	nn	30	SENT_64	[p3l953t2256r1213b2343],
30	dose	NN	O	dose	nsubjpass	15	SENT_64	[p3l1244t2256r1396b2320],
31	followed	VBN	O	follow	_	0	SENT_64	[p3l1428t2256r1726b2320],
32	by	IN	O	by	_	0	SENT_64	[p3l1755t2256r1839b2343],
33	a	DT	O	a	det	35	SENT_64	[p3l1868t2281r1902b2320],
34	maintenance	NN	O	maintenance	nn	35	SENT_64	[p3l1933t2259r2139b2320, p3l51t2377r315b2424],
35	dose	NN	O	dose	prep_followed_by	15	SENT_64	[p3l353t2360r505b2424],
36	of	IN	O	of	_	0	SENT_64	[p3l544t2360r622b2424],
37	75	CD	NUMBER	75	num	39	SENT_64	[p3l649t2360r727b2425],
38	mg/day	NN	O	mg/day	nn	39	SENT_64	[p3l769t2358r1053b2447],
39	)	NN	O	)	prep_of	35	SENT_64	[p3l769t2358r1053b2447],
40	for	IN	O	for	_	0	SENT_64	[p3l1093t2360r1192b2424],
41	at	IN	DURATION	at	quantmod	43	SENT_64	[p3l1229t2377r1291b2424],
42	least	JJS	DURATION	least	mwe	41	SENT_64	[p3l1325t2360r1480b2424],
43	7	CD	DURATION	7	num	44	SENT_64	[p3l1517t2361r1556b2425],
44	days	NNS	NUMBER	day	prep_for	39	SENT_64	[p3l1593t2360r1759b2447],
45	.	.	O	.	_	0	SENT_64	[p3l1593t2360r1759b2447],

1	Exclusion	NN	MISC	exclusion	dep	101	SENT_65	[p3l1801t2360r2141b2424],
2	criteria	NNS	O	criterion	dep	101	SENT_65	[p3l52t2468r294b2530],
3	included	VBD	O	include	dep	101	SENT_65	[p3l353t2465r669b2530],
4	:	:	O	:	_	0	SENT_65	[p3l353t2465r669b2530],
5	contraindications	NNS	O	contraindication	dep	101	SENT_65	[p3l735t2465r1336b2530],
6	to	TO	O	to	dep	101	SENT_65	[p3l1398t2482r1465b2530],
7	statin	NN	O	statin	dep	101	SENT_65	[p3l1529t2468r1718b2530],
8	treatment	NN	O	treatment	dep	101	SENT_65	[p3l1779t2482r2138b2544],
9	;	:	O	;	_	0	SENT_65	[p3l1779t2482r2138b2544],
10	acute	JJ	O	acute	dep	101	SENT_65	[p3l52t2588r229b2636],
11	renal	JJ	O	renal	dep	101	SENT_65	[p3l288t2571r459b2636],
12	failure	NN	O	failure	dep	101	SENT_65	[p3l517t2571r734b2636],
13	or	CC	O	or	dep	101	SENT_65	[p3l795t2596r866b2636],
14	end-stage	JJ	O	end-stage	dep	101	SENT_65	[p3l924t2571r1259b2658],
15	renal	JJ	O	renal	dep	101	SENT_65	[p3l1318t2571r1489b2636],
16	failure	NN	O	failure	dep	101	SENT_65	[p3l1547t2571r1764b2636],
17	requiring	VBG	O	require	dep	101	SENT_65	[p3l1824t2574r2143b2659],
18	dialysis	NN	O	dialysis	dep	101	SENT_65	[p3l52t2676r318b2764],
19	;	:	O	;	_	0	SENT_65	[p3l52t2676r318b2764],
20	active	JJ	O	active	dep	101	SENT_65	[p3l364t2679r558b2741],
21	liver	NN	O	liver	dep	101	SENT_65	[p3l598t2676r748b2741],
22	disease	NN	O	disease	dep	101	SENT_65	[p3l789t2676r1026b2741],
23	or	CC	O	or	dep	101	SENT_65	[p3l1069t2701r1140b2741],
24	liver	NN	O	liver	dep	101	SENT_65	[p3l1178t2676r1328b2741],
25	cirrhosis	NN	O	cirrhosis	dep	101	SENT_65	[p3l1369t2676r1678b2756],
26	;	:	O	;	_	0	SENT_65	[p3l1369t2676r1678b2756],
27	unexplained	JJ	O	unexplained	dep	101	SENT_65	[p3l1722t2676r2142b2764],
28	transaminase	NN	O	transaminase	dep	101	SENT_65	[p3l51t2785r501b2846],
29	increase	NN	O	increase	dep	101	SENT_65	[p3l538t2785r811b2846],
30	>	RBR	O	>	dep	101	SENT_65	[p3l853t2785r959b2847],
31	2	CD	NUMBER	2	dep	101	SENT_65	[p3l853t2785r959b2847],
32	times	NNS	O	time	dep	101	SENT_65	[p3l996t2785r1181b2846],
33	the	DT	O	the	dep	101	SENT_65	[p3l1217t2782r1325b2846],
34	upper	JJ	O	upper	dep	101	SENT_65	[p3l1360t2807r1561b2869],
35	limit	NN	O	limit	dep	101	SENT_65	[p3l1593t2782r1759b2846],
36	of	IN	O	of	dep	101	SENT_65	[p3l1794t2782r1872b2846],
37	normal	JJ	O	normal	dep	101	SENT_65	[p3l1896t2782r2143b2846],
38	(	NN	O	(	dep	101	SENT_65	[p3l54t2885r316b2966],
39	ULN	NN	O	uln	dep	101	SENT_65	[p3l54t2885r316b2966],
40	)	NN	O	)	dep	101	SENT_65	[p3l54t2885r316b2966],
41	;	:	O	;	_	0	SENT_65	[p3l54t2885r316b2966],
42	peripheral	JJ	O	peripheral	dep	101	SENT_65	[p3l355t2887r708b2974],
43	muscle	NN	O	muscle	dep	101	SENT_65	[p3l745t2887r980b2951],
44	disease	NN	O	disease	dep	101	SENT_65	[p3l1019t2887r1257b2951],
45	or	CC	O	or	dep	101	SENT_65	[p3l1295t2912r1366b2951],
46	creatine	NN	O	creatine	dep	101	SENT_65	[p3l1402t2890r1672b2951],
47	kinase	NN	O	kinase	dep	101	SENT_65	[p3l1710t2887r1925b2951],
48	>	JJR	O	>	dep	101	SENT_65	[p3l1968t2887r2139b2952],
49	2.5	CD	NUMBER	2.5	dep	101	SENT_65	[p3l1968t2887r2139b2952],
50	times	NNS	O	time	dep	101	SENT_65	[p3l51t2994r235b3055],
51	ULN	NN	O	uln	dep	101	SENT_65	[p3l258t2992r468b3070],
52	;	:	O	;	_	0	SENT_65	[p3l258t2992r468b3070],
53	treatment	NN	O	treatment	dep	101	SENT_65	[p3l494t3008r834b3055],
54	with	IN	O	with	dep	101	SENT_65	[p3l851t2991r1010b3056],
55	a	DT	O	a	dep	101	SENT_65	[p3l1034t3016r1068b3055],
56	glycoprotein	NN	O	glycoprotein	dep	101	SENT_65	[p3l1088t2991r1521b3078],
57	IIb	NN	O	iib	dep	101	SENT_65	[p3l1543t2991r1681b3055],
58	/	:	O	/	dep	101	SENT_65	[p3l1543t2991r1681b3055],
59	Illa	NNP	PERSON	Illa	dep	101	SENT_65	[p3l1682t2992r1815b3055],
60	inhibitor	NN	O	inhibitor	dep	101	SENT_65	[p3l1837t2991r2143b3055],
61	within	IN	O	within	dep	101	SENT_65	[p3l47t3097r275b3162],
62	the	DT	DATE	the	dep	101	SENT_65	[p3l305t3097r413b3162],
63	past	JJ	DATE	past	dep	101	SENT_65	[p3l443t3114r584b3185],
64	week	NN	DATE	week	dep	101	SENT_65	[p3l609t3097r806b3176],
65	;	:	O	;	_	0	SENT_65	[p3l609t3097r806b3176],
66	current	JJ	DATE	current	dep	101	SENT_65	[p3l839t3114r1088b3162],
67	treatment	NN	O	treatment	dep	101	SENT_65	[p3l1116t3114r1456b3162],
68	with	IN	O	with	dep	101	SENT_65	[p3l1481t3097r1639b3162],
69	proton-pump	NN	O	proton-pump	dep	101	SENT_65	[p3l1668t3114r2140b3185],
70	inhibitors	NNS	O	inhibitor	dep	101	SENT_65	[p3l51t3202r385b3267],
71	and	CC	O	and	dep	101	SENT_65	[p3l418t3202r574b3267],
72	/	:	O	/	dep	101	SENT_65	[p3l418t3202r574b3267],
73	or	CC	O	or	dep	101	SENT_65	[p3l577t3227r648b3267],
74	omega	JJ	O	omega	dep	101	SENT_65	[p3l677t3206r1001b3289],
75	—	NN	O	—	dep	101	SENT_65	[p3l677t3206r1001b3289],
76	3	CD	NUMBER	3	dep	101	SENT_65	[p3l677t3206r1001b3289],
77	;	:	O	;	_	0	SENT_65	[p3l677t3206r1001b3289],
78	active	JJ	O	active	dep	101	SENT_65	[p3l1035t3205r1229b3267],
79	bleeding	NN	O	bleeding	dep	101	SENT_65	[p3l1257t3202r1555b3289],
80	or	CC	O	or	dep	101	SENT_65	[p3l1584t3227r1655b3267],
81	recent	JJ	O	recent	dep	101	SENT_65	[p3l1683t3219r1896b3267],
82	bleeding	NN	O	bleeding	dep	101	SENT_65	[p3l1921t3202r2139b3267, p3l51t3310r161b3395],
83	diathesis	NN	O	diathesis	dep	101	SENT_65	[p3l211t3307r509b3372],
84	(	NN	O	(	dep	101	SENT_65	[p3l564t3305r814b3386],
85	within	IN	O	within	dep	101	SENT_65	[p3l564t3305r814b3386],
86	the	DT	DATE	the	dep	101	SENT_65	[p3l865t3307r973b3372],
87	past	JJ	DATE	past	dep	101	SENT_65	[p3l1023t3324r1164b3395],
88	month	NN	DATE	month	dep	101	SENT_65	[p3l1214t3305r1493b3387],
89	)	NN	O	)	dep	101	SENT_65	[p3l1214t3305r1493b3387],
90	;	:	O	;	_	0	SENT_65	[p3l1214t3305r1493b3387],
91	platelet	NN	O	platelet	dep	101	SENT_65	[p3l1545t3307r1801b3395],
92	function	NN	O	function	dep	101	SENT_65	[p3l1850t3307r2142b3372],
93	disorder	NN	O	disorder	dep	101	SENT_65	[p3l52t3413r334b3477],
94	or	CC	O	or	dep	101	SENT_65	[p3l359t3438r429b3477],
95	platelet	NN	O	platelet	dep	101	SENT_65	[p3l451t3413r707b3500],
96	count	NN	O	count	dep	101	SENT_65	[p3l732t3430r926b3477],
97	<	JJR	O	<	dep	101	SENT_65	[p3l955t3413r1149b3477],
98	150	CD	NUMBER	150	dep	101	SENT_65	[p3l955t3413r1149b3477],
99	>	JJR	O	>	dep	101	SENT_65	[p3l1183t3423r1235b3474],
100	<	JJR	O	<	dep	101	SENT_65	[p3l1183t3423r1235b3474],
101	103/p	CD	NUMBER	103/p	_	0	SENT_65	[p3l1273t3400r1516b3494],
102	.	.	O	.	_	0	SENT_65	[p3l1273t3400r1516b3494],

1	l	NN	O	l	_	0	SENT_66	[p3l1273t3400r1516b3494],
2	;	:	O	;	_	0	SENT_66	[p3l1273t3400r1516b3494],
3	hemoglobin	NN	O	hemoglobin	dep	4	SENT_66	[p3l1544t3412r1960b3499],
4	<	JJR	O	<	dep	1	SENT_66	[p3l1990t3416r2141b3477],
5	10	CD	NUMBER	10	num	6	SENT_66	[p3l1990t3416r2141b3477],
6	g/dl	NN	O	g/dl	dep	4	SENT_66	[p3l50t3517r207b3604],
7	;	:	O	;	_	0	SENT_66	[p3l50t3517r207b3604],
8	need	NN	O	need	conj_and	4	SENT_66	[p3l261t3517r423b3582],
9	for	IN	O	for	_	0	SENT_66	[p3l472t3517r570b3582],
10	warfarin	NN	O	warfarin	nn	11	SENT_66	[p3l614t3517r905b3582],
11	treatment	NN	O	treatment	prep_for	8	SENT_66	[p3l954t3534r1312b3596],
12	;	:	O	;	_	0	SENT_66	[p3l954t3534r1312b3596],
13	previous	JJ	O	previous	amod	15	SENT_66	[p3l1363t3520r1651b3605],
14	hemorrhagic	JJ	O	hemorrhagic	amod	15	SENT_66	[p3l1702t3517r2142b3604],
15	stroke	NN	O	stroke	conj_and	4	SENT_66	[p3l52t3623r279b3701],
16	;	:	O	;	_	0	SENT_66	[p3l52t3623r279b3701],
17	malignancy	NN	O	malignancy	dep	15	SENT_66	[p3l333t3622r748b3710],
18	;	:	O	;	_	0	SENT_66	[p3l333t3622r748b3710],
19	and	CC	O	and	_	0	SENT_66	[p3l803t3622r928b3687],
20	refusal	NN	O	refusal	conj_and	4	SENT_66	[p3l977t3622r1205b3687],
21	of	IN	O	of	_	0	SENT_66	[p3l1255t3622r1333b3687],
22	consent	NN	O	consent	prep_of	20	SENT_66	[p3l1372t3639r1654b3687],
23	.	.	O	.	_	0	SENT_66	[p3l1372t3639r1654b3687],

1	Of	IN	O	of	_	0	SENT_67	[p3l1711t3622r1816b3687],
2	the	DT	O	the	det	5	SENT_67	[p3l1855t3622r1963b3687],
3	209	CD	NUMBER	209	num	4	SENT_67	[p3l2012t3626r2139b3688],
4	patients	NNS	O	patient	dep	5	SENT_67	[p3l50t3730r321b3815],
5	screened	VBN	O	screen	pobj	1	SENT_67	[p3l355t3727r650b3792],
6	for	IN	O	for	_	0	SENT_67	[p3l680t3727r779b3792],
7	the	DT	O	the	det	8	SENT_67	[p3l807t3728r915b3792],
8	study	NN	O	study	prep_for	5	SENT_67	[p3l947t3727r1148b3815],
9	,	,	O	,	_	0	SENT_67	[p3l947t3727r1148b3815],
10	90	CD	PERCENT	90	number	11	SENT_67	[p3l1182t3731r1263b3792],
11	(	CD	PERCENT	(	appos	8	SENT_67	[p3l1298t3725r1498b3806],
12	43	CD	PERCENT	43	num	13	SENT_67	[p3l1298t3725r1498b3806],
13	%	NN	PERCENT	%	dep	11	SENT_67	[p3l1298t3725r1498b3806],
14	)	CD	NUMBER	)	num	5	SENT_67	[p3l1298t3725r1498b3806],
15	presented	VBN	O	present	partmod	5	SENT_67	[p3l1531t3727r1866b3815],
16	HTPR	NN	O	htpr	dobj	15	SENT_67	[p3l1896t3726r2144b3791],

1	immediately	RB	O	immediately	advmod	2	SENT_68	[p4l51t17r484b104],
2	before	IN	O	before	_	0	SENT_68	[p4l530t17r747b81],
3	PCI	NN	O	pcus	pobj	2	SENT_68	[p4l801t17r965b81],
4	.	.	O	.	_	0	SENT_68	[p4l801t17r965b81],

1	HTPR	NN	ORGANIZATION	htpr	nsubjpass	3	SENT_69	[p4l1023t15r1271b80],
2	was	VBD	O	be	auxpass	3	SENT_69	[p4l1318t42r1444b81],
3	deﬁned	VBN	O	deﬁned	dep	8	SENT_69	[p4l1500t17r1755b81],
4	as	IN	O	as	_	0	SENT_69	[p4l1809t42r1871b81],
5	P2Y12	NN	O	p2y12	nn	7	SENT_69	[p4l1926t18r2141b101],
6	reaction	NN	O	reaction	nn	7	SENT_69	[p4l51t125r335b186],
7	units	NNS	O	unit	prep_as	3	SENT_69	[p4l391t125r550b186],
8	(	VBP	O	(	_	0	SENT_69	[p4l608t120r825b200],
9	PRU	NNP	ORGANIZATION	PRU	dobj	8	SENT_69	[p4l608t120r825b200],
10	)	CD	NUMBER	)	number	11	SENT_69	[p4l608t120r825b200],
11	2235	CD	DATE	2235	dep	9	SENT_69	[p4l887t122r1072b187],
12	according	VBG	O	accord	_	0	SENT_69	[p4l1130t122r1447b209],
13	to	TO	O	to	prepc_according_to	11	SENT_69	[p4l1498t139r1562b186],
14	the	DT	O	the	det	19	SENT_69	[p4l1617t122r1720b186],
15	VerifyNow	NNP	O	VerifyNow	nn	19	SENT_69	[p4l1774t122r2144b209],
16	P2Y12	NN	O	p2y12	nn	19	SENT_69	[p4l51t227r267b310],
17	platelet	NN	O	platelet	nn	19	SENT_69	[p4l326t226r583b313],
18	function	NN	O	function	nn	19	SENT_69	[p4l641t226r933b290],
19	test	NN	O	test	pobj	11	SENT_69	[p4l993t243r1115b290],
20	(	CD	NUMBER	(	num	21	SENT_69	[p4l1176t224r1654b305],
21	Accumetrics	NNS	O	accumetric	nsubj	8	SENT_69	[p4l1176t224r1654b305],
22	,	,	O	,	_	0	SENT_69	[p4l1176t224r1654b305],
23	San	NNP	LOCATION	San	nn	24	SENT_69	[p4l1721t226r1845b291],
24	Diego	NNP	LOCATION	Diego	appos	21	SENT_69	[p4l1906t227r2138b313],
25	,	,	O	,	_	0	SENT_69	[p4l1906t227r2138b313],
26	California	NNP	LOCATION	California	appos	24	SENT_69	[p4l53t329r428b410],
27	)	CD	NUMBER	)	num	26	SENT_69	[p4l53t329r428b410],
28	(	CD	NUMBER	(	num	30	SENT_69	[p4l458t329r756b410],
29	16-19	CD	NUMBER	16-19	num	30	SENT_69	[p4l458t329r756b410],
30	)	NN	O	)	dep	26	SENT_69	[p4l458t329r756b410],
31	.	.	O	.	_	0	SENT_69	[p4l458t329r756b410],

1	Of	IN	O	of	_	0	SENT_70	[p4l787t331r892b396],
2	these	DT	O	these	prep_of	5	SENT_70	[p4l904t331r1100b410],
3	,	,	O	,	_	0	SENT_70	[p4l904t331r1100b410],
4	12	CD	NUMBER	12	nsubj	5	SENT_70	[p4l1131t334r1209b397],
5	had	VBD	O	have	_	0	SENT_70	[p4l1235t331r1362b396],
6	exclusion	NN	O	exclusion	nn	7	SENT_70	[p4l1387t331r1704b396],
7	criteria	NNS	O	criterion	dobj	5	SENT_70	[p4l1729t334r1988b410],
8	,	,	O	,	_	0	SENT_70	[p4l1729t334r1988b410],
9	and	CC	O	and	cc	5	SENT_70	[p4l2017t331r2142b396],
10	thus	RB	O	thus	advmod	5	SENT_70	[p4l51t436r196b501],
11	a	DT	O	a	det	12	SENT_70	[p4l248t462r282b501],
12	total	NN	O	total	nsubjpass	17	SENT_70	[p4l330t436r487b501],
13	of	IN	O	of	_	0	SENT_70	[p4l535t436r613b501],
14	78	CD	NUMBER	78	num	15	SENT_70	[p4l653t438r732b501],
15	patients	NNS	O	patient	prep_of	12	SENT_70	[p4l783t439r1055b524],
16	were	VBD	O	be	auxpass	17	SENT_70	[p4l1102t461r1265b501],
17	enrolled	VBN	O	enrol	ccomp	5	SENT_70	[p4l1316t436r1597b501],
18	in	IN	O	in	_	0	SENT_70	[p4l1645t439r1711b500],
19	this	DT	O	this	det	20	SENT_70	[p4l1761t436r1885b501],
20	study	NN	O	study	prep_in	17	SENT_70	[p4l1937t436r2137b523],
21	.	.	O	.	_	0	SENT_70	[p4l1937t436r2137b523],

1	Patient	NN	O	patient	nn	2	SENT_71	[p4l51t542r302b606],
2	disposition	NN	O	disposition	nsubjpass	4	SENT_71	[p4l343t541r722b629],
3	is	VBZ	O	be	auxpass	4	SENT_71	[p4l764t544r813b606],
4	summarized	VBN	O	summarize	_	0	SENT_71	[p4l858t541r1280b606],
5	in	IN	O	in	_	0	SENT_71	[p4l1321t544r1387b605],
6	Figure	NNP	O	Figure	prep_in	4	SENT_71	[p4l1430t542r1654b629],
7	1	CD	NUMBER	1	num	6	SENT_71	[p4l1701t545r1754b606],
8	.	.	O	.	_	0	SENT_71	[p4l1701t545r1754b606],

1	Per	IN	O	per	amod	3	SENT_72	[p4l1800t542r1919b606],
2	study	NN	O	study	nn	3	SENT_72	[p4l1960t541r2145b629],
3	protocol	NN	O	protocol	nsubj	6	SENT_72	[p4l50t646r358b734],
4	,	,	O	,	_	0	SENT_72	[p4l50t646r358b734],
5	all	DT	O	all	nsubj	6	SENT_72	[p4l403t646r481b711],
6	enrolled	VBD	O	enrol	_	0	SENT_72	[p4l522t646r803b711],
7	patients	NNS	O	patient	nsubjpass	9	SENT_72	[p4l841t649r1113b734],
8	were	VBD	O	be	auxpass	9	SENT_72	[p4l1152t671r1316b711],
9	treated	VBN	O	treat	ccomp	6	SENT_72	[p4l1357t646r1597b711],
10	with	IN	O	with	_	0	SENT_72	[p4l1634t646r1792b711],
11	a	DT	O	a	det	14	SENT_72	[p4l1835t672r1868b711],
12	double	JJ	O	double	amod	14	SENT_72	[p4l1909t646r2141b711],
13	maintenance	NN	O	maintenance	nn	14	SENT_72	[p4l52t755r492b816],
14	dose	NN	O	dose	prep_with	9	SENT_72	[p4l529t752r681b816],
15	of	IN	O	of	_	0	SENT_72	[p4l719t752r797b816],
16	clopidogrel	NN	O	clopidogrel	nn	17	SENT_72	[p4l821t752r1209b839],
17	(	NN	O	(	prep_of	14	SENT_72	[p4l1246t750r1398b830],
18	150	CD	NUMBER	150	num	20	SENT_72	[p4l1246t750r1398b830],
19	mg/day	JJ	O	mg/day	amod	20	SENT_72	[p4l1436t750r1742b839],
20	)	NN	O	)	dep	17	SENT_72	[p4l1436t750r1742b839],
21	.	.	O	.	_	0	SENT_72	[p4l1436t750r1742b839],

1	This	DT	O	this	det	2	SENT_73	[p4l1779t750r1940b816],
2	regimen	NN	O	regimen	nsubjpass	4	SENT_73	[p4l1977t755r2139b839, p4l52t881r201b920],
3	was	VBD	O	be	auxpass	4	SENT_73	[p4l251t881r378b921],
4	chosen	VBN	O	choose	_	0	SENT_73	[p4l433t856r689b935],
5	,	,	O	,	_	0	SENT_73	[p4l433t856r689b935],
6	given	VBN	O	give	dep	4	SENT_73	[p4l744t859r929b943],
7	its	PRP$	O	its	poss	8	SENT_73	[p4l982t859r1059b920],
8	eﬂicacy	NN	O	eﬂicacy	dobj	4	SENT_73	[p4l1114t856r1365b943],
9	in	IN	O	in	_	0	SENT_73	[p4l1415t859r1481b920],
10	reducing	VBG	O	reduce	prepc_in	4	SENT_73	[p4l1533t856r1837b943],
11	platelet	NN	O	platelet	nn	12	SENT_73	[p4l1887t856r2143b943],
12	reactivity	NN	O	reactivity	dobj	10	SENT_73	[p4l51t964r369b1048],
13	in	IN	O	in	_	0	SENT_73	[p4l399t964r465b1025],
14	patients	NNS	O	patient	prep_in	10	SENT_73	[p4l498t964r769b1049],
15	With	IN	O	with	_	0	SENT_73	[p4l800t961r959b1026],
16	HTPR	NN	O	htpr	prep_with	14	SENT_73	[p4l993t959r1241b1025],
17	as	IN	O	as	mark	23	SENT_73	[p4l1273t987r1335b1026],
18	observed	VBN	O	observe	csubj	23	SENT_73	[p4l1371t961r1673b1026],
19	in	IN	O	in	_	0	SENT_73	[p4l1706t964r1772b1025],
20	other	JJ	O	other	amod	22	SENT_73	[p4l1806t961r1989b1026],
21	PD	NN	O	pd	nn	22	SENT_73	[p4l2021t962r2139b1025],
22	investigations	NNS	O	investigation	prep_in	18	SENT_73	[p4l51t1069r524b1153],
23	(	VBP	O	(	advcl	10	SENT_73	[p4l559t1064r846b1145],
24	13-15	CD	NUMBER	13-15	num	25	SENT_73	[p4l559t1064r846b1145],
25	)	CD	NUMBER	)	dobj	23	SENT_73	[p4l559t1064r846b1145],
26	.	.	O	.	_	0	SENT_73	[p4l559t1064r846b1145],

1	More	RBR	O	more	advmod	2	SENT_74	[p4l878t1067r1072b1131],
2	potent	JJ	O	potent	amod	4	SENT_74	[p4l1101t1083r1328b1154],
3	treatment	NN	O	treatment	nn	4	SENT_74	[p4l1356t1083r1696b1131],
4	strategies	NNS	O	strategy	nsubjpass	23	SENT_74	[p4l1726t1069r2044b1153],
5	in	IN	O	in	_	0	SENT_74	[p4l2075t1069r2142b1130],
6	overcoming	VBG	O	overcome	prepc_in	4	SENT_74	[p4l52t1174r459b1259],
7	I-ITPR	NN	O	i-itpr	dobj	6	SENT_74	[p4l499t1170r763b1251],
8	,	,	O	,	_	0	SENT_74	[p4l499t1170r763b1251],
9	such	JJ	O	such	_	0	SENT_74	[p4l809t1172r962b1236],
10	as	IN	O	as	_	0	SENT_74	[p4l1004t1197r1066b1236],
11	by	IN	O	by	prepc_such_as	7	SENT_74	[p4l1106t1171r1191b1259],
12	the	DT	O	the	det	17	SENT_74	[p4l1227t1171r1336b1236],
13	novel	JJ	O	novel	amod	17	SENT_74	[p4l1378t1171r1562b1236],
14	P2Y12	NN	O	p2y12	nn	17	SENT_74	[p4l1602t1172r1817b1256],
15	receptor	NN	O	receptor	nn	17	SENT_74	[p4l1859t1188r2143b1259],
16	inhibitors	NNS	O	inhibitor	nn	17	SENT_74	[p4l51t1277r385b1342],
17	prasugrel	NN	O	prasugrel	pobj	11	SENT_74	[p4l415t1277r733b1365],
18	or	CC	O	or	_	0	SENT_74	[p4l762t1302r832b1342],
19	ticagrelor	NN	O	ticagrelor	conj_or	17	SENT_74	[p4l860t1277r1205b1364],
20	,	,	O	,	_	0	SENT_74	[p4l860t1277r1205b1364],
21	were	VBD	O	be	auxpass	23	SENT_74	[p4l1233t1302r1396b1342],
22	not	RB	O	not	neg	23	SENT_74	[p4l1427t1294r1543b1342],
23	considered	VBN	O	consider	_	0	SENT_74	[p4l1571t1277r1943b1342],
24	since	IN	O	since	mark	27	SENT_74	[p4l1973t1280r2141b1342],
25	these	DT	O	these	det	26	SENT_74	[p4l51t1382r227b1447],
26	drugs	NNS	O	drug	nsubj	27	SENT_74	[p4l257t1382r444b1470],
27	have	VBP	O	have	advcl	23	SENT_74	[p4l474t1382r629b1447],
28	an	DT	O	a	det	29	SENT_74	[p4l659t1408r738b1447],
29	indication	NN	O	indication	dobj	27	SENT_74	[p4l767t1382r1116b1447],
30	for	IN	O	for	_	0	SENT_74	[p4l1144t1382r1242b1447],
31	use	NN	O	use	prep_for	29	SENT_74	[p4l1268t1408r1377b1447],
32	only	RB	O	only	advmod	27	SENT_74	[p4l1407t1382r1557b1470],
33	in	IN	O	in	_	0	SENT_74	[p4l1581t1385r1648b1446],
34	the	DT	O	the	det	35	SENT_74	[p4l1676t1383r1784b1447],
35	setting	NN	O	setting	prep_in	27	SENT_74	[p4l1815t1385r2047b1470],
36	of	IN	O	of	_	0	SENT_74	[p4l2075t1382r2153b1447],
37	acute	JJ	O	acute	amod	39	SENT_74	[p4l52t1505r229b1553],
38	coronary	JJ	O	coronary	amod	39	SENT_74	[p4l273t1514r577b1576],
39	syndromes	NNS	O	syndrome	prep_of	35	SENT_74	[p4l617t1489r1004b1576],
40	,	,	O	,	_	0	SENT_74	[p4l617t1489r1004b1576],
41	and	CC	O	and	_	0	SENT_74	[p4l1052t1489r1177b1553],
42	our	PRP$	O	we	poss	43	SENT_74	[p4l1219t1514r1334b1553],
43	population	NN	O	population	nsubjpass	45	SENT_74	[p4l1374t1489r1750b1576],
44	was	VBD	O	be	auxpass	45	SENT_74	[p4l1789t1514r1916b1553],
45	composed	VBN	O	compose	conj_and	23	SENT_74	[p4l1961t1514r2139b1553, p4l50t1594r250b1681],
46	of	IN	O	of	_	0	SENT_74	[p4l282t1594r361b1658],
47	stable	JJ	O	stable	amod	49	SENT_74	[p4l383t1594r577b1658],
48	CAD	NN	O	cad	nn	49	SENT_74	[p4l612t1592r806b1658],
49	patients	NNS	O	patient	prep_of	45	SENT_74	[p4l839t1597r1130b1681],
50	.	.	O	.	_	0	SENT_74	[p4l839t1597r1130b1681],

1	Randomization	NN	O	randomization	nsubjpass	12	SENT_75	[p4l140t1698r678b1763],
2	(	CD	NUMBER	(	number	3	SENT_75	[p4l715t1696r872b1777],
3	1:1	CD	NUMBER	1:1	num	4	SENT_75	[p4l715t1696r872b1777],
4	)	NN	O	)	dep	1	SENT_75	[p4l715t1696r872b1777],
5	to	TO	O	to	_	0	SENT_75	[p4l909t1715r976b1763],
6	the	DT	O	the	det	10	SENT_75	[p4l1012t1698r1120b1763],
7	atorvastatin	NN	O	atorvastatin	nn	10	SENT_75	[p4l1156t1701r1558b1763],
8	or	CC	O	or	_	0	SENT_75	[p4l1593t1723r1664b1763],
9	control	NN	O	control	nn	10	SENT_75	[p4l1697t1698r1943b1763],
10	arms	NNS	O	arm	prep_to	1	SENT_75	[p4l1977t1723r2139b1763],
11	was	VBD	O	be	auxpass	12	SENT_75	[p4l48t1829r174b1868],
12	performed	VBN	O	perform	_	0	SENT_75	[p4l228t1803r591b1891],
13	immediately	RB	O	immediately	advmod	12	SENT_75	[p4l644t1803r1077b1890],
14	after	IN	O	after	_	0	SENT_75	[p4l1128t1803r1283b1868],
15	PCI	NN	O	pcus	prep_after	12	SENT_75	[p4l1336t1803r1480b1868],
16	by	IN	O	by	_	0	SENT_75	[p4l1534t1803r1618b1890],
17	computerized	JJ	O	computerized	amod	21	SENT_75	[p4l1668t1803r2142b1891],
18	open	JJ	O	open	amod	21	SENT_75	[p4l52t1908r419b1996],
19	—	NN	O	—	nn	21	SENT_75	[p4l52t1908r419b1996],
20	label	NN	O	label	nn	21	SENT_75	[p4l52t1908r419b1996],
21	assignments	NNS	O	assignment	agent	12	SENT_75	[p4l442t1911r860b1995],
22	in	IN	O	in	_	0	SENT_75	[p4l885t1911r951b1972],
23	consecutive	JJ	O	consecutive	amod	25	SENT_75	[p4l975t1911r1370b1973],
24	blinded	JJ	O	blinded	amod	25	SENT_75	[p4l1392t1908r1656b1973],
25	envelopes	NNS	O	envelope	prep_in	21	SENT_75	[p4l1679t1908r2030b1996],
26	:	:	O	:	_	0	SENT_75	[p4l1679t1908r2030b1996],
27	39	CD	NUMBER	39	num	28	SENT_75	[p4l2059t1912r2139b1973],
28	patients	NNS	O	patient	dep	12	SENT_75	[p4l50t2017r334b2102],
29	were	VBD	O	be	auxpass	30	SENT_75	[p4l395t2039r564b2079],
30	assigned	VBN	O	assign	rcmod	28	SENT_75	[p4l629t2014r931b2102],
31	to	TO	O	to	aux	32	SENT_75	[p4l994t2031r1062b2079],
32	receive	VB	O	receive	xcomp	30	SENT_75	[p4l1126t2017r1371b2079],
33	clopidogrel	NN	O	clopidogrel	dobj	32	SENT_75	[p4l1436t2014r1840b2102],
34	at	IN	O	at	_	0	SENT_75	[p4l1904t2031r1968b2079],
35	the	DT	O	the	det	36	SENT_75	[p4l2029t2015r2141b2079],
36	maintenance	NN	O	maintenance	prep_at	32	SENT_75	[p4l52t2123r509b2184],
37	dose	NN	O	dose	dep	55	SENT_75	[p4l542t2120r699b2184],
38	of	IN	O	of	_	0	SENT_75	[p4l731t2120r811b2184],
39	150	CD	NUMBER	150	num	40	SENT_75	[p4l835t2120r961b2184],
40	mg	NN	O	mg	prep_of	37	SENT_75	[p4l993t2120r1137b2207],
41	/	:	O	/	punct	42	SENT_75	[p4l993t2120r1137b2207],
42	day	NN	DURATION	day	dep	40	SENT_75	[p4l1142t2120r1265b2207],
43	(	CD	NUMBER	(	number	44	SENT_75	[p4l1295t2118r1360b2198],
44	8	CD	TIME	8	dep	42	SENT_75	[p4l1295t2118r1360b2198],
45	AM	NNP	TIME	AM	nn	46	SENT_75	[p4l1391t2117r1524b2198],
46	)	NN	O	)	dep	44	SENT_75	[p4l1391t2117r1524b2198],
47	and	CC	O	and	_	0	SENT_75	[p4l1560t2119r1689b2184],
48	atorvastatin	NN	O	atorvastatin	conj_and	46	SENT_75	[p4l1720t2122r2142b2184],
49	80	CD	NUMBER	80	num	50	SENT_75	[p4l54t2228r135b2289],
50	mg	NN	O	mg	dep	44	SENT_75	[p4l163t2224r307b2312],
51	/	:	O	/	punct	42	SENT_75	[p4l163t2224r307b2312],
52	day	NN	DURATION	day	dep	55	SENT_75	[p4l312t2224r435b2312],
53	(	CD	NUMBER	(	num	52	SENT_75	[p4l460t2222r572b2303],
54	10	CD	TIME	10	num	55	SENT_75	[p4l460t2222r572b2303],
55	PM	NN	TIME	pm	dep	63	SENT_75	[p4l599t2222r722b2303],
56	)	CD	NUMBER	)	number	57	SENT_75	[p4l599t2222r722b2303],
57	(	CD	NUMBER	(	dep	55	SENT_75	[p4l754t2222r1205b2303],
58	atorvastatin	NN	O	atorvastatin	nn	59	SENT_75	[p4l754t2222r1205b2303],
59	group	NN	O	group	dep	57	SENT_75	[p4l1229t2222r1465b2312],
60	)	CD	NUMBER	)	nn	63	SENT_75	[p4l1229t2222r1465b2312],
61	and	CC	O	and	_	0	SENT_75	[p4l1496t2224r1625b2289],
62	39	CD	NUMBER	39	conj_and	60	SENT_75	[p4l1650t2228r1733b2289],
63	patients	NNS	O	patient	dep	28	SENT_75	[p4l1760t2227r2044b2312],
64	to	TO	O	to	aux	65	SENT_75	[p4l2071t2241r2140b2289],
65	receive	VB	O	receive	infmod	63	SENT_75	[p4l51t2334r295b2395],
66	only	RB	O	only	advmod	67	SENT_75	[p4l336t2331r491b2418],
67	clopidogrel	NN	O	clopidogrel	dobj	65	SENT_75	[p4l528t2331r933b2418],
68	at	IN	O	at	_	0	SENT_75	[p4l972t2348r1036b2395],
69	150	CD	NUMBER	150	num	72	SENT_75	[p4l1078t2331r1204b2395],
70	mg/day	JJ	O	mg/day	amod	72	SENT_75	[p4l1245t2330r1517b2418],
71	(	NN	O	(	nn	72	SENT_75	[p4l1556t2329r1841b2409],
72	control	NN	O	control	prep_at	65	SENT_75	[p4l1556t2329r1841b2409],
73	group	NN	O	group	dep	72	SENT_75	[p4l1878t2329r2137b2418],
74	)	CD	NUMBER	)	num	73	SENT_75	[p4l1878t2329r2137b2418],
75	.	.	O	.	_	0	SENT_75	[p4l1878t2329r2137b2418],

1	Antiplatelet	JJ	O	antiplatelet	amod	4	SENT_76	[p4l49t2466r488b2555],
2	and	CC	O	and	_	0	SENT_76	[p4l538t2468r666b2532],
3	statin	JJ	O	statin	conj_and	1	SENT_76	[p4l717t2471r915b2532],
4	regimens	NNS	O	regimen	nsubjpass	6	SENT_76	[p4l965t2471r1290b2555],
5	were	VBD	O	be	auxpass	6	SENT_76	[p4l1338t2493r1507b2532],
6	maintained	VBN	O	maintain	_	0	SENT_76	[p4l1559t2468r1966b2532],
7	unBoehringer	NN	O	unboehringer	dobj	6	SENT_76	[p4l2015t2493r2139b2532, p4l50t2743r325b2804],

1	Ingelheim	NNP	O	Ingelheim	_	0	SENT_77	[p4l344t2743r606b2804],
2	,	,	O	,	_	0	SENT_77	[p4l344t2743r606b2804],
3	and	CC	O	and	_	0	SENT_77	[p4l630t2743r717b2788],
4	Pﬁzer	NNP	PERSON	Pﬁzer	conj_and	1	SENT_77	[p4l737t2743r891b2788],
5	.	.	O	.	_	0	SENT_77	[p4l737t2743r891b2788],

1	All	DT	O	all	det	3	SENT_78	[p4l913t2742r990b2788],
2	other	JJ	O	other	amod	3	SENT_78	[p4l1010t2743r1138b2788],
3	authors	NNS	O	author	nsubj	5	SENT_78	[p4l1158t2743r1336b2788],
4	have	VBP	O	have	aux	5	SENT_78	[p4l1357t2743r1466b2788],
5	reported	VBN	O	report	_	0	SENT_78	[p4l1487t2743r1692b2804],
6	that	IN	O	that	complm	8	SENT_78	[p4l1712t2743r1809b2788],
7	they	PRP	O	they	nsubj	8	SENT_78	[p4l1828t2743r1933b2804],
8	have	VBP	O	have	ccomp	5	SENT_78	[p4l1951t2743r2060b2788],
9	no	DT	O	no	det	10	SENT_78	[p4l2082t2761r2141b2788],
10	relationships	NNS	O	relationship	nsubj	11	SENT_78	[p4l50t2824r358b2885],
11	relevant	JJ	O	relevant	xcomp	8	SENT_78	[p4l382t2824r574b2869],
12	to	TO	O	to	_	0	SENT_78	[p4l595t2835r642b2869],
13	the	DT	O	the	det	14	SENT_78	[p4l665t2824r741b2869],
14	contents	NNS	O	contents	prep_to	11	SENT_78	[p4l765t2835r968b2869],
15	of	IN	O	of	_	0	SENT_78	[p4l992t2823r1047b2869],
16	this	DT	O	this	det	17	SENT_78	[p4l1061t2824r1148b2869],
17	paper	NN	O	paper	prep_of	14	SENT_78	[p4l1171t2841r1307b2885],
18	to	TO	O	to	aux	19	SENT_78	[p4l1328t2835r1374b2869],
19	disclose	VB	O	disclose	infmod	17	SENT_78	[p4l1399t2824r1597b2869],
20	.	.	O	.	_	0	SENT_78	[p4l1399t2824r1597b2869],

1	Manuscript	NN	O	manuscript	nsubj	2	SENT_79	[p4l49t2975r334b3035],
2	received	VBD	O	receive	_	0	SENT_79	[p4l359t2974r556b3019],
3	May	NNP	DATE	May	tmod	2	SENT_79	[p4l582t2975r696b3035],
4	24	CD	DATE	24	num	3	SENT_79	[p4l720t2976r793b3030],
5	,	,	DATE	,	_	0	SENT_79	[p4l720t2976r793b3030],
6	2012	CD	DATE	2012	num	3	SENT_79	[p4l821t2976r956b3030],
7	;	:	O	;	_	0	SENT_79	[p4l821t2976r956b3030],
8	revised	VBN	O	revise	amod	9	SENT_79	[p4l985t2974r1152b3019],
9	manuscript	NN	O	manuscript	nsubj	10	SENT_79	[p4l1180t2976r1452b3035],
10	received	VBD	O	receive	parataxis	2	SENT_79	[p4l1478t2974r1675b3019],
11	August	NNP	DATE	August	dobj	10	SENT_79	[p4l1700t2973r1879b3035],
12	30	CD	DATE	30	num	11	SENT_79	[p4l1905t2976r1977b3030],
13	,	,	DATE	,	_	0	SENT_79	[p4l1905t2976r1977b3030],
14	2012	CD	DATE	2012	num	11	SENT_79	[p4l2005t2976r2140b3030],
15	,	,	O	,	_	0	SENT_79	[p4l2005t2976r2140b3030],
16	accepted	VBN	O	accept	partmod	11	SENT_79	[p4l51t3051r260b3112],
17	September	NNP	DATE	September	tmod	16	SENT_79	[p4l284t3051r543b3112],
18	12	CD	DATE	12	num	17	SENT_79	[p4l568t3053r637b3106],
19	,	,	DATE	,	_	0	SENT_79	[p4l568t3053r637b3106],
20	2012	CD	DATE	2012	num	17	SENT_79	[p4l660t3053r794b3097],
21	.	.	O	.	_	0	SENT_79	[p4l660t3053r794b3097],

1	JACC	NN	O	jacc	_	0	SENT_80	[p4l42t3193r112b3208],
2	:	:	O	:	_	0	SENT_80	[p4l42t3193r112b3208],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_80	[p4l129t3193r363b3208],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_80	[p4l379t3193r594b3210],
5	.	.	O	.	_	0	SENT_80	[p4l379t3193r594b3210],

1	VOL	NNP	O	VOL	_	0	SENT_81	[p4l611t3193r668b3208],
2	.	.	O	.	_	0	SENT_81	[p4l611t3193r668b3208],

1	6	CD	NUMBER	6	_	0	SENT_82	[p4l684t3193r705b3210],
2	.	.	O	.	_	0	SENT_82	[p4l684t3193r705b3210],

1	No.	NN	O	no.	_	0	SENT_83	[p4l722t3193r764b3208],
2	2	CD	NUMBER	2	dep	1	SENT_83	[p4l781t3193r801b3210],
3	.	.	O	.	_	0	SENT_83	[p4l781t3193r801b3210],

1	2013	CD	DATE	2013	num	2	SENT_84	[p4l818t3193r876b3208],
2	Leoncini	NNP	O	Leoncini	dep	8	SENT_84	[p4l1788t3187r1889b3208],
3	et	FW	O	et	nn	4	SENT_84	[p4l1903t3188r1927b3208],
4	al.	FW	O	al.	dep	2	SENT_84	[p4l1938t3187r1965b3208],
5	171	CD	NUMBER	171	num	6	SENT_84	[p4l2067t3187r2117b3208],
6	FEBRUARY	NN	DATE	february	dep	8	SENT_84	[p4l43t3231r174b3246],
7	2o13	CD	NUMBER	2o13	num	8	SENT_84	[p4l188t3232r355b3246],
8	:159	CD	NUMBER	:159	_	0	SENT_84	[p4l188t3232r355b3246],
9	—	NN	O	—	nn	12	SENT_84	[p4l188t3232r355b3246],
10	79	CD	NUMBER	79	num	12	SENT_84	[p4l188t3232r355b3246],
11	High-Dose	NNP	O	High-Dose	nn	12	SENT_84	[p4l1388t3226r1512b3251],
12	Atorvastatin	NNP	O	Atorvastatin	dep	8	SENT_84	[p4l1522t3226r1672b3246],
13	and	CC	O	and	_	0	SENT_84	[p4l1684t3226r1728b3246],
14	Platelet	NN	O	platelet	nn	15	SENT_84	[p4l1741t3226r1835b3246],
15	Reactivity	NN	O	reactivity	dep	8	SENT_84	[p4l1847t3226r1967b3251],

1	Statin	NN	O	statin	_	0	SENT_85	[p5l604t120r678b143],
2	na	TO	O	na	infmod	1	SENT_85	[p5l686t122r755b143],
3	'	''	O	'	_	0	SENT_85	[p5l686t122r755b143],
4	1	CD	NUMBER	1	dep	2	SENT_85	[p5l686t122r755b143],
5	‘	CD	NUMBER	‘	num	7	SENT_85	[p5l686t122r755b143],
6	ve	NN	O	ve	nn	7	SENT_85	[p5l686t122r755b143],
7	patients	NNS	O	patient	dep	1	SENT_85	[p5l764t120r864b150],
8	with	IN	O	with	_	0	SENT_85	[p5l873t120r931b143],
9	stable	JJ	O	stable	amod	11	SENT_85	[p5l940t120r1014b143],
10	CAD	NN	O	cad	nn	11	SENT_85	[p5l1023t120r1090b143],
11	candidates	NNS	O	candidate	prep_with	7	SENT_85	[p5l1100t120r1235b143],
12	for	IN	O	for	_	0	SENT_85	[p5l1244t120r1282b143],
13	PCI	NN	O	pcus	prep_for	11	SENT_85	[p5l1290t120r1339b143],
14	with	IN	O	with	_	0	SENT_85	[p5l1348t120r1405b143],
15	stent	NN	O	stent	prep_with	13	SENT_85	[p5l1414t123r1474b143],

1	Aspirin	NN	O	aspirin	nn	2	SENT_86	[p5l662t157r759b187],
2	(	NN	O	(	_	0	SENT_86	[p5l768t157r825b187],
3	100	CD	NUMBER	100	num	5	SENT_86	[p5l768t157r825b187],
4	mg/day	JJ	O	mg/day	amod	5	SENT_86	[p5l835t157r941b187],
5	)	NN	O	)	dep	2	SENT_86	[p5l835t157r941b187],
6	+	CC	O	+	_	0	SENT_86	[p5l950t160r968b178],
7	Clopidogrel	NN	O	clopidogrel	nn	9	SENT_86	[p5l977t157r1130b187],
8	75	CD	NUMBER	75	num	9	SENT_86	[p5l1140t158r1169b181],
9	mg/day	NN	O	mg/day	dep	2	SENT_86	[p5l1180t157r1276b187],
10	pretreated	JJ	O	pretreated	amod	11	SENT_86	[p5l1284t157r1414b187],
11	n	NN	O	n	dep	9	SENT_86	[p5l988t227r1004b242],
12	=	JJ	O	=	amod	11	SENT_86	[p5l1013t228r1030b235],
13	209	CD	NUMBER	209	tmod	12	SENT_86	[p5l1040t220r1086b243],

1	Pre-PCI	NNP	O	Pre-PCI	nn	2	SENT_87	[p5l828t337r931b360],
2	Verify	NNP	O	Verify	_	0	SENT_87	[p5l940t336r1024b366],
3	Now	RB	DATE	now	advmod	4	SENT_87	[p5l1032t337r1095b360],
4	test	NN	O	test	dep	2	SENT_87	[p5l1103t340r1148b360],
5	(	CD	NUMBER	(	num	7	SENT_87	[p5l1157t336r1223b366],
6	T-o	JJ	O	t-o	amod	7	SENT_87	[p5l1157t336r1223b366],
7	)	NN	O	)	dep	2	SENT_87	[p5l1157t336r1223b366],

1	Patients	NNS	O	patient	_	0	SENT_88	[p5l444t435r545b459],
2	with	IN	O	with	_	0	SENT_88	[p5l554t435r612b459],
3	pre-PCI	JJ	O	pre-pci	amod	4	SENT_88	[p5l620t436r722b465],
4	PRU	NN	O	pru	prep_with	1	SENT_88	[p5l731t436r793b459],
5	<	JJR	O	<	dep	1	SENT_88	[p5l802t440r820b455],
6	235	CD	NUMBER	235	dep	5	SENT_88	[p5l828t436r874b459],

1	n	NN	O	n	_	0	SENT_89	[p5l611t505r627b520],
2	=	JJ	O	=	dep	1	SENT_89	[p5l635t506r653b513],
3	1	CD	NUMBER	1	number	4	SENT_89	[p5l665t498r673b520],
4	19	CD	NUMBER	19	dep	2	SENT_89	[p5l681t498r708b521],

1	Patients	NNS	O	patient	_	0	SENT_90	[p5l836t606r937b629],
2	eligible	JJ	O	eligible	amod	1	SENT_90	[p5l948t606r1043b636],
3	for	IN	O	for	_	0	SENT_90	[p5l1052t606r1090b629],
4	inclusion	NN	O	inclusion	nn	5	SENT_90	[p5l1098t606r1216b629],
5	n	NN	O	n	prep_for	2	SENT_90	[p5l989t676r1022b691],
6	=	JJ	O	=	dep	1	SENT_90	[p5l989t676r1022b691],
7	90	CD	NUMBER	90	tmod	6	SENT_90	[p5l1032t669r1062b692],

1	12	CD	NUMBER	12	num	2	SENT_91	[p5l1243t784r1270b806],
2	patients	NNS	O	patient	nsubj	3	SENT_91	[p5l1279t783r1379b813],
3	excluded	VBN	O	exclude	_	0	SENT_91	[p5l1389t783r1505b806],
4	for	IN	O	for	_	0	SENT_91	[p5l1514t783r1557b806],
5	:	:	O	:	_	0	SENT_91	[p5l1514t783r1557b806],
6	-	:	O	-	_	0	SENT_91	[p5l1265t834r1273b837],
7	contraindication	NN	O	contraindication	prep_for	3	SENT_91	[p5l1283t820r1493b843],
8	to	TO	O	to	_	0	SENT_91	[p5l1501t823r1525b843],
9	statins	NNS	O	statin	nn	10	SENT_91	[p5l1535t820r1616b843],
10	n	NN	O	n	prep_to	7	SENT_91	[p5l1625t828r1641b843],
11	=	JJ	O	=	amod	10	SENT_91	[p5l1649t829r1667b836],
12	4	CD	NUMBER	4	tmod	11	SENT_91	[p5l1675t821r1690b843],
13	-	:	O	-	_	0	SENT_91	[p5l1265t871r1273b874],
14	need	VB	O	need	dep	10	SENT_91	[p5l1283t857r1344b881],
15	for	IN	O	for	_	0	SENT_91	[p5l1353t857r1390b881],
16	warfarin	NN	O	warfarin	nn	18	SENT_91	[p5l1397t857r1507b880],
17	treatment	NN	O	treatment	nn	18	SENT_91	[p5l1515t861r1637b881],
18	n	NN	O	n	prep_for	14	SENT_91	[p5l1645t865r1661b880],
19	=	JJ	O	=	quantmod	21	SENT_91	[p5l1670t866r1687b873],
20	2	CD	NUMBER	2	number	21	SENT_91	[p5l1696t858r1710b880],
21	—	CD	NUMBER	—	num	26	SENT_91	[p5l1265t908r1273b911],
22	end	NN	O	end	nn	26	SENT_91	[p5l1283t895r1329b918],
23	stage	NN	O	stage	nn	26	SENT_91	[p5l1338t898r1403b924],
24	renal	JJ	O	renal	amod	26	SENT_91	[p5l1412t895r1476b918],
25	disease	NN	O	disease	nn	26	SENT_91	[p5l1485t894r1577b918],
26	n	NN	O	n	nsubj	30	SENT_91	[p5l1586t902r1602b917],
27	=	JJ	O	=	amod	26	SENT_91	[p5l1610t903r1628b910],
28	1	CD	NUMBER	1	tmod	27	SENT_91	[p5l1640t895r1649b917],
29	—	RB	O	—	advmod	30	SENT_91	[p5l1265t946r1273b948],
30	known	VBN	O	know	rcmod	18	SENT_91	[p5l1283t932r1370b955],
31	myopathy	NN	O	myopathy	dobj	30	SENT_91	[p5l1379t932r1507b962],
32	=	JJ	O	=	amod	31	SENT_91	[p5l1516t940r1534b947],
33	2	CD	NUMBER	2	tmod	32	SENT_91	[p5l1543t932r1557b955],
34	-	:	O	-	_	0	SENT_91	[p5l1265t983r1273b986],
35	malignancy	NN	O	malignancy	dep	7	SENT_91	[p5l1283t969r1433b999],
36	=	JJ	O	=	amod	37	SENT_91	[p5l1442t977r1459b984],
37	l	NN	O	l	tmod	35	SENT_91	[p5l1472t970r1480b992],
38	informed	VBN	O	inform	partmod	7	SENT_91	[p5l1283t1006r1401b1028],
39	refusal	NN	O	refusal	dobj	38	SENT_91	[p5l1409t1006r1494b1028],
40	of	IN	O	of	_	0	SENT_91	[p5l1506t1006r1535b1028],
41	consent	NN	O	consent	nn	42	SENT_91	[p5l1541t1009r1639b1028],
42	n	NN	O	n	prep_of	39	SENT_91	[p5l1647t1014r1661b1028],
43	=	JJ	O	=	amod	42	SENT_91	[p5l1671t1015r1689b1022],
44	2	CD	NUMBER	2	tmod	43	SENT_91	[p5l1698t1007r1712b1028],

1	Randomized	VBN	O	randomize	_	0	SENT_92	[p5l911t1097r1075b1120],
2	n	NN	O	n	dobj	1	SENT_92	[p5l1083t1105r1099b1120],
3	=	JJ	O	=	amod	2	SENT_92	[p5l1107t1106r1125b1113],
4	78	CD	NUMBER	78	tmod	3	SENT_92	[p5l1134t1098r1164b1120],

1	Assigned	VBN	O	assign	_	0	SENT_93	[p5l570t1236r690b1266],
2	to	TO	O	to	aux	3	SENT_93	[p5l698t1240r722b1260],
3	Assigned	VBN	O	assign	xcomp	1	SENT_93	[p5l1315t1236r1436b1266],
4	to	TO	O	to	xcomp	3	SENT_93	[p5l1444t1240r1468b1260],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_94	[p5l489t1274r642b1304],
2	150	CD	NUMBER	150	num	1	SENT_94	[p5l655t1274r699b1297],
3	mg/day	JJ	O	mg/day	amod	4	SENT_94	[p5l708t1274r805b1304],
4	Atorvastatin	NN	O	atorvastatin	dep	1	SENT_94	[p5l1064t1274r1223b1297],
5	80	CD	NUMBER	80	num	6	SENT_94	[p5l1233t1274r1263b1297],
6	mg/day	NN	O	mg/day	dep	4	SENT_94	[p5l1273t1274r1369b1304],
7	+	CC	O	+	_	0	SENT_94	[p5l1378t1277r1395b1294],
8	Clopidogrel	NN	O	clopidogrel	nn	11	SENT_94	[p5l1405t1274r1557b1304],
9	150	CD	NUMBER	150	num	11	SENT_94	[p5l1570t1274r1614b1297],
10	mg/day	NN	O	mg/day	nn	11	SENT_94	[p5l1623t1274r1720b1304],
11	n	NN	O	n	conj_+	4	SENT_94	[p5l605t1319r621b1334],
12	=	JJ	O	=	amod	14	SENT_94	[p5l630t1320r647b1327],
13	39	CD	NUMBER	39	tmod	12	SENT_94	[p5l657t1312r687b1335],
14	n	NN	O	n	dep	11	SENT_94	[p5l1354t1319r1370b1334],
15	=	JJ	O	=	amod	14	SENT_94	[p5l1379t1320r1396b1327],
16	39	CD	NUMBER	39	tmod	15	SENT_94	[p5l1406t1312r1436b1335],

1	10	CD	NUMBER	10	number	2	SENT_95	[p5l854t1403r900b1433],
2	”‘	CD	NUMBER	”‘	num	3	SENT_95	[p5l854t1403r900b1433],
3	day-Verify	JJ	O	day-verify	_	0	SENT_95	[p5l909t1410r1050b1440],
4	Now	RB	DATE	now	advmod	3	SENT_95	[p5l1057t1411r1121b1433],
5	test	NN	O	test	nn	8	SENT_95	[p5l1129t1413r1174b1433],
6	(	CD	NUMBER	(	num	8	SENT_95	[p5l1183t1410r1249b1440],
7	T-1	NN	O	t-1	nn	8	SENT_95	[p5l1183t1410r1249b1440],
8	)	NN	O	)	dep	3	SENT_95	[p5l1183t1410r1249b1440],

1	Clinical	JJ	O	clinical	amod	2	SENT_96	[p5l786t1447r887b1471],
2	follow-up	NN	O	follow-up	_	0	SENT_96	[p5l896t1447r1022b1474],
3	and	CC	O	and	_	0	SENT_96	[p5l1032t1447r1078b1471],
4	lipid	NN	O	lipid	nn	6	SENT_96	[p5l1087t1447r1145b1474],
5	level	NN	O	level	nn	6	SENT_96	[p5l1154t1447r1216b1471],
6	control	NN	O	control	conj_and	2	SENT_96	[p5l1225t1447r1315b1471],

1	1	CD	NUMBER	1	num	2	SENT_97	[p5l721t1554r729b1577],
2	patient	NN	O	patient	_	0	SENT_97	[p5l741t1554r829b1583],
3	Clopidogrel	NNP	O	Clopidogrel	dep	2	SENT_97	[p5l718t1591r871b1621],
4	intolerance	NN	O	intolerance	dep	2	SENT_97	[p5l881t1591r1023b1614],

1	30	CD	NUMBER	30	_	0	SENT_98	[p5l852t1671r900b1702],
2	"	``	O	"	punct	3	SENT_98	[p5l852t1671r900b1702],
3	‘	CD	NUMBER	‘	dep	1	SENT_98	[p5l852t1671r900b1702],
4	day-Verify	JJ	O	day-verify	amod	3	SENT_98	[p5l909t1678r1050b1708],
5	Now	RB	DATE	now	advmod	3	SENT_98	[p5l1057t1679r1121b1702],
6	test	NN	O	test	nn	9	SENT_98	[p5l1129t1682r1174b1702],
7	(	CD	NUMBER	(	num	9	SENT_98	[p5l1183t1678r1249b1708],
8	T-2	NN	O	t-2	nn	9	SENT_98	[p5l1183t1678r1249b1708],
9	)	NN	O	)	dep	3	SENT_98	[p5l1183t1678r1249b1708],

1	Clinical	JJ	O	clinical	amod	2	SENT_99	[p5l786t1715r887b1739],
2	follow-up	NN	O	follow-up	_	0	SENT_99	[p5l896t1715r1022b1742],
3	and	CC	O	and	_	0	SENT_99	[p5l1032t1715r1078b1739],
4	lipid	NN	O	lipid	nn	6	SENT_99	[p5l1087t1715r1145b1742],
5	level	NN	O	level	nn	6	SENT_99	[p5l1154t1715r1216b1739],
6	control	NN	O	control	conj_and	2	SENT_99	[p5l1225t1715r1315b1739],

1	Completed	VBN	O	complete	_	0	SENT_100	[p5l538t1813r679b1843],
2	study	NN	O	study	dobj	1	SENT_100	[p5l689t1813r758b1843],
3	Completed	VBN	O	complete	partmod	2	SENT_100	[p5l1295t1817r1436b1847],
4	study	NN	O	study	dobj	3	SENT_100	[p5l1445t1817r1514b1847],

1	1	CD	NUMBER	1	_	0	SENT_101	[p5l607t1858r622b1873],
2	'	''	O	'	_	0	SENT_101	[p5l607t1858r622b1873],
3	1	CD	NUMBER	1	dep	1	SENT_101	[p5l607t1858r622b1873],
4	2	CD	NUMBER	2	number	5	SENT_101	[p5l631t1859r648b1866],
5	38	CD	NUMBER	38	num	6	SENT_101	[p5l658t1851r688b1873],
6	n	NN	O	n	dep	1	SENT_101	[p5l1363t1862r1378b1877],
7	=	JJ	O	=	amod	6	SENT_101	[p5l1387t1863r1404b1870],
8	38	CD	NUMBER	38	tmod	7	SENT_101	[p5l1414t1855r1444b1878],

1	Enrollment	NN	O	enrollment	_	0	SENT_102	[p5l69t2028r201b2049],
2	criteria	NNS	O	criterion	dep	1	SENT_102	[p5l212t2029r294b2049],
3	and	CC	O	and	_	0	SENT_102	[p5l306t2028r350b2049],
4	trial	NN	O	trial	nn	5	SENT_102	[p5l362t2028r407b2049],
5	ﬂow	NN	O	ﬂow	dep	1	SENT_102	[p5l418t2027r476b2049],
6	.	.	O	.	_	0	SENT_102	[p5l418t2027r476b2049],

1	CAD	NN	O	cad	nn	5	SENT_103	[p5l488t2028r540b2049],
2	=	JJ	O	=	amod	5	SENT_103	[p5l554t2036r572b2043],
3	coronary	JJ	O	coronary	amod	5	SENT_103	[p5l586t2034r693b2055],
4	artery	NN	O	artery	nn	5	SENT_103	[p5l703t2031r773b2055],
5	disease	NN	O	disease	_	0	SENT_103	[p5l784t2028r878b2052],
6	;	:	O	;	_	0	SENT_103	[p5l784t2028r878b2052],
7	PCI	NN	O	pcus	dep	11	SENT_103	[p5l891t2028r926b2049],
8	2	CD	NUMBER	2	num	11	SENT_103	[p5l941t2036r959b2043],
9	percutaneous	JJ	O	percutaneous	amod	11	SENT_103	[p5l974t2031r1139b2055],
10	coronary	JJ	O	coronary	amod	11	SENT_103	[p5l1150t2034r1257b2055],
11	intervention	NN	O	intervention	dep	5	SENT_103	[p5l1269t2029r1423b2052],
12	;	:	O	;	_	0	SENT_103	[p5l1269t2029r1423b2052],
13	PRU	NNP	ORGANIZATION	PRU	dep	17	SENT_103	[p5l1435t2028r1482b2049],
14	=	JJ	O	=	amod	17	SENT_103	[p5l1496t2036r1514b2043],
15	P2Y12	NN	O	p2y12	nn	17	SENT_103	[p5l1529t2029r1596b2055],
16	reaction	NN	O	reaction	nn	17	SENT_103	[p5l1609t2029r1705b2049],
17	units	NNS	O	unit	parataxis	11	SENT_103	[p5l1718t2029r1782b2049],
18	.	.	O	.	_	0	SENT_103	[p5l1718t2029r1782b2049],

1	1	CD	NUMBER	1	num	2	SENT_104	[p5l1477t1554r1485b1577],
2	patient	NN	O	patient	_	0	SENT_104	[p5l1497t1554r1585b1583],
3	Statin	NN	O	statin	nn	4	SENT_104	[p5l1475t1591r1548b1614],
4	intolerance	NN	O	intolerance	dep	2	SENT_104	[p5l1558t1591r1699b1614],

1	Figure	NNP	O	Figure	_	0	SENT_105	[p5l68t1965r147b1991],
2	1	CD	NUMBER	1	dep	1	SENT_105	[p5l159t1966r182b1986],
3	.	.	O	.	_	0	SENT_105	[p5l159t1966r182b1986],

1	Study	NNP	O	Study	nn	3	SENT_106	[p5l194t1965r268b1991],
2	Flow	NN	O	flow	nn	3	SENT_106	[p5l279t1966r338b1986],
3	Chart	NN	O	chart	nsubj	4	SENT_106	[p5l349t1965r419b1986],
4	changed	VBD	O	change	_	0	SENT_106	[p5l9t2210r313b2300],
5	for	IN	O	for	_	0	SENT_106	[p5l366t2210r470b2277],
6	30	CD	DURATION	30	num	7	SENT_106	[p5l522t2214r608b2277],
7	days	NNS	NUMBER	day	prep_for	4	SENT_106	[p5l663t2210r839b2300],
8	.	.	O	.	_	0	SENT_106	[p5l663t2210r839b2300],

1	One	CD	NUMBER	one	num	2	SENT_107	[p5l899t2210r1054b2277],
2	patient	NN	O	patient	nsubj	13	SENT_107	[p5l1107t2213r1367b2300],
3	in	IN	O	in	_	0	SENT_107	[p5l1419t2213r1488b2276],
4	the	DT	O	the	det	6	SENT_107	[p5l1542t2210r1655b2277],
5	atorvastatin	NN	O	atorvastatin	nn	6	SENT_107	[p5l1711t2213r2140b2277],
6	group	NN	O	group	prep_in	2	SENT_107	[p5l7t2343r219b2407],
7	and	CC	O	and	_	0	SENT_107	[p5l248t2317r379b2384],
8	1	CD	NUMBER	1	conj_and	2	SENT_107	[p5l408t2321r440b2383],
9	in	IN	O	in	_	0	SENT_107	[p5l471t2320r541b2383],
10	the	DT	O	the	det	12	SENT_107	[p5l566t2318r680b2384],
11	control	NN	O	control	nn	12	SENT_107	[p5l708t2317r970b2384],
12	group	NN	O	group	prep_in	8	SENT_107	[p5l994t2343r1205b2407],
13	withdrew	VBD	O	withdraw	_	0	SENT_107	[p5l1229t2317r1582b2384],
14	from	IN	O	from	_	0	SENT_107	[p5l1605t2317r1780b2384],
15	the	DT	O	the	det	16	SENT_107	[p5l1807t2317r1920b2384],
16	study	NN	O	study	prep_from	13	SENT_107	[p5l1949t2317r2145b2407],
17	due	JJ	O	due	_	0	SENT_107	[p5l9t2423r136b2490],
18	to	TO	O	to	_	0	SENT_107	[p5l168t2440r238b2490],
19	drug	NN	O	drug	nn	20	SENT_107	[p5l271t2423r438b2513],
20	intolerance	NN	O	intolerance	prep_due_to	16	SENT_107	[p5l467t2423r896b2490],
21	.	.	O	.	_	0	SENT_107	[p5l467t2423r896b2490],

1	Thus	RB	O	thus	advmod	5	SENT_108	[p5l928t2422r1142b2504],
2	,	,	O	,	_	0	SENT_108	[p5l928t2422r1142b2504],
3	76	CD	NUMBER	76	num	4	SENT_108	[p5l1177t2425r1260b2490],
4	patients	NNS	O	patient	nsubj	5	SENT_108	[p5l1292t2426r1582b2513],
5	completed	VBD	O	complete	_	0	SENT_108	[p5l1615t2423r1997b2513],
6	the	DT	O	the	det	7	SENT_108	[p5l2027t2423r2140b2490],
7	study	NN	O	study	dobj	5	SENT_108	[p5l9t2530r222b2620],
8	.	.	O	.	_	0	SENT_108	[p5l9t2530r222b2620],

1	All	DT	O	all	det	2	SENT_109	[p5l94t2635r206b2702],
2	patients	NNS	O	patient	nsubj	3	SENT_109	[p5l242t2639r519b2726],
3	continued	VBD	O	continue	_	0	SENT_109	[p5l559t2636r913b2703],
4	treatment	NN	O	treatment	dobj	3	SENT_109	[p5l949t2654r1296b2703],
5	with	IN	O	with	_	0	SENT_109	[p5l1328t2637r1489b2703],
6	aspirin	NN	O	aspirin	nn	7	SENT_109	[p5l1528t2639r1764b2726],
7	(	NN	O	(	prep_with	3	SENT_109	[p5l1805t2634r1960b2717],
8	100	CD	NUMBER	100	num	9	SENT_109	[p5l1805t2634r1960b2717],
9	mg	NN	O	mg	dep	7	SENT_109	[p5l1999t2636r2143b2726],
10	/	:	O	/	punct	11	SENT_109	[p5l1999t2636r2143b2726],
11	day	NN	DURATION	day	dep	7	SENT_109	[p5l9t2740r153b2832],
12	)	CD	NUMBER	)	num	11	SENT_109	[p5l9t2740r153b2832],
13	indeﬁnitely	RB	O	indeﬁnitely	advmod	3	SENT_109	[p5l201t2742r619b2832],
14	.	.	O	.	_	0	SENT_109	[p5l201t2742r619b2832],

1	At	IN	O	at	_	0	SENT_110	[p5l665t2741r760b2809],
2	the	DT	O	the	det	3	SENT_110	[p5l802t2743r912b2809],
3	end	NN	O	end	prep_at	16	SENT_110	[p5l958t2742r1086b2809],
4	of	IN	O	of	_	0	SENT_110	[p5l1130t2742r1210b2809],
5	the	DT	O	the	det	6	SENT_110	[p5l1242t2743r1352b2809],
6	study	NN	O	study	prep_of	3	SENT_110	[p5l1398t2742r1603b2832],
7	,	,	O	,	_	0	SENT_110	[p5l1398t2742r1603b2832],
8	the	DT	O	the	det	9	SENT_110	[p5l1650t2743r1760b2809],
9	choice	NN	O	choice	nsubjpass	16	SENT_110	[p5l1806t2742r2028b2809],
10	of	IN	O	of	_	0	SENT_110	[p5l2073t2742r2153b2809],
11	antiplatelet	JJ	O	antiplatelet	amod	14	SENT_110	[p5l9t2848r406b2938],
12	and	CC	O	and	_	0	SENT_110	[p5l429t2848r556b2915],
13	statin	JJ	O	statin	conj_and	11	SENT_110	[p5l581t2851r774b2915],
14	dosage	NN	O	dosage	prep_of	9	SENT_110	[p5l798t2848r1035b2938],
15	was	VBD	O	be	auxpass	16	SENT_110	[p5l1055t2875r1184b2915],
16	left	VBN	O	leave	_	0	SENT_110	[p5l1209t2848r1324b2915],
17	at	IN	O	at	_	0	SENT_110	[p5l1348t2865r1411b2915],
18	the	DT	O	the	det	19	SENT_110	[p5l1433t2848r1543b2915],
19	discretion	NN	O	discretion	prep_at	16	SENT_110	[p5l1568t2848r1914b2915],
20	of	IN	O	of	_	0	SENT_110	[p5l1939t2848r2019b2915],
21	the	DT	O	the	det	23	SENT_110	[p5l2030t2848r2140b2915],
22	treating	VBG	O	treat	amod	23	SENT_110	[p5l8t2958r284b3045],
23	physician	NN	O	physician	prep_of	19	SENT_110	[p5l308t2955r658b3045],
24	.	.	O	.	_	0	SENT_110	[p5l308t2955r658b3045],

1	PCI	NN	O	pcus	nsubjpass	3	SENT_111	[p5l691t2955r839b3022],
2	was	VBD	O	be	auxpass	3	SENT_111	[p5l865t2982r994b3022],
3	performed	VBN	O	perform	_	0	SENT_111	[p5l1023t2955r1394b3045],
4	according	VBG	O	accord	_	0	SENT_111	[p5l1422t2955r1765b3045],
5	to	TO	O	to	prepc_according_to	3	SENT_111	[p5l1792t2973r1859b3022],
6	current	JJ	DATE	current	amod	8	SENT_111	[p5l1890t2973r2143b3022],
7	standard	JJ	O	standard	amod	8	SENT_111	[p5l9t3061r312b3128],
8	guidelines	NNS	O	guideline	pobj	3	SENT_111	[p5l354t3061r731b3151],
9	;	:	O	;	_	0	SENT_111	[p5l354t3061r731b3151],
10	the	DT	O	the	det	11	SENT_111	[p5l779t3061r889b3128],
11	type	NN	O	type	nsubj	14	SENT_111	[p5l934t3078r1081b3151],
12	of	IN	O	of	_	0	SENT_111	[p5l1127t3061r1207b3128],
13	stent	JJ	O	stent	prep_of	11	SENT_111	[p5l1241t3079r1412b3128],
14	implanted	VBN	O	implant	parataxis	3	SENT_111	[p5l1454t3061r1814b3151],
15	and	CC	O	and	_	0	SENT_111	[p5l1859t3061r1987b3128],
16	the	DT	O	the	det	18	SENT_111	[p5l2030t3061r2140b3128],
17	periprocedural	JJ	O	periprocedural	amod	18	SENT_111	[p5l7t3168r521b3258],
18	use	NN	O	use	nsubjpass	34	SENT_111	[p5l576t3195r688b3235],
19	of	IN	O	of	_	0	SENT_111	[p5l747t3168r827b3235],
20	antithrombotic	JJ	O	antithrombotic	amod	21	SENT_111	[p5l874t3168r1408b3235],
21	therapy	NN	O	therapy	prep_of	18	SENT_111	[p5l1464t3168r1748b3258],
22	,	,	O	,	_	0	SENT_111	[p5l1464t3168r1748b3258],
23	including	VBG	O	include	_	0	SENT_111	[p5l1809t3168r2143b3258],
24	glycoprotein	NN	O	glycoprotein	nn	27	SENT_111	[p5l7t3274r448b3364],
25	IIb/IIIa	NN	O	iib/iiia	nn	27	SENT_111	[p5l482t3274r759b3341],
26	inhibitor	NN	O	inhibitor	nn	27	SENT_111	[p5l793t3274r1106b3341],
27	use	NN	O	use	prep_including	18	SENT_111	[p5l1137t3301r1249b3341],
28	and	CC	O	and	_	0	SENT_111	[p5l1286t3274r1414b3341],
29	choice	NN	O	choice	prep_including	18	SENT_111	[p5l1448t3274r1670b3341],
30	of	IN	O	of	_	0	SENT_111	[p5l1706t3274r1787b3341],
31	anticoagulant	JJ	O	anticoagulant	prep_of	27	SENT_111	[p5l1810t3277r2138b3364, p5l7t3380r206b3461],
32	,	,	O	,	_	0	SENT_111	[p5l1810t3277r2138b3364, p5l7t3380r206b3461],
33	were	VBD	O	be	auxpass	34	SENT_111	[p5l238t3406r405b3447],
34	left	VBN	O	leave	parataxis	3	SENT_111	[p5l437t3380r554b3447],
35	to	TO	O	to	_	0	SENT_111	[p5l585t3397r653b3447],
36	the	DT	O	the	det	37	SENT_111	[p5l687t3380r797b3447],
37	discretion	NN	O	discretion	prep_to	34	SENT_111	[p5l832t3380r1178b3447],
38	of	IN	O	of	_	0	SENT_111	[p5l1212t3380r1292b3447],
39	the	DT	O	the	det	40	SENT_111	[p5l1313t3380r1423b3447],
40	operator	NN	O	operator	prep_of	37	SENT_111	[p5l1458t3397r1771b3470],
41	.	.	O	.	_	0	SENT_111	[p5l1458t3397r1771b3470],

1	Periprocedural	JJ	O	periprocedural	amod	3	SENT_112	[p5l99t3486r621b3576],
2	myocardial	JJ	O	myocardial	amod	3	SENT_112	[p5l654t3486r1044b3576],
3	infarction	NN	O	infarction	nsubjpass	5	SENT_112	[p5l1076t3486r1421b3553],
4	was	VBD	O	be	auxpass	5	SENT_112	[p5l1451t3513r1581b3553],
5	defined	VBN	O	define	_	0	SENT_112	[p5l1617t3486r1879b3553],
6	as	IN	O	as	_	0	SENT_112	[p5l1914t3513r1976b3553],
7	creatine	NN	O	creatine	nn	8	SENT_112	[p5l2013t3512r2147b3553, p5l11t3596r181b3659],
8	kinase	NN	O	kinase	prep_as	5	SENT_112	[p5l212t3593r611b3659],
9	.	.	O	.	_	0	SENT_112	[p5l212t3593r611b3659],

1	—	NN	O	—	_	0	SENT_113	[p5l212t3593r611b3659],
2	.	.	O	.	_	0	SENT_113	[p5l212t3593r611b3659],

1	MB	NN	O	mb	_	0	SENT_114	[p5l212t3593r611b3659],
2	(	CD	NUMBER	(	num	3	SENT_114	[p5l648t3590r1009b3673],
3	CK	NN	O	ck	dep	1	SENT_114	[p5l648t3590r1009b3673],
4	.	.	O	.	_	0	SENT_114	[p5l648t3590r1009b3673],

1	—	NN	O	—	_	0	SENT_115	[p5l648t3590r1009b3673],
2	.	.	O	.	_	0	SENT_115	[p5l648t3590r1009b3673],

1	MB	NN	O	mb	nn	4	SENT_116	[p5l648t3590r1009b3673],
2	)	CD	NUMBER	)	num	4	SENT_116	[p5l648t3590r1009b3673],
3	mass	NN	O	mass	nn	4	SENT_116	[p5l1043t3619r1211b3659],
4	elevation	NN	O	elevation	_	0	SENT_116	[p5l1244t3592r1560b3659],
5	23	CD	NUMBER	23	number	6	SENT_116	[p5l1595t3596r1702b3659],
6	times	NNS	O	time	dep	4	SENT_116	[p5l1736t3596r1925b3659],
7	ULN	NN	O	uln	dep	6	SENT_116	[p5l1955t3593r2148b3659],

1	within	IN	O	within	_	0	SENT_117	[p6l6t20r239b87],
2	24	CD	NUMBER	24	num	3	SENT_117	[p6l268t24r356b88],
3	h	NN	O	h	prep_within	18	SENT_117	[p6l387t20r432b86],
4	after	IN	O	after	_	0	SENT_117	[p6l465t20r625b87],
5	PCI	NN	O	pcus	prep_after	3	SENT_117	[p6l654t20r803b87],
6	or	CC	O	or	_	0	SENT_117	[p6l837t46r909b87],
7	the	DT	O	the	det	8	SENT_117	[p6l938t20r1049b87],
8	development	NN	O	development	prep_within	18	SENT_117	[p6l1082t20r1540b110],
9	of	IN	O	of	_	0	SENT_117	[p6l1571t20r1650b87],
10	new	JJ	O	new	amod	11	SENT_117	[p6l1671t47r1817b87],
11	Qwaves	NNPS	O	Qwaves	prep_of	8	SENT_117	[p6l1846t20r2148b104],
12	in	IN	O	in	_	0	SENT_117	[p6l9t130r77b193],
13	2	CD	NUMBER	2	prep_in	11	SENT_117	[p6l123t131r165b195],
14	or	CC	O	or	_	0	SENT_117	[p6l215t153r287b194],
15	more	JJR	O	more	prep_in	11	SENT_117	[p6l335t153r514b194],
16	contiguous	JJ	O	contiguous	amod	17	SENT_117	[p6l564t130r949b217],
17	electrocardiographic	NN	O	electrocardiographic	nsubj	18	SENT_117	[p6l1000t127r1722b217],
18	leads	VBZ	O	lead	_	0	SENT_117	[p6l1768t127r1942b194],
19	with	IN	O	with	_	0	SENT_117	[p6l1988t127r2150b194],
20	CK	NN	O	ck	prep_with	18	SENT_117	[p6l11t233r315b300],
21	.	.	O	.	_	0	SENT_117	[p6l11t233r315b300],

1	—	NN	O	—	_	0	SENT_118	[p6l11t233r315b300],
2	.	.	O	.	_	0	SENT_118	[p6l11t233r315b300],

1	MB	NN	O	mb	_	0	SENT_119	[p6l11t233r315b300],
2	greater	JJR	O	greater	dep	1	SENT_119	[p6l351t250r597b323],
3	than	IN	O	than	_	0	SENT_119	[p6l628t234r787b300],
4	ULN	NNP	O	ULN	nn	5	SENT_119	[p6l818t234r1012b300],
5	Yx	NN	O	yx	prep_than	2	SENT_119	[p6l1050t231r1165b314],
6	+	CC	O	+	rcmod	5	SENT_119	[p6l1050t231r1165b314],

1	Clinical	JJ	O	clinical	nsubjpass	11	SENT_120	[p6l100t340r397b421],
2	,	,	O	,	_	0	SENT_120	[p6l100t340r397b421],
3	biochemical	JJ	O	biochemical	amod	5	SENT_120	[p6l427t340r875b421],
4	,	,	O	,	_	0	SENT_120	[p6l427t340r875b421],
5	angiographic	JJ	O	angiographic	dep	11	SENT_120	[p6l908t340r1386b430],
6	,	,	O	,	_	0	SENT_120	[p6l908t340r1386b430],
7	and	CC	O	and	_	0	SENT_120	[p6l1419t340r1547b407],
8	genotyping	VBG	O	genotype	conj_and	5	SENT_120	[p6l1574t343r1975b430],
9	data	NNS	O	datum	dobj	8	SENT_120	[p6l2003t340r2151b407],
10	were	VBD	O	be	auxpass	11	SENT_120	[p6l6t472r172b513],
11	recorded	VBN	O	record	_	0	SENT_120	[p6l206t446r515b513],
12	for	IN	O	for	_	0	SENT_120	[p6l547t446r648b513],
13	all	DT	O	all	det	14	SENT_120	[p6l681t446r762b513],
14	patients	NNS	O	patient	prep_for	11	SENT_120	[p6l792t449r1071b536],
15	in	IN	O	in	_	0	SENT_120	[p6l1106t449r1173b512],
16	a	DT	O	a	det	18	SENT_120	[p6l1208t473r1243b513],
17	dedicated	JJ	O	dedicated	amod	18	SENT_120	[p6l1276t446r1615b513],
18	database	NN	O	database	prep_in	14	SENT_120	[p6l1648t446r1966b513],
19	.	.	O	.	_	0	SENT_120	[p6l1648t446r1966b513],

1	The	DT	O	the	det	2	SENT_121	[p6l2001t445r2149b513],
2	protocol	NN	O	protocol	nsubjpass	4	SENT_121	[p6l8t553r304b643],
3	was	VBD	O	be	auxpass	4	SENT_121	[p6l336t580r466b620],
4	approved	VBN	O	approve	_	0	SENT_121	[p6l505t553r828b643],
5	by	IN	O	by	_	0	SENT_121	[p6l862t553r948b643],
6	our	PRP$	O	we	poss	9	SENT_121	[p6l981t579r1099b620],
7	institutional	JJ	O	institutional	amod	9	SENT_121	[p6l1133t553r1566b620],
8	ethics	NNS	O	ethic	nn	9	SENT_121	[p6l1601t553r1802b620],
9	committee	NN	O	committee	agent	4	SENT_121	[p6l1841t556r2147b620, p6l9t713r130b776],
10	,	,	O	,	_	0	SENT_121	[p6l1841t556r2147b620, p6l9t713r130b776],

1	and	CC	O	and	cc	4	SENT_122	[p6l168t695r296b762],
2	all	DT	O	all	det	3	SENT_122	[p6l330t695r410b762],
3	patients	NNS	O	patient	nsubj	4	SENT_122	[p6l440t698r719b785],
4	gave	VBD	O	give	_	0	SENT_122	[p6l753t722r908b785],
5	written	VBN	O	write	amod	7	SENT_122	[p6l938t698r1196b762],
6	informed	VBN	O	inform	amod	7	SENT_122	[p6l1229t695r1557b762],
7	consent	NN	O	consent	dobj	4	SENT_122	[p6l1591t713r1879b762],
8	.	.	O	.	_	0	SENT_122	[p6l1591t713r1879b762],

1	Platelet	NN	O	platelet	_	0	SENT_123	[p6l12t808r272b867],
2	reactivity	NN	O	reactivity	dep	1	SENT_123	[p6l301t810r639b884],
3	.	.	O	.	_	0	SENT_123	[p6l301t810r639b884],

1	Platelet	NN	O	platelet	nn	2	SENT_124	[p6l688t801r957b868],
2	reactivity	NN	O	reactivity	nsubjpass	4	SENT_124	[p6l981t804r1307b891],
3	was	VBD	O	be	auxpass	4	SENT_124	[p6l1326t828r1456b868],
4	evaluated	VBN	O	evaluate	_	0	SENT_124	[p6l1485t801r1815b868],
5	immediately	RB	O	immediately	advmod	4	SENT_124	[p6l1841t801r2147b868, p6l11t907r176b997],
6	before	IN	O	before	_	0	SENT_124	[p6l203t907r425b974],
7	PCI	NN	O	pcus	nn	9	SENT_124	[p6l459t907r607b974],
8	(	CD	NUMBER	(	num	9	SENT_124	[p6l646t905r838b988],
9	T	NN	O	t	prep_before	4	SENT_124	[p6l646t905r838b988],
10	.	.	O	.	_	0	SENT_124	[p6l646t905r838b988],

1	—	NN	O	—	_	0	SENT_125	[p6l646t905r838b988],
2	.	.	O	.	_	0	SENT_125	[p6l646t905r838b988],

1	O	NN	O	o	nn	2	SENT_126	[p6l646t905r838b988],
2	)	NN	O	)	_	0	SENT_126	[p6l646t905r838b988],
3	and	CC	O	and	_	0	SENT_126	[p6l876t907r1004b974],
4	at	IN	O	at	advmod	2	SENT_126	[p6l1038t925r1102b974],
5	10	CD	NUMBER	10	number	6	SENT_126	[p6l1137t911r1218b974],
6	(	CD	NUMBER	(	num	7	SENT_126	[p6l1255t905r1448b988],
7	T	NN	O	t	pobj	4	SENT_126	[p6l1255t905r1448b988],
8	—	CD	NUMBER	—	number	9	SENT_126	[p6l1255t905r1448b988],
9	1	CD	NUMBER	1	num	10	SENT_126	[p6l1255t905r1448b988],
10	)	NN	O	)	conj_and	2	SENT_126	[p6l1255t905r1448b988],
11	and	CC	O	and	_	0	SENT_126	[p6l1486t907r1614b974],
12	30	CD	NUMBER	30	number	13	SENT_126	[p6l1647t911r1731b974],
13	(	CD	NUMBER	(	num	15	SENT_126	[p6l1768t905r1960b988],
14	T	NN	O	t	nn	15	SENT_126	[p6l1768t905r1960b988],
15	—	NN	O	—	conj_and	2	SENT_126	[p6l1768t905r1960b988],
16	2	CD	NUMBER	2	number	17	SENT_126	[p6l1768t905r1960b988],
17	)	CD	NUMBER	)	num	18	SENT_126	[p6l1768t905r1960b988],
18	days	NNS	NUMBER	day	dep	15	SENT_126	[p6l1998t907r2148b997],
19	using	VBG	O	use	partmod	2	SENT_126	[p6l8t1016r199b1103],
20	the	DT	O	the	det	23	SENT_126	[p6l228t1014r338b1080],
21	VerifyNovv	NNP	O	VerifyNovv	nn	23	SENT_126	[p6l369t1013r768b1103],
22	P2Y12	NN	O	p2y12	nn	23	SENT_126	[p6l796t1014r1016b1100],
23	assay	NN	O	assay	dobj	19	SENT_126	[p6l1049t1040r1241b1103],
24	.	.	O	.	_	0	SENT_126	[p6l1049t1040r1241b1103],

1	This	DT	O	this	det	3	SENT_127	[p6l1273t1012r1437b1080],
2	point	NN	O	point	nn	3	SENT_127	[p6l1468t1013r1943b1103],
3	—	NN	O	—	_	0	SENT_127	[p6l1468t1013r1943b1103],
4	of	IN	O	of	_	0	SENT_127	[p6l1468t1013r1943b1103],
5	—	CD	NUMBER	—	num	6	SENT_127	[p6l1468t1013r1943b1103],
6	care	NN	O	care	prep_of	3	SENT_127	[p6l1468t1013r1943b1103],
7	assay	NN	O	assay	nn	9	SENT_127	[p6l1976t1040r2154b1103],
8	172	CD	NUMBER	172	num	9	SENT_127	[p6l11t1117r114b1160],
9	Leoncini	NNP	O	Leoncini	dep	3	SENT_127	[p6l332t1118r548b1161],
10	et	FW	O	et	nn	11	SENT_127	[p6l571t1119r623b1161],
11	al.	FW	O	al.	dep	9	SENT_127	[p6l640t1118r698b1161],
12	.	.	O	.	_	0	SENT_127	[p6l640t1118r698b1161],

1	High-Dose	JJ	O	high-dose	amod	2	SENT_128	[p6l332t1200r597b1253],
2	Atorvastatin	NN	O	atorvastatin	nsubj	6	SENT_128	[p6l617t1200r936b1242],
3	and	CC	O	and	_	0	SENT_128	[p6l960t1200r1055b1242],
4	Platelet	NN	O	platelet	nn	5	SENT_128	[p6l1081t1200r1282b1242],
5	Reactivity	NN	O	reactivity	nsubj	6	SENT_128	[p6l1306t1200r1562b1253],
6	measures	VBZ	O	measure	_	0	SENT_128	[p6l11t1440r328b1481],
7	the	DT	O	the	det	8	SENT_128	[p6l362t1414r472b1481],
8	inhibition	NN	O	inhibition	dobj	6	SENT_128	[p6l505t1414r857b1481],
9	of	IN	O	of	_	0	SENT_128	[p6l890t1414r969b1481],
10	P2Y12	NN	O	p2y12	nn	12	SENT_128	[p6l990t1415r1209b1501],
11	ADP	NN	O	adp	nn	12	SENT_128	[p6l1240t1413r1431b1480],
12	receptors	NNS	O	receptor	prep_of	8	SENT_128	[p6l1463t1432r1781b1504],
13	on	IN	O	on	_	0	SENT_128	[p6l1816t1441r1903b1481],
14	platelets	NNS	O	platelet	prep_on	6	SENT_128	[p6l1934t1414r2137b1504, p6l9t1520r146b1587],
15	.	.	O	.	_	0	SENT_128	[p6l1934t1414r2137b1504, p6l9t1520r146b1587],

1	Technical	NNP	O	Technical	nn	2	SENT_129	[p6l198t1519r551b1587],
2	details	NNS	O	detail	nsubjpass	8	SENT_129	[p6l602t1520r824b1587],
3	of	IN	O	of	_	0	SENT_129	[p6l878t1520r958b1587],
4	the	DT	O	the	det	5	SENT_129	[p6l996t1521r1106b1587],
5	assay	NN	O	assay	prep_of	2	SENT_129	[p6l1160t1547r1336b1610],
6	have	VBP	O	have	aux	8	SENT_129	[p6l1384t1521r1541b1587],
7	been	VBN	O	be	auxpass	8	SENT_129	[p6l1591t1520r1757b1587],
8	described	VBN	O	describe	_	0	SENT_129	[p6l1809t1520r2141b1587],
9	previously	RB	DATE	previously	advmod	8	SENT_129	[p6l9t1627r369b1716],
10	(	RB	O	(	amod	12	SENT_129	[p6l401t1624r560b1707],
11	20	CD	NUMBER	20	tmod	10	SENT_129	[p6l401t1624r560b1707],
12	)	NN	O	)	dobj	8	SENT_129	[p6l401t1624r560b1707],
13	.	.	O	.	_	0	SENT_129	[p6l401t1624r560b1707],

1	Blood	NN	O	blood	nn	2	SENT_130	[p6l598t1626r811b1693],
2	samples	NNS	O	sample	nsubjpass	8	SENT_130	[p6l844t1627r1117b1716],
3	for	IN	O	for	_	0	SENT_130	[p6l1151t1626r1252b1693],
4	platelet	NN	O	platelet	nn	6	SENT_130	[p6l1282t1626r1543b1716],
5	function	NN	O	function	nn	6	SENT_130	[p6l1574t1626r1870b1693],
6	testing	NN	O	testing	prep_for	2	SENT_130	[p6l1903t1629r2142b1716],
7	were	VBD	O	be	auxpass	8	SENT_130	[p6l7t1758r173b1799],
8	collected	VBN	O	collect	_	0	SENT_130	[p6l227t1732r536b1799],
9	just	RB	O	just	advmod	8	SENT_130	[p6l578t1734r712b1822],
10	before	IN	O	before	_	0	SENT_130	[p6l760t1732r981b1799],
11	PCI	NN	O	pcus	prep_before	8	SENT_130	[p6l1034t1732r1181b1799],
12	and	CC	O	and	_	0	SENT_130	[p6l1237t1732r1364b1799],
13	2	CD	NUMBER	2	number	15	SENT_130	[p6l1414t1736r1455b1800],
14	to	TO	O	to	dep	15	SENT_130	[p6l1508t1750r1576b1799],
15	4	CD	NUMBER	4	num	16	SENT_130	[p6l1629t1736r1670b1798],
16	h	NN	O	h	prep_before	8	SENT_130	[p6l1722t1732r1767b1798],
17	after	IN	O	after	_	0	SENT_130	[p6l1820t1732r1978b1799],
18	the	DT	O	the	det	19	SENT_130	[p6l2028t1732r2139b1799],
19	ingestion	NN	O	ingestion	prep_after	8	SENT_130	[p6l10t1841r334b1928],
20	of	IN	O	of	_	0	SENT_130	[p6l362t1838r441b1905],
21	the	DT	O	the	det	24	SENT_130	[p6l456t1838r566b1905],
22	last	JJ	O	last	amod	24	SENT_130	[p6l593t1839r713b1905],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_130	[p6l739t1838r1134b1928],
24	dose	NN	O	dose	prep_of	19	SENT_130	[p6l1160t1838r1334b1905],
25	.	.	O	.	_	0	SENT_130	[p6l1160t1838r1334b1905],

1	We	PRP	O	we	nsubj	2	SENT_131	[p6l1362t1839r1492b1905],
2	note	VBP	O	note	_	0	SENT_131	[p6l1521t1855r1673b1905],
3	that	IN	O	that	_	0	SENT_131	[p6l1701t1838r1842b1905],
4	the	DT	O	the	det	9	SENT_131	[p6l1867t1838r1977b1905],
5	first	JJ	ORDINAL	first	amod	9	SENT_131	[p6l2005t1838r2142b1905],
6	blood	NN	O	blood	nn	9	SENT_131	[p6l8t1944r210b2011],
7	sample	NN	O	sample	nn	9	SENT_131	[p6l258t1945r500b2034],
8	(	CD	NUMBER	(	num	9	SENT_131	[p6l552t1942r743b2025],
9	T	NN	O	t	prep_that	2	SENT_131	[p6l552t1942r743b2025],
10	.	.	O	.	_	0	SENT_131	[p6l552t1942r743b2025],

1	—	NN	O	—	_	0	SENT_132	[p6l552t1942r743b2025],
2	.	.	O	.	_	0	SENT_132	[p6l552t1942r743b2025],

1	O	NN	O	o	nn	2	SENT_133	[p6l552t1942r743b2025],
2	)	NN	O	)	nsubjpass	4	SENT_133	[p6l552t1942r743b2025],
3	was	VBD	O	be	auxpass	4	SENT_133	[p6l791t1971r920b2011],
4	drawn	VBN	O	draw	_	0	SENT_133	[p6l971t1944r1189b2011],
5	before	IN	O	before	_	0	SENT_133	[p6l1235t1944r1456b2011],
6	administration	NN	O	administration	prep_before	4	SENT_133	[p6l1506t1944r2024b2011],
7	of	IN	O	of	_	0	SENT_133	[p6l2073t1944r2152b2011],
8	glycoprotein	NN	O	glycoprotein	nn	10	SENT_133	[p6l9t2050r450b2140],
9	IIb/IIIa	NN	O	iib/iiia	nn	10	SENT_133	[p6l474t2050r751b2117],
10	inhibitors	NNS	O	inhibitor	prep_of	6	SENT_133	[p6l775t2050r1135b2117],
11	.	.	O	.	_	0	SENT_133	[p6l775t2050r1135b2117],

1	The	DT	O	the	det	4	SENT_134	[p6l1161t2049r1308b2117],
2	VerifyNovv	NNP	O	VerifyNovv	nn	4	SENT_134	[p6l1334t2050r1731b2140],
3	instrument	NN	O	instrument	nn	4	SENT_134	[p6l1752t2053r2142b2117],
4	reports	NNS	O	report	_	0	SENT_134	[p6l10t2173r253b2246],
5	3	CD	NUMBER	3	num	7	SENT_134	[p6l281t2160r317b2223],
6	different	JJ	O	different	amod	7	SENT_134	[p6l347t2156r643b2223],
7	parameters	NNS	O	parameter	dep	4	SENT_134	[p6l665t2174r1051b2246],
8	for	IN	O	for	_	0	SENT_134	[p6l1077t2156r1178b2223],
9	each	DT	O	each	det	10	SENT_134	[p6l1202t2156r1358b2223],
10	assay	NN	O	assay	prep_for	7	SENT_134	[p6l1384t2183r1575b2246],
11	:	:	O	:	_	0	SENT_134	[p6l1384t2183r1575b2246],
12	1	CD	NUMBER	1	number	13	SENT_134	[p6l1609t2154r1671b2237],
13	)	CD	NUMBER	)	num	14	SENT_134	[p6l1609t2154r1671b2237],
14	PRU	NNP	ORGANIZATION	PRU	dep	4	SENT_134	[p6l1701t2157r1898b2237],
15	,	,	O	,	_	0	SENT_134	[p6l1701t2157r1898b2237],
16	which	WDT	O	which	nsubj	17	SENT_134	[p6l1923t2156r2140b2223],
17	express	VBP	O	express	rcmod	14	SENT_134	[p6l11t2288r259b2352],
18	the	DT	O	the	det	19	SENT_134	[p6l287t2262r398b2329],
19	extent	NN	O	extent	dobj	17	SENT_134	[p6l427t2279r643b2329],
20	of	IN	O	of	_	0	SENT_134	[p6l669t2262r749b2329],
21	ADP-mediated	JJ	O	adp-mediated	amod	23	SENT_134	[p6l761t2261r1319b2329],
22	aggregation	NN	O	aggregation	nn	23	SENT_134	[p6l1347t2265r1760b2352],
23	speciﬁc	NN	O	speciﬁc	prep_of	19	SENT_134	[p6l1788t2262r2045b2352],
24	to	TO	O	to	_	0	SENT_134	[p6l2071t2279r2139b2329],
25	the	DT	O	the	det	27	SENT_134	[p6l10t2369r120b2435],
26	P2Y12	NN	O	p2y12	nn	27	SENT_134	[p6l159t2369r378b2455],
27	receptors	NNS	O	receptor	prep_to	17	SENT_134	[p6l417t2386r756b2458],
28	;	:	O	;	_	0	SENT_134	[p6l417t2386r756b2458],
29	2	CD	NUMBER	2	number	30	SENT_134	[p6l795t2366r864b2449],
30	)	CD	NUMBER	)	num	31	SENT_134	[p6l795t2366r864b2449],
31	iso	NN	O	iso	dep	14	SENT_134	[p6l905t2367r1282b2435],
32	.	.	O	.	_	0	SENT_134	[p6l905t2367r1282b2435],

1	—	NN	O	—	_	0	SENT_135	[p6l905t2367r1282b2435],
2	.	.	O	.	_	0	SENT_135	[p6l905t2367r1282b2435],

1	TRAP	NN	O	trap	nn	3	SENT_136	[p6l905t2367r1282b2435],
2	reaction	NN	O	reaction	nn	3	SENT_136	[p6l1319t2371r1602b2435],
3	units	NNS	O	unit	nsubj	4	SENT_136	[p6l1639t2371r1811b2435],
4	(	VBP	O	(	_	0	SENT_136	[p6l1853t2366r2137b2449],
5	BASE	NN	O	base	nn	6	SENT_136	[p6l1853t2366r2137b2449],
6	)	NN	O	)	dobj	4	SENT_136	[p6l1853t2366r2137b2449],
7	which	WDT	O	which	nsubj	8	SENT_136	[p6l7t2474r224b2541],
8	represents	VBZ	O	represent	rcmod	6	SENT_136	[p6l283t2492r637b2564],
9	total	JJ	O	total	amod	11	SENT_136	[p6l698t2474r857b2541],
10	platelet	NN	O	platelet	nn	11	SENT_136	[p6l915t2474r1176b2564],
11	function	NN	O	function	dobj	8	SENT_136	[p6l1233t2474r1550b2555],
12	,	,	O	,	_	0	SENT_136	[p6l1233t2474r1550b2555],
13	despite	IN	O	despite	dep	8	SENT_136	[p6l1613t2474r1859b2564],
14	P2Y12	NN	O	p2y12	nn	16	SENT_136	[p6l1920t2475r2139b2561],
15	receptor	NN	O	receptor	nn	16	SENT_136	[p6l10t2598r299b2671],
16	blockage	NN	O	blockage	pobj	13	SENT_136	[p6l348t2581r678b2671],
17	,	,	O	,	_	0	SENT_136	[p6l348t2581r678b2671],
18	in	IN	O	in	_	0	SENT_136	[p6l733t2584r801b2647],
19	response	NN	O	response	nsubj	25	SENT_136	[p6l853t2607r1155b2671],
20	to	TO	O	to	_	0	SENT_136	[p6l1208t2598r1276b2648],
21	iso	NN	O	iso	nn	24	SENT_136	[p6l1330t2581r1800b2648],
22	—	CD	NUMBER	—	num	24	SENT_136	[p6l1330t2581r1800b2648],
23	thrombin	NN	O	thrombin	nn	24	SENT_136	[p6l1330t2581r1800b2648],
24	receptor	NN	O	receptor	prep_to	19	SENT_136	[p6l1852t2598r2142b2671],
25	activating	VBG	O	activate	prepc_in	8	SENT_136	[p6l12t2690r354b2777],
26	peptides	NNS	O	peptide	nsubj	28	SENT_136	[p6l399t2687r692b2777],
27	(	CD	NUMBER	(	num	28	SENT_136	[p6l745t2685r1173b2768],
28	iso	NN	O	iso	xcomp	25	SENT_136	[p6l745t2685r1173b2768],
29	.	.	O	.	_	0	SENT_136	[p6l745t2685r1173b2768],

1	—	NN	O	—	_	0	SENT_137	[p6l745t2685r1173b2768],
2	.	.	O	.	_	0	SENT_137	[p6l745t2685r1173b2768],

1	TRAP	NN	O	trap	_	0	SENT_138	[p6l745t2685r1173b2768],
2	)	CD	NUMBER	)	num	1	SENT_138	[p6l745t2685r1173b2768],
3	specific	JJ	O	specific	amod	1	SENT_138	[p6l1226t2687r1482b2777],
4	to	TO	O	to	_	0	SENT_138	[p6l1529t2704r1597b2754],
5	the	DT	O	the	det	8	SENT_138	[p6l1646t2687r1756b2754],
6	thrombin	NN	O	thrombin	nn	8	SENT_138	[p6l1805t2687r2140b2754],
7	protease	NN	O	protease	nn	8	SENT_138	[p6l9t2793r653b2883],
8	—	NN	O	—	prep_to	3	SENT_138	[p6l9t2793r653b2883],
9	activated	VBN	O	activate	partmod	8	SENT_138	[p6l9t2793r653b2883],
10	receptor	NN	O	receptor	nn	11	SENT_138	[p6l676t2797r1039b2883],
11	—	NN	O	—	dobj	9	SENT_138	[p6l676t2797r1039b2883],
12	1	CD	NUMBER	1	number	13	SENT_138	[p6l676t2797r1039b2883],
13	(	CD	NUMBER	(	num	17	SENT_138	[p6l1071t2791r1382b2874],
14	PAR	NN	O	par	nn	17	SENT_138	[p6l1071t2791r1382b2874],
15	—	NN	O	—	nn	17	SENT_138	[p6l1071t2791r1382b2874],
16	1	CD	NUMBER	1	num	17	SENT_138	[p6l1071t2791r1382b2874],
17	)	NN	O	)	dep	11	SENT_138	[p6l1071t2791r1382b2874],
18	and	CC	O	and	_	0	SENT_138	[p6l1412t2793r1540b2860],
19	PARS	NN	O	par	conj_and	11	SENT_138	[p6l1563t2792r1890b2874],
20	—	CD	NUMBER	—	number	21	SENT_138	[p6l1563t2792r1890b2874],
21	4	CD	NUMBER	4	dep	19	SENT_138	[p6l1563t2792r1890b2874],
22	;	:	O	;	_	0	SENT_138	[p6l1563t2792r1890b2874],
23	and	CC	O	and	_	0	SENT_138	[p6l1919t2793r2046b2860],
24	3	CD	PERCENT	3	num	26	SENT_138	[p6l2071t2791r2136b2874],
25	)	NN	PERCENT	)	nn	26	SENT_138	[p6l2071t2791r2136b2874],
26	percent	NN	PERCENT	percent	conj_and	11	SENT_138	[p6l9t2917r272b2989],
27	platelet	NN	O	platelet	nn	32	SENT_138	[p6l298t2900r559b2989],
28	P2Y12	NN	O	p2y12	nn	32	SENT_138	[p6l586t2900r805b2986],
29	inhibition	NN	O	inhibition	nn	32	SENT_138	[p6l835t2899r1186b2966],
30	(	CD	NUMBER	(	num	32	SENT_138	[p6l1218t2897r1419b2980],
31	IPA	NN	O	ipa	nn	32	SENT_138	[p6l1218t2897r1419b2980],
32	)	NN	O	)	nsubj	40	SENT_138	[p6l1218t2897r1419b2980],
33	calculated	VBN	O	calculate	partmod	32	SENT_138	[p6l1452t2899r1801b2966],
34	based	VBN	O	base	_	0	SENT_138	[p6l1826t2899r2024b2966],
35	on	IN	O	on	prepc_based_on	33	SENT_138	[p6l2053t2926r2140b2966],
36	the	DT	O	the	det	37	SENT_138	[p6l10t3005r120b3072],
37	PRU	NNP	ORGANIZATION	PRU	pobj	33	SENT_138	[p6l175t3006r355b3072],
38	and	CC	O	and	_	0	SENT_138	[p6l410t3005r537b3072],
39	BASE	NNP	O	BASE	pobj	33	SENT_138	[p6l591t3004r821b3072],
40	results	VBZ	O	result	rcmod	26	SENT_138	[p6l876t3005r1099b3072],
41	according	VBG	O	accord	_	0	SENT_138	[p6l1157t3005r1499b3095],
42	to	TO	O	to	prepc_according_to	40	SENT_138	[p6l1552t3023r1620b3072],
43	the	DT	O	the	det	44	SENT_138	[p6l1676t3005r1786b3072],
44	formula	NN	O	formulum	pobj	40	SENT_138	[p6l1841t3005r2135b3072],
45	:	:	O	:	_	0	SENT_138	[p6l1841t3005r2135b3072],
46	[	CD	NUMBER	[	number	47	SENT_138	[p6l15t3110r301b3192],
47	(	CD	NUMBER	(	num	48	SENT_138	[p6l15t3110r301b3192],
48	BASE	NN	O	base	dep	1	SENT_138	[p6l15t3110r301b3192],
49	—	CD	NUMBER	—	num	51	SENT_138	[p6l353t3146r406b3151],
50	PRU	NNP	O	PRU	nn	51	SENT_138	[p6l458t3110r662b3192],
51	)	NN	O	)	dep	48	SENT_138	[p6l458t3110r662b3192],
52	+	CC	O	+	_	0	SENT_138	[p6l717t3128r770b3169],
53	BASE	NN	O	base	nn	54	SENT_138	[p6l822t3110r1078b3192],
54	]	NN	O	]	dep	1	SENT_138	[p6l822t3110r1078b3192],
55	X	NN	O	x	num	59	SENT_138	[p6l1135t3122r1188b3174],
56	100	CD	NUMBER	100	number	55	SENT_138	[p6l1244t3116r1369b3178],
57	(	CD	NUMBER	(	number	55	SENT_138	[p6l1416t3110r1575b3192],
58	20	CD	NUMBER	20	number	55	SENT_138	[p6l1416t3110r1575b3192],
59	)	NN	O	)	dep	54	SENT_138	[p6l1416t3110r1575b3192],
60	.	.	O	.	_	0	SENT_138	[p6l1416t3110r1575b3192],

1	We	PRP	O	we	nsubj	2	SENT_139	[p6l1618t3113r1748b3179],
2	calculated	VBD	O	calculate	_	0	SENT_139	[p6l1792t3112r2141b3178],
3	absolute	JJ	O	absolute	amod	6	SENT_139	[p7l12t20r298b87],
4	and	CC	O	and	_	0	SENT_139	[p7l330t20r458b87],
5	relative	JJ	O	relative	amod	6	SENT_139	[p7l487t20r740b87],
6	changes	NNS	O	change	dobj	2	SENT_139	[p7l772t20r1048b110],
7	over	IN	O	over	_	0	SENT_139	[p7l1080t46r1228b87],
8	time	NN	O	time	prep_over	2	SENT_139	[p7l1257t23r1414b87],
9	in	IN	O	in	_	0	SENT_139	[p7l1445t23r1512b86],
10	PRU	NNP	ORGANIZATION	PRU	prep_in	2	SENT_139	[p7l1543t21r1722b87],
11	and	CC	O	and	_	0	SENT_139	[p7l1752t20r1880b87],
12	BASE	NN	O	base	nn	13	SENT_139	[p7l1909t19r2139b87],
13	values	NNS	O	value	conj_and	10	SENT_139	[p7l7t127r239b193],
14	.	.	O	.	_	0	SENT_139	[p7l7t127r239b193],

1	The	DT	O	the	det	2	SENT_140	[p7l282t125r429b193],
2	quality	NN	O	quality	nsubj	3	SENT_140	[p7l473t126r714b216],
3	controls	VBZ	O	control	dep	9	SENT_140	[p7l754t126r1033b193],
4	for	IN	O	for	_	0	SENT_140	[p7l1077t126r1177b193],
5	our	PRP$	O	we	poss	6	SENT_140	[p7l1219t152r1336b193],
6	laboratory	NN	O	laboratory	prep_for	3	SENT_140	[p7l1375t126r1736b216],
7	have	VBP	O	have	aux	9	SENT_140	[p7l1775t126r1933b193],
8	been	VBN	O	be	auxpass	9	SENT_140	[p7l1974t127r2140b193],
9	reported	VBN	O	report	_	0	SENT_140	[p7l10t232r309b322],
10	elsewhere	RB	O	elsewhere	advmod	9	SENT_140	[p7l333t232r673b299],
11	(	RB	O	(	advmod	9	SENT_140	[p7l701t230r860b313],
12	18	CD	NUMBER	18	num	13	SENT_140	[p7l701t230r860b313],
13	)	NN	O	)	nsubjpass	9	SENT_140	[p7l701t230r860b313],
14	.	.	O	.	_	0	SENT_140	[p7l701t230r860b313],

1	Clinical	JJ	O	clinical	nsubj	2	SENT_141	[p7l891t232r1168b299],
2	follow	VBP	O	follow	_	0	SENT_141	[p7l1191t232r1535b322],
3	—	RB	O	—	advmod	2	SENT_141	[p7l1191t232r1535b322],
4	up	RB	O	up	advmod	2	SENT_141	[p7l1191t232r1535b322],
5	and	CC	O	and	_	0	SENT_141	[p7l1562t232r1690b299],
6	plasma	NN	O	plasma	nn	8	SENT_141	[p7l1712t232r1959b322],
7	lipid	NN	O	lipid	nn	8	SENT_141	[p7l1980t232r2141b322],
8	levels	NNS	O	level	nsubjpass	11	SENT_141	[p7l9t338r196b405],
9	were	VBD	O	be	auxpass	11	SENT_141	[p7l225t364r392b405],
10	also	RB	O	also	advmod	11	SENT_141	[p7l425t338r555b405],
11	carried	VBN	O	carry	conj_and	2	SENT_141	[p7l588t338r827b405],
12	out	RP	O	out	prt	11	SENT_141	[p7l858t356r974b405],
13	at	IN	O	at	_	0	SENT_141	[p7l1004t356r1067b405],
14	T-o	NNP	O	T-o	prep_at	11	SENT_141	[p7l1093t337r1255b419],
15	,	,	O	,	_	0	SENT_141	[p7l1093t337r1255b419],
16	T	NN	O	t	prep_at	11	SENT_141	[p7l1286t337r1448b419],
17	—	CD	NUMBER	—	number	18	SENT_141	[p7l1286t337r1448b419],
18	1	CD	NUMBER	1	dep	16	SENT_141	[p7l1286t337r1448b419],
19	,	,	O	,	_	0	SENT_141	[p7l1286t337r1448b419],
20	and	CC	O	and	_	0	SENT_141	[p7l1483t338r1610b405],
21	T-2	NN	O	t-2	prep_at	11	SENT_141	[p7l1638t337r1798b406],
22	.	.	O	.	_	0	SENT_141	[p7l1638t337r1798b406],

1	Compliance	NN	O	compliance	nsubjpass	6	SENT_142	[p7l1835t338r2137b428, p7l12t471r165b511],
2	and	CC	O	and	_	0	SENT_142	[p7l217t444r345b511],
3	adverse	JJ	O	adverse	amod	4	SENT_142	[p7l395t444r650b511],
4	events	NNS	O	event	conj_and	1	SENT_142	[p7l701t461r916b511],
5	were	VBD	O	be	auxpass	6	SENT_142	[p7l964t470r1130b511],
6	assessed	VBN	O	assess	_	0	SENT_142	[p7l1182t444r1465b511],
7	by	IN	O	by	_	0	SENT_142	[p7l1512t444r1598b534],
8	the	DT	O	the	det	10	SENT_142	[p7l1643t444r1753b511],
9	attending	VBG	O	attend	amod	10	SENT_142	[p7l1805t444r2142b534],
10	physician	NN	O	physician	agent	6	SENT_142	[p7l9t551r340b641],
11	based	VBN	O	base	_	0	SENT_142	[p7l388t551r586b618],
12	on	IN	O	on	prepc_based_on	10	SENT_142	[p7l637t578r724b618],
13	interview	NN	O	interview	pobj	10	SENT_142	[p7l775t554r1120b632],
14	,	,	O	,	_	0	SENT_142	[p7l775t554r1120b632],
15	pill	NN	O	pill	nn	16	SENT_142	[p7l1172t551r1285b641],
16	count	NN	O	count	pobj	10	SENT_142	[p7l1336t569r1552b632],
17	,	,	O	,	_	0	SENT_142	[p7l1336t569r1552b632],
18	and	CC	O	and	_	0	SENT_142	[p7l1607t551r1735b618],
19	laboratory	NN	O	laboratory	nn	20	SENT_142	[p7l1783t551r2144b641],
20	evaluation	NN	O	evaluation	conj_and	13	SENT_142	[p7l11t656r388b722],
21	.	.	O	.	_	0	SENT_142	[p7l11t656r388b722],

1	Genotyping	NN	O	genotyping	_	0	SENT_143	[p7l11t772r437b845],
2	.	.	O	.	_	0	SENT_143	[p7l11t772r437b845],

1	Genomic	JJ	O	genomic	amod	2	SENT_144	[p7l488t762r817b829],
2	DNA	NN	O	dna	nsubjpass	4	SENT_144	[p7l849t761r1056b828],
3	was	VBD	O	be	auxpass	4	SENT_144	[p7l1083t789r1212b829],
4	isolated	VBN	O	isolate	_	0	SENT_144	[p7l1246t762r1516b829],
5	from	IN	O	from	_	0	SENT_144	[p7l1548t762r1718b829],
6	venous	JJ	O	venous	amod	8	SENT_144	[p7l1747t789r1990b829],
7	peripheral	JJ	O	peripheral	amod	8	SENT_144	[p7l2023t789r2137b852, p7l10t868r284b958],
8	blood	NN	O	blood	prep_from	4	SENT_144	[p7l316t868r518b935],
9	using	VBG	O	use	partmod	8	SENT_144	[p7l552t871r742b958],
10	Tecan	NNP	ORGANIZATION	Tecan	dobj	9	SENT_144	[p7l773t867r1014b949],
11	,	,	O	,	_	0	SENT_144	[p7l773t867r1014b949],
12	Freedom	NNP	O	Freedom	nn	15	SENT_144	[p7l1053t868r1369b935],
13	EVO	NNP	O	EVO	nn	15	SENT_144	[p7l1407t868r1597b935],
14	liquid	JJ	O	liquid	amod	15	SENT_144	[p7l1633t868r1839b958],
15	handler	NN	O	handler	dobj	9	SENT_144	[p7l1873t868r2142b935],
16	(	CD	NUMBER	(	num	18	SENT_144	[p7l13t972r258b1055],
17	Tecan	NNP	ORGANIZATION	Tecan	nn	18	SENT_144	[p7l13t972r258b1055],
18	Group	NNP	ORGANIZATION	Group	dep	15	SENT_144	[p7l292t974r544b1064],
19	,	,	O	,	_	0	SENT_144	[p7l292t974r544b1064],
20	Mannedorf	NNP	PERSON	Mannedorf	conj_and	10	SENT_144	[p7l576t974r1000b1055],
21	,	,	O	,	_	0	SENT_144	[p7l576t974r1000b1055],
22	Switzerland	NNP	LOCATION	Switzerland	nn	23	SENT_144	[p7l1038t972r1480b1055],
23	)	NNP	O	)	dobj	9	SENT_144	[p7l1038t972r1480b1055],
24	and	CC	O	and	_	0	SENT_144	[p7l1517t975r1644b1041],
25	the	DT	O	the	det	27	SENT_144	[p7l1675t975r1785b1041],
26	magnetic	JJ	O	magnetic	amod	27	SENT_144	[p7l1818t977r2141b1064],
27	bead	NN	O	bead	dobj	9	SENT_144	[p7l8t1080r174b1147],
28	based	VBN	O	base	partmod	27	SENT_144	[p7l224t1080r422b1147],
29	GeneCatcher	NNP	O	GeneCatcher	nn	31	SENT_144	[p7l476t1080r954b1147],
30	gDNA	NNP	O	gDNA	nn	31	SENT_144	[p7l1004t1079r1255b1170],
31	Blood	NNP	O	Blood	dobj	28	SENT_144	[p7l1307t1080r1520b1147],
32	kit	NN	O	kit	nn	34	SENT_144	[p7l1573t1081r1667b1147],
33	(	CD	NUMBER	(	num	34	SENT_144	[p7l1721t1078r2137b1170],
34	Invitrogen	NNP	ORGANIZATION	Invitrogen	dep	31	SENT_144	[p7l1721t1078r2137b1170],
35	,	,	O	,	_	0	SENT_144	[p7l1721t1078r2137b1170],
36	Carlsbad	NNP	LOCATION	Carlsbad	appos	31	SENT_144	[p7l12t1186r344b1267],
37	,	,	O	,	_	0	SENT_144	[p7l12t1186r344b1267],
38	California	NNP	LOCATION	California	nn	39	SENT_144	[p7l381t1184r785b1267],
39	)	NN	O	)	appos	36	SENT_144	[p7l381t1184r785b1267],
40	.	.	O	.	_	0	SENT_144	[p7l381t1184r785b1267],

1	DNA	NN	O	dna	nn	2	SENT_145	[p7l821t1185r1028b1253],
2	purity	NN	O	purity	nsubjpass	6	SENT_145	[p7l1057t1189r1270b1276],
3	and	CC	O	and	_	0	SENT_145	[p7l1300t1186r1427b1253],
4	concentration	NN	O	concentration	nsubjpass	6	SENT_145	[p7l1459t1190r1945b1253],
5	were	VBD	O	be	auxpass	6	SENT_145	[p7l1973t1212r2139b1253],
6	determined	VBN	O	determine	_	0	SENT_145	[p7l11t1292r415b1359],
7	by	IN	O	by	_	0	SENT_145	[p7l464t1293r552b1382],
8	NanoDrop	NNP	O	NanoDrop	agent	6	SENT_145	[p7l602t1293r1003b1382],
9	spectrophotometer	NN	O	spectrophotometer	nn	12	SENT_145	[p7l1061t1292r1757b1382],
10	(	CD	NUMBER	(	num	12	SENT_145	[p7l1813t1290r2139b1373],
11	Thermo	NNP	ORGANIZATION	Thermo	nn	12	SENT_145	[p7l1813t1290r2139b1373],
12	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	dep	6	SENT_145	[p7l13t1398r373b1480],
13	,	,	O	,	_	0	SENT_145	[p7l13t1398r373b1480],
14	Wilmington	NNP	LOCATION	Wilmington	appos	12	SENT_145	[p7l436t1398r901b1488],
15	,	,	O	,	_	0	SENT_145	[p7l436t1398r901b1488],
16	Delaware	NNP	LOCATION	Delaware	nn	17	SENT_145	[p7l965t1396r1347b1479],
17	)	NN	O	)	appos	12	SENT_145	[p7l965t1396r1347b1479],
18	.	.	O	.	_	0	SENT_145	[p7l965t1396r1347b1479],

1	Genotyping	NN	O	genotyping	nsubjpass	21	SENT_146	[p7l1415t1398r1840b1488],
2	of	IN	O	of	_	0	SENT_146	[p7l1900t1398r1980b1465],
3	the	DT	O	the	det	8	SENT_146	[p7l2029t1399r2139b1465],
4	CYP2C19	NN	O	cyp2c19	nn	8	SENT_146	[p7l17t1508r431b1572],
5	*	NN	O	*	nn	8	SENT_146	[p7l17t1508r431b1572],
6	2	CD	NUMBER	2	num	8	SENT_146	[p7l17t1508r431b1572],
7	loss	NN	O	loss	nn	8	SENT_146	[p7l476t1504r1048b1571],
8	—	NN	O	—	prep_of	1	SENT_146	[p7l476t1504r1048b1571],
9	of	IN	O	of	_	0	SENT_146	[p7l476t1504r1048b1571],
10	—	CD	NUMBER	—	num	11	SENT_146	[p7l476t1504r1048b1571],
11	function	NN	O	function	prep_of	8	SENT_146	[p7l476t1504r1048b1571],
12	polymorphism	NN	O	polymorphism	nn	14	SENT_146	[p7l1094t1504r1609b1594],
13	(	NN	O	(	nn	14	SENT_146	[p7l1660t1502r1888b1585],
14	681G	NN	O	681g	dep	8	SENT_146	[p7l1660t1502r1888b1585],
15	>	JJR	O	>	dep	14	SENT_146	[p7l1942t1515r2002b1566],
16	A	DT	O	a	dep	15	SENT_146	[p7l2053t1503r2137b1585],
17	,	,	O	,	_	0	SENT_146	[p7l2053t1503r2137b1585],
18	rs4244285	NN	O	rs4244285	nn	19	SENT_146	[p7l10t1608r405b1691],
19	)	NN	O	)	appos	8	SENT_146	[p7l10t1608r405b1691],
20	was	VBD	O	be	auxpass	21	SENT_146	[p7l443t1637r573b1677],
21	performed	VBN	O	perform	dep	24	SENT_146	[p7l612t1610r982b1700],
22	using	VBG	O	use	xcomp	21	SENT_146	[p7l1018t1613r1209b1700],
23	TaqMan	NN	O	taqman	dobj	22	SENT_146	[p7l1242t1609r1560b1700],
24	validated	VBD	O	validate	_	0	SENT_146	[p7l1595t1610r1915b1677],
25	Drug	NN	O	drug	nn	28	SENT_146	[p7l1953t1611r2142b1700],
26	Metabolism	NN	O	metabolism	nn	28	SENT_146	[p7l8t1716r436b1783],
27	Genotyping	NN	O	genotyping	nn	28	SENT_146	[p7l470t1716r896b1806],
28	assay	NN	O	assay	dobj	24	SENT_146	[p7l927t1743r1104b1806],
29	with	IN	O	with	_	0	SENT_146	[p7l1128t1716r1289b1783],
30	the	DT	O	the	det	33	SENT_146	[p7l1321t1716r1431b1783],
31	790OHT	NNP	O	790OHT	nn	33	SENT_146	[p7l1465t1715r1776b1783],
32	Sequence	NN	O	sequence	nn	33	SENT_146	[p7l1811t1716r2139b1806],
33	Detection	NN	O	detection	prep_with	24	SENT_146	[p7l10t1823r363b1889],
34	System	NNP	O	System	nn	37	SENT_146	[p7l402t1822r651b1912],
35	(	NNP	O	(	nn	37	SENT_146	[p7l690t1820r1002b1912],
36	Applied	NNP	O	Applied	nn	37	SENT_146	[p7l690t1820r1002b1912],
37	Biosystems	NNP	O	Biosystems	nsubj	24	SENT_146	[p7l1036t1823r1450b1912],
38	,	,	O	,	_	0	SENT_146	[p7l1036t1823r1450b1912],
39	Foster	NNP	LOCATION	Foster	nn	40	SENT_146	[p7l1489t1823r1712b1889],
40	City	NNP	LOCATION	City	appos	37	SENT_146	[p7l1748t1822r1919b1912],
41	,	,	O	,	_	0	SENT_146	[p7l1748t1822r1919b1912],
42	California	NNP	LOCATION	California	appos	40	SENT_146	[p7l1959t1822r2137b1889, p7l10t1925r243b2007],
43	)	CD	NUMBER	)	num	42	SENT_146	[p7l1959t1822r2137b1889, p7l10t1925r243b2007],
44	(	CD	NUMBER	(	number	45	SENT_146	[p7l283t1925r442b2007],
45	21	CD	NUMBER	21	num	46	SENT_146	[p7l283t1925r442b2007],
46	)	NN	O	)	dep	42	SENT_146	[p7l283t1925r442b2007],
47	.	.	O	.	_	0	SENT_146	[p7l283t1925r442b2007],

1	Study	NNP	O	Study	_	0	SENT_147	[p7l11t2041r209b2116],
2	endpoints	NNS	O	endpoint	dep	1	SENT_147	[p7l245t2041r593b2115],
3	and	CC	O	and	_	0	SENT_147	[p7l630t2041r756b2099],
4	sample	NN	O	sample	nn	6	SENT_147	[p7l796t2041r1041b2115],
5	size	NN	O	size	nn	6	SENT_147	[p7l1079t2043r1205b2099],
6	calculation	NN	O	calculation	dep	1	SENT_147	[p7l1242t2041r1636b2099],
7	.	.	O	.	_	0	SENT_147	[p7l1242t2041r1636b2099],

1	The	DT	O	the	det	3	SENT_148	[p7l1681t2032r1828b2100],
2	primary	JJ	O	primary	amod	3	SENT_148	[p7l1864t2036r2144b2123],
3	endpoint	NN	O	endpoint	nsubj	17	SENT_148	[p7l11t2139r329b2229],
4	of	IN	O	of	_	0	SENT_148	[p7l362t2139r441b2206],
5	the	DT	O	the	det	6	SENT_148	[p7l462t2139r573b2206],
6	study	NN	O	study	prep_of	3	SENT_148	[p7l608t2140r798b2229],
7	was	VBD	O	be	cop	17	SENT_148	[p7l824t2166r953b2206],
8	the	DT	O	the	det	17	SENT_148	[p7l988t2140r1098b2206],
9	PRU	NNP	ORGANIZATION	PRU	dep	17	SENT_148	[p7l1132t2140r1312b2206],
10	after	IN	O	after	_	0	SENT_148	[p7l1346t2139r1505b2206],
11	30	CD	DURATION	30	num	12	SENT_148	[p7l1537t2143r1621b2206],
12	days	NNS	NUMBER	day	prep_after	9	SENT_148	[p7l1657t2139r1805b2229],
13	(	JJ	O	(	amod	17	SENT_148	[p7l1844t2137r2035b2220],
14	T	NN	O	t	nn	17	SENT_148	[p7l1844t2137r2035b2220],
15	—	NN	O	—	nn	17	SENT_148	[p7l1844t2137r2035b2220],
16	2	CD	NUMBER	2	num	17	SENT_148	[p7l1844t2137r2035b2220],
17	)	NN	O	)	_	0	SENT_148	[p7l1844t2137r2035b2220],
18	of	IN	O	of	_	0	SENT_148	[p7l2073t2139r2153b2206],
19	treatment	NN	O	treatment	prep_of	17	SENT_148	[p7l10t2262r373b2312],
20	.	.	O	.	_	0	SENT_148	[p7l10t2262r373b2312],

1	The	DT	O	the	det	3	SENT_149	[p7l426t2244r573b2312],
2	sample	NN	O	sample	nn	3	SENT_149	[p7l627t2245r869b2335],
3	size	NN	O	size	nsubjpass	5	SENT_149	[p7l922t2248r1048b2312],
4	was	VBD	O	be	auxpass	5	SENT_149	[p7l1098t2272r1226b2312],
5	calculated	VBN	O	calculate	_	0	SENT_149	[p7l1281t2245r1629b2312],
6	by	IN	O	by	_	0	SENT_149	[p7l1678t2245r1764b2335],
7	assuming	VBG	O	assume	agent	5	SENT_149	[p7l1814t2248r2142b2335],
8	mean	JJ	O	mean	amod	11	SENT_149	[p7l11t2378r201b2418],
9	baseline	NN	O	baseline	nn	11	SENT_149	[p7l240t2351r522b2418],
10	PRU	NNP	ORGANIZATION	PRU	nn	11	SENT_149	[p7l565t2352r744b2418],
11	values	NNS	O	value	nsubj	14	SENT_149	[p7l781t2351r993b2418],
12	of	IN	O	of	_	0	SENT_149	[p7l1036t2351r1116b2418],
13	285	CD	NUMBER	285	prep_of	11	SENT_149	[p7l1144t2351r1272b2419],
14	i	FW	O	i	xcomp	7	SENT_149	[p7l1325t2361r1378b2414],
15	47	CD	NUMBER	47	nsubjpass	5	SENT_149	[p7l1428t2353r1514b2418],
16	in	IN	O	in	_	0	SENT_149	[p7l1555t2354r1622b2417],
17	patients	NNS	O	patient	prep_in	15	SENT_149	[p7l1662t2354r1940b2441],
18	with	IN	O	with	_	0	SENT_149	[p7l1979t2351r2140b2418],
19	I-ITPR	NN	O	i-itpr	prep_with	17	SENT_149	[p7l11t2455r280b2537],
20	,	,	O	,	_	0	SENT_149	[p7l11t2455r280b2537],
21	deﬁned	VBN	O	deﬁned	partmod	5	SENT_149	[p7l337t2456r598b2522],
22	as	IN	O	as	_	0	SENT_149	[p7l651t2482r714b2522],
23	PRU	NNP	O	PRU	prep_as	21	SENT_149	[p7l769t2457r949b2522],
24	2235	CD	DATE	2235	num	23	SENT_149	[p7l1006t2456r1202b2523],
25	while	IN	O	while	dep	21	SENT_149	[p7l1254t2456r1447b2522],
26	on	IN	O	on	_	0	SENT_149	[p7l1501t2482r1589b2522],
27	standard	JJ	O	standard	amod	30	SENT_149	[p7l1643t2456r2139b2522],
28	—	NN	O	—	nn	30	SENT_149	[p7l1643t2456r2139b2522],
29	dose	NN	O	dose	nn	30	SENT_149	[p7l1643t2456r2139b2522],
30	clopidogrel	NN	O	clopidogrel	prep_on	21	SENT_149	[p7l11t2562r424b2652],
31	,	,	O	,	_	0	SENT_149	[p7l11t2562r424b2652],
32	and	CC	O	and	_	0	SENT_149	[p7l471t2562r598b2629],
33	a	DT	O	a	det	36	SENT_149	[p7l641t2589r675b2629],
34	mean	JJ	O	mean	amod	36	SENT_149	[p7l717t2589r907b2629],
35	PRU	NNP	ORGANIZATION	PRU	nn	36	SENT_149	[p7l950t2563r1129b2629],
36	reduction	NN	O	reduction	prep_on	21	SENT_149	[p7l1170t2562r1507b2629],
37	of	IN	O	of	_	0	SENT_149	[p7l1549t2562r1629b2629],
38	24	CD	PERCENT	24	num	39	SENT_149	[p7l1658t2566r1811b2630],
39	%	NN	PERCENT	%	prep_of	36	SENT_149	[p7l1658t2566r1811b2630],
40	after	IN	O	after	_	0	SENT_149	[p7l1855t2562r2014b2629],
41	30	CD	DURATION	30	num	42	SENT_149	[p7l2055t2566r2139b2629],
42	days	NNS	NUMBER	day	prep_after	21	SENT_149	[p7l11t2668r160b2758],
43	of	IN	O	of	_	0	SENT_149	[p7l204t2668r284b2735],
44	150	CD	NUMBER	150	number	45	SENT_149	[p7l318t2668r596b2758],
45	—	CD	NUMBER	—	num	47	SENT_149	[p7l318t2668r596b2758],
46	mg	NN	O	mg	nn	47	SENT_149	[p7l318t2668r596b2758],
47	clopidogrel	NN	O	clopidogrel	prep_of	42	SENT_149	[p7l637t2668r1032b2758],
48	(	CD	NUMBER	(	number	49	SENT_149	[p7l1076t2666r1235b2749],
49	15	CD	NUMBER	15	num	50	SENT_149	[p7l1076t2666r1235b2749],
50	)	NN	O	)	dep	47	SENT_149	[p7l1076t2666r1235b2749],
51	.	.	O	.	_	0	SENT_149	[p7l1076t2666r1235b2749],

1	Thus	RB	O	thus	advmod	44	SENT_150	[p7l1278t2667r1484b2749],
2	,	,	O	,	_	0	SENT_150	[p7l1278t2667r1484b2749],
3	74	CD	NUMBER	74	num	4	SENT_150	[p7l1531t2670r1615b2735],
4	patients	NNS	O	patient	nsubjpass	6	SENT_150	[p7l1656t2671r1933b2758],
5	were	VBD	O	be	auxpass	6	SENT_150	[p7l1973t2694r2139b2735],
6	required	VBN	O	require	parataxis	44	SENT_150	[p7l10t2774r304b2864],
7	(	RB	O	(	advmod	6	SENT_150	[p7l342t2772r454b2855],
8	37	CD	NUMBER	37	npadvmod	6	SENT_150	[p7l342t2772r454b2855],
9	per	IN	O	per	_	0	SENT_150	[p7l488t2800r601b2864],
10	treatment	NN	O	treatment	nn	11	SENT_150	[p7l635t2791r982b2841],
11	group	NN	O	group	prep_per	6	SENT_150	[p7l1015t2772r1246b2864],
12	)	CD	NUMBER	)	num	11	SENT_150	[p7l1015t2772r1246b2864],
13	to	TO	O	to	aux	14	SENT_150	[p7l1286t2792r1353b2841],
14	detect	VB	O	detect	xcomp	6	SENT_150	[p7l1391t2775r1604b2841],
15	a	DT	O	a	det	20	SENT_150	[p7l1640t2801r1674b2841],
16	further	JJ	O	further	amod	20	SENT_150	[p7l1708t2774r1954b2841],
17	15	CD	PERCENT	15	number	18	SENT_150	[p7l1992t2774r2139b2841],
18	%	NN	PERCENT	%	amod	20	SENT_150	[p7l1992t2774r2139b2841],
19	relative	JJ	O	relative	amod	20	SENT_150	[p7l10t2879r263b2945],
20	reduction	NN	O	reduction	dobj	14	SENT_150	[p7l301t2879r638b2945],
21	in	IN	O	in	_	0	SENT_150	[p7l676t2882r743b2944],
22	mean	JJ	O	mean	amod	24	SENT_150	[p7l782t2905r972b2945],
23	PRU	NNP	ORGANIZATION	PRU	nn	24	SENT_150	[p7l1011t2880r1190b2945],
24	values	NNS	O	value	prep_in	20	SENT_150	[p7l1224t2879r1435b2945],
25	in	IN	O	in	_	0	SENT_150	[p7l1475t2882r1543b2944],
26	the	DT	O	the	det	27	SENT_150	[p7l1580t2879r1690b2945],
27	atorvastatin	NN	O	atorvastatin	prep_in	14	SENT_150	[p7l1730t2882r2140b2945],
28	compared	VBN	O	compare	_	0	SENT_150	[p7l11t2985r358b3075],
29	with	IN	O	with	prepc_compared_with	27	SENT_150	[p7l391t2985r552b3052],
30	the	DT	O	the	det	32	SENT_150	[p7l589t2985r700b3052],
31	control	NN	O	control	nn	32	SENT_150	[p7l739t2985r990b3052],
32	group	NN	O	group	pobj	27	SENT_150	[p7l1025t3011r1251b3075],
33	,	,	O	,	_	0	SENT_150	[p7l1025t3011r1251b3075],
34	with	IN	O	with	_	0	SENT_150	[p7l1288t2985r1449b3052],
35	80	CD	PERCENT	80	number	36	SENT_150	[p7l1489t2989r1638b3052],
36	%	NN	PERCENT	%	amod	37	SENT_150	[p7l1489t2989r1638b3052],
37	power	NN	O	power	prep_with	6	SENT_150	[p7l1675t3011r1893b3075],
38	at	IN	O	at	_	0	SENT_150	[p7l1930t3002r1993b3052],
39	the	DT	O	the	det	40	SENT_150	[p7l2029t2985r2139b3052],
40	conventional	JJ	O	conventional	prep_at	37	SENT_150	[p7l11t3091r482b3172],
41	,	,	O	,	_	0	SENT_150	[p7l11t3091r482b3172],
42	2	CD	NUMBER	2	num	43	SENT_150	[p7l510t3091r776b3159],
43	—	CD	NUMBER	—	nsubj	44	SENT_150	[p7l510t3091r776b3159],
44	sided	VBD	O	side	_	0	SENT_150	[p7l510t3091r776b3159],
45	signiﬁcance	NN	O	signiﬁcance	nn	46	SENT_150	[p7l803t3091r1212b3181],
46	level	NN	O	level	dobj	44	SENT_150	[p7l1238t3091r1397b3158],
47	of	IN	O	of	_	0	SENT_150	[p7l1423t3091r1504b3158],
48	5	CD	PERCENT	5	num	49	SENT_150	[p7l1518t3091r1644b3158],
49	%	NN	PERCENT	%	prep_of	46	SENT_150	[p7l1518t3091r1644b3158],
50	.	.	O	.	_	0	SENT_150	[p7l1518t3091r1644b3158],

1	Our	PRP$	O	we	poss	2	SENT_151	[p7l1677t3091r1822b3158],
2	protocol	NN	O	protocol	nsubj	3	SENT_151	[p7l1846t3091r2141b3181],
3	required	VBD	O	require	_	0	SENT_151	[p7l10t3198r304b3288],
4	that	IN	O	that	complm	7	SENT_151	[p7l344t3199r485b3265],
5	each	DT	O	each	det	6	SENT_151	[p7l525t3198r681b3265],
6	group	NN	O	group	nsubj	7	SENT_151	[p7l720t3224r925b3288],
7	comprise	VBP	O	comprise	ccomp	3	SENT_151	[p7l968t3201r1285b3288],
8	at	IN	O	at	quantmod	10	SENT_151	[p7l1328t3216r1391b3265],
9	least	JJS	O	least	mwe	8	SENT_151	[p7l1429t3198r1587b3265],
10	39	CD	NUMBER	39	num	11	SENT_151	[p7l1627t3202r1709b3265],
11	patients	NNS	O	patient	dobj	7	SENT_151	[p7l1752t3201r2028b3288],
12	to	TO	O	to	aux	13	SENT_151	[p7l2071t3216r2138b3265],
13	allow	VB	O	allow	xcomp	7	SENT_151	[p7l12t3304r199b3371],
14	a	DT	O	a	det	18	SENT_151	[p7l231t3331r265b3371],
15	5	CD	PERCENT	5	number	16	SENT_151	[p7l298t3304r406b3371],
16	%	NN	PERCENT	%	amod	18	SENT_151	[p7l298t3304r406b3371],
17	dropout	NN	O	dropout	nn	18	SENT_151	[p7l441t3304r723b3394],
18	rate	NN	O	rate	dobj	13	SENT_151	[p7l755t3321r904b3371],
19	.	.	O	.	_	0	SENT_151	[p7l755t3321r904b3371],

1	Additional	JJ	O	additional	amod	3	SENT_152	[p7l941t3303r1328b3371],
2	exploratory	NN	O	exploratory	nn	3	SENT_152	[p7l1362t3304r1761b3394],
3	endpoints	NNS	O	endpoint	nsubj	4	SENT_152	[p7l1792t3304r2138b3394],
4	were	VBD	O	be	_	0	SENT_152	[p7l7t3437r192b3478],
5	:	:	O	:	_	0	SENT_152	[p7l7t3437r192b3478],
6	1	CD	NUMBER	1	number	7	SENT_152	[p7l228t3409r290b3492],
7	)	CD	NUMBER	)	num	9	SENT_152	[p7l228t3409r290b3492],
8	the	DT	O	the	det	9	SENT_152	[p7l320t3411r431b3478],
9	percentage	NN	O	percentage	nsubj	22	SENT_152	[p7l457t3429r837b3501],
10	of	IN	O	of	_	0	SENT_152	[p7l866t3411r946b3478],
11	patients	NNS	O	patient	prep_of	9	SENT_152	[p7l959t3414r1236b3501],
12	with	IN	O	with	_	0	SENT_152	[p7l1261t3412r1423b3478],
13	optimal	JJ	O	optimal	amod	14	SENT_152	[p7l1450t3412r1722b3501],
14	response	NN	O	response	prep_with	11	SENT_152	[p7l1747t3437r2050b3501],
15	at	IN	O	at	_	0	SENT_152	[p7l2079t3429r2142b3478],
16	30	CD	DURATION	30	num	17	SENT_152	[p7l11t3521r95b3584],
17	days	NNS	NUMBER	day	prep_at	14	SENT_152	[p7l124t3518r294b3607],
18	,	,	O	,	_	0	SENT_152	[p7l124t3518r294b3607],
19	deﬁned	VBN	O	deﬁned	partmod	17	SENT_152	[p7l326t3517r586b3584],
20	as	IN	O	as	_	0	SENT_152	[p7l615t3544r678b3584],
21	PRU	NNP	ORGANIZATION	PRU	prep_as	19	SENT_152	[p7l708t3518r887b3584],
22	<	JJR	O	<	parataxis	4	SENT_152	[p7l919t3517r1138b3598],
23	235	CD	NUMBER	235	dep	22	SENT_152	[p7l919t3517r1138b3598],
24	;	:	O	;	_	0	SENT_152	[p7l919t3517r1138b3598],
25	2	CD	NUMBER	2	number	26	SENT_152	[p7l1166t3515r1235b3598],
26	)	CD	NUMBER	)	num	28	SENT_152	[p7l1166t3515r1235b3598],
27	the	DT	O	the	det	28	SENT_152	[p7l1266t3518r1376b3584],
28	changes	NNS	O	change	parataxis	4	SENT_152	[p7l1406t3518r1682b3607],
29	over	IN	O	over	_	0	SENT_152	[p7l1712t3543r1861b3584],
30	time	NN	O	time	prep_over	28	SENT_152	[p7l1886t3520r2044b3584],
31	in	IN	O	in	_	0	SENT_152	[p7l2073t3520r2140b3583],
32	PRU	NNP	ORGANIZATION	PRU	prep_in	30	SENT_152	[p7l10t3624r190b3690],
33	and	CC	O	and	_	0	SENT_152	[p7l223t3623r351b3690],
34	BASE	NNP	O	BASE	conj_and	32	SENT_152	[p7l383t3622r634b3704],
35	;	:	O	;	_	0	SENT_152	[p7l383t3622r634b3704],
36	and	CC	O	and	_	0	SENT_152	[p7l671t3623r799b3690],
37	3	CD	NUMBER	3	num	39	SENT_152	[p7l832t3621r898b3704],
38	)	NN	O	)	nn	39	SENT_152	[p7l832t3621r898b3704],
39	correlations	NNS	O	correlation	conj_and	22	SENT_152	[p7l935t3624r1345b3690],
40	with	IN	O	with	_	0	SENT_152	[p7l1375t3624r1537b3690],
41	lipid	NN	O	lipid	nn	42	SENT_152	[p7l1568t3623r1730b3713],
42	levels	NNS	O	level	prep_with	39	SENT_152	[p7l1760t3624r1964b3690],
43	.	.	O	.	_	0	SENT_152	[p7l1760t3624r1964b3690],

1	Statistical	JJ	O	statistical	amod	2	SENT_153	[p7l11t3737r341b3795],
2	analysis	NN	O	analysis	_	0	SENT_153	[p7l391t3737r680b3812],
3	.	.	O	.	_	0	SENT_153	[p7l391t3737r680b3812],

1	Variables	NNS	O	variable	nsubjpass	3	SENT_154	[p7l729t3729r1054b3796],
2	were	VBD	O	be	auxpass	3	SENT_154	[p7l1098t3755r1265b3796],
3	analyzed	VBN	O	analyze	_	0	SENT_154	[p7l1314t3729r1617b3819],
4	for	IN	O	for	_	0	SENT_154	[p7l1663t3729r1764b3796],
5	a	DT	O	a	det	7	SENT_154	[p7l1810t3756r1844b3796],
6	normal	JJ	O	normal	amod	7	SENT_154	[p7l1890t3729r2141b3796],
7	distribution	NN	O	distribution	prep_for	3	SENT_154	[p8l11t15r424b82],
8	with	IN	O	with	_	0	SENT_154	[p8l458t15r620b82],
9	the	DT	O	the	det	11	SENT_154	[p8l657t15r768b82],
10	Kolmogorov-Smirnov	NNP	MISC	Kolmogorov-Smirnov	nn	11	SENT_154	[p8l809t15r1593b105],
11	test	NN	O	test	prep_with	7	SENT_154	[p8l1628t32r1770b96],
12	,	,	O	,	_	0	SENT_154	[p8l1628t32r1770b96],
13	and	CC	O	and	_	0	SENT_154	[p8l1813t15r1940b82],
14	variJACC	NN	O	varijacc	conj_and	7	SENT_154	[p8l1974t18r2137b82, p8l351t265r501b296],
15	:	:	O	:	_	0	SENT_154	[p8l1974t18r2137b82, p8l351t265r501b296],

1	CARDIOVASCULAR	JJ	O	cardiovascular	amod	2	SENT_155	[p8l537t265r1036b296],
2	INTERVENTIONS	NNS	O	intervention	_	0	SENT_155	[p8l1074t265r1532b301],
3	,	,	O	,	_	0	SENT_155	[p8l1074t265r1532b301],
4	VOL	NNP	O	VOL	appos	2	SENT_155	[p8l1568t265r1691b296],
5	.	.	O	.	_	0	SENT_155	[p8l1568t265r1691b296],

1	6	CD	NUMBER	6	_	0	SENT_156	[p8l1727t266r1771b301],
2	,	,	O	,	_	0	SENT_156	[p8l1727t266r1771b301],
3	NO.	NNP	O	NO.	appos	1	SENT_156	[p8l1809t265r1899b296],
4	2	CD	NUMBER	2	num	3	SENT_156	[p8l1936t266r1979b301],
5	,	,	O	,	_	0	SENT_156	[p8l1936t266r1979b301],
6	2013	CD	DATE	2013	num	3	SENT_156	[p8l2016t266r2140b296],
7	FEBRUARY	NNP	DATE	FEBRUARY	dep	1	SENT_156	[p8l1470t330r1749b361],
8	2013:169	CD	DATE	2013:169	num	7	SENT_156	[p8l1785t330r2141b361],
9	—	CD	NUMBER	—	number	10	SENT_156	[p8l1785t330r2141b361],
10	79	CD	NUMBER	79	dep	7	SENT_156	[p8l1785t330r2141b361],

1	ables	NNS	O	able	nsubjpass	3	SENT_157	[p8l13t523r181b590],
2	are	VBP	O	be	auxpass	3	SENT_157	[p8l213t549r313b590],
3	presented	VBN	O	present	_	0	SENT_157	[p8l341t523r682b613],
4	as	IN	O	as	_	0	SENT_157	[p8l712t550r775b590],
5	mean	JJ	O	mean	amod	6	SENT_157	[p8l806t550r996b590],
6	i	FW	O	i	prep_as	3	SENT_157	[p8l1033t533r1086b586],
7	SD	NN	O	sd	dobj	3	SENT_157	[p8l1127t523r1239b590],
8	or	CC	O	or	_	0	SENT_157	[p8l1270t549r1343b590],
9	as	IN	O	as	amod	12	SENT_157	[p8l1371t550r1433b590],
10	median	JJ	O	median	amod	12	SENT_157	[p8l1465t523r1725b590],
11	(	NN	O	(	nn	12	SENT_157	[p8l1756t521r2138b613],
12	interquar	NN	O	interquar	dobj	3	SENT_157	[p8l1756t521r2138b613],
13	—	CD	NUMBER	—	num	16	SENT_157	[p8l1756t521r2138b613],
14	tile	NN	O	tile	nn	16	SENT_157	[p8l11t630r119b697],
15	range	NN	O	range	nn	16	SENT_157	[p8l158t628r400b720],
16	)	NN	O	)	dep	12	SENT_157	[p8l158t628r400b720],
17	.	.	O	.	_	0	SENT_157	[p8l158t628r400b720],

1	Categorical	JJ	O	categorical	amod	2	SENT_158	[p8l444t630r849b720],
2	variables	NNS	O	variable	nsubjpass	11	SENT_158	[p8l883t630r1187b697],
3	were	VBD	O	be	auxpass	4	SENT_158	[p8l1223t656r1390b697],
4	presented	VBN	O	present	_	0	SENT_158	[p8l1428t630r1769b720],
5	as	IN	O	as	_	0	SENT_158	[p8l1808t657r1872b697],
6	counts	NNS	O	count	prep_as	4	SENT_158	[p8l1913t648r2140b697],
7	and	CC	O	and	_	0	SENT_158	[p8l13t776r140b843],
8	percentages	NNS	O	percentage	prep_as	4	SENT_158	[p8l188t794r620b866],
9	,	,	O	,	_	0	SENT_158	[p8l188t794r620b866],
10	and	CC	O	and	_	0	SENT_158	[p8l675t776r803b843],
11	compared	VBN	O	compare	conj_and	4	SENT_158	[p8l853t776r1200b866],
12	by	IN	O	by	_	0	SENT_158	[p8l1247t776r1334b866],
13	chi-square	NN	O	chi-square	prep_by	11	SENT_158	[p8l1381t776r1748b866],
14	or	CC	O	or	_	0	SENT_158	[p8l1800t802r1872b843],
15	Fisher	NNP	O	Fisher	nn	17	SENT_158	[p8l1921t776r2143b843],
16	exact	JJ	O	exact	amod	17	SENT_158	[p8l12t900r189b949],
17	test	NN	O	test	conj_or	13	SENT_158	[p8l215t899r356b949],
18	.	.	O	.	_	0	SENT_158	[p8l215t899r356b949],

1	Continuous	JJ	O	continuous	amod	2	SENT_159	[p8l390t882r806b949],
2	variables	NNS	O	variable	nsubjpass	4	SENT_159	[p8l832t882r1136b949],
3	were	VBD	O	be	auxpass	4	SENT_159	[p8l1162t908r1328b949],
4	compared	VBN	O	compare	_	0	SENT_159	[p8l1358t882r1705b972],
5	by	IN	O	by	_	0	SENT_159	[p8l1730t882r1816b972],
6	t	NN	O	t	nn	7	SENT_159	[p8l1839t899r1866b949],
7	test	NN	O	test	agent	4	SENT_159	[p8l1892t900r2017b949],
8	for	IN	O	for	prep	7	SENT_159	[p8l2043t882r2143b949],
9	normally	RB	O	normally	pcomp	8	SENT_159	[p8l12t988r327b1078],
10	distributed	VBN	O	distribute	partmod	7	SENT_159	[p8l355t988r737b1055],
11	values	NNS	O	value	dobj	10	SENT_159	[p8l763t988r997b1069],
12	;	:	O	;	_	0	SENT_159	[p8l763t988r997b1069],
13	the	DT	O	the	det	16	SENT_159	[p8l1030t989r1140b1055],
14	Mann-Whitney	NNP	O	Mann-Whitney	nn	16	SENT_159	[p8l1169t988r1744b1078],
15	U	NNP	O	U	nn	16	SENT_159	[p8l1778t993r1844b1055],
16	test	NN	O	test	nsubjpass	18	SENT_159	[p8l1861t1005r1986b1055],
17	was	VBD	O	be	auxpass	18	SENT_159	[p8l2011t1015r2140b1055],
18	used	VBN	O	use	parataxis	4	SENT_159	[p8l10t1094r169b1161],
19	alternatively	RB	O	alternatively	advmod	18	SENT_159	[p8l212t1094r657b1184],
20	.	.	O	.	_	0	SENT_159	[p8l212t1094r657b1184],

1	The	DT	O	the	det	3	SENT_160	[p8l700t1093r847b1161],
2	repeated-measure	JJ	O	repeated-measure	amod	3	SENT_160	[p8l889t1094r1516b1184],
3	analysis	NN	O	analysis	nsubjpass	7	SENT_160	[p8l1560t1094r1825b1184],
4	of	IN	O	of	_	0	SENT_160	[p8l1869t1094r1949b1161],
5	variance	NN	O	variance	prep_of	3	SENT_160	[p8l1975t1097r2138b1161, p8l13t1227r166b1267],
6	was	VBD	O	be	auxpass	7	SENT_160	[p8l222t1227r352b1267],
7	used	VBN	O	use	_	0	SENT_160	[p8l411t1200r570b1267],
8	to	TO	O	to	aux	9	SENT_160	[p8l629t1218r696b1267],
9	evaluate	VB	O	evaluate	xcomp	7	SENT_160	[p8l758t1200r1039b1267],
10	platelet	NN	O	platelet	nn	11	SENT_160	[p8l1098t1200r1359b1290],
11	reactivity	NN	O	reactivity	dobj	9	SENT_160	[p8l1416t1203r1740b1290],
12	and	CC	O	and	_	0	SENT_160	[p8l1797t1200r1924b1267],
13	lipid	NN	O	lipid	nn	15	SENT_160	[p8l1981t1200r2142b1290],
14	fraction	NN	O	fraction	nn	15	SENT_160	[p8l11t1307r284b1374],
15	changes	NNS	O	change	dobj	9	SENT_160	[p8l332t1307r608b1397],
16	over	IN	O	over	_	0	SENT_160	[p8l658t1333r806b1374],
17	time	NN	O	time	prep_over	9	SENT_160	[p8l851t1310r1028b1374],
18	.	.	O	.	_	0	SENT_160	[p8l851t1310r1028b1374],

1	Pairwise	JJ	O	pairwise	amod	2	SENT_161	[p8l1080t1308r1376b1374],
2	comparisons	NNS	O	comparison	nsubjpass	6	SENT_161	[p8l1425t1310r1863b1397],
3	within	IN	O	within	_	0	SENT_161	[p8l1909t1307r2141b1374],
4	group	NN	O	group	prep_within	2	SENT_161	[p8l10t1477r214b1541],
5	were	VBD	O	be	auxpass	6	SENT_161	[p8l249t1477r415b1518],
6	approached	VBN	O	approach	_	0	SENT_161	[p8l454t1451r860b1541],
7	with	IN	O	with	_	0	SENT_161	[p8l892t1451r1054b1518],
8	2	CD	NUMBER	2	number	9	SENT_161	[p8l1092t1467r1121b1517],
9	‘	CD	NUMBER	‘	num	10	SENT_161	[p8l1092t1467r1121b1517],
10	test	NN	O	test	prep_with	6	SENT_161	[p8l1151t1469r1276b1518],
11	for	IN	O	for	_	0	SENT_161	[p8l1310t1451r1411b1518],
12	paired	JJ	O	paired	amod	13	SENT_161	[p8l1445t1451r1665b1541],
13	samples	NNS	O	sample	prep_for	10	SENT_161	[p8l1702t1451r1975b1541],
14	and	CC	O	and	_	0	SENT_161	[p8l2014t1451r2142b1518],
15	Bonferroni	NNS	LOCATION	bonferronus	prep_for	10	SENT_161	[p8l11t1557r399b1624],
16	adjustment	NN	O	adjustment	dobj	6	SENT_161	[p8l433t1557r825b1647],
17	(	CD	NUMBER	(	num	16	SENT_161	[p8l859t1555r1167b1647],
18	yielding	VBG	O	yield	partmod	16	SENT_161	[p8l859t1555r1167b1647],
19	a	DT	O	a	det	21	SENT_161	[p8l1199t1584r1233b1624],
20	signiﬁcance	NN	O	signiﬁcance	nn	21	SENT_161	[p8l1265t1557r1674b1647],
21	threshold	NN	O	threshold	dobj	18	SENT_161	[p8l1707t1557r2042b1624],
22	of	IN	O	of	_	0	SENT_161	[p8l2074t1557r2153b1624],
23	0.016	CD	NUMBER	0.016	num	24	SENT_161	[p8l11t1660r256b1742],
24	)	CD	NUMBER	)	prep_of	21	SENT_161	[p8l11t1660r256b1742],
25	.	.	O	.	_	0	SENT_161	[p8l11t1660r256b1742],

1	The	DT	O	the	det	4	SENT_162	[p8l309t1661r456b1728],
2	Pearson	NNP	O	Pearson	nn	4	SENT_162	[p8l509t1663r789b1728],
3	correlation	NN	O	correlation	nn	4	SENT_162	[p8l842t1662r1221b1728],
4	coeﬂicient	NN	O	coeﬂicient	nsubjpass	6	SENT_162	[p8l1274t1662r1633b1728],
5	was	VBD	O	be	auxpass	6	SENT_162	[p8l1679t1689r1808b1728],
6	used	VBN	O	use	_	0	SENT_162	[p8l1861t1662r2020b1728],
7	to	TO	O	to	aux	8	SENT_162	[p8l2072t1680r2139b1728],
8	measure	VB	O	measure	xcomp	6	SENT_162	[p8l12t1794r299b1835],
9	the	DT	O	the	det	10	SENT_162	[p8l324t1769r434b1835],
10	relationship	NN	O	relationship	dobj	8	SENT_162	[p8l459t1768r876b1858],
11	between	IN	O	between	_	0	SENT_162	[p8l900t1769r1193b1835],
12	PRU	NNP	ORGANIZATION	PRU	prep_between	10	SENT_162	[p8l1218t1769r1398b1835],
13	and	CC	O	and	_	0	SENT_162	[p8l1423t1768r1550b1835],
14	BASE	NNP	O	BASE	prep_between	10	SENT_162	[p8l1574t1767r1804b1835],
15	and	CC	O	and	_	0	SENT_162	[p8l1831t1768r1959b1835],
16	lipid	NN	O	lipid	nn	18	SENT_162	[p8l1981t1768r2142b1858],
17	fraction	NN	O	fraction	nn	18	SENT_162	[p8l11t1874r283b1941],
18	values	NNS	O	value	conj_and	12	SENT_162	[p8l310t1874r542b1941],
19	.	.	O	.	_	0	SENT_162	[p8l310t1874r542b1941],

1	The	DT	O	the	det	3	SENT_163	[p8l573t1873r720b1941],
2	univariate	JJ	O	univariate	amod	3	SENT_163	[p8l750t1877r1098b1941],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_163	[p8l1130t1875r1395b1964],
4	was	VBD	O	be	auxpass	5	SENT_163	[p8l1423t1901r1553b1941],
5	used	VBN	O	use	_	0	SENT_163	[p8l1583t1874r1743b1941],
6	to	TO	O	to	aux	7	SENT_163	[p8l1771t1891r1840b1941],
7	identify	VB	O	identify	xcomp	5	SENT_163	[p8l1871t1874r2145b1964],
8	the	DT	O	the	det	9	SENT_163	[p8l11t1981r121b2048],
9	variables	NNS	O	variable	nsubj	11	SENT_163	[p8l153t1981r456b2048],
10	significantly	RB	O	significantly	advmod	11	SENT_163	[p8l494t1981r923b2071],
11	associated	VBN	O	associate	ccomp	7	SENT_163	[p8l955t1981r1307b2048],
12	with	IN	O	with	_	0	SENT_163	[p8l1337t1981r1498b2048],
13	optimal	JJ	O	optimal	amod	16	SENT_163	[p8l1533t1981r1805b2071],
14	response	NN	O	response	dep	13	SENT_163	[p8l1838t2007r2140b2071],
15	(	CD	NUMBER	(	num	14	SENT_163	[p8l14t2085r220b2168],
16	PRU	NNP	ORGANIZATION	PRU	prep_with	11	SENT_163	[p8l14t2085r220b2168],
17	<	JJR	O	<	dobj	11	SENT_163	[p8l273t2086r498b2168],
18	235	CD	NUMBER	235	num	19	SENT_163	[p8l273t2086r498b2168],
19	)	NN	O	)	npadvmod	20	SENT_163	[p8l273t2086r498b2168],
20	at	IN	O	at	advmod	17	SENT_163	[p8l552t2105r615b2154],
21	30	CD	DURATION	30	num	22	SENT_163	[p8l663t2091r746b2154],
22	days	NNS	NUMBER	day	tmod	17	SENT_163	[p8l797t2088r966b2177],
23	.	.	O	.	_	0	SENT_163	[p8l797t2088r966b2177],

1	For	IN	O	for	_	0	SENT_164	[p8l1019t2088r1145b2154],
2	baseline	NN	O	baseline	nn	4	SENT_164	[p8l1190t2087r1472b2154],
3	PRU	NN	ORGANIZATION	pru	nn	4	SENT_164	[p8l1521t2088r1701b2154],
4	values	NNS	O	value	prep_for	11	SENT_164	[p8l1745t2087r1978b2168],
5	,	,	O	,	_	0	SENT_164	[p8l1745t2087r1978b2168],
6	the	DT	O	the	det	9	SENT_164	[p8l2030t2087r2140b2154],
7	optimal	JJ	O	optimal	amod	9	SENT_164	[p8l12t2194r283b2284],
8	cutoff	NN	O	cutoff	nn	9	SENT_164	[p8l318t2194r528b2261],
9	values	NNS	O	value	nsubjpass	11	SENT_164	[p8l548t2195r760b2261],
10	were	VBD	O	be	auxpass	11	SENT_164	[p8l794t2220r960b2261],
11	calculated	VBN	O	calculate	_	0	SENT_164	[p8l998t2194r1346b2261],
12	by	IN	O	by	_	0	SENT_164	[p8l1379t2195r1465b2284],
13	receiver-operating	JJ	O	receiver-operating	amod	16	SENT_164	[p8l1497t2197r2143b2284],
14	characteristic	JJ	O	characteristic	amod	16	SENT_164	[p8l12t2334r476b2401],
15	curve	NN	O	curve	nn	16	SENT_164	[p8l510t2360r693b2401],
16	analysis	NN	O	analysis	agent	11	SENT_164	[p8l730t2334r995b2424],
17	as	IN	O	as	_	0	SENT_164	[p8l1032t2361r1095b2401],
18	the	DT	O	the	det	19	SENT_164	[p8l1131t2334r1241b2401],
19	closest	JJS	O	closest	prep_as	16	SENT_164	[p8l1276t2334r1507b2401],
20	to	TO	O	to	_	0	SENT_164	[p8l1539t2352r1607b2401],
21	the	DT	O	the	det	23	SENT_164	[p8l1642t2334r1752b2401],
22	upper-left	JJ	O	upper-left	amod	23	SENT_164	[p8l1786t2334r2143b2424],
23	corner	NN	O	corner	prep_to	19	SENT_164	[p8l12t2466r252b2507],
24	.	.	O	.	_	0	SENT_164	[p8l12t2466r252b2507],

1	The	DT	O	the	det	2	SENT_165	[p8l294t2439r441b2507],
2	association	NN	O	association	nsubjpass	10	SENT_165	[p8l484t2443r867b2507],
3	with	IN	O	with	_	0	SENT_165	[p8l904t2440r1065b2507],
4	optimal	JJ	O	optimal	amod	5	SENT_165	[p8l1106t2440r1378b2530],
5	response	NN	O	response	prep_with	2	SENT_165	[p8l1417t2466r1719b2530],
6	at	IN	O	at	_	0	SENT_165	[p8l1762t2458r1825b2507],
7	30	CD	DURATION	30	num	8	SENT_165	[p8l1865t2444r1948b2507],
8	days	NNS	NUMBER	day	prep_at	5	SENT_165	[p8l1991t2440r2139b2530],
9	was	VBD	O	be	auxpass	10	SENT_165	[p8l7t2573r136b2613],
10	expressed	VBN	O	express	_	0	SENT_165	[p8l174t2546r509b2636],
11	as	IN	O	as	mark	30	SENT_165	[p8l545t2573r608b2613],
12	the	DT	O	the	det	13	SENT_165	[p8l645t2547r755b2613],
13	odds	NNS	O	odds	nsubjpass	30	SENT_165	[p8l792t2546r954b2613],
14	ratio	NN	O	ratio	nn	17	SENT_165	[p8l991t2549r1151b2613],
15	(	CD	NUMBER	(	num	17	SENT_165	[p8l1191t2544r1397b2628],
16	OR	NN	O	or	nn	17	SENT_165	[p8l1191t2544r1397b2628],
17	)	NN	O	)	dep	13	SENT_165	[p8l1191t2544r1397b2628],
18	,	,	O	,	_	0	SENT_165	[p8l1191t2544r1397b2628],
19	and	CC	O	and	_	0	SENT_165	[p8l1437t2547r1564b2613],
20	the	DT	O	the	det	27	SENT_165	[p8l1598t2546r1709b2613],
21	95	CD	PERCENT	95	number	22	SENT_165	[p8l1746t2546r1897b2613],
22	%	NN	PERCENT	%	amod	27	SENT_165	[p8l1746t2546r1897b2613],
23	confidence	NN	O	confidence	nn	27	SENT_165	[p8l1933t2546r2138b2613, p8l12t2652r213b2719],
24	interval	NN	O	interval	nn	27	SENT_165	[p8l265t2652r530b2719],
25	(	CD	NUMBER	(	num	27	SENT_165	[p8l583t2650r731b2733],
26	CI	NN	O	ci	nn	27	SENT_165	[p8l583t2650r731b2733],
27	)	NN	O	)	nsubjpass	30	SENT_165	[p8l583t2650r731b2733],
28	was	VBD	O	be	auxpass	30	SENT_165	[p8l783t2679r912b2719],
29	also	RB	O	also	advmod	30	SENT_165	[p8l967t2652r1097b2719],
30	reported	VBN	O	report	advcl	10	SENT_165	[p8l1150t2653r1466b2742],
31	.	.	O	.	_	0	SENT_165	[p8l1150t2653r1466b2742],

1	All	DT	O	all	det	3	SENT_166	[p8l1520t2651r1632b2718],
2	p	NN	O	p	nn	3	SENT_166	[p8l1681t2679r1723b2742],
3	values	NNS	O	value	nsubj	6	SENT_166	[p8l1773t2652r1985b2719],
4	are	VBP	O	be	cop	6	SENT_166	[p8l2040t2678r2140b2719],
5	2	CD	NUMBER	2	number	6	SENT_166	[p8l9t2758r305b2839],
6	—	CD	NUMBER	—	_	0	SENT_166	[p8l9t2758r305b2839],
7	tailed	VBD	O	tail	rcmod	6	SENT_166	[p8l9t2758r305b2839],
8	,	,	O	,	_	0	SENT_166	[p8l9t2758r305b2839],
9	and	CC	O	and	_	0	SENT_166	[p8l334t2758r462b2825],
10	statistical	JJ	O	statistical	amod	11	SENT_166	[p8l487t2758r815b2825],
11	signiﬁcance	NN	O	signiﬁcance	nsubjpass	13	SENT_166	[p8l840t2758r1248b2848],
12	was	VBD	O	be	auxpass	13	SENT_166	[p8l1271t2785r1399b2825],
13	deﬁned	VBN	O	deﬁned	conj_and	6	SENT_166	[p8l1427t2758r1688b2825],
14	as	IN	O	as	_	0	SENT_166	[p8l1714t2785r1777b2825],
15	p	NN	O	p	prep_as	13	SENT_166	[p8l1802t2785r1844b2848],
16	<	JJR	O	<	dep	17	SENT_166	[p8l1876t2769r1936b2820],
17	0.05	CD	NUMBER	0.05	advmod	13	SENT_166	[p8l1967t2758r2137b2825],
18	.	.	O	.	_	0	SENT_166	[p8l1967t2758r2137b2825],

1	All	DT	O	all	det	2	SENT_167	[p8l9t2863r120b2930],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_167	[p8l150t2865r430b2954],
3	were	VBD	O	be	auxpass	4	SENT_167	[p8l457t2890r624b2931],
4	performed	VBN	O	perform	_	0	SENT_167	[p8l653t2864r1023b2954],
5	with	IN	O	with	_	0	SENT_167	[p8l1049t2864r1210b2931],
6	SPSS	NNS	ORGANIZATION	spss	prep_with	4	SENT_167	[p8l1243t2864r1433b2931],
7	statistical	JJ	O	statistical	amod	8	SENT_167	[p8l1467t2864r1795b2931],
8	software	NN	O	software	dep	6	SENT_167	[p8l1824t2864r2138b2945],
9	,	,	O	,	_	0	SENT_167	[p8l1824t2864r2138b2945],
10	version	NN	O	version	appos	6	SENT_167	[p8l8t2973r261b3037],
11	19.0	CD	NUMBER	19.0	number	12	SENT_167	[p8l299t2974r446b3037],
12	(	CD	NUMBER	(	num	13	SENT_167	[p8l483t2968r725b3052],
13	SPSS	NNS	ORGANIZATION	spss	dep	10	SENT_167	[p8l483t2968r725b3052],
14	,	,	O	,	_	0	SENT_167	[p8l483t2968r725b3052],
15	Chicago	NNP	LOCATION	Chicago	appos	6	SENT_167	[p8l763t2970r1077b3060],
16	,	,	O	,	_	0	SENT_167	[p8l763t2970r1077b3060],
17	Illinois	NNP	LOCATION	Illinois	nn	18	SENT_167	[p8l1113t2968r1407b3051],
18	)	NN	O	)	appos	15	SENT_167	[p8l1113t2968r1407b3051],
19	.	.	O	.	_	0	SENT_167	[p8l1113t2968r1407b3051],

1	Results	NNS	O	result	_	0	SENT_168	[p8l13t3200r334b3262],

1	The	DT	O	the	det	3	SENT_169	[p9l8t38r151b106],
2	mean	NN	O	mean	nn	3	SENT_169	[p9l182t66r368b106],
3	age	NN	O	age	nsubj	12	SENT_169	[p9l398t66r507b129],
4	for	IN	O	for	_	0	SENT_169	[p9l537t39r634b106],
5	the	DT	O	the	det	8	SENT_169	[p9l661t40r768b106],
6	entire	JJ	O	entire	amod	8	SENT_169	[p9l798t42r990b106],
7	study	NN	O	study	nn	8	SENT_169	[p9l1021t39r1203b129],
8	cohort	NN	O	cohort	prep_for	3	SENT_169	[p9l1229t39r1449b106],
9	was	VBD	O	be	cop	12	SENT_169	[p9l1472t66r1598b106],
10	67	CD	NUMBER	67	number	11	SENT_169	[p9l1630t41r1713b106],
11	1	CD	NUMBER	1	num	12	SENT_169	[p9l1751t49r1803b102],
12	“	NN	O	“	_	0	SENT_169	[p9l1751t49r1803b102],
13	11	CD	DURATION	11	num	14	SENT_169	[p9l1846t43r1920b105],
14	years	NNS	NUMBER	year	tmod	12	SENT_169	[p9l1951t65r2138b129],
15	,	,	O	,	_	0	SENT_169	[p9l1951t65r2138b129],
16	and	CC	O	and	_	0	SENT_169	[p9l13t145r136b212],
17	43	CD	PERCENT	43	num	18	SENT_169	[p9l160t149r309b212],
18	%	NN	PERCENT	%	nsubj	25	SENT_169	[p9l160t149r309b212],
19	of	IN	O	of	_	0	SENT_169	[p9l335t145r413b212],
20	patients	NNS	O	patient	prep_of	18	SENT_169	[p9l425t148r690b235],
21	were	VBD	O	be	cop	25	SENT_169	[p9l713t171r874b212],
22	over	IN	O	over	advmod	25	SENT_169	[p9l900t171r1044b212],
23	70	CD	DURATION	70	num	24	SENT_169	[p9l1068t147r1149b212],
24	years	NNS	NUMBER	year	pobj	22	SENT_169	[p9l1173t171r1340b235],
25	old	JJ	DURATION	old	conj_and	12	SENT_169	[p9l1367t145r1489b212],
26	.	.	O	.	_	0	SENT_169	[p9l1367t145r1489b212],

1	Forty	CD	PERCENT	forty	number	2	SENT_170	[p9l1519t146r1864b235],
2	—	CD	PERCENT	—	nsubj	8	SENT_170	[p9l1519t146r1864b235],
3	two	CD	PERCENT	two	num	4	SENT_170	[p9l1519t146r1864b235],
4	percent	NN	PERCENT	percent	dep	2	SENT_170	[p9l1889t163r2143b235],
5	of	IN	O	of	_	0	SENT_170	[p9l12t251r90b318],
6	patients	NNS	O	patient	prep_of	2	SENT_170	[p9l110t254r375b341],
7	had	VBD	O	have	aux	8	SENT_170	[p9l411t251r537b318],
8	estimated	VBN	O	estimate	_	0	SENT_170	[p9l571t251r898b318],
9	creatinine	NN	O	creatinine	nn	10	SENT_170	[p9l932t254r1262b318],
10	clearance	NN	O	clearance	dobj	8	SENT_170	[p9l1297t251r1604b318],
11	<	JJR	O	<	dep	19	SENT_170	[p9l1643t255r1793b318],
12	60	CD	NUMBER	60	num	13	SENT_170	[p9l1643t255r1793b318],
13	mL	NN	O	ml	nsubj	19	SENT_170	[p9l1829t251r1985b318],
14	/	:	O	/	punct	15	SENT_170	[p9l1829t251r1985b318],
15	min	NN	DURATION	min	dep	13	SENT_170	[p9l1985t254r2138b332],
16	,	,	O	,	_	0	SENT_170	[p9l1985t254r2138b332],
17	36	CD	PERCENT	36	num	18	SENT_170	[p9l12t361r160b424],
18	%	NN	PERCENT	%	appos	15	SENT_170	[p9l12t361r160b424],
19	had	VBD	O	have	dep	8	SENT_170	[p9l211t357r337b424],
20	diabetes	NN	O	diabetes	nn	21	SENT_170	[p9l388t357r658b424],
21	mellitus	NN	O	mellitus	dobj	19	SENT_170	[p9l712t357r997b438],
22	,	,	O	,	_	0	SENT_170	[p9l712t357r997b438],
23	and	CC	O	and	_	0	SENT_170	[p9l1052t357r1176b424],
24	64	CD	PERCENT	64	num	25	SENT_170	[p9l1228t361r1375b424],
25	%	NN	PERCENT	%	dobj	19	SENT_170	[p9l1228t361r1375b424],
26	multivessel	JJ	O	multivessel	amod	28	SENT_170	[p9l1426t357r1798b424],
27	coronary	JJ	O	coronary	amod	28	SENT_170	[p9l1848t383r2145b447],
28	disease	NN	O	disease	dep	25	SENT_170	[p9l12t463r261b530],
29	.	.	O	.	_	0	SENT_170	[p9l12t463r261b530],

1	Clinical	JJ	O	clinical	nsubj	9	SENT_171	[p9l306t463r587b544],
2	,	,	O	,	_	0	SENT_171	[p9l306t463r587b544],
3	biochemical	JJ	O	biochemical	appos	1	SENT_171	[p9l627t463r1054b544],
4	,	,	O	,	_	0	SENT_171	[p9l627t463r1054b544],
5	and	CC	O	and	_	0	SENT_171	[p9l1097t463r1221b530],
6	procedural	JJ	O	procedural	amod	7	SENT_171	[p9l1258t463r1619b553],
7	variables	NNS	O	variable	appos	1	SENT_171	[p9l1653t463r1942b530],
8	were	VBD	O	be	cop	9	SENT_171	[p9l1979t489r2141b530],
9	comparable	JJ	O	comparable	_	0	SENT_171	[p9l12t569r401b659],
10	in	IN	O	in	_	0	SENT_171	[p9l437t572r503b635],
11	the	DT	O	the	det	14	SENT_171	[p9l538t569r645b636],
12	2	CD	NUMBER	2	num	14	SENT_171	[p9l679t573r720b637],
13	treatment	NN	O	treatment	nn	14	SENT_171	[p9l757t587r1090b636],
14	arms	NNS	O	arm	prep_in	9	SENT_171	[p9l1125t595r1302b636],
15	.	.	O	.	_	0	SENT_171	[p9l1125t595r1302b636],

1	In	IN	O	in	_	0	SENT_172	[p9l1342t570r1417b635],
2	particular	JJ	O	particular	amod	5	SENT_172	[p9l1452t569r1790b659],
3	,	,	O	,	_	0	SENT_172	[p9l1452t569r1790b659],
4	advanced	JJ	O	advanced	amod	5	SENT_172	[p9l1830t569r2142b636],
5	age	NN	O	age	prep_in	21	SENT_172	[p9l12t702r141b765],
6	,	,	O	,	_	0	SENT_172	[p9l12t702r141b765],
7	diabetes	NN	O	diabetes	nn	8	SENT_172	[p9l184t675r454b742],
8	mellitus	NN	O	mellitus	nsubjpass	21	SENT_172	[p9l496t675r781b756],
9	,	,	O	,	_	0	SENT_172	[p9l496t675r781b756],
10	poor	JJ	O	poor	amod	12	SENT_172	[p9l823t701r981b765],
11	renal	JJ	O	renal	amod	12	SENT_172	[p9l1018t675r1186b742],
12	function	NN	O	function	nsubjpass	21	SENT_172	[p9l1224t675r1526b756],
13	,	,	O	,	_	0	SENT_172	[p9l1224t675r1526b756],
14	and	CC	O	and	_	0	SENT_172	[p9l1570t675r1694b742],
15	higher	JJR	O	higher	amod	18	SENT_172	[p9l1732t675r1953b765],
16	total	JJ	O	total	amod	18	SENT_172	[p9l1990t675r2143b742],
17	cholesterol	NN	O	cholesterol	nn	18	SENT_172	[p9l12t781r376b848],
18	levels	NNS	O	level	nsubjpass	21	SENT_172	[p9l405t781r583b848],
19	were	VBD	O	be	auxpass	21	SENT_172	[p9l613t807r774b848],
20	evenly	RB	O	evenly	advmod	21	SENT_172	[p9l807t781r1020b871],
21	distributed	VBN	O	distribute	_	0	SENT_172	[p9l1049t781r1414b848],
22	in	IN	O	in	_	0	SENT_172	[p9l1444t784r1510b847],
23	the	DT	O	the	det	25	SENT_172	[p9l1541t782r1648b848],
24	2	CD	NUMBER	2	num	25	SENT_172	[p9l1677t785r1719b849],
25	groups	NNS	O	group	prep_in	21	SENT_172	[p9l1751t807r1996b871],
26	.	.	O	.	_	0	SENT_172	[p9l1751t807r1996b871],

1	No	DT	O	no	det	3	SENT_173	[p9l2031t782r2139b848],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_173	[p9l12t887r362b977],
3	differences	NNS	O	difference	nsubjpass	5	SENT_173	[p9l401t887r754b954],
4	were	VBD	O	be	auxpass	5	SENT_173	[p9l793t913r954b954],
5	observed	VBN	O	observe	_	0	SENT_173	[p9l995t887r1291b954],
6	in	IN	O	in	_	0	SENT_173	[p9l1331t890r1397b953],
7	CYP2CJ9	NN	O	cyp2cj9	nn	8	SENT_173	[p9l1444t891r1843b954],
8	*	NN	O	*	prep_in	5	SENT_173	[p9l1444t891r1843b954],
9	2	CD	NUMBER	2	num	12	SENT_173	[p9l1444t891r1843b954],
10	lossoffunction	NN	O	lossoffunction	nn	12	SENT_173	[p9l1882t887r2138b954, p9l11t993r295b1060],
11	allele	NN	O	allele	nn	12	SENT_173	[p9l326t993r494b1060],
12	frequencies	NNS	O	frequency	dep	8	SENT_173	[p9l524t993r902b1083],
13	(	RB	O	(	dep	14	SENT_173	[p9l937t991r1156b1074],
14	Table	NNP	O	Table	dep	8	SENT_173	[p9l937t991r1156b1074],
15	1	CD	NUMBER	1	number	16	SENT_173	[p9l1191t991r1271b1074],
16	)	CD	NUMBER	)	num	14	SENT_173	[p9l1191t991r1271b1074],
17	.	.	O	.	_	0	SENT_173	[p9l1191t991r1271b1074],

1	Platelet	NN	O	platelet	_	0	SENT_174	[p9l14t1105r273b1164],
2	reactivity	NN	O	reactivity	dep	1	SENT_174	[p9l332t1107r668b1180],
3	.	.	O	.	_	0	SENT_174	[p9l332t1107r668b1180],

1	The	DT	O	the	det	4	SENT_175	[p9l714t1097r857b1164],
2	mean	JJ	O	mean	amod	4	SENT_175	[p9l914t1124r1099b1164],
3	time	NN	O	time	nn	4	SENT_175	[p9l1154t1101r1306b1164],
4	intervals	NNS	O	interval	nsubj	34	SENT_175	[p9l1362t1098r1641b1164],
5	between	IN	O	between	_	0	SENT_175	[p9l1696t1098r1979b1164],
6	the	DT	O	the	det	8	SENT_175	[p9l2033t1098r2140b1164],
7	loading	VBG	O	load	amod	8	SENT_175	[p9l10t1204r264b1294],
8	dose	NN	O	dose	prep_between	4	SENT_175	[p9l290t1204r440b1271],
9	of	IN	O	of	_	0	SENT_175	[p9l469t1204r547b1271],
10	clopidogrel	NN	O	clopidogrel	prep_of	8	SENT_175	[p9l562t1204r939b1294],
11	and	CC	O	and	_	0	SENT_175	[p9l966t1204r1090b1271],
12	T-o	NN	O	t-o	conj_and	10	SENT_175	[p9l1113t1203r1251b1271],
13	were	VBD	O	be	cop	34	SENT_175	[p9l1275t1230r1436b1271],
14	10	CD	NUMBER	10	nn	34	SENT_175	[p9l1468t1208r1547b1271],
15	i	FW	O	i	dep	14	SENT_175	[p9l1583t1214r1637b1267],
16	3	CD	NUMBER	3	dep	15	SENT_175	[p9l1673t1208r1709b1271],
17	and	CC	O	and	_	0	SENT_175	[p9l1742t1204r1866b1271],
18	10	CD	NUMBER	10	conj_and	16	SENT_175	[p9l1896t1208r1974b1271],
19	:	:	O	:	_	0	SENT_175	[p9l2011t1214r2064b1267],
20	2	CD	DURATION	2	num	21	SENT_175	[p9l2098t1208r2139b1272],
21	days	NNS	NUMBER	day	dep	15	SENT_175	[p9l12t1311r155b1401],
22	in	IN	O	in	_	0	SENT_175	[p9l188t1314r254b1377],
23	the	DT	O	the	det	27	SENT_175	[p9l284t1312r391b1378],
24	atorvastatin	NN	O	atorvastatin	nn	27	SENT_175	[p9l424t1314r815b1378],
25	and	CC	O	and	_	0	SENT_175	[p9l847t1311r971b1378],
26	control	NN	O	control	nn	27	SENT_175	[p9l1002t1312r1242b1378],
27	groups	NNS	O	group	prep_in	21	SENT_175	[p9l1271t1337r1518b1401],
28	,	,	O	,	_	0	SENT_175	[p9l1271t1337r1518b1401],
29	respectively	RB	O	respectively	advmod	31	SENT_175	[p9l1551t1311r1943b1401],
30	(	CD	NUMBER	(	num	31	SENT_175	[p9l1973t1309r2038b1401],
31	p	NN	O	p	rcmod	21	SENT_175	[p9l1973t1309r2038b1401],
32	=	JJ	O	=	amod	34	SENT_175	[p9l2079t1337r2132b1358],
33	0.68	CD	NUMBER	0.68	tmod	32	SENT_175	[p9l11t1415r202b1498],
34	)	NN	O	)	_	0	SENT_175	[p9l11t1415r202b1498],
35	.	.	O	.	_	0	SENT_175	[p9l11t1415r202b1498],

1	All	DT	O	all	det	2	SENT_176	[p9l231t1416r340b1483],
2	patients	NNS	O	patient	nsubj	7	SENT_176	[p9l364t1421r629b1507],
3	enrolled	VBN	O	enrol	partmod	2	SENT_176	[p9l658t1417r932b1484],
4	in	IN	O	in	_	0	SENT_176	[p9l958t1420r1024b1483],
5	the	DT	O	the	det	6	SENT_176	[p9l1051t1418r1157b1484],
6	study	NN	O	study	prep_in	3	SENT_176	[p9l1186t1417r1368b1507],
7	underwent	VBD	O	undergo	_	0	SENT_176	[p9l1390t1417r1757b1484],
8	all	PDT	O	all	predet	11	SENT_176	[p9l1784t1417r1860b1484],
9	the	DT	O	the	det	11	SENT_176	[p9l1886t1418r1992b1484],
10	PD	NN	O	pd	nn	11	SENT_176	[p9l2021t1418r2139b1483],
11	testing	NN	O	testing	dobj	7	SENT_176	[p9l11t1526r239b1613],
12	as	IN	O	as	mark	13	SENT_176	[p9l276t1550r338b1590],
13	scheduled	VBN	O	schedule	advcl	7	SENT_176	[p9l378t1523r729b1604],
14	,	,	O	,	_	0	SENT_176	[p9l378t1523r729b1604],
15	and	CC	O	and	_	0	SENT_176	[p9l771t1523r896b1590],
16	the	DT	O	the	det	18	SENT_176	[p9l932t1523r1038b1590],
17	time	NN	O	time	nn	18	SENT_176	[p9l1076t1526r1228b1590],
18	intervals	NNS	O	interval	nsubj	20	SENT_176	[p9l1267t1523r1546b1590],
19	were	VBD	O	be	cop	20	SENT_176	[p9l1582t1549r1743b1590],
20	similar	JJ	O	similar	conj_and	7	SENT_176	[p9l1783t1524r2011b1590],
21	for	IN	O	for	mark	24	SENT_176	[p9l2046t1523r2143b1590],
22	both	DT	O	both	det	23	SENT_176	[p9l9t1629r168b1696],
23	groups	NNS	O	group	nsubj	24	SENT_176	[p9l187t1655r414b1719],
24	(	VBP	O	(	advcl	20	SENT_176	[p9l440t1627r658b1710],
25	Table	NNP	O	Table	nsubj	27	SENT_176	[p9l440t1627r658b1710],
26	2	CD	NUMBER	2	num	27	SENT_176	[p9l678t1627r765b1710],
27	)	CD	NUMBER	)	xcomp	24	SENT_176	[p9l678t1627r765b1710],
28	.	.	O	.	_	0	SENT_176	[p9l678t1627r765b1710],

1	Results	NNS	O	result	nsubjpass	13	SENT_177	[p9l792t1629r1033b1696],
2	of	IN	O	of	_	0	SENT_177	[p9l1056t1629r1134b1696],
3	platelet	NN	O	platelet	nn	4	SENT_177	[p9l1142t1629r1390b1719],
4	reactivity	NN	O	reactivity	prep_of	1	SENT_177	[p9l1408t1632r1718b1719],
5	at	IN	O	at	_	0	SENT_177	[p9l1736t1646r1797b1696],
6	each	DT	O	each	det	8	SENT_177	[p9l1817t1630r1968b1696],
7	time	NN	O	time	nn	8	SENT_177	[p9l1988t1632r2140b1696],
8	point	NN	O	point	prep_at	4	SENT_177	[p9l10t1738r192b1825],
9	for	IN	O	for	_	0	SENT_177	[p9l231t1735r327b1802],
10	both	DT	O	both	det	11	SENT_177	[p9l364t1735r523b1802],
11	groups	NNS	O	group	prep_for	8	SENT_177	[p9l563t1761r790b1825],
12	are	VBP	O	be	auxpass	13	SENT_177	[p9l834t1761r931b1802],
13	presented	VBN	O	present	_	0	SENT_177	[p9l971t1735r1299b1825],
14	in	IN	O	in	_	0	SENT_177	[p9l1339t1738r1405b1801],
15	Table	NNP	O	Table	prep_in	13	SENT_177	[p9l1443t1734r1640b1801],
16	2	CD	NUMBER	2	num	15	SENT_177	[p9l1680t1739r1739b1803],
17	.	.	O	.	_	0	SENT_177	[p9l1680t1739r1739b1803],

1	The	DT	O	the	det	3	SENT_178	[p9l1781t1734r1925b1802],
2	PRU	NNP	O	PRU	nn	3	SENT_178	[p9l1966t1736r2142b1802],
3	values	NNS	O	value	nsubj	4	SENT_178	[p9l8t1841r211b1908],
4	decreased	VBD	O	decrease	conj_and	4	SENT_178	[p9l256t1841r581b1908],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	4	SENT_178	[p9l624t1841r1034b1931],
6	from	IN	O	from	_	0	SENT_178	[p9l1073t1841r1238b1908],
7	baseline	NN	O	baseline	prep_from	4	SENT_178	[p9l1279t1841r1548b1908],
8	to	TO	O	to	_	0	SENT_178	[p9l1592t1859r1658b1908],
9	10	CD	DURATION	10	num	10	SENT_178	[p9l1706t1845r1784b1908],
10	days	NNS	NUMBER	day	prep_to	4	SENT_178	[p9l1829t1841r1973b1931],
11	and	CC	O	and	_	0	SENT_178	[p9l2018t1841r2142b1908],
12	from	IN	O	from	_	0	SENT_178	[p9l11t1947r176b2014],
13	baseline	NN	O	baseline	prep_from	4	SENT_178	[p9l211t1947r480b2014],
14	to	TO	O	to	_	0	SENT_178	[p9l518t1965r584b2014],
15	30	CD	DURATION	30	num	16	SENT_178	[p9l623t1951r705b2014],
16	days	NNS	NUMBER	day	prep_to	4	SENT_178	[p9l743t1947r887b2037],
17	in	IN	O	in	_	0	SENT_178	[p9l925t1950r991b2013],
18	both	DT	O	both	det	20	SENT_178	[p9l1025t1947r1185b2014],
19	treatment	NN	O	treatment	nn	20	SENT_178	[p9l1221t1965r1554b2014],
20	arms	NNS	O	arm	prep_in	16	SENT_178	[p9l1590t1973r1768b2014],
21	.	.	O	.	_	0	SENT_178	[p9l1590t1973r1768b2014],

1	However	RB	O	however	advmod	8	SENT_179	[p9l1809t1948r2138b2028],
2	,	,	O	,	_	0	SENT_179	[p9l1809t1948r2138b2028],
3	patients	NNS	O	patient	nsubj	8	SENT_179	[p9l10t2057r275b2144],
4	in	IN	O	in	_	0	SENT_179	[p9l308t2057r373b2120],
5	the	DT	O	the	det	7	SENT_179	[p9l404t2054r511b2121],
6	atorvastatin	NN	O	atorvastatin	nn	7	SENT_179	[p9l544t2057r935b2121],
7	group	NN	O	group	prep_in	3	SENT_179	[p9l965t2080r1162b2144],
8	achieved	VBD	O	achieve	_	0	SENT_179	[p9l1196t2054r1487b2121],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_179	[p9l1518t2054r1928b2144],
10	lower	JJR	O	lower	amod	11	SENT_179	[p9l1954t2054r2143b2121],
11	PRU	NNP	ORGANIZATION	PRU	nsubj	21	SENT_179	[p9l11t2161r187b2227],
12	than	IN	O	than	_	0	SENT_179	[p9l210t2160r363b2227],
13	patients	NNS	O	patient	prep_than	11	SENT_179	[p9l387t2163r639b2250],
14	in	IN	O	in	_	0	SENT_179	[p9l663t2163r727b2226],
15	the	DT	O	the	det	17	SENT_179	[p9l749t2161r852b2227],
16	control	NN	O	control	nn	17	SENT_179	[p9l877t2160r1106b2227],
17	group	NN	O	group	prep_in	13	SENT_179	[p9l1127t2186r1317b2250],
18	at	IN	O	at	_	0	SENT_179	[p9l1342t2178r1402b2227],
19	30	CD	DURATION	30	num	20	SENT_179	[p9l1423t2164r1504b2227],
20	days	NNS	NUMBER	day	prep_at	17	SENT_179	[p9l1528t2160r1666b2250],
21	(	VBP	O	(	ccomp	8	SENT_179	[p9l1693t2158r1836b2241],
22	188	CD	NUMBER	188	num	24	SENT_179	[p9l1693t2158r1836b2241],
23	:	:	O	:	_	0	SENT_179	[p9l1870t2170r1923b2223],
24	48	CD	NUMBER	48	dobj	21	SENT_179	[p9l1954t2164r2034b2227],
25	vs.	CC	O	vs.	prep	24	SENT_179	[p9l2056t2187r2137b2227],
26	223	CD	NUMBER	223	num	27	SENT_179	[p9l9t2270r130b2334],
27	i	FW	O	i	dep	25	SENT_179	[p9l171t2276r225b2329],
28	53	CD	NUMBER	53	dep	27	SENT_179	[p9l263t2266r368b2347],
29	,	,	O	,	_	0	SENT_179	[p9l263t2266r368b2347],
30	respectively	RB	O	respectively	advmod	27	SENT_179	[p9l403t2266r829b2356],
31	;	:	O	;	_	0	SENT_179	[p9l403t2266r829b2356],
32	p	NN	O	p	dep	33	SENT_179	[p9l863t2293r905b2356],
33	<	JJR	O	<	dep	27	SENT_179	[p9l944t2277r1004b2328],
34	0.01	CD	NUMBER	0.01	dep	33	SENT_179	[p9l1043t2270r1215b2347],
35	;	:	O	;	_	0	SENT_179	[p9l1043t2270r1215b2347],
36	primary	JJ	O	primary	amod	37	SENT_179	[p9l1249t2269r1529b2356],
37	endpoint	NN	O	endpoint	dep	27	SENT_179	[p9l1559t2264r1923b2356],
38	)	NN	O	)	dep	37	SENT_179	[p9l1559t2264r1923b2356],
39	.	.	O	.	_	0	SENT_179	[p9l1559t2264r1923b2356],

1	The	DT	O	the	det	2	SENT_180	[p9l97t2370r244b2437],
2	distribution	NN	O	distribution	nsubjpass	13	SENT_180	[p9l279t2371r692b2437],
3	of	IN	O	of	_	0	SENT_180	[p9l726t2371r806b2437],
4	mean	NN	O	mean	nn	6	SENT_180	[p9l828t2397r1018b2437],
5	PRU	NN	ORGANIZATION	pru	nn	6	SENT_180	[p9l1052t2372r1231b2437],
6	values	NNS	O	value	prep_of	2	SENT_180	[p9l1260t2371r1472b2437],
7	over	IN	O	over	_	0	SENT_180	[p9l1508t2397r1656b2437],
8	time	NN	O	time	prep_over	6	SENT_180	[p9l1687t2374r1845b2437],
9	in	IN	O	in	_	0	SENT_180	[p9l1879t2374r1946b2436],
10	both	DT	O	both	det	11	SENT_180	[p9l1978t2371r2141b2437],
11	groups	NNS	O	group	prep_in	8	SENT_180	[p9l10t2503r246b2567],
12	is	VBZ	O	be	auxpass	13	SENT_180	[p9l281t2480r331b2544],
13	shown	VBN	O	show	_	0	SENT_180	[p9l369t2478r596b2544],
14	in	IN	O	in	_	0	SENT_180	[p9l630t2480r697b2543],
15	Figure	NNP	O	Figure	nn	16	SENT_180	[p9l731t2478r960b2567],
16	2A	NN	O	2a	prep_in	13	SENT_180	[p9l993t2476r1120b2545],
17	.	.	O	.	_	0	SENT_180	[p9l993t2476r1120b2545],

1	PRU	NNP	ORGANIZATION	PRU	nn	2	SENT_181	[p9l1158t2478r1337b2544],
2	values	NNS	O	value	nsubj	7	SENT_181	[p9l1367t2478r1579b2544],
3	in	IN	O	in	_	0	SENT_181	[p9l1614t2480r1682b2543],
4	the	DT	O	the	det	6	SENT_181	[p9l1715t2478r1825b2544],
5	atorvastatin	NN	O	atorvastatin	nn	6	SENT_181	[p9l1861t2494r2138b2544, p9l11t2586r174b2650],
6	group	NN	O	group	prep_in	2	SENT_181	[p9l210t2609r415b2673],
7	decreased	VBD	O	decrease	_	0	SENT_181	[p9l455t2583r794b2650],
8	consistently	RB	O	consistently	advmod	7	SENT_181	[p9l832t2584r1250b2673],
9	for	IN	O	for	_	0	SENT_181	[p9l1283t2583r1384b2650],
10	30	CD	DURATION	30	num	11	SENT_181	[p9l1421t2587r1504b2650],
11	days	NNS	NUMBER	day	prep_for	7	SENT_181	[p9l1544t2583r1714b2673],
12	,	,	O	,	_	0	SENT_181	[p9l1544t2583r1714b2673],
13	whereas	IN	O	whereas	mark	21	SENT_181	[p9l1751t2583r2034b2650],
14	in	IN	O	in	_	0	SENT_181	[p9l2074t2586r2141b2649],
15	the	DT	O	the	det	17	SENT_181	[p9l11t2689r121b2756],
16	control	NN	O	control	nn	17	SENT_181	[p9l154t2689r405b2756],
17	group	NN	O	group	prep_in	21	SENT_181	[p9l434t2715r660b2779],
18	,	,	O	,	_	0	SENT_181	[p9l434t2715r660b2779],
19	PRU	NNP	ORGANIZATION	PRU	nn	20	SENT_181	[p9l695t2690r874b2756],
20	values	NNS	O	value	nsubj	21	SENT_181	[p9l901t2690r1112b2756],
21	showed	VBD	O	show	advcl	7	SENT_181	[p9l1147t2689r1412b2756],
22	a	DT	O	a	det	24	SENT_181	[p9l1444t2716r1479b2756],
23	marked	JJ	O	marked	amod	24	SENT_181	[p9l1510t2689r1774b2756],
24	reduction	NN	O	reduction	dobj	21	SENT_181	[p9l1805t2689r2141b2756],
25	in	IN	O	in	_	0	SENT_181	[p9l11t2798r79b2861],
26	the	DT	O	the	det	27	SENT_181	[p9l122t2795r232b2862],
27	ﬁrst	NN	O	ﬁrst	prep_in	21	SENT_181	[p9l277t2795r414b2862],
28	10	CD	DURATION	10	num	29	SENT_181	[p9l460t2799r540b2862],
29	days	NNS	NUMBER	day	tmod	27	SENT_181	[p9l585t2795r734b2885],
30	and	CC	O	and	_	0	SENT_181	[p9l781t2795r908b2862],
31	a	DT	O	a	det	33	SENT_181	[p9l952t2822r987b2862],
32	slight	JJ	O	slight	amod	33	SENT_181	[p9l1031t2795r1225b2885],
33	increase	NN	O	increase	conj_and	27	SENT_181	[p9l1266t2798r1545b2862],
34	thereafter	RB	O	thereafter	advmod	21	SENT_181	[p9l1590t2795r1949b2862],
35	.	.	O	.	_	0	SENT_181	[p9l1590t2795r1949b2862],

1	The	DT	O	the	det	2	SENT_182	[p9l1994t2794r2141b2862],
2	extent	NN	O	extent	nsubj	7	SENT_182	[p9l12t2917r228b2966],
3	of	IN	O	of	_	0	SENT_182	[p9l272t2900r352b2966],
4	relative	JJ	O	relative	amod	6	SENT_182	[p9l383t2901r637b2966],
5	PRU	NNP	ORGANIZATION	PRU	nn	6	SENT_182	[p9l683t2901r862b2966],
6	reduction	NN	O	reduction	prep_of	2	SENT_182	[p9l906t2900r1242b2966],
7	mirrors	VBZ	O	mirror	_	0	SENT_182	[p9l1288t2903r1543b2966],
8	this	DT	O	this	det	9	SENT_182	[p9l1590t2900r1716b2966],
9	trend	NN	O	trend	dobj	7	SENT_182	[p9l1762t2900r1950b2966],
10	over	IN	O	over	_	0	SENT_182	[p9l1995t2926r2143b2966],
11	mcc	NN	O	mcc	prep_over	9	SENT_182	[p9l43t3047r113b3062],
12	:	:	O	:	_	0	SENT_182	[p9l43t3047r113b3062],
13	AAAAAAAAAAAAAAAAAAAAAAAAAAAAA	NNP	O	AAAAAAAAAAAAAAAAAAAAAAAAAAAAA	nn	14	SENT_182	[p9l130t3047r625b3064],
14	oL	NN	O	ol	dep	9	SENT_182	[p9l630t3047r669b3062],
15	.	.	O	.	_	0	SENT_182	[p9l630t3047r669b3062],

1	6	CD	NUMBER	6	_	0	SENT_183	[p9l686t3047r706b3064],
2	.	.	O	.	_	0	SENT_183	[p9l686t3047r706b3064],

1	No.	NN	O	no.	_	0	SENT_184	[p9l723t3047r765b3062],
2	z	SYM	O	z	dep	1	SENT_184	[p9l782t3047r792b3062],
3	,	,	O	,	_	0	SENT_184	[p9l797t3057r802b3064],
4	z	SYM	O	z	dep	7	SENT_184	[p9l819t3047r829b3062],
5	o	NN	O	o	nn	7	SENT_184	[p9l835t3047r846b3062],
6	13	CD	NUMBER	13	num	7	SENT_184	[p9l852t3047r877b3062],
7	Leoncini	NNP	O	Leoncini	dep	10	SENT_184	[p9l1790t3041r1891b3062],
8	et	FW	O	et	nn	9	SENT_184	[p9l1904t3042r1928b3062],
9	al.	FW	O	al.	dep	7	SENT_184	[p9l1939t3041r1966b3062],
10	173	CD	NUMBER	173	dep	2	SENT_184	[p9l2069t3041r2117b3062],

1	High-Dose	JJ	O	high-dose	amod	2	SENT_185	[p9l1390t3079r1514b3104],
2	Atorvastatin	NN	O	atorvastatin	_	0	SENT_185	[p9l1524t3079r1673b3099],
3	and	CC	O	and	_	0	SENT_185	[p9l1685t3079r1730b3099],
4	Platelet	NN	O	platelet	nn	5	SENT_185	[p9l1742t3079r1837b3099],
5	Reactivity	NN	O	reactivity	conj_and	2	SENT_185	[p9l1848t3079r1969b3104],

1	Table	NNP	O	Table	_	0	SENT_186	[p10l356t72r425b93],
2	1	CD	NUMBER	1	dep	1	SENT_186	[p10l437t72r460b92],
3	.	.	O	.	_	0	SENT_186	[p10l437t72r460b92],

1	clinical	JJ	O	clinical	amod	2	SENT_187	[p10l472t72r567b93],
2	characteristics	NNS	O	characteristic	_	0	SENT_187	[p10l579t72r785b97],
3	,	,	O	,	_	0	SENT_187	[p10l579t72r785b97],
4	and	CC	O	and	_	0	SENT_187	[p10l798t72r843b93],
5	Biological	JJ	O	biological	amod	8	SENT_187	[p10l856t72r982b98],
6	and	CC	O	and	_	0	SENT_187	[p10l993t72r1039b93],
7	Angiographic	JJ	O	angiographic	conj_and	5	SENT_187	[p10l1050t72r1220b98],
8	Parameters	NNS	O	parameter	conj_and	2	SENT_187	[p10l1232t72r1380b93],
9	of	IN	O	of	_	0	SENT_187	[p10l1391t72r1416b93],
10	the	DT	O	the	det	12	SENT_187	[p10l1425t72r1467b93],
11	Study	NNP	O	Study	nn	12	SENT_187	[p10l1477t72r1551b98],
12	Groups	NNS	O	group	prep_of	2	SENT_187	[p10l1561t72r1651b97],

1	Atorvastatin	NNP	ORGANIZATION	Atorvastatin	nn	2	SENT_188	[p10l876t140r1024b159],
2	Group	NNP	ORGANIZATION	Group	_	0	SENT_188	[p10l1035t140r1105b164],
3	(	NN	O	(	nn	4	SENT_188	[p10l1115t140r1138b164],
4	n	NN	O	n	dep	2	SENT_188	[p10l1115t140r1138b164],
5	=	JJ	O	=	amod	7	SENT_188	[p10l1151t146r1168b155],
6	38	CD	NUMBER	38	tmod	5	SENT_188	[p10l1180t140r1220b164],
7	)	NN	O	)	dep	4	SENT_188	[p10l1180t140r1220b164],

1	control	NN	O	control	_	0	SENT_189	[p10l1326t140r1412b159],
2	Group	NNP	O	Group	nn	4	SENT_189	[p10l1423t140r1493b164],
3	(	CD	NUMBER	(	num	4	SENT_189	[p10l1503t140r1526b164],
4	n	NN	O	n	dep	1	SENT_189	[p10l1503t140r1526b164],
5	=	JJ	O	=	amod	7	SENT_189	[p10l1539t146r1556b155],
6	38	CD	NUMBER	38	tmod	5	SENT_189	[p10l1568t140r1609b164],
7	)	NN	O	)	dep	4	SENT_189	[p10l1568t140r1609b164],

1	p	NN	O	p	nn	3	SENT_190	[p10l1714t145r1727b164],
2	Value	NN	O	value	nn	3	SENT_190	[p10l1737t140r1803b159],
3	Age	NN	O	age	nsubj	5	SENT_190	[p10l356t211r406b236],
4	,	,	O	,	_	0	SENT_190	[p10l356t211r406b236],
5	yrs	VBZ	DURATION	yr	_	0	SENT_190	[p10l416t216r447b236],
6	Age	NNP	O	Age	nn	8	SENT_190	[p10l356t257r400b282],
7	270	CD	DURATION	270	num	8	SENT_190	[p10l412t258r459b276],
8	yrs	NNS	DURATION	yr	iobj	5	SENT_190	[p10l469t262r501b282],
9	Men	NN	O	man	nn	11	SENT_190	[p10l357t303r404b322],
10	Risk	NN	O	risk	nn	11	SENT_190	[p10l357t348r400b368],
11	factors	NNS	O	factor	dobj	5	SENT_190	[p10l409t348r485b368],
12	Hypertension	NN	O	hypertension	prep	11	SENT_190	[p10l384t395r534b420],
13	Diabetes	NNP	O	Diabetes	dep	12	SENT_190	[p10l384t441r481b460],
14	mellitus	NN	O	mellitus	prep	11	SENT_190	[p10l493t441r580b460],
15	Active	JJ	O	active	amod	17	SENT_190	[p10l383t488r452b506],
16	smoking	NN	O	smoking	nn	17	SENT_190	[p10l463t487r558b512],
17	BMI	NN	O	bmus	dep	14	SENT_190	[p10l384t533r430b556],
18	,	,	O	,	_	0	SENT_190	[p10l384t533r430b556],
19	kg/m2	NN	O	kg/m2	nn	21	SENT_190	[p10l442t528r510b558],
20	Total	JJ	O	total	amod	21	SENT_190	[p10l382t579r438b599],
21	cholesterol	NN	O	cholesterol	dobj	5	SENT_190	[p10l449t579r572b599],
22	>	JJR	O	>	dep	21	SENT_190	[p10l585t580r646b599],
23	200	CD	NUMBER	200	num	26	SENT_190	[p10l585t580r646b599],
24	mg/dl	NN	O	mg/dl	nn	26	SENT_190	[p10l658t579r723b604],
25	Creatinine	NN	O	creatinine	nn	26	SENT_190	[p10l383t625r498b645],
26	clearance	NN	O	clearance	dep	31	SENT_190	[p10l509t625r615b645],
27	<	JJR	O	<	dep	26	SENT_190	[p10l627t626r675b645],
28	60	CD	NUMBER	60	num	29	SENT_190	[p10l627t626r675b645],
29	ml/min	NN	O	ml/min	dep	31	SENT_190	[p10l686t625r765b645],
30	Previous	JJ	O	previous	amod	31	SENT_190	[p10l357t672r451b691],
31	Ml	NN	O	ml	dep	21	SENT_190	[p10l463t672r488b690],
32	Previous	JJ	O	previous	amod	33	SENT_190	[p10l357t718r451b737],
33	PCI	NN	O	pcus	dep	31	SENT_190	[p10l463t717r496b737],
34	or	CC	O	or	_	0	SENT_190	[p10l508t723r531b737],
35	CABG	NNP	O	CABG	nn	39	SENT_190	[p10l540t717r603b737],
36	Baseline	NNP	O	Baseline	nn	39	SENT_190	[p10l357t763r448b783],
37	LV	NNP	O	LV	nn	39	SENT_190	[p10l460t764r486b783],
38	ejection	NN	O	ejection	nn	39	SENT_190	[p10l496t764r584b788],
39	fraction	NN	O	fraction	conj_or	31	SENT_190	[p10l595t763r687b786],
40	,	,	O	,	_	0	SENT_190	[p10l595t763r687b786],
41	%	NN	O	%	nn	42	SENT_190	[p10l697t764r718b783],
42	Laboraton	NN	O	laboraton	appos	39	SENT_190	[p10l357t809r479b834],
43	/	:	O	/	punct	45	SENT_190	[p10l357t809r479b834],
44	variables	NNS	O	variable	nn	45	SENT_190	[p10l488t809r588b829],
45	Hemoglobin	NN	O	hemoglobin	dep	42	SENT_190	[p10l384t855r529b880],
46	,	,	O	,	_	0	SENT_190	[p10l384t855r529b880],
47	mg/dl	JJ	O	mg/dl	amod	48	SENT_190	[p10l541t855r606b880],
48	RBCS	NN	O	rbc	appos	45	SENT_190	[p10l384t902r443b924],
49	,	,	O	,	_	0	SENT_190	[p10l384t902r443b924],
50	103/pl	CD	NUMBER	103/pl	num	51	SENT_190	[p10l456t896r523b926],
51	WBCS	NNS	O	wbc	appos	45	SENT_190	[p10l383t948r451b970],
52	,	,	O	,	_	0	SENT_190	[p10l383t948r451b970],
53	103/pl	JJ	O	103/pl	amod	55	SENT_190	[p10l464t942r532b972],
54	Platelet	NN	O	platelet	nn	55	SENT_190	[p10l384t993r468b1013],
55	count	NN	O	count	appos	45	SENT_190	[p10l478t996r548b1016],
56	,	,	O	,	_	0	SENT_190	[p10l478t996r548b1016],
57	103/ul	JJ	O	103/ul	amod	58	SENT_190	[p10l560t989r628b1018],
58	MPV	NN	O	mpv	appos	45	SENT_190	[p10l384t1040r439b1062],
59	,	,	O	,	_	0	SENT_190	[p10l384t1040r439b1062],
60	109/p	NN	O	109/p	appos	45	SENT_190	[p10l451t1034r519b1064],
61	.	.	O	.	_	0	SENT_190	[p10l451t1034r519b1064],

1	l	NN	O	l	nn	2	SENT_191	[p10l451t1034r519b1064],
2	hs	NNS	O	h	_	0	SENT_191	[p10l384t1085r466b1108],
3	.	.	O	.	_	0	SENT_191	[p10l384t1085r466b1108],

1	—	NN	O	—	_	0	SENT_192	[p10l384t1085r466b1108],
2	.	.	O	.	_	0	SENT_192	[p10l384t1085r466b1108],

1	CRP	NN	ORGANIZATION	crp	_	0	SENT_193	[p10l384t1085r466b1108],
2	,	,	O	,	_	0	SENT_193	[p10l384t1085r466b1108],
3	mg/I	NN	O	mg/i	nn	5	SENT_193	[p10l478t1085r528b1110],
4	Creatinine	NN	O	creatinine	nn	5	SENT_193	[p10l383t1132r498b1151],
5	clearance	NN	O	clearance	appos	1	SENT_193	[p10l509t1131r621b1154],
6	,	,	O	,	_	0	SENT_193	[p10l509t1131r621b1154],
7	ml/min	JJ	O	ml/min	amod	10	SENT_193	[p10l632t1131r711b1152],
8	Baseline	NN	O	baseline	nn	10	SENT_193	[p10l384t1177r475b1197],
9	cTn	NN	O	ctn	nn	10	SENT_193	[p10l486t1178r537b1200],
10	|	NN	O	|	appos	1	SENT_193	[p10l486t1178r537b1200],
11	,	,	O	,	_	0	SENT_193	[p10l486t1178r537b1200],
12	ng/ml	NN	O	ng/ml	nn	14	SENT_193	[p10l548t1177r613b1203],
13	Baseline	NN	O	baseline	nn	14	SENT_193	[p10l384t1223r475b1243],
14	CK	NN	O	ck	appos	1	SENT_193	[p10l486t1224r565b1246],
15	.	.	O	.	_	0	SENT_193	[p10l486t1224r565b1246],

1	—	NN	O	—	_	0	SENT_194	[p10l486t1224r565b1246],
2	.	.	O	.	_	0	SENT_194	[p10l486t1224r565b1246],

1	MB	NNP	O	MB	nn	4	SENT_195	[p10l486t1224r565b1246],
2	,	,	O	,	_	0	SENT_195	[p10l486t1224r565b1246],
3	ng/ml	NNP	O	ng/ml	conj_and	4	SENT_195	[p10l576t1223r642b1249],
4	Angiographic	NNP	O	Angiographic	_	0	SENT_195	[p10l356t1269r509b1295],
5	and	CC	O	and	_	0	SENT_195	[p10l519t1269r560b1289],
6	PCI	NNP	O	PCI	conj_and	4	SENT_195	[p10l573t1270r606b1289],
7	data	NNS	O	datum	nsubj	23	SENT_195	[p10l617t1269r665b1289],
8	Multivessel	JJ	O	multivessel	amod	13	SENT_195	[p10l384t1315r507b1335],
9	disease	NN	O	disease	nn	13	SENT_195	[p10l519t1315r601b1335],
10	Multivessel	JJ	O	multivessel	amod	13	SENT_195	[p10l384t1361r507b1381],
11	PCI	NN	O	pcus	nn	13	SENT_195	[p10l520t1362r553b1381],
12	Lesion	NN	O	lesion	nn	13	SENT_195	[p10l384t1408r454b1427],
13	location	NN	O	location	nsubj	14	SENT_195	[p10l467t1407r555b1427],
14	Left	VBN	O	leave	rcmod	7	SENT_195	[p10l412t1453r453b1473],
15	anterior	JJ	O	anterior	dobj	14	SENT_195	[p10l463t1454r551b1473],
16	descending	VBG	O	descend	amod	15	SENT_195	[p10l561t1453r691b1479],
17	Left	VBN	O	leave	partmod	15	SENT_195	[p10l411t1499r453b1519],
18	circumﬂex	NN	O	circumﬂex	nn	19	SENT_195	[p10l463t1499r579b1519],
19	artery	NN	O	artery	dobj	17	SENT_195	[p10l589t1503r654b1525],
20	Right	RB	O	right	advmod	17	SENT_195	[p10l412t1546r469b1571],
21	coronary	JJ	O	coronary	amod	22	SENT_195	[p10l480t1551r579b1571],
22	artery	NN	O	artery	pobj	20	SENT_195	[p10l589t1549r654b1571],
23	Left	VBN	O	leave	rcmod	4	SENT_195	[p10l411t1591r453b1612],
24	main	JJ	O	main	amod	26	SENT_195	[p10l464t1593r517b1612],
25	Saphenous	JJ	MISC	saphenous	amod	26	SENT_195	[p10l411t1638r535b1663],
26	vein	NN	O	vein	nsubj	29	SENT_195	[p10l545t1639r591b1658],
27	graft	NN	O	graft	nn	29	SENT_195	[p10l603t1637r655b1663],
28	Mean	NN	O	mean	nn	29	SENT_195	[p10l384t1685r444b1704],
29	number	NN	O	number	xcomp	23	SENT_195	[p10l457t1684r545b1704],
30	of	IN	O	of	_	0	SENT_195	[p10l555t1683r579b1704],
31	stents	NNS	O	stent	prep_of	29	SENT_195	[p10l587t1687r653b1704],
32	Total	JJ	O	total	amod	34	SENT_195	[p10l382t1730r438b1750],
33	stent	NN	O	stent	nn	34	SENT_195	[p10l449t1733r505b1750],
34	length	NN	O	length	dep	31	SENT_195	[p10l516t1730r594b1755],
35	,	,	O	,	_	0	SENT_195	[p10l516t1730r594b1755],
36	mm	NN	O	mm	nn	38	SENT_195	[p10l605t1736r647b1750],
37	Stent	NN	O	stent	nn	38	SENT_195	[p10l384t1777r442b1796],
38	type	NN	O	type	appos	31	SENT_195	[p10l452t1779r502b1801],
39	Drug	NN	O	drug	dep	4	SENT_195	[p10l412t1822r554b1847],
40	—	CD	NUMBER	—	num	39	SENT_195	[p10l412t1822r554b1847],
41	e	SYM	O	e	dep	85	SENT_195	[p10l412t1822r554b1847],
42	|	SYM	O	|	dep	43	SENT_195	[p10l412t1822r554b1847],
43	uting	VBG	O	ute	dep	85	SENT_195	[p10l412t1822r554b1847],
44	stents	NNS	O	stent	dobj	43	SENT_195	[p10l565t1825r632b1842],
45	Bare	JJ	O	bare	amod	47	SENT_195	[p10l412t1868r531b1888],
46	—	NN	O	—	nn	47	SENT_195	[p10l412t1868r531b1888],
47	meta	NN	O	meta	dep	63	SENT_195	[p10l412t1868r531b1888],
48	|	CD	NUMBER	|	num	49	SENT_195	[p10l412t1868r531b1888],
49	stents	NNS	O	stent	dep	47	SENT_195	[p10l543t1871r609b1888],
50	GP	NN	O	gp	nn	59	SENT_195	[p10l384t1915r414b1934],
51	llb/Illa	NN	O	llb/illa	nn	59	SENT_195	[p10l425t1914r492b1935],
52	inhibitor	NN	O	inhibitor	nn	59	SENT_195	[p10l504t1914r611b1934],
53	*	NN	O	*	nn	59	SENT_195	[p10l504t1914r611b1934],
54	CYP2C19	NN	O	cyp2c19	nn	59	SENT_195	[p10l357t1961r478b1980],
55	*	NN	O	*	nn	59	SENT_195	[p10l357t1961r478b1980],
56	2	CD	NUMBER	2	num	59	SENT_195	[p10l357t1961r478b1980],
57	polymorphism	NN	O	polymorphism	nn	59	SENT_195	[p10l489t1960r651b1986],
58	genotype	NN	O	genotype	nn	59	SENT_195	[p10l663t1963r770b1986],
59	*	NN	O	*	dep	49	SENT_195	[p10l383t2007r428b2026],
60	1	CD	NUMBER	1	num	61	SENT_195	[p10l383t2007r428b2026],
61	*	NN	O	*	dep	63	SENT_195	[p10l383t2007r428b2026],
62	1	CD	NUMBER	1	num	63	SENT_195	[p10l383t2007r428b2026],
63	*	NN	O	*	dep	67	SENT_195	[p10l383t2053r432b2072],
64	1	CD	NUMBER	1	num	65	SENT_195	[p10l383t2053r432b2072],
65	*	NN	O	*	dep	63	SENT_195	[p10l383t2053r432b2072],
66	2	CD	NUMBER	2	num	67	SENT_195	[p10l383t2053r432b2072],
67	*	NN	O	*	dep	69	SENT_195	[p10l383t2099r432b2118],
68	2	CD	NUMBER	2	num	69	SENT_195	[p10l383t2099r432b2118],
69	*	NN	O	*	dep	72	SENT_195	[p10l383t2099r432b2118],
70	2	CD	NUMBER	2	num	72	SENT_195	[p10l383t2099r432b2118],
71	Concomitant	JJ	O	concomitant	amod	72	SENT_195	[p10l356t2145r503b2165],
72	medications	NNS	O	medication	dep	43	SENT_195	[p10l514t2145r650b2165],
73	at	IN	O	at	_	0	SENT_195	[p10l661t2148r682b2165],
74	T	NN	O	t	nn	77	SENT_195	[p10l691t2146r726b2165],
75	—	CD	NUMBER	—	num	77	SENT_195	[p10l691t2146r726b2165],
76	o	NN	O	o	nn	77	SENT_195	[p10l691t2146r726b2165],
77	Beta	NN	O	beta	prep_at	72	SENT_195	[p10l385t2191r535b2211],
78	—	NN	O	—	nn	79	SENT_195	[p10l385t2191r535b2211],
79	blockers	NNS	O	blocker	dep	43	SENT_195	[p10l385t2191r535b2211],
80	Calcium	NN	MISC	calcium	nn	82	SENT_195	[p10l384t2237r472b2257],
81	channel	NN	O	channel	nn	82	SENT_195	[p10l484t2237r571b2257],
82	blockers	NNS	O	blocker	dep	79	SENT_195	[p10l584t2237r676b2257],
83	ACE	NN	O	ace	nn	84	SENT_195	[p10l383t2283r428b2303],
84	inhibitors	NNS	O	inhibitor	nsubj	85	SENT_195	[p10l439t2283r544b2303],
85	ARB	VBP	O	arb	dep	39	SENT_195	[p10l383t2330r428b2349],
86	Nitrates	NNS	O	nitrate	nsubj	88	SENT_195	[p10l385t2376r470b2395],
87	Diuretic	JJ	O	diuretic	amod	88	SENT_195	[p10l385t2422r471b2441],
88	Insulin	NN	O	insulin	xcomp	85	SENT_195	[p10l385t2467r456b2487],

1	Values	NNS	O	value	nsubj	8	SENT_196	[p10l356t2529r420b2546],
2	are	VBP	O	be	cop	8	SENT_196	[p10l427t2534r457b2546],
3	mean	JJ	O	mean	advmod	8	SENT_196	[p10l464t2534r518b2546],
4	1	CD	NUMBER	1	num	6	SENT_196	[p10l528t2531r542b2545],
5	SD	NN	O	sd	nn	6	SENT_196	[p10l551t2529r578b2546],
6	n	NN	O	n	dep	3	SENT_196	[p10l585t2529r634b2549],
7	(	CD	PERCENT	(	num	8	SENT_196	[p10l585t2529r634b2549],
8	%	NN	PERCENT	%	_	0	SENT_196	[p10l585t2529r634b2549],
9	)	CD	NUMBER	)	dep	8	SENT_196	[p10l585t2529r634b2549],
10	,	,	O	,	_	0	SENT_196	[p10l585t2529r634b2549],
11	or	CC	O	or	_	0	SENT_196	[p10l641t2534r661b2546],
12	median	JJ	O	median	amod	16	SENT_196	[p10l668t2529r741b2546],
13	[	NN	O	[	nn	16	SENT_196	[p10l750t2529r878b2551],
14	interquartile	NN	O	interquartile	nn	16	SENT_196	[p10l750t2529r878b2551],
15	range	NN	O	range	nn	16	SENT_196	[p10l885t2529r953b2551],
16	]	NN	O	]	conj_or	8	SENT_196	[p10l885t2529r953b2551],
17	.	.	O	.	_	0	SENT_196	[p10l885t2529r953b2551],

1	*	NN	O	*	nsubjpass	5	SENT_197	[p10l960t2529r1016b2551],
2	Only	RB	O	only	advmod	3	SENT_197	[p10l960t2529r1016b2551],
3	eptiﬁbatide	NN	O	eptiﬁbatide	dep	1	SENT_197	[p10l1022t2528r1137b2551],
4	was	VBD	O	be	auxpass	5	SENT_197	[p10l1143t2534r1181b2546],
5	used	VBN	O	use	_	0	SENT_197	[p10l1188t2529r1239b2546],
6	.	.	O	.	_	0	SENT_197	[p10l1188t2529r1239b2546],

1	ACE	NN	O	ace	_	0	SENT_198	[p10l380t2567r419b2584],
2	=	JJ	O	=	amod	4	SENT_198	[p10l428t2573r443b2579],
3	angiotensin-converting	JJ	O	angiotensin-converting	amod	4	SENT_198	[p10l452t2567r685b2589],
4	enzyme	NN	O	enzyme	dep	1	SENT_198	[p10l693t2571r775b2589],
5	;	:	O	;	_	0	SENT_198	[p10l693t2571r775b2589],
6	ARB	NN	O	arb	nn	8	SENT_198	[p10l783t2567r822b2584],
7	=	JJ	O	=	amod	8	SENT_198	[p10l831t2573r846b2579],
8	angiotensin	NN	O	angiotensin	dep	1	SENT_198	[p10l855t2567r971b2589],
9	II	CD	NUMBER	ii	num	11	SENT_198	[p10l980t2567r989b2584],
10	receptor	NN	O	receptor	nn	11	SENT_198	[p10l997t2569r1081b2588],
11	blockers	NNS	O	blocker	dep	8	SENT_198	[p10l1089t2566r1175b2586],
12	;	:	O	;	_	0	SENT_198	[p10l1089t2566r1175b2586],
13	BMI	NN	O	bmus	dep	1	SENT_198	[p10l1183t2567r1218b2584],
14	=	JJ	O	=	amod	17	SENT_198	[p10l1228t2573r1243b2579],
15	body	NN	O	body	nn	17	SENT_198	[p10l1253t2566r1303b2589],
16	mass	NN	O	mass	nn	17	SENT_198	[p10l1310t2571r1359b2584],
17	index	NN	O	index	dep	13	SENT_198	[p10l1367t2566r1425b2586],
18	;	:	O	;	_	0	SENT_198	[p10l1367t2566r1425b2586],
19	CABG	NN	O	cabg	nn	23	SENT_198	[p10l1432t2567r1488b2584],
20	=	JJ	O	=	amod	23	SENT_198	[p10l1497t2573r1512b2579],
21	coronary	JJ	O	coronary	amod	23	SENT_198	[p10l1521t2571r1609b2589],
22	artery	NN	O	artery	nn	23	SENT_198	[p10l1616t2569r1674b2589],
23	bypass	NN	O	bypass	dep	1	SENT_198	[p10l1681t2566r1748b2589],
24	graft	NN	O	graft	dep	23	SENT_198	[p10l1755t2566r1807b2589],
25	;	:	O	;	_	0	SENT_198	[p10l1755t2566r1807b2589],
26	CK-MB	NN	O	ck-mb	dep	1	SENT_198	[p10l356t2604r421b2621],
27	=	JJ	O	=	amod	29	SENT_198	[p10l432t2610r447b2616],
28	creation	NN	O	creation	nn	29	SENT_198	[p10l458t2604r538b2621],
29	kinase-MB	NN	O	kinase-mb	dep	26	SENT_198	[p10l548t2604r654b2624],
30	;	:	O	;	_	0	SENT_198	[p10l548t2604r654b2624],
31	cTn	NN	O	ctn	nn	32	SENT_198	[p10l663t2605r702b2621],
32	|	NN	O	|	dep	1	SENT_198	[p10l663t2605r702b2621],
33	=	JJ	O	=	amod	36	SENT_198	[p10l714t2610r729b2616],
34	cardiac	JJ	O	cardiac	amod	36	SENT_198	[p10l740t2604r810b2621],
35	troponin	NN	O	troponin	nn	36	SENT_198	[p10l819t2604r905b2626],
36	I	NN	O	i	dep	32	SENT_198	[p10l916t2605r924b2624],
37	;	:	O	;	_	0	SENT_198	[p10l916t2605r924b2624],
38	GP	NN	O	gp	dep	1	SENT_198	[p10l933t2604r960b2621],
39	=	JJ	O	=	amod	40	SENT_198	[p10l971t2610r985b2616],
40	glycoprotein	NN	O	glycoprotein	dep	38	SENT_198	[p10l996t2604r1128b2626],
41	;	:	O	;	_	0	SENT_198	[p10l996t2604r1128b2626],
42	hs-CRP	NN	O	hs-crp	nn	45	SENT_198	[p10l1137t2604r1205b2621],
43	=	JJ	O	=	amod	45	SENT_198	[p10l1216t2610r1231b2616],
44	high	JJ	O	high	amod	45	SENT_198	[p10l1242t2604r1285b2626],
45	sensitivity	NN	O	sensitivity	dep	1	SENT_198	[p10l1295t2604r1394b2626],
46	C-reactive	JJ	MISC	c-reactive	amod	47	SENT_198	[p10l1402t2604r1501b2621],
47	protein	NN	O	protein	dep	45	SENT_198	[p10l1511t2604r1587b2626],
48	;	:	O	;	_	0	SENT_198	[p10l1511t2604r1587b2626],
49	LV	NN	O	lv	nsubj	51	SENT_198	[p10l1597t2604r1620b2621],
50	=	JJ	O	=	amod	49	SENT_198	[p10l1631t2610r1645b2616],
51	left	VBD	O	leave	dep	1	SENT_198	[p10l1657t2603r1688b2621],
52	ventricular	JJ	O	ventricular	acomp	51	SENT_198	[p10l1696t2604r1807b2624],
53	;	:	O	;	_	0	SENT_198	[p10l1696t2604r1807b2624],
54	WBC	NN	ORGANIZATION	wbc	dep	1	SENT_198	[p10l356t2642r402b2659],
55	=	JJ	O	=	amod	58	SENT_198	[p10l409t2648r424b2654],
56	white	JJ	O	white	amod	58	SENT_198	[p10l431t2641r487b2659],
57	blood	NN	O	blood	nn	58	SENT_198	[p10l493t2641r549b2659],
58	cell	NN	O	cell	dep	54	SENT_198	[p10l556t2641r593b2661],
59	;	:	O	;	_	0	SENT_198	[p10l556t2641r593b2661],
60	Ml	NN	O	ml	dep	1	SENT_198	[p10l599t2642r621b2659],
61	=	JJ	O	=	amod	63	SENT_198	[p10l630t2648r645b2654],
62	myocardial	JJ	O	myocardial	amod	63	SENT_198	[p10l653t2641r761b2664],
63	infarction	NN	O	infarction	dep	60	SENT_198	[p10l768t2641r867b2662],
64	;	:	O	;	_	0	SENT_198	[p10l768t2641r867b2662],
65	MPV	NN	O	mpv	dep	1	SENT_198	[p10l873t2642r917b2659],
66	=	JJ	O	=	amod	69	SENT_198	[p10l924t2648r939b2654],
67	mean	NN	O	mean	nn	69	SENT_198	[p10l947t2646r1001b2659],
68	platelet	NN	O	platelet	nn	69	SENT_198	[p10l1008t2641r1082b2663],
69	volume	NN	O	volume	dep	65	SENT_198	[p10l1087t2641r1167b2662],
70	;	:	O	;	_	0	SENT_198	[p10l1087t2641r1167b2662],
71	PCI	NN	O	pcus	dep	1	SENT_198	[p10l1173t2642r1202b2659],
72	=	JJ	O	=	amod	75	SENT_198	[p10l1211t2648r1225b2654],
73	percutaneous	JJ	O	percutaneous	amod	75	SENT_198	[p10l1234t2644r1369b2663],
74	coronary	JJ	O	coronary	amod	75	SENT_198	[p10l1375t2646r1463b2664],
75	intervention	NN	O	intervention	dep	71	SENT_198	[p10l1469t2642r1595b2661],
76	;	:	O	;	_	0	SENT_198	[p10l1469t2642r1595b2661],
77	RBC	NN	O	rbc	dep	1	SENT_198	[p10l1602t2642r1639b2659],
78	=	JJ	O	=	amod	81	SENT_198	[p10l1647t2648r1661b2654],
79	red	JJ	O	red	amod	81	SENT_198	[p10l1670t2641r1700b2659],
80	blood	NN	O	blood	nn	81	SENT_198	[p10l1707t2641r1763b2659],
81	cell	NN	O	cell	dep	77	SENT_198	[p10l1770t2641r1808b2661],
82	;	:	O	;	_	0	SENT_198	[p10l1770t2641r1808b2661],
83	T-o	NN	O	t-o	dep	1	SENT_198	[p10l355t2680r386b2696],
84	=	JJ	O	=	amod	86	SENT_198	[p10l395t2685r410b2691],
85	enrollment	NN	O	enrollment	nn	86	SENT_198	[p10l418t2679r528b2696],
86	time	NN	O	time	dep	83	SENT_198	[p10l533t2679r583b2696],
87	.	.	O	.	_	0	SENT_198	[p10l533t2679r583b2696],

1	Leoncini	NNP	O	Leoncini	_	0	SENT_199	[p10l193t2795r294b2816],
2	et	FW	O	et	nn	3	SENT_199	[p10l305t2796r330b2816],
3	al.	FW	O	al.	dep	1	SENT_199	[p10l338t2795r365b2816],
4	.	.	O	.	_	0	SENT_199	[p10l338t2795r365b2816],

1	High-Dose	JJ	O	high-dose	amod	2	SENT_200	[p10l193t2833r318b2858],
2	Atorvastatin	NN	O	atorvastatin	_	0	SENT_200	[p10l327t2833r477b2853],
3	and	CC	O	and	_	0	SENT_200	[p10l488t2833r532b2853],
4	Platelet	NN	O	platelet	nn	5	SENT_200	[p10l544t2833r639b2853],
5	Reactivity	NN	O	reactivity	conj_and	2	SENT_200	[p10l650t2833r770b2858],

1	JACC	NN	O	jacc	_	0	SENT_201	[p10l1277t2801r1347b2816],
2	:	:	O	:	_	0	SENT_201	[p10l1277t2801r1347b2816],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_201	[p10l1364t2801r1598b2816],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_201	[p10l1616t2801r1831b2818],
5	,	,	O	,	_	0	SENT_201	[p10l1616t2801r1831b2818],
6	VOL	NNP	O	VOL	appos	4	SENT_201	[p10l1847t2801r1905b2816],
7	.	.	O	.	_	0	SENT_201	[p10l1847t2801r1905b2816],

1	6	CD	NUMBER	6	_	0	SENT_202	[p10l1922t2801r1942b2818],
2	.	.	O	.	_	0	SENT_202	[p10l1922t2801r1942b2818],

1	NO.	NN	O	no.	_	0	SENT_203	[p10l1960t2801r2002b2816],
2	2	CD	NUMBER	2	dep	1	SENT_203	[p10l2020t2801r2040b2818],
3	.	.	O	.	_	0	SENT_203	[p10l2020t2801r2040b2818],

1	2013	CD	DATE	2013	num	3	SENT_204	[p10l2057t2801r2116b2816],
2	FEBRUARY	NNP	DATE	FEBRUARY	nn	3	SENT_204	[p10l1802t2838r1932b2853],
3	Z013	NN	O	z013	_	0	SENT_204	[p10l1949t2839r2116b2853],
4	:169	CD	NUMBER	:169	number	5	SENT_204	[p10l1949t2839r2116b2853],
5	—	CD	NUMBER	—	dep	3	SENT_204	[p10l1949t2839r2116b2853],
6	79	CD	NUMBER	79	dep	5	SENT_204	[p10l1949t2839r2116b2853],

1	Table	NNP	O	Table	_	0	SENT_205	[p11l354t72r424b93],
2	2	CD	NUMBER	2	dep	1	SENT_205	[p11l435t72r459b92],
3	.	.	O	.	_	0	SENT_205	[p11l435t72r459b92],

1	Distribution	NN	O	distribution	_	0	SENT_206	[p11l472t72r621b93],
2	of	IN	O	of	dep	1	SENT_206	[p11l632t72r657b93],
3	Platelet	NN	O	platelet	nn	5	SENT_206	[p11l667t72r768b93],
4	Function	NN	O	function	nn	5	SENT_206	[p11l780t72r890b93],
5	Parameters	NNS	O	parameter	pobj	2	SENT_206	[p11l903t72r1051b93],
6	Over	IN	O	over	dep	1	SENT_206	[p11l1062t72r1120b93],
7	Study	NNP	O	Study	nn	9	SENT_206	[p11l1130t72r1204b98],
8	Time	NNP	O	Time	nn	9	SENT_206	[p11l1214t72r1276b93],
9	course	NN	O	course	pobj	6	SENT_206	[p11l1287t72r1377b93],

1	Atorvastatin	NNP	O	Atorvastatin	nn	2	SENT_207	[p11l924t140r1072b159],
2	Group	NNP	O	Group	_	0	SENT_207	[p11l1083t140r1153b164],
3	control	NN	O	control	dep	2	SENT_207	[p11l1486t140r1572b159],
4	Group	NNP	O	Group	dep	2	SENT_207	[p11l1583t140r1653b164],

1	T-o	JJ	O	t-o	amod	2	SENT_208	[p11l834t222r870b242],
2	T-1	NN	O	t-1	_	0	SENT_208	[p11l1004t222r1041b241],
3	T-2	NN	O	t-2	nn	6	SENT_208	[p11l1190t222r1226b241],
4	T-o	NN	O	t-o	nn	6	SENT_208	[p11l1370t222r1407b242],
5	T-1	NN	O	t-1	nn	6	SENT_208	[p11l1540t222r1577b241],
6	T-2	NN	O	t-2	dep	2	SENT_208	[p11l1721t222r1757b241],

1	Time	NNP	O	Time	dep	205	SENT_209	[p11l354t293r409b312],
2	to	TO	O	to	dep	205	SENT_209	[p11l419t296r442b313],
3	determination	NN	O	determination	dep	205	SENT_209	[p11l453t293r619b316],
4	,	,	O	,	_	0	SENT_209	[p11l453t293r619b316],
5	days	NNS	DURATION	day	dep	205	SENT_209	[p11l630t293r680b318],
6	11	CD	NUMBER	11	dep	205	SENT_209	[p11l970t294r990b312],
7	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1004t295r1021b311],
8	2	CD	NUMBER	2	dep	205	SENT_209	[p11l1030t294r1042b312],
9	32	CD	NUMBER	32	dep	205	SENT_209	[p11l1151t294r1177b312],
10	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1187t295r1203b312],
11	4	CD	NUMBER	4	dep	205	SENT_209	[p11l1212t294r1226b312],
12	10	CD	NUMBER	10	dep	205	SENT_209	[p11l1520t294r1545b312],
13	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1554t295r1570b312],
14	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1582t294r1588b312],
15	32	CD	NUMBER	32	dep	205	SENT_209	[p11l1691t294r1717b313],
16	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1726t295r1743b311],
17	4	CD	NUMBER	4	dep	205	SENT_209	[p11l1752t294r1765b312],
18	PRU	NNP	ORGANIZATION	PRU	dep	205	SENT_209	[p11l356t341r399b361],
19	290	CD	NUMBER	290	dep	205	SENT_209	[p11l802t342r842b361],
20	1	CD	NUMBER	1	dep	205	SENT_209	[p11l851t343r868b359],
21	35	CD	NUMBER	35	dep	205	SENT_209	[p11l877t342r902b361],
22	200	CD	NUMBER	200	dep	205	SENT_209	[p11l955t342r995b360],
23	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1004t343r1021b359],
24	50	CD	NUMBER	50	dep	205	SENT_209	[p11l1030t341r1068b360],
25	*	NN	O	*	dep	205	SENT_209	[p11l1030t341r1068b360],
26	188	CD	NUMBER	188	dep	205	SENT_209	[p11l1139t342r1177b361],
27	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1187t343r1203b360],
28	48	CD	NUMBER	48	dep	205	SENT_209	[p11l1212t341r1277b362],
29	*	NN	O	*	dep	205	SENT_209	[p11l1212t341r1277b362],
30	‘	CD	NUMBER	‘	dep	205	SENT_209	[p11l1212t341r1277b362],
31	l'	NN	O	l'	dep	205	SENT_209	[p11l1212t341r1277b362],
32	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1212t341r1277b362],
33	=	JJ	O	=	dep	205	SENT_209	[p11l1212t341r1277b362],
34	292	CD	NUMBER	292	dep	205	SENT_209	[p11l1338t342r1378b360],
35	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1387t343r1404b359],
36	37	CD	NUMBER	37	dep	205	SENT_209	[p11l1414t342r1439b360],
37	210	CD	NUMBER	210	dep	205	SENT_209	[p11l1505t342r1545b360],
38	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1554t343r1570b359],
39	58	CD	NUMBER	58	dep	205	SENT_209	[p11l1580t341r1618b361],
40	*	NN	O	*	dep	205	SENT_209	[p11l1580t341r1618b361],
41	223	CD	NUMBER	223	dep	205	SENT_209	[p11l1677t342r1716b361],
42	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1726t343r1743b359],
43	53	CD	NUMBER	53	dep	205	SENT_209	[p11l1753t341r1803b362],
44	*	NN	O	*	dep	205	SENT_209	[p11l1753t341r1803b362],
45	‘	CD	NUMBER	‘	dep	205	SENT_209	[p11l1753t341r1803b362],
46	l'	NN	O	l'	dep	205	SENT_209	[p11l1753t341r1803b362],
47	Absolute	JJ	O	absolute	dep	205	SENT_209	[p11l382t388r482b408],
48	difference	NN	O	difference	dep	205	SENT_209	[p11l492t388r605b408],
49	from	IN	O	from	dep	205	SENT_209	[p11l615t388r667b408],
50	T-O	JJ	O	t-o	dep	205	SENT_209	[p11l678t389r713b408],
51	-90	CD	NUMBER	-90	dep	205	SENT_209	[p11l948t390r995b408],
52	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1004t391r1021b407],
53	58	CD	NUMBER	58	dep	205	SENT_209	[p11l1030t390r1056b408],
54	-102	CD	NUMBER	-102	dep	205	SENT_209	[p11l1117t390r1177b408],
55	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1187t391r1203b407],
56	54	CD	NUMBER	54	dep	205	SENT_209	[p11l1213t389r1253b409],
57	¢	NN	O	¢	dep	205	SENT_209	[p11l1213t389r1253b409],
58	-82	CD	NUMBER	-82	dep	205	SENT_209	[p11l1498t390r1544b408],
59	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1554t391r1570b407],
60	53	CD	NUMBER	53	dep	205	SENT_209	[p11l1580t390r1605b408],
61	-69	CD	NUMBER	-69	dep	205	SENT_209	[p11l1670t390r1717b408],
62	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1726t391r1743b407],
63	51	CD	NUMBER	51	dep	205	SENT_209	[p11l1753t390r1774b408],
64	Relative	JJ	O	relative	dep	205	SENT_209	[p11l383t436r470b456],
65	difference	NN	O	difference	dep	205	SENT_209	[p11l480t436r593b456],
66	from	IN	O	from	dep	205	SENT_209	[p11l603t436r655b456],
67	T-o	NN	O	t-o	dep	205	SENT_209	[p11l666t437r706b459],
68	,	,	O	,	_	0	SENT_209	[p11l666t437r706b459],
69	%	NN	O	%	dep	205	SENT_209	[p11l717t438r737b456],
70	-31	CD	NUMBER	-31	dep	205	SENT_209	[p11l948t438r991b456],
71	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1004t439r1021b455],
72	17	CD	NUMBER	17	dep	205	SENT_209	[p11l1032t438r1056b456],
73	-35	CD	NUMBER	-35	dep	205	SENT_209	[p11l1131t438r1177b456],
74	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1187t439r1204b455],
75	16	CD	NUMBER	16	dep	205	SENT_209	[p11l1215t437r1253b457],
76	¢	NN	O	¢	dep	205	SENT_209	[p11l1215t437r1253b457],
77	-28	CD	NUMBER	-28	dep	205	SENT_209	[p11l1498t438r1545b456],
78	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1554t439r1571b455],
79	17	CD	NUMBER	17	dep	205	SENT_209	[p11l1582t438r1606b456],
80	-23	CD	NUMBER	-23	dep	205	SENT_209	[p11l1671t438r1716b456],
81	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1726t439r1743b455],
82	16	CD	NUMBER	16	dep	205	SENT_209	[p11l1754t438r1779b456],
83	Absolute	JJ	O	absolute	dep	205	SENT_209	[p11l382t484r482b504],
84	difference	NN	O	difference	dep	205	SENT_209	[p11l492t484r605b504],
85	from	IN	O	from	dep	205	SENT_209	[p11l615t484r667b504],
86	T-1	NN	O	t-1	dep	205	SENT_209	[p11l678t485r709b504],
87	-12	CD	NUMBER	-12	dep	205	SENT_209	[p11l1131t486r1177b504],
88	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1187t487r1204b503],
89	35	CD	NUMBER	35	dep	205	SENT_209	[p11l1213t485r1253b505],
90	*	CD	NUMBER	*	dep	205	SENT_209	[p11l1213t485r1253b505],
91	13	CD	NUMBER	13	dep	205	SENT_209	[p11l1693t486r1716b504],
92	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1727t487r1743b503],
93	49	CD	NUMBER	49	dep	205	SENT_209	[p11l1752t486r1779b504],
94	Relative	JJ	O	relative	dep	205	SENT_209	[p11l383t532r470b552],
95	difference	NN	O	difference	dep	205	SENT_209	[p11l481t532r593b552],
96	from	IN	O	from	dep	205	SENT_209	[p11l603t532r655b552],
97	T-1	NN	O	t-1	dep	205	SENT_209	[p11l666t533r707b555],
98	,	,	O	,	_	0	SENT_209	[p11l666t533r707b555],
99	%	NN	O	%	dep	205	SENT_209	[p11l717t533r737b552],
100	-4	CD	NUMBER	-4	dep	205	SENT_209	[p11l1145t534r1178b552],
101	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1187t535r1204b551],
102	20:1	CD	NUMBER	20:1	dep	205	SENT_209	[p11l1213t533r1253b553],
103	:	:	O	:	_	0	SENT_209	[p11l1213t533r1253b553],
104	12	CD	NUMBER	12	dep	205	SENT_209	[p11l1693t533r1717b552],
105	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1727t535r1743b551],
106	31	CD	NUMBER	31	dep	205	SENT_209	[p11l1753t534r1774b552],
107	BASE	NN	O	base	dep	205	SENT_209	[p11l356t581r411b600],
108	312139	CD	NUMBER	312139	dep	205	SENT_209	[p11l802t581r904b600],
109	290135	CD	NUMBER	290135	dep	205	SENT_209	[p11l955t581r1081b601],
110	*	NN	O	*	dep	205	SENT_209	[p11l955t581r1081b601],
111	1	CD	NUMBER	1	dep	205	SENT_209	[p11l955t581r1081b601],
112	=	JJ	O	=	dep	205	SENT_209	[p11l955t581r1081b601],
113	2981341	CD	NUMBER	2981341	dep	205	SENT_209	[p11l1138t581r1253b601],
114	316129	CD	NUMBER	316129	dep	205	SENT_209	[p11l1338t581r1440b600],
115	313137	CD	NUMBER	313137	dep	205	SENT_209	[p11l1505t581r1606b600],
116	310120	CD	NUMBER	310120	dep	205	SENT_209	[p11l1677t581r1779b600],
117	Absolute	JJ	O	absolute	dep	205	SENT_209	[p11l382t628r482b648],
118	difference	NN	O	difference	dep	205	SENT_209	[p11l493t628r605b648],
119	from	IN	O	from	dep	205	SENT_209	[p11l615t628r667b648],
120	T	NN	O	t	dep	205	SENT_209	[p11l678t629r713b648],
121	—	CD	NUMBER	—	dep	205	SENT_209	[p11l678t629r713b648],
122	o	NN	O	o	dep	205	SENT_209	[p11l678t629r713b648],
123	-23	CD	NUMBER	-23	dep	205	SENT_209	[p11l948t629r994b648],
124	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1004t630r1021b647],
125	291	CD	NUMBER	291	dep	205	SENT_209	[p11l1030t629r1070b649],
126	:	:	O	:	_	0	SENT_209	[p11l1030t629r1070b649],
127	-14	CD	NUMBER	-14	dep	205	SENT_209	[p11l1131t630r1178b648],
128	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1187t630r1204b647],
129	46	CD	NUMBER	46	dep	205	SENT_209	[p11l1212t629r1239b648],
130	-3	CD	NUMBER	-3	dep	205	SENT_209	[p11l1512t629r1544b648],
131	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1554t630r1571b647],
132	34	CD	NUMBER	34	dep	205	SENT_209	[p11l1580t629r1607b648],
133	-6	CD	NUMBER	-6	dep	205	SENT_209	[p11l1684t629r1717b648],
134	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1727t630r1743b647],
135	30	CD	NUMBER	30	dep	205	SENT_209	[p11l1753t629r1779b648],
136	Relative	JJ	O	relative	dep	205	SENT_209	[p11l383t676r470b696],
137	difference	NN	O	difference	dep	205	SENT_209	[p11l481t676r593b696],
138	from	IN	O	from	dep	205	SENT_209	[p11l603t676r656b696],
139	T	NN	O	t	dep	205	SENT_209	[p11l666t677r707b699],
140	—	CD	NUMBER	—	dep	205	SENT_209	[p11l666t677r707b699],
141	o	NN	O	o	dep	205	SENT_209	[p11l666t677r707b699],
142	,	,	O	,	_	0	SENT_209	[p11l666t677r707b699],
143	%	NN	O	%	dep	205	SENT_209	[p11l717t677r737b696],
144	-7	CD	NUMBER	-7	dep	205	SENT_209	[p11l962t677r995b696],
145	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1004t678r1021b695],
146	8	CD	NUMBER	8	dep	205	SENT_209	[p11l1030t677r1056b697],
147	*	NN	O	*	dep	205	SENT_209	[p11l1030t677r1056b697],
148	-3	CD	NUMBER	-3	dep	205	SENT_209	[p11l1145t677r1177b696],
149	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1187t678r1204b695],
150	13	CD	NUMBER	13	dep	205	SENT_209	[p11l1215t677r1239b696],
151	-1	CD	NUMBER	-1	dep	205	SENT_209	[p11l1512t677r1541b696],
152	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1554t678r1571b695],
153	11	CD	NUMBER	11	dep	205	SENT_209	[p11l1582t677r1602b696],
154	-1	CD	NUMBER	-1	dep	205	SENT_209	[p11l1685t677r1713b696],
155	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1727t678r1743b695],
156	9	CD	NUMBER	9	dep	205	SENT_209	[p11l1753t677r1765b696],
157	Absolute	JJ	O	absolute	dep	205	SENT_209	[p11l382t724r482b744],
158	difference	NN	O	difference	dep	205	SENT_209	[p11l493t723r605b744],
159	from	IN	O	from	dep	205	SENT_209	[p11l615t723r668b744],
160	T-1	NN	O	t-1	dep	205	SENT_209	[p11l678t725r709b743],
161	9	CD	NUMBER	9	dep	205	SENT_209	[p11l1165t725r1178b744],
162	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1187t726r1204b743],
163	35	CD	NUMBER	35	dep	205	SENT_209	[p11l1213t725r1238b744],
164	-3	CD	NUMBER	-3	dep	205	SENT_209	[p11l1685t725r1716b744],
165	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1727t726r1743b743],
166	30	CD	NUMBER	30	dep	205	SENT_209	[p11l1753t725r1779b744],
167	Relative	JJ	O	relative	dep	205	SENT_209	[p11l383t772r470b792],
168	difference	NN	O	difference	dep	205	SENT_209	[p11l481t771r593b792],
169	from	IN	O	from	dep	205	SENT_209	[p11l603t771r656b792],
170	T-1	NN	O	t-1	dep	205	SENT_209	[p11l666t773r707b795],
171	,	,	O	,	_	0	SENT_209	[p11l666t773r707b795],
172	%	NN	O	%	dep	205	SENT_209	[p11l717t773r737b792],
173	4	CD	NUMBER	4	dep	205	SENT_209	[p11l1165t773r1178b791],
174	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1187t774r1204b791],
175	12	CD	NUMBER	12	dep	205	SENT_209	[p11l1215t773r1239b791],
176	-0.05	CD	NUMBER	-0.05	dep	205	SENT_209	[p11l1651t773r1716b792],
177	1	CD	NUMBER	1	dep	205	SENT_209	[p11l1727t774r1743b791],
178	10	CD	NUMBER	10	dep	205	SENT_209	[p11l1755t773r1779b792],
179	|	NN	O	|	dep	205	SENT_209	[p11l356t820r427b843],
180	PA	NN	ORGANIZATION	pa	dep	205	SENT_209	[p11l356t820r427b843],
181	,	,	O	,	_	0	SENT_209	[p11l356t820r427b843],
182	%	NN	O	%	dep	205	SENT_209	[p11l356t820r427b843],
183	817	CD	NUMBER	817	dep	205	SENT_209	[p11l830t821r889b840],
184	3l117	NN	O	3l117	dep	205	SENT_209	[p11l969t821r1068b840],
185	*	CD	NUMBER	*	dep	205	SENT_209	[p11l969t821r1068b840],
186	37114	CD	NUMBER	37114	dep	205	SENT_209	[p11l1152t821r1278b841],
187	*	NN	O	*	dep	205	SENT_209	[p11l1152t821r1278b841],
188	‘	CD	NUMBER	‘	dep	205	SENT_209	[p11l1152t821r1278b841],
189	l'	NN	O	l'	dep	205	SENT_209	[p11l1152t821r1278b841],
190	=	JJ	O	=	dep	205	SENT_209	[p11l1152t821r1278b841],
191	l	NN	O	l	dep	205	SENT_209	[p11l1152t821r1278b841],
192	:	:	O	:	_	0	SENT_209	[p11l1152t821r1278b841],
193	1017	CD	DATE	1017	dep	205	SENT_209	[p11l1354t821r1426b840],
194	33116	CD	NUMBER	33116	dep	205	SENT_209	[p11l1519t821r1618b840],
195	*	NN	O	*	dep	205	SENT_209	[p11l1519t821r1618b840],
196	281l5	CD	NUMBER	281l5	dep	205	SENT_209	[p11l1691t821r1803b841],
197	*	CD	NUMBER	*	dep	205	SENT_209	[p11l1691t821r1803b841],
198	‘	NN	O	‘	dep	205	SENT_209	[p11l1691t821r1803b841],
199	l	NN	O	l	dep	205	SENT_209	[p11l1691t821r1803b841],
200	‘	CD	NUMBER	‘	dep	205	SENT_209	[p11l1691t821r1803b841],
201	Values	NNS	O	value	dep	205	SENT_209	[p11l354t881r418b899],
202	are	VBP	O	be	dep	205	SENT_209	[p11l424t886r454b899],
203	mean	JJ	O	mean	dep	205	SENT_209	[p11l460t886r514b899],
204	1	CD	NUMBER	1	dep	205	SENT_209	[p11l522t883r537b898],
205	SD	NN	O	sd	_	0	SENT_209	[p11l545t882r576b899],
206	.	.	O	.	_	0	SENT_209	[p11l545t882r576b899],

1	*	NN	O	*	nn	2	SENT_210	[p11l581t882r604b903],
2	p	NN	O	p	_	0	SENT_210	[p11l581t882r604b903],
3	<	JJR	O	<	dep	2	SENT_210	[p11l610t884r627b898],
4	0.01	CD	NUMBER	0.01	dep	3	SENT_210	[p11l633t882r670b899],
5	versus	CC	O	versus	prep	4	SENT_210	[p11l679t886r741b899],
6	baseline	NN	O	baseline	dep	5	SENT_210	[p11l748t881r829b899],
7	(	CD	NUMBER	(	num	6	SENT_210	[p11l835t882r883b902],
8	T	NN	O	t	nn	11	SENT_210	[p11l835t882r883b902],
9	—	CD	NUMBER	—	num	11	SENT_210	[p11l835t882r883b902],
10	o	NN	O	o	nn	11	SENT_210	[p11l835t882r883b902],
11	)	NN	O	)	dep	6	SENT_210	[p11l835t882r883b902],
12	;	:	O	;	_	0	SENT_210	[p11l835t882r883b902],
13	1	CD	NUMBER	1	dep	6	SENT_210	[p11l889t882r915b903],
14	'	''	O	'	_	0	SENT_210	[p11l889t882r915b903],
15	p	NN	O	p	dep	2	SENT_210	[p11l889t882r915b903],
16	<	JJR	O	<	dep	15	SENT_210	[p11l921t884r938b898],
17	0.01	CD	NUMBER	0.01	dep	2	SENT_210	[p11l944t882r981b899],
18	within	IN	O	within	_	0	SENT_210	[p11l990t881r1052b899],
19	group	NN	O	group	prep_within	17	SENT_210	[p11l1058t886r1118b904],
20	(	CD	NUMBER	(	num	23	SENT_210	[p11l1124t881r1234b902],
21	Bonferroni	NNP	PERSON	Bonferroni	nn	23	SENT_210	[p11l1124t881r1234b902],
22	adjustment	NN	O	adjustment	nn	23	SENT_210	[p11l1240t881r1366b904],
23	)	NN	O	)	dep	2	SENT_210	[p11l1240t881r1366b904],
24	;	:	O	;	_	0	SENT_210	[p11l1240t881r1366b904],
25	tp	NN	O	tp	dep	23	SENT_210	[p11l1372t882r1397b903],
26	<	JJR	O	<	dep	25	SENT_210	[p11l1404t884r1420b898],
27	0.01	CD	NUMBER	0.01	num	28	SENT_210	[p11l1427t882r1464b899],
28	atorvastatin	NN	O	atorvastatin	dep	2	SENT_210	[p11l1473t882r1590b899],
29	versus	CC	O	versus	prep	28	SENT_210	[p11l1596t886r1659b899],
30	control	NN	O	control	nn	31	SENT_210	[p11l1664t881r1734b899],
31	group	NN	O	group	dep	29	SENT_210	[p11l1740t886r1805b904],
32	.	.	O	.	_	0	SENT_210	[p11l1740t886r1805b904],

1	BASE	NN	O	base	nn	3	SENT_211	[p11l379t919r428b936],
2	=	JJ	O	=	amod	3	SENT_211	[p11l437t925r452b931],
3	iso	NN	O	iso	nsubj	30	SENT_211	[p11l461t919r546b936],
4	«	CD	NUMBER	«	num	7	SENT_211	[p11l461t919r546b936],
5	TRAP	NN	O	trap	nn	7	SENT_211	[p11l461t919r546b936],
6	reaction	NN	O	reaction	nn	7	SENT_211	[p11l554t919r633b936],
7	units	NNS	O	unit	dep	3	SENT_211	[p11l641t919r693b939],
8	;	:	O	;	_	0	SENT_211	[p11l641t919r693b939],
9	IPA	NN	O	ipa	dep	3	SENT_211	[p11l700t920r732b936],
10	=	JJ	O	=	amod	13	SENT_211	[p11l740t925r754b931],
11	percent	NN	O	percent	nn	13	SENT_211	[p11l764t922r839b941],
12	P2Y12	NN	O	p2y12	nn	13	SENT_211	[p11l846t920r901b941],
13	inhibition	NN	O	inhibition	dep	9	SENT_211	[p11l908t919r1008b939],
14	;	:	O	;	_	0	SENT_211	[p11l908t919r1008b939],
15	PRU	NNP	ORGANIZATION	PRU	nn	18	SENT_211	[p11l1015t920r1054b936],
16	=	JJ	O	=	amod	18	SENT_211	[p11l1063t925r1078b931],
17	PZY12	NN	O	pzy12	nn	18	SENT_211	[p11l1087t920r1142b941],
18	reaction	NN	O	reaction	dep	3	SENT_211	[p11l1149t919r1228b936],
19	units	NNS	O	unit	nn	20	SENT_211	[p11l1236t919r1283b936],
20	time	NN	O	time	dep	18	SENT_211	[p11l8t1118r186b1196],
21	,	,	O	,	_	0	SENT_211	[p11l8t1118r186b1196],
22	and	CC	O	and	_	0	SENT_211	[p11l239t1115r366b1181],
23	the	DT	O	the	det	24	SENT_211	[p11l414t1115r524b1181],
24	difference	NN	O	difference	nsubj	30	SENT_211	[p11l575t1115r915b1181],
25	between	IN	O	between	_	0	SENT_211	[p11l962t1115r1256b1181],
26	the	DT	O	the	det	28	SENT_211	[p11l1305t1115r1415b1181],
27	2	CD	NUMBER	2	num	28	SENT_211	[p11l1463t1118r1504b1182],
28	groups	NNS	O	group	prep_between	24	SENT_211	[p11l1553t1141r1789b1204],
29	becomes	VBZ	O	become	cop	30	SENT_211	[p11l1837t1115r2139b1181],
30	signiﬁcant	JJ	O	signiﬁcant	dep	35	SENT_211	[p11l9t1224r375b1313],
31	only	RB	O	only	advmod	35	SENT_211	[p11l408t1224r561b1313],
32	at	IN	O	at	_	0	SENT_211	[p11l593t1241r657b1290],
33	30	CD	DURATION	30	num	34	SENT_211	[p11l690t1227r773b1291],
34	days	NNS	NUMBER	day	prep_at	31	SENT_211	[p11l810t1224r959b1313],
35	(	VBP	O	(	_	0	SENT_211	[p11l998t1222r1106b1304],
36	35	CD	PERCENT	35	number	37	SENT_211	[p11l998t1222r1106b1304],
37	1	CD	PERCENT	1	dobj	35	SENT_211	[p11l1152t1233r1206b1286],
38	16	CD	PERCENT	16	num	39	SENT_211	[p11l1253t1227r1401b1291],
39	%	NN	PERCENT	%	dep	37	SENT_211	[p11l1253t1227r1401b1291],
40	vs.	CC	O	vs.	_	0	SENT_211	[p11l1432t1250r1521b1290],
41	23	CD	PERCENT	23	number	42	SENT_211	[p11l1558t1227r1641b1291],
42	1	CD	PERCENT	1	dobj	35	SENT_211	[p11l1688t1233r1741b1286],
43	16	CD	PERCENT	16	num	44	SENT_211	[p11l1789t1227r1956b1305],
44	%	NN	PERCENT	%	dep	42	SENT_211	[p11l1789t1227r1956b1305],
45	,	,	O	,	_	0	SENT_211	[p11l1789t1227r1956b1305],
46	p	NN	O	p	dep	47	SENT_211	[p11l1993t1250r2035b1313],
47	<	JJR	O	<	dobj	35	SENT_211	[p11l2075t1234r2135b1285],
48	0.01	CD	NUMBER	0.01	num	49	SENT_211	[p11l8t1331r187b1414],
49	)	NN	O	)	dep	47	SENT_211	[p11l8t1331r187b1414],
50	(	CD	NUMBER	(	num	51	SENT_211	[p11l250t1331r478b1413],
51	Table	NNP	O	Table	nsubj	35	SENT_211	[p11l250t1331r478b1413],
52	2	CD	NUMBER	2	num	51	SENT_211	[p11l535t1337r598b1414],
53	,	,	O	,	_	0	SENT_211	[p11l535t1337r598b1414],
54	Fig	NN	O	fig	appos	51	SENT_211	[p11l659t1334r793b1422],
55	.	.	O	.	_	0	SENT_211	[p11l659t1334r793b1422],

1	2B	NN	O	2b	_	0	SENT_212	[p11l853t1331r1002b1413],
2	)	NN	O	)	dep	1	SENT_212	[p11l853t1331r1002b1413],
3	.	.	O	.	_	0	SENT_212	[p11l853t1331r1002b1413],

1	Iso	NNP	O	Iso	_	0	SENT_213	[p11l1063t1331r1826b1399],
2	.	.	O	.	_	0	SENT_213	[p11l1063t1331r1826b1399],

1	—	NN	O	—	_	0	SENT_214	[p11l1063t1331r1826b1399],
2	.	.	O	.	_	0	SENT_214	[p11l1063t1331r1826b1399],

1	TRAP-mediated	JJ	O	trap-mediated	amod	3	SENT_215	[p11l1063t1331r1826b1399],
2	platelet	NN	O	platelet	nn	3	SENT_215	[p11l1882t1333r2144b1422],
3	reactivity	NN	O	reactivity	nsubj	10	SENT_215	[p11l8t1445r349b1531],
4	,	,	O	,	_	0	SENT_215	[p11l8t1445r349b1531],
5	expressed	VBN	O	express	partmod	3	SENT_215	[p11l376t1442r711b1532],
6	by	IN	O	by	_	0	SENT_215	[p11l732t1442r818b1531],
7	BASE	NN	O	base	nn	8	SENT_215	[p11l839t1441r1069b1509],
8	values	NNS	O	value	agent	5	SENT_215	[p11l1090t1442r1324b1523],
9	,	,	O	,	_	0	SENT_215	[p11l1090t1442r1324b1523],
10	decreased	VBD	O	decrease	_	0	SENT_215	[p11l1352t1442r1691b1508],
11	slightly	RB	O	slightly	advmod	10	SENT_215	[p11l1716t1442r1974b1531],
12	over	IN	O	over	_	0	SENT_215	[p11l1995t1468r2143b1509],
13	time	NN	O	time	prep_over	10	SENT_215	[p11l8t1556r165b1620],
14	in	IN	O	in	_	0	SENT_215	[p11l219t1556r287b1619],
15	the	DT	O	the	det	17	SENT_215	[p11l339t1553r450b1620],
16	control	NN	O	control	nn	17	SENT_215	[p11l504t1553r755b1620],
17	group	NN	O	group	prep_in	13	SENT_215	[p11l806t1579r1030b1643],
18	.	.	O	.	_	0	SENT_215	[p11l806t1579r1030b1643],

1	AtorVastatin	NNP	O	AtorVastatin	nsubj	5	SENT_216	[p11l1085t1552r1811b1620],
2	—	CD	NUMBER	—	num	4	SENT_216	[p11l1085t1552r1811b1620],
3	treated	JJ	O	treated	amod	4	SENT_216	[p11l1085t1552r1811b1620],
4	patients	NNS	O	patient	dep	1	SENT_216	[p11l1862t1556r2139b1643],
5	showed	VBD	O	show	_	0	SENT_216	[p11l9t1663r275b1729],
6	a	DT	O	a	det	8	SENT_216	[p11l324t1689r358b1729],
7	distinctive	JJ	O	distinctive	amod	8	SENT_216	[p11l406t1663r768b1729],
8	pattern	NN	O	pattern	dobj	5	SENT_216	[p11l816t1680r1070b1752],
9	of	IN	O	of	_	0	SENT_216	[p11l1119t1663r1199b1729],
10	BASE	NN	O	base	nn	11	SENT_216	[p11l1236t1661r1465b1729],
11	reduction	NN	O	reduction	prep_of	8	SENT_216	[p11l1515t1663r1852b1729],
12	with	IN	O	with	_	0	SENT_216	[p11l1897t1663r2058b1729],
13	a	DT	O	a	det	16	SENT_216	[p11l2108t1689r2143b1729],
14	signiﬁcant	JJ	O	signiﬁcant	amod	16	SENT_216	[p11l9t1771r375b1860],
15	marked	JJ	O	marked	amod	16	SENT_216	[p11l411t1771r676b1837],
16	decrease	NN	O	decrease	prep_with	5	SENT_216	[p11l712t1771r1004b1837],
17	in	IN	O	in	_	0	SENT_216	[p11l1040t1774r1108b1836],
18	the	DT	O	the	det	23	SENT_216	[p11l1144t1771r1254b1837],
19	short	JJ	O	short	amod	23	SENT_216	[p11l1293t1771r1472b1837],
20	term	NN	O	term	nn	23	SENT_216	[p11l1507t1788r1671b1837],
21	(	NN	O	(	nn	23	SENT_216	[p11l1711t1769r1902b1851],
22	T-1	NN	O	t-1	nn	23	SENT_216	[p11l1711t1769r1902b1851],
23	)	NN	O	)	prep_in	16	SENT_216	[p11l1711t1769r1902b1851],
24	and	CC	O	and	_	0	SENT_216	[p11l1944t1771r2071b1837],
25	a	DT	O	a	det	29	SENT_216	[p11l2109t1797r2143b1837],
26	later	JJ	O	later	amod	29	SENT_216	[p11l7t1880r164b1946],
27	increase	NN	O	increase	nn	29	SENT_216	[p11l211t1883r491b1946],
28	(	NN	O	(	nn	29	SENT_216	[p11l544t1878r736b1960],
29	T	NN	O	t	conj_and	16	SENT_216	[p11l544t1878r736b1960],
30	—	CD	NUMBER	—	number	31	SENT_216	[p11l544t1878r736b1960],
31	2	CD	NUMBER	2	num	32	SENT_216	[p11l544t1878r736b1960],
32	)	NN	O	)	dep	29	SENT_216	[p11l544t1878r736b1960],
33	to	TO	O	to	_	0	SENT_216	[p11l789t1897r856b1946],
34	levels	NNS	O	level	prep_to	5	SENT_216	[p11l906t1880r1094b1946],
35	similar	JJ	O	similar	amod	34	SENT_216	[p11l1147t1880r1385b1946],
36	to	TO	O	to	_	0	SENT_216	[p11l1433t1897r1501b1946],
37	that	DT	O	that	prep_to	35	SENT_216	[p11l1552t1880r1693b1946],
38	of	IN	O	of	_	0	SENT_216	[p11l1742t1880r1822b1946],
39	controls	NNS	O	control	prep_of	37	SENT_216	[p11l1860t1880r2139b1946],
40	(	RB	O	(	advmod	34	SENT_216	[p11l11t1987r239b2070],
41	Table	NNP	O	Table	dep	34	SENT_216	[p11l11t1987r239b2070],
42	2	CD	NUMBER	2	num	41	SENT_216	[p11l270t1993r332b2070],
43	,	,	O	,	_	0	SENT_216	[p11l270t1993r332b2070],
44	Fig	NN	O	fig	appos	34	SENT_216	[p11l367t1990r501b2078],
45	.	.	O	.	_	0	SENT_216	[p11l367t1990r501b2078],

1	3	CD	NUMBER	3	_	0	SENT_217	[p11l537t1987r625b2070],
2	)	NN	O	)	dep	1	SENT_217	[p11l537t1987r625b2070],
3	.	.	O	.	_	0	SENT_217	[p11l537t1987r625b2070],

1	Based	VBN	O	base	_	0	SENT_218	[p11l661t1989r870b2055],
2	on	IN	O	on	prepc_based_on	15	SENT_218	[p11l902t2015r989b2055],
3	the	DT	O	the	det	4	SENT_218	[p11l1020t1989r1130b2055],
4	results	NNS	O	result	pobj	15	SENT_218	[p11l1162t1989r1385b2055],
5	of	IN	O	of	_	0	SENT_218	[p11l1419t1989r1498b2055],
6	PRU	NNP	ORGANIZATION	PRU	prep_of	4	SENT_218	[p11l1518t1990r1698b2056],
7	and	CC	O	and	_	0	SENT_218	[p11l1729t1989r1856b2055],
8	BASE	NNP	O	BASE	prep_of	4	SENT_218	[p11l1888t1988r2138b2070],
9	,	,	O	,	_	0	SENT_218	[p11l1888t1988r2138b2070],
10	the	DT	O	the	det	12	SENT_218	[p11l8t2098r118b2165],
11	mean	NN	O	mean	nn	12	SENT_218	[p11l164t2125r354b2165],
12	IPA	NN	ORGANIZATION	ipa	nsubj	15	SENT_218	[p11l397t2097r550b2164],
13	was	VBD	O	be	cop	15	SENT_218	[p11l588t2125r717b2165],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_218	[p11l764t2098r1193b2187],
15	higher	JJR	O	higher	_	0	SENT_218	[p11l1233t2098r1463b2187],
16	after	IN	O	after	_	0	SENT_218	[p11l1506t2098r1665b2165],
17	1	CD	DURATION	1	num	18	SENT_218	[p11l1712t2102r1743b2164],
18	month	NN	NUMBER	month	prep_after	15	SENT_218	[p11l1793t2098r2029b2165],
19	of	IN	O	of	_	0	SENT_218	[p11l2073t2098r2153b2165],
20	treatment	NN	O	treatment	prep_of	18	SENT_218	[p11l8t2225r355b2273],
21	with	IN	O	with	_	0	SENT_218	[p11l400t2208r562b2273],
22	atorvastatin	NN	O	atorvastatin	nn	23	SENT_218	[p11l615t2210r1025b2273],
23	(	NN	O	(	prep_with	20	SENT_218	[p11l1079t2205r1191b2287],
24	37	CD	PERCENT	37	number	25	SENT_218	[p11l1079t2205r1191b2287],
25	1	CD	PERCENT	1	prep	15	SENT_218	[p11l1250t2217r1304b2270],
26	14	CD	PERCENT	14	num	27	SENT_218	[p11l1368t2211r1516b2273],
27	%	NN	PERCENT	%	dep	25	SENT_218	[p11l1368t2211r1516b2273],
28	vs.	CC	O	vs.	prep	15	SENT_218	[p11l1564t2234r1652b2273],
29	28	CD	PERCENT	28	number	30	SENT_218	[p11l1705t2211r1790b2274],
30	1	CD	PERCENT	1	dep	28	SENT_218	[p11l1853t2217r1906b2270],
31	15	CD	PERCENT	15	number	32	SENT_218	[p11l1970t2207r2138b2288],
32	%	NN	PERCENT	%	amod	30	SENT_218	[p11l1970t2207r2138b2288],
33	,	,	O	,	_	0	SENT_218	[p11l1970t2207r2138b2288],
34	respectively	RB	O	respectively	advmod	15	SENT_218	[p11l8t2317r434b2406],
35	;	:	O	;	_	0	SENT_218	[p11l8t2317r434b2406],
36	p	NN	O	p	dep	40	SENT_218	[p11l469t2343r511b2406],
37	<	JJR	O	<	dep	36	SENT_218	[p11l551t2327r611b2378],
38	0.01	CD	NUMBER	0.01	num	39	SENT_218	[p11l650t2315r828b2397],
39	)	NN	O	)	dep	40	SENT_218	[p11l650t2315r828b2397],
40	(	CD	NUMBER	(	dep	43	SENT_218	[p11l868t2315r1096b2397],
41	Table	NNP	O	Table	dep	40	SENT_218	[p11l868t2315r1096b2397],
42	2	CD	NUMBER	2	num	43	SENT_218	[p11l1128t2315r1219b2397],
43	)	CD	NUMBER	)	dep	15	SENT_218	[p11l1128t2315r1219b2397],
44	.	.	O	.	_	0	SENT_218	[p11l1128t2315r1219b2397],

1	High	JJ	O	high	amod	3	SENT_219	[p11l13t2434r170b2509],
2	residual	JJ	O	residual	amod	3	SENT_219	[p11l220t2434r488b2493],
3	platelet	NN	O	platelet	_	0	SENT_219	[p11l539t2434r801b2508],
4	reactivity	NN	O	reactivity	dep	3	SENT_219	[p11l848t2436r1186b2510],
5	.	.	O	.	_	0	SENT_219	[p11l848t2436r1186b2510],

1	A	DT	O	a	det	3	SENT_220	[p11l1233t2425r1299b2492],
2	higher	JJR	O	higher	amod	3	SENT_220	[p11l1342t2427r1572b2516],
3	number	NN	O	number	nsubj	14	SENT_220	[p11l1616t2427r1909b2508],
4	,	,	O	,	_	0	SENT_220	[p11l1616t2427r1909b2508],
5	albeit	IN	O	albeit	mark	6	SENT_220	[p11l1958t2427r2151b2493],
6	not	RB	O	not	dep	3	SENT_220	[p11l11t2555r129b2604],
7	signiﬁcant	JJ	O	signiﬁcant	dep	6	SENT_220	[p11l191t2538r577b2627],
8	,	,	O	,	_	0	SENT_220	[p11l191t2538r577b2627],
9	of	IN	O	of	_	0	SENT_220	[p11l643t2538r724b2604],
10	patients	NNS	O	patient	prep_of	3	SENT_220	[p11l773t2541r1052b2627],
11	randomized	VBN	O	randomize	partmod	10	SENT_220	[p11l1116t2538r1540b2604],
12	to	TO	O	to	_	0	SENT_220	[p11l1602t2555r1670b2604],
13	atorvastatin	NN	O	atorvastatin	prep_to	11	SENT_220	[p11l1736t2541r2149b2604],
14	changed	VBD	O	change	_	0	SENT_220	[p11l11t2683r306b2772],
15	their	PRP$	O	they	poss	17	SENT_220	[p11l330t2683r497b2749],
16	response	NN	O	response	nn	17	SENT_220	[p11l520t2709r825b2772],
17	status	NN	O	status	dobj	14	SENT_220	[p11l852t2700r1070b2764],
18	,	,	O	,	_	0	SENT_220	[p11l852t2700r1070b2764],
19	becoming	VBG	O	become	partmod	14	SENT_220	[p11l1096t2683r1448b2772],
20	optimal	JJ	O	optimal	amod	21	SENT_220	[p11l1472t2683r1744b2772],
21	responders	NNS	O	responder	attr	19	SENT_220	[p11l1768t2683r2148b2772],
22	at	IN	O	at	_	0	SENT_220	[p11l12t2810r75b2859],
23	T-1	NN	O	t-1	prep_at	19	SENT_220	[p11l99t2792r236b2859],
24	(	CD	NUMBER	(	number	25	SENT_220	[p11l274t2791r384b2874],
25	10	CD	DURATION	10	num	26	SENT_220	[p11l274t2791r384b2874],
26	days	NNS	NUMBER	day	tmod	19	SENT_220	[p11l415t2791r592b2882],
27	)	RB	O	)	advmod	19	SENT_220	[p11l415t2791r592b2882],
28	compared	VBN	O	compare	_	0	SENT_220	[p11l625t2793r974b2883],
29	with	IN	O	with	_	0	SENT_220	[p11l998t2793r1160b2860],
30	patients	NNS	O	patient	prep_compared_with	19	SENT_220	[p11l1187t2796r1465b2883],
31	in	IN	O	in	_	0	SENT_220	[p11l1496t2796r1564b2859],
32	the	DT	O	the	det	34	SENT_220	[p11l1592t2793r1703b2859],
33	control	NN	O	control	nn	34	SENT_220	[p11l1733t2793r1985b2859],
34	arm	NN	O	arm	prep_in	30	SENT_220	[p11l2014t2819r2149b2859],
35	(	CD	PERCENT	(	number	36	SENT_220	[p11l13t2902r192b2984],
36	74	CD	PERCENT	74	num	37	SENT_220	[p11l13t2902r192b2984],
37	%	NN	PERCENT	%	dobj	19	SENT_220	[p11l13t2902r192b2984],
38	vs.	CC	O	vs.	prep	37	SENT_220	[p11l223t2930r312b2970],
39	63	CD	PERCENT	63	num	40	SENT_220	[p11l353t2907r524b2984],
40	%	NN	PERCENT	%	dep	38	SENT_220	[p11l353t2907r524b2984],
41	,	,	O	,	_	0	SENT_220	[p11l353t2907r524b2984],
42	p	NN	O	p	appos	40	SENT_220	[p11l560t2930r602b2993],
43	=	JJ	O	=	amod	45	SENT_220	[p11l646t2929r700b2950],
44	0.1	CD	NUMBER	0.1	tmod	43	SENT_220	[p11l744t2901r900b2984],
45	)	NN	O	)	dep	42	SENT_220	[p11l744t2901r900b2984],
46	.	.	O	.	_	0	SENT_220	[p11l744t2901r900b2984],

1	This	DT	O	this	det	2	SENT_221	[p11l936t2902r1100b2970],
2	number	NN	O	number	nsubj	4	SENT_221	[p11l1137t2903r1413b2970],
3	further	RB	O	further	advmod	4	SENT_221	[p11l1445t2903r1692b2970],
4	increased	VBD	O	increase	_	0	SENT_221	[p11l1724t2903r2053b2970],
5	at	IN	O	at	_	0	SENT_221	[p11l2088t2920r2152b2970],
6	T	NN	O	t	nn	7	SENT_221	[p11l7t3012r148b3081],
7	—	NN	O	—	prep_at	4	SENT_221	[p11l7t3012r148b3081],
8	2	CD	NUMBER	2	number	9	SENT_221	[p11l7t3012r148b3081],
9	(	CD	NUMBER	(	amod	7	SENT_221	[p11l177t3012r288b3094],
10	30	CD	DURATION	30	num	11	SENT_221	[p11l177t3012r288b3094],
11	days	NNS	NUMBER	day	tmod	9	SENT_221	[p11l313t3012r514b3103],
12	)	RB	O	)	advmod	4	SENT_221	[p11l313t3012r514b3103],
13	,	,	O	,	_	0	SENT_221	[p11l313t3012r514b3103],
14	reaching	VBG	O	reach	xcomp	4	SENT_221	[p11l540t3014r845b3103],
15	statistical	JJ	O	statistical	amod	17	SENT_221	[p11l868t3014r1197b3080],
16	signiﬁcance	NN	O	signiﬁcance	nn	17	SENT_221	[p11l1221t3014r1631b3103],
17	(	NN	O	(	dobj	14	SENT_221	[p11l1658t3012r1837b3094],
18	84	CD	PERCENT	84	num	19	SENT_221	[p11l1658t3012r1837b3094],
19	%	NN	PERCENT	%	dep	17	SENT_221	[p11l1658t3012r1837b3094],
20	vs.	CC	O	vs.	_	0	SENT_221	[p11l1858t3040r1947b3080],
21	58	CD	PERCENT	58	num	22	SENT_221	[p11l1975t3014r2147b3095],
22	%	NN	PERCENT	%	conj_vs.	17	SENT_221	[p11l1975t3014r2147b3095],
23	,	,	O	,	_	0	SENT_221	[p11l1975t3014r2147b3095],
24	p	NN	O	p	appos	22	SENT_221	[p11l9t3149r51b3212],
25	=	JJ	O	=	advmod	29	SENT_221	[p11l103t3149r156b3169],
26	0.02	CD	NUMBER	0.02	dep	25	SENT_221	[p11l207t3121r386b3203],
27	)	CD	NUMBER	)	number	28	SENT_221	[p11l207t3121r386b3203],
28	(	CD	NUMBER	(	num	29	SENT_221	[p11l434t3121r596b3212],
29	Fig	NN	O	fig	rcmod	24	SENT_221	[p11l434t3121r596b3212],
30	.	.	O	.	_	0	SENT_221	[p11l434t3121r596b3212],

1	4	CD	NUMBER	4	_	0	SENT_222	[p11l642t3121r732b3203],
2	)	NN	O	)	dep	1	SENT_222	[p11l642t3121r732b3203],
3	.	.	O	.	_	0	SENT_222	[p11l642t3121r732b3203],

1	Baseline	NN	O	baseline	nn	2	SENT_223	[p11l778t3123r1048b3189],
2	variables	NNS	O	variable	nsubj	12	SENT_223	[p11l1084t3123r1360b3189],
3	signiﬁcantly	RB	O	signiﬁcantly	advmod	4	SENT_223	[p11l1402t3123r1793b3212],
4	associated	VBN	O	associate	partmod	2	SENT_223	[p11l1829t3123r2151b3189],
5	with	IN	O	with	_	0	SENT_223	[p11l7t3234r158b3300],
6	30-day	JJ	DURATION	30-day	amod	8	SENT_223	[p11l187t3234r418b3323],
7	optimal	JJ	O	optimal	amod	8	SENT_223	[p11l442t3234r694b3323],
8	response	NN	O	response	prep_with	4	SENT_223	[p11l720t3260r999b3323],
9	at	IN	O	at	_	0	SENT_223	[p11l1030t3251r1090b3300],
10	univariate	JJ	O	univariate	amod	11	SENT_223	[p11l1115t3237r1432b3300],
11	analysis	NN	O	analysis	prep_at	8	SENT_223	[p11l1462t3234r1703b3323],
12	included	VBD	O	include	_	0	SENT_223	[p11l1734t3234r2013b3300],
13	age	NN	O	age	dobj	12	SENT_223	[p11l2042t3260r2149b3323],
14	(	CD	NUMBER	(	num	15	SENT_223	[p11l13t3342r179b3424],
15	OR	NN	O	or	dep	13	SENT_223	[p11l13t3342r179b3424],
16	:	:	O	:	_	0	SENT_223	[p11l13t3342r179b3424],
17	0.94	CD	PERCENT	0.94	number	18	SENT_223	[p11l209t3347r352b3411],
18	[	CD	PERCENT	[	dep	13	SENT_223	[p11l383t3342r551b3425],
19	95	CD	PERCENT	95	num	21	SENT_223	[p11l383t3342r551b3425],
20	%	NN	PERCENT	%	nn	21	SENT_223	[p11l383t3342r551b3425],
21	Cl	NN	O	cl	dep	18	SENT_223	[p11l579t3344r684b3411],
22	:	:	O	:	_	0	SENT_223	[p11l579t3344r684b3411],
23	0.89	CD	NUMBER	0.89	dep	13	SENT_223	[p11l715t3347r855b3411],
24	to	TO	O	to	_	0	SENT_223	[p11l882t3361r947b3410],
25	0.99	CD	NUMBER	0.99	num	26	SENT_223	[p11l975t3342r1161b3425],
26	]	CD	NUMBER	]	prep_to	23	SENT_223	[p11l975t3342r1161b3425],
27	;	:	O	;	_	0	SENT_223	[p11l975t3342r1161b3425],
28	p	NN	O	p	dep	13	SENT_223	[p11l1189t3370r1231b3433],
29	=	JJ	O	=	amod	28	SENT_223	[p11l1267t3370r1320b3390],
30	0.032	CD	NUMBER	0.032	num	31	SENT_223	[p11l1356t3342r1581b3425],
31	)	NN	O	)	tmod	29	SENT_223	[p11l1356t3342r1581b3425],
32	,	,	O	,	_	0	SENT_223	[p11l1356t3342r1581b3425],
33	noncarrier	JJ	O	noncarrier	amod	34	SENT_223	[p11l1611t3347r1943b3410],
34	status	NN	O	status	appos	31	SENT_223	[p11l1969t3361r2148b3410],
35	of	IN	O	of	_	0	SENT_223	[p11l11t3455r88b3521],
36	the	DT	O	the	det	40	SENT_223	[p11l104t3455r207b3521],
37	CYP2CJ9	NN	O	cyp2cj9	nn	40	SENT_223	[p11l244t3458r631b3522],
38	*	NN	O	*	nn	40	SENT_223	[p11l244t3458r631b3522],
39	2	CD	NUMBER	2	num	40	SENT_223	[p11l244t3458r631b3522],
40	allele	NN	O	allele	prep_of	28	SENT_223	[p11l660t3455r819b3522],
41	(	CD	NUMBER	(	num	42	SENT_223	[p11l852t3453r1018b3536],
42	OR	NN	O	or	dep	28	SENT_223	[p11l852t3453r1018b3536],
43	:	:	O	:	_	0	SENT_223	[p11l852t3453r1018b3536],
44	2.9	CD	PERCENT	2.9	number	45	SENT_223	[p11l1049t3459r1150b3523],
45	[	CD	PERCENT	[	dep	13	SENT_223	[p11l1187t3453r1355b3536],
46	95	CD	PERCENT	95	num	48	SENT_223	[p11l1187t3453r1355b3536],
47	%	NN	PERCENT	%	nn	48	SENT_223	[p11l1187t3453r1355b3536],
48	CI	NN	O	ci	dep	45	SENT_223	[p11l1385t3455r1491b3522],
49	:	:	O	:	_	0	SENT_223	[p11l1385t3455r1491b3522],
50	1.01	CD	NUMBER	1.01	number	52	SENT_223	[p11l1528t3459r1661b3522],
51	to	TO	O	to	dep	52	SENT_223	[p11l1695t3472r1759b3521],
52	8.39	CD	NUMBER	8.39	dep	13	SENT_223	[p11l1793t3453r1976b3536],
53	]	CD	NUMBER	]	dep	52	SENT_223	[p11l1793t3453r1976b3536],
54	;	:	O	;	_	0	SENT_223	[p11l1793t3453r1976b3536],
55	p	NN	O	p	dep	13	SENT_223	[p11l2007t3482r2049b3545],
56	=	JJ	O	=	amod	61	SENT_223	[p11l2087t3481r2140b3501],
57	0.043	CD	NUMBER	0.043	num	58	SENT_223	[p11l10t3563r236b3646],
58	)	NN	O	)	tmod	56	SENT_223	[p11l10t3563r236b3646],
59	,	,	O	,	_	0	SENT_223	[p11l10t3563r236b3646],
60	baseline	NN	O	baseline	appos	58	SENT_223	[p11l263t3565r521b3632],
61	higher	JJR	O	higher	dep	55	SENT_223	[p11l549t3565r761b3655],
62	PRU	NNP	O	PRU	nsubj	63	SENT_223	[p11l787t3566r960b3632],
63	values	VBZ	O	value	rcmod	13	SENT_223	[p11l982t3566r1177b3632],
64	(	CD	NUMBER	(	num	65	SENT_223	[p11l1209t3563r1375b3646],
65	OR	NN	O	or	dobj	63	SENT_223	[p11l1209t3563r1375b3646],
66	:	:	O	:	_	0	SENT_223	[p11l1209t3563r1375b3646],
67	0.98	CD	PERCENT	0.98	num	71	SENT_223	[p11l1407t3569r1546b3632],
68	[	CD	PERCENT	[	number	69	SENT_223	[p11l1582t3563r1749b3646],
69	95	CD	PERCENT	95	dep	70	SENT_223	[p11l1582t3563r1749b3646],
70	%	NN	PERCENT	%	dep	71	SENT_223	[p11l1582t3563r1749b3646],
71	Cl	NN	O	cl	dep	65	SENT_223	[p11l1778t3565r1883b3632],
72	:	:	O	:	_	0	SENT_223	[p11l1778t3565r1883b3632],
73	0.96	CD	NUMBER	0.96	dep	65	SENT_223	[p11l1915t3569r2055b3632],
74	to	TO	O	to	_	0	SENT_223	[p11l2084t3583r2149b3632],
75	0.99	CD	NUMBER	0.99	num	76	SENT_223	[p11l10t3674r197b3757],
76	]	CD	NUMBER	]	prep_to	73	SENT_223	[p11l10t3674r197b3757],
77	;	:	O	;	_	0	SENT_223	[p11l10t3674r197b3757],
78	p	NN	O	p	dep	65	SENT_223	[p11l222t3702r264b3765],
79	=	JJ	O	=	amod	81	SENT_223	[p11l297t3701r351b3722],
80	0.005	CD	NUMBER	0.005	tmod	79	SENT_223	[p11l384t3674r609b3757],
81	)	NN	O	)	dep	78	SENT_223	[p11l384t3674r609b3757],
82	,	,	O	,	_	0	SENT_223	[p11l384t3674r609b3757],
83	and	CC	O	and	_	0	SENT_223	[p11l637t3676r758b3742],
84	use	NN	O	use	dep	65	SENT_223	[p11l779t3702r884b3742],
85	of	IN	O	of	_	0	SENT_223	[p11l909t3676r985b3742],
86	atorvastatin	NN	O	atorvastatin	nn	88	SENT_223	[p11l998t3679r1371b3742],
87	(	CD	NUMBER	(	num	88	SENT_223	[p11l1397t3674r1563b3756],
88	OR	NN	O	or	prep_of	84	SENT_223	[p11l1397t3674r1563b3756],
89	:	:	O	:	_	0	SENT_223	[p11l1397t3674r1563b3756],
90	3.8	CD	PERCENT	3.8	number	91	SENT_223	[p11l1592t3679r1689b3742],
91	[	CD	PERCENT	[	dep	65	SENT_223	[p11l1721t3674r1890b3756],
92	95	CD	PERCENT	95	num	94	SENT_223	[p11l1721t3674r1890b3756],
93	%	NN	PERCENT	%	nn	94	SENT_223	[p11l1721t3674r1890b3756],
94	CI	NN	O	ci	dep	91	SENT_223	[p11l1915t3676r2020b3742],
95	:	:	O	:	_	0	SENT_223	[p11l1915t3676r2020b3742],
96	1.3	CD	NUMBER	1.3	dep	65	SENT_223	[p11l2052t3679r2146b3742],

1	-	:	O	-	_	0	SENT_224	[p12l885t130r905b133],
2	-	:	O	-	_	0	SENT_224	[p12l915t120r963b143],
3	o	NN	O	o	_	0	SENT_224	[p12l915t120r963b143],
4	-	:	O	-	_	0	SENT_224	[p12l915t120r963b143],
5	-	:	O	-	_	0	SENT_224	[p12l974t130r993b133],
6	Clopidogrel	NN	O	clopidogrel	dep	3	SENT_224	[p12l1010t117r1202b155],
7	150	CD	NUMBER	150	num	6	SENT_224	[p12l1218t117r1277b147],
8	.	.	O	.	_	0	SENT_224	[p12l883t200r1000b223],

1	—	NN	O	—	_	0	SENT_225	[p12l883t200r1000b223],
2	.	.	O	.	_	0	SENT_225	[p12l883t200r1000b223],

1	I	PRP	O	I	_	0	SENT_226	[p12l883t200r1000b223],
2	Atorvastatin	NN	O	atorvastatin	dep	1	SENT_226	[p12l1008t197r1429b235],
3	+	CC	O	+	_	0	SENT_226	[p12l1008t197r1429b235],
4	C	NN	O	c	nn	6	SENT_226	[p12l1008t197r1429b235],
5	|	JJ	O	|	amod	6	SENT_226	[p12l1008t197r1429b235],
6	opidogre	NN	O	opidogre	dep	1	SENT_226	[p12l1008t197r1429b235],
7	|	NN	O	|	dep	1	SENT_226	[p12l1008t197r1429b235],
8	150	CD	NUMBER	150	num	7	SENT_226	[p12l1445t197r1504b227],

1	A	DT	O	a	det	2	SENT_227	[p12l255t251r295b293],
2	B	NN	O	b	_	0	SENT_227	[p12l1296t268r1331b311],
3	T-1	NN	O	t-1	dep	2	SENT_227	[p12l1412t285r1458b311],
4	vs	CC	O	vs	_	0	SENT_227	[p12l1473t292r1510b311],
5	T-o	JJ	O	t-o	amod	6	SENT_227	[p12l1521t285r1572b311],
6	T-2	NN	O	t-2	dep	2	SENT_227	[p12l1686t285r1736b311],
7	vs	CC	O	vs	_	0	SENT_227	[p12l1747t292r1784b311],
8	T-o	NN	O	t-o	conj_vs	6	SENT_227	[p12l1795t285r1846b311],

1	-35	CD	NUMBER	-35	num	2	SENT_228	[p12l1309t617r1338b632],
2	150	CD	NUMBER	150	_	0	SENT_228	[p12l255t685r300b707],
3	_	NN	O	_	nn	4	SENT_228	[p12l1309t703r1338b719],
4	5o	NN	O	5o	dep	2	SENT_228	[p12l1309t703r1338b719],

1	P	NN	O	p	_	0	SENT_229	[p12l1437t760r1453b781],
2	=	JJ	O	=	amod	4	SENT_229	[p12l1462t766r1476b775],
3	0.4	CD	NUMBER	0.4	tmod	2	SENT_229	[p12l1486t760r1522b781],
4	P	NN	O	p	dep	1	SENT_229	[p12l1736t760r1752b781],
5	=	JJ	O	=	amod	4	SENT_229	[p12l1762t766r1775b775],
6	0.003	CD	NUMBER	0.003	tmod	5	SENT_229	[p12l1785t760r1852b781],

1	Figure	NN	O	figure	_	0	SENT_230	[p12l68t852r147b878],
2	2	CD	NUMBER	2	dep	1	SENT_230	[p12l159t852r182b873],
3	.	.	O	.	_	0	SENT_230	[p12l159t852r182b873],

1	Differences	NNS	O	difference	nsubj	7	SENT_231	[p12l195t852r341b873],
2	in	IN	O	in	_	0	SENT_231	[p12l352t852r373b873],
3	ADP-Induced	JJ	O	adp-induced	amod	5	SENT_231	[p12l384t852r549b873],
4	Platelet	NN	O	platelet	nn	5	SENT_231	[p12l562t852r662b873],
5	Reactivity	NN	O	reactivity	prep_in	1	SENT_231	[p12l674t852r804b878],
6	as	IN	O	as	prep	5	SENT_231	[p12l815t857r844b873],
7	Expressed	VBN	O	express	_	0	SENT_231	[p12l856t852r988b878],
8	by	IN	O	by	_	0	SENT_231	[p12l1000t853r1028b878],
9	PRU	NNP	O	PRU	prep_by	7	SENT_231	[p12l1039t853r1093b873],
10	(	CD	NUMBER	(	num	9	SENT_231	[p12l68t915r103b939],
11	A	DT	O	a	det	14	SENT_231	[p12l68t915r103b939],
12	)	NN	O	)	nn	14	SENT_231	[p12l68t915r103b939],
13	Mean	NN	O	mean	nn	14	SENT_231	[p12l116t915r181b936],
14	P2Y12	NN	O	p2y12	dobj	7	SENT_231	[p12l194t915r261b942],
15	reaction	NN	O	reaction	nn	16	SENT_231	[p12l273t916r370b936],
16	units	NNS	O	unit	nsubj	17	SENT_231	[p12l383t915r441b936],
17	(	VBP	O	(	rcmod	14	SENT_231	[p12l453t915r516b939],
18	PRU	NNP	ORGANIZATION	PRU	nn	20	SENT_231	[p12l453t915r516b939],
19	)	CD	NUMBER	)	num	20	SENT_231	[p12l453t915r516b939],
20	values	NNS	O	value	dobj	17	SENT_231	[p12l528t914r604b936],
21	at	IN	O	at	_	0	SENT_231	[p12l615t918r638b936],
22	baseline	NN	O	baseline	nn	24	SENT_231	[p12l650t914r748b936],
23	(	CD	NUMBER	(	num	24	SENT_231	[p12l761t915r819b939],
24	T	NN	O	t	prep_at	17	SENT_231	[p12l761t915r819b939],
25	.	.	O	.	_	0	SENT_231	[p12l761t915r819b939],

1	—	NN	O	—	_	0	SENT_232	[p12l761t915r819b939],
2	.	.	O	.	_	0	SENT_232	[p12l761t915r819b939],

1	O	NN	O	o	nn	2	SENT_233	[p12l761t915r819b939],
2	)	NN	O	)	nsubj	6	SENT_233	[p12l761t915r819b939],
3	,	,	O	,	_	0	SENT_233	[p12l761t915r819b939],
4	10	CD	DURATION	10	num	5	SENT_233	[p12l833t916r859b936],
5	days	NNS	NUMBER	day	appos	2	SENT_233	[p12l870t914r924b942],
6	(	VBP	O	(	_	0	SENT_233	[p12l937t915r988b939],
7	T-1	NN	O	t-1	nn	8	SENT_233	[p12l937t915r988b939],
8	)	NN	O	)	nsubj	12	SENT_233	[p12l937t915r988b939],
9	and	CC	O	and	_	0	SENT_233	[p12l1000t914r1044b936],
10	30	CD	DURATION	30	num	11	SENT_233	[p12l1057t916r1085b936],
11	days	NNS	NUMBER	day	nsubj	12	SENT_233	[p12l1097t914r1150b942],
12	(	VBP	O	(	ccomp	6	SENT_233	[p12l1163t915r1214b939],
13	T-2	NN	O	t-2	nn	14	SENT_233	[p12l1163t915r1214b939],
14	)	NN	O	)	dobj	12	SENT_233	[p12l1163t915r1214b939],
15	in	IN	O	in	_	0	SENT_233	[p12l1227t915r1247b936],
16	aton/astatin	NN	O	aton/astatin	prep_in	14	SENT_233	[p12l1259t914r1565b942],
17	+	CC	O	+	_	0	SENT_233	[p12l1259t914r1565b942],
18	c	NN	O	c	nn	21	SENT_233	[p12l1259t914r1565b942],
19	|	NN	O	|	nn	21	SENT_233	[p12l1259t914r1565b942],
20	opidogre	NN	O	opidogre	nn	21	SENT_233	[p12l1259t914r1565b942],
21	|	NN	O	|	conj_+	14	SENT_233	[p12l1259t914r1565b942],
22	150	CD	NUMBER	150	num	25	SENT_233	[p12l1580t916r1621b936],
23	mg	NN	O	mg	nn	25	SENT_233	[p12l1633t921r1670b942],
24	(	NN	O	(	nn	25	SENT_233	[p12l1683t915r1800b941],
25	squares	NNS	O	square	dep	21	SENT_233	[p12l1683t915r1800b941],
26	)	CD	NUMBER	)	dep	31	SENT_233	[p12l1683t915r1800b941],
27	and	CC	O	and	_	0	SENT_233	[p12l1812t914r1856b936],
28	clopidogrel	NN	O	clopidogrel	dep	31	SENT_233	[p12l1869t914r2005b942],
29	150	CD	NUMBER	150	num	30	SENT_233	[p12l2020t916r2061b936],
30	mg	NN	O	mg	dep	31	SENT_233	[p12l69t960r106b981],
31	patients	NNS	O	patient	dep	34	SENT_233	[p12l119t955r215b981],
32	(	CD	NUMBER	(	num	33	SENT_233	[p12l228t954r331b979],
33	circles	NNS	O	circle	dep	31	SENT_233	[p12l228t954r331b979],
34	)	CD	NUMBER	)	dep	12	SENT_233	[p12l228t954r331b979],
35	.	.	O	.	_	0	SENT_233	[p12l228t954r331b979],

1	(	NN	O	(	nn	2	SENT_234	[p12l343t954r376b979],
2	B	NN	O	b	_	0	SENT_234	[p12l343t954r376b979],
3	)	CD	NUMBER	)	num	4	SENT_234	[p12l343t954r376b979],
4	Differences	NNS	O	difference	dep	2	SENT_234	[p12l389t954r524b975],
5	in	IN	O	in	_	0	SENT_234	[p12l536t955r556b975],
6	mean	NN	O	mean	nn	9	SENT_234	[p12l569t960r635b975],
7	relative	JJ	O	relative	amod	9	SENT_234	[p12l648t954r735b975],
8	PRU	NNP	ORGANIZATION	PRU	nn	9	SENT_234	[p12l748t955r794b975],
9	reduction	NN	O	reduction	prep_in	4	SENT_234	[p12l808t954r922b975],
10	from	IN	O	from	_	0	SENT_234	[p12l934t954r991b975],
11	T	NN	O	t	prep_from	9	SENT_234	[p12l1002t955r1040b975],
12	.	.	O	.	_	0	SENT_234	[p12l1002t955r1040b975],

1	—	NN	O	—	_	0	SENT_235	[p12l1002t955r1040b975],
2	.	.	O	.	_	0	SENT_235	[p12l1002t955r1040b975],

1	O	NN	O	o	conj_and	1	SENT_236	[p12l1002t955r1040b975],
2	to	TO	O	to	_	0	SENT_236	[p12l1050t957r1075b975],
3	T-1	NN	O	t-1	prep_to	1	SENT_236	[p12l1085t955r1119b975],
4	and	CC	O	and	_	0	SENT_236	[p12l1135t954r1179b975],
5	from	IN	O	from	_	0	SENT_236	[p12l1190t954r1247b975],
6	T	NN	O	t	prep_from	1	SENT_236	[p12l1258t955r1296b975],
7	.	.	O	.	_	0	SENT_236	[p12l1258t955r1296b975],

1	—	NN	O	—	_	0	SENT_237	[p12l1258t955r1296b975],
2	.	.	O	.	_	0	SENT_237	[p12l1258t955r1296b975],

1	O	NN	O	o	nsubj	14	SENT_238	[p12l1258t955r1296b975],
2	to	TO	O	to	_	0	SENT_238	[p12l1307t957r1331b975],
3	T-2	NN	O	t-2	prep_to	1	SENT_238	[p12l1341t955r1385b975],
4	:	:	O	:	_	0	SENT_238	[p12l1341t955r1385b975],
5	atorvastatin	NN	O	atorvastatin	dep	3	SENT_238	[p12l1397t954r1703b981],
6	+	CC	O	+	_	0	SENT_238	[p12l1397t954r1703b981],
7	c	NN	O	c	nn	10	SENT_238	[p12l1397t954r1703b981],
8	|	NN	O	|	nn	10	SENT_238	[p12l1397t954r1703b981],
9	opidogre	NN	O	opidogre	nn	10	SENT_238	[p12l1397t954r1703b981],
10	|	NN	O	|	conj_+	5	SENT_238	[p12l1397t954r1703b981],
11	150	CD	NUMBER	150	num	12	SENT_238	[p12l1717t955r1758b975],
12	mg	NN	O	mg	dep	10	SENT_238	[p12l1771t960r1808b981],
13	are	VBP	O	be	cop	14	SENT_238	[p12l1820t960r1857b975],
14	red	JJ	O	red	_	0	SENT_238	[p12l1869t954r1918b979],
15	,	,	O	,	_	0	SENT_238	[p12l1869t954r1918b979],
16	and	CC	O	and	_	0	SENT_238	[p12l1929t954r1973b975],
17	clopidogrel	NN	O	clopidogrel	nsubj	22	SENT_238	[p12l1986t954r2052b981, p12l68t994r145b1021],
18	150	CD	NUMBER	150	num	20	SENT_238	[p12l159t995r201b1015],
19	mg	NN	O	mg	nn	20	SENT_238	[p12l213t1000r250b1021],
20	patients	NNS	O	patient	dep	17	SENT_238	[p12l263t995r360b1021],
21	are	VBP	O	be	cop	22	SENT_238	[p12l371t1000r408b1015],
22	gray	JJ	O	gray	conj_and	14	SENT_238	[p12l419t1000r482b1021],
23	.	.	O	.	_	0	SENT_238	[p12l419t1000r482b1021],

1	ADP	NN	O	adp	_	0	SENT_239	[p12l493t994r545b1015],
2	=	JJ	O	=	amod	4	SENT_239	[p12l558t1002r576b1009],
3	adenosine	NN	O	adenosine	nn	4	SENT_239	[p12l590t994r715b1015],
4	diphosphate	NN	O	diphosphate	dep	1	SENT_239	[p12l726t994r885b1021],
5	.	.	O	.	_	0	SENT_239	[p12l726t994r885b1021],

1	JACC	NN	O	jacc	_	0	SENT_240	[p12l42t1131r112b1146],
2	:	:	O	:	_	0	SENT_240	[p12l42t1131r112b1146],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_240	[p12l129t1131r363b1146],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_240	[p12l379t1131r594b1148],
5	.	.	O	.	_	0	SENT_240	[p12l379t1131r594b1148],

1	VOL	NNP	O	VOL	_	0	SENT_241	[p12l611t1131r668b1146],
2	.	.	O	.	_	0	SENT_241	[p12l611t1131r668b1146],

1	6	CD	NUMBER	6	_	0	SENT_242	[p12l684t1131r705b1148],
2	.	.	O	.	_	0	SENT_242	[p12l684t1131r705b1148],

1	No.	NN	O	no.	_	0	SENT_243	[p12l722t1131r764b1146],
2	2	CD	NUMBER	2	dep	1	SENT_243	[p12l781t1131r801b1148],
3	.	.	O	.	_	0	SENT_243	[p12l781t1131r801b1148],

1	2013	CD	DATE	2013	num	2	SENT_244	[p12l818t1131r876b1146],
2	Leoncini	NNP	O	Leoncini	dep	11	SENT_244	[p12l1788t1125r1889b1146],
3	et	FW	O	et	nn	4	SENT_244	[p12l1903t1126r1927b1146],
4	al.	FW	O	al.	dep	2	SENT_244	[p12l1938t1125r1965b1146],
5	175	CD	NUMBER	175	num	6	SENT_244	[p12l2067t1125r2116b1146],
6	FEBRUARY	NN	DATE	february	dep	11	SENT_244	[p12l43t1169r174b1184],
7	2o13	CD	NUMBER	2o13	num	11	SENT_244	[p12l188t1170r305b1184],
8	:159	CD	NUMBER	:159	num	11	SENT_244	[p12l188t1170r305b1184],
9	-79	CD	NUMBER	-79	num	11	SENT_244	[p12l313t1170r355b1184],
10	High-Dose	NNP	O	High-Dose	nn	11	SENT_244	[p12l1388t1164r1512b1189],
11	Atorvastatin	NNP	O	Atorvastatin	_	0	SENT_244	[p12l1522t1164r1672b1184],
12	and	CC	O	and	_	0	SENT_244	[p12l1684t1164r1728b1184],
13	Platelet	NN	O	platelet	nn	14	SENT_244	[p12l1741t1164r1835b1184],
14	Reactivity	NN	O	reactivity	conj_and	11	SENT_244	[p12l1847t1164r1967b1189],

1	--	:	O	--	_	0	SENT_245	[p12l1024t1345r1097b1367],
2	O	NN	O	o	_	0	SENT_245	[p12l1024t1345r1097b1367],
3	-	:	O	-	_	0	SENT_245	[p12l1024t1345r1097b1367],
4	-	:	O	-	_	0	SENT_245	[p12l1107t1355r1125b1358],
5	Clopidogrel	NN	O	clopidogrel	dep	2	SENT_245	[p12l1141t1343r1321b1378],
6	150	CD	NUMBER	150	dep	5	SENT_245	[p12l1336t1343r1392b1371],
7	.	.	O	.	_	0	SENT_245	[p12l1022t1421r1131b1443],

1	—	NN	O	—	_	0	SENT_246	[p12l1022t1421r1131b1443],
2	.	.	O	.	_	0	SENT_246	[p12l1022t1421r1131b1443],

1	I	PRP	O	I	_	0	SENT_247	[p12l1022t1421r1131b1443],
2	Atorvastatin	NN	O	atorvastatin	dep	1	SENT_247	[p12l1139t1418r1534b1453],
3	+	CC	O	+	_	0	SENT_247	[p12l1139t1418r1534b1453],
4	C	NN	O	c	nn	6	SENT_247	[p12l1139t1418r1534b1453],
5	|	JJ	O	|	amod	6	SENT_247	[p12l1139t1418r1534b1453],
6	opidogre	NN	O	opidogre	dep	1	SENT_247	[p12l1139t1418r1534b1453],
7	|	NN	O	|	dep	1	SENT_247	[p12l1139t1418r1534b1453],
8	150	CD	NUMBER	150	num	7	SENT_247	[p12l1549t1418r1605b1446],

1	B3	NN	O	b3	_	0	SENT_248	[p12l1283t1487r1347b1548],
2	T1vsT-0	NN	O	t1vst-0	nn	3	SENT_248	[p12l1436t1502r1566b1522],
3	T2vsT0	NN	O	t2vst0	dep	1	SENT_248	[p12l1704t1502r1835b1522],

1	P	NN	O	p	_	0	SENT_249	[p12l1483t1938r1498b1958],
2	=	JJ	O	=	amod	4	SENT_249	[p12l1507t1944r1520b1953],
3	0.004	CD	NUMBER	0.004	tmod	2	SENT_249	[p12l1530t1938r1595b1958],
4	P	NN	O	p	dep	1	SENT_249	[p12l1742t1938r1757b1958],
5	=	JJ	O	=	amod	4	SENT_249	[p12l1766t1944r1779b1953],
6	0.5	CD	NUMBER	0.5	tmod	5	SENT_249	[p12l1789t1938r1825b1958],

1	Figure	NNP	O	Figure	_	0	SENT_250	[p12l68t2065r147b2091],
2	3	CD	NUMBER	3	dep	1	SENT_250	[p12l158t2065r182b2086],
3	.	.	O	.	_	0	SENT_250	[p12l158t2065r182b2086],

1	Differences	NNS	O	difference	_	0	SENT_251	[p12l195t2065r341b2086],
2	In	IN	O	in	dep	1	SENT_251	[p12l352t2065r373b2086],
3	lso-TRAP-Induced	JJ	O	lso-trap-induced	amod	5	SENT_251	[p12l385t2065r617b2086],
4	Platelet	NN	O	platelet	nn	5	SENT_251	[p12l630t2065r730b2086],
5	Reactlvlty	NN	O	reactlvlty	pobj	2	SENT_251	[p12l742t2065r872b2091],
6	as	IN	O	as	advmod	7	SENT_251	[p12l883t2070r912b2086],
7	Expressed	VBN	O	express	partmod	5	SENT_251	[p12l924t2065r1056b2091],
8	by	IN	O	by	_	0	SENT_251	[p12l1068t2065r1096b2091],
9	BASE	NN	O	base	nn	14	SENT_251	[p12l1108t2065r1178b2086],
10	(	NN	O	(	nn	14	SENT_251	[p12l68t2128r103b2152],
11	A	NN	O	a	nn	14	SENT_251	[p12l68t2128r103b2152],
12	)	CD	NUMBER	)	num	14	SENT_251	[p12l68t2128r103b2152],
13	Mean	NN	O	mean	nn	14	SENT_251	[p12l116t2128r181b2149],
14	iso	NN	O	iso	agent	7	SENT_251	[p12l194t2127r349b2149],
15	—	CD	NUMBER	—	num	17	SENT_251	[p12l194t2127r349b2149],
16	thrombin	NN	O	thrombin	nn	17	SENT_251	[p12l194t2127r349b2149],
17	receptor	NN	O	receptor	dep	14	SENT_251	[p12l362t2130r464b2154],
18	activating	VBG	O	activate	xcomp	7	SENT_251	[p12l475t2128r593b2154],
19	peptide	NN	O	peptide	nn	21	SENT_251	[p12l606t2127r699b2154],
20	(	NN	O	(	nn	21	SENT_251	[p12l711t2128r831b2152],
21	iso	NN	O	iso	dobj	18	SENT_251	[p12l711t2128r831b2152],
22	.	.	O	.	_	0	SENT_251	[p12l711t2128r831b2152],

1	—	NN	O	—	_	0	SENT_252	[p12l711t2128r831b2152],
2	.	.	O	.	_	0	SENT_252	[p12l711t2128r831b2152],

1	TRAP	NN	O	trap	nn	4	SENT_253	[p12l711t2128r831b2152],
2	)	CD	NUMBER	)	num	4	SENT_253	[p12l711t2128r831b2152],
3	reaction	NN	O	reaction	nn	4	SENT_253	[p12l844t2128r941b2149],
4	unit	NN	O	unit	_	0	SENT_253	[p12l954t2128r1000b2149],
5	(	CD	NUMBER	(	num	8	SENT_253	[p12l1012t2128r1088b2152],
6	BASE	NN	O	base	nn	8	SENT_253	[p12l1012t2128r1088b2152],
7	)	NN	O	)	nn	8	SENT_253	[p12l1012t2128r1088b2152],
8	values	NNS	O	value	dep	4	SENT_253	[p12l1100t2127r1175b2149],
9	at	IN	O	at	_	0	SENT_253	[p12l1187t2131r1209b2149],
10	baseline	NN	O	baseline	nn	12	SENT_253	[p12l1221t2127r1320b2149],
11	(	CD	NUMBER	(	num	12	SENT_253	[p12l1332t2128r1391b2152],
12	T	NN	O	t	prep_at	8	SENT_253	[p12l1332t2128r1391b2152],
13	.	.	O	.	_	0	SENT_253	[p12l1332t2128r1391b2152],

1	—	NN	O	—	_	0	SENT_254	[p12l1332t2128r1391b2152],
2	.	.	O	.	_	0	SENT_254	[p12l1332t2128r1391b2152],

1	O	NN	O	o	nn	2	SENT_255	[p12l1332t2128r1391b2152],
2	)	NN	O	)	nsubj	6	SENT_255	[p12l1332t2128r1391b2152],
3	,	,	O	,	_	0	SENT_255	[p12l1332t2128r1391b2152],
4	10	CD	DURATION	10	num	5	SENT_255	[p12l1404t2129r1430b2149],
5	days	NNS	NUMBER	day	appos	2	SENT_255	[p12l1442t2127r1496b2155],
6	(	VBP	O	(	_	0	SENT_255	[p12l1508t2128r1567b2152],
7	T-1	NN	O	t-1	nn	8	SENT_255	[p12l1508t2128r1567b2152],
8	)	NN	O	)	dobj	6	SENT_255	[p12l1508t2128r1567b2152],
9	,	,	O	,	_	0	SENT_255	[p12l1508t2128r1567b2152],
10	and	CC	O	and	_	0	SENT_255	[p12l1578t2127r1622b2149],
11	30	CD	DURATION	30	num	12	SENT_255	[p12l1635t2129r1663b2149],
12	days	NNS	NUMBER	day	nsubj	13	SENT_255	[p12l1674t2127r1728b2155],
13	(	VBP	O	(	conj_and	6	SENT_255	[p12l1740t2128r1792b2152],
14	T-2	NN	O	t-2	nn	15	SENT_255	[p12l1740t2128r1792b2152],
15	)	NN	O	)	dobj	13	SENT_255	[p12l1740t2128r1792b2152],
16	in	IN	O	in	_	0	SENT_255	[p12l1805t2128r1825b2148],
17	atorvastatin	NN	O	atorvastatin	prep_in	15	SENT_255	[p12l1837t2128r2003b2149],
18	+	CC	O	+	_	0	SENT_255	[p12l1837t2128r2003b2149],
19	clopidogrel	NN	O	clopidogrel	conj_+	15	SENT_255	[p12l68t2167r204b2194],
20	150	CD	NUMBER	150	num	23	SENT_255	[p12l219t2168r260b2188],
21	mg	NN	O	mg	nn	23	SENT_255	[p12l272t2173r309b2194],
22	(	NN	O	(	nn	23	SENT_255	[p12l322t2167r439b2194],
23	squares	NNS	O	square	dep	19	SENT_255	[p12l322t2167r439b2194],
24	)	CD	NUMBER	)	dep	29	SENT_255	[p12l322t2167r439b2194],
25	and	CC	O	and	_	0	SENT_255	[p12l451t2167r495b2188],
26	clopidogrel	NN	O	clopidogrel	dep	29	SENT_255	[p12l508t2167r644b2194],
27	150	CD	NUMBER	150	num	28	SENT_255	[p12l659t2168r700b2188],
28	mg	NN	O	mg	dep	29	SENT_255	[p12l712t2173r749b2194],
29	patients	NNS	O	patient	dep	32	SENT_255	[p12l762t2168r859b2194],
30	(	CD	NUMBER	(	num	31	SENT_255	[p12l871t2167r974b2191],
31	circles	NNS	O	circle	dep	29	SENT_255	[p12l871t2167r974b2191],
32	)	CD	NUMBER	)	dep	13	SENT_255	[p12l871t2167r974b2191],
33	.	.	O	.	_	0	SENT_255	[p12l871t2167r974b2191],

1	(	NN	O	(	nn	2	SENT_256	[p12l987t2167r1019b2191],
2	B	NN	O	b	_	0	SENT_256	[p12l987t2167r1019b2191],
3	)	CD	NUMBER	)	num	4	SENT_256	[p12l987t2167r1019b2191],
4	Differences	NNS	O	difference	dep	2	SENT_256	[p12l1033t2166r1167b2188],
5	in	IN	O	in	_	0	SENT_256	[p12l1179t2168r1199b2188],
6	mean	NN	O	mean	prep_in	4	SENT_256	[p12l1212t2173r1278b2188],
7	relative	JJ	O	relative	amod	9	SENT_256	[p12l1291t2167r1379b2188],
8	BASE	NN	O	base	nn	9	SENT_256	[p12l1391t2168r1451b2188],
9	reduction	NN	O	reduction	dep	2	SENT_256	[p12l1463t2167r1578b2188],
10	from	IN	O	from	_	0	SENT_256	[p12l1590t2166r1646b2188],
11	T	NN	O	t	prep_from	9	SENT_256	[p12l1657t2168r1695b2188],
12	.	.	O	.	_	0	SENT_256	[p12l1657t2168r1695b2188],

1	—	NN	O	—	_	0	SENT_257	[p12l1657t2168r1695b2188],
2	.	.	O	.	_	0	SENT_257	[p12l1657t2168r1695b2188],

1	O	NN	O	o	conj_and	1	SENT_258	[p12l1657t2168r1695b2188],
2	to	TO	O	to	_	0	SENT_258	[p12l1706t2170r1730b2188],
3	T-1	NN	O	t-1	prep_to	1	SENT_258	[p12l1741t2168r1774b2188],
4	and	CC	O	and	_	0	SENT_258	[p12l1790t2167r1834b2188],
5	from	IN	O	from	_	0	SENT_258	[p12l1846t2166r1902b2188],
6	T	NN	O	t	prep_from	1	SENT_258	[p12l1913t2168r1951b2188],
7	.	.	O	.	_	0	SENT_258	[p12l1913t2168r1951b2188],

1	—	NN	O	—	_	0	SENT_259	[p12l1913t2168r1951b2188],
2	.	.	O	.	_	0	SENT_259	[p12l1913t2168r1951b2188],

1	O	NN	O	o	_	0	SENT_260	[p12l1913t2168r1951b2188],
2	to	TO	O	to	_	0	SENT_260	[p12l1962t2170r1987b2188],
3	T-2	NN	O	t-2	prep_to	1	SENT_260	[p12l1997t2168r2041b2188],
4	:	:	O	:	_	0	SENT_260	[p12l1997t2168r2041b2188],
5	atorvastatin-l-clopidogrel	NN	O	atorvastatin-l-clopidogrel	dep	1	SENT_260	[p12l68t2206r374b2234],
6	150	CD	NUMBER	150	num	7	SENT_260	[p12l388t2208r430b2228],
7	mg	NN	O	mg	nsubjpass	9	SENT_260	[p12l442t2213r479b2234],
8	is	VBZ	O	be	auxpass	9	SENT_260	[p12l492t2207r508b2228],
9	indicated	VBN	O	indicate	rcmod	5	SENT_260	[p12l520t2206r631b2228],
10	by	IN	O	by	_	0	SENT_260	[p12l644t2206r673b2234],
11	the	DT	O	the	det	17	SENT_260	[p12l683t2206r722b2228],
12	red	JJ	O	red	amod	17	SENT_260	[p12l734t2206r781b2231],
13	,	,	O	,	_	0	SENT_260	[p12l734t2206r781b2231],
14	and	CC	O	and	_	0	SENT_260	[p12l793t2206r837b2228],
15	clopidogrel	NN	O	clopidogrel	conj_and	12	SENT_260	[p12l849t2206r986b2234],
16	150	CD	NUMBER	150	num	15	SENT_260	[p12l1000t2208r1041b2228],
17	mg	NN	O	mg	agent	9	SENT_260	[p12l1054t2213r1091b2234],
18	by	IN	O	by	_	0	SENT_260	[p12l1104t2206r1133b2234],
19	the	DT	O	the	det	20	SENT_260	[p12l1143t2206r1182b2228],
20	gray	JJ	O	gray	agent	9	SENT_260	[p12l1193t2212r1257b2234],
21	.	.	O	.	_	0	SENT_260	[p12l1193t2212r1257b2234],

1	to	TO	O	to	dep	5	SENT_261	[p12l8t2414r73b2463],
2	11.5	CD	NUMBER	11.5	number	3	SENT_261	[p12l109t2395r292b2478],
3	]	CD	NUMBER	]	pobj	1	SENT_261	[p12l109t2395r292b2478],
4	;	:	O	;	_	0	SENT_261	[p12l109t2395r292b2478],
5	p	NN	O	p	_	0	SENT_261	[p12l325t2423r367b2486],
6	=	JJ	O	=	amod	13	SENT_261	[p12l407t2423r461b2443],
7	0.011	CD	NUMBER	0.011	num	8	SENT_261	[p12l501t2395r727b2478],
8	)	CD	NUMBER	)	tmod	6	SENT_261	[p12l501t2395r727b2478],
9	,	,	O	,	_	0	SENT_261	[p12l501t2395r727b2478],
10	(	CD	NUMBER	(	num	11	SENT_261	[p12l764t2395r975b2477],
11	Table	NNP	O	Table	appos	8	SENT_261	[p12l764t2395r975b2477],
12	3	CD	NUMBER	3	num	11	SENT_261	[p12l1008t2395r1088b2477],
13	)	NN	O	)	dep	5	SENT_261	[p12l1008t2395r1088b2477],
14	.	.	O	.	_	0	SENT_261	[p12l1008t2395r1088b2477],

1	The	DT	O	the	det	5	SENT_262	[p12l1121t2395r1262b2463],
2	receiver-operating	JJ	O	receiver-operating	amod	5	SENT_262	[p12l1293t2400r1883b2486],
3	characteristic	JJ	O	characteristic	amod	5	SENT_262	[p12l1912t2397r2149b2463, p12l8t2506r222b2569],
4	curve	NN	O	curve	nn	5	SENT_262	[p12l258t2529r428b2569],
5	analysis	NN	O	analysis	nsubj	6	SENT_262	[p12l466t2503r708b2592],
6	showed	VBD	O	show	_	0	SENT_262	[p12l747t2503r996b2569],
7	that	IN	O	that	complm	13	SENT_262	[p12l1031t2503r1162b2569],
8	pre	JJ	O	pre	amod	9	SENT_262	[p12l1195t2503r1678b2592],
9	—	NN	O	—	nsubj	13	SENT_262	[p12l1195t2503r1678b2592],
10	procedural	JJ	O	procedural	amod	11	SENT_262	[p12l1195t2503r1678b2592],
11	PRU	NN	O	pru	dep	9	SENT_262	[p12l1713t2504r1886b2569],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_262	[p12l1922t2503r2149b2592, p12l9t2609r204b2698],
13	discriminate	VBP	O	discriminate	conj_and	13	SENT_262	[p12l226t2609r623b2675],
14	between	IN	O	between	_	0	SENT_262	[p12l647t2609r921b2675],
15	patients	NNS	O	patient	prep_between	13	SENT_262	[p12l945t2612r1199b2698],
16	with	IN	O	with	_	0	SENT_262	[p12l1221t2609r1373b2675],
17	and	CC	O	and	_	0	SENT_262	[p12l1399t2609r1521b2675],
18	without	IN	O	without	_	0	SENT_262	[p12l1541t2609r1802b2675],
19	HTPR	NN	ORGANIZATION	htpr	prep_without	13	SENT_262	[p12l1826t2607r2070b2674],
20	at	IN	O	at	_	0	SENT_262	[p12l2093t2626r2153b2675],
21	30	CD	DURATION	30	num	22	SENT_262	[p12l9t2718r89b2781],
22	days	NNS	NUMBER	day	prep_at	13	SENT_262	[p12l112t2715r269b2804],
23	,	,	O	,	_	0	SENT_262	[p12l112t2715r269b2804],
24	with	IN	O	with	_	0	SENT_262	[p12l290t2715r441b2781],
25	an	DT	O	a	det	26	SENT_262	[p12l464t2741r541b2781],
26	area	NN	O	area	prep_with	13	SENT_262	[p12l564t2741r694b2781],
27	under	IN	O	under	_	0	SENT_262	[p12l713t2715r907b2781],
28	the	DT	O	the	det	29	SENT_262	[p12l926t2715r1029b2781],
29	curve	NN	O	curve	prep_under	26	SENT_262	[p12l1052t2741r1222b2781],
30	of	IN	O	of	_	0	SENT_262	[p12l1245t2715r1322b2781],
31	0.77	CD	PERCENT	0.77	num	35	SENT_262	[p12l1331t2716r1474b2781],
32	(	CD	PERCENT	(	number	33	SENT_262	[p12l1498t2713r1667b2795],
33	95	CD	PERCENT	95	dep	34	SENT_262	[p12l1498t2713r1667b2795],
34	%	NN	PERCENT	%	dep	35	SENT_262	[p12l1498t2713r1667b2795],
35	CI	NN	O	ci	prep_of	29	SENT_262	[p12l1690t2715r1796b2781],
36	:	:	O	:	_	0	SENT_262	[p12l1690t2715r1796b2781],
37	0.6	CD	NUMBER	0.6	num	39	SENT_262	[p12l1821t2718r1920b2781],
38	to	TO	O	to	dep	39	SENT_262	[p12l1944t2732r2008b2781],
39	0.9	CD	NUMBER	0.9	dep	35	SENT_262	[p12l2032t2718r2149b2796],
40	,	,	O	,	_	0	SENT_262	[p12l2032t2718r2149b2796],
41	p	NN	O	p	appos	39	SENT_262	[p12l7t2847r49b2910],
42	=	JJ	O	=	amod	44	SENT_262	[p12l91t2847r145b2867],
43	0.001	CD	NUMBER	0.001	tmod	42	SENT_262	[p12l186t2819r411b2901],
44	)	NN	O	)	dep	41	SENT_262	[p12l186t2819r411b2901],
45	.	.	O	.	_	0	SENT_262	[p12l186t2819r411b2901],

1	A	DT	O	a	det	3	SENT_263	[p12l445t2819r512b2886],
2	PRU	NNP	ORGANIZATION	PRU	nn	3	SENT_263	[p12l543t2822r717b2887],
3	Value	NNP	O	Value	_	0	SENT_263	[p12l744t2821r912b2887],
4	<	JJR	O	<	amod	3	SENT_263	[p12l951t2824r1137b2888],
5	298	CD	NUMBER	298	nsubjpass	7	SENT_263	[p12l951t2824r1137b2888],
6	was	VBD	O	be	auxpass	7	SENT_263	[p12l1169t2847r1291b2887],
7	identiﬁed	VBN	O	identiﬁed	ccomp	4	SENT_263	[p12l1325t2821r1637b2887],
8	as	IN	O	as	_	0	SENT_263	[p12l1670t2847r1729b2887],
9	the	DT	O	the	det	12	SENT_263	[p12l1763t2821r1867b2887],
10	optimal	JJ	O	optimal	amod	12	SENT_263	[p12l1901t2821r2153b2910],
11	cutoff	NN	O	cutoff	nn	12	SENT_263	[p12l9t2927r201b2993],
12	point	NN	O	point	prep_as	7	SENT_263	[p12l205t2930r381b3016],
13	to	TO	O	to	aux	14	SENT_263	[p12l397t2944r461b2993],
14	predict	VB	O	predict	xcomp	7	SENT_263	[p12l479t2927r708b3016],
15	optimal	JJ	O	optimal	amod	16	SENT_263	[p12l724t2927r976b3016],
16	response	NN	O	response	dobj	14	SENT_263	[p12l992t2953r1272b3016],
17	at	IN	O	at	_	0	SENT_263	[p12l1291t2944r1351b2993],
18	30	CD	DURATION	30	num	19	SENT_263	[p12l1368t2930r1448b2993],
19	days	NNS	NUMBER	day	tmod	20	SENT_263	[p12l1468t2927r1607b3016],
20	(	RB	O	(	amod	21	SENT_263	[p12l1629t2925r1795b3007],
21	OR	NN	O	or	prep_at	4	SENT_263	[p12l1629t2925r1795b3007],
22	:	:	O	:	_	0	SENT_263	[p12l1629t2925r1795b3007],
23	10.7	CD	PERCENT	10.7	number	24	SENT_263	[p12l1821t2928r1960b2993],
24	[	CD	PERCENT	[	dep	3	SENT_263	[p12l1983t2925r2151b3007],
25	95	CD	PERCENT	95	num	27	SENT_263	[p12l1983t2925r2151b3007],
26	%	NN	PERCENT	%	nn	27	SENT_263	[p12l1983t2925r2151b3007],
27	CI	NN	O	ci	dep	24	SENT_263	[p12l10t3034r116b3100],
28	:	:	O	:	_	0	SENT_263	[p12l10t3034r116b3100],
29	3.3	CD	NUMBER	3.3	number	31	SENT_263	[p12l147t3037r243b3100],
30	to	TO	O	to	dep	31	SENT_263	[p12l273t3051r338b3100],
31	34.8	CD	NUMBER	34.8	dep	3	SENT_263	[p12l367t3032r553b3115],
32	]	CD	NUMBER	]	dep	31	SENT_263	[p12l367t3032r553b3115],
33	;	:	O	;	_	0	SENT_263	[p12l367t3032r553b3115],
34	p	NN	O	p	dep	3	SENT_263	[p12l581t3060r623b3123],
35	=	JJ	O	=	amod	37	SENT_263	[p12l659t3060r713b3080],
36	0.0001	CD	NUMBER	0.0001	tmod	35	SENT_263	[p12l748t3032r1014b3114],
37	)	NN	O	)	dep	34	SENT_263	[p12l748t3032r1014b3114],
38	.	.	O	.	_	0	SENT_263	[p12l748t3032r1014b3114],

1	Lipid	NN	O	lipid	nn	2	SENT_264	[p12l11t3147r176b3221],
2	levels	NNS	O	level	_	0	SENT_264	[p12l205t3147r416b3206],
3	.	.	O	.	_	0	SENT_264	[p12l205t3147r416b3206],

1	Patients	NNS	O	patient	nsubj	8	SENT_265	[p12l466t3141r726b3206],
2	treated	VBN	O	treat	partmod	1	SENT_265	[p12l747t3140r972b3206],
3	with	IN	O	with	_	0	SENT_265	[p12l987t3140r1139b3206],
4	high	JJ	O	high	amod	7	SENT_265	[p12l1159t3140r1487b3229],
5	—	NN	O	—	nn	7	SENT_265	[p12l1159t3140r1487b3229],
6	dose	NN	O	dose	nn	7	SENT_265	[p12l1159t3140r1487b3229],
7	atorvastatin	NN	O	atorvastatin	prep_with	2	SENT_265	[p12l1509t3143r1882b3206],
8	showed	VBD	O	show	_	0	SENT_265	[p12l1904t3140r2152b3206],
9	a	DT	O	a	det	11	SENT_265	[p12l9t3272r44b3312],
10	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_265	[p12l68t3246r404b3335],
11	reduction	NN	O	reduction	dobj	8	SENT_265	[p12l426t3246r736b3312],
12	in	IN	O	in	_	0	SENT_265	[p12l761t3249r825b3311],
13	all	DT	O	all	det	14	SENT_265	[p12l851t3246r924b3312],
14	fractions	NNS	O	fraction	prep_in	8	SENT_265	[p12l947t3246r1223b3312],
15	of	IN	O	of	_	0	SENT_265	[p12l1250t3246r1327b3312],
16	cholesterol	NN	O	cholesterol	prep_of	14	SENT_265	[p12l1340t3246r1688b3312],
17	and	CC	O	and	_	0	SENT_265	[p12l1713t3246r1833b3312],
18	triglycerides	NNS	O	triglyceride	prep_of	14	SENT_265	[p12l1857t3246r2149b3335, p12l8t3352r133b3418],
19	at	IN	O	at	quantmod	20	SENT_265	[p12l177t3369r237b3418],
20	10	CD	NUMBER	10	num	23	SENT_265	[p12l281t3355r358b3418],
21	and	CC	O	and	_	0	SENT_265	[p12l402t3352r524b3418],
22	30	CD	DURATION	30	num	23	SENT_265	[p12l565t3355r646b3418],
23	days	NNS	NUMBER	day	tmod	8	SENT_265	[p12l689t3352r845b3441],
24	.	.	O	.	_	0	SENT_265	[p12l689t3352r845b3441],

1	In	IN	O	in	_	0	SENT_266	[p12l890t3353r964b3417],
2	particular	JJ	O	particular	amod	7	SENT_266	[p12l1004t3352r1327b3441],
3	,	,	O	,	_	0	SENT_266	[p12l1004t3352r1327b3441],
4	low	JJ	O	low	amod	7	SENT_266	[p12l1370t3352r1757b3441],
5	—	NN	O	—	nn	7	SENT_266	[p12l1370t3352r1757b3441],
6	density	NN	O	density	nn	7	SENT_266	[p12l1370t3352r1757b3441],
7	lipoprotein	NN	O	lipoprotein	prep_in	12	SENT_266	[p12l1793t3352r2152b3441],
8	cholesterol	NN	O	cholesterol	nn	9	SENT_266	[p12l9t3458r357b3524],
9	levels	NNS	O	level	nsubj	12	SENT_266	[p12l381t3458r552b3524],
10	were	VBD	O	be	cop	12	SENT_266	[p12l576t3484r733b3524],
11	markedly	RB	O	markedly	advmod	12	SENT_266	[p12l761t3458r1068b3547],
12	lower	JJR	O	lower	dep	24	SENT_266	[p12l1089t3458r1272b3524],
13	in	IN	O	in	_	0	SENT_266	[p12l1296t3461r1361b3523],
14	patients	NNS	O	patient	prep_in	12	SENT_266	[p12l1386t3461r1640b3547],
15	randomized	VBN	O	randomize	partmod	14	SENT_266	[p12l1668t3458r2060b3524],
16	to	TO	O	to	_	0	SENT_266	[p12l2085t3475r2150b3524],
17	treatment	NN	O	treatment	prep_to	15	SENT_266	[p12l8t3581r328b3630],
18	with	IN	O	with	_	0	SENT_266	[p12l349t3564r500b3630],
19	atorvastatin	NN	O	atorvastatin	prep_with	15	SENT_266	[p12l528t3567r901b3630],
20	at	IN	O	at	_	0	SENT_266	[p12l929t3581r988b3630],
21	both	DT	O	both	det	23	SENT_266	[p12l1011t3564r1165b3630],
22	time	NN	O	time	nn	23	SENT_266	[p12l1191t3567r1339b3630],
23	points	NNS	O	point	prep_at	15	SENT_266	[p12l1365t3567r1565b3653],
24	(	VBP	O	(	_	0	SENT_266	[p12l1596t3562r1808b3644],
25	Table	NNP	O	Table	dobj	24	SENT_266	[p12l1596t3562r1808b3644],
26	4	CD	NUMBER	4	num	25	SENT_266	[p12l1835t3562r1917b3644],
27	)	CD	NUMBER	)	nsubj	24	SENT_266	[p12l1835t3562r1917b3644],
28	.	.	O	.	_	0	SENT_266	[p12l1835t3562r1917b3644],

1	However	RB	O	however	advmod	7	SENT_267	[p12l1948t3565r2149b3630, p12l9t3696r155b3751],
2	,	,	O	,	_	0	SENT_267	[p12l1948t3565r2149b3630, p12l9t3696r155b3751],
3	no	DT	O	no	det	5	SENT_267	[p12l185t3696r268b3736],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_267	[p12l296t3670r632b3759],
5	correlations	NNS	O	correlation	nsubjpass	7	SENT_267	[p12l656t3670r1029b3736],
6	were	VBD	O	be	auxpass	7	SENT_267	[p12l1053t3696r1209b3736],
7	found	VBN	O	find	_	0	SENT_267	[p12l1236t3670r1431b3736],
8	between	IN	O	between	_	0	SENT_267	[p12l1453t3670r1728b3736],
9	the	DT	O	the	det	12	SENT_267	[p12l1753t3670r1857b3736],
10	different	JJ	O	different	amod	12	SENT_267	[p12l1884t3670r2153b3736],
11	lipid	NN	O	lipid	nn	12	SENT_267	[p13l7t16r154b105],
12	fractions	NNS	O	fraction	prep_between	7	SENT_267	[p13l180t16r456b82],
13	and	CC	O	and	_	0	SENT_267	[p13l485t16r606b82],
14	PRU	NNP	ORGANIZATION	PRU	nn	17	SENT_267	[p13l632t17r805b82],
15	and	CC	O	and	_	0	SENT_267	[p13l832t16r953b82],
16	BASE	NNP	O	BASE	conj_and	14	SENT_267	[p13l978t14r1199b82],
17	Values	NNS	O	value	prep_between	7	SENT_267	[p13l1223t16r1435b82],
18	.	.	O	.	_	0	SENT_267	[p13l1223t16r1435b82],

1	Adverse	JJ	O	adverse	amod	2	SENT_268	[p13l8t130r288b189],
2	events	NNS	O	event	_	0	SENT_268	[p13l323t138r550b189],
3	and	CC	O	and	_	0	SENT_268	[p13l585t130r712b189],
4	follow-up	NN	O	follow-up	conj_and	2	SENT_268	[p13l748t129r1100b204],
5	.	.	O	.	_	0	SENT_268	[p13l748t129r1100b204],

1	Clinical	JJ	O	clinical	nsubjpass	6	SENT_269	[p13l1151t123r1418b189],
2	follow	VBP	O	follow	dep	1	SENT_269	[p13l1448t123r1781b212],
3	—	CD	NUMBER	—	dobj	2	SENT_269	[p13l1448t123r1781b212],
4	up	RP	O	up	prt	2	SENT_269	[p13l1448t123r1781b212],
5	was	VBD	O	be	auxpass	6	SENT_269	[p13l1810t149r1937b189],
6	completed	VBN	O	complete	_	0	SENT_269	[p13l1972t149r2149b189, p13l7t228r217b317],
7	in	IN	O	in	_	0	SENT_269	[p13l241t231r307b293],
8	all	DT	O	all	det	9	SENT_269	[p13l334t228r411b294],
9	patients	NNS	O	patient	prep_in	6	SENT_269	[p13l433t231r718b317],
10	.	.	O	.	_	0	SENT_269	[p13l433t231r718b317],

1	Overall	RB	O	overall	advmod	11	SENT_270	[p13l750t228r1016b309],
2	,	,	O	,	_	0	SENT_270	[p13l750t228r1016b309],
3	the	DT	O	the	det	4	SENT_270	[p13l1044t228r1152b294],
4	occurrence	NN	O	occurrence	nsubj	11	SENT_270	[p13l1178t254r1542b294],
5	of	IN	O	of	_	0	SENT_270	[p13l1569t228r1647b294],
6	periprocedural	JJ	O	periprocedural	amod	8	SENT_270	[p13l1659t228r2153b317],
7	myocardial	JJ	O	myocardial	amod	8	SENT_270	[p13l9t334r383b423],
8	infarction	NN	O	infarction	prep_of	4	SENT_270	[p13l410t334r739b400],
9	was	VBD	O	be	cop	11	SENT_270	[p13l765t360r891b400],
10	18	CD	PERCENT	18	num	11	SENT_270	[p13l925t337r1088b415],
11	%	NN	PERCENT	%	_	0	SENT_270	[p13l925t337r1088b415],
12	,	,	O	,	_	0	SENT_270	[p13l925t337r1088b415],
13	without	IN	O	without	_	0	SENT_270	[p13l1116t334r1388b400],
14	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_270	[p13l1415t334r1767b423],
15	differences	NNS	O	difference	prep_without	11	SENT_270	[p13l1795t334r2150b400],
16	between	IN	O	between	_	0	SENT_270	[p13l6t440r291b506],
17	the	DT	O	the	det	19	SENT_270	[p13l314t440r422b506],
18	2	CD	NUMBER	2	num	19	SENT_270	[p13l444t443r486b507],
19	groups	NNS	O	group	prep_between	15	SENT_270	[p13l510t466r738b529],
20	(	CD	NUMBER	(	num	21	SENT_270	[p13l767t438r1204b521],
21	atorvastatin	NN	O	atorvastatin	dep	19	SENT_270	[p13l767t438r1204b521],
22	,	,	O	,	_	0	SENT_270	[p13l767t438r1204b521],
23	16	CD	PERCENT	16	num	24	SENT_270	[p13l1235t443r1398b521],
24	%	NN	PERCENT	%	appos	21	SENT_270	[p13l1235t443r1398b521],
25	,	,	O	,	_	0	SENT_270	[p13l1235t443r1398b521],
26	Vs.	NN	O	v.	nn	27	SENT_270	[p13l1422t466r1507b506],
27	control	NN	O	control	appos	21	SENT_270	[p13l1536t440r1794b521],
28	,	,	O	,	_	0	SENT_270	[p13l1536t440r1794b521],
29	21	CD	PERCENT	21	num	30	SENT_270	[p13l1819t443r1989b521],
30	%	NN	PERCENT	%	appos	21	SENT_270	[p13l1819t443r1989b521],
31	,	,	O	,	_	0	SENT_270	[p13l1819t443r1989b521],
32	p	NN	O	p	appos	21	SENT_270	[p13l2014t466r2056b529],
33	=	JJ	O	=	amod	35	SENT_270	[p13l2089t466r2143b486],
34	0.7	CD	NUMBER	0.7	tmod	33	SENT_270	[p13l8t544r159b627],
35	)	NN	O	)	dep	32	SENT_270	[p13l8t544r159b627],
36	;	:	O	;	_	0	SENT_270	[p13l8t544r159b627],
37	the	DT	O	the	det	40	SENT_270	[p13l190t546r297b612],
38	mean	NN	O	mean	nn	40	SENT_270	[p13l327t572r513b612],
39	peak	NN	O	peak	nn	40	SENT_270	[p13l540t546r703b635],
40	CK	NN	O	ck	dep	19	SENT_270	[p13l728t546r1026b612],
41	.	.	O	.	_	0	SENT_270	[p13l728t546r1026b612],

1	—	NN	O	—	_	0	SENT_271	[p13l728t546r1026b612],
2	.	.	O	.	_	0	SENT_271	[p13l728t546r1026b612],

1	MB	NNP	O	MB	nn	2	SENT_272	[p13l728t546r1026b612],
2	Values	NNS	O	value	nsubj	5	SENT_272	[p13l1054t546r1259b612],
3	were	VBD	O	be	cop	5	SENT_272	[p13l1284t572r1447b612],
4	7	CD	NUMBER	7	num	5	SENT_272	[p13l1477t547r1517b612],
5	1	CD	NUMBER	1	_	0	SENT_272	[p13l1553t555r1607b608],
6	8	CD	NUMBER	8	num	7	SENT_272	[p13l1647t549r1682b612],
7	ng	NN	O	ng	nn	16	SENT_272	[p13l1714t546r1830b635],
8	/	:	O	/	punct	9	SENT_272	[p13l1714t546r1830b635],
9	ml	NN	O	ml	dep	7	SENT_272	[p13l1831t546r1921b611],
10	Versus	NNP	O	Versus	dep	9	SENT_272	[p13l1944t572r2150b612],
11	10	CD	NUMBER	10	num	10	SENT_272	[p13l12t655r91b718],
12	1	CD	NUMBER	1	number	13	SENT_272	[p13l157t661r211b714],
13	17	CD	NUMBER	17	num	14	SENT_272	[p13l281t653r361b718],
14	ng	NN	O	ng	dep	10	SENT_272	[p13l419t652r535b741],
15	/	:	O	/	punct	9	SENT_272	[p13l419t652r535b741],
16	ml	NN	O	ml	attr	5	SENT_272	[p13l536t652r626b717],
17	in	IN	O	in	_	0	SENT_272	[p13l682t655r748b717],
18	the	DT	O	the	det	22	SENT_272	[p13l804t652r912b718],
19	atorvastatin	NN	O	atorvastatin	nn	22	SENT_272	[p13l971t655r1364b718],
20	and	CC	O	and	_	0	SENT_272	[p13l1423t652r1547b718],
21	control	NN	O	control	conj_and	19	SENT_272	[p13l1604t652r1846b718],
22	groups	NNS	O	group	prep_in	16	SENT_272	[p13l1900t678r2149b741],
23	,	,	O	,	_	0	SENT_272	[p13l1900t678r2149b741],
24	respectively	RB	O	respectively	advmod	16	SENT_272	[p13l8t758r402b847],
25	(	CD	NUMBER	(	num	26	SENT_272	[p13l457t756r522b847],
26	p	NN	O	p	dep	16	SENT_272	[p13l457t756r522b847],
27	=	JJ	O	=	amod	29	SENT_272	[p13l588t784r641b804],
28	0.2	CD	NUMBER	0.2	tmod	27	SENT_272	[p13l706t756r855b838],
29	)	NN	O	)	dep	26	SENT_272	[p13l706t756r855b838],
30	.	.	O	.	_	0	SENT_272	[p13l706t756r855b838],

1	No	DT	O	no	det	4	SENT_273	[p13l915t759r1024b824],
2	other	JJ	O	other	amod	4	SENT_273	[p13l1082t758r1262b824],
3	ischemic	JJ	O	ischemic	amod	4	SENT_273	[p13l1316t758r1613b824],
4	events	NNS	O	event	nsubjpass	12	SENT_273	[p13l1669t775r1896b839],
5	,	,	O	,	_	0	SENT_273	[p13l1669t775r1896b839],
6	major	JJ	O	major	amod	7	SENT_273	[p13l1956t759r2154b847],
7	bleeding	NN	O	bleeding	nsubjpass	12	SENT_273	[p13l6t865r316b954],
8	,	,	O	,	_	0	SENT_273	[p13l6t865r316b954],
9	or	CC	O	or	_	0	SENT_273	[p13l351t890r422b931],
10	transfusions	NNS	O	transfusion	conj_or	4	SENT_273	[p13l452t865r857b931],
11	were	VBD	O	be	auxpass	12	SENT_273	[p13l887t891r1049b931],
12	reported	VBN	O	report	_	0	SENT_273	[p13l1082t865r1370b954],
13	during	IN	O	during	_	0	SENT_273	[p13l1402t865r1628b954],
14	the	DT	O	the	det	15	SENT_273	[p13l1657t865r1765b931],
15	follow-up	NN	O	follow-up	prep_during	12	SENT_273	[p13l1797t865r2148b954],
16	.	.	O	.	_	0	SENT_273	[p13l1797t865r2148b954],

1	Control	NNP	ORGANIZATION	Control	nn	4	SENT_274	[p13l675t1061r778b1085],
2	Group	NNP	ORGANIZATION	Group	nn	4	SENT_274	[p13l790t1061r877b1092],
3	Atorvastatin	NNP	ORGANIZATION	Atorvastatin	nn	4	SENT_274	[p13l1324t1062r1499b1087],
4	Group	NNP	ORGANIZATION	Group	_	0	SENT_274	[p13l1510t1062r1598b1093],

1	HRPR	NN	O	hrpr	nn	2	SENT_275	[p13l725t1133r798b1153],
2	HRPR	NN	O	hrpr	_	0	SENT_275	[p13l1413t1130r1485b1150],

1	53	CD	PERCENT	53	num	2	SENT_276	[p13l544t1672r597b1692],
2	%	NN	PERCENT	%	_	0	SENT_276	[p13l544t1672r597b1692],
3	Full	JJ	O	full	amod	4	SENT_276	[p13l664t1669r706b1689],
4	responders	NNS	O	responder	dep	2	SENT_276	[p13l714t1669r850b1694],
5	59	CD	PERCENT	59	num	6	SENT_276	[p13l940t1672r993b1692],
6	%	NN	PERCENT	%	dep	4	SENT_276	[p13l940t1672r993b1692],
7	74	CD	PERCENT	74	number	8	SENT_276	[p13l1231t1671r1284b1691],
8	%	NN	PERCENT	%	amod	10	SENT_276	[p13l1231t1671r1284b1691],
9	Full	JJ	O	full	amod	10	SENT_276	[p13l1349t1668r1391b1688],
10	responders	NNS	O	responder	dep	6	SENT_276	[p13l1399t1668r1536b1692],
11	84	CD	PERCENT	84	num	12	SENT_276	[p13l1630t1668r1683b1688],
12	%	NN	PERCENT	%	dep	2	SENT_276	[p13l1630t1668r1683b1688],

1	T-1	NN	O	t-1	nn	4	SENT_277	[p13l541t1741r583b1766],
2	T-2	NN	O	t-2	nn	4	SENT_277	[p13l940t1743r988b1767],
3	T-1	NN	O	t-1	nn	4	SENT_277	[p13l1233t1741r1277b1766],
4	T-2	NN	O	t-2	_	0	SENT_277	[p13l1623t1741r1671b1766],

1	Figure	NNP	O	Figure	_	0	SENT_278	[p13l68t1833r147b1859],
2	4	CD	NUMBER	4	dep	1	SENT_278	[p13l158t1834r182b1854],
3	.	.	O	.	_	0	SENT_278	[p13l158t1834r182b1854],

1	Responsiveness	NN	O	responsiveness	nn	2	SENT_279	[p13l195t1833r402b1859],
2	Status	NN	O	status	nsubj	13	SENT_279	[p13l413t1833r498b1854],
3	at	IN	O	at	_	0	SENT_279	[p13l509t1834r535b1854],
4	10	CD	NUMBER	10	prep_at	2	SENT_279	[p13l546t1833r579b1854],
5	and	CC	O	and	_	0	SENT_279	[p13l590t1834r636b1854],
6	30	CD	DURATION	30	num	9	SENT_279	[p13l647t1833r681b1854],
7	Days	NNS	DURATION	day	nn	9	SENT_279	[p13l693t1834r754b1859],
8	Responsiveness	NN	O	responsiveness	nn	9	SENT_279	[p13l69t1896r258b1922],
9	status	NN	O	status	conj_and	2	SENT_279	[p13l269t1899r340b1917],
10	at	IN	O	at	_	0	SENT_279	[p13l351t1899r374b1917],
11	10	CD	DURATION	10	num	12	SENT_279	[p13l387t1897r413b1917],
12	days	NNS	NUMBER	day	prep_at	9	SENT_279	[p13l424t1895r478b1923],
13	(	VBP	O	(	_	0	SENT_279	[p13l491t1896r542b1920],
14	T-1	NN	O	t-1	nn	15	SENT_279	[p13l491t1896r542b1920],
15	)	NN	O	)	nsubj	19	SENT_279	[p13l491t1896r542b1920],
16	and	CC	O	and	_	0	SENT_279	[p13l555t1895r599b1917],
17	30	CD	DURATION	30	num	18	SENT_279	[p13l611t1897r639b1917],
18	days	NNS	NUMBER	day	nsubj	19	SENT_279	[p13l651t1895r705b1923],
19	(	VBP	O	(	ccomp	13	SENT_279	[p13l717t1896r775b1920],
20	T-2	NN	O	t-2	nn	21	SENT_279	[p13l717t1896r775b1920],
21	)	NN	O	)	dobj	19	SENT_279	[p13l717t1896r775b1920],
22	.	.	O	.	_	0	SENT_279	[p13l717t1896r775b1920],

1	P2Y	NN	O	p2y	nsubj	5	SENT_280	[p13l788t1896r855b1923],
2	,2	CD	NUMBER	,2	num	4	SENT_280	[p13l788t1896r855b1923],
3	reaction	NN	O	reaction	nn	4	SENT_280	[p13l867t1897r964b1917],
4	units	NNS	O	unit	dep	1	SENT_280	[p13l977t1897r1034b1917],
5	(	VBP	O	(	_	0	SENT_280	[p13l1047t1896r1110b1920],
6	PRU	NNP	ORGANIZATION	PRU	nsubjpass	20	SENT_280	[p13l1047t1896r1110b1920],
7	)	CD	NUMBER	)	num	8	SENT_280	[p13l1047t1896r1110b1920],
8	values	NNS	O	value	dep	6	SENT_280	[p13l1122t1895r1198b1917],
9	2235	CD	DATE	2235	number	10	SENT_280	[p13l1211t1897r1276b1917],
10	(	CD	NUMBER	(	num	16	SENT_280	[p13l1289t1895r1349b1923],
11	high	JJ	O	high	amod	16	SENT_280	[p13l1289t1895r1349b1923],
12	on-treatment	JJ	O	on-treatment	amod	16	SENT_280	[p13l1362t1899r1524b1917],
13	platelet	NN	O	platelet	nn	16	SENT_280	[p13l1536t1895r1626b1922],
14	reactivity	NN	O	reactivity	nn	16	SENT_280	[p13l1638t1897r1748b1923],
15	[	CD	NUMBER	[	num	16	SENT_280	[p13l1760t1896r1846b1920],
16	HTPR	NN	O	htpr	dep	6	SENT_280	[p13l1760t1896r1846b1920],
17	]	CD	NUMBER	]	num	18	SENT_280	[p13l1760t1896r1846b1920],
18	)	NN	O	)	dep	16	SENT_280	[p13l1760t1896r1846b1920],
19	are	VBP	O	be	auxpass	20	SENT_280	[p13l1858t1902r1895b1917],
20	indicated	VBN	O	indicate	ccomp	5	SENT_280	[p13l1907t1895r2018b1917],
21	by	IN	O	by	_	0	SENT_280	[p13l2031t1895r2060b1923],
22	the	DT	O	the	det	23	SENT_280	[p13l67t1935r107b1956],
23	red	JJ	O	red	agent	20	SENT_280	[p13l119t1935r166b1960],
24	,	,	O	,	_	0	SENT_280	[p13l119t1935r166b1960],
25	and	CC	O	and	_	0	SENT_280	[p13l178t1935r222b1956],
26	PRU	NNP	ORGANIZATION	PRU	nn	27	SENT_280	[p13l235t1936r281b1956],
27	values	NNS	O	value	dep	28	SENT_280	[p13l293t1935r369b1956],
28	<	JJR	O	<	conj_and	23	SENT_280	[p13l382t1936r447b1956],
29	235	CD	NUMBER	235	num	32	SENT_280	[p13l382t1936r447b1956],
30	(	NN	O	(	nn	32	SENT_280	[p13l460t1935r559b1962],
31	optimal	JJ	O	optimal	amod	32	SENT_280	[p13l460t1935r559b1962],
32	responders	NNS	O	responder	dep	28	SENT_280	[p13l573t1935r714b1962],
33	)	RB	O	)	advmod	20	SENT_280	[p13l573t1935r714b1962],
34	by	IN	O	by	_	0	SENT_280	[p13l727t1935r756b1962],
35	the	DT	O	the	det	36	SENT_280	[p13l766t1935r805b1956],
36	blue	NN	O	blue	agent	20	SENT_280	[p13l817t1935r879b1956],
37	.	.	O	.	_	0	SENT_280	[p13l817t1935r879b1956],

1	Continuous	JJ	O	continuous	amod	2	SENT_281	[p13l890t1935r1039b1956],
2	lines	NNS	O	line	nsubj	3	SENT_281	[p13l1051t1935r1110b1956],
3	show	VBP	O	show	_	0	SENT_281	[p13l1122t1935r1185b1956],
4	patients	NNS	O	patient	dobj	3	SENT_281	[p13l1197t1936r1294b1962],
5	with	IN	O	with	_	0	SENT_281	[p13l1305t1935r1357b1956],
6	stable	JJ	O	stable	amod	7	SENT_281	[p13l1369t1935r1441b1956],
7	reactivity	NN	O	reactivity	prep_with	3	SENT_281	[p13l1453t1936r1563b1962],
8	between	IN	O	between	_	0	SENT_281	[p13l1575t1935r1679b1956],
9	T-1	NN	O	t-1	prep_between	7	SENT_281	[p13l1690t1936r1724b1956],
10	and	CC	O	and	_	0	SENT_281	[p13l1739t1935r1784b1956],
11	T-2	NN	O	t-2	conj_and	9	SENT_281	[p13l1795t1936r1839b1956],
12	.	.	O	.	_	0	SENT_281	[p13l1795t1936r1839b1956],

1	Arrows	NNS	O	arrow	nsubj	2	SENT_282	[p13l1849t1936r1941b1956],
2	indicate	VBP	O	indicate	_	0	SENT_282	[p13l1953t1935r2049b1956],
3	patients	NNS	O	patient	dobj	2	SENT_282	[p13l69t1976r165b2002],
4	who	WP	O	who	nsubj	5	SENT_282	[p13l176t1975r228b1996],
5	change	VBP	O	change	rcmod	3	SENT_282	[p13l240t1975r329b2002],
6	their	PRP$	O	they	poss	7	SENT_282	[p13l340t1975r396b1996],
7	reactivity	NN	O	reactivity	dobj	5	SENT_282	[p13l408t1976r518b2002],
8	between	IN	O	between	_	0	SENT_282	[p13l529t1975r633b1996],
9	T-1	NN	O	t-1	prep_between	7	SENT_282	[p13l645t1976r678b1996],
10	and	CC	O	and	_	0	SENT_282	[p13l694t1975r738b1996],
11	T-2	NN	O	t-2	conj_and	9	SENT_282	[p13l749t1976r793b1996],
12	.	.	O	.	_	0	SENT_282	[p13l749t1976r793b1996],

1	Responsiveness	NN	O	responsiveness	nn	2	SENT_283	[p13l806t1975r994b2002],
2	status	NN	O	status	nsubjpass	7	SENT_283	[p13l1006t1978r1076b1996],
3	at	IN	O	at	_	0	SENT_283	[p13l1088t1978r1110b1996],
4	baseline	NN	O	baseline	prep_at	2	SENT_283	[p13l1122t1975r1221b1996],
5	is	VBZ	O	be	auxpass	7	SENT_283	[p13l1233t1976r1249b1996],
6	not	RB	O	not	neg	7	SENT_283	[p13l1262t1978r1301b1996],
7	represented	VBN	O	represent	_	0	SENT_283	[p13l1313t1975r1464b2002],
8	:	:	O	:	_	0	SENT_283	[p13l1313t1975r1464b2002],
9	all	DT	O	all	det	10	SENT_283	[p13l1476t1975r1501b1996],
10	patients	NNS	O	patient	nsubj	11	SENT_283	[p13l1514t1976r1611b2002],
11	had	VBD	O	have	parataxis	7	SENT_283	[p13l1623t1975r1666b1996],
12	PRU	NNP	O	PRU	nn	13	SENT_283	[p13l1680t1975r1726b1996],
13	values	NNS	O	value	dobj	11	SENT_283	[p13l1738t1975r1814b1996],
14	2235	CD	DATE	2235	dep	13	SENT_283	[p13l1827t1976r1899b1996],
15	.	.	O	.	_	0	SENT_283	[p13l1827t1976r1899b1996],

1	176	CD	NUMBER	176	_	0	SENT_284	[p13l44t2106r93b2127],
2	Leoncinietal	JJ	O	leoncinietal	dep	1	SENT_284	[p13l194t2106r366b2127],
3	.	.	O	.	_	0	SENT_284	[p13l194t2106r366b2127],

1	JACC	NN	O	jacc	_	0	SENT_285	[p13l1278t2112r1348b2127],
2	:	:	O	:	_	0	SENT_285	[p13l1278t2112r1348b2127],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_285	[p13l1365t2112r1599b2127],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_285	[p13l1617t2112r1832b2129],
5	,	,	O	,	_	0	SENT_285	[p13l1617t2112r1832b2129],
6	voL	NN	O	vol	appos	4	SENT_285	[p13l1848t2112r1906b2127],
7	.	.	O	.	_	0	SENT_285	[p13l1848t2112r1906b2127],

1	5	CD	NUMBER	5	dep	20	SENT_286	[p13l1923t2112r1943b2129],
2	,	,	O	,	_	0	SENT_286	[p13l1923t2112r1943b2129],
3	No.	NN	O	no.	conj_and	1	SENT_286	[p13l1961t2112r2003b2127],
4	2	CD	NUMBER	2	num	3	SENT_286	[p13l2021t2112r2041b2129],
5	,	,	O	,	_	0	SENT_286	[p13l2021t2112r2041b2129],
6	2013	CD	DATE	2013	num	8	SENT_286	[p13l2058t2112r2117b2127],
7	High-Dose	NNP	MISC	High-Dose	nn	8	SENT_286	[p13l194t2144r319b2169],
8	Atorvastatin	NNP	MISC	Atorvastatin	dep	20	SENT_286	[p13l328t2144r478b2164],
9	and	CC	O	and	_	0	SENT_286	[p13l489t2144r533b2164],
10	Platelet	NN	O	platelet	nn	17	SENT_286	[p13l545t2144r640b2164],
11	Reactivity	NN	O	reactivity	nn	17	SENT_286	[p13l651t2144r771b2169],
12	F	NN	O	f	nn	17	SENT_286	[p13l1803t2149r1812b2164],
13	E	NN	O	e	nn	17	SENT_286	[p13l1818t2149r1827b2164],
14	B	NN	O	b	nn	17	SENT_286	[p13l1834t2149r1845b2164],
15	R	NN	O	r	nn	17	SENT_286	[p13l1851t2149r1862b2164],
16	u	NN	O	u	nn	17	SENT_286	[p13l1868t2149r1880b2164],
17	A	NN	O	a	dep	20	SENT_286	[p13l1886t2149r1899b2164],
18	av	NN	O	av	dep	20	SENT_286	[p13l1905t2149r1933b2164],
19	2	CD	NUMBER	2	num	18	SENT_286	[p13l1950t2150r1960b2164],
20	o	NN	O	o	dep	26	SENT_286	[p13l1966t2150r1977b2164],
21	1	CD	NUMBER	1	number	22	SENT_286	[p13l1983t2150r1990b2164],
22	3	CD	NUMBER	3	num	23	SENT_286	[p13l1998t2150r2008b2164],
23	:1	NN	O	:1	dep	20	SENT_286	[p13l2015t2150r2032b2164],
24	5	CD	NUMBER	5	number	25	SENT_286	[p13l2041t2150r2051b2164],
25	9	CD	NUMBER	9	amod	23	SENT_286	[p13l2057t2150r2067b2164],
26	—	NN	O	—	_	0	SENT_286	[p13l2075t2157r2085b2159],
27	79	CD	NUMBER	79	num	26	SENT_286	[p13l2091t2150r2117b2164],

1	Table	NNP	O	Table	_	0	SENT_287	[p13l355t2272r425b2293],
2	3	CD	NUMBER	3	dep	1	SENT_287	[p13l436t2272r460b2293],
3	.	.	O	.	_	0	SENT_287	[p13l436t2272r460b2293],

1	Univariate	NNP	O	Univariate	_	0	SENT_288	[p13l472t2272r603b2293],
2	Analysis	NN	O	analysis	dep	1	SENT_288	[p13l613t2272r721b2298],
3	of	IN	O	of	_	0	SENT_288	[p13l732t2272r757b2293],
4	Predictors	NNS	O	predictor	prep_of	2	SENT_288	[p13l767t2272r899b2293],
5	of	IN	O	of	_	0	SENT_288	[p13l910t2272r935b2293],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_288	[p13l945t2272r1089b2298],
7	Response	NN	O	response	prep_of	4	SENT_288	[p13l1102t2272r1227b2297],
8	at	IN	O	at	_	0	SENT_288	[p13l1238t2272r1264b2293],
9	30	CD	DURATION	30	num	10	SENT_288	[p13l1274t2272r1308b2293],
10	Days	NNS	DURATION	day	prep_at	7	SENT_288	[p13l1320t2272r1382b2298],

1	Optimal	JJ	O	optimal	amod	2	SENT_289	[p13l883t2340r975b2364],
2	Responders	NNS	O	responder	nsubj	3	SENT_289	[p13l987t2340r1126b2364],
3	(	VBP	O	(	_	0	SENT_289	[p13l1137t2340r1185b2364],
4	Pry	NN	O	pry	nsubj	5	SENT_289	[p13l1137t2340r1185b2364],
5	<	JJR	O	<	xcomp	3	SENT_289	[p13l1198t2340r1274b2364],
6	235	CD	NUMBER	235	num	7	SENT_289	[p13l1198t2340r1274b2364],
7	)	NN	O	)	dep	5	SENT_289	[p13l1198t2340r1274b2364],
8	HTPR	NN	O	htpr	nn	10	SENT_289	[p13l1387t2340r1452b2359],
9	(	CD	NUMBER	(	num	10	SENT_289	[p13l1463t2340r1511b2364],
10	Pry	NNP	O	Pry	dep	5	SENT_289	[p13l1463t2340r1511b2364],
11	2235	CD	DATE	2235	number	12	SENT_289	[p13l1522t2340r1600b2364],
12	)	CD	NUMBER	)	dep	10	SENT_289	[p13l1522t2340r1600b2364],

1	(	NN	O	(	nn	2	SENT_290	[p13l1026t2373r1049b2397],
2	n	NN	O	n	_	0	SENT_290	[p13l1026t2373r1049b2397],
3	=	JJ	O	=	quantmod	5	SENT_290	[p13l1062t2379r1079b2388],
4	54	CD	NUMBER	54	number	5	SENT_290	[p13l1092t2373r1131b2397],
5	)	CD	NUMBER	)	num	11	SENT_290	[p13l1092t2373r1131b2397],
6	(	NN	O	(	nn	11	SENT_290	[p13l1441t2373r1464b2397],
7	n	NN	O	n	nn	11	SENT_290	[p13l1441t2373r1464b2397],
8	=	JJ	O	=	amod	11	SENT_290	[p13l1477t2379r1494b2388],
9	22	CD	NUMBER	22	num	11	SENT_290	[p13l1506t2373r1546b2397],
10	)	NN	O	)	nn	11	SENT_290	[p13l1506t2373r1546b2397],
11	p	NN	O	p	dep	2	SENT_290	[p13l1713t2378r1726b2397],
12	Value	NN	O	value	dep	11	SENT_290	[p13l1736t2373r1802b2393],

1	Age	NNP	O	Age	dep	312	SENT_291	[p13l356t2445r405b2469],
2	,	,	O	,	_	0	SENT_291	[p13l356t2445r405b2469],
3	yrs	VBZ	DURATION	yr	dep	312	SENT_291	[p13l415t2449r446b2469],
4	65	CD	NUMBER	65	dep	312	SENT_291	[p13l1042t2445r1068b2464],
5	:	:	O	:	_	0	SENT_291	[p13l1078t2446r1094b2463],
6	11	CD	NUMBER	11	dep	312	SENT_291	[p13l1106t2445r1126b2463],
7	72	CD	NUMBER	72	dep	312	SENT_291	[p13l1458t2445r1483b2463],
8	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t2446r1509b2463],
9	10	CD	NUMBER	10	dep	312	SENT_291	[p13l1521t2445r1545b2464],
10	0.027	CD	NUMBER	0.027	dep	312	SENT_291	[p13l1722t2445r1782b2464],
11	Age	NNP	O	Age	dep	312	SENT_291	[p13l356t2493r399b2517],
12	270	CD	DURATION	270	dep	312	SENT_291	[p13l411t2493r459b2512],
13	yrs	NNS	DURATION	yr	dep	312	SENT_291	[p13l469t2497r500b2517],
14	20	CD	NUMBER	20	dep	312	SENT_291	[p13l1028t2493r1054b2511],
15	(	NN	O	(	dep	312	SENT_291	[p13l1062t2492r1102b2515],
16	37	CD	NUMBER	37	dep	312	SENT_291	[p13l1062t2492r1102b2515],
17	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1062t2492r1102b2515],
18	13	CD	NUMBER	13	dep	312	SENT_291	[p13l1445t2493r1468b2511],
19	(	NN	O	(	dep	312	SENT_291	[p13l1477t2492r1517b2515],
20	59	CD	NUMBER	59	dep	312	SENT_291	[p13l1477t2492r1517b2515],
21	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1477t2492r1517b2515],
22	0.08	CD	NUMBER	0.08	dep	312	SENT_291	[p13l1722t2493r1768b2512],
23	Male	NN	O	male	dep	312	SENT_291	[p13l356t2539r409b2559],
24	41	CD	NUMBER	41	dep	312	SENT_291	[p13l1027t2541r1050b2559],
25	(	CD	NUMBER	(	dep	312	SENT_291	[p13l1062t2540r1102b2562],
26	76	CD	NUMBER	76	dep	312	SENT_291	[p13l1062t2540r1102b2562],
27	)	NN	O	)	dep	312	SENT_291	[p13l1062t2540r1102b2562],
28	16	CD	NUMBER	16	dep	312	SENT_291	[p13l1445t2541r1469b2559],
29	(	CD	NUMBER	(	dep	312	SENT_291	[p13l1477t2540r1517b2562],
30	73	CD	NUMBER	73	dep	312	SENT_291	[p13l1477t2540r1517b2562],
31	)	NN	O	)	dep	312	SENT_291	[p13l1477t2540r1517b2562],
32	0.77	CD	NUMBER	0.77	dep	312	SENT_291	[p13l1722t2541r1768b2559],
33	Diabetes	NNP	O	Diabetes	dep	312	SENT_291	[p13l357t2587r454b2607],
34	mellitus	NN	O	mellitus	dep	312	SENT_291	[p13l465t2587r553b2607],
35	16	CD	NUMBER	16	dep	312	SENT_291	[p13l1030t2589r1054b2607],
36	(	CD	NUMBER	(	dep	312	SENT_291	[p13l1062t2588r1102b2610],
37	30	CD	NUMBER	30	dep	312	SENT_291	[p13l1062t2588r1102b2610],
38	)	NN	O	)	dep	312	SENT_291	[p13l1062t2588r1102b2610],
39	11	CD	NUMBER	11	dep	312	SENT_291	[p13l1445t2589r1465b2607],
40	(	NN	O	(	dep	312	SENT_291	[p13l1477t2588r1517b2610],
41	50	CD	NUMBER	50	dep	312	SENT_291	[p13l1477t2588r1517b2610],
42	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1477t2588r1517b2610],
43	0.09	CD	NUMBER	0.09	dep	312	SENT_291	[p13l1722t2589r1768b2607],
44	Hypertension	NN	O	hypertension	dep	312	SENT_291	[p13l357t2636r506b2661],
45	38	CD	NUMBER	38	dep	312	SENT_291	[p13l1028t2637r1054b2655],
46	(	NN	O	(	dep	312	SENT_291	[p13l1062t2636r1102b2658],
47	70	CD	NUMBER	70	dep	312	SENT_291	[p13l1062t2636r1102b2658],
48	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1062t2636r1102b2658],
49	15	CD	NUMBER	15	dep	312	SENT_291	[p13l1445t2637r1468b2655],
50	(	NN	O	(	dep	312	SENT_291	[p13l1477t2636r1517b2658],
51	68	CD	NUMBER	68	dep	312	SENT_291	[p13l1477t2636r1517b2658],
52	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1477t2636r1517b2658],
53	0.84	CD	NUMBER	0.84	dep	312	SENT_291	[p13l1722t2637r1768b2655],
54	BMI	NN	O	bmus	dep	312	SENT_291	[p13l357t2684r403b2706],
55	,	,	O	,	_	0	SENT_291	[p13l357t2684r403b2706],
56	kg/m2	NN	O	kg/m2	dep	312	SENT_291	[p13l414t2679r482b2708],
57	26	CD	NUMBER	26	dep	312	SENT_291	[p13l1021t2685r1047b2703],
58	[	CD	NUMBER	[	dep	312	SENT_291	[p13l1056t2684r1136b2706],
59	24	CD	NUMBER	24	dep	312	SENT_291	[p13l1056t2684r1136b2706],
60	—	NN	O	—	dep	312	SENT_291	[p13l1056t2684r1136b2706],
61	29	CD	NUMBER	29	dep	312	SENT_291	[p13l1056t2684r1136b2706],
62	]	CD	NUMBER	]	dep	312	SENT_291	[p13l1056t2684r1136b2706],
63	27	CD	NUMBER	27	dep	312	SENT_291	[p13l1436t2685r1462b2703],
64	[	NN	O	[	dep	312	SENT_291	[p13l1470t2684r1551b2706],
65	25	CD	NUMBER	25	dep	312	SENT_291	[p13l1470t2684r1551b2706],
66	—	CD	NUMBER	—	dep	312	SENT_291	[p13l1470t2684r1551b2706],
67	29	CD	NUMBER	29	dep	312	SENT_291	[p13l1470t2684r1551b2706],
68	]	NN	O	]	dep	312	SENT_291	[p13l1470t2684r1551b2706],
69	0.26	CD	NUMBER	0.26	dep	312	SENT_291	[p13l1722t2685r1768b2703],
70	Laboratory	NNP	O	Laboratory	dep	312	SENT_291	[p13l357t2731r478b2757],
71	variables	NNS	O	variable	dep	312	SENT_291	[p13l488t2731r587b2751],
72	Hemoglobin	NN	O	hemoglobin	dep	312	SENT_291	[p13l384t2779r529b2804],
73	,	,	O	,	_	0	SENT_291	[p13l384t2779r529b2804],
74	mg/dl	NN	O	mg/dl	dep	312	SENT_291	[p13l540t2779r605b2804],
75	13.8	CD	NUMBER	13.8	dep	312	SENT_291	[p13l1025t2780r1069b2799],
76	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1078t2782r1094b2798],
77	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1106t2781r1112b2799],
78	13.7	CD	NUMBER	13.7	dep	312	SENT_291	[p13l1439t2780r1483b2799],
79	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t2782r1509b2798],
80	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1521t2781r1527b2799],
81	0.74	CD	NUMBER	0.74	dep	312	SENT_291	[p13l1722t2780r1768b2799],
82	RBCS	NNS	O	rbc	dep	312	SENT_291	[p13l384t2828r443b2850],
83	,	,	O	,	_	0	SENT_291	[p13l384t2828r443b2850],
84	103/Ml	NN	O	103/ml	dep	312	SENT_291	[p13l455t2822r523b2852],
85	4.5	CD	NUMBER	4.5	dep	312	SENT_291	[p13l1036t2829r1068b2847],
86	:	:	O	:	_	0	SENT_291	[p13l1078t2829r1094b2846],
87	0.4	CD	NUMBER	0.4	dep	312	SENT_291	[p13l1104t2828r1136b2847],
88	4.6	CD	NUMBER	4.6	dep	312	SENT_291	[p13l1451t2828r1483b2847],
89	:	:	O	:	_	0	SENT_291	[p13l1493t2829r1509b2846],
90	0.3	CD	NUMBER	0.3	dep	312	SENT_291	[p13l1519t2828r1550b2847],
91	0.99	CD	NUMBER	0.99	dep	312	SENT_291	[p13l1722t2828r1768b2847],
92	WBC5	NN	O	wbc5	dep	312	SENT_291	[p13l382t2876r451b2898],
93	,	,	O	,	_	0	SENT_291	[p13l382t2876r451b2898],
94	103	CD	NUMBER	103	dep	312	SENT_291	[p13l463t2870r531b2900],
95	/	:	O	/	dep	312	SENT_291	[p13l463t2870r531b2900],
96	)	CD	NUMBER	)	dep	312	SENT_291	[p13l463t2870r531b2900],
97	u.l	NN	O	u.l	dep	312	SENT_291	[p13l463t2870r531b2900],
98	6.8	CD	NUMBER	6.8	dep	312	SENT_291	[p13l1037t2876r1069b2895],
99	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1078t2877r1094b2894],
100	1.9	CD	NUMBER	1.9	dep	312	SENT_291	[p13l1106t2876r1136b2895],
101	6.4	CD	NUMBER	6.4	dep	312	SENT_291	[p13l1451t2876r1484b2895],
102	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t2877r1509b2894],
103	1.3	CD	NUMBER	1.3	dep	312	SENT_291	[p13l1521t2876r1550b2895],
104	0.38	CD	NUMBER	0.38	dep	312	SENT_291	[p13l1722t2876r1768b2895],
105	Platelet	NN	O	platelet	dep	312	SENT_291	[p13l384t2923r467b2943],
106	count	NN	O	count	dep	312	SENT_291	[p13l477t2926r547b2946],
107	,	,	O	,	_	0	SENT_291	[p13l477t2926r547b2946],
108	103/pa	CD	NUMBER	103/pa	dep	312	SENT_291	[p13l560t2918r627b2948],
109	21o	CD	NUMBER	21o	dep	312	SENT_291	[p13l1029t2924r1069b2943],
110	:	:	O	:	_	0	SENT_291	[p13l1078t2925r1094b2942],
111	51	CD	NUMBER	51	dep	312	SENT_291	[p13l1104t2924r1126b2943],
112	196	CD	NUMBER	196	dep	312	SENT_291	[p13l1445t2924r1483b2943],
113	:	:	O	:	_	0	SENT_291	[p13l1493t2925r1509b2942],
114	45	CD	NUMBER	45	dep	312	SENT_291	[p13l1518t2924r1544b2943],
115	0.33	CD	NUMBER	0.33	dep	312	SENT_291	[p13l1722t2924r1767b2943],
116	MPV	NNP	O	MPV	dep	312	SENT_291	[p13l383t2971r438b2994],
117	,	,	O	,	_	0	SENT_291	[p13l383t2971r438b2994],
118	109	CD	NUMBER	109	dep	312	SENT_291	[p13l451t2966r518b2996],
119	/	:	O	/	dep	312	SENT_291	[p13l451t2966r518b2996],
120	,0	CD	NUMBER	,0	dep	312	SENT_291	[p13l451t2966r518b2996],
121	9.5	CD	NUMBER	9.5	dep	312	SENT_291	[p13l1037t2972r1068b2991],
122	:	:	O	:	_	0	SENT_291	[p13l1078t2973r1094b2990],
123	1.4	CD	NUMBER	1.4	dep	312	SENT_291	[p13l1106t2972r1136b2991],
124	9.3	CD	NUMBER	9.3	dep	312	SENT_291	[p13l1452t2972r1483b2991],
125	:	:	O	:	_	0	SENT_291	[p13l1493t2973r1509b2990],
126	1.1	CD	NUMBER	1.1	dep	312	SENT_291	[p13l1521t2972r1546b2991],
127	0.53	CD	NUMBER	0.53	dep	312	SENT_291	[p13l1722t2972r1767b2991],
128	Creatinine	NN	O	creatinine	dep	312	SENT_291	[p13l383t3019r498b3039],
129	clearance	NN	O	clearance	dep	312	SENT_291	[p13l508t3019r620b3042],
130	,	,	O	,	_	0	SENT_291	[p13l508t3019r620b3042],
131	ml/min	JJ	O	ml/min	dep	312	SENT_291	[p13l632t3019r711b3039],
132	69	CD	NUMBER	69	dep	312	SENT_291	[p13l1042t3020r1069b3039],
133	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1078t3021r1094b3038],
134	20	CD	NUMBER	20	dep	312	SENT_291	[p13l1104t3020r1130b3039],
135	60	CD	NUMBER	60	dep	312	SENT_291	[p13l1457t3020r1483b3039],
136	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t3021r1509b3038],
137	18	CD	NUMBER	18	dep	312	SENT_291	[p13l1521t3020r1545b3039],
138	0.12	CD	NUMBER	0.12	dep	312	SENT_291	[p13l1722t3020r1767b3039],
139	hs-CRP	NN	O	hs-crp	dep	312	SENT_291	[p13l384t3067r465b3090],
140	,	,	O	,	_	0	SENT_291	[p13l384t3067r465b3090],
141	mg/I	NN	O	mg/i	dep	312	SENT_291	[p13l477t3067r527b3092],
142	0.24	CD	NUMBER	0.24	dep	312	SENT_291	[p13l1023t3068r1069b3086],
143	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1078t3069r1094b3086],
144	0.6	CD	NUMBER	0.6	dep	312	SENT_291	[p13l1104t3068r1136b3087],
145	0.31	CD	NUMBER	0.31	dep	312	SENT_291	[p13l1438t3068r1479b3087],
146	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t3069r1509b3086],
147	0.4	CD	NUMBER	0.4	dep	312	SENT_291	[p13l1519t3068r1551b3086],
148	0.45	CD	NUMBER	0.45	dep	312	SENT_291	[p13l1722t3068r1767b3086],
149	Creatinine	NN	O	creatinine	dep	312	SENT_291	[p13l356t3115r471b3134],
150	clearance	NN	O	clearance	dep	312	SENT_291	[p13l481t3114r588b3134],
151	<	JJR	O	<	dep	312	SENT_291	[p13l599t3116r647b3134],
152	60	CD	NUMBER	60	dep	312	SENT_291	[p13l599t3116r647b3134],
153	ml/min	NN	O	ml/min	dep	312	SENT_291	[p13l658t3114r737b3135],
154	20	CD	NUMBER	20	dep	312	SENT_291	[p13l1028t3116r1054b3134],
155	(	NN	O	(	dep	312	SENT_291	[p13l1062t3115r1102b3137],
156	37	CD	NUMBER	37	dep	312	SENT_291	[p13l1062t3115r1102b3137],
157	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1062t3115r1102b3137],
158	12	CD	NUMBER	12	dep	312	SENT_291	[p13l1445t3116r1469b3134],
159	(	NN	O	(	dep	312	SENT_291	[p13l1477t3115r1517b3137],
160	55	CD	NUMBER	55	dep	312	SENT_291	[p13l1477t3115r1517b3137],
161	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1477t3115r1517b3137],
162	0.16	CD	NUMBER	0.16	dep	312	SENT_291	[p13l1722t3116r1768b3134],
163	Baseline	NN	O	baseline	dep	312	SENT_291	[p13l357t3162r448b3182],
164	LV	NN	O	lv	dep	312	SENT_291	[p13l459t3163r485b3182],
165	ejection	NN	O	ejection	dep	312	SENT_291	[p13l495t3163r584b3188],
166	fraction	NN	O	fraction	dep	312	SENT_291	[p13l594t3162r686b3185],
167	,	,	O	,	_	0	SENT_291	[p13l594t3162r686b3185],
168	%	NN	O	%	dep	312	SENT_291	[p13l697t3164r717b3182],
169	52	CD	NUMBER	52	dep	312	SENT_291	[p13l1043t3164r1068b3182],
170	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1078t3165r1094b3181],
171	9	CD	NUMBER	9	dep	312	SENT_291	[p13l1104t3164r1116b3182],
172	55	CD	NUMBER	55	dep	312	SENT_291	[p13l1457t3164r1482b3182],
173	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t3165r1509b3181],
174	6	CD	NUMBER	6	dep	312	SENT_291	[p13l1519t3164r1531b3182],
175	0.21	CD	NUMBER	0.21	dep	312	SENT_291	[p13l1722t3164r1764b3182],
176	CYP2C19	NN	O	cyp2c19	dep	312	SENT_291	[p13l356t3211r477b3230],
177	*	NN	O	*	dep	312	SENT_291	[p13l356t3211r477b3230],
178	2	CD	NUMBER	2	dep	312	SENT_291	[p13l356t3211r477b3230],
179	polymorphism	NN	O	polymorphism	dep	312	SENT_291	[p13l488t3210r651b3236],
180	genotype	NN	O	genotype	dep	312	SENT_291	[p13l662t3213r770b3236],
181	0.008	CD	NUMBER	0.008	dep	312	SENT_291	[p13l1722t3211r1793b3230],
182	*	CD	NUMBER	*	dep	312	SENT_291	[p13l1722t3211r1793b3230],
183	*	NN	O	*	dep	312	SENT_291	[p13l383t3259r402b3278],
184	1	CD	NUMBER	1	dep	312	SENT_291	[p13l383t3259r402b3278],
185	*	NN	O	*	dep	312	SENT_291	[p13l408t3259r427b3278],
186	1	CD	NUMBER	1	dep	312	SENT_291	[p13l408t3259r427b3278],
187	42	CD	NUMBER	42	dep	312	SENT_291	[p13l1027t3259r1054b3278],
188	(	NN	O	(	dep	312	SENT_291	[p13l1062t3259r1102b3281],
189	78	CD	NUMBER	78	dep	312	SENT_291	[p13l1062t3259r1102b3281],
190	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1062t3259r1102b3281],
191	12	CD	NUMBER	12	dep	312	SENT_291	[p13l1445t3259r1468b3278],
192	(	NN	O	(	dep	312	SENT_291	[p13l1477t3259r1517b3281],
193	55	CD	NUMBER	55	dep	312	SENT_291	[p13l1477t3259r1517b3281],
194	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1477t3259r1517b3281],
195	*	NN	O	*	dep	312	SENT_291	[p13l383t3307r402b3326],
196	1	CD	NUMBER	1	dep	312	SENT_291	[p13l383t3307r402b3326],
197	*	NN	O	*	dep	312	SENT_291	[p13l408t3307r431b3326],
198	2	CD	NUMBER	2	dep	312	SENT_291	[p13l408t3307r431b3326],
199	12	CD	NUMBER	12	dep	312	SENT_291	[p13l1030t3307r1054b3326],
200	(	NN	O	(	dep	312	SENT_291	[p13l1062t3306r1102b3329],
201	22	CD	NUMBER	22	dep	312	SENT_291	[p13l1062t3306r1102b3329],
202	)	NN	O	)	dep	312	SENT_291	[p13l1062t3306r1102b3329],
203	7	CD	NUMBER	7	dep	312	SENT_291	[p13l1457t3308r1469b3326],
204	(	NN	O	(	dep	312	SENT_291	[p13l1477t3306r1517b3329],
205	32	CD	NUMBER	32	dep	312	SENT_291	[p13l1477t3306r1517b3329],
206	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1477t3306r1517b3329],
207	*	NN	O	*	dep	312	SENT_291	[p13l383t3355r431b3374],
208	2	CD	NUMBER	2	dep	312	SENT_291	[p13l383t3355r431b3374],
209	*	NN	O	*	dep	312	SENT_291	[p13l383t3355r431b3374],
210	2	CD	NUMBER	2	dep	312	SENT_291	[p13l383t3355r431b3374],
211	—	CD	NUMBER	—	dep	312	SENT_291	[p13l1048t3365r1074b3368],
212	3	CD	NUMBER	3	dep	312	SENT_291	[p13l1457t3355r1468b3374],
213	(	NN	O	(	dep	312	SENT_291	[p13l1477t3354r1517b3377],
214	14	CD	NUMBER	14	dep	312	SENT_291	[p13l1477t3354r1517b3377],
215	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1477t3354r1517b3377],
216	Allocation	NN	O	allocation	dep	312	SENT_291	[p13l356t3402r468b3422],
217	to	TO	O	to	dep	312	SENT_291	[p13l479t3405r502b3422],
218	high	JJ	O	high	dep	312	SENT_291	[p13l513t3402r625b3427],
219	—	NN	O	—	dep	312	SENT_291	[p13l513t3402r625b3427],
220	dose	NN	O	dose	dep	312	SENT_291	[p13l513t3402r625b3427],
221	atorvastatin	NN	O	atorvastatin	dep	312	SENT_291	[p13l636t3403r768b3422],
222	32	CD	NUMBER	32	dep	312	SENT_291	[p13l1029t3403r1055b3422],
223	(	CD	NUMBER	(	dep	312	SENT_291	[p13l1063t3402r1123b3425],
224	59.3	CD	NUMBER	59.3	dep	312	SENT_291	[p13l1063t3402r1123b3425],
225	)	NN	O	)	dep	312	SENT_291	[p13l1063t3402r1123b3425],
226	6	CD	NUMBER	6	dep	312	SENT_291	[p13l1458t3403r1470b3422],
227	(	NN	O	(	dep	312	SENT_291	[p13l1478t3402r1538b3425],
228	27.3	CD	NUMBER	27.3	dep	312	SENT_291	[p13l1478t3402r1538b3425],
229	)	CD	NUMBER	)	dep	312	SENT_291	[p13l1478t3402r1538b3425],
230	0.02	CD	NUMBER	0.02	dep	312	SENT_291	[p13l1722t3403r1767b3422],
231	Total	JJ	O	total	dep	312	SENT_291	[p13l355t3450r410b3470],
232	cholesterol	NN	O	cholesterol	dep	312	SENT_291	[p13l422t3450r551b3473],
233	,	,	O	,	_	0	SENT_291	[p13l422t3450r551b3473],
234	mg/dl	NN	O	mg/dl	dep	312	SENT_291	[p13l562t3450r628b3475],
235	182	CD	NUMBER	182	dep	312	SENT_291	[p13l1030t3451r1068b3470],
236	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1078t3452r1094b3469],
237	36	CD	NUMBER	36	dep	312	SENT_291	[p13l1104t3451r1130b3470],
238	181	CD	NUMBER	181	dep	312	SENT_291	[p13l1445t3451r1479b3470],
239	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t3452r1509b3469],
240	34	CD	NUMBER	34	dep	312	SENT_291	[p13l1519t3451r1545b3470],
241	0.90	CD	NUMBER	0.90	dep	312	SENT_291	[p13l1722t3451r1768b3470],
242	LDL	NN	O	ldl	dep	312	SENT_291	[p13l357t3498r537b3521],
243	—	CD	NUMBER	—	dep	312	SENT_291	[p13l357t3498r537b3521],
244	cho	NN	O	cho	dep	312	SENT_291	[p13l357t3498r537b3521],
245	|	NN	O	|	dep	312	SENT_291	[p13l357t3498r537b3521],
246	esterol	NN	O	esterol	dep	312	SENT_291	[p13l357t3498r537b3521],
247	,	,	O	,	_	0	SENT_291	[p13l357t3498r537b3521],
248	mg/dl	NN	O	mg/dl	dep	312	SENT_291	[p13l549t3498r614b3523],
249	118	CD	NUMBER	118	dep	312	SENT_291	[p13l1030t3499r1069b3518],
250	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1078t3500r1095b3517],
251	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1106t3499r1112b3517],
252	116	CD	NUMBER	116	dep	312	SENT_291	[p13l1445t3499r1484b3518],
253	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t3500r1509b3517],
254	35	CD	NUMBER	35	dep	312	SENT_291	[p13l1519t3499r1544b3518],
255	0.83	CD	NUMBER	0.83	dep	312	SENT_291	[p13l1722t3499r1767b3518],
256	HDL	NN	O	hdl	dep	312	SENT_291	[p13l357t3546r542b3569],
257	—	NN	O	—	dep	312	SENT_291	[p13l357t3546r542b3569],
258	cholestero	NN	O	cholestero	dep	312	SENT_291	[p13l357t3546r542b3569],
259	|	NN	O	|	dep	312	SENT_291	[p13l357t3546r542b3569],
260	,	,	O	,	_	0	SENT_291	[p13l357t3546r542b3569],
261	mg/dl	NN	O	mg/dl	dep	312	SENT_291	[p13l553t3546r619b3571],
262	40	CD	NUMBER	40	dep	312	SENT_291	[p13l1042t3547r1069b3566],
263	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1078t3548r1095b3565],
264	9	CD	NUMBER	9	dep	312	SENT_291	[p13l1104t3547r1116b3566],
265	37	CD	NUMBER	37	dep	312	SENT_291	[p13l1458t3547r1483b3566],
266	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t3548r1509b3565],
267	8	CD	NUMBER	8	dep	312	SENT_291	[p13l1519t3547r1531b3566],
268	0.32	CD	NUMBER	0.32	dep	312	SENT_291	[p13l1722t3547r1768b3566],
269	Triglycerides	NNS	O	triglyceride	dep	312	SENT_291	[p13l355t3593r503b3619],
270	,	,	O	,	_	0	SENT_291	[p13l355t3593r503b3619],
271	mg/dl	NN	O	mg/dl	dep	312	SENT_291	[p13l515t3593r580b3619],
272	124	CD	NUMBER	124	dep	312	SENT_291	[p13l1030t3595r1069b3613],
273	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1078t3596r1095b3613],
274	55	CD	NUMBER	55	dep	312	SENT_291	[p13l1104t3595r1129b3614],
275	139	CD	NUMBER	139	dep	312	SENT_291	[p13l1445t3595r1483b3614],
276	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t3596r1509b3613],
277	63	CD	NUMBER	63	dep	312	SENT_291	[p13l1519t3595r1544b3614],
278	0.33	CD	NUMBER	0.33	dep	312	SENT_291	[p13l1722t3595r1767b3614],
279	Baseline	NN	O	baseline	dep	312	SENT_291	[p13l357t3641r448b3661],
280	(	CD	NUMBER	(	dep	312	SENT_291	[p13l459t3642r507b3664],
281	T-o	NN	O	t-o	dep	312	SENT_291	[p13l459t3642r507b3664],
282	)	CD	NUMBER	)	dep	312	SENT_291	[p13l459t3642r507b3664],
283	PRU	NNP	ORGANIZATION	PRU	dep	312	SENT_291	[p13l519t3642r562b3661],
284	283	CD	NUMBER	283	dep	312	SENT_291	[p13l1029t3643r1068b3661],
285	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1078t3644r1095b3660],
286	35	CD	NUMBER	35	dep	312	SENT_291	[p13l1104t3643r1129b3661],
287	311	CD	NUMBER	311	dep	312	SENT_291	[p13l1444t3643r1479b3661],
288	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t3644r1509b3660],
289	29	CD	NUMBER	29	dep	312	SENT_291	[p13l1519t3643r1545b3661],
290	0.002	CD	NUMBER	0.002	dep	312	SENT_291	[p13l1722t3643r1781b3661],
291	Baseline	NN	O	baseline	dep	312	SENT_291	[p13l357t3689r448b3709],
292	(	CD	NUMBER	(	dep	312	SENT_291	[p13l459t3690r507b3712],
293	T-o	NN	O	t-o	dep	312	SENT_291	[p13l459t3690r507b3712],
294	)	CD	NUMBER	)	dep	312	SENT_291	[p13l459t3690r507b3712],
295	BASE	NN	O	base	dep	312	SENT_291	[p13l519t3690r575b3709],
296	314	CD	NUMBER	314	dep	312	SENT_291	[p13l1029t3691r1069b3709],
297	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1078t3692r1095b3708],
298	35	CD	NUMBER	35	dep	312	SENT_291	[p13l1104t3691r1129b3709],
299	313	CD	NUMBER	313	dep	312	SENT_291	[p13l1444t3691r1483b3709],
300	1	CD	NUMBER	1	dep	312	SENT_291	[p13l1493t3692r1509b3708],
301	32	CD	NUMBER	32	dep	312	SENT_291	[p13l1519t3691r1545b3709],
302	0.87	CD	NUMBER	0.87	dep	312	SENT_291	[p13l1722t3691r1768b3709],
303	Values	NNS	O	value	dep	312	SENT_291	[p13l355t3751r419b3769],
304	are	VBP	O	be	dep	312	SENT_291	[p13l426t3756r456b3769],
305	mean	JJ	O	mean	dep	312	SENT_291	[p13l464t3756r518b3769],
306	1	CD	NUMBER	1	dep	312	SENT_291	[p13l527t3753r541b3768],
307	SD	NN	O	sd	dep	312	SENT_291	[p13l551t3752r582b3771],
308	,	,	O	,	_	0	SENT_291	[p13l551t3752r582b3771],
309	n	NN	O	n	dep	312	SENT_291	[p13l589t3751r638b3771],
310	(	CD	PERCENT	(	dep	312	SENT_291	[p13l589t3751r638b3771],
311	%	NN	PERCENT	%	dep	312	SENT_291	[p13l589t3751r638b3771],
312	)	CD	NUMBER	)	_	0	SENT_291	[p13l589t3751r638b3771],
313	.	.	O	.	_	0	SENT_291	[p13l589t3751r638b3771],

1	or	CC	O	or	cc	3	SENT_292	[p13l645t3756r665b3769],
2	median	JJ	O	median	amod	3	SENT_292	[p13l672t3751r745b3769],
3	linterquartile	NN	O	linterquartile	_	0	SENT_292	[p13l753t3751r881b3773],
4	range	NN	O	range	nn	5	SENT_292	[p13l889t3752r957b3773],
5	]	NN	O	]	dep	3	SENT_292	[p13l889t3752r957b3773],
6	.	.	O	.	_	0	SENT_292	[p13l889t3752r957b3773],

1	*	NN	O	*	nn	2	SENT_293	[p13l963t3751r1037b3769],
2	Values	NNS	O	value	nsubjpass	4	SENT_293	[p13l963t3751r1037b3769],
3	were	VBD	O	be	auxpass	4	SENT_293	[p13l1043t3756r1092b3769],
4	compared	VBN	O	compare	_	0	SENT_293	[p13l1099t3751r1199b3773],
5	using	VBG	O	use	xcomp	4	SENT_293	[p13l1207t3752r1259b3774],
6	the	DT	O	the	det	7	SENT_293	[p13l1266t3751r1298b3769],
7	p	NN	O	p	dobj	5	SENT_293	[p13l1306t3756r1317b3773],
8	for	IN	O	for	_	0	SENT_293	[p13l1323t3751r1351b3769],
9	trend	NN	O	trend	nn	10	SENT_293	[p13l1357t3751r1410b3769],
10	test	NN	O	test	prep_for	7	SENT_293	[p13l1417t3754r1458b3769],
11	.	.	O	.	_	0	SENT_293	[p13l1417t3754r1458b3769],

1	HDL	NN	O	hdl	_	0	SENT_294	[p13l380t3789r422b3806],
2	=	JJ	O	=	amod	4	SENT_294	[p13l430t3795r444b3801],
3	high-density	JJ	O	high-density	amod	4	SENT_294	[p13l453t3789r578b3811],
4	lipoprotein	NN	O	lipoprotein	dep	1	SENT_294	[p13l584t3789r699b3811],
5	;	:	O	;	_	0	SENT_294	[p13l584t3789r699b3811],
6	LDL	NN	O	ldl	dep	1	SENT_294	[p13l706t3789r743b3806],
7	=	JJ	O	=	amod	9	SENT_294	[p13l751t3795r765b3801],
8	low-density	JJ	O	low-density	amod	9	SENT_294	[p13l775t3789r890b3811],
9	lipoprotein	NN	O	lipoprotein	dep	6	SENT_294	[p13l897t3789r1011b3811],
10	;	:	O	;	_	0	SENT_294	[p13l897t3789r1011b3811],
11	otherabbreviations	NNS	O	otherabbreviation	dep	1	SENT_294	[p13l1017t3789r1212b3806],
12	as	IN	O	as	prep	11	SENT_294	[p13l1218t3794r1238b3806],
13	in	IN	O	in	pcomp	12	SENT_294	[p13l1245t3789r1261b3806],
14	Table	NNP	O	Table	pobj	13	SENT_294	[p13l1268t3789r1322b3806],
15	1	CD	NUMBER	1	num	14	SENT_294	[p13l1330t3790r1344b3806],
16	.	.	O	.	_	0	SENT_294	[p13l1330t3790r1344b3806],

1	At	IN	O	at	_	0	SENT_295	[p14l42t68r86b100],
2	30	CD	DURATION	30	num	3	SENT_295	[p14l110t70r149b100],
3	days	NNS	NUMBER	day	prep_at	13	SENT_295	[p14l174t69r251b111],
4	,	,	O	,	_	0	SENT_295	[p14l174t69r251b111],
5	2	CD	NUMBER	2	num	6	SENT_295	[p14l276t70r295b101],
6	patients	NNS	O	patient	nsubj	13	SENT_295	[p14l320t70r453b111],
7	,	,	O	,	_	0	SENT_295	[p14l320t70r453b111],
8	both	DT	O	both	nsubj	9	SENT_295	[p14l478t69r553b100],
9	randomized	VBN	O	randomize	rcmod	6	SENT_295	[p14l577t69r768b100],
10	to	TO	O	to	_	0	SENT_295	[p14l792t77r823b100],
11	atorvastatin	NN	O	atorvastatin	prep_to	9	SENT_295	[p14l849t70r1041b107],
12	,	,	O	,	_	0	SENT_295	[p14l849t70r1041b107],
13	presented	VBD	O	present	_	0	SENT_295	[p14l43t118r197b160],
14	a	DT	O	a	det	16	SENT_295	[p14l211t130r227b149],
15	transarninase	NN	O	transarninase	nn	16	SENT_295	[p14l240t119r446b149],
16	increase	NN	O	increase	nsubj	17	SENT_295	[p14l460t119r586b149],
17	>	RBR	O	>	xcomp	13	SENT_295	[p14l602t119r652b149],
18	2	CD	NUMBER	2	dep	19	SENT_295	[p14l602t119r652b149],
19	>	JJR	O	>	npadvmod	20	SENT_295	[p14l671t122r696b147],
20	<	JJR	O	<	amod	21	SENT_295	[p14l671t122r696b147],
21	ULN	NN	O	uln	dobj	13	SENT_295	[p14l713t118r810b149],
22	.	.	O	.	_	0	SENT_295	[p14l713t118r810b149],

1	Discussion	NN	O	discussion	_	0	SENT_296	[p14l45t226r258b255],

1	The	DT	O	the	det	2	SENT_297	[p14l42t316r111b348],
2	results	NNS	O	result	nsubj	11	SENT_297	[p14l123t317r228b348],
3	of	IN	O	of	_	0	SENT_297	[p14l241t317r279b348],
4	this	DT	O	this	det	7	SENT_297	[p14l285t317r345b348],
5	prospective	JJ	O	prospective	amod	7	SENT_297	[p14l357t318r553b359],
6	,	,	O	,	_	0	SENT_297	[p14l357t318r553b359],
7	PD	NN	O	pd	prep_of	2	SENT_297	[p14l567t317r634b355],
8	,	,	O	,	_	0	SENT_297	[p14l567t317r634b355],
9	randomized	VBN	O	randomize	partmod	7	SENT_297	[p14l647t317r845b348],
10	study	NN	O	study	dobj	9	SENT_297	[p14l858t317r946b359],
11	show	VBP	O	show	_	0	SENT_297	[p14l957t317r1044b348],
12	that	IN	O	that	complm	25	SENT_297	[p14l43t366r110b397],
13	treatment	NN	O	treatment	nsubj	25	SENT_297	[p14l125t374r288b397],
14	with	IN	O	with	_	0	SENT_297	[p14l301t366r377b397],
15	high	JJ	O	high	amod	18	SENT_297	[p14l394t366r560b408],
16	—	NN	O	—	nn	18	SENT_297	[p14l394t366r560b408],
17	dose	NN	O	dose	nn	18	SENT_297	[p14l394t366r560b408],
18	atorvastatin	NN	O	atorvastatin	prep_with	13	SENT_297	[p14l577t368r770b397],
19	associated	VBN	O	associate	partmod	18	SENT_297	[p14l787t366r952b397],
20	with	IN	O	with	_	0	SENT_297	[p14l966t366r1042b397],
21	double	JJ	O	double	amod	24	SENT_297	[p14l44t416r246b447],
22	—	JJ	O	—	amod	24	SENT_297	[p14l44t416r246b447],
23	dose	NN	O	dose	nn	24	SENT_297	[p14l44t416r246b447],
24	clopidogrel	NN	O	clopidogrel	prep_with	19	SENT_297	[p14l267t416r452b458],
25	reduces	VBZ	O	reduce	ccomp	11	SENT_297	[p14l471t416r593b447],
26	platelet	NN	O	platelet	nn	27	SENT_297	[p14l613t416r735b458],
27	reactivity	NN	O	reactivity	dobj	25	SENT_297	[p14l754t418r907b458],
28	signiﬁcantly	RB	O	signiﬁcantly	advmod	25	SENT_297	[p14l925t416r1041b458, p14l44t466r143b508],
29	more	RBR	O	more	quantmod	31	SENT_297	[p14l159t478r243b497],
30	than	IN	O	than	quantmod	31	SENT_297	[p14l262t466r336b497],
31	double	JJ	O	double	num	34	SENT_297	[p14l355t466r557b497],
32	—	JJ	O	—	amod	34	SENT_297	[p14l355t466r557b497],
33	dose	NN	O	dose	nn	34	SENT_297	[p14l355t466r557b497],
34	clopidogrel	NN	O	clopidogrel	tmod	25	SENT_297	[p14l576t466r761b508],
35	alone	RB	O	alone	advmod	34	SENT_297	[p14l779t466r866b497],
36	in	IN	O	in	_	0	SENT_297	[p14l884t467r916b497],
37	statinnaive	JJ	O	statinnaive	amod	38	SENT_297	[p14l935t467r1041b497, p14l1119t70r1203b100],
38	patients	NNS	O	patient	prep_in	34	SENT_297	[p14l1217t70r1347b111],
39	with	IN	O	with	_	0	SENT_297	[p14l1360t69r1435b100],
40	stable	JJ	O	stable	amod	41	SENT_297	[p14l1450t69r1542b100],
41	CAD	NN	O	cad	prep_with	38	SENT_297	[p14l1557t68r1650b100],
42	and	CC	O	and	_	0	SENT_297	[p14l1665t69r1725b100],
43	HTPR	NN	O	htpr	prep_with	38	SENT_297	[p14l1739t68r1858b100],
44	before	IN	O	before	_	0	SENT_297	[p14l1869t69r1972b100],
45	PCI	NNP	O	PCI	prep_before	38	SENT_297	[p14l1987t69r2065b100],
46	.	.	O	.	_	0	SENT_297	[p14l1987t69r2065b100],

1	In	IN	O	in	_	0	SENT_298	[p14l2081t69r2117b100],
2	particular	JJ	O	particular	prep_in	12	SENT_298	[p14l1118t118r1285b160],
3	,	,	O	,	_	0	SENT_298	[p14l1118t118r1285b160],
4	the	DT	O	the	det	6	SENT_298	[p14l1303t118r1354b149],
5	antiplatelet	JJ	O	antiplatelet	amod	6	SENT_298	[p14l1372t118r1558b160],
6	efFects	NNS	O	effect	nsubj	15	SENT_298	[p14l1574t118r1674b149],
7	of	IN	O	of	_	0	SENT_298	[p14l1692t118r1730b149],
8	high	JJ	O	high	amod	11	SENT_298	[p14l1741t118r1907b160],
9	—	NN	O	—	nn	11	SENT_298	[p14l1741t118r1907b160],
10	dose	NN	O	dose	nn	11	SENT_298	[p14l1741t118r1907b160],
11	atorvastatin	NN	O	atorvastatin	prep_of	6	SENT_298	[p14l1925t119r2117b149],
12	occur	VBP	O	occur	_	0	SENT_298	[p14l1119t180r1208b199],
13	early	JJ	O	early	acomp	12	SENT_298	[p14l1222t168r1300b210],
14	and	CC	O	and	_	0	SENT_298	[p14l1314t168r1373b199],
15	persist	VBP	O	persist	conj_and	12	SENT_298	[p14l1387t169r1494b210],
16	over	IN	O	over	_	0	SENT_298	[p14l1508t180r1578b199],
17	time	NN	O	time	prep_over	15	SENT_298	[p14l1591t169r1675b206],
18	;	:	O	;	_	0	SENT_298	[p14l1591t169r1675b206],
19	they	PRP	O	they	nsubj	29	SENT_298	[p14l1690t168r1762b210],
20	are	VBP	O	be	cop	21	SENT_298	[p14l1775t180r1822b199],
21	additive	JJ	O	additive	parataxis	12	SENT_298	[p14l1838t168r1968b199],
22	to	TO	O	to	_	0	SENT_298	[p14l1982t176r2014b199],
23	those	DT	O	those	prep_to	21	SENT_298	[p14l2029t168r2116b199],
24	of	IN	O	of	_	0	SENT_298	[p14l1119t217r1156b248],
25	clopidogrel	NN	O	clopidogrel	prep_of	23	SENT_298	[p14l1165t217r1350b259],
26	and	CC	O	and	_	0	SENT_298	[p14l1365t217r1425b248],
27	do	VBP	O	do	aux	29	SENT_298	[p14l1439t217r1479b248],
28	not	RB	O	not	neg	29	SENT_298	[p14l1494t225r1549b248],
29	correlate	VB	O	correlate	parataxis	12	SENT_298	[p14l1563t217r1704b248],
30	with	IN	O	with	_	0	SENT_298	[p14l1718t217r1793b248],
31	the	DT	O	the	det	32	SENT_298	[p14l1808t217r1859b248],
32	degree	NN	O	degree	prep_with	29	SENT_298	[p14l1874t217r1981b259],
33	of	IN	O	of	_	0	SENT_298	[p14l1996t217r2034b248],
34	lipid	NN	O	lipid	nn	35	SENT_298	[p14l2042t217r2117b259],
35	reduction	NN	O	reduction	prep_of	32	SENT_298	[p14l1118t267r1276b298],
36	observed	VBN	O	observe	partmod	35	SENT_298	[p14l1292t267r1436b298],
37	during	IN	O	during	_	0	SENT_298	[p14l1452t267r1561b309],
38	the	DT	O	the	det	40	SENT_298	[p14l1576t267r1627b298],
39	study	NN	O	study	nn	40	SENT_298	[p14l1644t267r1733b309],
40	period	NN	O	period	prep_during	36	SENT_298	[p14l1746t267r1860b309],
41	.	.	O	.	_	0	SENT_298	[p14l1746t267r1860b309],

1	Statins	NNS	O	statin	nsubjpass	3	SENT_299	[p14l1162t316r1273b348],
2	are	VBP	O	be	auxpass	3	SENT_299	[p14l1297t328r1344b348],
3	known	VBN	O	know	_	0	SENT_299	[p14l1367t316r1480b348],
4	to	TO	O	to	aux	5	SENT_299	[p14l1502t324r1534b348],
5	have	VB	O	have	xcomp	3	SENT_299	[p14l1557t316r1632b348],
6	multiple	JJ	O	multiple	amod	9	SENT_299	[p14l1655t316r1792b359],
7	nonlipid-lowering	JJ	O	nonlipid-lowering	amod	9	SENT_299	[p14l1816t316r2118b359],
8	(	NN	O	(	nn	9	SENT_299	[p14l1120t365r1357b408],
9	“	NN	O	“	dobj	5	SENT_299	[p14l1120t365r1357b408],
10	pleiotropic	JJ	O	pleiotropic	amod	13	SENT_299	[p14l1120t365r1357b408],
11	”	NN	O	”	nn	13	SENT_299	[p14l1120t365r1357b408],
12	)	NN	O	)	nn	13	SENT_299	[p14l1120t365r1357b408],
13	effects	NNS	O	effect	dep	9	SENT_299	[p14l1389t366r1501b397],
14	.	.	O	.	_	0	SENT_299	[p14l1389t366r1501b397],

1	They	PRP	O	they	nsubj	2	SENT_300	[p14l1532t365r1622b408],
2	have	VBP	O	have	_	0	SENT_300	[p14l1650t366r1725b397],
3	vasoprotective	JJ	O	vasoprotective	amod	9	SENT_300	[p14l1754t367r2004b408],
4	,	,	O	,	_	0	SENT_300	[p14l1754t367r2004b408],
5	antiinﬂammatory	JJ	O	antiinﬂammatory	amod	9	SENT_300	[p14l2036t367r2115b397, p14l1118t416r1351b458],
6	,	,	O	,	_	0	SENT_300	[p14l2036t367r2115b397, p14l1118t416r1351b458],
7	antioxidant	JJ	O	antioxidant	amod	9	SENT_300	[p14l1372t416r1569b454],
8	,	,	O	,	_	0	SENT_300	[p14l1372t416r1569b454],
9	immunomodulating	JJ	O	immunomodulating	amod	10	SENT_300	[p14l1589t416r1923b458],
10	properties	NNS	O	property	dobj	2	SENT_300	[p14l1941t418r2116b458],
11	,	,	O	,	_	0	SENT_300	[p14l1941t418r2116b458],
12	and	CC	O	and	_	0	SENT_300	[p14l1119t466r1179b497],
13	also	RB	O	also	advmod	2	SENT_300	[p14l1196t466r1258b497],
14	inhibit	VBP	O	inhibit	conj_and	2	SENT_300	[p14l1275t466r1387b497],
15	platelet	NN	O	platelet	nn	17	SENT_300	[p14l1403t466r1525b508],
16	function	NN	O	function	nn	17	SENT_300	[p14l1542t466r1681b497],
17	pr	NN	O	pr	dep	14	SENT_300	[p14l1699t465r1754b504],
18	*	CD	NUMBER	*	dep	17	SENT_300	[p14l1699t465r1754b504],
19	In	IN	O	in	dep	17	SENT_300	[p14l1772t466r1809b497],
20	particular	JJ	O	particular	pobj	19	SENT_300	[p14l1826t466r1993b508],
21	,	,	O	,	_	0	SENT_300	[p14l1826t466r1993b508],
22	statins	NNS	O	statin	appos	20	SENT_300	[p14l2012t467r2116b497],

1	Table	NNP	O	Table	_	0	SENT_301	[p14l355t590r425b611],
2	4	CD	NUMBER	4	dep	1	SENT_301	[p14l436t590r460b610],
3	.	.	O	.	_	0	SENT_301	[p14l436t590r460b610],

1	change	NN	O	change	_	0	SENT_302	[p14l472t590r569b616],
2	in	IN	O	in	_	0	SENT_302	[p14l581t590r602b610],
3	Lipid	NN	O	lipid	nn	4	SENT_302	[p14l614t590r673b615],
4	Profile	NNP	O	Profile	prep_in	1	SENT_302	[p14l685t590r766b611],
5	Over	IN	O	over	dep	1	SENT_302	[p14l777t590r836b611],
6	Time	NNP	O	Time	pobj	5	SENT_302	[p14l845t590r908b611],
7	in	IN	O	in	dep	1	SENT_302	[p14l919t590r940b610],
8	Atorvastatin	NNP	O	Atorvastatin	pobj	7	SENT_302	[p14l951t590r1111b611],
9	and	CC	O	and	_	0	SENT_302	[p14l1122t590r1168b611],
10	control	JJ	O	control	amod	11	SENT_302	[p14l1179t590r1272b611],
11	Group	NN	O	group	pobj	7	SENT_302	[p14l1284t590r1360b615],

1	Atorvastatin	NNP	O	Atorvastatin	nn	2	SENT_303	[p14l862t658r1010b677],
2	Group	NNP	O	Group	_	0	SENT_303	[p14l1021t658r1091b682],
3	control	NN	O	control	dep	2	SENT_303	[p14l1475t658r1562b677],
4	Group	NNP	O	Group	dep	2	SENT_303	[p14l1573t658r1643b682],

1	T-o	JJ	O	t-o	amod	7	SENT_304	[p14l749t740r786b760],
2	T-1	NN	O	t-1	nn	7	SENT_304	[p14l942t740r979b760],
3	T	NN	O	t	nn	7	SENT_304	[p14l1150t740r1187b760],
4	—	NN	O	—	nn	7	SENT_304	[p14l1150t740r1187b760],
5	2	CD	NUMBER	2	num	7	SENT_304	[p14l1150t740r1187b760],
6	T-o	NN	O	t-o	nn	7	SENT_304	[p14l1348t740r1384b760],
7	T-1	NN	O	t-1	_	0	SENT_304	[p14l1529t740r1567b760],
8	T	NN	O	t	nn	9	SENT_304	[p14l1722t740r1758b760],
9	—	NN	O	—	dep	7	SENT_304	[p14l1722t740r1758b760],
10	2	CD	NUMBER	2	dep	9	SENT_304	[p14l1722t740r1758b760],

1	181	CD	NUMBER	181	dep	4	SENT_305	[p14l1318t812r1352b831],
2	t28	NN	O	t28	dep	1	SENT_305	[p14l1365t812r1417b831],
3	170	CD	NUMBER	170	dep	4	SENT_305	[p14l1499t812r1537b831],
4	i	FW	O	i	dep	13	SENT_305	[p14l1547t813r1563b830],
5	33	CD	NUMBER	33	number	6	SENT_305	[p14l1573t812r1598b831],
6	165	CD	NUMBER	165	dep	4	SENT_305	[p14l1679t812r1717b831],
7	i	FW	O	i	dep	6	SENT_305	[p14l1727t813r1743b830],
8	39	CD	NUMBER	39	num	9	SENT_305	[p14l1753t812r1804b832],
9	*	NN	O	*	dep	6	SENT_305	[p14l1753t812r1804b832],
10	=	JJ	O	=	amod	11	SENT_305	[p14l1753t812r1804b832],
11	l	NN	O	l	tmod	6	SENT_305	[p14l1753t812r1804b832],
12	=	JJ	O	=	amod	13	SENT_305	[p14l1753t812r1804b832],
13	117t29	CD	NUMBER	117t29	dep	16	SENT_305	[p14l1318t860r1417b879],
14	109i29	CD	NUMBER	109i29	num	15	SENT_305	[p14l1499t860r1599b879],
15	105i37	CD	NUMBER	105i37	dep	13	SENT_305	[p14l1679t860r1792b880],
16	$	$	MONEY	$	_	0	SENT_305	[p14l1679t860r1792b880],
17	38t10	CD	MONEY	38t10	num	16	SENT_305	[p14l1330t908r1417b927],
18	35i9	CD	MONEY	35i9	num	16	SENT_305	[p14l1512t908r1585b927],
19	36i8	CD	MONEY	36i8	num	21	SENT_305	[p14l1692t908r1765b927],
20	132i61	NN	O	132i61	nn	21	SENT_305	[p14l1499t956r1595b975],
21	119i55	NN	O	119i55	dep	16	SENT_305	[p14l1679t956r1778b975],

1	Total	JJ	O	total	amod	2	SENT_306	[p14l355t811r410b831],
2	cholesterol	NN	O	cholesterol	_	0	SENT_306	[p14l422t811r551b834],
3	,	,	O	,	_	0	SENT_306	[p14l422t811r551b834],
4	mg/dl	NN	O	mg/dl	nn	5	SENT_306	[p14l562t811r628b836],
5	LDL	NN	O	ldl	appos	2	SENT_306	[p14l357t859r537b882],
6	—	CD	NUMBER	—	num	7	SENT_306	[p14l357t859r537b882],
7	cholesterol	NN	O	cholesterol	dep	2	SENT_306	[p14l357t859r537b882],
8	,	,	O	,	_	0	SENT_306	[p14l357t859r537b882],
9	mg/dl	NN	O	mg/dl	nn	10	SENT_306	[p14l549t859r614b884],
10	HDL	NN	O	hdl	appos	7	SENT_306	[p14l357t907r542b930],
11	—	CD	NUMBER	—	num	12	SENT_306	[p14l357t907r542b930],
12	cholesterol	NN	O	cholesterol	dep	10	SENT_306	[p14l357t907r542b930],
13	,	,	O	,	_	0	SENT_306	[p14l357t907r542b930],
14	mg/dl	NN	O	mg/dl	nn	15	SENT_306	[p14l553t907r619b932],
15	Triglycerides	NNS	O	triglyceride	appos	7	SENT_306	[p14l355t955r503b980],
16	,	,	O	,	_	0	SENT_306	[p14l355t955r503b980],
17	mg/dl	NN	O	mg/dl	appos	15	SENT_306	[p14l515t955r580b980],

1	183i42	NN	O	183i42	nn	2	SENT_307	[p14l719t812r818b831],
2	117i34	NN	O	117i34	_	0	SENT_307	[p14l719t860r819b879],
3	40i8	CD	NUMBER	40i8	num	4	SENT_307	[p14l730t908r805b927],
4	127i54	NN	O	127i54	dep	2	SENT_307	[p14l719t956r819b975],

1	146	CD	NUMBER	146	dep	9	SENT_308	[p14l899t812r937b831],
2	i	FW	O	i	dep	1	SENT_308	[p14l947t813r963b830],
3	38	CD	NUMBER	38	number	4	SENT_308	[p14l973t812r1023b832],
4	*	CD	NUMBER	*	dep	2	SENT_308	[p14l973t812r1023b832],
5	‘	CD	NUMBER	‘	num	6	SENT_308	[p14l973t812r1023b832],
6	l'	NN	O	l'	dep	9	SENT_308	[p14l973t812r1023b832],
7	91	CD	NUMBER	91	num	9	SENT_308	[p14l911t860r933b879],
8	:	:	O	:	_	0	SENT_308	[p14l947t861r963b878],
9	30	CD	NUMBER	30	dep	14	SENT_308	[p14l973t860r1023b880],
10	*	CD	NUMBER	*	number	11	SENT_308	[p14l973t860r1023b880],
11	‘	CD	NUMBER	‘	dep	9	SENT_308	[p14l973t860r1023b880],
12	l'	NN	O	l'	dep	11	SENT_308	[p14l973t860r1023b880],
13	35	CD	NUMBER	35	num	12	SENT_308	[p14l911t908r936b927],
14	i	FW	O	i	dep	18	SENT_308	[p14l947t909r963b926],
15	8	CD	NUMBER	8	number	16	SENT_308	[p14l973t908r996b927],
16	*	CD	NUMBER	*	dep	14	SENT_308	[p14l973t908r996b927],
17	95	CD	NUMBER	95	dep	16	SENT_308	[p14l911t956r936b975],
18	i	FW	O	i	_	0	SENT_308	[p14l947t957r963b974],
19	39	CD	NUMBER	39	number	20	SENT_308	[p14l973t956r1023b976],
20	*	CD	NUMBER	*	dep	18	SENT_308	[p14l973t956r1023b976],
21	‘	CD	NUMBER	‘	num	22	SENT_308	[p14l973t956r1023b976],
22	l'	NN	O	l'	dep	20	SENT_308	[p14l973t956r1023b976],

1	134	CD	NUMBER	134	dep	11	SENT_309	[p14l1100t812r1138b831],
2	i	FW	O	i	dep	1	SENT_309	[p14l1147t813r1164b830],
3	24	CD	NUMBER	24	number	4	SENT_309	[p14l1173t812r1238b832],
4	*	CD	NUMBER	*	num	5	SENT_309	[p14l1173t812r1238b832],
5	‘	NN	O	‘	dep	2	SENT_309	[p14l1173t812r1238b832],
6	l	NN	O	l	tmod	2	SENT_309	[p14l1173t812r1238b832],
7	‘	NN	O	‘	nn	9	SENT_309	[p14l1173t812r1238b832],
8	=	JJ	O	=	amod	9	SENT_309	[p14l1173t812r1238b832],
9	l5	NN	O	l5	dep	2	SENT_309	[p14l1173t812r1238b832],
10	81	CD	NUMBER	81	dep	11	SENT_309	[p14l1112t860r1134b879],
11	i	FW	O	i	dep	19	SENT_309	[p14l1147t861r1164b878],
12	17	CD	NUMBER	17	number	13	SENT_309	[p14l1175t860r1238b880],
13	*	CD	NUMBER	*	dep	11	SENT_309	[p14l1175t860r1238b880],
14	‘	CD	NUMBER	‘	num	15	SENT_309	[p14l1175t860r1238b880],
15	l'	NN	O	l'	dep	13	SENT_309	[p14l1175t860r1238b880],
16	=	JJ	O	=	amod	17	SENT_309	[p14l1175t860r1238b880],
17	l	NN	O	l	tmod	13	SENT_309	[p14l1175t860r1238b880],
18	¢	CD	NUMBER	¢	num	19	SENT_309	[p14l1175t860r1238b880],
19	36	CD	NUMBER	36	_	0	SENT_309	[p14l1112t908r1138b927],
20	:	:	O	:	_	0	SENT_309	[p14l1147t909r1164b926],
21	1O	CD	NUMBER	1o	num	22	SENT_309	[p14l1175t908r1224b928],
22	*	NN	O	*	dep	28	SENT_309	[p14l1175t908r1224b928],
23	1	CD	NUMBER	1	dep	22	SENT_309	[p14l1175t908r1224b928],
24	=	JJ	O	=	amod	23	SENT_309	[p14l1175t908r1224b928],
25	88	CD	NUMBER	88	tmod	24	SENT_309	[p14l1112t956r1138b975],
26	i	FW	O	i	dep	23	SENT_309	[p14l1147t957r1164b974],
27	34	CD	NUMBER	34	dep	28	SENT_309	[p14l1174t956r1238b976],
28	*	CD	NUMBER	*	dep	35	SENT_309	[p14l1174t956r1238b976],
29	‘	CD	NUMBER	‘	num	30	SENT_309	[p14l1174t956r1238b976],
30	l'	NN	O	l'	dep	28	SENT_309	[p14l1174t956r1238b976],
31	1	CD	NUMBER	1	num	34	SENT_309	[p14l1174t956r1238b976],
32	=	JJ	O	=	amod	34	SENT_309	[p14l1174t956r1238b976],
33	127	CD	NUMBER	127	tmod	32	SENT_309	[p14l1318t956r1356b974],
34	t	NN	O	t	dep	30	SENT_309	[p14l1365t957r1382b974],
35	55	CD	NUMBER	55	dep	19	SENT_309	[p14l1392t956r1417b975],

1	Values	NNS	O	value	nsubj	4	SENT_310	[p14l355t1016r419b1034],
2	are	VBP	O	be	cop	4	SENT_310	[p14l425t1021r455b1034],
3	mean	JJ	O	mean	amod	4	SENT_310	[p14l461t1021r515b1034],
4	i	FW	O	i	_	0	SENT_310	[p14l523t1018r538b1033],
5	SD	NN	O	sd	dep	4	SENT_310	[p14l546t1017r577b1034],
6	.	.	O	.	_	0	SENT_310	[p14l546t1017r577b1034],

1	*	NN	O	*	nn	2	SENT_311	[p14l582t1017r605b1038],
2	p	NN	O	p	dep	3	SENT_311	[p14l582t1017r605b1038],
3	<	JJR	O	<	_	0	SENT_311	[p14l611t1019r628b1033],
4	0.01	CD	NUMBER	0.01	dep	15	SENT_311	[p14l634t1017r671b1034],
5	versus	CC	O	versus	prep	4	SENT_311	[p14l680t1021r742b1034],
6	baseline	NN	O	baseline	dep	5	SENT_311	[p14l749t1016r830b1034],
7	(	CD	NUMBER	(	num	6	SENT_311	[p14l836t1017r884b1037],
8	T	NN	O	t	nn	11	SENT_311	[p14l836t1017r884b1037],
9	—	CD	NUMBER	—	num	11	SENT_311	[p14l836t1017r884b1037],
10	o	NN	O	o	nn	11	SENT_311	[p14l836t1017r884b1037],
11	)	NN	O	)	dep	15	SENT_311	[p14l836t1017r884b1037],
12	;	:	O	;	_	0	SENT_311	[p14l836t1017r884b1037],
13	1	CD	NUMBER	1	dep	11	SENT_311	[p14l890t1017r916b1038],
14	'	''	O	'	_	0	SENT_311	[p14l890t1017r916b1038],
15	p	NN	O	p	rcmod	3	SENT_311	[p14l890t1017r916b1038],
16	<	JJR	O	<	dep	15	SENT_311	[p14l922t1019r939b1033],
17	0.01	CD	NUMBER	0.01	num	18	SENT_311	[p14l945t1017r982b1034],
18	atorvastatin	NN	O	atorvastatin	dep	15	SENT_311	[p14l991t1017r1109b1034],
19	versus	CC	O	versus	prep	18	SENT_311	[p14l1115t1021r1177b1034],
20	control	NN	O	control	nn	21	SENT_311	[p14l1183t1016r1252b1034],
21	group	NN	O	group	dep	19	SENT_311	[p14l1259t1021r1323b1039],
22	;	:	O	;	_	0	SENT_311	[p14l1259t1021r1323b1039],
23	tp	NN	O	tp	dep	3	SENT_311	[p14l1329t1017r1355b1039],
24	<	JJR	O	<	amod	31	SENT_311	[p14l1362t1019r1378b1033],
25	0.01	CD	NUMBER	0.01	dep	24	SENT_311	[p14l1385t1017r1422b1034],
26	within	IN	O	within	dep	25	SENT_311	[p14l1430t1016r1492b1034],
27	group	NN	O	group	nn	30	SENT_311	[p14l1498t1021r1558b1039],
28	(	CD	NUMBER	(	num	30	SENT_311	[p14l1564t1016r1675b1037],
29	Bonferroni	NNP	PERSON	Bonferroni	nn	30	SENT_311	[p14l1564t1016r1675b1037],
30	adjustment	NN	O	adjustment	pobj	26	SENT_311	[p14l1681t1016r1806b1039],
31	)	NN	O	)	dep	23	SENT_311	[p14l1681t1016r1806b1039],
32	.	.	O	.	_	0	SENT_311	[p14l1681t1016r1806b1039],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_312	[p14l379t1054r518b1071],
2	as	IN	O	as	prep	1	SENT_312	[p14l525t1059r544b1071],
3	in	IN	O	in	pcomp	2	SENT_312	[p14l551t1054r567b1071],
4	Table	NNP	O	Table	pobj	3	SENT_312	[p14l574t1054r628b1071],
5	3	CD	NUMBER	3	num	4	SENT_312	[p14l635t1055r650b1071],
6	.	.	O	.	_	0	SENT_312	[p14l635t1055r650b1071],

1	JACC	NN	O	jacc	_	0	SENT_313	[p14l8t1255r158b1286],
2	:	:	O	:	_	0	SENT_313	[p14l8t1255r158b1286],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_313	[p14l193t1255r692b1286],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_313	[p14l728t1255r1187b1291],
5	,	,	O	,	_	0	SENT_313	[p14l728t1255r1187b1291],
6	VOL	NNP	O	VOL	appos	4	SENT_313	[p14l1221t1255r1344b1286],
7	.	.	O	.	_	0	SENT_313	[p14l1221t1255r1344b1286],

1	6	CD	NUMBER	6	_	0	SENT_314	[p14l1379t1256r1422b1291],
2	,	,	O	,	_	0	SENT_314	[p14l1379t1256r1422b1291],
3	NO.	NNP	O	NO.	appos	1	SENT_314	[p14l1459t1255r1549b1286],
4	2	CD	NUMBER	2	num	3	SENT_314	[p14l1584t1256r1627b1291],
5	,	,	O	,	_	0	SENT_314	[p14l1584t1256r1627b1291],
6	2013	CD	DATE	2013	num	3	SENT_314	[p14l1663t1256r1787b1286],
7	FEBRUARY	NNP	DATE	FEBRUARY	dep	1	SENT_314	[p14l11t1320r289b1351],
8	2013:169	CD	DATE	2013:169	num	7	SENT_314	[p14l320t1320r676b1351],
9	—	CD	NUMBER	—	number	10	SENT_314	[p14l320t1320r676b1351],
10	79	CD	NUMBER	79	dep	7	SENT_314	[p14l320t1320r676b1351],

1	have	VBP	O	have	aux	3	SENT_315	[p14l10t1511r168b1578],
2	been	VBN	O	be	auxpass	3	SENT_315	[p14l222t1511r388b1578],
3	shown	VBN	O	show	_	0	SENT_315	[p14l445t1511r673b1578],
4	to	TO	O	to	aux	5	SENT_315	[p14l727t1528r795b1578],
5	reduce	VB	O	reduce	xcomp	3	SENT_315	[p14l852t1511r1081b1578],
6	platelet	NN	O	platelet	nn	7	SENT_315	[p14l1136t1511r1398b1601],
7	aggregation	NN	O	aggregation	dobj	5	SENT_315	[p14l1453t1514r1884b1601],
8	,	,	O	,	_	0	SENT_315	[p14l1453t1514r1884b1601],
9	dense	JJ	O	dense	amod	11	SENT_315	[p14l1944t1511r2139b1578],
10	granule	NN	O	granule	nn	11	SENT_315	[p14l9t1617r270b1707],
11	release	NN	O	release	dobj	5	SENT_315	[p14l300t1617r552b1698],
12	,	,	O	,	_	0	SENT_315	[p14l300t1617r552b1698],
13	and	CC	O	and	_	0	SENT_315	[p14l586t1617r714b1684],
14	platelet-mediated	JJ	O	platelet-mediated	amod	16	SENT_315	[p14l741t1617r1367b1707],
15	thrombus	NN	O	thrombus	nn	16	SENT_315	[p14l1396t1617r1735b1684],
16	formation	NN	O	formation	conj_and	7	SENT_315	[p14l1766t1617r2137b1698],
17	,	,	O	,	_	0	SENT_315	[p14l1766t1617r2137b1698],
18	all	DT	O	all	det	26	SENT_315	[p14l12t1723r91b1790],
19	rapidly	RB	O	rapidly	dep	26	SENT_315	[p14l137t1723r383b1813],
20	and	CC	O	and	_	0	SENT_315	[p14l428t1723r555b1790],
21	in	IN	O	in	dep	26	SENT_315	[p14l601t1726r669b1789],
22	a	DT	O	a	det	24	SENT_315	[p14l718t1750r752b1790],
23	dose	NN	O	dose	nn	24	SENT_315	[p14l798t1723r1367b1813],
24	—	NN	O	—	pobj	21	SENT_315	[p14l798t1723r1367b1813],
25	dependent	JJ	O	dependent	amod	24	SENT_315	[p14l798t1723r1367b1813],
26	manner	NN	O	manner	appos	16	SENT_315	[p14l1413t1749r1683b1790],
27	(	CD	NUMBER	(	number	28	SENT_315	[p14l1731t1721r2136b1804],
28	3,4,22,23	CD	NUMBER	3,4,22,23	num	29	SENT_315	[p14l1731t1721r2136b1804],
29	)	NN	O	)	dep	26	SENT_315	[p14l1731t1721r2136b1804],
30	.	.	O	.	_	0	SENT_315	[p14l1731t1721r2136b1804],

1	Moreover	RB	O	moreover	dep	131	SENT_316	[p14l8t1830r377b1910],
2	,	,	O	,	_	0	SENT_316	[p14l8t1830r377b1910],
3	the	DT	O	the	dep	131	SENT_316	[p14l428t1829r538b1896],
4	combination	NN	O	combination	dep	131	SENT_316	[p14l588t1829r1033b1896],
5	of	IN	O	of	dep	131	SENT_316	[p14l1083t1829r1162b1896],
6	standard	JJ	O	standard	dep	131	SENT_316	[p14l1200t1829r1697b1896],
7	—	NN	O	—	dep	131	SENT_316	[p14l1200t1829r1697b1896],
8	dose	NN	O	dose	dep	131	SENT_316	[p14l1200t1829r1697b1896],
9	clopidogrel	NN	O	clopidogrel	dep	131	SENT_316	[p14l1747t1829r2141b1919],
10	(	CD	NUMBER	(	dep	131	SENT_316	[p14l13t1933r121b2016],
11	75	CD	NUMBER	75	dep	131	SENT_316	[p14l13t1933r121b2016],
12	mg	NN	O	mg	dep	131	SENT_316	[p14l160t1933r296b2025],
13	)	NN	O	)	dep	131	SENT_316	[p14l160t1933r296b2025],
14	with	IN	O	with	dep	131	SENT_316	[p14l331t1936r493b2002],
15	atorvastatin	NN	O	atorvastatin	dep	131	SENT_316	[p14l529t1938r938b2002],
16	(	CD	NUMBER	(	dep	131	SENT_316	[p14l976t1933r1087b2016],
17	40	CD	NUMBER	40	dep	131	SENT_316	[p14l976t1933r1087b2016],
18	mg	NN	O	mg	dep	131	SENT_316	[p14l1124t1933r1283b2025],
19	)	NN	O	)	dep	131	SENT_316	[p14l1124t1933r1283b2025],
20	,	,	O	,	_	0	SENT_316	[p14l1124t1933r1283b2025],
21	leads	VBZ	O	lead	dep	131	SENT_316	[p14l1320t1935r1493b2002],
22	to	TO	O	to	dep	131	SENT_316	[p14l1529t1953r1597b2002],
23	further	JJ	O	further	dep	131	SENT_316	[p14l1633t1935r1879b2002],
24	reduction	NN	O	reduction	dep	131	SENT_316	[p14l1912t1935r2137b2002, p14l10t2044r150b2108],
25	in	IN	O	in	dep	131	SENT_316	[p14l190t2044r258b2107],
26	ADP	NN	O	adp	dep	131	SENT_316	[p14l295t2040r520b2107],
27	—	NN	O	—	dep	131	SENT_316	[p14l295t2040r520b2107],
28	and	CC	O	and	dep	131	SENT_316	[p14l564t2041r692b2108],
29	TRAP	NN	O	trap	dep	131	SENT_316	[p14l728t2040r1291b2108],
30	—	NN	O	—	dep	131	SENT_316	[p14l728t2040r1291b2108],
31	induced	VBD	O	induce	dep	131	SENT_316	[p14l728t2040r1291b2108],
32	platelet	NN	O	platelet	dep	131	SENT_316	[p14l1329t2041r1591b2131],
33	activation	NN	O	activation	dep	131	SENT_316	[p14l1630t2044r1972b2108],
34	and	CC	O	and	dep	131	SENT_316	[p14l2014t2041r2141b2108],
35	TRAP	NN	O	trap	dep	131	SENT_316	[p14l7t2146r570b2214],
36	—	NN	O	—	dep	131	SENT_316	[p14l7t2146r570b2214],
37	induced	VBD	O	induce	dep	131	SENT_316	[p14l7t2146r570b2214],
38	platelet	NN	O	platelet	dep	131	SENT_316	[p14l594t2147r855b2237],
39	aggregation	NN	O	aggregation	dep	131	SENT_316	[p14l879t2150r1292b2237],
40	p	NN	O	p	dep	131	SENT_316	[p14l1320t2145r1434b2228],
41	8	CD	NUMBER	8	dep	131	SENT_316	[p14l1320t2145r1434b2228],
42	*	NN	O	*	dep	131	SENT_316	[p14l1320t2145r1434b2228],
43	This	DT	O	this	dep	131	SENT_316	[p14l1461t2146r1624b2214],
44	additive	JJ	O	additive	dep	131	SENT_316	[p14l1653t2147r1930b2214],
45	effect	NN	O	effect	dep	131	SENT_316	[p14l1957t2147r2142b2214],
46	is	VBZ	O	be	dep	131	SENT_316	[p14l10t2256r60b2320],
47	already	RB	O	already	dep	131	SENT_316	[p14l101t2253r352b2343],
48	evident	JJ	O	evident	dep	131	SENT_316	[p14l387t2253r644b2320],
49	with	IN	O	with	dep	131	SENT_316	[p14l676t2254r837b2320],
50	low	JJ	O	low	dep	131	SENT_316	[p14l873t2253r1194b2320],
51	—	NN	O	—	dep	131	SENT_316	[p14l873t2253r1194b2320],
52	dose	NN	O	dose	dep	131	SENT_316	[p14l873t2253r1194b2320],
53	(	NN	O	(	dep	131	SENT_316	[p14l1236t2251r1347b2334],
54	20	CD	NUMBER	20	dep	131	SENT_316	[p14l1236t2251r1347b2334],
55	mg	NN	O	mg	dep	131	SENT_316	[p14l1386t2251r1522b2343],
56	)	NN	O	)	dep	131	SENT_316	[p14l1386t2251r1522b2343],
57	atorvastatin	NN	O	atorvastatin	dep	131	SENT_316	[p14l1565t2256r1974b2320],
58	and	CC	O	and	dep	131	SENT_316	[p14l2014t2253r2141b2320],
59	persists	VBZ	O	persist	dep	131	SENT_316	[p14l9t2362r266b2449],
60	over	IN	O	over	dep	131	SENT_316	[p14l312t2385r460b2426],
61	time	NN	O	time	dep	131	SENT_316	[p14l502t2362r660b2426],
62	L	NN	O	l	dep	131	SENT_316	[p14l708t2357r822b2440],
63	*	CD	NUMBER	*	dep	131	SENT_316	[p14l708t2357r822b2440],
64	Although	IN	O	although	dep	131	SENT_316	[p14l868t2358r1212b2449],
65	PD	NN	O	pd	dep	131	SENT_316	[p14l1257t2360r1377b2425],
66	interaction	NN	O	interaction	dep	131	SENT_316	[p14l1423t2362r1805b2426],
67	between	IN	O	between	dep	131	SENT_316	[p14l1847t2360r2140b2426],
68	clopidogrel	NN	O	clopidogrel	dep	131	SENT_316	[p14l11t2465r405b2555],
69	and	CC	O	and	dep	131	SENT_316	[p14l437t2465r564b2532],
70	atorvastatin	NN	O	atorvastatin	dep	131	SENT_316	[p14l596t2468r1026b2546],
71	,	,	O	,	_	0	SENT_316	[p14l596t2468r1026b2546],
72	both	CC	O	both	dep	131	SENT_316	[p14l1057t2465r1222b2532],
73	substrates	NNS	O	substrate	dep	131	SENT_316	[p14l1254t2465r1595b2532],
74	of	IN	O	of	dep	131	SENT_316	[p14l1629t2465r1708b2532],
75	cytochrome	NN	O	cytochrome	dep	131	SENT_316	[p14l1728t2465r2139b2555],
76	CYP3A4	NN	O	cyp3a4	dep	131	SENT_316	[p14l12t2570r360b2652],
77	,	,	O	,	_	0	SENT_316	[p14l12t2570r360b2652],
78	has	VBZ	O	have	dep	131	SENT_316	[p14l403t2572r515b2638],
79	been	VBN	O	be	dep	131	SENT_316	[p14l554t2571r720b2638],
80	described	VBN	O	describe	dep	131	SENT_316	[p14l760t2571r1092b2638],
81	in	IN	O	in	dep	131	SENT_316	[p14l1130t2574r1198b2637],
82	the	DT	O	the	dep	131	SENT_316	[p14l1237t2571r1347b2638],
83	early	JJ	O	early	dep	131	SENT_316	[p14l1388t2572r1555b2661],
84	phase	NN	O	phase	dep	131	SENT_316	[p14l1589t2572r1787b2661],
85	of	IN	O	of	dep	131	SENT_316	[p14l1828t2571r1908b2638],
86	clopidogrel	NN	O	clopidogrel	dep	131	SENT_316	[p14l1935t2572r2137b2661, p14l11t2678r232b2767],
87	treatment	NN	O	treatment	dep	131	SENT_316	[p14l257t2694r603b2744],
88	(	CD	NUMBER	(	dep	131	SENT_316	[p14l630t2675r960b2758],
89	standard	JJ	O	standard	dep	131	SENT_316	[p14l630t2675r960b2758],
90	loading	VBG	O	load	dep	131	SENT_316	[p14l984t2677r1249b2767],
91	dose	NN	O	dose	dep	131	SENT_316	[p14l1274t2675r1455b2758],
92	)	NN	O	)	dep	131	SENT_316	[p14l1274t2675r1455b2758],
93	(	CD	NUMBER	(	dep	131	SENT_316	[p14l1487t2675r1671b2758],
94	5,6	CD	NUMBER	5,6	dep	131	SENT_316	[p14l1487t2675r1671b2758],
95	)	NN	O	)	dep	131	SENT_316	[p14l1487t2675r1671b2758],
96	,	,	O	,	_	0	SENT_316	[p14l1487t2675r1671b2758],
97	a	DT	O	a	dep	131	SENT_316	[p14l1701t2704r1735b2744],
98	lack	NN	O	lack	dep	131	SENT_316	[p14l1758t2678r1901b2744],
99	of	IN	O	of	dep	131	SENT_316	[p14l1924t2677r2004b2744],
100	PD	NN	O	pd	dep	131	SENT_316	[p14l2018t2678r2138b2743],
101	interaction	NN	O	interaction	dep	131	SENT_316	[p14l10t2786r392b2850],
102	has	VBZ	O	have	dep	131	SENT_316	[p14l427t2783r539b2850],
103	been	VBN	O	be	dep	131	SENT_316	[p14l573t2783r740b2850],
104	shown	VBN	O	show	dep	131	SENT_316	[p14l776t2783r1002b2850],
105	with	IN	O	with	dep	131	SENT_316	[p14l1034t2783r1195b2850],
106	high	JJ	O	high	dep	131	SENT_316	[p14l1229t2783r1388b2873],
107	clopidogrel	NN	O	clopidogrel	dep	131	SENT_316	[p14l1423t2783r1818b2873],
108	doses	NNS	O	dose	dep	131	SENT_316	[p14l1852t2783r2038b2850],
109	as	RB	O	as	dep	131	SENT_316	[p14l2076t2810r2139b2850],
110	well	RB	O	well	dep	131	SENT_316	[p14l7t2890r152b2957],
111	as	IN	O	as	dep	131	SENT_316	[p14l206t2917r269b2957],
112	once	RB	DATE	once	dep	131	SENT_316	[p14l326t2917r487b2957],
113	patients	NNS	O	patient	dep	131	SENT_316	[p14l540t2893r818b2980],
114	are	VBP	O	be	dep	131	SENT_316	[p14l874t2916r975b2957],
115	in	IN	O	in	dep	131	SENT_316	[p14l1030t2893r1097b2956],
116	the	DT	O	the	dep	131	SENT_316	[p14l1151t2890r1261b2957],
117	maintenance	NN	O	maintenance	dep	131	SENT_316	[p14l1317t2893r1766b2957],
118	phase	NN	O	phase	dep	131	SENT_316	[p14l1819t2890r2017b2980],
119	of	IN	O	of	dep	131	SENT_316	[p14l2073t2890r2152b2957],
120	treatment	NN	O	treatment	dep	131	SENT_316	[p14l10t3013r374b3077],
121	,	,	O	,	_	0	SENT_316	[p14l10t3013r374b3077],
122	which	WDT	O	which	dep	131	SENT_316	[p14l407t2996r624b3063],
123	was	VBD	O	be	dep	131	SENT_316	[p14l653t3023r782b3063],
124	the	DT	O	the	dep	131	SENT_316	[p14l816t2996r927b3063],
125	setting	NN	O	setting	dep	131	SENT_316	[p14l962t2999r1200b3086],
126	of	IN	O	of	dep	131	SENT_316	[p14l1231t2996r1311b3063],
127	our	PRP$	O	we	dep	131	SENT_316	[p14l1333t3022r1450b3063],
128	study	NN	O	study	dep	131	SENT_316	[p14l1483t2996r1672b3086],
129	(	CD	NUMBER	(	dep	131	SENT_316	[p14l1704t2994r1952b3077],
130	7-11	CD	NUMBER	7-11	dep	131	SENT_316	[p14l1704t2994r1952b3077],
131	)	NN	O	)	_	0	SENT_316	[p14l1704t2994r1952b3077],
132	.	.	O	.	_	0	SENT_316	[p14l1704t2994r1952b3077],

1	Our	PRP$	O	we	poss	2	SENT_317	[p14l101t3103r245b3170],
2	study	NN	O	study	nsubj	3	SENT_317	[p14l278t3103r467b3193],
3	expands	VBZ	O	expand	dep	37	SENT_317	[p14l497t3103r776b3193],
4	upon	IN	O	upon	_	0	SENT_317	[p14l810t3130r990b3193],
5	previous	JJ	O	previous	amod	6	SENT_317	[p14l1021t3106r1315b3193],
6	data	NNS	O	datum	prep_upon	3	SENT_317	[p14l1350t3103r1497b3170],
7	showing	VBG	O	show	partmod	6	SENT_317	[p14l1531t3103r1827b3193],
8	that	IN	O	that	dep	7	SENT_317	[p14l1857t3103r1998b3170],
9	the	DT	O	the	det	10	SENT_317	[p14l2029t3103r2139b3170],
10	addition	NN	O	addition	dep	19	SENT_317	[p14l12t3209r305b3276],
11	of	IN	O	of	_	0	SENT_317	[p14l343t3209r422b3276],
12	high	JJ	O	high	amod	14	SENT_317	[p14l448t3209r802b3299],
13	—	NN	O	—	nn	14	SENT_317	[p14l448t3209r802b3299],
14	dose	NN	O	dose	prep_of	10	SENT_317	[p14l448t3209r802b3299],
15	atorvastatin	NN	O	atorvastatin	dep	19	SENT_317	[p14l842t3212r1252b3276],
16	(	CD	NUMBER	(	num	15	SENT_317	[p14l1292t3207r1403b3290],
17	80	CD	NUMBER	80	num	19	SENT_317	[p14l1292t3207r1403b3290],
18	mg	NN	O	mg	nn	19	SENT_317	[p14l1442t3207r1578b3299],
19	)	NN	O	)	dep	25	SENT_317	[p14l1442t3207r1578b3299],
20	in	IN	O	in	_	0	SENT_317	[p14l1620t3212r1687b3275],
21	statin	NN	O	statin	nn	22	SENT_317	[p14l1726t3212r2139b3276],
22	—	NN	O	—	prep_in	19	SENT_317	[p14l1726t3212r2139b3276],
23	naive	JJ	O	naive	amod	25	SENT_317	[p14l1726t3212r2139b3276],
24	HTPR	NN	O	htpr	nn	25	SENT_317	[p14l11t3314r263b3381],
25	patients	NNS	O	patient	dep	8	SENT_317	[p14l316t3318r593b3405],
26	simultaneously	RB	O	simultaneously	advmod	25	SENT_317	[p14l652t3315r1179b3405],
27	with	IN	O	with	_	0	SENT_317	[p14l1228t3316r1389b3382],
28	increased	VBN	O	increase	amod	29	SENT_317	[p14l1445t3315r1772b3382],
29	doses	NNS	O	dose	prep_with	25	SENT_317	[p14l1829t3315r2014b3382],
30	of	IN	O	of	_	0	SENT_317	[p14l2073t3315r2152b3382],
31	clopidogrel	NN	O	clopidogrel	nn	32	SENT_317	[p14l11t3421r405b3511],
32	(	NN	O	(	prep_of	29	SENT_317	[p14l447t3419r602b3502],
33	150	CD	NUMBER	150	num	35	SENT_317	[p14l447t3419r602b3502],
34	mg	NN	O	mg	nn	35	SENT_317	[p14l644t3419r780b3511],
35	)	NN	O	)	nsubjpass	37	SENT_317	[p14l644t3419r780b3511],
36	is	VBZ	O	be	auxpass	37	SENT_317	[p14l824t3425r874b3488],
37	associated	VBN	O	associate	_	0	SENT_317	[p14l918t3422r1270b3488],
38	with	IN	O	with	_	0	SENT_317	[p14l1305t3421r1466b3488],
39	enhanced	VBN	O	enhance	amod	42	SENT_317	[p14l1508t3421r1843b3488],
40	platelet	NN	O	platelet	nn	42	SENT_317	[p14l1881t3421r2142b3511],
41	inhibitory	JJ	O	inhibitory	amod	42	SENT_317	[p14l10t3527r363b3617],
42	effects	NNS	O	effect	prep_with	37	SENT_317	[p14l411t3527r645b3608],
43	,	,	O	,	_	0	SENT_317	[p14l411t3527r645b3608],
44	in	IN	O	in	_	0	SENT_317	[p14l698t3530r766b3593],
45	particular	JJ	O	particular	amod	51	SENT_317	[p14l815t3527r1153b3617],
46	with	IN	O	with	_	0	SENT_317	[p14l1198t3528r1359b3594],
47	more	JJR	O	more	amod	49	SENT_317	[p14l1410t3553r1589b3594],
48	potent	JJ	O	potent	amod	49	SENT_317	[p14l1640t3545r1871b3617],
49	P2Y12	NN	O	p2y12	prep_with	45	SENT_317	[p14l1919t3528r2139b3614],
50	receptor	NN	O	receptor	nn	51	SENT_317	[p14l10t3650r299b3723],
51	inhibition	NN	O	inhibition	prep_in	37	SENT_317	[p14l327t3633r679b3700],
52	at	IN	O	at	_	0	SENT_317	[p14l710t3650r773b3700],
53	30	CD	DURATION	30	num	54	SENT_317	[p14l802t3637r885b3700],
54	days	NNS	NUMBER	day	prep_at	51	SENT_317	[p14l917t3633r1066b3723],
55	compared	VBN	O	compare	_	0	SENT_317	[p14l1098t3633r1445b3723],
56	with	IN	O	with	prepc_compared_with	54	SENT_317	[p14l1470t3634r1631b3700],
57	controls	NNS	O	control	pobj	54	SENT_317	[p14l1662t3634r1961b3700],
58	.	.	O	.	_	0	SENT_317	[p14l1662t3634r1961b3700],

1	The	DT	O	the	det	2	SENT_318	[p14l1992t3632r2139b3700],
2	reduction	NN	O	reduction	nsubj	9	SENT_318	[p14l10t3739r346b3806],
3	of	IN	O	of	_	0	SENT_318	[p14l370t3739r450b3806],
4	ADP	NN	O	adp	prep_of	2	SENT_318	[p14l458t3738r1016b3806],
5	—	CD	NUMBER	—	num	4	SENT_318	[p14l458t3738r1016b3806],
6	mediated	VBN	O	mediate	partmod	4	SENT_318	[p14l458t3738r1016b3806],
7	reactivity	NN	O	reactivity	dobj	6	SENT_318	[p14l1038t3742r1363b3829],
8	is	VBZ	O	be	cop	9	SENT_318	[p14l1383t3742r1433b3806],
9	greater	JJR	O	greater	_	0	SENT_318	[p14l1457t3757r1702b3829],
10	in	IN	O	in	_	0	SENT_318	[p14l1723t3742r1791b3805],
11	our	PRP$	O	we	poss	12	SENT_318	[p14l1815t3765r1932b3806],
12	study	NN	O	study	prep_in	9	SENT_318	[p14l1955t3739r2144b3829],
13	than	IN	O	than	mark	77	SENT_318	[p15l10t20r168b87],
14	in	IN	O	in	_	0	SENT_318	[p15l218t23r285b86],
15	previous	JJ	O	previous	amod	16	SENT_318	[p15l334t23r627b110],
16	studies	NNS	O	study	prep_in	77	SENT_318	[p15l680t20r917b87],
17	that	WDT	O	that	nsubj	18	SENT_318	[p15l969t20r1110b87],
18	showed	VBD	O	show	rcmod	16	SENT_318	[p15l1159t20r1424b87],
19	minimal	JJ	O	minimal	amod	20	SENT_318	[p15l1474t20r1769b87],
20	effect	NN	O	effect	nsubj	24	SENT_318	[p15l1819t20r2004b87],
21	on	IN	O	on	_	0	SENT_318	[p15l2053t47r2140b87],
22	ADP	NN	O	adp	nn	23	SENT_318	[p15l8t125r519b193],
23	—	NN	O	—	prep_on	20	SENT_318	[p15l8t125r519b193],
24	induced	VBD	O	induce	ccomp	18	SENT_318	[p15l8t125r519b193],
25	aggregation	NN	O	aggregation	nn	26	SENT_318	[p15l551t129r963b216],
26	L	NN	O	l	nsubj	30	SENT_318	[p15l998t124r1113b207],
27	+	CC	O	+	_	0	SENT_318	[p15l998t124r1113b207],
28	This	DT	O	this	nsubj	30	SENT_318	[p15l1147t125r1310b193],
29	could	MD	O	could	aux	30	SENT_318	[p15l1345t126r1536b193],
30	depend	VB	O	depend	ccomp	24	SENT_318	[p15l1568t126r1826b216],
31	on	IN	O	on	_	0	SENT_318	[p15l1857t153r1945b193],
32	various	JJ	O	various	amod	33	SENT_318	[p15l1974t129r2137b193, p15l11t259r126b299],
33	factors	NNS	O	factor	prep_on	30	SENT_318	[p15l186t232r439b313],
34	,	,	O	,	_	0	SENT_318	[p15l186t232r439b313],
35	including	VBG	O	include	_	0	SENT_318	[p15l502t232r836b322],
36	the	DT	O	the	det	43	SENT_318	[p15l893t232r1003b299],
37	very	RB	O	very	advmod	38	SENT_318	[p15l1059t258r1209b322],
38	high	JJ	O	high	amod	43	SENT_318	[p15l1264t233r1423b322],
39	dose	NN	O	dose	nn	43	SENT_318	[p15l1483t232r1638b299],
40	(	NN	O	(	nn	43	SENT_318	[p15l1701t230r1812b313],
41	80	CD	NUMBER	80	num	43	SENT_318	[p15l1701t230r1812b313],
42	mg	NN	O	mg	nn	43	SENT_318	[p15l1873t230r2009b322],
43	)	NN	O	)	prep_including	30	SENT_318	[p15l1873t230r2009b322],
44	of	IN	O	of	_	0	SENT_318	[p15l2073t232r2152b299],
45	atorvastatin	NN	O	atorvastatin	prep_of	43	SENT_318	[p15l12t341r421b405],
46	administered	VBN	O	administer	partmod	45	SENT_318	[p15l468t338r927b405],
47	in	IN	O	in	_	0	SENT_318	[p15l971t341r1039b404],
48	our	PRP$	O	we	poss	49	SENT_318	[p15l1084t364r1202b405],
49	study	NN	O	study	prep_in	46	SENT_318	[p15l1246t338r1451b428],
50	,	,	O	,	_	0	SENT_318	[p15l1246t338r1451b428],
51	the	DT	O	the	det	54	SENT_318	[p15l1499t338r1609b405],
52	relatively	RB	O	relatively	advmod	53	SENT_318	[p15l1655t338r1974b428],
53	low	JJ	O	low	amod	54	SENT_318	[p15l2014t338r2144b405],
54	eﬂicacy	NN	O	eﬂicacy	appos	49	SENT_318	[p15l11t444r266b534],
55	of	IN	O	of	_	0	SENT_318	[p15l293t444r373b511],
56	high-dose	JJ	O	high-dose	amod	57	SENT_318	[p15l390t444r745b534],
57	clopidogrel	NN	O	clopidogrel	prep_of	54	SENT_318	[p15l776t444r1171b534],
58	in	IN	O	in	_	0	SENT_318	[p15l1199t447r1267b510],
59	I-ITPR	NN	O	i-itpr	nn	60	SENT_318	[p15l1297t443r1550b510],
60	patients	NNS	O	patient	prep_in	57	SENT_318	[p15l1576t447r1874b534],
61	,	,	O	,	_	0	SENT_318	[p15l1576t447r1874b534],
62	and	CC	O	and	_	0	SENT_318	[p15l1908t444r2068b511],
63	/	:	O	/	punct	66	SENT_318	[p15l1908t444r2068b511],
64	or	CC	O	or	cc	66	SENT_318	[p15l2070t470r2142b511],
65	the	DT	O	the	quantmod	66	SENT_318	[p15l10t551r120b617],
66	synergy	NN	O	synergy	dep	24	SENT_318	[p15l145t576r412b640],
67	in	IN	O	in	_	0	SENT_318	[p15l432t553r499b616],
68	inhibition	NN	O	inhibition	nn	69	SENT_318	[p15l523t550r874b617],
69	ofADP	NN	O	ofadp	prep_in	66	SENT_318	[p15l899t549r1545b617],
70	—	CD	NUMBER	—	num	69	SENT_318	[p15l899t549r1545b617],
71	mediated	VBN	O	mediate	ccomp	18	SENT_318	[p15l899t549r1545b617],
72	and	CC	O	and	_	0	SENT_318	[p15l1569t550r1697b617],
73	isoTRAPmediated	VBN	O	isotrapmediate	conj_and	24	SENT_318	[p15l1719t549r2142b617, p15l11t656r337b723],
74	platelet	NN	O	platelet	nn	76	SENT_318	[p15l373t657r634b746],
75	aggregation	NN	O	aggregation	nn	76	SENT_318	[p15l671t659r1084b746],
76	pathways	NNS	O	pathway	nsubj	77	SENT_318	[p15l1120t656r1445b746],
77	(	VBP	O	(	advcl	9	SENT_318	[p15l1488t654r1647b737],
78	24	CD	NUMBER	24	num	79	SENT_318	[p15l1488t654r1647b737],
79	)	CD	NUMBER	)	dobj	77	SENT_318	[p15l1488t654r1647b737],
80	.	.	O	.	_	0	SENT_318	[p15l1488t654r1647b737],

1	In	IN	O	in	_	0	SENT_319	[p15l1689t657r1766b722],
2	fact	NN	O	fact	prep_in	9	SENT_319	[p15l1803t656r1950b737],
3	,	,	O	,	_	0	SENT_319	[p15l1803t656r1950b737],
4	only	RB	O	only	advmod	5	SENT_319	[p15l1992t657r2144b746],
5	atorvastatin	NN	O	atorvastatin	nsubj	9	SENT_319	[p15l12t762r705b829],
6	—	CD	NUMBER	—	num	8	SENT_319	[p15l12t762r705b829],
7	treated	JJ	O	treated	amod	8	SENT_319	[p15l12t762r705b829],
8	patients	NNS	O	patient	dep	5	SENT_319	[p15l733t765r1010b852],
9	had	VBD	O	have	_	0	SENT_319	[p15l1041t762r1171b829],
10	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_319	[p15l1201t762r1566b852],
11	early	JJ	O	early	amod	12	SENT_319	[p15l1595t763r1763b852],
12	inhibition	NN	O	inhibition	dobj	9	SENT_319	[p15l1788t762r2140b829],
13	of	IN	O	of	_	0	SENT_319	[p15l11t868r90b935],
14	iso	NN	O	iso	prep_of	12	SENT_319	[p15l139t867r880b935],
15	.	.	O	.	_	0	SENT_319	[p15l139t867r880b935],

1	—	NN	O	—	_	0	SENT_320	[p15l139t867r880b935],
2	.	.	O	.	_	0	SENT_320	[p15l139t867r880b935],

1	TRAP	NN	O	trap	_	0	SENT_321	[p15l139t867r880b935],
2	.	.	O	.	_	0	SENT_321	[p15l139t867r880b935],

1	—	NN	O	—	_	0	SENT_322	[p15l139t867r880b935],
2	.	.	O	.	_	0	SENT_322	[p15l139t867r880b935],

1	.	.	O	.	_	0	SENT_323	[p15l139t867r880b935],

1	—	NN	O	—	_	0	SENT_324	[p15l139t867r880b935],
2	.	.	O	.	_	0	SENT_324	[p15l139t867r880b935],

1	induced	VBN	O	induce	_	0	SENT_325	[p15l139t867r880b935],
2	aggregation	NN	O	aggregation	dobj	1	SENT_325	[p15l942t871r1372b958],
3	.	.	O	.	_	0	SENT_325	[p15l942t871r1372b958],

1	This	DT	O	this	det	2	SENT_326	[p15l1435t867r1598b935],
2	effect	NN	O	effect	nsubjpass	5	SENT_326	[p15l1662t868r1847b935],
3	is	VBZ	O	be	auxpass	5	SENT_326	[p15l1906t871r1957b935],
4	less	RBR	O	less	advmod	5	SENT_326	[p15l2018t868r2138b935],
5	appreciated	VBN	O	appreciate	_	0	SENT_326	[p15l12t974r416b1064],
6	at	IN	O	at	_	0	SENT_326	[p15l467t992r530b1041],
7	30	CD	DURATION	30	num	8	SENT_326	[p15l579t978r662b1041],
8	days	NNS	NUMBER	day	prep_at	5	SENT_326	[p15l714t974r863b1064],
9	when	WRB	O	when	advmod	15	SENT_326	[p15l911t975r1106b1041],
10	the	DT	O	the	det	11	SENT_326	[p15l1155t975r1266b1041],
11	values	NNS	O	value	nsubj	15	SENT_326	[p15l1313t974r1525b1041],
12	of	IN	O	of	_	0	SENT_326	[p15l1577t974r1657b1041],
13	BASE	NN	O	base	prep_of	11	SENT_326	[p15l1695t973r1925b1041],
14	were	VBD	O	be	cop	15	SENT_326	[p15l1973t1000r2139b1041],
15	similar	JJ	O	similar	dep	8	SENT_326	[p15l11t1081r250b1147],
16	in	IN	O	in	_	0	SENT_326	[p15l279t1083r346b1146],
17	the	DT	O	the	det	20	SENT_326	[p15l377t1080r487b1147],
18	2	CD	NUMBER	2	num	20	SENT_326	[p15l517t1084r558b1148],
19	study	NN	O	study	nn	20	SENT_326	[p15l592t1080r781b1170],
20	groups	NNS	O	group	prep_in	15	SENT_326	[p15l807t1106r1063b1170],
21	.	.	O	.	_	0	SENT_326	[p15l807t1106r1063b1170],

1	We	PRP	O	we	nsubj	3	SENT_327	[p15l1094t1081r1224b1147],
2	could	MD	O	could	aux	3	SENT_327	[p15l1257t1080r1448b1147],
3	assume	VB	O	assume	_	0	SENT_327	[p15l1479t1107r1729b1147],
4	that	IN	O	that	complm	18	SENT_327	[p15l1760t1080r1902b1147],
5	in	IN	O	in	_	0	SENT_327	[p15l1931t1083r1998b1146],
6	the	DT	O	the	det	8	SENT_327	[p15l2029t1080r2139b1147],
7	early	JJ	O	early	amod	8	SENT_327	[p15l11t1186r178b1276],
8	period	NN	O	period	prep_in	18	SENT_327	[p15l204t1186r431b1276],
9	following	VBG	O	follow	_	0	SENT_327	[p15l461t1186r797b1276],
10	PCI	NNP	MISC	PCI	prep_following	8	SENT_327	[p15l827t1186r996b1267],
11	,	,	O	,	_	0	SENT_327	[p15l827t1186r996b1267],
12	when	WRB	O	when	advmod	15	SENT_327	[p15l1027t1186r1221b1253],
13	thrombin	NN	O	thrombin	nn	14	SENT_327	[p15l1252t1186r1587b1253],
14	levels	NNS	O	level	nsubj	15	SENT_327	[p15l1617t1186r1805b1253],
15	increase	VBP	O	increase	dep	10	SENT_327	[p15l1838t1189r2137b1267],
16	,	,	O	,	_	0	SENT_327	[p15l1838t1189r2137b1267],
17	atorvastatin	NN	O	atorvastatin	nsubj	18	SENT_327	[p15l12t1296r421b1360],
18	exerts	VBZ	O	exert	ccomp	3	SENT_327	[p15l450t1311r649b1360],
19	a	DT	O	a	det	22	SENT_327	[p15l680t1320r714b1360],
20	protective	JJ	O	protective	amod	22	SENT_327	[p15l739t1296r1088b1383],
21	role	NN	O	role	nn	22	SENT_327	[p15l1116t1293r1247b1360],
22	(	NN	O	(	dobj	18	SENT_327	[p15l1279t1291r1417b1374],
23	17	CD	NUMBER	17	num	24	SENT_327	[p15l1279t1291r1417b1374],
24	)	NN	O	)	npadvmod	25	SENT_327	[p15l1279t1291r1417b1374],
25	as	IN	O	as	advmod	26	SENT_327	[p15l1450t1320r1512b1360],
26	supported	VBN	O	support	partmod	22	SENT_327	[p15l1544t1293r1895b1383],
27	by	IN	O	by	_	0	SENT_327	[p15l1919t1293r2006b1383],
28	the	DT	O	the	det	29	SENT_327	[p15l2029t1293r2139b1360],
29	inhibition	NN	O	inhibition	agent	26	SENT_327	[p15l10t1400r361b1466],
30	of	IN	O	of	_	0	SENT_327	[p15l395t1399r475b1466],
31	iso	NN	O	iso	prep_of	29	SENT_327	[p15l496t1398r1248b1466],
32	.	.	O	.	_	0	SENT_327	[p15l496t1398r1248b1466],

1	—	NN	O	—	_	0	SENT_328	[p15l496t1398r1248b1466],
2	.	.	O	.	_	0	SENT_328	[p15l496t1398r1248b1466],

1	TRAP	NN	O	trap	_	0	SENT_329	[p15l496t1398r1248b1466],
2	.	.	O	.	_	0	SENT_329	[p15l496t1398r1248b1466],

1	—	NN	O	—	_	0	SENT_330	[p15l496t1398r1248b1466],
2	.	.	O	.	_	0	SENT_330	[p15l496t1398r1248b1466],

1	mediated	VBN	O	mediate	_	0	SENT_331	[p15l496t1398r1248b1466],
2	aggregation	NN	O	aggregation	dobj	1	SENT_331	[p15l1281t1402r1712b1489],
3	.	.	O	.	_	0	SENT_331	[p15l1281t1402r1712b1489],

1	Our	PRP$	O	we	poss	2	SENT_332	[p15l101t1505r245b1572],
2	series	NN	O	series	nsubj	24	SENT_332	[p15l277t1508r464b1572],
3	of	IN	O	of	_	0	SENT_332	[p15l498t1505r578b1572],
4	stable	JJ	O	stable	amod	6	SENT_332	[p15l599t1506r796b1572],
5	CAD	NN	O	cad	nn	6	SENT_332	[p15l831t1504r1028b1572],
6	patients	NNS	O	patient	prep_of	2	SENT_332	[p15l1061t1508r1359b1595],
7	,	,	O	,	_	0	SENT_332	[p15l1061t1508r1359b1595],
8	undergoing	VBG	O	undergo	dep	2	SENT_332	[p15l1392t1505r1800b1595],
9	PCI	NNP	O	PCI	dobj	8	SENT_332	[p15l1831t1505r1978b1572],
10	and	CC	O	and	_	0	SENT_332	[p15l2013t1505r2141b1572],
11	treated	VBN	O	treat	dep	2	SENT_332	[p15l10t1611r254b1678],
12	with	IN	O	with	_	0	SENT_332	[p15l311t1611r472b1678],
13	clopidogrel	NN	O	clopidogrel	prep_with	11	SENT_332	[p15l534t1611r928b1701],
14	(	CD	NUMBER	(	number	15	SENT_332	[p15l991t1609r1099b1692],
15	75	CD	NUMBER	75	num	17	SENT_332	[p15l991t1609r1099b1692],
16	mg	NN	O	mg	nn	17	SENT_332	[p15l1164t1610r1301b1701],
17	)	NN	O	)	dobj	11	SENT_332	[p15l1164t1610r1301b1701],
18	for	IN	O	for	_	0	SENT_332	[p15l1365t1611r1465b1678],
19	at	IN	DURATION	at	quantmod	21	SENT_332	[p15l1526t1628r1589b1678],
20	least	JJS	DURATION	least	mwe	19	SENT_332	[p15l1647t1611r1805b1678],
21	7	CD	DURATION	7	num	22	SENT_332	[p15l1866t1613r1906b1678],
22	days	NNS	NUMBER	day	prep_for	17	SENT_332	[p15l1967t1611r2137b1701],
23	,	,	O	,	_	0	SENT_332	[p15l1967t1611r2137b1701],
24	presented	VBD	O	present	_	0	SENT_332	[p15l9t1717r351b1807],
25	a	DT	O	a	det	29	SENT_332	[p15l387t1744r421b1784],
26	relatively	RB	O	relatively	advmod	27	SENT_332	[p15l454t1717r774b1807],
27	high	JJ	O	high	amod	29	SENT_332	[p15l805t1717r964b1807],
28	incidence	NN	O	incidence	nn	29	SENT_332	[p15l999t1717r1332b1784],
29	(	NN	O	(	dobj	24	SENT_332	[p15l1371t1715r1575b1798],
30	43	CD	PERCENT	43	number	31	SENT_332	[p15l1371t1715r1575b1798],
31	%	NN	PERCENT	%	amod	29	SENT_332	[p15l1371t1715r1575b1798],
32	)	CD	NUMBER	)	tmod	24	SENT_332	[p15l1371t1715r1575b1798],
33	of	IN	O	of	_	0	SENT_332	[p15l1614t1717r1694b1784],
34	I-ITPR	NN	O	i-itpr	prep_of	32	SENT_332	[p15l1718t1716r1988b1798],
35	,	,	O	,	_	0	SENT_332	[p15l1718t1716r1988b1798],
36	but	CC	O	but	_	0	SENT_332	[p15l2024t1718r2142b1784],
37	overall	JJ	O	overall	nsubj	42	SENT_332	[p15l11t1822r242b1888],
38	consistent	JJ	O	consistent	amod	37	SENT_332	[p15l268t1825r623b1888],
39	with	IN	O	with	_	0	SENT_332	[p15l644t1822r805b1888],
40	other	JJ	O	other	amod	41	SENT_332	[p15l831t1823r1018b1888],
41	studies	NNS	O	study	prep_with	38	SENT_332	[p15l1044t1822r1282b1888],
42	(	VBP	O	(	conj_but	24	SENT_332	[p15l1312t1820r1472b1902],
43	25	CD	NUMBER	25	dobj	42	SENT_332	[p15l1312t1820r1472b1902],
44	This	DT	O	this	nsubj	47	SENT_332	[p15l1500t1821r1663b1888],
45	could	MD	O	could	aux	47	SENT_332	[p15l1692t1822r1883b1888],
46	be	VB	O	be	cop	47	SENT_332	[p15l1907t1823r1987b1888],
47	due	JJ	O	due	rcmod	43	SENT_332	[p15l2015t1823r2139b1888],
48	to	TO	O	to	_	0	SENT_332	[p15l10t1946r78b1995],
49	the	DT	O	the	det	51	SENT_332	[p15l103t1928r213b1995],
50	advanced	JJ	O	advanced	amod	51	SENT_332	[p15l240t1928r565b1995],
51	age	NN	O	age	prep_to	47	SENT_332	[p15l589t1955r703b2018],
52	and	CC	O	and	_	0	SENT_332	[p15l729t1928r857b1995],
53	high	JJ	O	high	amod	74	SENT_332	[p15l880t1928r1040b2018],
54	prevalence	NN	O	prevalence	dep	53	SENT_332	[p15l1063t1928r1432b2018],
55	of	IN	O	of	_	0	SENT_332	[p15l1458t1928r1538b1995],
56	diabetes	NN	O	diabetes	nn	57	SENT_332	[p15l1551t1928r1833b1995],
57	mellitus	NN	O	mellitus	prep_of	54	SENT_332	[p15l1861t1928r2138b1995],
58	and	CC	O	and	_	0	SENT_332	[p15l12t2034r139b2101],
59	renal	JJ	O	renal	amod	60	SENT_332	[p15l177t2034r351b2101],
60	dysfunction	NN	O	dysfunction	dep	53	SENT_332	[p15l390t2034r803b2124],
61	in	IN	O	in	_	0	SENT_332	[p15l842t2037r909b2100],
62	our	PRP$	O	we	poss	64	SENT_332	[p15l950t2060r1066b2101],
63	study	NN	O	study	nn	64	SENT_332	[p15l1105t2034r1295b2124],
64	population	NN	O	population	prep_in	60	SENT_332	[p15l1329t2034r1731b2124],
65	,	,	O	,	_	0	SENT_332	[p15l1329t2034r1731b2124],
66	all	DT	O	all	det	68	SENT_332	[p15l1775t2034r1855b2101],
67	clinical	JJ	O	clinical	amod	68	SENT_332	[p15l1894t2034r2142b2101],
68	factors	NNS	O	factor	appos	54	SENT_332	[p15l10t2139r242b2205],
69	associated	VBN	O	associate	partmod	68	SENT_332	[p15l281t2139r633b2205],
70	with	IN	O	with	_	0	SENT_332	[p15l665t2140r826b2205],
71	HTPR	NN	O	htpr	prep_with	69	SENT_332	[p15l863t2138r1116b2204],
72	(	CD	NUMBER	(	number	73	SENT_332	[p15l1152t2137r1535b2220],
73	13,26,27	CD	NUMBER	13,26,27	num	74	SENT_332	[p15l1152t2137r1535b2220],
74	)	NN	O	)	prep_to	47	SENT_332	[p15l1152t2137r1535b2220],
75	.	.	O	.	_	0	SENT_332	[p15l1152t2137r1535b2220],

1	The	DT	O	the	det	2	SENT_333	[p15l1573t2138r1719b2205],
2	association	NN	O	association	nsubj	16	SENT_333	[p15l1758t2142r2140b2205],
3	of	IN	O	of	_	0	SENT_333	[p15l11t2245r90b2312],
4	high-dose	JJ	O	high-dose	amod	5	SENT_333	[p15l102t2245r456b2335],
5	atorvastatin	NN	O	atorvastatin	prep_of	2	SENT_333	[p15l481t2248r891b2312],
6	and	CC	O	and	_	0	SENT_333	[p15l915t2245r1043b2312],
7	double	JJ	O	double	amod	10	SENT_333	[p15l1066t2245r1497b2312],
8	—	JJ	O	—	amod	10	SENT_333	[p15l1066t2245r1497b2312],
9	dose	NN	O	dose	nn	10	SENT_333	[p15l1066t2245r1497b2312],
10	clopidogrel	NN	O	clopidogrel	conj_and	2	SENT_333	[p15l1522t2245r1917b2335],
11	in	IN	O	in	_	0	SENT_333	[p15l1938t2248r2006b2311],
12	the	DT	O	the	det	14	SENT_333	[p15l2029t2245r2139b2312],
13	present	JJ	DATE	present	amod	14	SENT_333	[p15l9t2369r267b2441],
14	study	NN	O	study	prep_in	10	SENT_333	[p15l321t2351r511b2441],
15	signiﬁcantly	RB	O	signiﬁcantly	advmod	16	SENT_333	[p15l563t2351r992b2441],
16	reduced	VBD	O	reduce	_	0	SENT_333	[p15l1042t2351r1320b2418],
17	30-day	JJ	DURATION	30-day	amod	19	SENT_333	[p15l1374t2351r1622b2441],
18	HTPR	NN	O	htpr	nn	19	SENT_333	[p15l1673t2350r1926b2417],
19	rates	NNS	O	rate	dobj	16	SENT_333	[p15l1977t2368r2138b2418],
20	compared	VBN	O	compare	_	0	SENT_333	[p15l11t2458r358b2547],
21	with	IN	O	with	prepc_compared_with	16	SENT_333	[p15l378t2458r539b2524],
22	clopidogrel	NN	O	clopidogrel	nn	24	SENT_333	[p15l565t2457r959b2547],
23	150	CD	NUMBER	150	num	24	SENT_333	[p15l986t2457r1111b2524],
24	mg	NN	O	mg	pobj	16	SENT_333	[p15l1137t2484r1250b2547],
25	alone	RB	O	alone	advmod	28	SENT_333	[p15l1274t2457r1459b2524],
26	(	RB	O	(	advmod	28	SENT_333	[p15l1487t2455r1665b2538],
27	16	CD	PERCENT	16	num	28	SENT_333	[p15l1487t2455r1665b2538],
28	%	NN	PERCENT	%	dep	24	SENT_333	[p15l1487t2455r1665b2538],
29	vs.	CC	O	vs.	prep	28	SENT_333	[p15l1686t2484r1775b2524],
30	42	CD	PERCENT	42	num	31	SENT_333	[p15l1803t2461r1975b2538],
31	%	NN	PERCENT	%	dep	29	SENT_333	[p15l1803t2461r1975b2538],
32	,	,	O	,	_	0	SENT_333	[p15l1803t2461r1975b2538],
33	p	NN	O	p	dep	34	SENT_333	[p15l2001t2484r2043b2547],
34	<	JJR	O	<	appos	28	SENT_333	[p15l2075t2468r2135b2519],
35	0.02	CD	NUMBER	0.02	num	36	SENT_333	[p15l10t2561r210b2644],
36	)	NN	O	)	dep	34	SENT_333	[p15l10t2561r210b2644],
37	.	.	O	.	_	0	SENT_333	[p15l10t2561r210b2644],

1	We	PRP	O	we	nsubj	2	SENT_334	[p15l264t2564r395b2630],
2	note	VBP	O	note	_	0	SENT_334	[p15l451t2581r603b2630],
3	that	IN	O	that	complm	26	SENT_334	[p15l657t2563r799b2630],
4	the	DT	O	the	det	5	SENT_334	[p15l851t2563r961b2630],
5	percentage	NN	O	percentage	nsubj	26	SENT_334	[p15l1015t2581r1394b2653],
6	of	IN	O	of	_	0	SENT_334	[p15l1450t2563r1529b2630],
7	30-day	JJ	DURATION	30-day	amod	10	SENT_334	[p15l1572t2564r1819b2653],
8	optimal	JJ	O	optimal	amod	10	SENT_334	[p15l1870t2563r2141b2653],
9	responder	NN	O	responder	nn	10	SENT_334	[p15l10t2670r360b2760],
10	patients	NNS	O	patient	prep_of	5	SENT_334	[p15l409t2673r686b2760],
11	attributable	JJ	O	attributable	amod	10	SENT_334	[p15l742t2670r1146b2737],
12	to	TO	O	to	_	0	SENT_334	[p15l1199t2687r1267b2737],
13	high-dose	JJ	O	high-dose	amod	16	SENT_334	[p15l1321t2670r1675b2760],
14	atorvastatin	NN	O	atorvastatin	nn	16	SENT_334	[p15l1730t2673r2140b2737],
15	(	CD	NUMBER	(	num	16	SENT_334	[p15l13t2774r291b2857],
16	~	NN	O	~	prep_to	11	SENT_334	[p15l13t2774r291b2857],
17	26	CD	NUMBER	26	num	18	SENT_334	[p15l13t2774r291b2857],
18	°	CD	NUMBER	°	dep	10	SENT_334	[p15l13t2774r291b2857],
19	/	:	O	/	punct	18	SENT_334	[p15l13t2774r291b2857],
20	0	CD	NUMBER	0	num	21	SENT_334	[p15l13t2774r291b2857],
21	)	NN	O	)	nsubj	23	SENT_334	[p15l13t2774r291b2857],
22	was	VBD	O	be	cop	23	SENT_334	[p15l329t2803r458b2843],
23	similar	JJ	O	similar	dep	18	SENT_334	[p15l499t2776r738b2843],
24	to	TO	O	to	_	0	SENT_334	[p15l773t2794r841b2843],
25	that	DT	O	that	prep_to	23	SENT_334	[p15l880t2776r1021b2843],
26	reported	VBN	O	report	ccomp	2	SENT_334	[p15l1056t2776r1355b2866],
27	with	IN	O	with	_	0	SENT_334	[p15l1388t2776r1550b2843],
28	the	DT	O	the	det	29	SENT_334	[p15l1587t2776r1697b2843],
29	switch	NN	O	switch	prep_with	26	SENT_334	[p15l1737t2776r1961b2843],
30	to	TO	O	to	_	0	SENT_334	[p15l1999t2793r2067b2843],
31	a	DT	O	a	det	32	SENT_334	[p15l2107t2803r2142b2843],
32	non	JJ	O	non	prep_to	26	SENT_334	[p15l11t2881r995b2949],
33	.	.	O	.	_	0	SENT_334	[p15l11t2881r995b2949],

1	—	NN	O	—	_	0	SENT_335	[p15l11t2881r995b2949],
2	.	.	O	.	_	0	SENT_335	[p15l11t2881r995b2949],

1	CYP3A4	NN	O	cyp3a4	_	0	SENT_336	[p15l11t2881r995b2949],
2	.	.	O	.	_	0	SENT_336	[p15l11t2881r995b2949],

1	—	NN	O	—	_	0	SENT_337	[p15l11t2881r995b2949],
2	.	.	O	.	_	0	SENT_337	[p15l11t2881r995b2949],

1	metabolized	VBN	O	metabolize	_	0	SENT_338	[p15l11t2881r995b2949],
2	statin	JJ	O	statin	amod	4	SENT_338	[p15l1020t2885r1212b2949],
3	(	NN	O	(	nn	4	SENT_338	[p15l1240t2880r1518b2963],
4	~	NN	O	~	nsubj	6	SENT_338	[p15l1240t2880r1518b2963],
5	24	CD	PERCENT	24	num	6	SENT_338	[p15l1240t2880r1518b2963],
6	%	NN	PERCENT	%	ccomp	1	SENT_338	[p15l1240t2880r1518b2963],
7	)	CD	NUMBER	)	dobj	6	SENT_338	[p15l1240t2880r1518b2963],
8	in	IN	O	in	_	0	SENT_338	[p15l1546t2885r1614b2948],
9	stable	JJ	O	stable	amod	10	SENT_338	[p15l1640t2883r1837b2949],
10	patients	NNS	O	patient	prep_in	7	SENT_338	[p15l1862t2885r2138b2972],
11	with	IN	O	with	_	0	SENT_338	[p15l7t2987r167b3053],
12	I-ITPR	NN	O	i-itpr	prep_with	10	SENT_338	[p15l196t2986r449b3052],
13	while	IN	O	while	dep	6	SENT_338	[p15l470t2987r662b3053],
14	on	IN	O	on	_	0	SENT_338	[p15l691t3013r778b3053],
15	chronic	JJ	O	chronic	amod	16	SENT_338	[p15l807t2987r1070b3053],
16	coadministration	NN	O	coadministration	prep_on	6	SENT_338	[p15l1097t2987r1696b3053],
17	of	IN	O	of	_	0	SENT_338	[p15l1724t2987r1804b3053],
18	low	JJ	O	low	amod	20	SENT_338	[p15l1818t2987r2139b3053],
19	—	NN	O	—	nn	20	SENT_338	[p15l1818t2987r2139b3053],
20	dose	NN	O	dose	prep_of	16	SENT_338	[p15l1818t2987r2139b3053],

1	(	NN	O	(	nn	4	SENT_339	[p15l13t3091r124b3174],
2	10	CD	NUMBER	10	num	4	SENT_339	[p15l13t3091r124b3174],
3	mg	NN	O	mg	nn	4	SENT_339	[p15l163t3091r299b3183],
4	)	NN	O	)	_	0	SENT_339	[p15l163t3091r299b3183],
5	atorvastatin	NN	O	atorvastatin	dep	4	SENT_339	[p15l343t3096r752b3160],
6	and	CC	O	and	_	0	SENT_339	[p15l791t3093r919b3160],
7	standard	JJ	O	standard	amod	10	SENT_339	[p15l957t3093r1454b3160],
8	—	NN	O	—	nn	10	SENT_339	[p15l957t3093r1454b3160],
9	dose	NN	O	dose	nn	10	SENT_339	[p15l957t3093r1454b3160],
10	clopidogrel	NN	O	clopidogrel	conj_and	5	SENT_339	[p15l1493t3093r1888b3183],
11	in	IN	O	in	_	0	SENT_339	[p15l1924t3096r1992b3159],
12	the	DT	O	the	det	13	SENT_339	[p15l2029t3093r2139b3160],
13	ACCEL	NNP	ORGANIZATION	ACCEL	prep_in	4	SENT_339	[p15l8t3198r711b3266],
14	.	.	O	.	_	0	SENT_339	[p15l8t3198r711b3266],

1	—	NN	O	—	_	0	SENT_340	[p15l8t3198r711b3266],
2	.	.	O	.	_	0	SENT_340	[p15l8t3198r711b3266],

1	STATIN	JJ	O	statin	amod	2	SENT_341	[p15l8t3198r711b3266],
2	(	NN	O	(	nsubj	3	SENT_341	[p15l779t3197r1230b3280],
3	Accelerated	VBN	O	accelerate	_	0	SENT_341	[p15l779t3197r1230b3280],
4	Platelet	NN	O	platelet	nn	5	SENT_341	[p15l1293t3200r1566b3266],
5	Inhibition	NN	O	inhibition	dobj	3	SENT_341	[p15l1627t3200r1995b3266],
6	by	IN	O	by	_	0	SENT_341	[p15l2057t3200r2144b3289],
7	Switching	VBG	O	switch	prepc_by	3	SENT_341	[p15l14t3305r398b3395],
8	From	IN	O	from	_	0	SENT_341	[p15l466t3306r672b3372],
9	Atorvastatin	NNP	O	Atorvastatin	prep_from	7	SENT_341	[p15l740t3304r1222b3372],
10	to	TO	O	to	_	0	SENT_341	[p15l1291t3322r1363b3372],
11	a	DT	O	a	det	12	SENT_341	[p15l1435t3332r1470b3372],
12	Non	NNP	O	Non	prep_to	7	SENT_341	[p15l1537t3304r2137b3372],
13	.	.	O	.	_	0	SENT_341	[p15l1537t3304r2137b3372],

1	—	NN	O	—	_	0	SENT_342	[p15l1537t3304r2137b3372],
2	.	.	O	.	_	0	SENT_342	[p15l1537t3304r2137b3372],

1	CYP3A4	NN	O	cyp3a4	nn	2	SENT_343	[p15l1537t3304r2137b3372],
2	Leoncini	NNP	O	Leoncini	_	0	SENT_343	[p15l1440t3410r1656b3453],
3	et	FW	O	et	nn	4	SENT_343	[p15l1684t3412r1736b3453],
4	al.	FW	O	al.	dep	2	SENT_343	[p15l1759t3410r1816b3453],
5	177	CD	NUMBER	177	dep	2	SENT_343	[p15l2035t3409r2138b3452],

1	High-Dose	JJ	O	high-dose	amod	2	SENT_344	[p15l587t3492r852b3545],
2	Atorvastatin	NN	O	atorvastatin	_	0	SENT_344	[p15l873t3492r1192b3534],
3	and	CC	O	and	_	0	SENT_344	[p15l1217t3492r1312b3534],
4	Platelet	NN	O	platelet	nn	5	SENT_344	[p15l1339t3492r1540b3534],
5	Reactivity	NN	O	reactivity	conj_and	2	SENT_344	[p15l1565t3492r1821b3545],

1	Metabolized	VBN	O	metabolize	_	0	SENT_345	[p16l8t87r457b154],
2	Statin	NN	O	statin	dobj	1	SENT_345	[p16l498t87r706b154],
3	in	IN	O	in	_	0	SENT_345	[p16l744t90r812b153],
4	Patients	NNS	O	patient	prep_in	1	SENT_345	[p16l851t88r1134b154],
5	With	IN	O	with	_	0	SENT_345	[p16l1171t87r1364b154],
6	High	JJ	O	high	amod	8	SENT_345	[p16l1403t87r1590b177],
7	Platelet	NN	O	platelet	nn	8	SENT_345	[p16l1629t87r1896b154],
8	Reactivity	NN	O	reactivity	prep_with	1	SENT_345	[p16l1935t88r2137b154, p16l10t191r214b283],
9	)	CD	NUMBER	)	num	10	SENT_345	[p16l1935t88r2137b154, p16l10t191r214b283],
10	study	NN	O	study	dep	8	SENT_345	[p16l256t193r445b283],
11	(	CD	NUMBER	(	number	12	SENT_345	[p16l481t191r641b274],
12	28	CD	NUMBER	28	num	13	SENT_345	[p16l481t191r641b274],
13	)	NN	O	)	dep	10	SENT_345	[p16l481t191r641b274],
14	.	.	O	.	_	0	SENT_345	[p16l481t191r641b274],

1	The	DT	O	the	det	3	SENT_346	[p16l680t192r826b260],
2	2	CD	NUMBER	2	num	3	SENT_346	[p16l862t197r904b261],
3	studies	NNS	O	study	nsubj	5	SENT_346	[p16l944t193r1182b260],
4	were	VBD	O	be	cop	5	SENT_346	[p16l1217t219r1384b260],
5	different	JJ	O	different	_	0	SENT_346	[p16l1423t193r1719b260],
6	for	IN	O	for	_	0	SENT_346	[p16l1755t193r1855b260],
7	design	NN	O	design	prep_for	5	SENT_346	[p16l1892t193r2137b283],
8	,	,	O	,	_	0	SENT_346	[p16l1892t193r2137b283],
9	clinical	JJ	O	clinical	amod	12	SENT_346	[p16l11t300r259b367],
10	and	CC	O	and	_	0	SENT_346	[p16l302t300r430b367],
11	genetic	JJ	O	genetic	conj_and	9	SENT_346	[p16l471t303r724b390],
12	characteristics	NNS	O	characteristic	prep_for	5	SENT_346	[p16l766t300r1260b367],
13	of	IN	O	of	_	0	SENT_346	[p16l1305t300r1385b367],
14	patient	NN	O	patient	nn	15	SENT_346	[p16l1415t303r1663b390],
15	populations	NNS	O	population	prep_of	12	SENT_346	[p16l1703t300r2137b390],
16	,	,	O	,	_	0	SENT_346	[p16l1703t300r2137b390],
17	and	CC	O	and	_	0	SENT_346	[p16l12t406r139b473],
18	strategy	NN	O	strategy	conj_and	7	SENT_346	[p16l170t423r460b496],
19	:	:	O	:	_	0	SENT_346	[p16l170t423r460b496],
20	in	IN	O	in	_	0	SENT_346	[p16l495t409r563b472],
21	this	DT	O	this	det	23	SENT_346	[p16l593t406r720b473],
22	ACHIDO	NN	O	achido	nn	23	SENT_346	[p16l750t405r1133b473],
23	study	NN	O	study	prep_in	28	SENT_346	[p16l1168t406r1372b496],
24	,	,	O	,	_	0	SENT_346	[p16l1168t406r1372b496],
25	high-dose	JJ	O	high-dose	amod	26	SENT_346	[p16l1406t406r1761b496],
26	atorvastatin	NN	O	atorvastatin	nsubjpass	28	SENT_346	[p16l1794t423r2137b473, p16l10t515r106b579],
27	was	VBD	O	be	auxpass	28	SENT_346	[p16l145t539r274b579],
28	added	VBN	O	add	parataxis	5	SENT_346	[p16l320t512r531b579],
29	in	IN	O	in	_	0	SENT_346	[p16l572t515r640b578],
30	separate	JJ	O	separate	amod	33	SENT_346	[p16l684t529r966b602],
31	administration	NN	O	administration	nn	33	SENT_346	[p16l1011t512r1529b579],
32	(	NN	O	(	nn	33	SENT_346	[p16l1575t510r2012b593],
33	atorvastatin	NN	O	atorvastatin	prep_in	28	SENT_346	[p16l1575t510r2012b593],
34	10	CD	TIME	10	num	35	SENT_346	[p16l2059t516r2139b579],
35	PM	NN	TIME	pm	dep	33	SENT_346	[p16l10t638r125b699],
36	,	,	O	,	_	0	SENT_346	[p16l10t638r125b699],
37	clopidogrel	NN	O	clopidogrel	appos	33	SENT_346	[p16l160t618r554b708],
38	8	CD	TIME	8	num	37	SENT_346	[p16l587t622r622b685],
39	AM	NNP	TIME	AM	dep	37	SENT_346	[p16l654t616r786b699],
40	)	CD	NUMBER	)	num	39	SENT_346	[p16l654t616r786b699],
41	to	TO	O	to	_	0	SENT_346	[p16l821t636r889b685],
42	double	JJ	O	double	amod	45	SENT_346	[p16l922t618r1354b685],
43	—	JJ	O	—	amod	45	SENT_346	[p16l922t618r1354b685],
44	dose	NN	O	dose	nn	45	SENT_346	[p16l922t618r1354b685],
45	clopidogrel	NN	O	clopidogrel	prep_to	28	SENT_346	[p16l1387t618r1781b708],
46	in	IN	O	in	_	0	SENT_346	[p16l1811t621r1879b684],
47	statinnaive	JJ	O	statinnaive	amod	49	SENT_346	[p16l1912t621r2137b685, p16l11t727r191b791],
48	HTPR	NN	O	htpr	nn	49	SENT_346	[p16l226t723r479b790],
49	patients	NNS	O	patient	prep_in	45	SENT_346	[p16l507t727r784b814],
50	already	RB	O	already	advmod	49	SENT_346	[p16l821t724r1072b814],
51	on	IN	O	on	_	0	SENT_346	[p16l1101t751r1189b791],
52	clopidogrel	NN	O	clopidogrel	prep_on	49	SENT_346	[p16l1223t724r1617b814],
53	(	CD	NUMBER	(	number	54	SENT_346	[p16l1652t722r1761b805],
54	75	CD	NUMBER	75	dep	49	SENT_346	[p16l1652t722r1761b805],
55	mg	NN	O	mg	nn	56	SENT_346	[p16l1798t722r1956b814],
56	)	NN	O	)	dep	54	SENT_346	[p16l1798t722r1956b814],
57	.	.	O	.	_	0	SENT_346	[p16l1798t722r1956b814],

1	The	DT	O	the	det	3	SENT_347	[p16l96t829r243b897],
2	minimal	JJ	O	minimal	amod	3	SENT_347	[p16l273t831r569b897],
3	impact	NN	O	impact	nsubj	11	SENT_347	[p16l596t833r838b920],
4	on	IN	O	on	_	0	SENT_347	[p16l866t857r953b897],
5	HTPR	NN	O	htpr	prep_on	3	SENT_347	[p16l983t829r1235b896],
6	with	IN	O	with	_	0	SENT_347	[p16l1258t830r1419b897],
7	only	RB	O	only	advmod	9	SENT_347	[p16l1448t831r1601b920],
8	150-mg	JJ	O	150-mg	amod	9	SENT_347	[p16l1630t830r1908b920],
9	clopidogrel	NN	O	clopidogrel	prep_with	5	SENT_347	[p16l1935t830r2137b920, p16l11t936r246b1026],
10	is	VBZ	O	be	cop	11	SENT_347	[p16l312t939r365b1003],
11	consistent	JJ	O	consistent	_	0	SENT_347	[p16l435t939r814b1003],
12	with	IN	O	with	mark	17	SENT_347	[p16l876t936r1045b1003],
13	ﬁndings	NNS	O	ﬁndings	nsubj	17	SENT_347	[p16l1112t936r1412b1026],
14	of	IN	O	of	_	0	SENT_347	[p16l1481t936r1564b1003],
15	other	JJ	O	other	amod	16	SENT_347	[p16l1620t936r1817b1003],
16	studies	NNS	O	study	prep_of	13	SENT_347	[p16l1884t936r2138b1003],
17	(	VBP	O	(	advcl	11	SENT_347	[p16l13t1040r395b1123],
18	13,15,29	CD	NUMBER	13,15,29	number	19	SENT_347	[p16l13t1040r395b1123],
19	)	CD	NUMBER	)	dobj	17	SENT_347	[p16l13t1040r395b1123],
20	.	.	O	.	_	0	SENT_347	[p16l13t1040r395b1123],

1	Furthermore	RB	O	furthermore	advmod	20	SENT_348	[p16l439t1043r912b1123],
2	,	,	O	,	_	0	SENT_348	[p16l439t1043r912b1123],
3	similar	JJ	O	similar	ccomp	20	SENT_348	[p16l955t1043r1194b1109],
4	to	TO	O	to	_	0	SENT_348	[p16l1231t1060r1299b1109],
5	previous	JJ	O	previous	amod	6	SENT_348	[p16l1339t1045r1632b1132],
6	studies	NNS	O	study	prep_to	3	SENT_348	[p16l1674t1042r1912b1109],
7	using	VBG	O	use	partmod	6	SENT_348	[p16l1952t1045r2142b1132],
8	standard	JJ	O	standard	amod	12	SENT_348	[p16l11t1148r313b1215],
9	(	NN	O	(	nn	12	SENT_348	[p16l366t1146r474b1229],
10	75	CD	NUMBER	75	num	12	SENT_348	[p16l366t1146r474b1229],
11	mg	NN	O	mg	nn	12	SENT_348	[p16l529t1146r665b1238],
12	)	NN	O	)	nsubj	14	SENT_348	[p16l529t1146r665b1238],
13	maintenance	NN	O	maintenance	nn	14	SENT_348	[p16l720t1151r1168b1215],
14	dose	NN	O	dose	xcomp	7	SENT_348	[p16l1221t1148r1375b1215],
15	of	IN	O	of	_	0	SENT_348	[p16l1427t1148r1507b1215],
16	clopidogrel	NN	O	clopidogrel	prep_of	14	SENT_348	[p16l1546t1148r1959b1238],
17	,	,	O	,	_	0	SENT_348	[p16l1546t1148r1959b1238],
18	this	DT	O	this	det	19	SENT_348	[p16l2012t1149r2138b1215],
19	study	NN	O	study	nsubj	20	SENT_348	[p16l11t1255r200b1345],
20	shows	VBZ	O	show	_	0	SENT_348	[p16l227t1256r437b1322],
21	a	DT	O	a	det	23	SENT_348	[p16l468t1282r503b1322],
22	temporal	JJ	O	temporal	amod	23	SENT_348	[p16l530t1255r847b1345],
23	variability	NN	O	variability	dobj	20	SENT_348	[p16l871t1255r1225b1345],
24	in	IN	O	in	_	0	SENT_348	[p16l1249t1258r1317b1321],
25	platelet	NN	O	platelet	nn	26	SENT_348	[p16l1344t1255r1606b1345],
26	reactivity	NN	O	reactivity	prep_in	23	SENT_348	[p16l1632t1258r1957b1345],
27	even	RB	O	even	advmod	20	SENT_348	[p16l1982t1282r2140b1322],
28	with	IN	O	with	_	0	SENT_348	[p16l7t1361r168b1428],
29	150	CD	NUMBER	150	number	30	SENT_348	[p16l212t1361r490b1451],
30	—	CD	NUMBER	—	num	32	SENT_348	[p16l212t1361r490b1451],
31	mg	NN	O	mg	nn	32	SENT_348	[p16l212t1361r490b1451],
32	clopidogrel	NN	O	clopidogrel	prep_with	20	SENT_348	[p16l529t1361r924b1451],
33	(	CD	NUMBER	(	number	34	SENT_348	[p16l966t1359r1125b1442],
34	30	CD	NUMBER	30	num	35	SENT_348	[p16l966t1359r1125b1442],
35	)	NN	O	)	dep	32	SENT_348	[p16l966t1359r1125b1442],
36	.	.	O	.	_	0	SENT_348	[p16l966t1359r1125b1442],

1	The	DT	O	the	det	4	SENT_349	[p16l1166t1360r1313b1428],
2	late	JJ	O	late	amod	4	SENT_349	[p16l1353t1361r1477b1428],
3	slight	JJ	O	slight	amod	4	SENT_349	[p16l1519t1361r1713b1451],
4	increase	NN	O	increase	nsubj	24	SENT_349	[p16l1752t1364r2031b1428],
5	of	IN	O	of	_	0	SENT_349	[p16l2072t1361r2152b1428],
6	PRU	NNP	ORGANIZATION	PRU	nn	7	SENT_349	[p16l10t1468r190b1534],
7	values	NNS	O	value	prep_of	4	SENT_349	[p16l213t1468r425b1534],
8	(	CD	NUMBER	(	dep	12	SENT_349	[p16l458t1465r654b1548],
9	from	IN	O	from	_	0	SENT_349	[p16l458t1465r654b1548],
10	T	NN	O	t	prep_from	8	SENT_349	[p16l679t1466r817b1533],
11	—	CD	NUMBER	—	dep	12	SENT_349	[p16l679t1466r817b1533],
12	1	CD	NUMBER	1	dep	17	SENT_349	[p16l679t1466r817b1533],
13	to	TO	O	to	_	0	SENT_349	[p16l849t1485r917b1534],
14	T	NN	O	t	nn	15	SENT_349	[p16l944t1465r1111b1548],
15	—	NN	O	—	prep_to	12	SENT_349	[p16l944t1465r1111b1548],
16	2	CD	NUMBER	2	num	17	SENT_349	[p16l944t1465r1111b1548],
17	)	NN	O	)	dep	4	SENT_349	[p16l944t1465r1111b1548],
18	in	IN	O	in	_	0	SENT_349	[p16l1143t1470r1210b1533],
19	the	DT	O	the	det	21	SENT_349	[p16l1239t1468r1348b1534],
20	control	NN	O	control	nn	21	SENT_349	[p16l1378t1467r1629b1534],
21	group	NN	O	group	prep_in	4	SENT_349	[p16l1654t1493r1859b1557],
22	may	MD	O	may	aux	24	SENT_349	[p16l1889t1494r2037b1557],
23	be	VB	O	be	cop	24	SENT_349	[p16l2059t1468r2139b1534],
24	due	JJ	O	due	_	0	SENT_349	[p16l11t1573r135b1640],
25	to	TO	O	to	_	0	SENT_349	[p16l188t1591r256b1640],
26	the	DT	O	the	det	28	SENT_349	[p16l310t1573r420b1640],
27	metabolic	JJ	O	metabolic	amod	28	SENT_349	[p16l474t1573r819b1640],
28	adaptation	NN	O	adaptation	prep_to	24	SENT_349	[p16l872t1573r1245b1663],
29	to	TO	O	to	_	0	SENT_349	[p16l1297t1591r1365b1640],
30	the	DT	O	the	det	32	SENT_349	[p16l1419t1573r1529b1640],
31	higher	JJR	O	higher	amod	32	SENT_349	[p16l1582t1573r1812b1663],
32	dose	NN	O	dose	prep_to	24	SENT_349	[p16l1863t1573r2018b1640],
33	of	IN	O	of	_	0	SENT_349	[p16l2073t1573r2152b1640],
34	clopidogrel	NN	O	clopidogrel	prep_of	32	SENT_349	[p16l11t1679r422b1769],
35	.	.	O	.	_	0	SENT_349	[p16l11t1679r422b1769],

1	This	DT	O	this	det	2	SENT_350	[p16l458t1678r622b1746],
2	effect	NN	O	effect	nsubj	5	SENT_350	[p16l659t1679r844b1746],
3	does	VBZ	O	do	aux	5	SENT_350	[p16l878t1679r1032b1746],
4	not	RB	O	not	neg	5	SENT_350	[p16l1069t1697r1187b1746],
5	take	VB	O	take	_	0	SENT_350	[p16l1219t1680r1364b1746],
6	place	NN	O	place	dobj	5	SENT_350	[p16l1398t1680r1576b1769],
7	in	IN	O	in	_	0	SENT_350	[p16l1611t1682r1679b1745],
8	the	DT	O	the	det	12	SENT_350	[p16l1713t1679r1823b1746],
9	atorvas	NN	O	atorva	nn	12	SENT_350	[p16l1860t1696r2137b1746],
10	—	NN	O	—	nn	12	SENT_350	[p16l1860t1696r2137b1746],
11	tatin	NN	O	tatin	nn	12	SENT_350	[p16l10t1788r172b1852],
12	group	NN	O	group	prep_in	6	SENT_350	[p16l196t1811r400b1875],
13	as	IN	O	as	_	0	SENT_350	[p16l427t1812r490b1852],
14	reﬂected	JJ	O	reﬂected	prep_as	5	SENT_350	[p16l516t1785r817b1852],
15	in	IN	O	in	_	0	SENT_350	[p16l841t1788r908b1851],
16	the	DT	O	the	det	18	SENT_350	[p16l933t1786r1043b1852],
17	further	JJ	O	further	amod	18	SENT_350	[p16l1067t1785r1313b1852],
18	increase	NN	O	increase	prep_in	5	SENT_350	[p16l1336t1788r1615b1852],
19	in	IN	O	in	_	0	SENT_350	[p16l1640t1788r1707b1851],
20	the	DT	O	the	det	21	SENT_350	[p16l1731t1785r1842b1852],
21	number	NN	O	number	prep_in	18	SENT_350	[p16l1868t1785r2142b1852],
22	of	IN	O	of	_	0	SENT_350	[p16l11t1891r90b1958],
23	optimal	JJ	O	optimal	amod	24	SENT_350	[p16l138t1891r410b1981],
24	responders	NNS	O	responder	prep_of	21	SENT_350	[p16l467t1891r846b1981],
25	at	IN	O	at	_	0	SENT_350	[p16l908t1909r971b1958],
26	T-2	NN	O	t-2	prep_at	5	SENT_350	[p16l1025t1890r1186b1959],
27	.	.	O	.	_	0	SENT_350	[p16l1025t1890r1186b1959],

1	This	DT	DATE	this	nsubj	3	SENT_351	[p16l1246t1890r1410b1958],
2	may	MD	DATE	may	aux	3	SENT_351	[p16l1471t1918r1619b1981],
3	have	VB	O	have	_	0	SENT_351	[p16l1674t1891r1832b1958],
4	clinical	JJ	O	clinical	amod	5	SENT_351	[p16l1894t1891r2141b1958],
5	relevance	NN	O	relevance	dobj	3	SENT_351	[p16l10t1998r333b2065],
6	because	IN	O	because	mark	9	SENT_351	[p16l360t1998r629b2065],
7	prior	JJ	O	prior	amod	8	SENT_351	[p16l657t2001r831b2088],
8	investigations	NNS	O	investigation	nsubj	9	SENT_351	[p16l858t2001r1340b2088],
9	show	VBP	O	show	advcl	3	SENT_351	[p16l1372t1998r1555b2065],
10	that	IN	O	that	complm	18	SENT_351	[p16l1580t1998r1721b2065],
11	the	DT	O	the	det	13	SENT_351	[p16l1748t1998r1858b2065],
12	predictive	JJ	O	predictive	amod	13	SENT_351	[p16l1886t1998r2137b2088, p16l10t2107r134b2171],
13	value	NN	O	value	nsubj	18	SENT_351	[p16l156t2104r337b2171],
14	of	IN	O	of	_	0	SENT_351	[p16l363t2104r443b2171],
15	platelet	NN	O	platelet	nn	16	SENT_351	[p16l454t2104r715b2194],
16	reactivity	NN	O	reactivity	prep_of	13	SENT_351	[p16l737t2107r1062b2194],
17	Was	VBD	O	be	cop	18	SENT_351	[p16l1079t2131r1208b2171],
18	higher	JJR	O	higher	ccomp	9	SENT_351	[p16l1234t2104r1463b2194],
19	when	WRB	O	when	advmod	20	SENT_351	[p16l1483t2104r1677b2171],
20	evaluated	VBN	O	evaluate	ccomp	18	SENT_351	[p16l1702t2104r2031b2171],
21	30	CD	DURATION	30	num	22	SENT_351	[p16l2056t2108r2139b2171],
22	days	NNS	NUMBER	day	npadvmod	20	SENT_351	[p16l11t2210r160b2300],
23	after	IN	O	after	_	0	SENT_351	[p16l196t2210r355b2277],
24	PCI	NN	O	pcus	prep_after	20	SENT_351	[p16l386t2210r534b2277],
25	(	CD	NUMBER	(	number	26	SENT_351	[p16l572t2208r731b2291],
26	30	CD	NUMBER	30	num	27	SENT_351	[p16l572t2208r731b2291],
27	)	NN	O	)	dobj	20	SENT_351	[p16l572t2208r731b2291],
28	.	.	O	.	_	0	SENT_351	[p16l572t2208r731b2291],

1	Age	NNP	O	Age	nsubj	23	SENT_352	[p16l96t2315r262b2406],
2	,	,	O	,	_	0	SENT_352	[p16l96t2315r262b2406],
3	carrier	NN	O	carrier	nn	4	SENT_352	[p16l302t2319r526b2383],
4	status	NN	O	status	dep	11	SENT_352	[p16l562t2334r758b2383],
5	of	IN	O	of	_	0	SENT_352	[p16l796t2316r876b2383],
6	CYP2C	NN	O	cyp2c	prep_of	4	SENT_352	[p16l906t2320r1320b2383],
7	]	CD	NUMBER	]	num	6	SENT_352	[p16l906t2320r1320b2383],
8	9	CD	NUMBER	9	num	9	SENT_352	[p16l906t2320r1320b2383],
9	*	NN	O	*	dep	11	SENT_352	[p16l906t2320r1320b2383],
10	2	CD	NUMBER	2	num	11	SENT_352	[p16l906t2320r1320b2383],
11	loss	NN	O	loss	dep	1	SENT_352	[p16l1354t2316r1926b2383],
12	—	CD	NUMBER	—	num	14	SENT_352	[p16l1354t2316r1926b2383],
13	of-function	JJ	O	of-function	amod	14	SENT_352	[p16l1354t2316r1926b2383],
14	allele	NN	O	allele	dep	11	SENT_352	[p16l1963t2316r2139b2383],
15	and	CC	O	and	_	0	SENT_352	[p16l12t2422r139b2489],
16	higher	JJR	O	higher	amod	18	SENT_352	[p16l174t2422r403b2512],
17	PRU	NNP	ORGANIZATION	PRU	nn	18	SENT_352	[p16l438t2423r617b2489],
18	values	NNS	O	value	dep	11	SENT_352	[p16l649t2422r861b2489],
19	are	VBP	O	be	cop	23	SENT_352	[p16l900t2448r1000b2489],
20	the	DT	O	the	det	23	SENT_352	[p16l1037t2422r1147b2489],
21	baseline	NN	O	baseline	nn	23	SENT_352	[p16l1182t2422r1463b2489],
22	clinical	JJ	O	clinical	amod	23	SENT_352	[p16l1501t2422r1749b2489],
23	characteristics	NNS	O	characteristic	_	0	SENT_352	[p16l1785t2422r2137b2489, p16l10t2531r181b2595],
24	associated	VBN	O	associate	partmod	23	SENT_352	[p16l211t2528r563b2595],
25	with	IN	O	with	_	0	SENT_352	[p16l585t2528r746b2595],
26	HTPR	NN	ORGANIZATION	htpr	prep_with	24	SENT_352	[p16l774t2527r1027b2594],
27	at	IN	O	at	_	0	SENT_352	[p16l1052t2546r1115b2595],
28	30	CD	DURATION	30	num	29	SENT_352	[p16l1142t2532r1225b2595],
29	days	NNS	NUMBER	day	prep_at	24	SENT_352	[p16l1254t2528r1422b2618],
30	.	.	O	.	_	0	SENT_352	[p16l1254t2528r1422b2618],

1	Baseline	NN	O	baseline	nn	4	SENT_353	[p16l1454t2529r1747b2595],
2	high	JJ	O	high	amod	4	SENT_353	[p16l1775t2528r1934b2618],
3	PRU	NN	O	pru	nn	4	SENT_353	[p16l1961t2529r2141b2595],
4	values	NNS	O	value	nsubj	14	SENT_353	[p16l7t2635r218b2701],
5	(	VBP	O	(	_	0	SENT_353	[p16l253t2632r510b2715],
6	2298	CD	DATE	2298	number	7	SENT_353	[p16l253t2632r510b2715],
7	)	CD	NUMBER	)	nsubj	12	SENT_353	[p16l253t2632r510b2715],
8	are	VBP	O	be	cop	12	SENT_353	[p16l545t2660r645b2701],
9	the	DT	O	the	det	12	SENT_353	[p16l676t2635r786b2701],
10	most	RBS	O	most	advmod	11	SENT_353	[p16l818t2652r992b2701],
11	powerful	JJ	O	powerful	amod	12	SENT_353	[p16l1019t2634r1332b2724],
12	covariate	NN	O	covariate	ccomp	5	SENT_353	[p16l1362t2637r1672b2701],
13	and	CC	O	and	_	0	SENT_353	[p16l1705t2634r1832b2701],
14	indicate	VBP	O	indicate	conj_and	5	SENT_353	[p16l1862t2634r2139b2701],
15	the	DT	O	the	det	16	SENT_353	[p16l10t2740r120b2807],
16	possibility	NN	O	possibility	dobj	14	SENT_353	[p16l160t2740r521b2830],
17	for	IN	O	for	_	0	SENT_353	[p16l558t2740r659b2807],
18	early	JJ	O	early	amod	19	SENT_353	[p16l699t2741r866b2830],
19	identification	NN	O	identification	prep_for	14	SENT_353	[p16l903t2740r1374b2807],
20	of	IN	O	of	_	0	SENT_353	[p16l1416t2740r1495b2807],
21	risk	NN	O	risk	prep_of	19	SENT_353	[p16l1524t2740r1654b2807],
22	of	IN	O	of	_	0	SENT_353	[p16l1692t2740r1772b2807],
23	persistent	JJ	O	persistent	amod	24	SENT_353	[p16l1800t2743r2142b2830],
24	high	JJ	O	high	amod	34	SENT_353	[p16l10t2847r169b2937],
25	nonresponse	JJ	O	nonresponse	amod	34	SENT_353	[p16l231t2873r671b2937],
26	even	RB	O	even	advmod	25	SENT_353	[p16l733t2874r890b2914],
27	to	TO	O	to	_	0	SENT_353	[p16l951t2865r1018b2914],
28	higher	JJR	O	higher	amod	29	SENT_353	[p16l1080t2847r1309b2937],
29	doses	NNS	O	dose	prep_to	25	SENT_353	[p16l1369t2847r1555b2914],
30	of	IN	O	of	_	0	SENT_353	[p16l1618t2847r1698b2914],
31	clopidogrel	NN	O	clopidogrel	prep_of	29	SENT_353	[p16l1747t2847r2141b2937],
32	(	CD	NUMBER	(	number	33	SENT_353	[p16l13t2951r284b3034],
33	15,31	CD	NUMBER	15,31	num	31	SENT_353	[p16l13t2951r284b3034],
34	)	NN	O	)	prep_of	21	SENT_353	[p16l13t2951r284b3034],
35	.	.	O	.	_	0	SENT_353	[p16l13t2951r284b3034],

1	We	PRP	O	we	nsubj	4	SENT_354	[p16l344t2954r474b3020],
2	must	MD	O	must	aux	4	SENT_354	[p16l536t2970r710b3020],
3	also	RB	O	also	advmod	4	SENT_354	[p16l769t2954r899b3020],
4	point	VB	O	point	_	0	SENT_354	[p16l959t2956r1148b3043],
5	out	RP	O	out	prt	4	SENT_354	[p16l1207t2970r1321b3020],
6	that	IN	O	that	complm	11	SENT_354	[p16l1379t2954r1521b3020],
7	treatment	NN	O	treatment	nsubj	11	SENT_354	[p16l1578t2970r1925b3020],
8	with	IN	O	with	_	0	SENT_354	[p16l1979t2953r2140b3020],
9	high-dose	JJ	O	high-dose	amod	10	SENT_354	[p16l10t3059r364b3149],
10	atorvastatin	NN	O	atorvastatin	prep_with	7	SENT_354	[p16l395t3062r805b3126],
11	had	VBD	O	have	ccomp	4	SENT_354	[p16l834t3059r964b3126],
12	a	DT	O	a	det	14	SENT_354	[p16l993t3086r1027b3126],
13	predictive	JJ	O	predictive	amod	14	SENT_354	[p16l1053t3059r1399b3149],
14	value	NN	O	value	nsubj	15	SENT_354	[p16l1425t3060r1606b3126],
15	similar	JJ	O	similar	xcomp	11	SENT_354	[p16l1637t3059r1876b3126],
16	to	TO	O	to	_	0	SENT_354	[p16l1902t3076r1971b3126],
17	that	DT	O	that	prep_to	15	SENT_354	[p16l2000t3059r2142b3126],
18	of	IN	O	of	_	0	SENT_354	[p16l11t3164r90b3230],
19	noncarrier	JJ	O	noncarrier	amod	20	SENT_354	[p16l107t3167r470b3230],
20	status	NN	O	status	prep_of	17	SENT_354	[p16l498t3182r694b3230],
21	of	IN	O	of	_	0	SENT_354	[p16l725t3164r805b3230],
22	CYP2CJ9	NN	O	cyp2cj9	nn	23	SENT_354	[p16l827t3168r1241b3231],
23	*	NN	O	*	prep_of	17	SENT_354	[p16l827t3168r1241b3231],
24	2	CD	NUMBER	2	num	25	SENT_354	[p16l827t3168r1241b3231],
25	loss	NN	O	loss	dep	17	SENT_354	[p16l1267t3164r1838b3230],
26	—	CD	NUMBER	—	num	28	SENT_354	[p16l1267t3164r1838b3230],
27	of-function	JJ	O	of-function	amod	28	SENT_354	[p16l1267t3164r1838b3230],
28	allele	NN	O	allele	tmod	11	SENT_354	[p16l1868t3164r2044b3230],
29	in	IN	O	in	_	0	SENT_354	[p16l2073t3167r2140b3229],
30	this	DT	O	this	det	31	SENT_354	[p16l10t3270r136b3337],
31	study	NN	O	study	prep_in	28	SENT_354	[p16l173t3270r376b3360],
32	.	.	O	.	_	0	SENT_354	[p16l173t3270r376b3360],

1	To	TO	O	to	_	0	SENT_355	[p16l96t3375r201b3443],
2	date	NN	O	date	prep_to	19	SENT_355	[p16l232t3376r398b3457],
3	,	,	O	,	_	0	SENT_355	[p16l232t3376r398b3457],
4	the	DT	O	the	det	7	SENT_355	[p16l430t3376r540b3443],
5	exact	JJ	O	exact	amod	7	SENT_355	[p16l571t3394r748b3443],
6	biological	JJ	O	biological	amod	7	SENT_355	[p16l773t3376r1117b3466],
7	mechanisms	NNS	O	mechanism	nsubjpass	19	SENT_355	[p16l1146t3376r1577b3443],
8	involved	VBN	O	involve	partmod	7	SENT_355	[p16l1608t3376r1905b3443],
9	in	IN	O	in	_	0	SENT_355	[p16l1933t3379r2001b3442],
10	the	DT	O	the	det	12	SENT_355	[p16l2029t3376r2139b3443],
11	statin	NN	O	statin	nn	12	SENT_355	[p16l11t3485r204b3549],
12	modulation	NN	O	modulation	prep_in	8	SENT_355	[p16l241t3482r649b3549],
13	of	IN	O	of	_	0	SENT_355	[p16l686t3482r766b3549],
14	platelet	NN	O	platelet	nn	15	SENT_355	[p16l789t3482r1050b3572],
15	function	NN	O	function	prep_of	12	SENT_355	[p16l1085t3482r1382b3549],
16	are	VBP	O	be	auxpass	19	SENT_355	[p16l1420t3508r1520b3549],
17	not	RB	O	not	neg	19	SENT_355	[p16l1559t3500r1676b3549],
18	fully	RB	O	fully	advmod	19	SENT_355	[p16l1711t3482r1868b3572],
19	understood	VBN	O	understand	_	0	SENT_355	[p16l1900t3482r2137b3549, p16l11t3588r220b3655],
20	.	.	O	.	_	0	SENT_355	[p16l1900t3482r2137b3549, p16l11t3588r220b3655],

1	Both	DT	O	both	det	4	SENT_356	[p16l287t3588r463b3655],
2	lipid	NN	O	lipid	nn	4	SENT_356	[p16l523t3588r1033b3678],
3	—	CD	NUMBER	—	num	4	SENT_356	[p16l523t3588r1033b3678],
4	loWering	NN	O	lowering	nsubj	11	SENT_356	[p16l523t3588r1033b3678],
5	and	CC	O	and	_	0	SENT_356	[p16l1095t3588r1223b3655],
6	nonlipid	JJ	O	nonlipid	amod	9	SENT_356	[p16l1285t3588r1861b3678],
7	—	NN	O	—	nn	9	SENT_356	[p16l1285t3588r1861b3678],
8	related	JJ	O	related	amod	9	SENT_356	[p16l1285t3588r1861b3678],
9	effects	NNS	O	effect	conj_and	4	SENT_356	[p16l1923t3588r2137b3655],
10	probably	RB	O	probably	advmod	11	SENT_356	[p16l9t3696r320b3785],
11	contribute	VBP	O	contribute	_	0	SENT_356	[p16l354t3696r736b3776],
12	,	,	O	,	_	0	SENT_356	[p16l354t3696r736b3776],
13	because	IN	O	because	_	0	SENT_356	[p16l774t3696r1043b3762],
14	patients	NNS	O	patient	prep_because	11	SENT_356	[p16l1080t3698r1356b3785],
15	with	IN	O	with	_	0	SENT_356	[p16l1391t3695r1553b3762],
16	hypercholester	NN	O	hypercholester	nn	17	SENT_356	[p16l1590t3695r2137b3785],
17	—	NN	O	—	prep_with	14	SENT_356	[p16l1590t3695r2137b3785],

1	olemia	NN	O	olemia	nsubj	2	SENT_357	[p17l11t32r246b99],
2	have	VBP	O	have	_	0	SENT_357	[p17l271t32r429b99],
3	hyperreactive	JJ	O	hyperreactive	amod	4	SENT_357	[p17l456t32r924b122],
4	platelets	NNS	O	platelet	dobj	2	SENT_357	[p17l950t32r1239b122],
5	that	WDT	O	that	nsubj	7	SENT_357	[p17l1267t33r1408b99],
6	may	MD	O	may	aux	7	SENT_357	[p17l1434t59r1582b122],
7	normalize	VB	O	normalize	rcmod	4	SENT_357	[p17l1606t32r1955b99],
8	after	IN	O	after	_	0	SENT_357	[p17l1983t32r2142b99],
9	lipid	NN	O	lipid	nn	12	SENT_357	[p17l9t138r517b228],
10	—	CD	NUMBER	—	num	12	SENT_357	[p17l9t138r517b228],
11	lowering	NN	O	lowering	nn	12	SENT_357	[p17l9t138r517b228],
12	treatment	NN	O	treatment	prep_after	7	SENT_357	[p17l570t155r917b205],
13	(	CD	NUMBER	(	number	14	SENT_357	[p17l973t136r1132b219],
14	32	CD	NUMBER	32	num	15	SENT_357	[p17l973t136r1132b219],
15	)	NN	O	)	dep	7	SENT_357	[p17l973t136r1132b219],
16	.	.	O	.	_	0	SENT_357	[p17l973t136r1132b219],

1	By	IN	O	by	_	0	SENT_358	[p17l1192t139r1290b228],
2	contrast	NN	O	contrast	prep_by	5	SENT_358	[p17l1342t155r1642b219],
3	,	,	O	,	_	0	SENT_358	[p17l1342t155r1642b219],
4	statins	NNS	O	statin	nsubj	5	SENT_358	[p17l1702t141r1924b205],
5	have	VBP	O	have	_	0	SENT_358	[p17l1981t138r2139b205],
6	antithrombotic	JJ	O	antithrombotic	amod	7	SENT_358	[p17l12t244r545b311],
7	effects	NNS	O	effect	dobj	5	SENT_358	[p17l578t244r791b311],
8	through	IN	O	through	_	0	SENT_358	[p17l826t244r1109b334],
9	mechanisms	NNS	O	mechanism	prep_through	5	SENT_358	[p17l1143t244r1575b311],
10	that	WDT	O	that	nsubj	11	SENT_358	[p17l1609t244r1750b311],
11	are	VBP	O	be	rcmod	9	SENT_358	[p17l1783t270r1883b311],
12	prevalently	RB	O	prevalently	advmod	11	SENT_358	[p17l1916t270r2137b334, p17l9t350r208b440],
13	cholesterol	NN	O	cholesterol	nn	15	SENT_358	[p17l231t350r612b417],
14	independent	JJ	O	independent	amod	15	SENT_358	[p17l636t350r1080b440],
15	(	NN	O	(	tmod	11	SENT_358	[p17l1106t348r1266b431],
16	33	CD	NUMBER	33	num	17	SENT_358	[p17l1106t348r1266b431],
17	)	NN	O	)	dep	15	SENT_358	[p17l1106t348r1266b431],
18	.	.	O	.	_	0	SENT_358	[p17l1106t348r1266b431],

1	In	IN	O	in	_	0	SENT_359	[p17l1295t351r1372b416],
2	this	DT	O	this	det	3	SENT_359	[p17l1397t351r1524b417],
3	study	NN	O	study	prep_in	10	SENT_359	[p17l1552t350r1757b440],
4	,	,	O	,	_	0	SENT_359	[p17l1552t350r1757b440],
5	high	JJ	O	high	amod	8	SENT_359	[p17l1785t350r2139b440],
6	—	NN	O	—	nn	8	SENT_359	[p17l1785t350r2139b440],
7	dose	NN	O	dose	nn	8	SENT_359	[p17l1785t350r2139b440],
8	atorvastatin	NN	O	atorvastatin	nsubj	10	SENT_359	[p17l12t460r421b524],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_359	[p17l446t457r874b547],
10	decreased	VBD	O	decrease	_	0	SENT_359	[p17l895t457r1234b524],
11	lipid	NN	O	lipid	nn	12	SENT_359	[p17l1255t457r1416b547],
12	levels	NNS	O	level	dobj	10	SENT_359	[p17l1437t457r1624b524],
13	with	IN	O	with	_	0	SENT_359	[p17l1645t457r1807b524],
14	a	DT	O	a	det	15	SENT_359	[p17l1832t484r1866b524],
15	pattern	NN	O	pattern	prep_with	10	SENT_359	[p17l1886t474r2140b547],
16	similar	JJ	O	similar	amod	15	SENT_359	[p17l11t563r250b630],
17	to	TO	O	to	_	0	SENT_359	[p17l279t580r347b630],
18	that	DT	O	that	prep_to	16	SENT_359	[p17l380t563r521b630],
19	of	IN	O	of	_	0	SENT_359	[p17l551t563r631b630],
20	decreasing	VBG	O	decrease	amod	22	SENT_359	[p17l651t563r1021b653],
21	PRU	NNP	O	PRU	nn	22	SENT_359	[p17l1051t564r1230b630],
22	values	NNS	O	value	prep_of	18	SENT_359	[p17l1257t563r1489b630],
23	.	.	O	.	_	0	SENT_359	[p17l1257t563r1489b630],

1	However	RB	O	however	advmod	6	SENT_360	[p17l1526t564r1866b644],
2	,	,	O	,	_	0	SENT_360	[p17l1526t564r1866b644],
3	we	PRP	O	we	nsubj	6	SENT_360	[p17l1897t590r1995b630],
4	did	VBD	O	do	aux	6	SENT_360	[p17l2028t563r2141b630],
5	not	RB	O	not	neg	6	SENT_360	[p17l11t687r128b736],
6	ﬁnd	VB	O	ﬁnd	_	0	SENT_360	[p17l161t669r301b736],
7	any	DT	O	any	det	8	SENT_360	[p17l337t696r460b759],
8	correlations	NNS	O	correlation	dobj	6	SENT_360	[p17l492t669r901b736],
9	between	IN	O	between	_	0	SENT_360	[p17l936t669r1230b736],
10	lipid	NN	O	lipid	nn	11	SENT_360	[p17l1263t669r1425b759],
11	fractions	NNS	O	fraction	prep_between	8	SENT_360	[p17l1458t669r1761b736],
12	and	CC	O	and	_	0	SENT_360	[p17l1800t669r1927b736],
13	PRU	NNP	ORGANIZATION	PRU	dobj	6	SENT_360	[p17l1962t670r2141b736],
14	and	CC	O	and	_	0	SENT_360	[p17l12t775r139b842],
15	BASE	NN	O	base	nn	16	SENT_360	[p17l187t774r417b842],
16	values	NNS	O	value	conj_and	13	SENT_360	[p17l462t775r696b856],
17	,	,	O	,	_	0	SENT_360	[p17l462t775r696b856],
18	suggesting	VBG	O	suggest	partmod	6	SENT_360	[p17l748t778r1120b865],
19	that	IN	O	that	complm	23	SENT_360	[p17l1167t775r1308b842],
20	atorvastatin	NN	O	atorvastatin	nsubj	23	SENT_360	[p17l1356t778r1766b842],
21	may	MD	O	may	aux	23	SENT_360	[p17l1815t802r1963b865],
22	also	RB	O	also	advmod	23	SENT_360	[p17l2009t775r2139b842],
23	have	VB	O	have	ccomp	18	SENT_360	[p17l10t881r168b948],
24	nonlipid	JJ	O	nonlipid	amod	25	SENT_360	[p17l203t881r777b971],
25	—	NN	O	—	dobj	23	SENT_360	[p17l203t881r777b971],
26	related	JJ	O	related	amod	28	SENT_360	[p17l203t881r777b971],
27	antithrombotic	JJ	O	antithrombotic	amod	28	SENT_360	[p17l811t881r1345b948],
28	mechanisms	NNS	O	mechanism	dep	25	SENT_360	[p17l1378t881r1830b948],
29	.	.	O	.	_	0	SENT_360	[p17l1378t881r1830b948],

1	The	DT	O	the	det	3	SENT_361	[p17l96t986r243b1054],
2	clinical	JJ	O	clinical	amod	3	SENT_361	[p17l279t987r528b1054],
3	implications	NNS	O	implication	nsubj	10	SENT_361	[p17l561t987r993b1077],
4	of	IN	O	of	_	0	SENT_361	[p17l1030t987r1110b1054],
5	our	PRP$	O	we	poss	6	SENT_361	[p17l1133t1013r1251b1054],
6	study	NN	O	study	prep_of	3	SENT_361	[p17l1285t987r1474b1077],
7	can	MD	O	can	aux	10	SENT_361	[p17l1506t1014r1623b1054],
8	only	RB	O	only	advmod	10	SENT_361	[p17l1659t988r1811b1077],
9	be	VB	O	be	cop	10	SENT_361	[p17l1840t988r1921b1054],
10	speculative	JJ	O	speculative	_	0	SENT_361	[p17l1958t1014r2137b1077, p17l9t1093r259b1160],
11	.	.	O	.	_	0	SENT_361	[p17l1958t1014r2137b1077, p17l9t1093r259b1160],

1	Larger	JJR	O	larger	nsubjpass	6	SENT_362	[p17l309t1094r544b1183],
2	randomized	VBN	O	randomize	partmod	1	SENT_362	[p17l587t1093r1009b1160],
3	clinical	JJ	O	clinical	amod	4	SENT_362	[p17l1053t1093r1301b1160],
4	studies	NNS	O	study	dobj	2	SENT_362	[p17l1346t1093r1584b1160],
5	are	VBP	O	be	auxpass	6	SENT_362	[p17l1631t1119r1732b1160],
6	needed	VBN	O	need	_	0	SENT_362	[p17l1778t1093r2027b1160],
7	to	TO	O	to	aux	8	SENT_362	[p17l2071t1111r2139b1160],
8	deﬁne	VB	O	deﬁne	xcomp	6	SENT_362	[p17l11t1199r224b1266],
9	whether	IN	O	whether	complm	24	SENT_362	[p17l257t1199r550b1266],
10	the	DT	O	the	det	12	SENT_362	[p17l584t1199r694b1266],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_362	[p17l732t1199r1097b1289],
12	enhancement	NN	O	enhancement	nsubj	24	SENT_362	[p17l1132t1199r1607b1266],
13	of	IN	O	of	_	0	SENT_362	[p17l1642t1199r1722b1266],
14	clopidogrel	NN	O	clopidogrel	nn	16	SENT_362	[p17l1747t1199r2141b1289],
15	antiplatelet	JJ	O	antiplatelet	amod	16	SENT_362	[p17l12t1307r407b1396],
16	activity	NN	O	activity	prep_of	12	SENT_362	[p17l446t1309r701b1396],
17	exerted	VBN	O	exert	partmod	16	SENT_362	[p17l738t1306r992b1373],
18	by	IN	O	by	_	0	SENT_362	[p17l1028t1307r1114b1396],
19	high	JJ	O	high	amod	22	SENT_362	[p17l1150t1306r1504b1396],
20	—	NN	O	—	nn	22	SENT_362	[p17l1150t1306r1504b1396],
21	dose	NN	O	dose	nn	22	SENT_362	[p17l1150t1306r1504b1396],
22	atorvastatin	NN	O	atorvastatin	agent	17	SENT_362	[p17l1546t1309r1956b1373],
23	may	MD	O	may	aux	24	SENT_362	[p17l1996t1333r2144b1396],
24	provide	VB	O	provide	ccomp	8	SENT_362	[p17l9t1450r273b1540],
25	biological	JJ	O	biological	amod	26	SENT_362	[p17l310t1450r654b1540],
26	support	NN	O	support	dobj	24	SENT_362	[p17l694t1467r961b1540],
27	for	IN	O	for	_	0	SENT_362	[p17l999t1450r1099b1517],
28	a	DT	O	a	det	30	SENT_362	[p17l1138t1477r1172b1517],
29	beneﬁcial	JJ	O	beneﬁcial	amod	30	SENT_362	[p17l1208t1450r1545b1517],
30	impact	NN	O	impact	prep_for	24	SENT_362	[p17l1583t1453r1826b1540],
31	on	IN	O	on	_	0	SENT_362	[p17l1864t1477r1951b1517],
32	outcome	NN	O	outcome	prep_on	30	SENT_362	[p17l1991t1467r2137b1517, p17l11t1583r196b1623],
33	in	IN	O	in	_	0	SENT_362	[p17l226t1559r294b1622],
34	patients	NNS	O	patient	nsubj	37	SENT_362	[p17l321t1559r598b1646],
35	with	IN	O	with	_	0	SENT_362	[p17l625t1557r787b1623],
36	HTPR	NN	O	htpr	prep_with	34	SENT_362	[p17l816t1555r1069b1622],
37	undergoing	VBG	O	undergo	prepc_in	24	SENT_362	[p17l1095t1556r1502b1646],
38	PCI	NN	O	pcus	dobj	37	SENT_362	[p17l1530t1556r1698b1623],
39	.	.	O	.	_	0	SENT_362	[p17l1530t1556r1698b1623],

1	The	DT	O	the	det	2	SENT_363	[p17l1728t1555r1875b1623],
2	lack	NN	O	lack	nsubj	12	SENT_363	[p17l1904t1556r2047b1623],
3	of	IN	O	of	_	0	SENT_363	[p17l2073t1556r2152b1623],
4	clinical	JJ	O	clinical	amod	5	SENT_363	[p17l11t1662r259b1729],
5	beneﬁts	NNS	O	beneﬁts	prep_of	2	SENT_363	[p17l305t1662r579b1729],
6	with	IN	O	with	_	0	SENT_363	[p17l627t1662r788b1729],
7	high	JJ	O	high	amod	9	SENT_363	[p17l837t1662r1192b1752],
8	—	NN	O	—	nn	9	SENT_363	[p17l837t1662r1192b1752],
9	dose	NN	O	dose	prep_with	5	SENT_363	[p17l837t1662r1192b1752],
10	conventional	JJ	O	conventional	amod	12	SENT_363	[p17l1243t1662r1696b1729],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_363	[p17l1746t1662r2142b1752],
12	therapy	NN	O	therapy	_	0	SENT_363	[p17l10t1769r277b1858],
13	(	CD	NUMBER	(	num	12	SENT_363	[p17l306t1766r474b1858],
14	e.g.	FW	O	e.g.	dobj	12	SENT_363	[p17l306t1766r474b1858],
15	,	,	O	,	_	0	SENT_363	[p17l306t1766r474b1858],
16	GRAVITAS	NNP	O	GRAVITAS	appos	14	SENT_363	[p17l508t1767r974b1835],
17	[	CD	NUMBER	[	num	19	SENT_363	[p17l1012t1766r1349b1858],
18	Gauging	NNP	O	Gauging	nn	19	SENT_363	[p17l1012t1766r1349b1858],
19	Responsiveness	NN	O	responsiveness	dep	16	SENT_363	[p17l1378t1769r1920b1858],
20	With	IN	O	with	_	0	SENT_363	[p17l1947t1769r2140b1835],
21	A	DT	O	a	det	23	SENT_363	[p17l8t1873r74b1940],
22	VerifyNow	NNP	O	VerifyNow	nn	23	SENT_363	[p17l115t1874r512b1964],
23	Assay	NN	O	assay	prep_with	12	SENT_363	[p17l548t1873r1052b1964],
24	.	.	O	.	_	0	SENT_363	[p17l548t1873r1052b1964],

1	—	NN	O	—	_	0	SENT_364	[p17l548t1873r1052b1964],
2	.	.	O	.	_	0	SENT_364	[p17l548t1873r1052b1964],

1	Impact	NN	O	impact	nsubj	12	SENT_365	[p17l548t1873r1052b1964],
2	on	IN	O	on	_	0	SENT_365	[p17l1094t1901r1181b1941],
3	Thrombosis	NNP	O	Thrombosis	nn	8	SENT_365	[p17l1220t1873r1651b1941],
4	And	CC	O	and	_	0	SENT_365	[p17l1692t1873r1851b1941],
5	Safety	NNP	O	Safety	nn	8	SENT_365	[p17l1897t1872r2134b1964],
6	]	CD	NUMBER	]	num	8	SENT_365	[p17l1897t1872r2134b1964],
7	study	NN	O	study	nn	8	SENT_365	[p17l11t1979r222b2071],
8	)	NN	O	)	prep_on	1	SENT_365	[p17l11t1979r222b2071],
9	currently	RB	DATE	currently	advmod	8	SENT_365	[p17l252t1981r568b2071],
10	does	VBZ	O	do	aux	12	SENT_365	[p17l590t1982r744b2048],
11	not	RB	O	not	neg	12	SENT_365	[p17l772t1999r889b2048],
12	support	VB	O	support	_	0	SENT_365	[p17l914t1999r1182b2071],
13	such	JJ	O	such	prep	12	SENT_365	[p17l1206t1982r1362b2048],
14	a	DT	O	a	det	16	SENT_365	[p17l1389t2008r1423b2048],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_365	[p17l1446t1982r1843b2071],
16	strategy	NN	O	strategy	dep	13	SENT_365	[p17l1869t1998r2144b2071],
17	178	CD	NUMBER	178	num	18	SENT_365	[p17l15t2085r120b2129],
18	Leoncini	NNP	O	Leoncini	tmod	12	SENT_365	[p17l336t2086r551b2129],
19	et	FW	O	et	nn	20	SENT_365	[p17l575t2088r626b2129],
20	al.	FW	O	al.	dep	18	SENT_365	[p17l644t2086r702b2129],
21	.	.	O	.	_	0	SENT_365	[p17l644t2086r702b2129],

1	High-Dose	JJ	O	high-dose	amod	2	SENT_366	[p17l336t2168r600b2221],
2	Atorvastatin	NN	O	atorvastatin	nsubj	13	SENT_366	[p17l620t2168r939b2210],
3	and	CC	O	and	_	0	SENT_366	[p17l963t2168r1057b2210],
4	Platelet	NN	O	platelet	nn	5	SENT_366	[p17l1084t2168r1284b2210],
5	Reactivity	NN	O	reactivity	conj_and	2	SENT_366	[p17l1308t2168r1564b2221],
6	in	IN	O	in	_	0	SENT_366	[p17l14t2385r82b2448],
7	patients	NNS	O	patient	prep_in	2	SENT_366	[p17l125t2385r401b2472],
8	with	IN	O	with	_	0	SENT_366	[p17l443t2383r604b2449],
9	stable	JJ	O	stable	amod	10	SENT_366	[p17l649t2383r847b2449],
10	CAD	NN	O	cad	prep_with	7	SENT_366	[p17l894t2381r1090b2449],
11	and	CC	O	and	_	0	SENT_366	[p17l1138t2382r1265b2449],
12	HTPR	NN	O	htpr	conj_and	10	SENT_366	[p17l1309t2381r1562b2448],
13	identiﬁed	VBN	O	identiﬁed	_	0	SENT_366	[p17l1603t2382r1940b2449],
14	by	IN	O	by	_	0	SENT_366	[p17l1981t2382r2067b2472],
15	a	DT	O	a	det	18	SENT_366	[p17l2108t2409r2143b2449],
16	single	JJ	O	single	amod	18	SENT_366	[p17l16t2489r216b2578],
17	function	NN	O	function	nn	18	SENT_366	[p17l254t2488r550b2555],
18	test	NN	O	test	prep_by	13	SENT_366	[p17l587t2505r711b2555],
19	(	CD	NUMBER	(	number	20	SENT_366	[p17l749t2486r908b2569],
20	25	CD	NUMBER	25	num	21	SENT_366	[p17l749t2486r908b2569],
21	)	NN	O	)	dobj	13	SENT_366	[p17l749t2486r908b2569],
22	.	.	O	.	_	0	SENT_366	[p17l749t2486r908b2569],

1	We	PRP	O	we	nsubj	3	SENT_367	[p17l946t2489r1076b2555],
2	also	RB	O	also	advmod	3	SENT_367	[p17l1116t2489r1246b2555],
3	know	VBP	O	know	_	0	SENT_367	[p17l1284t2489r1480b2555],
4	that	IN	O	that	complm	14	SENT_367	[p17l1514t2489r1655b2555],
5	regardless	RB	O	regardless	_	0	SENT_367	[p17l1690t2488r2034b2578],
6	of	IN	O	of	_	0	SENT_367	[p17l2073t2488r2153b2555],
7	PD	NN	O	pd	nn	8	SENT_367	[p17l15t2594r135b2658],
8	results	NNS	O	result	prep_regardless_of	14	SENT_367	[p17l164t2593r408b2673],
9	,	,	O	,	_	0	SENT_367	[p17l164t2593r408b2673],
10	ample	JJ	O	ample	amod	12	SENT_367	[p17l439t2593r649b2682],
11	clinical	JJ	O	clinical	amod	12	SENT_367	[p17l677t2593r925b2659],
12	studies	NNS	O	study	appos	8	SENT_367	[p17l952t2593r1190b2659],
13	have	VBP	O	have	aux	14	SENT_367	[p17l1219t2593r1377b2659],
14	shown	VBN	O	show	dep	3	SENT_367	[p17l1405t2593r1633b2659],
15	better	RBR	O	better	advmod	14	SENT_367	[p17l1658t2594r1865b2659],
16	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_367	[p17l1891t2593r2139b2659, p17l11t2699r293b2765],
17	outcomes	NNS	O	outcome	dobj	14	SENT_367	[p17l327t2716r660b2765],
18	in	IN	O	in	_	0	SENT_367	[p17l697t2702r765b2764],
19	patients	NNS	O	patient	prep_in	14	SENT_367	[p17l799t2702r1076b2788],
20	treated	VBN	O	treat	partmod	19	SENT_367	[p17l1113t2699r1357b2765],
21	with	IN	O	with	_	0	SENT_367	[p17l1388t2699r1549b2765],
22	clopidogrel	NN	O	clopidogrel	prep_with	20	SENT_367	[p17l1585t2699r1979b2788],
23	and	CC	O	and	_	0	SENT_367	[p17l2015t2699r2142b2765],
24	statin	NN	O	statin	conj_and	22	SENT_367	[p17l16t2807r208b2870],
25	compared	VBN	O	compare	_	0	SENT_367	[p17l238t2804r585b2893],
26	with	IN	O	with	prepc_compared_with	14	SENT_367	[p17l610t2804r771b2870],
27	those	DT	O	those	pobj	14	SENT_367	[p17l800t2804r986b2870],
28	who	WP	O	who	nsubj	29	SENT_367	[p17l1012t2804r1164b2870],
29	received	VBD	O	receive	rcmod	27	SENT_367	[p17l1194t2804r1480b2870],
30	clopidogrel	NN	O	clopidogrel	nsubj	31	SENT_367	[p17l1510t2804r1904b2893],
31	alone	RB	O	alone	xcomp	29	SENT_367	[p17l1934t2804r2138b2884],
32	,	,	O	,	_	0	SENT_367	[p17l1934t2804r2138b2884],
33	independent	JJ	O	independent	acomp	29	SENT_367	[p17l14t2910r458b3000],
34	of	IN	O	of	_	0	SENT_367	[p17l492t2910r571b2977],
35	the	DT	O	the	det	36	SENT_367	[p17l594t2911r704b2977],
36	type	NN	O	type	prep_of	33	SENT_367	[p17l739t2928r885b3000],
37	of	IN	O	of	_	0	SENT_367	[p17l922t2910r1001b2977],
38	statin	NN	O	statin	prep_of	36	SENT_367	[p17l1025t2913r1218b2977],
39	administered	VBN	O	administer	partmod	38	SENT_367	[p17l1254t2911r1712b2977],
40	(	CD	NUMBER	(	num	42	SENT_367	[p17l1749t2908r2138b2991, p17l15t3041r87b3081],
41	CYP3A4or	NN	O	cyp3a4or	nn	42	SENT_367	[p17l1749t2908r2138b2991, p17l15t3041r87b3081],
42	non-CYP3A4	NN	O	non-cyp3a4	nsubj	43	SENT_367	[p17l136t3014r1118b3081],
43	—	CD	NUMBER	—	xcomp	39	SENT_367	[p17l136t3014r1118b3081],
44	metabolized	VBN	O	metabolize	partmod	43	SENT_367	[p17l136t3014r1118b3081],
45	statin	NN	O	statin	nn	46	SENT_367	[p17l1168t3013r1386b3095],
46	)	NN	O	)	dobj	44	SENT_367	[p17l1168t3013r1386b3095],
47	(	CD	NUMBER	(	num	46	SENT_367	[p17l1441t3013r1600b3095],
48	34	CD	NUMBER	34	num	49	SENT_367	[p17l1441t3013r1600b3095],
49	)	NN	O	)	nsubj	14	SENT_367	[p17l1441t3013r1600b3095],
50	.	.	O	.	_	0	SENT_367	[p17l1441t3013r1600b3095],

1	These	DT	O	these	det	2	SENT_368	[p17l1651t3014r1868b3081],
2	results	NNS	O	result	nsubj	3	SENT_368	[p17l1917t3016r2139b3081],
3	suggest	VBP	O	suggest	_	0	SENT_368	[p17l16t3140r273b3211],
4	that	IN	O	that	complm	15	SENT_368	[p17l323t3122r464b3188],
5	improved	VBN	O	improve	amod	6	SENT_368	[p17l515t3122r850b3211],
6	outcome	NN	O	outcome	nsubj	15	SENT_368	[p17l902t3139r1204b3188],
7	with	IN	O	with	_	0	SENT_368	[p17l1254t3122r1415b3188],
8	statins	NNS	O	statin	prep_with	6	SENT_368	[p17l1468t3125r1691b3188],
9	in	IN	O	in	_	0	SENT_368	[p17l1744t3125r1812b3187],
10	patients	NNS	O	patient	prep_in	8	SENT_368	[p17l1863t3125r2139b3211],
11	treated	VBN	O	treat	partmod	10	SENT_368	[p17l14t3227r258b3293],
12	with	IN	O	with	_	0	SENT_368	[p17l315t3227r476b3293],
13	clopidogrel	NN	O	clopidogrel	prep_with	11	SENT_368	[p17l538t3227r932b3316],
14	is	VBZ	O	be	cop	15	SENT_368	[p17l992t3230r1042b3293],
15	due	JJ	O	due	ccomp	3	SENT_368	[p17l1106t3227r1230b3293],
16	to	TO	O	to	prep	15	SENT_368	[p17l1292t3244r1360b3293],
17	more	JJR	O	more	quantmod	18	SENT_368	[p17l1423t3253r1602b3293],
18	than	IN	O	than	pobj	16	SENT_368	[p17l1664t3227r1822b3293],
19	platelet	NN	O	platelet	nn	20	SENT_368	[p17l1882t3227r2143b3316],
20	inhibition	NN	O	inhibition	dep	18	SENT_368	[p17l14t3332r383b3398],
21	.	.	O	.	_	0	SENT_368	[p17l14t3332r383b3398],

1	Study	NNP	O	Study	_	0	SENT_369	[p18l16t33r213b108],
2	limitations	NNS	O	limitation	dep	1	SENT_369	[p18l259t33r641b92],
3	.	.	O	.	_	0	SENT_369	[p18l259t33r641b92],

1	First	RB	ORDINAL	first	advmod	9	SENT_370	[p18l690t27r872b107],
2	,	,	O	,	_	0	SENT_370	[p18l690t27r872b107],
3	only	RB	O	only	advmod	9	SENT_370	[p18l920t26r1072b115],
4	the	DT	O	the	det	7	SENT_370	[p18l1112t26r1222b92],
5	VerifyNow	NNP	O	VerifyNow	nn	7	SENT_370	[p18l1266t26r1662b115],
6	P2Y12	NN	O	p2y12	nn	7	SENT_370	[p18l1703t27r1922b112],
7	assay	NN	O	assay	nsubjpass	9	SENT_370	[p18l1969t52r2145b115],
8	was	VBD	O	be	auxpass	9	SENT_370	[p18l11t157r139b197],
9	used	VBN	O	use	_	0	SENT_370	[p18l182t131r341b197],
10	to	TO	O	to	aux	11	SENT_370	[p18l382t148r450b197],
11	evaluate	VB	O	evaluate	xcomp	9	SENT_370	[p18l494t131r775b197],
12	platelet	NN	O	platelet	nn	13	SENT_370	[p18l816t131r1077b220],
13	function	NN	O	function	dobj	11	SENT_370	[p18l1117t131r1431b197],
14	.	.	O	.	_	0	SENT_370	[p18l1117t131r1431b197],

1	Second	RB	ORDINAL	second	advmod	4	SENT_371	[p18l1481t131r1754b212],
2	,	,	O	,	_	0	SENT_371	[p18l1481t131r1754b212],
3	it	PRP	O	it	nsubj	4	SENT_371	[p18l1799t134r1849b197],
4	had	VBD	O	have	_	0	SENT_371	[p18l1890t131r2019b197],
5	an	DT	O	a	det	7	SENT_371	[p18l2061t157r2141b197],
6	open-label	JJ	O	open-label	amod	7	SENT_371	[p18l15t237r389b326],
7	design	NN	O	design	dobj	4	SENT_371	[p18l417t237r661b326],
8	,	,	O	,	_	0	SENT_371	[p18l417t237r661b326],
9	although	IN	O	although	mark	16	SENT_371	[p18l694t237r1006b326],
10	platelet	NN	O	platelet	nn	11	SENT_371	[p18l1033t237r1293b326],
11	reactivity	NN	O	reactivity	nsubjpass	16	SENT_371	[p18l1319t240r1644b326],
12	and	CC	O	and	_	0	SENT_371	[p18l1669t237r1796b303],
13	genotyping	NN	O	genotyping	nsubjpass	16	SENT_371	[p18l1823t254r2138b326, p18l14t346r127b433],
14	were	VBD	O	be	auxpass	16	SENT_371	[p18l144t369r311b410],
15	blindly	RB	O	blindly	advmod	16	SENT_371	[p18l333t343r581b433],
16	evaluated	VBN	O	evaluate	advcl	4	SENT_371	[p18l601t343r947b410],
17	.	.	O	.	_	0	SENT_371	[p18l601t343r947b410],

1	Third	NNP	ORDINAL	Third	nsubj	9	SENT_372	[p18l972t342r1201b424],
2	,	,	O	,	_	0	SENT_372	[p18l972t342r1201b424],
3	the	DT	O	the	det	6	SENT_372	[p18l1227t343r1336b410],
4	small	JJ	O	small	amod	6	SENT_372	[p18l1362t343r1545b410],
5	sample	NN	O	sample	nn	6	SENT_372	[p18l1568t343r1810b433],
6	size	NN	O	size	appos	1	SENT_372	[p18l1835t346r1961b410],
7	does	VBZ	O	do	aux	9	SENT_372	[p18l1986t343r2140b410],
8	not	RB	O	not	neg	9	SENT_372	[p18l15t465r132b514],
9	allow	VB	O	allow	_	0	SENT_372	[p18l176t448r363b514],
10	deﬁnitive	JJ	O	deﬁnitive	amod	11	SENT_372	[p18l405t448r731b514],
11	conclusions	NNS	O	conclusion	dobj	9	SENT_372	[p18l778t448r1182b514],
12	about	IN	O	about	_	0	SENT_372	[p18l1229t449r1426b514],
13	the	DT	O	the	det	15	SENT_372	[p18l1468t448r1578b514],
14	biological	JJ	O	biological	amod	15	SENT_372	[p18l1621t448r1964b537],
15	link	NN	O	link	prep_about	9	SENT_372	[p18l2006t448r2146b513],
16	between	IN	O	between	_	0	SENT_372	[p18l12t553r305b619],
17	platelet	NN	O	platelet	nn	18	SENT_372	[p18l332t553r592b642],
18	reactivity	NN	O	reactivity	prep_between	15	SENT_372	[p18l617t556r942b642],
19	and	CC	O	and	_	0	SENT_372	[p18l966t553r1094b619],
20	achieved	VBD	O	achieve	conj_and	9	SENT_372	[p18l1122t553r1424b619],
21	lipid	NN	O	lipid	nn	22	SENT_372	[p18l1449t553r1609b642],
22	levels	NNS	O	level	dobj	20	SENT_372	[p18l1635t553r1842b619],
23	.	.	O	.	_	0	SENT_372	[p18l1635t553r1842b619],

1	Fourth	JJ	ORDINAL	fourth	advmod	5	SENT_373	[p18l1874t553r2138b633],
2	,	,	O	,	_	0	SENT_373	[p18l1874t553r2138b633],
3	we	PRP	O	we	nsubj	5	SENT_373	[p18l11t684r109b724],
4	only	RB	O	only	advmod	5	SENT_373	[p18l136t658r288b747],
5	looked	VBD	O	look	_	0	SENT_373	[p18l309t658r546b724],
6	for	IN	O	for	_	0	SENT_373	[p18l571t658r672b724],
7	the	DT	O	the	det	11	SENT_373	[p18l695t659r805b724],
8	CYP2C19	NN	O	cyp2c19	nn	11	SENT_373	[p18l838t662r1251b725],
9	*	NN	O	*	nn	11	SENT_373	[p18l838t662r1251b725],
10	2	CD	NUMBER	2	num	11	SENT_373	[p18l838t662r1251b725],
11	polymorphism	NN	O	polymorphism	nsubj	20	SENT_373	[p18l1275t658r1790b747],
12	due	JJ	O	due	_	0	SENT_373	[p18l1816t658r1940b724],
13	to	TO	O	to	_	0	SENT_373	[p18l1966t676r2034b724],
14	its	PRP$	O	its	poss	16	SENT_373	[p18l2061t661r2140b724],
15	consistent	JJ	O	consistent	amod	16	SENT_373	[p18l15t767r369b830],
16	association	NN	O	association	prep_due_to	11	SENT_373	[p18l413t767r794b830],
17	with	IN	O	with	_	0	SENT_373	[p18l835t764r996b830],
18	poor	JJ	O	poor	amod	19	SENT_373	[p18l1038t790r1202b853],
19	clopidogrel	NN	O	clopidogrel	prep_with	16	SENT_373	[p18l1245t764r1639b853],
20	metabolizing	VBG	O	metabolize	prepc_for	5	SENT_373	[p18l1682t764r2143b853],
21	status	NN	O	status	nn	24	SENT_373	[p18l16t922r212b971],
22	and	CC	O	and	_	0	SENT_373	[p18l265t905r392b971],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_373	[p18l442t905r836b994],
24	response	NN	O	response	dobj	20	SENT_373	[p18l884t931r1205b994],
25	.	.	O	.	_	0	SENT_373	[p18l884t931r1205b994],

1	Indeed	RB	O	indeed	advmod	46	SENT_374	[p18l1259t905r1524b986],
2	,	,	O	,	_	0	SENT_374	[p18l1259t905r1524b986],
3	other	JJ	O	other	amod	4	SENT_374	[p18l1578t905r1763b971],
4	polymorphisms	NNS	O	polymorphism	nsubjpass	8	SENT_374	[p18l1811t905r2138b994, p18l13t1011r266b1101],
5	could	MD	O	could	aux	8	SENT_374	[p18l332t1011r527b1078],
6	have	VB	O	have	aux	8	SENT_374	[p18l589t1012r750b1078],
7	been	VBN	O	be	auxpass	8	SENT_374	[p18l812t1011r982b1078],
8	considered	VBN	O	consider	parataxis	46	SENT_374	[p18l1046t1011r1432b1078],
9	(	CD	NUMBER	(	dobj	8	SENT_374	[p18l1498t1009r1671b1101],
10	e.g.	FW	O	e.g.	dep	9	SENT_374	[p18l1498t1009r1671b1101],
11	,	,	O	,	_	0	SENT_374	[p18l1498t1009r1671b1101],
12	CYP3ﬂ4	NN	O	cyp3ﬂ4	appos	9	SENT_374	[p18l1745t1015r2138b1092],
13	/	:	O	/	punct	14	SENT_374	[p18l1745t1015r2138b1092],
14	5	CD	NUMBER	5	dep	12	SENT_374	[p18l1745t1015r2138b1092],
15	,	,	O	,	_	0	SENT_374	[p18l1745t1015r2138b1092],
16	ﬂBCB	NN	O	ﬂbcb	nn	18	SENT_374	[p18l6t1114r328b1197],
17	]	CD	NUMBER	]	num	18	SENT_374	[p18l6t1114r328b1197],
18	)	NN	O	)	appos	14	SENT_374	[p18l6t1114r328b1197],
19	;	:	O	;	_	0	SENT_374	[p18l6t1114r328b1197],
20	however	RB	O	however	advmod	25	SENT_374	[p18l388t1116r701b1197],
21	,	,	O	,	_	0	SENT_374	[p18l388t1116r701b1197],
22	PD	NN	O	pd	nn	23	SENT_374	[p18l762t1117r882b1181],
23	studies	NNS	O	study	nsubj	25	SENT_374	[p18l942t1116r1180b1182],
24	have	VBP	O	have	aux	25	SENT_374	[p18l1238t1117r1396b1182],
25	found	VBN	O	find	rcmod	12	SENT_374	[p18l1454t1116r1661b1182],
26	inconsistent	JJ	O	inconsistent	amod	27	SENT_374	[p18l1717t1119r2143b1182],
27	association	NN	O	association	dobj	25	SENT_374	[p18l16t1225r398b1289],
28	with	IN	O	with	_	0	SENT_374	[p18l417t1222r578b1289],
29	clopidogrel	NN	O	clopidogrel	nn	30	SENT_374	[p18l602t1222r996b1312],
30	response	NN	O	response	prep_with	25	SENT_374	[p18l1018t1248r1319b1312],
31	(	CD	NUMBER	(	number	32	SENT_374	[p18l1346t1220r1506b1303],
32	35	CD	NUMBER	35	num	30	SENT_374	[p18l1346t1220r1506b1303],
33	Finally	RB	O	finally	advmod	25	SENT_374	[p18l1533t1222r1795b1312],
34	,	,	O	,	_	0	SENT_374	[p18l1533t1222r1795b1312],
35	given	VBN	O	give	prep	46	SENT_374	[p18l1820t1225r2008b1312],
36	the	DT	O	the	det	38	SENT_374	[p18l2030t1222r2140b1289],
37	pilot	NN	O	pilot	nn	38	SENT_374	[p18l13t1328r177b1416],
38	nature	NN	O	nature	dep	35	SENT_374	[p18l215t1345r436b1393],
39	of	IN	O	of	_	0	SENT_374	[p18l476t1327r556b1393],
40	this	DT	O	this	det	41	SENT_374	[p18l582t1327r708b1393],
41	study	NN	O	study	prep_of	38	SENT_374	[p18l749t1327r954b1416],
42	,	,	O	,	_	0	SENT_374	[p18l749t1327r954b1416],
43	it	PRP	O	it	nsubjpass	46	SENT_374	[p18l995t1330r1046b1393],
44	was	VBD	O	be	auxpass	46	SENT_374	[p18l1079t1353r1208b1393],
45	not	RB	O	not	neg	46	SENT_374	[p18l1249t1345r1366b1393],
46	designed	VBN	O	design	_	0	SENT_374	[p18l1403t1327r1713b1416],
47	to	TO	O	to	aux	48	SENT_374	[p18l1751t1344r1819b1393],
48	evaluate	VB	O	evaluate	xcomp	46	SENT_374	[p18l1859t1327r2140b1393],
49	clinical	JJ	O	clinical	amod	50	SENT_374	[p18l15t1433r263b1499],
50	outcomes	NNS	O	outcome	dobj	48	SENT_374	[p18l295t1450r650b1513],
51	,	,	O	,	_	0	SENT_374	[p18l295t1450r650b1513],
52	which	WDT	O	which	nsubj	54	SENT_374	[p18l682t1433r899b1499],
53	would	MD	O	would	aux	54	SENT_374	[p18l928t1433r1149b1499],
54	require	VB	O	require	rcmod	50	SENT_374	[p18l1180t1436r1426b1522],
55	larger	JJR	O	larger	amod	56	SENT_374	[p18l1459t1433r1660b1522],
56	populations	NNS	O	population	dobj	54	SENT_374	[p18l1691t1433r2122b1522],
57	.	.	O	.	_	0	SENT_374	[p18l1691t1433r2122b1522],

1	Conclusions	NNS	O	conclusion	_	0	SENT_375	[p18l14t1663r530b1726],

1	In	IN	O	in	_	0	SENT_376	[p18l14t1858r91b1922],
2	stable	JJ	O	stable	amod	4	SENT_376	[p18l127t1857r325b1923],
3	CAD	NN	O	cad	nn	4	SENT_376	[p18l362t1855r559b1923],
4	patients	NNS	O	patient	pobj	1	SENT_376	[p18l595t1860r871b1946],
5	with	IN	O	with	_	0	SENT_376	[p18l904t1857r1065b1923],
6	HTPR	NN	O	htpr	prep_with	4	SENT_376	[p18l1101t1855r1353b1922],
7	undergoing	VBG	O	undergo	partmod	6	SENT_376	[p18l1384t1857r1791b1946],
8	PCI	NNP	O	PCI	dobj	7	SENT_376	[p18l1824t1857r1993b1938],
9	,	,	O	,	_	0	SENT_376	[p18l1824t1857r1993b1938],
10	the	DT	O	the	det	11	SENT_376	[p18l2030t1857r2140b1923],
11	addition	NN	O	addition	appos	8	SENT_376	[p18l16t1960r309b2025],
12	of	IN	O	of	_	0	SENT_376	[p18l343t1960r423b2025],
13	high-dose	JJ	O	high-dose	amod	14	SENT_376	[p18l445t1960r799b2048],
14	atorvastatin	NN	O	atorvastatin	prep_of	11	SENT_376	[p18l835t1963r1245b2025],
15	for	IN	O	for	_	0	SENT_376	[p18l1278t1960r1379b2025],
16	30	CD	DURATION	30	num	17	SENT_376	[p18l1412t1963r1495b2025],
17	days	NNS	NUMBER	day	prep_for	7	SENT_376	[p18l1531t1960r1680b2048],
18	significantly	RB	O	significantly	advmod	19	SENT_376	[p18l1717t1960r2145b2048],
19	improves	VBZ	O	improve	dep	17	SENT_376	[p18l14t2069r332b2154],
20	the	DT	O	the	det	22	SENT_376	[p18l368t2066r478b2131],
21	pharmacodynamic	JJ	O	pharmacodynamic	amod	22	SENT_376	[p18l511t2066r1163b2154],
22	effects	NNS	O	effect	dobj	19	SENT_376	[p18l1197t2066r1410b2131],
23	of	IN	O	of	_	0	SENT_376	[p18l1447t2066r1526b2131],
24	high-dose	JJ	O	high-dose	amod	25	SENT_376	[p18l1548t2066r1902b2154],
25	clopidogrel	NN	O	clopidogrel	prep_of	22	SENT_376	[p18l1937t2066r2138b2154, p18l15t2210r236b2298],

1	and	CC	O	and	dep	3	SENT_377	[p18l267t2210r394b2275],
2	is	VBZ	O	be	auxpass	3	SENT_377	[p18l424t2213r474b2275],
3	associated	VBN	O	associate	_	0	SENT_377	[p18l508t2210r859b2275],
4	with	IN	O	with	_	0	SENT_377	[p18l886t2210r1047b2275],
5	improved	VBN	O	improve	amod	6	SENT_377	[p18l1077t2210r1412b2298],
6	rates	NNS	O	rate	prep_with	3	SENT_377	[p18l1442t2227r1603b2275],
7	optimal	JJ	O	optimal	amod	8	SENT_377	[p18l1635t2210r1907b2298],
8	clopidogrel	NN	O	clopidogrel	dep	6	SENT_377	[p18l1937t2210r2138b2298, p18l15t2353r236b2441],

1	response	NN	O	response	_	0	SENT_378	[p18l277t2378r598b2441],
2	.	.	O	.	_	0	SENT_378	[p18l277t2378r598b2441],

1	Further	JJ	O	further	amod	2	SENT_379	[p18l645t2353r915b2418],
2	studies	NNS	O	study	nsubj	4	SENT_379	[p18l957t2353r1195b2418],
3	are	VBP	O	be	cop	4	SENT_379	[p18l1240t2378r1340b2418],
4	necessary	JJ	O	necessary	_	0	SENT_379	[p18l1384t2378r1712b2441],
5	to	TO	O	to	aux	6	SENT_379	[p18l1750t2370r1819b2418],
6	demonstrate	VB	O	demonstrate	xcomp	4	SENT_379	[p18l1863t2353r2138b2418, p18l16t2513r204b2561],

1	the	DT	O	the	det	3	SENT_380	[p18l238t2496r348b2561],
2	clinical	JJ	O	clinical	amod	3	SENT_380	[p18l383t2496r630b2561],
3	impact	NN	O	impact	_	0	SENT_380	[p18l662t2499r904b2584],
4	of	IN	O	of	_	0	SENT_380	[p18l936t2496r1016b2561],
5	this	DT	O	this	det	6	SENT_380	[p18l1036t2496r1163b2561],
6	strategy	NN	O	strategy	prep_of	3	SENT_380	[p18l1199t2513r1488b2584],
7	.	.	O	.	_	0	SENT_380	[p18l1199t2513r1488b2584],

1	Reprint	JJ	MISC	reprint	amod	2	SENT_381	[p18l16t2702r276b2781],
2	requests	NNS	O	request	_	0	SENT_381	[p18l325t2716r599b2781],
3	and	CC	O	and	_	0	SENT_381	[p18l653t2700r775b2761],
4	correspondence	NN	O	correspondence	conj_and	2	SENT_381	[p18l826t2700r1369b2781],
5	:	:	O	:	_	0	SENT_381	[p18l826t2700r1369b2781],
6	Dr.	NNP	O	Dr.	nn	8	SENT_381	[p18l1425t2702r1530b2761],
7	Mario	NNP	PERSON	Mario	nn	8	SENT_381	[p18l1585t2702r1784b2761],
8	Leoncini	NNP	PERSON	Leoncini	dep	2	SENT_381	[p18l1838t2702r2139b2774],
9	,	,	O	,	_	0	SENT_381	[p18l1838t2702r2139b2774],
10	Division	NNP	O	Division	appos	2	SENT_381	[p18l14t2806r285b2864],
11	of	IN	O	of	_	0	SENT_381	[p18l319t2805r391b2864],
12	Cardiology	NNP	O	Cardiology	nn	14	SENT_381	[p18l416t2805r786b2885],
13	,	,	O	,	_	0	SENT_381	[p18l416t2805r786b2885],
14	Misericordia	NNP	PERSON	Misericordia	prep_of	10	SENT_381	[p18l820t2805r1228b2864],
15	e	LS	O	e	dep	17	SENT_381	[p18l1261t2828r1290b2864],
16	Dolce	NNP	ORGANIZATION	Dolce	nn	17	SENT_381	[p18l1324t2805r1513b2864],
17	Hospital	NNP	ORGANIZATION	Hospital	dep	2	SENT_381	[p18l1547t2805r1840b2885],
18	,	,	O	,	_	0	SENT_381	[p18l1547t2805r1840b2885],
19	Via	NNP	LOCATION	Via	prep	17	SENT_381	[p18l1876t2806r1986b2865],
20	Cavour	NNP	LOCATION	Cavour	dep	19	SENT_381	[p18l2020t2805r2139b2864, p18l11t2932r170b2982],
21	,	,	O	,	_	0	SENT_381	[p18l2020t2805r2139b2864, p18l11t2932r170b2982],
22	2	CD	NUMBER	2	num	25	SENT_381	[p18l201t2913r238b2970],
23	Prato	NNP	LOCATION	Prato	nn	25	SENT_381	[p18l270t2910r459b2982],
24	,	,	O	,	_	0	SENT_381	[p18l270t2910r459b2982],
25	Italy	NNP	LOCATION	Italy	appos	2	SENT_381	[p18l491t2910r649b2990],
26	.	.	O	.	_	0	SENT_381	[p18l491t2910r649b2990],

1	E	NN	O	e	nn	3	SENT_382	[p18l684t2910r924b2969],
2	—	CD	NUMBER	—	num	3	SENT_382	[p18l684t2910r924b2969],
3	mail	NN	O	mail	_	0	SENT_382	[p18l684t2910r924b2969],
4	:	:	O	:	_	0	SENT_382	[p18l684t2910r924b2969],
5	leoncini.mario@tiscali.it	NN	O	leoncini.mario@tiscali.it	dep	3	SENT_382	[p18l956t2910r1746b2969],
6	.	.	O	.	_	0	SENT_382	[p18l956t2910r1746b2969],

1	REFERENCES	NNS	O	reference	_	0	SENT_383	[p18l15t3212r403b3257],

1	1	LS	NUMBER	1	_	0	SENT_384	[p18l53t3366r97b3416],
2	.	.	O	.	_	0	SENT_384	[p18l53t3366r97b3416],

1	Levine	NNP	ORGANIZATION	Levine	nn	2	SENT_385	[p18l122t3364r313b3416],
2	GN	NNP	ORGANIZATION	GN	_	0	SENT_385	[p18l347t3363r473b3428],
3	,	,	O	,	_	0	SENT_385	[p18l347t3363r473b3428],
4	Bates	NNP	PERSON	Bates	nn	5	SENT_385	[p18l508t3364r659b3416],
5	ER	NN	O	er	appos	2	SENT_385	[p18l694t3364r804b3428],
6	,	,	O	,	_	0	SENT_385	[p18l694t3364r804b3428],
7	Blankenship	NNP	PERSON	Blankenship	nn	8	SENT_385	[p18l839t3364r1190b3434],
8	JC	NNP	O	JC	appos	2	SENT_385	[p18l1217t3363r1314b3431],
9	,	,	O	,	_	0	SENT_385	[p18l1217t3363r1314b3431],
10	et	FW	O	et	nn	11	SENT_385	[p18l1349t3377r1400b3416],
11	al.	FW	O	al.	appos	2	SENT_385	[p18l1432t3364r1491b3416],
12	.	.	O	.	_	0	SENT_385	[p18l1432t3364r1491b3416],

1	American	NNP	ORGANIZATION	American	nn	2	SENT_386	[p18l1525t3362r1805b3416],
2	College	NNP	ORGANIZATION	College	_	0	SENT_386	[p18l1839t3363r2054b3434],
3	of	IN	ORGANIZATION	of	_	0	SENT_386	[p18l2087t3363r2151b3416],
4	Cardiology	NNP	ORGANIZATION	Cardiology	nn	5	SENT_386	[p18l122t3441r439b3512],
5	Foundation	NNP	ORGANIZATION	Foundation	prep_of	2	SENT_386	[p18l467t3442r813b3506],
6	;	:	O	;	_	0	SENT_386	[p18l467t3442r813b3506],
7	American	NNP	ORGANIZATION	American	nn	11	SENT_386	[p18l845t3440r1125b3494],
8	Heart	NNP	ORGANIZATION	Heart	nn	11	SENT_386	[p18l1156t3442r1322b3494],
9	Association	NNP	ORGANIZATION	Association	nn	11	SENT_386	[p18l1350t3440r1681b3494],
10	Task	NNP	ORGANIZATION	Task	nn	11	SENT_386	[p18l1710t3440r1854b3494],
11	Force	NNP	ORGANIZATION	Force	dep	2	SENT_386	[p18l1881t3442r2039b3494],
12	on	IN	O	on	_	0	SENT_386	[p18l2072t3462r2142b3494],
13	Practice	NNP	O	Practice	nn	14	SENT_386	[p18l121t3520r346b3572],
14	Guidelines	NNS	O	guideline	prep_on	11	SENT_386	[p18l397t3519r719b3584],
15	;	:	O	;	_	0	SENT_386	[p18l397t3519r719b3584],
16	Society	NNP	ORGANIZATION	Society	dep	2	SENT_386	[p18l773t3519r976b3590],
17	for	IN	ORGANIZATION	for	_	0	SENT_386	[p18l1022t3519r1102b3572],
18	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	19	SENT_386	[p18l1152t3519r1572b3572],
19	Angiography	NNP	ORGANIZATION	Angiography	prep_for	16	SENT_386	[p18l1617t3518r1993b3590],
20	and	CC	O	and	_	0	SENT_386	[p18l2040t3519r2142b3572],
21	Interventions	NNPS	O	Interventions	prep_for	16	SENT_386	[p18l121t3598r513b3650],
22	.	.	O	.	_	0	SENT_386	[p18l121t3598r513b3650],

1	2011	CD	DATE	2011	num	3	SENT_387	[p18l553t3600r690b3651],
2	ACCF/AHA/SCAI	NNP	O	ACCF/AHA/SCAI	nn	3	SENT_387	[p18l730t3596r1316b3650],
3	guideline	NN	O	guideline	_	0	SENT_387	[p18l1355t3598r1614b3668],
4	for	IN	O	for	_	0	SENT_387	[p18l1653t3597r1733b3650],
5	percutaneous	JJ	O	percutaneous	amod	7	SENT_387	[p18l1769t3611r2140b3668],
6	coronary	JJ	O	coronary	amod	7	SENT_387	[p18l122t3696r369b3746],
7	intervention	NN	O	intervention	prep_for	3	SENT_387	[p18l388t3678r748b3728],
8	:	:	O	:	_	0	SENT_387	[p18l388t3678r748b3728],
9	a	DT	O	a	det	10	SENT_387	[p18l776t3696r803b3728],
10	report	NN	O	report	dep	3	SENT_387	[p18l825t3689r997b3746],
11	of	IN	O	of	_	0	SENT_387	[p18l1019t3675r1083b3728],
12	the	DT	O	the	det	14	SENT_387	[p18l1096t3676r1184b3728],
13	American	NNP	ORGANIZATION	American	nn	14	SENT_387	[p18l1206t3674r1486b3728],
14	College	NNP	ORGANIZATION	College	prep_of	10	SENT_387	[p18l1511t3675r1725b3746],
15	of	IN	ORGANIZATION	of	_	0	SENT_387	[p18l1749t3675r1813b3728],
16	Cardiology	NNP	ORGANIZATION	Cardiology	nn	21	SENT_387	[p18l1828t3675r2145b3746],
17	Foundation/American	NNP	ORGANIZATION	Foundation/American	nn	21	SENT_387	[p18l121t3752r757b3806],
18	Heart	NNP	ORGANIZATION	Heart	nn	21	SENT_387	[p18l807t3754r973b3806],
19	Association	NNP	ORGANIZATION	Association	nn	21	SENT_387	[p18l1020t3752r1351b3806],
20	Task	NNP	ORGANIZATION	Task	nn	21	SENT_387	[p18l1398t3752r1542b3806],
21	Force	NNP	ORGANIZATION	Force	prep_of	14	SENT_387	[p18l1588t3754r1746b3806],
22	on	IN	O	on	_	0	SENT_387	[p18l1796t3774r1867b3806],
23	Practice	NNP	O	Practice	prep_on	21	SENT_387	[p18l1916t3754r2140b3806],

1	Guidelines	NNS	O	guideline	_	0	SENT_388	[p19l122t20r428b73],
2	and	CC	O	and	_	0	SENT_388	[p19l477t21r579b73],
3	the	DT	O	the	conj_and	1	SENT_388	[p19l625t21r729b85],
4	,	,	O	,	_	0	SENT_388	[p19l625t21r729b85],
5	Society	NNP	ORGANIZATION	Society	appos	1	SENT_388	[p19l781t20r985b91],
6	for	IN	ORGANIZATION	for	_	0	SENT_388	[p19l1028t20r1109b73],
7	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	8	SENT_388	[p19l1156t20r1576b73],
8	Angiography	NNP	ORGANIZATION	Angiography	prep_for	5	SENT_388	[p19l1619t19r1996b91],
9	and	CC	O	and	_	0	SENT_388	[p19l2040t21r2142b73],
10	Interventions	NNPS	O	Interventions	prep_for	5	SENT_388	[p19l121t100r513b152],
11	.	.	O	.	_	0	SENT_388	[p19l121t100r513b152],

1	J	NNP	O	J	nn	4	SENT_389	[p19l535t100r564b167],
2	Am	NNP	O	Am	nn	4	SENT_389	[p19l588t98r696b151],
3	Coll	NNP	O	Coll	nn	4	SENT_389	[p19l725t99r846b152],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_389	[p19l873t99r1087b152],
5	2011	CD	DATE	2011	num	4	SENT_389	[p19l1111t99r1625b164],
6	;	:	O	;	_	0	SENT_389	[p19l1111t99r1625b164],
7	58	CD	NUMBER	58	dep	4	SENT_389	[p19l1111t99r1625b164],
8	:	:	O	:	_	0	SENT_389	[p19l1111t99r1625b164],
9	e44-122	NN	O	e44-122	dep	7	SENT_389	[p19l1111t99r1625b164],
10	.	.	O	.	_	0	SENT_389	[p19l1111t99r1625b164],

1	.	.	O	.	_	0	SENT_390	[p19l88t177r392b230],

1	Davidson	NNP	PERSON	Davidson	nn	2	SENT_391	[p19l88t177r392b230],
2	MH	NNP	O	MH	_	0	SENT_391	[p19l422t178r565b230],
3	.	.	O	.	_	0	SENT_391	[p19l422t178r565b230],

1	Clinical	JJ	O	clinical	amod	2	SENT_392	[p19l602t177r824b230],
2	signiﬁcance	NN	O	signiﬁcance	_	0	SENT_392	[p19l856t177r1182b248],
3	of	IN	O	of	_	0	SENT_392	[p19l1216t177r1279b230],
4	statin	NN	O	statin	nn	6	SENT_392	[p19l1303t180r1457b230],
5	pleiotropic	JJ	O	pleiotropic	amod	6	SENT_392	[p19l1487t177r1792b248],
6	effects	NNS	O	effect	prep_of	2	SENT_392	[p19l1824t177r2011b230],
7	:	:	O	:	_	0	SENT_392	[p19l1824t177r2011b230],
8	hypotheses	NNS	O	hypothesis	dep	2	SENT_392	[p19l2046t177r2139b248, p19l120t256r361b326],
9	versus	CC	O	versus	prep	8	SENT_392	[p19l386t276r556b308],
10	evidence	NN	O	evidence	dep	9	SENT_392	[p19l584t255r840b308],
11	.	.	O	.	_	0	SENT_392	[p19l584t255r840b308],

1	Circulation	NN	O	circulation	_	0	SENT_393	[p19l871t255r1192b308],
2	2005	CD	DATE	2005	num	1	SENT_393	[p19l1216t256r1736b320],
3	;	:	O	;	_	0	SENT_393	[p19l1216t256r1736b320],
4	111:2280	CD	NUMBER	111:2280	number	5	SENT_393	[p19l1216t256r1736b320],
5	-1	CD	NUMBER	-1	dep	1	SENT_393	[p19l1216t256r1736b320],
6	.	.	O	.	_	0	SENT_393	[p19l1216t256r1736b320],

1	.	.	O	.	_	0	SENT_394	[p19l88t379r97b387],

1	Piorkowski	NNP	PERSON	Piorkowski	nn	2	SENT_395	[p19l121t334r439b387],
2	M	NNP	O	M	nsubj	19	SENT_395	[p19l464t335r548b399],
3	,	,	O	,	_	0	SENT_395	[p19l464t335r548b399],
4	Weikert	NNP	PERSON	Weikert	nn	5	SENT_395	[p19l573t335r811b388],
5	U	NNP	PERSON	U	appos	2	SENT_395	[p19l835t335r902b399],
6	,	,	O	,	_	0	SENT_395	[p19l835t335r902b399],
7	Schwimmbeck	NNP	ORGANIZATION	Schwimmbeck	nn	8	SENT_395	[p19l934t334r1350b387],
8	PL	NNP	ORGANIZATION	PL	appos	2	SENT_395	[p19l1374t335r1477b399],
9	,	,	O	,	_	0	SENT_395	[p19l1374t335r1477b399],
10	Martus	NNP	PERSON	Martus	nn	11	SENT_395	[p19l1504t335r1710b387],
11	P	NN	PERSON	p	appos	2	SENT_395	[p19l1738t335r1794b399],
12	,	,	O	,	_	0	SENT_395	[p19l1738t335r1794b399],
13	Schultheiss	NNP	ORGANIZATION	Schultheiss	nn	14	SENT_395	[p19l1826t334r2140b387],
14	HP	NNP	ORGANIZATION	HP	appos	2	SENT_395	[p19l122t413r238b477],
15	,	,	O	,	_	0	SENT_395	[p19l122t413r238b477],
16	Rauch	NNP	ORGANIZATION	Rauch	nn	18	SENT_395	[p19l264t412r442b465],
17	U.	NNP	ORGANIZATION	U.	nn	18	SENT_395	[p19l463t413r529b465],
18	ADP	NN	ORGANIZATION	adp	appos	2	SENT_395	[p19l552t411r705b464],
19	induced	VBD	O	induce	_	0	SENT_395	[p19l727t412r951b465],
20	platelet	NN	O	platelet	nn	21	SENT_395	[p19l971t412r1180b483],
21	degranulation	NN	O	degranulation	nsubjpass	26	SENT_395	[p19l1201t413r1591b483],
22	in	IN	O	in	_	0	SENT_395	[p19l1612t415r1666b464],
23	healthy	JJ	O	healthy	amod	24	SENT_395	[p19l1688t413r1898b483],
24	individuals	NNS	O	individual	prep_in	21	SENT_395	[p19l1916t412r2139b465, p19l120t491r227b543],
25	is	VBZ	O	be	auxpass	26	SENT_395	[p19l266t493r306b543],
26	reduced	VBN	O	reduce	ccomp	19	SENT_395	[p19l346t490r568b543],
27	by	IN	O	by	_	0	SENT_395	[p19l604t490r673b561],
28	clopidogrel	NN	O	clopidogrel	agent	26	SENT_395	[p19l709t490r1024b561],
29	after	IN	O	after	_	0	SENT_395	[p19l1062t490r1189b543],
30	pretreatment	NN	O	pretreatment	prep_after	26	SENT_395	[p19l1225t504r1594b561],
31	with	IN	O	with	_	0	SENT_395	[p19l1628t491r1757b543],
32	atorvastatin	NN	O	atorvastatin	prep_with	26	SENT_395	[p19l1796t493r2138b543],
33	.	.	O	.	_	0	SENT_395	[p19l1796t493r2138b543],

1	Thromb	NNP	O	Thromb	nn	2	SENT_396	[p19l119t568r358b622],
2	Haemost	NNP	O	Haemost	_	0	SENT_396	[p19l386t570r645b622],
3	2004	CD	DATE	2004	num	2	SENT_396	[p19l669t572r1153b634],
4	;	:	O	;	_	0	SENT_396	[p19l669t572r1153b634],
5	92:614	CD	NUMBER	92:614	number	6	SENT_396	[p19l669t572r1153b634],
6	-20	CD	NUMBER	-20	dep	2	SENT_396	[p19l669t572r1153b634],
7	.	.	O	.	_	0	SENT_396	[p19l669t572r1153b634],

1	.	.	O	.	_	0	SENT_397	[p19l88t693r97b701],

1	Piorkowski	NNP	PERSON	Piorkowski	nn	2	SENT_398	[p19l121t648r439b701],
2	M	NNP	O	M	_	0	SENT_398	[p19l456t649r540b713],
3	,	,	O	,	_	0	SENT_398	[p19l456t649r540b713],
4	Fischer	NNP	PERSON	Fischer	nn	5	SENT_398	[p19l562t649r769b701],
5	S	NNP	O	S	appos	2	SENT_398	[p19l789t648r838b713],
6	,	,	O	,	_	0	SENT_398	[p19l789t648r838b713],
7	Stellbaum	NNP	O	Stellbaum	nn	8	SENT_398	[p19l862t648r1144b701],
8	C	NNP	O	C	appos	2	SENT_398	[p19l1165t648r1229b713],
9	,	,	O	,	_	0	SENT_398	[p19l1165t648r1229b713],
10	et	FW	O	et	nn	11	SENT_398	[p19l1251t662r1302b701],
11	al.	FW	O	al.	appos	2	SENT_398	[p19l1321t649r1380b701],
12	.	.	O	.	_	0	SENT_398	[p19l1321t649r1380b701],

1	Treatment	NN	O	treatment	dep	21	SENT_399	[p19l1400t647r1706b701],
2	with	IN	O	with	_	0	SENT_399	[p19l1721t649r1850b701],
3	ezetimibe	NN	O	ezetimibe	prep_with	1	SENT_399	[p19l1870t649r2140b701],
4	plus	CC	O	plus	prep	3	SENT_399	[p19l120t726r233b797],
5	low	JJ	O	low	amod	8	SENT_399	[p19l275t726r531b779],
6	—	NN	O	—	nn	8	SENT_399	[p19l275t726r531b779],
7	dose	NN	O	dose	nn	8	SENT_399	[p19l275t726r531b779],
8	atorvastatin	NN	O	atorvastatin	dep	4	SENT_399	[p19l576t729r903b779],
9	compared	VBN	O	compare	_	0	SENT_399	[p19l946t726r1223b797],
10	with	IN	O	with	prepc_compared_with	8	SENT_399	[p19l1262t727r1391b779],
11	higher	JJR	O	higher	pobj	8	SENT_399	[p19l1433t726r1771b797],
12	—	CD	NUMBER	—	num	14	SENT_399	[p19l1433t726r1771b797],
13	dose	NN	O	dose	nn	14	SENT_399	[p19l1433t726r1771b797],
14	atorvastatin	NN	O	atorvastatin	npadvmod	15	SENT_399	[p19l1814t729r2142b779],
15	alone	RB	O	alone	advmod	11	SENT_399	[p19l122t805r285b857],
16	:	:	O	:	_	0	SENT_399	[p19l122t805r285b857],
17	is	VBZ	O	be	aux	21	SENT_399	[p19l326t807r367b857],
18	suﬂicient	JJ	O	suﬂicient	amod	20	SENT_399	[p19l407t804r659b857],
19	cholesterol	NN	O	cholesterol	nn	20	SENT_399	[p19l697t805r1279b875],
20	—	NN	O	—	nsubj	21	SENT_399	[p19l697t805r1279b875],
21	lowering	VBG	O	lower	_	0	SENT_399	[p19l697t805r1279b875],
22	enough	RB	O	enough	advmod	21	SENT_399	[p19l1316t805r1525b875],
23	to	TO	O	to	aux	24	SENT_399	[p19l1563t818r1617b857],
24	inhibit	VB	O	inhibit	xcomp	21	SENT_399	[p19l1657t804r1847b857],
25	platelets	NNS	O	platelet	dobj	24	SENT_399	[p19l1882t805r2140b875],
26	?	.	O	?	_	0	SENT_399	[p19l1882t805r2140b875],

1	J	NNP	O	J	nn	4	SENT_400	[p19l113t884r142b951],
2	Am	NNP	O	Am	nn	4	SENT_400	[p19l166t882r275b935],
3	Coll	NNP	O	Coll	nn	4	SENT_400	[p19l303t883r425b936],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_400	[p19l451t883r665b936],
5	2007	CD	DATE	2007	num	4	SENT_400	[p19l689t884r1209b948],
6	;	:	O	;	_	0	SENT_400	[p19l689t884r1209b948],
7	49:1035	CD	NUMBER	49:1035	number	8	SENT_400	[p19l689t884r1209b948],
8	—	CD	NUMBER	—	dep	4	SENT_400	[p19l689t884r1209b948],
9	42	CD	NUMBER	42	dep	8	SENT_400	[p19l689t884r1209b948],
10	.	.	O	.	_	0	SENT_400	[p19l689t884r1209b948],

1	JACC	NN	O	jacc	_	0	SENT_401	[p19l349t1111r499b1142],
2	:	:	O	:	_	0	SENT_401	[p19l349t1111r499b1142],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_401	[p19l536t1111r1036b1142],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_401	[p19l1073t1111r1533b1147],
5	,	,	O	,	_	0	SENT_401	[p19l1073t1111r1533b1147],
6	VOL	NNP	O	VOL	appos	4	SENT_401	[p19l1569t1111r1691b1142],
7	.	.	O	.	_	0	SENT_401	[p19l1569t1111r1691b1142],

1	6	CD	NUMBER	6	_	0	SENT_402	[p19l1728t1112r1772b1147],
2	,	,	O	,	_	0	SENT_402	[p19l1728t1112r1772b1147],
3	NO.	NNP	O	NO.	appos	1	SENT_402	[p19l1810t1111r1900b1142],
4	2	CD	NUMBER	2	num	3	SENT_402	[p19l1937t1112r1980b1147],
5	,	,	O	,	_	0	SENT_402	[p19l1937t1112r1980b1147],
6	2013	CD	DATE	2013	num	3	SENT_402	[p19l2017t1112r2141b1142],
7	FEBRUARY	NNP	DATE	FEBRUARY	dep	1	SENT_402	[p19l1471t1176r1750b1207],
8	2013:169	CD	DATE	2013:169	num	7	SENT_402	[p19l1786t1176r2142b1207],
9	—	CD	NUMBER	—	number	10	SENT_402	[p19l1786t1176r2142b1207],
10	79	CD	NUMBER	79	dep	7	SENT_402	[p19l1786t1176r2142b1207],

1	.	.	O	.	_	0	SENT_403	[p19l83t1412r92b1421],

1	Lau	NNP	PERSON	Lau	nn	2	SENT_404	[p19l117t1369r227b1421],
2	WC	NNP	O	WC	_	0	SENT_404	[p19l255t1368r399b1432],
3	,	,	O	,	_	0	SENT_404	[p19l255t1368r399b1432],
4	Waskell	NNP	ORGANIZATION	Waskell	nn	5	SENT_404	[p19l430t1368r663b1421],
5	LA	NNP	ORGANIZATION	LA	appos	2	SENT_404	[p19l695t1367r807b1432],
6	,	,	O	,	_	0	SENT_404	[p19l695t1367r807b1432],
7	Watkins	NNP	ORGANIZATION	Watkins	nn	8	SENT_404	[p19l837t1368r1082b1421],
8	PB	NN	ORGANIZATION	pb	appos	2	SENT_404	[p19l1115t1369r1218b1432],
9	,	,	O	,	_	0	SENT_404	[p19l1115t1369r1218b1432],
10	et	FW	O	et	nn	11	SENT_404	[p19l1252t1382r1303b1421],
11	al.	FW	O	al.	appos	2	SENT_404	[p19l1335t1368r1394b1421],
12	.	.	O	.	_	0	SENT_404	[p19l1335t1368r1394b1421],

1	Atorvastatin	NNP	O	Atorvastatin	nsubj	2	SENT_405	[p19l1427t1367r1781b1421],
2	reduces	VBZ	O	reduce	_	0	SENT_405	[p19l1812t1368r2021b1421],
3	the	DT	O	the	det	4	SENT_405	[p19l2054t1368r2142b1421],
4	ability	NN	O	ability	nsubj	8	SENT_405	[p19l117t1450r292b1522],
5	of	IN	O	of	_	0	SENT_405	[p19l318t1450r382b1503],
6	clopidogrel	NN	O	clopidogrel	prep_of	4	SENT_405	[p19l400t1450r716b1522],
7	to	TO	O	to	aux	8	SENT_405	[p19l743t1464r798b1503],
8	inhibit	VB	O	inhibit	xcomp	2	SENT_405	[p19l826t1450r1017b1503],
9	platelet	NN	O	platelet	nn	10	SENT_405	[p19l1042t1450r1251b1522],
10	aggregation	NN	O	aggregation	dobj	8	SENT_405	[p19l1279t1452r1623b1522],
11	:	:	O	:	_	0	SENT_405	[p19l1279t1452r1623b1522],
12	a	DT	O	a	det	17	SENT_405	[p19l1656t1471r1683b1503],
13	new	JJ	O	new	amod	17	SENT_405	[p19l1711t1471r1827b1503],
14	drug	NN	O	drug	nn	17	SENT_405	[p19l1853t1450r2144b1522],
15	—	NN	O	—	nn	17	SENT_405	[p19l1853t1450r2144b1522],
16	drug	NN	O	drug	nn	17	SENT_405	[p19l1853t1450r2144b1522],
17	interaction	NN	O	interaction	dep	10	SENT_405	[p19l116t1536r437b1586],
18	.	.	O	.	_	0	SENT_405	[p19l116t1536r437b1586],

1	Circulation	NN	O	circulation	_	0	SENT_406	[p19l468t1533r789b1586],
2	2003	CD	DATE	2003	num	1	SENT_406	[p19l814t1534r1256b1598],
3	;	:	O	;	_	0	SENT_406	[p19l814t1534r1256b1598],
4	107:32	CD	NUMBER	107:32	num	5	SENT_406	[p19l814t1534r1256b1598],
5	—	NN	O	—	dep	1	SENT_406	[p19l814t1534r1256b1598],
6	7	CD	NUMBER	7	dep	5	SENT_406	[p19l814t1534r1256b1598],
7	.	.	O	.	_	0	SENT_406	[p19l814t1534r1256b1598],

1	.	.	O	.	_	0	SENT_407	[p19l83t1660r92b1669],

1	Neubauer	NNP	PERSON	Neubauer	nn	2	SENT_408	[p19l116t1616r395b1669],
2	HB	NNP	O	HB	nsubj	17	SENT_408	[p19l424t1616r544b1681],
3	,	,	O	,	_	0	SENT_408	[p19l424t1616r544b1681],
4	Giinesdogan	NNP	PERSON	Giinesdogan	nn	5	SENT_408	[p19l578t1615r938b1687],
5	B	NNP	PERSON	B	appos	2	SENT_408	[p19l968t1616r1028b1681],
6	,	,	O	,	_	0	SENT_408	[p19l968t1616r1028b1681],
7	Hanefeld	NNP	ORGANIZATION	Hanefeld	nn	8	SENT_408	[p19l1061t1615r1325b1669],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_408	[p19l1356t1615r1421b1681],
9	,	,	O	,	_	0	SENT_408	[p19l1356t1615r1421b1681],
10	Spiecker	NNP	O	Spiecker	nn	11	SENT_408	[p19l1456t1615r1697b1687],
11	M	NNP	O	M	appos	2	SENT_408	[p19l1724t1616r1808b1680],
12	,	,	O	,	_	0	SENT_408	[p19l1724t1616r1808b1680],
13	Mugge	NNP	PERSON	Mugge	nn	16	SENT_408	[p19l1840t1616r2043b1687],
14	A.	NNP	PERSON	A.	nn	16	SENT_408	[p19l2072t1614r2139b1669],
15	Lipophilic	NNP	PERSON	Lipophilic	nn	16	SENT_408	[p19l117t1699r412b1770],
16	statins	NNS	O	statin	appos	2	SENT_408	[p19l435t1701r614b1752],
17	interfere	VBP	O	interfere	_	0	SENT_408	[p19l637t1698r876b1752],
18	with	IN	O	with	_	0	SENT_408	[p19l896t1699r1025b1752],
19	the	DT	O	the	det	21	SENT_408	[p19l1047t1699r1135b1752],
20	inhibitory	JJ	O	inhibitory	amod	21	SENT_408	[p19l1158t1698r1442b1770],
21	effects	NNS	O	effect	prep_with	17	SENT_408	[p19l1462t1698r1633b1752],
22	of	IN	O	of	_	0	SENT_408	[p19l1657t1698r1721b1752],
23	clopidogrel	NN	O	clopidogrel	prep_of	21	SENT_408	[p19l1734t1698r2051b1770],
24	on	IN	O	on	_	0	SENT_408	[p19l2073t1719r2143b1752],
25	platelet	NN	O	platelet	nn	26	SENT_408	[p19l115t1782r324b1854],
26	function	NN	O	function	prep_on	17	SENT_408	[p19l343t1782r596b1835],
27	:	:	O	:	_	0	SENT_408	[p19l343t1782r596b1835],
28	a	DT	O	a	det	31	SENT_408	[p19l621t1802r648b1835],
29	ﬂow	NN	O	ﬂow	nn	31	SENT_408	[p19l668t1782r791b1835],
30	cytometry	NN	O	cytometry	nn	31	SENT_408	[p19l810t1795r1094b1853],
31	study	NN	O	study	dobj	17	SENT_408	[p19l1112t1782r1276b1853],
32	.	.	O	.	_	0	SENT_408	[p19l1112t1782r1276b1853],

1	Eur	NNP	MISC	Eur	nn	2	SENT_409	[p19l1301t1782r1408b1835],
2	HeartJ	NNP	O	HeartJ	_	0	SENT_409	[p19l1428t1782r1635b1850],
3	2003	CD	DATE	2003	num	2	SENT_409	[p19l1654t1783r2045b1847],
4	;	:	O	;	_	0	SENT_409	[p19l1654t1783r2045b1847],
5	24:1744	CD	NUMBER	24:1744	number	6	SENT_409	[p19l1654t1783r2045b1847],
6	-9	CD	NUMBER	-9	dep	2	SENT_409	[p19l2054t1784r2139b1835],
7	.	.	O	.	_	0	SENT_409	[p19l2054t1784r2139b1835],

1	.	.	O	.	_	0	SENT_410	[p19l83t1908r92b1917],

1	Muller	NNP	PERSON	Muller	nn	2	SENT_411	[p19l115t1864r312b1917],
2	I	NNP	O	I	_	0	SENT_411	[p19l336t1865r376b1929],
3	,	,	O	,	_	0	SENT_411	[p19l336t1865r376b1929],
4	Besta	NNP	O	Besta	nn	18	SENT_411	[p19l404t1865r558b1917],
5	F	NN	O	f	nn	18	SENT_411	[p19l583t1865r638b1929],
6	,	,	O	,	_	0	SENT_411	[p19l583t1865r638b1929],
7	Schulz	NNP	PERSON	Schulz	dep	18	SENT_411	[p19l669t1864r858b1917],
8	C	NNP	O	C	nn	18	SENT_411	[p19l883t1864r948b1929],
9	,	,	O	,	_	0	SENT_411	[p19l883t1864r948b1929],
10	Li	NNP	LOCATION	Li	appos	18	SENT_411	[p19l977t1865r1040b1916],
11	Z	NNP	LOCATION	Z	nn	18	SENT_411	[p19l1067t1864r1129b1929],
12	,	,	O	,	_	0	SENT_411	[p19l1067t1864r1129b1929],
13	Massberg	NNP	LOCATION	Massberg	appos	18	SENT_411	[p19l1155t1864r1432b1936],
14	S	NNP	LOCATION	S	nn	18	SENT_411	[p19l1459t1864r1508b1929],
15	,	,	O	,	_	0	SENT_411	[p19l1459t1864r1508b1929],
16	Gawaz	NNP	O	Gawaz	appos	18	SENT_411	[p19l1538t1864r1735b1917],
17	M.	NNP	O	M.	nn	18	SENT_411	[p19l1757t1865r1840b1917],
18	Effects	NNS	O	effect	appos	2	SENT_411	[p19l1871t1864r2060b1917],
19	of	IN	O	of	_	0	SENT_411	[p19l2088t1864r2152b1917],
20	statins	NNS	O	statin	prep_of	18	SENT_411	[p19l117t1949r295b2000],
21	on	IN	O	on	_	0	SENT_411	[p19l332t1968r401b2000],
22	platelet	NN	O	platelet	nn	23	SENT_411	[p19l435t1947r644b2019],
23	inhibition	NN	O	inhibition	prep_on	20	SENT_411	[p19l677t1947r959b2000],
24	by	IN	O	by	_	0	SENT_411	[p19l991t1947r1060b2018],
25	a	DT	O	a	det	28	SENT_411	[p19l1092t1968r1120b2000],
26	high	JJ	O	high	amod	28	SENT_411	[p19l1153t1947r1281b2018],
27	loading	NN	O	loading	nn	28	SENT_411	[p19l1314t1947r1526b2018],
28	dose	NN	O	dose	prep_by	18	SENT_411	[p19l1560t1947r1684b2000],
29	of	IN	O	of	_	0	SENT_411	[p19l1719t1947r1784b2000],
30	clopidogrel	NN	O	clopidogrel	prep_of	18	SENT_411	[p19l1809t1947r2138b2019],
31	.	.	O	.	_	0	SENT_411	[p19l1809t1947r2138b2019],

1	Circulation	NN	O	circulation	_	0	SENT_412	[p19l117t2047r439b2100],
2	2003	CD	DATE	2003	num	1	SENT_412	[p19l463t2047r976b2111],
3	;	:	O	;	_	0	SENT_412	[p19l463t2047r976b2111],
4	108:2195	CD	NUMBER	108:2195	num	5	SENT_412	[p19l463t2047r976b2111],
5	—	NN	O	—	dep	1	SENT_412	[p19l463t2047r976b2111],
6	7	CD	NUMBER	7	dep	5	SENT_412	[p19l463t2047r976b2111],
7	.	.	O	.	_	0	SENT_412	[p19l463t2047r976b2111],

1	Serebruany	NNP	O	Serebruany	nn	2	SENT_413	[p19l119t2129r436b2201],
2	VL	NNP	O	VL	_	0	SENT_413	[p19l454t2130r565b2194],
3	,	,	O	,	_	0	SENT_413	[p19l454t2130r565b2194],
4	Midei	NNP	ORGANIZATION	Midei	nn	5	SENT_413	[p19l588t2129r762b2183],
5	MG	NN	ORGANIZATION	mg	appos	2	SENT_413	[p19l782t2129r925b2194],
6	,	,	O	,	_	0	SENT_413	[p19l782t2129r925b2194],
7	Malinin	NN	PERSON	malinin	appos	2	SENT_413	[p19l948t2129r1178b2183],
8	AT	IN	O	at	amod	7	SENT_413	[p19l1198t2128r1316b2194],
9	,	,	O	,	_	0	SENT_413	[p19l1198t2128r1316b2194],
10	et	FW	O	et	nn	11	SENT_413	[p19l1341t2143r1392b2182],
11	al.	FW	O	al.	appos	2	SENT_413	[p19l1414t2129r1473b2182],
12	.	.	O	.	_	0	SENT_413	[p19l1414t2129r1473b2182],

1	Absence	NN	O	absence	_	0	SENT_414	[p19l1496t2128r1737b2182],
2	of	IN	O	of	_	0	SENT_414	[p19l1760t2129r1824b2182],
3	interaction	NN	O	interaction	prep_of	1	SENT_414	[p19l1836t2132r2142b2183],
4	between	IN	O	between	_	0	SENT_414	[p19l114t2212r350b2266],
5	atorvastatin	NN	O	atorvastatin	nn	8	SENT_414	[p19l377t2215r705b2266],
6	or	CC	O	or	_	0	SENT_414	[p19l732t2233r790b2265],
7	other	JJ	O	other	nn	8	SENT_414	[p19l815t2212r964b2265],
8	statins	NNS	O	statin	prep_between	3	SENT_414	[p19l991t2215r1169b2265],
9	and	CC	O	and	_	0	SENT_414	[p19l1198t2212r1300b2265],
10	clopidogrel	NN	O	clopidogrel	prep_between	3	SENT_414	[p19l1326t2212r1656b2284],
11	:	:	O	:	_	0	SENT_414	[p19l1326t2212r1656b2284],
12	results	NNS	O	result	dep	1	SENT_414	[p19l1685t2212r1864b2265],
13	from	IN	O	from	_	0	SENT_414	[p19l1891t2212r2027b2265],
14	the	DT	O	the	det	16	SENT_414	[p19l2054t2212r2142b2265],
15	interaction	NN	O	interaction	nn	16	SENT_414	[p19l116t2298r422b2349],
16	study	NN	O	study	prep_from	12	SENT_414	[p19l449t2296r613b2367],
17	.	.	O	.	_	0	SENT_414	[p19l449t2296r613b2367],

1	Arch	NNP	O	Arch	nn	3	SENT_415	[p19l641t2294r785b2349],
2	Intern	NNP	O	Intern	nn	3	SENT_415	[p19l811t2296r988b2349],
3	Med	NNP	O	Med	_	0	SENT_415	[p19l1013t2296r1150b2349],
4	2004	CD	DATE	2004	num	3	SENT_415	[p19l1174t2296r1686b2361],
5	;	:	O	;	_	0	SENT_415	[p19l1174t2296r1686b2361],
6	164:2051	CD	NUMBER	164:2051	num	7	SENT_415	[p19l1174t2296r1686b2361],
7	—	NN	O	—	dep	3	SENT_415	[p19l1174t2296r1686b2361],
8	7	CD	NUMBER	7	dep	7	SENT_415	[p19l1174t2296r1686b2361],
9	.	.	O	.	_	0	SENT_415	[p19l1174t2296r1686b2361],

1	.	.	O	.	_	0	SENT_416	[p19l83t2379r290b2432],

1	Smith	NNP	ORGANIZATION	Smith	nn	2	SENT_417	[p19l83t2379r290b2432],
2	SM	NNP	ORGANIZATION	SM	_	0	SENT_417	[p19l328t2379r447b2444],
3	,	,	O	,	_	0	SENT_417	[p19l328t2379r447b2444],
4	Judge	NNP	O	Judge	nn	5	SENT_417	[p19l479t2379r644b2450],
5	HM	NNS	O	hm	appos	2	SENT_417	[p19l681t2379r824b2444],
6	,	,	O	,	_	0	SENT_417	[p19l681t2379r824b2444],
7	Peters	NNP	PERSON	Peters	nn	8	SENT_417	[p19l863t2379r1035b2432],
8	G	NNP	O	G	appos	2	SENT_417	[p19l1074t2379r1144b2444],
9	,	,	O	,	_	0	SENT_417	[p19l1074t2379r1144b2444],
10	Storey	NNP	O	Storey	nn	11	SENT_417	[p19l1185t2379r1365b2450],
11	RF	NNP	O	RF	appos	2	SENT_417	[p19l1400t2379r1502b2432],
12	.	.	O	.	_	0	SENT_417	[p19l1400t2379r1502b2432],

1	Multiple	JJ	O	multiple	amod	3	SENT_418	[p19l1540t2379r1789b2451],
2	antiplatelet	JJ	O	antiplatelet	amod	3	SENT_418	[p19l1827t2379r2144b2451],
3	effects	NNS	O	effect	nsubjpass	8	SENT_418	[p19l117t2463r288b2516],
4	of	IN	O	of	_	0	SENT_418	[p19l328t2463r393b2516],
5	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_418	[p19l423t2463r739b2535],
6	are	VBP	O	be	auxpass	8	SENT_418	[p19l778t2483r859b2516],
7	not	RB	O	not	neg	8	SENT_418	[p19l899t2477r993b2516],
8	modulated	VBN	O	modulate	_	0	SENT_418	[p19l1031t2463r1334b2516],
9	by	IN	O	by	_	0	SENT_418	[p19l1371t2463r1440b2534],
10	statin	NN	O	statin	nn	11	SENT_418	[p19l1477t2465r1631b2516],
11	type	NN	O	type	agent	8	SENT_418	[p19l1670t2476r1787b2535],
12	in	IN	O	in	_	0	SENT_418	[p19l1827t2465r1881b2515],
13	patients	NNS	O	patient	prep_in	8	SENT_418	[p19l1919t2465r2141b2535],
14	undergoing	VBG	O	undergo	partmod	13	SENT_418	[p19l115t2545r442b2617],
15	percutaneous	JJ	O	percutaneous	amod	17	SENT_418	[p19l486t2559r858b2617],
16	coronary	JJ	O	coronary	amod	17	SENT_418	[p19l907t2565r1155b2616],
17	intervention	NN	O	intervention	dobj	14	SENT_418	[p19l1199t2547r1559b2598],
18	.	.	O	.	_	0	SENT_418	[p19l1199t2547r1559b2598],

1	Platelets	NNS	O	platelet	_	0	SENT_419	[p19l1610t2545r1847b2598],
2	2004,15	CD	NUMBER	2004,15	num	1	SENT_419	[p19l1894t2545r2139b2610],
3	:	:	O	:	_	0	SENT_419	[p19l1894t2545r2139b2610],
4	465-74	CD	NUMBER	465-74	dep	1	SENT_419	[p19l116t2629r341b2682],
5	.	.	O	.	_	0	SENT_419	[p19l116t2629r341b2682],

1	Geisler	NNP	PERSON	Geisler	nn	2	SENT_420	[p19l117t2711r320b2764],
2	T	NN	O	t	_	0	SENT_420	[p19l347t2710r412b2776],
3	,	,	O	,	_	0	SENT_420	[p19l347t2710r412b2776],
4	Ziirn	NN	O	ziirn	nn	5	SENT_420	[p19l446t2712r591b2764],
5	C	NN	O	c	appos	2	SENT_420	[p19l623t2711r687b2776],
6	,	,	O	,	_	0	SENT_420	[p19l623t2711r687b2776],
7	Paterok	NN	O	paterok	nn	8	SENT_420	[p19l720t2711r942b2764],
8	M	NN	O	m	appos	2	SENT_420	[p19l968t2712r1052b2776],
9	,	,	O	,	_	0	SENT_420	[p19l968t2712r1052b2776],
10	et	FW	O	et	nn	11	SENT_420	[p19l1086t2725r1137b2764],
11	al.	FW	O	al.	appos	2	SENT_420	[p19l1167t2711r1226b2764],
12	.	.	O	.	_	0	SENT_420	[p19l1167t2711r1226b2764],

1	Statins	NNS	O	statin	nsubj	5	SENT_421	[p19l1263t2711r1454b2764],
2	do	VBP	O	do	aux	5	SENT_421	[p19l1486t2711r1554b2764],
3	not	RB	O	not	neg	5	SENT_421	[p19l1586t2725r1680b2764],
4	adversely	RB	O	adversely	advmod	5	SENT_421	[p19l1711t2711r1967b2783],
5	affect	VB	O	affect	_	0	SENT_421	[p19l1996t2711r2144b2764],
6	post	NN	O	post	nn	7	SENT_421	[p19l115t2795r660b2867],
7	—	NN	O	—	dobj	5	SENT_421	[p19l115t2795r660b2867],
8	interventional	JJ	O	interventional	amod	11	SENT_421	[p19l115t2795r660b2867],
9	residual	JJ	O	residual	amod	11	SENT_421	[p19l689t2795r908b2849],
10	platelet	NN	O	platelet	nn	11	SENT_421	[p19l935t2795r1145b2867],
11	aggregation	NN	O	aggregation	dep	7	SENT_421	[p19l1174t2798r1505b2867],
12	and	CC	O	and	_	0	SENT_421	[p19l1535t2795r1637b2849],
13	outcomes	NNS	O	outcome	dobj	5	SENT_421	[p19l1667t2809r1934b2848],
14	in	IN	O	in	_	0	SENT_421	[p19l1966t2798r2020b2848],
15	patients	NNS	O	patient	prep_in	13	SENT_421	[p19l2048t2816r2140b2867, p19l116t2907r270b2958],

1	undergoing	VBG	O	undergo	csubj	4	SENT_422	[p19l289t2905r616b2976],
2	coronary	JJ	O	coronary	amod	3	SENT_422	[p19l634t2925r881b2976],
3	stenting	NN	O	stenting	dobj	1	SENT_422	[p19l898t2907r1126b2976],
4	treated	VBN	O	treat	_	0	SENT_422	[p19l1143t2904r1339b2958],
5	by	IN	O	by	_	0	SENT_422	[p19l1355t2905r1425b2976],
6	dual	JJ	O	dual	amod	8	SENT_422	[p19l1441t2904r1560b2958],
7	antiplatelet	JJ	O	antiplatelet	amod	8	SENT_422	[p19l1579t2905r1896b2976],
8	therapy	NN	O	therapy	prep_by	4	SENT_422	[p19l1913t2905r2139b2976],
9	.	.	O	.	_	0	SENT_422	[p19l1913t2905r2139b2976],

1	Eur	NNP	O	Eur	nn	2	SENT_423	[p19l117t2988r224b3040],
2	Heart	NNP	O	Heart	_	0	SENT_423	[p19l249t2988r462b3055],
3	]	CD	NUMBER	]	num	4	SENT_423	[p19l249t2988r462b3055],
4	2008	CD	DATE	2008	dep	2	SENT_423	[p19l487t2988r1008b3052],
5	;	:	O	;	_	0	SENT_423	[p19l487t2988r1008b3052],
6	29:1635	CD	NUMBER	29:1635	number	7	SENT_423	[p19l487t2988r1008b3052],
7	—	CD	NUMBER	—	dep	2	SENT_423	[p19l487t2988r1008b3052],
8	43	CD	NUMBER	43	dep	7	SENT_423	[p19l487t2988r1008b3052],
9	.	.	O	.	_	0	SENT_423	[p19l487t2988r1008b3052],

1	Bates	NNP	PERSON	Bates	nn	2	SENT_424	[p19l116t3070r268b3123],
2	ER	NN	O	er	_	0	SENT_424	[p19l309t3070r420b3135],
3	,	,	O	,	_	0	SENT_424	[p19l309t3070r420b3135],
4	Lau	NNP	PERSON	Lau	nn	5	SENT_424	[p19l462t3070r572b3123],
5	WC	NNP	O	WC	appos	2	SENT_424	[p19l607t3070r751b3135],
6	,	,	O	,	_	0	SENT_424	[p19l607t3070r751b3135],
7	Angiolillo	NNP	O	Angiolillo	nn	8	SENT_424	[p19l791t3068r1078b3141],
8	DJ	NNP	O	DJ	appos	5	SENT_424	[p19l1118t3070r1211b3138],
9	.	.	O	.	_	0	SENT_424	[p19l1118t3070r1211b3138],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_425	[p19l1255t3070r1755b3142],
2	—	CD	NUMBER	—	num	4	SENT_425	[p19l1255t3070r1755b3142],
3	drug	NN	O	drug	nn	4	SENT_425	[p19l1255t3070r1755b3142],
4	interactions	NNS	O	interaction	dep	1	SENT_425	[p19l1793t3072r2139b3123],
5	.	.	O	.	_	0	SENT_425	[p19l1793t3072r2139b3123],

1	J	NNP	O	J	nn	4	SENT_426	[p19l108t3153r137b3219],
2	Am	NNP	O	Am	nn	4	SENT_426	[p19l161t3151r270b3204],
3	Coll	NNP	O	Coll	nn	4	SENT_426	[p19l299t3152r421b3204],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_426	[p19l447t3152r662b3204],
5	2011	CD	DATE	2011	num	4	SENT_426	[p19l686t3152r1114b3216],
6	;	:	O	;	_	0	SENT_426	[p19l686t3152r1114b3216],
7	57:1251	CD	NUMBER	57:1251	number	8	SENT_426	[p19l686t3152r1114b3216],
8	—	CD	NUMBER	—	dep	4	SENT_426	[p19l686t3152r1114b3216],
9	63	CD	NUMBER	63	dep	8	SENT_426	[p19l1125t3155r1207b3204],
10	.	.	O	.	_	0	SENT_426	[p19l1125t3155r1207b3204],

1	Brar	NNP	O	Brar	nn	2	SENT_427	[p19l116t3235r240b3287],
2	SS	NNP	O	SS	_	0	SENT_427	[p19l265t3234r353b3299],
3	,	,	O	,	_	0	SENT_427	[p19l265t3234r353b3299],
4	ten	CD	NUMBER	ten	num	6	SENT_427	[p19l378t3248r466b3287],
5	Berg	NNP	PERSON	Berg	nn	6	SENT_427	[p19l489t3235r624b3306],
6	J	NNP	PERSON	J	appos	2	SENT_427	[p19l638t3235r682b3302],
7	,	,	O	,	_	0	SENT_427	[p19l638t3235r682b3302],
8	Marcucci	NNP	PERSON	Marcucci	nn	9	SENT_427	[p19l705t3235r972b3287],
9	M	NNP	O	M	appos	2	SENT_427	[p19l993t3235r1077b3299],
10	,	,	O	,	_	0	SENT_427	[p19l993t3235r1077b3299],
11	et	FW	O	et	nn	12	SENT_427	[p19l1103t3248r1154b3287],
12	al.	FW	O	al.	appos	2	SENT_427	[p19l1177t3234r1236b3287],
13	.	.	O	.	_	0	SENT_427	[p19l1177t3234r1236b3287],

1	Impact	NN	O	impact	_	0	SENT_428	[p19l1262t3235r1463b3306],
2	of	IN	O	of	_	0	SENT_428	[p19l1485t3234r1550b3287],
3	platelet	NN	O	platelet	nn	4	SENT_428	[p19l1561t3234r1771b3306],
4	reactivity	NN	O	reactivity	prep_of	1	SENT_428	[p19l1792t3236r2052b3305],
5	on	IN	O	on	_	0	SENT_428	[p19l2073t3255r2143b3287],
6	clinical	JJ	O	clinical	amod	7	SENT_428	[p19l117t3317r316b3370],
7	outcomes	NNS	O	outcome	prep_on	4	SENT_428	[p19l339t3331r607b3370],
8	after	IN	O	after	_	0	SENT_428	[p19l633t3317r761b3370],
9	percutaneous	JJ	O	percutaneous	amod	11	SENT_428	[p19l782t3331r1154b3389],
10	coronary	JJ	O	coronary	amod	11	SENT_428	[p19l1181t3337r1428b3389],
11	intervention	NN	O	intervention	prep_after	7	SENT_428	[p19l1449t3319r1810b3370],
12	:	:	O	:	_	0	SENT_428	[p19l1449t3319r1810b3370],
13	a	DT	O	a	det	15	SENT_428	[p19l1839t3338r1866b3370],
14	collaborative	JJ	O	collaborative	amod	15	SENT_428	[p19l1890t3317r2140b3370, p19l117t3403r246b3453],
15	meta-analysis	NN	O	meta-analysis	dep	1	SENT_428	[p19l277t3400r659b3472],
16	of	IN	O	of	_	0	SENT_428	[p19l691t3400r755b3453],
17	individual	JJ	O	individual	amod	19	SENT_428	[p19l775t3400r1058b3454],
18	participant	NN	O	participant	nn	19	SENT_428	[p19l1086t3403r1394b3472],
19	data	NNS	O	datum	prep_of	15	SENT_428	[p19l1423t3400r1555b3453],
20	.	.	O	.	_	0	SENT_428	[p19l1423t3400r1555b3453],

1	J	NNP	O	J	nn	4	SENT_429	[p19l1580t3401r1609b3468],
2	Am	NNP	O	Am	nn	4	SENT_429	[p19l1637t3399r1745b3453],
3	Coll	NNP	O	Coll	nn	4	SENT_429	[p19l1777t3400r1899b3454],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_429	[p19l1929t3400r2144b3454],
5	2011	CD	DATE	2011	num	4	SENT_429	[p19l115t3483r627b3548],
6	;	:	O	;	_	0	SENT_429	[p19l115t3483r627b3548],
7	58:1945	CD	NUMBER	58:1945	number	8	SENT_429	[p19l115t3483r627b3548],
8	—	CD	NUMBER	—	dep	4	SENT_429	[p19l115t3483r627b3548],
9	54	CD	NUMBER	54	dep	8	SENT_429	[p19l115t3483r627b3548],
10	.	.	O	.	_	0	SENT_429	[p19l115t3483r627b3548],

1	Angiolillo	JJ	O	angiolillo	amod	2	SENT_430	[p19l114t3564r401b3637],
2	DJ	NNP	O	DJ	_	0	SENT_430	[p19l424t3566r519b3633],
3	,	,	O	,	_	0	SENT_430	[p19l424t3566r519b3633],
4	Shoemaker	NNP	O	Shoemaker	nn	5	SENT_430	[p19l545t3565r862b3619],
5	SB	NN	O	sb	appos	2	SENT_430	[p19l885t3565r981b3631],
6	,	,	O	,	_	0	SENT_430	[p19l885t3565r981b3631],
7	Desai	NNP	PERSON	Desai	nn	8	SENT_430	[p19l1006t3566r1166b3619],
8	B	NNP	O	B	appos	2	SENT_430	[p19l1188t3566r1248b3630],
9	,	,	O	,	_	0	SENT_430	[p19l1188t3566r1248b3630],
10	et	FW	O	et	nn	11	SENT_430	[p19l1273t3579r1323b3619],
11	al.	FW	O	al.	appos	2	SENT_430	[p19l1345t3566r1404b3619],
12	.	.	O	.	_	0	SENT_430	[p19l1345t3566r1404b3619],

1	Randomized	VBN	O	randomize	_	0	SENT_431	[p19l1431t3566r1792b3619],
2	comparison	NN	O	comparison	dobj	1	SENT_431	[p19l1814t3568r2142b3637],
3	of	IN	O	of	_	0	SENT_431	[p19l117t3650r180b3703],
4	a	DT	O	a	det	8	SENT_431	[p19l214t3670r242b3703],
5	high	JJ	O	high	amod	8	SENT_431	[p19l283t3650r412b3721],
6	clopidogrel	NN	O	clopidogrel	nn	8	SENT_431	[p19l454t3650r771b3722],
7	maintenance	NN	O	maintenance	nn	8	SENT_431	[p19l813t3652r1173b3703],
8	dose	NN	O	dose	prep_of	2	SENT_431	[p19l1216t3650r1340b3703],
9	in	IN	O	in	_	0	SENT_431	[p19l1384t3652r1438b3702],
10	patients	NNS	O	patient	prep_in	8	SENT_431	[p19l1480t3652r1702b3722],
11	with	IN	O	with	_	0	SENT_431	[p19l1743t3650r1872b3703],
12	diabetes	NN	O	diabetes	nn	13	SENT_431	[p19l1915t3650r2142b3703],
13	mellitus	NN	O	mellitus	prep_with	1	SENT_431	[p19l117t3733r339b3786],
14	and	CC	O	and	_	0	SENT_431	[p19l371t3733r473b3786],
15	coronary	JJ	O	coronary	amod	17	SENT_431	[p19l503t3753r751b3804],
16	artery	NN	O	artery	nn	17	SENT_431	[p19l778t3747r941b3804],
17	disease	NN	O	disease	prep_with	1	SENT_431	[p19l967t3733r1177b3786],
18	:	:	O	:	_	0	SENT_431	[p19l967t3733r1177b3786],
19	results	NNS	O	result	dobj	1	SENT_431	[p19l1210t3733r1388b3786],
20	of	IN	O	of	_	0	SENT_431	[p19l1419t3733r1483b3786],
21	the	DT	O	the	det	23	SENT_431	[p19l1503t3733r1591b3786],
22	Optimizing	VBG	O	optimize	amod	23	SENT_431	[p19l1623t3733r1956b3805],
23	Antiplatelet	NN	O	antiplatelet	prep_of	19	SENT_431	[p19l1982t3731r2140b3786, p20l115t13r324b85],

1	Therapy	NN	O	therapy	_	0	SENT_432	[p20l344t11r588b85],
2	in	IN	O	in	_	0	SENT_432	[p20l608t15r663b65],
3	Diabetes	NNP	MISC	Diabetes	nn	6	SENT_432	[p20l686t13r934b66],
4	Mellitus	NNP	MISC	Mellitus	nn	6	SENT_432	[p20l958t13r1195b66],
5	(	CD	NUMBER	(	num	6	SENT_432	[p20l1223t11r1602b78],
6	OPTIMUS	NNP	O	OPTIMUS	prep_in	1	SENT_432	[p20l1223t11r1602b78],
7	)	CD	NUMBER	)	num	8	SENT_432	[p20l1223t11r1602b78],
8	study	NN	O	study	dep	6	SENT_432	[p20l1629t13r1792b84],
9	.	.	O	.	_	0	SENT_432	[p20l1629t13r1792b84],

1	Circulation	NN	O	circulation	_	0	SENT_433	[p20l1821t13r2143b66],
2	2007	CD	DATE	2007	num	1	SENT_433	[p20l115t96r635b160],
3	;	:	O	;	_	0	SENT_433	[p20l115t96r635b160],
4	115:708	CD	NUMBER	115:708	number	5	SENT_433	[p20l115t96r635b160],
5	—	CD	NUMBER	—	dep	1	SENT_433	[p20l115t96r635b160],
6	16	CD	NUMBER	16	dep	5	SENT_433	[p20l115t96r635b160],
7	.	.	O	.	_	0	SENT_433	[p20l115t96r635b160],

1	Angiolillo	NN	O	angiolillo	nn	2	SENT_434	[p20l114t177r401b250],
2	D	NN	O	d	_	0	SENT_434	[p20l430t179r524b246],
3	]	CD	NUMBER	]	dep	2	SENT_434	[p20l430t179r524b246],
4	,	,	O	,	_	0	SENT_434	[p20l430t179r524b246],
5	Costa	NNP	LOCATION	Costa	nn	6	SENT_434	[p20l555t178r719b231],
6	MA	NNP	LOCATION	MA	appos	3	SENT_434	[p20l744t177r881b243],
7	,	,	O	,	_	0	SENT_434	[p20l744t177r881b243],
8	Shoemaker	NNP	O	Shoemaker	nn	9	SENT_434	[p20l913t178r1230b231],
9	SB	NN	O	sb	appos	3	SENT_434	[p20l1259t178r1355b243],
10	,	,	O	,	_	0	SENT_434	[p20l1259t178r1355b243],
11	et	FW	O	et	nn	12	SENT_434	[p20l1385t192r1436b231],
12	al.	FW	O	al.	appos	3	SENT_434	[p20l1463t178r1523b231],
13	.	.	O	.	_	0	SENT_434	[p20l1463t178r1523b231],

1	Functional	JJ	O	functional	amod	2	SENT_435	[p20l1554t178r1861b231],
2	effects	NNS	O	effect	_	0	SENT_435	[p20l1888t178r2059b231],
3	of	IN	O	of	_	0	SENT_435	[p20l2088t178r2152b231],
4	high	JJ	O	high	amod	7	SENT_435	[p20l116t262r243b334],
5	clopidogrel	NN	O	clopidogrel	nn	7	SENT_435	[p20l291t262r607b334],
6	maintenance	NN	O	maintenance	nn	7	SENT_435	[p20l653t265r1012b315],
7	dosing	NN	O	dosing	prep_of	2	SENT_435	[p20l1060t262r1247b334],
8	in	IN	O	in	_	0	SENT_435	[p20l1293t265r1347b315],
9	patients	NNS	O	patient	prep_in	2	SENT_435	[p20l1392t265r1614b334],
10	with	IN	O	with	_	0	SENT_435	[p20l1659t262r1788b316],
11	inadequate	JJ	O	inadequate	amod	13	SENT_435	[p20l1835t262r2142b334],
12	platelet	NN	O	platelet	nn	13	SENT_435	[p20l115t345r324b417],
13	inhibition	NN	O	inhibition	prep_with	9	SENT_435	[p20l342t346r624b399],
14	on	IN	O	on	_	0	SENT_435	[p20l645t366r715b399],
15	standard	JJ	O	standard	amod	17	SENT_435	[p20l735t346r978b399],
16	dose	NN	O	dose	nn	17	SENT_435	[p20l998t345r1122b399],
17	treatment	NN	O	treatment	prep_on	13	SENT_435	[p20l1142t359r1433b399],
18	.	.	O	.	_	0	SENT_435	[p20l1142t359r1433b399],

1	Am	VBP	O	be	dep	3	SENT_436	[p20l1454t344r1605b413],
2	]	CD	NUMBER	]	num	3	SENT_436	[p20l1454t344r1605b413],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_436	[p20l1626t345r1841b399],
4	2008	CD	DATE	2008	num	3	SENT_436	[p20l1858t348r2139b411],
5	;	:	O	;	_	0	SENT_436	[p20l1858t348r2139b411],
6	101	CD	NUMBER	101	dep	3	SENT_436	[p20l1858t348r2139b411],
7	:	:	O	:	_	0	SENT_436	[p20l1858t348r2139b411],
8	440-5	CD	NUMBER	440-5	dep	6	SENT_436	[p20l115t429r314b481],
9	.	.	O	.	_	0	SENT_436	[p20l115t429r314b481],

1	Barker	NNP	PERSON	Barker	nn	2	SENT_437	[p20l116t511r306b564],
2	CM	NN	O	cm	_	0	SENT_437	[p20l332t511r466b576],
3	,	,	O	,	_	0	SENT_437	[p20l332t511r466b576],
4	Murray	NNP	PERSON	Murray	nn	5	SENT_437	[p20l492t511r710b582],
5	SS	NNP	O	SS	appos	2	SENT_437	[p20l735t511r823b576],
6	,	,	O	,	_	0	SENT_437	[p20l735t511r823b576],
7	Teirstein	NNP	ORGANIZATION	Teirstein	nn	8	SENT_437	[p20l849t509r1107b564],
8	PS	NNP	ORGANIZATION	PS	appos	2	SENT_437	[p20l1133t511r1228b576],
9	,	,	O	,	_	0	SENT_437	[p20l1133t511r1228b576],
10	Kandzari	NNP	ORGANIZATION	Kandzari	nn	11	SENT_437	[p20l1258t511r1514b564],
11	DE	NN	ORGANIZATION	de	appos	2	SENT_437	[p20l1539t511r1659b576],
12	,	,	O	,	_	0	SENT_437	[p20l1539t511r1659b576],
13	Topol	NN	PERSON	topol	nn	14	SENT_437	[p20l1685t509r1861b583],
14	E	NN	O	e	appos	2	SENT_437	[p20l1887t511r1971b579],
15	]	CD	NUMBER	]	dep	14	SENT_437	[p20l1887t511r1971b579],
16	,	,	O	,	_	0	SENT_437	[p20l1887t511r1971b579],
17	Price	NNP	O	Price	poss	22	SENT_437	[p20l1999t511r2142b564],
18	'	POS	O	'	_	0	SENT_437	[p20l115t594r221b661],
19	O	NN	O	o	nn	22	SENT_437	[p20l115t594r221b661],
20	*	CD	NUMBER	*	num	22	SENT_437	[p20l115t594r221b661],
21	Pilot	NN	O	pilot	nn	22	SENT_437	[p20l269t593r406b646],
22	study	NN	O	study	appos	2	SENT_437	[p20l449t593r601b665],
23	of	IN	O	of	_	0	SENT_437	[p20l641t593r706b646],
24	the	DT	O	the	det	26	SENT_437	[p20l740t593r828b646],
25	antiplatelet	JJ	O	antiplatelet	amod	26	SENT_437	[p20l873t593r1190b665],
26	effect	NN	O	effect	prep_of	22	SENT_437	[p20l1233t593r1381b646],
27	of	IN	O	of	_	0	SENT_437	[p20l1424t593r1488b646],
28	increased	VBN	O	increase	amod	31	SENT_437	[p20l1522t593r1784b646],
29	clopidogrel	NN	O	clopidogrel	nn	31	SENT_437	[p20l1828t593r2144b665],
30	maintenance	NN	O	maintenance	nn	31	SENT_437	[p20l117t678r476b729],
31	dosing	NN	O	dosing	prep_of	26	SENT_437	[p20l516t676r704b747],
32	and	CC	O	and	_	0	SENT_437	[p20l742t676r844b729],
33	its	PRP$	O	its	poss	34	SENT_437	[p20l882t678r945b729],
34	relationship	NN	O	relationship	prep_of	26	SENT_437	[p20l985t676r1319b748],
35	to	TO	O	to	_	0	SENT_437	[p20l1359t690r1414b729],
36	CYP2C19	NN	O	cyp2c19	nn	37	SENT_437	[p20l1455t676r1753b730],
37	genotype	NN	O	genotype	prep_to	34	SENT_437	[p20l1792t690r2049b748],
38	in	IN	O	in	_	0	SENT_437	[p20l2088t678r2142b728],
39	patients	NNS	O	patient	prep_in	37	SENT_437	[p20l115t761r337b831],
40	with	IN	O	with	_	0	SENT_437	[p20l370t759r500b812],
41	high	JJ	O	high	amod	43	SENT_437	[p20l535t759r662b831],
42	on-treatment	JJ	O	on-treatment	amod	43	SENT_437	[p20l698t773r1077b812],
43	reactivity	NN	O	reactivity	prep_with	39	SENT_437	[p20l1110t761r1382b831],
44	.	.	O	.	_	0	SENT_437	[p20l1110t761r1382b831],

1	J	NNP	O	J	nn	5	SENT_438	[p20l1414t760r1442b827],
2	Am	NNP	O	Am	nn	5	SENT_438	[p20l1475t758r1584b812],
3	Coll	NNP	O	Coll	nn	5	SENT_438	[p20l1621t759r1743b812],
4	Cardiol	NNP	O	Cardiol	nn	5	SENT_438	[p20l1779t759r1993b812],
5	Intv	NNP	O	Intv	_	0	SENT_438	[p20l2027t760r2146b812],
6	2010	CD	DATE	2010	num	5	SENT_438	[p20l115t843r556b907],
7	;	:	O	;	_	0	SENT_438	[p20l115t843r556b907],
8	3:1001	CD	NUMBER	3:1001	num	9	SENT_438	[p20l115t843r556b907],
9	—	NN	O	—	dep	5	SENT_438	[p20l115t843r556b907],
10	7	CD	NUMBER	7	dep	9	SENT_438	[p20l115t843r556b907],
11	.	.	O	.	_	0	SENT_438	[p20l115t843r556b907],

1	Price	NN	O	price	nn	3	SENT_439	[p20l116t925r259b977],
2	M	NN	O	m	nn	3	SENT_439	[p20l278t925r386b992],
3	]	NN	O	]	_	0	SENT_439	[p20l278t925r386b992],
4	,	,	O	,	_	0	SENT_439	[p20l278t925r386b992],
5	Endemann	NNP	ORGANIZATION	Endemann	nn	6	SENT_439	[p20l410t924r724b977],
6	S	NNP	ORGANIZATION	S	appos	3	SENT_439	[p20l746t924r796b989],
7	,	,	O	,	_	0	SENT_439	[p20l746t924r796b989],
8	Gollapudi	NNP	O	Gollapudi	nn	9	SENT_439	[p20l820t924r1104b996],
9	RR	NNP	O	RR	appos	3	SENT_439	[p20l1126t925r1237b989],
10	,	,	O	,	_	0	SENT_439	[p20l1126t925r1237b989],
11	et	FW	O	et	nn	12	SENT_439	[p20l1260t938r1311b977],
12	al.	FW	O	al.	appos	3	SENT_439	[p20l1331t924r1390b977],
13	.	.	O	.	_	0	SENT_439	[p20l1331t924r1390b977],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_440	[p20l1414t925r1719b996],
2	signiﬁcance	NN	O	signiﬁcance	nsubj	9	SENT_440	[p20l1739t924r2067b996],
3	of	IN	O	of	_	0	SENT_440	[p20l2088t924r2152b977],
4	post	NN	O	post	nn	8	SENT_440	[p20l115t1009r582b1080],
5	—	CD	NUMBER	—	num	8	SENT_440	[p20l115t1009r582b1080],
6	clopidogrel	NN	O	clopidogrel	nn	8	SENT_440	[p20l115t1009r582b1080],
7	platelet	NN	O	platelet	nn	8	SENT_440	[p20l604t1008r813b1080],
8	reactivity	NN	O	reactivity	prep_of	2	SENT_440	[p20l835t1011r1095b1080],
9	assessed	VBN	O	assess	_	0	SENT_440	[p20l1117t1008r1343b1062],
10	by	IN	O	by	_	0	SENT_440	[p20l1365t1009r1434b1080],
11	a	DT	O	a	det	13	SENT_440	[p20l1456t1029r1483b1062],
12	point	NN	O	point	nn	13	SENT_440	[p20l1505t1008r1884b1080],
13	—	NN	O	—	prep_by	9	SENT_440	[p20l1505t1008r1884b1080],
14	of	IN	O	of	_	0	SENT_440	[p20l1505t1008r1884b1080],
15	—	CD	NUMBER	—	num	17	SENT_440	[p20l1505t1008r1884b1080],
16	care	NN	O	care	nn	17	SENT_440	[p20l1505t1008r1884b1080],
17	assay	NN	O	assay	prep_of	13	SENT_440	[p20l1909t1029r2051b1080],
18	on	IN	O	on	_	0	SENT_440	[p20l2073t1029r2143b1062],
19	thrombotic	JJ	O	thrombotic	amod	20	SENT_440	[p20l116t1092r434b1145],
20	events	NNS	O	event	prep_on	17	SENT_440	[p20l464t1106r637b1145],
21	after	IN	O	after	_	0	SENT_440	[p20l669t1092r796b1145],
22	drug	NN	O	drug	nn	23	SENT_440	[p20l825t1092r1183b1163],
23	—	NN	O	—	prep_after	9	SENT_440	[p20l825t1092r1183b1163],
24	eluting	VBG	O	elute	partmod	23	SENT_440	[p20l825t1092r1183b1163],
25	stent	NN	O	stent	nn	26	SENT_440	[p20l1212t1105r1349b1145],
26	implantation	NN	O	implantation	dobj	24	SENT_440	[p20l1377t1092r1757b1164],
27	.	.	O	.	_	0	SENT_440	[p20l1377t1092r1757b1164],

1	Eur	NNP	O	Eur	nn	2	SENT_441	[p20l1791t1092r1898b1145],
2	Heart	NNP	O	Heart	_	0	SENT_441	[p20l1926t1092r2143b1160],
3	]	CD	NUMBER	]	num	4	SENT_441	[p20l1926t1092r2143b1160],
4	2008	CD	DATE	2008	dep	2	SENT_441	[p20l114t1177r663b1239],
5	;	:	O	;	_	0	SENT_441	[p20l114t1177r663b1239],
6	29:992	CD	NUMBER	29:992	number	7	SENT_441	[p20l114t1177r663b1239],
7	—	CD	NUMBER	—	dep	2	SENT_441	[p20l114t1177r663b1239],
8	1000	CD	DATE	1000	dep	7	SENT_441	[p20l114t1177r663b1239],
9	.	.	O	.	_	0	SENT_441	[p20l114t1177r663b1239],

1	Patti	NNP	PERSON	Patti	nn	2	SENT_442	[p20l116t1257r252b1309],
2	G	NNP	PERSON	G	nsubj	28	SENT_442	[p20l295t1256r365b1321],
3	,	,	O	,	_	0	SENT_442	[p20l295t1256r365b1321],
4	Nusca	NNP	O	Nusca	nn	5	SENT_442	[p20l408t1257r585b1309],
5	A	NNP	O	A	appos	2	SENT_442	[p20l623t1255r692b1321],
6	,	,	O	,	_	0	SENT_442	[p20l623t1255r692b1321],
7	Mangiacapra	NNP	O	Mangiacapra	nn	8	SENT_442	[p20l734t1257r1107b1328],
8	F	NN	O	f	appos	2	SENT_442	[p20l1149t1257r1204b1321],
9	,	,	O	,	_	0	SENT_442	[p20l1149t1257r1204b1321],
10	Gatto	NNP	PERSON	Gatto	nn	11	SENT_442	[p20l1250t1256r1414b1309],
11	L	NNP	O	L	appos	2	SENT_442	[p20l1458t1257r1517b1321],
12	,	,	O	,	_	0	SENT_442	[p20l1458t1257r1517b1321],
13	D’Ambrosio	NNP	O	D’Ambrosio	nn	14	SENT_442	[p20l1561t1255r1915b1309],
14	A	NNP	O	A	appos	2	SENT_442	[p20l1956t1255r2024b1321],
15	,	,	O	,	_	0	SENT_442	[p20l1956t1255r2024b1321],
16	Di	NNP	O	Di	nn	20	SENT_442	[p20l2068t1257r2142b1308],
17	Sciascio	NNP	O	Sciascio	nn	20	SENT_442	[p20l119t1339r339b1392],
18	G.	NNP	O	G.	nn	20	SENT_442	[p20l372t1339r441b1392],
19	Point	NNP	O	Point	nn	20	SENT_442	[p20l475t1339r859b1392],
20	—	NN	O	—	appos	2	SENT_442	[p20l475t1339r859b1392],
21	of	IN	O	of	_	0	SENT_442	[p20l475t1339r859b1392],
22	—	CD	NUMBER	—	num	24	SENT_442	[p20l475t1339r859b1392],
23	care	NN	O	care	nn	24	SENT_442	[p20l475t1339r859b1392],
24	measurement	NN	O	measurement	prep_of	20	SENT_442	[p20l890t1353r1271b1392],
25	of	IN	O	of	_	0	SENT_442	[p20l1300t1339r1364b1392],
26	clopidogrel	NN	O	clopidogrel	nn	27	SENT_442	[p20l1386t1339r1702b1411],
27	responsiveness	NN	O	responsiveness	prep_of	24	SENT_442	[p20l1731t1341r2141b1411],
28	predicts	VBZ	O	predict	_	0	SENT_442	[p20l115t1423r336b1495],
29	clinical	JJ	O	clinical	amod	30	SENT_442	[p20l359t1423r558b1476],
30	outcome	NN	O	outcome	dobj	28	SENT_442	[p20l578t1437r821b1476],
31	in	IN	O	in	_	0	SENT_442	[p20l842t1425r896b1476],
32	patients	NNS	O	patient	prep_in	28	SENT_442	[p20l916t1425r1138b1495],
33	undergoing	VBG	O	undergo	partmod	32	SENT_442	[p20l1159t1423r1485b1495],
34	percutaneous	JJ	O	percutaneous	amod	36	SENT_442	[p20l1503t1437r1875b1495],
35	coronary	JJ	O	coronary	amod	36	SENT_442	[p20l1898t1443r2146b1495],
36	intervention	NN	O	intervention	dobj	33	SENT_442	[p20l116t1509r476b1559],
37	:	:	O	:	_	0	SENT_442	[p20l116t1509r476b1559],
38	results	NNS	O	result	dep	36	SENT_442	[p20l505t1506r683b1559],
39	of	IN	O	of	_	0	SENT_442	[p20l711t1506r775b1559],
40	the	DT	O	the	det	41	SENT_442	[p20l790t1506r879b1559],
41	ARMYDA	NNP	O	ARMYDA	prep_of	38	SENT_442	[p20l903t1505r1411b1560],
42	.	.	O	.	_	0	SENT_442	[p20l903t1505r1411b1560],

1	—	NN	O	—	_	0	SENT_443	[p20l903t1505r1411b1560],
2	.	.	O	.	_	0	SENT_443	[p20l903t1505r1411b1560],

1	PRO	FW	O	pro	nn	4	SENT_444	[p20l903t1505r1411b1560],
2	(	FW	O	(	nn	4	SENT_444	[p20l1441t1505r1803b1578],
3	Antiplatelet	NN	O	antiplatelet	nn	4	SENT_444	[p20l1441t1505r1803b1578],
4	therapy	NN	O	therapy	_	0	SENT_444	[p20l1826t1506r2041b1578],
5	for	IN	O	for	_	0	SENT_444	[p20l2063t1506r2144b1559],
6	Reduction	NN	O	reduction	prep_for	4	SENT_444	[p20l118t1589r411b1643],
7	of	IN	O	of	_	0	SENT_444	[p20l440t1589r504b1643],
8	Myocardial	JJ	O	myocardial	amod	9	SENT_444	[p20l521t1590r846b1661],
9	Damage	NN	O	damage	prep_of	4	SENT_444	[p20l873t1590r1111b1661],
10	during	IN	O	during	_	0	SENT_444	[p20l1141t1590r1328b1661],
11	Angioplasty	NNP	O	Angioplasty	prep_during	4	SENT_444	[p20l1353t1588r1950b1661],
12	.	.	O	.	_	0	SENT_444	[p20l1353t1588r1950b1661],

1	—	NN	O	—	_	0	SENT_445	[p20l1353t1588r1950b1661],
2	.	.	O	.	_	0	SENT_445	[p20l1353t1588r1950b1661],

1	Platelet	NN	O	platelet	nn	2	SENT_446	[p20l1353t1588r1950b1661],
2	Reactivity	NN	O	reactivity	nsubj	3	SENT_446	[p20l1979t1590r2140b1643, p20l116t1675r261b1744],
3	Predicts	VBZ	O	predict	_	0	SENT_446	[p20l285t1672r512b1726],
4	Outcome	NNP	O	Outcome	nsubj	6	SENT_446	[p20l541t1671r827b1737],
5	)	CD	NUMBER	)	num	6	SENT_446	[p20l541t1671r827b1737],
6	study	NN	O	study	xcomp	3	SENT_446	[p20l857t1673r1020b1744],
7	.	.	O	.	_	0	SENT_446	[p20l857t1673r1020b1744],

1	J	NNP	O	J	nn	4	SENT_447	[p20l1042t1673r1071b1740],
2	Am	NNP	O	Am	nn	4	SENT_447	[p20l1094t1671r1204b1725],
3	Coll	NNP	O	Coll	nn	4	SENT_447	[p20l1232t1672r1354b1726],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_447	[p20l1380t1672r1595b1726],
5	2008	CD	DATE	2008	num	4	SENT_447	[p20l1618t1673r2139b1738],
6	;	:	O	;	_	0	SENT_447	[p20l1618t1673r2139b1738],
7	52:1128	CD	NUMBER	52:1128	number	8	SENT_447	[p20l1618t1673r2139b1738],
8	—	CD	NUMBER	—	dep	4	SENT_447	[p20l1618t1673r2139b1738],
9	33	CD	NUMBER	33	dep	8	SENT_447	[p20l1618t1673r2139b1738],
10	.	.	O	.	_	0	SENT_447	[p20l1618t1673r2139b1738],

1	Marcucci	NNP	PERSON	Marcucci	nn	2	SENT_448	[p20l115t1756r381b1808],
2	R	NNP	PERSON	R	_	0	SENT_448	[p20l415t1756r476b1820],
3	,	,	O	,	_	0	SENT_448	[p20l415t1756r476b1820],
4	Gori	NNP	ORGANIZATION	Gori	nn	5	SENT_448	[p20l513t1756r646b1808],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_448	[p20l677t1755r815b1820],
6	,	,	O	,	_	0	SENT_448	[p20l677t1755r815b1820],
7	Paniccia	NNP	PERSON	Paniccia	nn	8	SENT_448	[p20l850t1756r1087b1808],
8	R	NNP	PERSON	R	appos	2	SENT_448	[p20l1120t1756r1181b1820],
9	,	,	O	,	_	0	SENT_448	[p20l1120t1756r1181b1820],
10	et	FW	O	et	nn	11	SENT_448	[p20l1217t1769r1268b1808],
11	al.	FW	O	al.	appos	2	SENT_448	[p20l1301t1756r1360b1808],
12	.	.	O	.	_	0	SENT_448	[p20l1301t1756r1360b1808],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_449	[p20l1398t1756r1819b1808],
2	death	NN	O	death	nsubjpass	16	SENT_449	[p20l1852t1756r2007b1808],
3	and	CC	O	and	_	0	SENT_449	[p20l2041t1756r2144b1808],
4	nonfatal	JJ	O	nonfatal	amod	6	SENT_449	[p20l117t1839r349b1892],
5	myocardial	JJ	O	myocardial	amod	6	SENT_449	[p20l387t1839r697b1910],
6	infarction	NN	O	infarction	conj_and	2	SENT_449	[p20l734t1839r1009b1892],
7	in	IN	O	in	_	0	SENT_449	[p20l1047t1841r1101b1891],
8	acute	JJ	O	acute	amod	11	SENT_449	[p20l1140t1853r1285b1892],
9	coronary	JJ	O	coronary	amod	11	SENT_449	[p20l1324t1859r1572b1910],
10	syndrome	NN	O	syndrome	nn	11	SENT_449	[p20l1608t1839r1882b1910],
11	patients	NNS	O	patient	prep_in	2	SENT_449	[p20l1920t1841r2142b1911],
12	receiving	VBG	O	receive	partmod	11	SENT_449	[p20l116t1951r370b2021],
13	coronary	JJ	O	coronary	amod	14	SENT_449	[p20l396t1969r643b2020],
14	stenting	NN	O	stenting	dobj	12	SENT_449	[p20l667t1951r895b2021],
15	are	VBP	O	be	auxpass	16	SENT_449	[p20l921t1969r1002b2002],
16	predicted	VBN	O	predict	_	0	SENT_449	[p20l1027t1949r1293b2021],
17	by	IN	O	by	_	0	SENT_449	[p20l1317t1949r1385b2020],
18	residual	JJ	O	residual	amod	20	SENT_449	[p20l1408t1949r1628b2002],
19	platelet	NN	O	platelet	nn	20	SENT_449	[p20l1652t1949r1861b2021],
20	reactivity	NN	O	reactivity	agent	16	SENT_449	[p20l1885t1951r2145b2020],
21	to	TO	O	to	_	0	SENT_449	[p20l116t2046r170b2085],
22	ADP	NN	ORGANIZATION	adp	prep_to	16	SENT_449	[p20l208t2031r361b2085],
23	detected	VBN	O	detect	partmod	22	SENT_449	[p20l399t2032r636b2085],
24	by	IN	O	by	_	0	SENT_449	[p20l672t2032r741b2104],
25	a	DT	O	a	det	27	SENT_449	[p20l777t2053r805b2085],
26	point	NN	O	point	nn	27	SENT_449	[p20l841t2032r1220b2104],
27	—	NN	O	—	agent	23	SENT_449	[p20l841t2032r1220b2104],
28	of	IN	O	of	_	0	SENT_449	[p20l841t2032r1220b2104],
29	—	CD	NUMBER	—	num	31	SENT_449	[p20l841t2032r1220b2104],
30	care	NN	O	care	nn	31	SENT_449	[p20l841t2032r1220b2104],
31	assay	NN	O	assay	prep_of	27	SENT_449	[p20l1260t2053r1413b2104],
32	:	:	O	:	_	0	SENT_449	[p20l1260t2053r1413b2104],
33	a	DT	O	a	det	34	SENT_449	[p20l1455t2053r1483b2085],
34	12-month	JJ	DURATION	12-month	nsubj	35	SENT_449	[p20l1524t2032r1809b2086],
35	follow	VBP	O	follow	parataxis	16	SENT_449	[p20l1847t2032r2139b2104],
36	—	RB	O	—	advmod	35	SENT_449	[p20l1847t2032r2139b2104],
37	up	RB	O	up	advmod	35	SENT_449	[p20l1847t2032r2139b2104],
38	.	.	O	.	_	0	SENT_449	[p20l1847t2032r2139b2104],

1	Circulation	NN	O	circulation	_	0	SENT_450	[p20l117t2115r439b2168],
2	2009	CD	DATE	2009	num	1	SENT_450	[p20l463t2117r985b2180],
3	;	:	O	;	_	0	SENT_450	[p20l463t2117r985b2180],
4	119:237	CD	NUMBER	119:237	number	5	SENT_450	[p20l463t2117r985b2180],
5	—	CD	NUMBER	—	dep	1	SENT_450	[p20l463t2117r985b2180],
6	42	CD	NUMBER	42	dep	5	SENT_450	[p20l463t2117r985b2180],
7	.	.	O	.	_	0	SENT_450	[p20l463t2117r985b2180],

1	Bonello	NNP	PERSON	Bonello	nn	2	SENT_451	[p20l116t2197r335b2250],
2	L	NNP	PERSON	L	_	0	SENT_451	[p20l379t2198r438b2262],
3	,	,	O	,	_	0	SENT_451	[p20l379t2198r438b2262],
4	Tantry	NNP	ORGANIZATION	Tantry	nn	5	SENT_451	[p20l480t2196r680b2269],
5	US	NNP	ORGANIZATION	US	appos	2	SENT_451	[p20l717t2197r824b2262],
6	,	,	O	,	_	0	SENT_451	[p20l717t2197r824b2262],
7	Marcucci	NNP	PERSON	Marcucci	nn	8	SENT_451	[p20l868t2198r1133b2251],
8	R	NNP	PERSON	R	appos	2	SENT_451	[p20l1178t2198r1238b2262],
9	,	,	O	,	_	0	SENT_451	[p20l1178t2198r1238b2262],
10	et	FW	O	et	nn	11	SENT_451	[p20l1284t2211r1335b2250],
11	al.	FW	O	al.	appos	2	SENT_451	[p20l1377t2197r1436b2250],
12	.	.	O	.	_	0	SENT_451	[p20l1377t2197r1436b2250],

1	Consensus	NN	O	consensus	nn	4	SENT_452	[p20l1483t2197r1785b2251],
2	and	CC	O	and	_	0	SENT_452	[p20l1829t2197r1931b2251],
3	future	JJ	DATE	future	nn	4	SENT_452	[p20l1973t2197r2142b2250],
4	directions	NNS	O	direction	_	0	SENT_452	[p20l117t2281r392b2334],
5	on	IN	O	on	_	0	SENT_452	[p20l420t2301r490b2334],
6	the	DT	O	the	det	7	SENT_452	[p20l516t2281r604b2334],
7	deﬁnition	NN	O	deﬁnition	prep_on	4	SENT_452	[p20l632t2280r907b2334],
8	of	IN	O	of	_	0	SENT_452	[p20l933t2280r997b2334],
9	high	JJ	O	high	amod	12	SENT_452	[p20l1013t2280r1141b2352],
10	on-treatment	JJ	O	on-treatment	amod	12	SENT_452	[p20l1168t2294r1547b2334],
11	platelet	NN	O	platelet	nn	12	SENT_452	[p20l1570t2281r1779b2352],
12	reactivity	NN	O	reactivity	prep_of	4	SENT_452	[p20l1804t2283r2064b2352],
13	to	TO	O	to	_	0	SENT_452	[p20l2087t2294r2141b2334],
14	adenosine	NN	O	adenosine	nn	15	SENT_452	[p20l117t2364r396b2417],
15	diphosphate	NN	O	diphosphate	prep_to	12	SENT_452	[p20l424t2364r786b2436],
16	.	.	O	.	_	0	SENT_452	[p20l424t2364r786b2436],

1	J	NNP	O	J	nn	4	SENT_453	[p20l808t2364r837b2432],
2	Am	NNP	O	Am	nn	4	SENT_453	[p20l861t2363r970b2416],
3	Coll	NNP	O	Coll	nn	4	SENT_453	[p20l998t2364r1120b2417],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_453	[p20l1147t2364r1362b2417],
5	2010	CD	DATE	2010	num	4	SENT_453	[p20l1386t2364r1871b2429],
6	;	:	O	;	_	0	SENT_453	[p20l1386t2364r1871b2429],
7	56:919	CD	NUMBER	56:919	number	8	SENT_453	[p20l1386t2364r1871b2429],
8	—	CD	NUMBER	—	dep	4	SENT_453	[p20l1386t2364r1871b2429],
9	33	CD	NUMBER	33	dep	8	SENT_453	[p20l1386t2364r1871b2429],
10	.	.	O	.	_	0	SENT_453	[p20l1386t2364r1871b2429],

1	Malinin	NN	PERSON	malinin	nn	2	SENT_454	[p20l115t2447r346b2500],
2	A	NN	O	a	_	0	SENT_454	[p20l365t2446r432b2512],
3	,	,	O	,	_	0	SENT_454	[p20l365t2446r432b2512],
4	Pokov	NNP	O	Pokov	nn	5	SENT_454	[p20l456t2447r636b2500],
5	A	NNP	O	A	appos	2	SENT_454	[p20l652t2445r720b2512],
6	,	,	O	,	_	0	SENT_454	[p20l652t2445r720b2512],
7	Swaim	NNP	PERSON	Swaim	nn	8	SENT_454	[p20l746t2447r935b2500],
8	L	NNP	PERSON	L	appos	2	SENT_454	[p20l957t2447r1017b2512],
9	,	,	O	,	_	0	SENT_454	[p20l957t2447r1017b2512],
10	Kotob	NNP	O	Kotob	nn	11	SENT_454	[p20l1042t2447r1216b2500],
11	M	NNP	O	M	appos	2	SENT_454	[p20l1237t2447r1321b2512],
12	,	,	O	,	_	0	SENT_454	[p20l1237t2447r1321b2512],
13	Serebruany	NNP	O	Serebruany	nn	15	SENT_454	[p20l1347t2447r1664b2518],
14	V.	NNP	O	V.	nn	15	SENT_454	[p20l1682t2447r1744b2500],
15	Validation	NNP	O	Validation	appos	2	SENT_454	[p20l1769t2447r2067b2500],
16	of	IN	O	of	_	0	SENT_454	[p20l2088t2447r2152b2500],
17	VerifyNow	NNP	O	VerifyNow	prep_of	15	SENT_454	[p20l116t2529r656b2600],
18	.	.	O	.	_	0	SENT_454	[p20l116t2529r656b2600],

1	—	NN	O	—	_	0	SENT_455	[p20l116t2529r656b2600],
2	.	.	O	.	_	0	SENT_455	[p20l116t2529r656b2600],

1	P2Y12	NN	O	p2y12	nn	2	SENT_456	[p20l116t2529r656b2600],
2	cartridge	NN	O	cartridge	_	0	SENT_456	[p20l695t2529r943b2601],
3	for	IN	O	for	_	0	SENT_456	[p20l980t2529r1061b2582],
4	monitoring	VBG	O	monitor	prepc_for	2	SENT_456	[p20l1097t2531r1418b2601],
5	platelet	NN	O	platelet	nn	6	SENT_456	[p20l1453t2529r1662b2601],
6	inhibition	NN	O	inhibition	dobj	4	SENT_456	[p20l1698t2529r1979b2582],
7	with	IN	O	with	_	0	SENT_456	[p20l2013t2529r2143b2582],
8	clopidogrel	NN	O	clopidogrel	prep_with	4	SENT_456	[p20l117t2612r446b2684],
9	.	.	O	.	_	0	SENT_456	[p20l117t2612r446b2684],

1	Methods	NNS	O	method	nsubj	2	SENT_457	[p20l475t2612r731b2665],
2	Find	VBP	O	find	_	0	SENT_457	[p20l760t2612r894b2665],
3	Exp	NN	O	exp	nn	5	SENT_457	[p20l921t2613r1033b2684],
4	Clin	NNP	O	Clin	nn	5	SENT_457	[p20l1062t2612r1186b2665],
5	Pharmacol	NNP	O	Pharmacol	dobj	2	SENT_457	[p20l1212t2612r1518b2665],
6	2006	CD	DATE	2006	num	5	SENT_457	[p20l1541t2612r2018b2677],
7	;	:	O	;	_	0	SENT_457	[p20l1541t2612r2018b2677],
8	28:315	CD	NUMBER	28:315	num	9	SENT_457	[p20l1541t2612r2018b2677],
9	-22	CD	NUMBER	-22	dep	5	SENT_457	[p20l1541t2612r2018b2677],
10	.	.	O	.	_	0	SENT_457	[p20l1541t2612r2018b2677],

1	Saracini	NNP	PERSON	Saracini	nn	2	SENT_458	[p20l119t2695r343b2748],
2	C	NNP	O	C	_	0	SENT_458	[p20l378t2695r443b2759],
3	,	,	O	,	_	0	SENT_458	[p20l378t2695r443b2759],
4	Vestrini	NNP	O	Vestrini	nn	5	SENT_458	[p20l480t2696r706b2748],
5	A	NNP	O	A	appos	2	SENT_458	[p20l738t2694r806b2759],
6	,	,	O	,	_	0	SENT_458	[p20l738t2694r806b2759],
7	Galora	NNP	LOCATION	Galora	nn	8	SENT_458	[p20l844t2695r1038b2748],
8	S	NNP	LOCATION	S	appos	2	SENT_458	[p20l1074t2695r1123b2759],
9	,	,	O	,	_	0	SENT_458	[p20l1074t2695r1123b2759],
10	Armillis	NNP	O	Armillis	nn	11	SENT_458	[p20l1158t2694r1391b2748],
11	A	NNP	O	A	appos	2	SENT_458	[p20l1424t2694r1492b2759],
12	,	,	O	,	_	0	SENT_458	[p20l1424t2694r1492b2759],
13	Abbate	NNP	PERSON	Abbate	nn	14	SENT_458	[p20l1527t2694r1734b2748],
14	R	NNP	PERSON	R	appos	2	SENT_458	[p20l1770t2696r1831b2759],
15	,	,	O	,	_	0	SENT_458	[p20l1770t2696r1831b2759],
16	Giusti	NNP	PERSON	Giusti	nn	18	SENT_458	[p20l1870t2695r2045b2748],
17	B.	NNP	PERSON	B.	nn	18	SENT_458	[p20l2080t2696r2139b2748],
18	Pharmacogenetics	NNP	PERSON	Pharmacogenetics	appos	2	SENT_458	[p20l116t2777r630b2849],
19	of	IN	O	of	_	0	SENT_458	[p20l652t2777r716b2830],
20	clopidogrel	NN	O	clopidogrel	prep_of	18	SENT_458	[p20l727t2777r1057b2849],
21	:	:	O	:	_	0	SENT_458	[p20l727t2777r1057b2849],
22	comparison	NN	O	comparison	dep	2	SENT_458	[p20l1081t2780r1409b2849],
23	between	IN	O	between	_	0	SENT_458	[p20l1427t2777r1662b2831],
24	a	DT	O	a	det	25	SENT_458	[p20l1683t2798r1711b2830],
25	standard	JJ	O	standard	prep_between	22	SENT_458	[p20l1731t2777r1973b2831],
26	and	CC	O	and	_	0	SENT_458	[p20l1994t2777r2095b2830],
27	a	DT	O	a	det	30	SENT_458	[p20l2116t2798r2144b2831],
28	rapid	JJ	O	rapid	amod	30	SENT_458	[p20l116t2861r261b2932],
29	genetic	JJ	O	genetic	amod	30	SENT_458	[p20l295t2863r498b2932],
30	testing	NN	O	testing	prep_between	22	SENT_458	[p20l532t2863r737b2932],
31	.	.	O	.	_	0	SENT_458	[p20l532t2863r737b2932],

1	Genet	NNP	O	Genet	nn	4	SENT_459	[p20l777t2860r954b2914],
2	Test	NNP	O	Test	nn	4	SENT_459	[p20l985t2859r1115b2914],
3	Mol	NNP	O	Mol	nn	4	SENT_459	[p20l1148t2861r1271b2914],
4	Biomarkers	NNS	O	biomarker	_	0	SENT_459	[p20l1306t2861r1630b2914],
5	2012	CD	DATE	2012	dep	4	SENT_459	[p20l1665t2863r1805b2914],
6	Jan	NNP	DATE	Jan	tmod	5	SENT_459	[p20l1834t2861r1931b2929],
7	12	CD	DATE	12	num	6	SENT_459	[p20l1969t2863r2139b2926],
8	;	:	O	;	_	0	SENT_459	[p20l1969t2863r2139b2926],
9	16	CD	NUMBER	16	dep	4	SENT_459	[p20l1969t2863r2139b2926],
10	:	:	O	:	_	0	SENT_459	[p20l1969t2863r2139b2926],
11	500-3	CD	NUMBER	500-3	dep	9	SENT_459	[p20l116t2944r314b2996],
12	.	.	O	.	_	0	SENT_459	[p20l116t2944r314b2996],

1	Obi	NN	MISC	obus	nn	2	SENT_460	[p20l117t3027r226b3080],
2	C	NN	MISC	c	_	0	SENT_460	[p20l275t3027r340b3092],
3	,	,	O	,	_	0	SENT_460	[p20l275t3027r340b3092],
4	Wysokinski	NNP	PERSON	Wysokinski	nn	5	SENT_460	[p20l387t3027r725b3098],
5	W	NNP	PERSON	W	appos	2	SENT_460	[p20l770t3027r860b3092],
6	,	,	O	,	_	0	SENT_460	[p20l770t3027r860b3092],
7	Karnicki	NNP	PERSON	Karnicki	nn	8	SENT_460	[p20l912t3027r1153b3080],
8	K	NNP	PERSON	K	appos	2	SENT_460	[p20l1203t3027r1264b3092],
9	,	,	O	,	_	0	SENT_460	[p20l1203t3027r1264b3092],
10	Owen	NNP	PERSON	Owen	nn	11	SENT_460	[p20l1316t3027r1487b3080],
11	WG	NNP	PERSON	WG	appos	2	SENT_460	[p20l1531t3027r1680b3092],
12	,	,	O	,	_	0	SENT_460	[p20l1531t3027r1680b3092],
13	McBane	NNP	PERSON	McBane	nn	14	SENT_460	[p20l1729t3027r1972b3080],
14	RD.	NNP	O	RD.	appos	2	SENT_460	[p20l2021t3027r2139b3080],
15	.	.	O	.	_	0	SENT_460	[p20l2021t3027r2139b3080],

1	Inhibition	NN	O	inhibition	_	0	SENT_461	[p20l115t3109r405b3162],
2	of	IN	O	of	_	0	SENT_461	[p20l433t3109r497b3162],
3	platelet-rich	JJ	O	platelet-rich	amod	5	SENT_461	[p20l514t3109r862b3181],
4	arterial	JJ	O	arterial	amod	5	SENT_461	[p20l890t3109r1087b3162],
5	thrombus	NN	O	thrombus	prep_of	1	SENT_461	[p20l1114t3109r1385b3162],
6	in	FW	O	in	prep	5	SENT_461	[p20l1414t3111r1468b3161],
7	vivo	FW	O	vivo	pobj	6	SENT_461	[p20l1493t3111r1624b3162],
8	:	:	O	:	_	0	SENT_461	[p20l1493t3111r1624b3162],
9	acute	JJ	O	acute	amod	11	SENT_461	[p20l1656t3123r1800b3162],
10	antithrombotic	JJ	O	antithrombotic	amod	11	SENT_461	[p20l1829t3109r2140b3162, p20l114t3192r256b3245],
11	effect	NN	O	effect	dep	1	SENT_461	[p20l281t3192r429b3245],
12	of	IN	O	of	_	0	SENT_461	[p20l453t3192r518b3245],
13	intravenous	JJ	O	intravenous	amod	16	SENT_461	[p20l533t3194r859b3245],
14	HMG-CoA	NN	O	hmg-coa	nn	16	SENT_461	[p20l886t3191r1243b3245],
15	reductase	NN	O	reductase	nn	16	SENT_461	[p20l1266t3192r1529b3245],
16	therapy	NN	O	therapy	prep_of	11	SENT_461	[p20l1555t3192r1780b3264],
17	.	.	O	.	_	0	SENT_461	[p20l1555t3192r1780b3264],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_462	[p20l1807t3191r2144b3245],
2	Thromb	NNP	O	Thromb	nn	4	SENT_462	[p20l114t3274r353b3328],
3	Vasc	NNP	O	Vasc	nn	4	SENT_462	[p20l381t3276r514b3328],
4	Biol	NNP	O	Biol	_	0	SENT_462	[p20l540t3275r658b3328],
5	2009	CD	DATE	2009	num	4	SENT_462	[p20l682t3276r1167b3338],
6	;	:	O	;	_	0	SENT_462	[p20l682t3276r1167b3338],
7	29:1271	CD	NUMBER	29:1271	number	8	SENT_462	[p20l682t3276r1167b3338],
8	—	CD	NUMBER	—	dep	4	SENT_462	[p20l682t3276r1167b3338],
9	6	CD	NUMBER	6	dep	8	SENT_462	[p20l682t3276r1167b3338],
10	.	.	O	.	_	0	SENT_462	[p20l682t3276r1167b3338],

1	JACC	NN	O	jacc	_	0	SENT_463	[p20l7t3361r157b3392],
2	:	:	O	:	_	0	SENT_463	[p20l7t3361r157b3392],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_463	[p20l193t3361r694b3392],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_463	[p20l730t3361r1191b3397],
5	,	,	O	,	_	0	SENT_463	[p20l730t3361r1191b3397],
6	VOL	NNP	O	VOL	appos	4	SENT_463	[p20l1226t3361r1349b3392],
7	.	.	O	.	_	0	SENT_463	[p20l1226t3361r1349b3392],

1	6	CD	NUMBER	6	_	0	SENT_464	[p20l1384t3362r1428b3397],
2	,	,	O	,	_	0	SENT_464	[p20l1384t3362r1428b3397],
3	NO.	NNP	O	NO.	appos	1	SENT_464	[p20l1465t3361r1555b3392],
4	2	CD	NUMBER	2	num	3	SENT_464	[p20l1591t3362r1634b3397],
5	,	,	O	,	_	0	SENT_464	[p20l1591t3362r1634b3397],
6	2013	CD	DATE	2013	num	3	SENT_464	[p20l1670t3362r1794b3392],

1	FEBRUARY	NNP	DATE	FEBRUARY	_	0	SENT_465	[p20l10t3450r289b3481],
2	2013:169	CD	NUMBER	2013:169	number	3	SENT_465	[p20l320t3450r678b3481],
3	—	CD	NUMBER	—	dep	1	SENT_465	[p20l320t3450r678b3481],
4	79	CD	NUMBER	79	dep	3	SENT_465	[p20l320t3450r678b3481],

1	23	CD	NUMBER	23	_	0	SENT_466	[p21l7t90r92b141],
2	.	.	O	.	_	0	SENT_466	[p21l7t90r92b141],

1	Sanguigni	NNP	MISC	Sanguigni	nn	2	SENT_467	[p21l119t87r403b159],
2	V	NNP	O	V	_	0	SENT_467	[p21l432t88r496b152],
3	,	,	O	,	_	0	SENT_467	[p21l432t88r496b152],
4	Pignatelli	NNP	PERSON	Pignatelli	nn	5	SENT_467	[p21l527t87r799b159],
5	P	NN	PERSON	p	appos	2	SENT_467	[p21l828t88r885b152],
6	,	,	O	,	_	0	SENT_467	[p21l828t88r885b152],
7	Lenti	NNP	PERSON	Lenti	nn	8	SENT_467	[p21l917t88r1071b140],
8	L	NNP	O	L	appos	2	SENT_467	[p21l1101t88r1160b152],
9	,	,	O	,	_	0	SENT_467	[p21l1101t88r1160b152],
10	et	FW	O	et	nn	11	SENT_467	[p21l1193t101r1244b140],
11	al.	FW	O	al.	appos	2	SENT_467	[p21l1273t87r1332b140],
12	.	.	O	.	_	0	SENT_467	[p21l1273t87r1332b140],

1	Short	JJ	O	short	amod	4	SENT_468	[p21l1368t87r1686b140],
2	—	NN	O	—	nn	4	SENT_468	[p21l1368t87r1686b140],
3	term	NN	O	term	nn	4	SENT_468	[p21l1368t87r1686b140],
4	treatment	NN	O	treatment	nsubj	7	SENT_468	[p21l1716t101r1994b140],
5	with	IN	O	with	_	0	SENT_468	[p21l2019t87r2149b140],
6	atorvastatin	NN	O	atorvastatin	prep_with	4	SENT_468	[p21l117t169r447b220],
7	reduces	VBZ	O	reduce	_	0	SENT_468	[p21l472t167r681b220],
8	platelet	NN	O	platelet	nn	10	SENT_468	[p21l707t167r917b239],
9	CD40	NN	O	cd40	nn	10	SENT_468	[p21l942t167r1120b220],
10	ligand	NN	O	ligand	dobj	7	SENT_468	[p21l1145t167r1322b239],
11	and	CC	O	and	_	0	SENT_468	[p21l1347t167r1449b220],
12	thrombin	NN	O	thrombin	nn	13	SENT_468	[p21l1474t167r1743b220],
13	generation	NN	O	generation	conj_and	10	SENT_468	[p21l1768t169r2070b239],
14	in	IN	O	in	_	0	SENT_468	[p21l2095t169r2149b220],
15	hypercholesterolemic	JJ	O	hypercholesterolemic	amod	16	SENT_468	[p21l116t247r721b319],
16	patients	NNS	O	patient	prep_in	10	SENT_468	[p21l746t249r984b319],
17	.	.	O	.	_	0	SENT_468	[p21l746t249r984b319],

1	Circulation	NN	O	circulation	_	0	SENT_469	[p21l1016t247r1338b301],
2	2005	CD	DATE	2005	num	1	SENT_469	[p21l1363t247r1841b312],
3	;	:	O	;	_	0	SENT_469	[p21l1363t247r1841b312],
4	111:412	CD	NUMBER	111:412	number	5	SENT_469	[p21l1363t247r1841b312],
5	-9	CD	NUMBER	-9	dep	1	SENT_469	[p21l1363t247r1841b312],
6	.	.	O	.	_	0	SENT_469	[p21l1363t247r1841b312],

1	24	CD	NUMBER	24	_	0	SENT_470	[p21l7t330r92b381],
2	.	.	O	.	_	0	SENT_470	[p21l7t330r92b381],

1	Angiolillo	NN	O	angiolillo	nn	2	SENT_471	[p21l114t326r402b399],
2	D	NN	O	d	_	0	SENT_471	[p21l444t328r539b395],
3	]	CD	NUMBER	]	dep	2	SENT_471	[p21l444t328r539b395],
4	,	,	O	,	_	0	SENT_471	[p21l444t328r539b395],
5	Capodanno	NNP	PERSON	Capodanno	nn	6	SENT_471	[p21l583t327r913b399],
6	D	NNP	PERSON	D	dep	2	SENT_471	[p21l955t328r1026b392],
7	,	,	O	,	_	0	SENT_471	[p21l955t328r1026b392],
8	Goto	NNP	PERSON	Goto	nn	9	SENT_471	[p21l1070t327r1217b380],
9	S.	NNP	O	S.	dep	2	SENT_471	[p21l1261t327r1309b380],
10	Platelet	NN	O	platelet	nn	13	SENT_471	[p21l1354t327r1569b380],
11	thrombin	NN	O	thrombin	nn	13	SENT_471	[p21l1608t327r1877b380],
12	receptor	NN	O	receptor	nn	13	SENT_471	[p21l1917t341r2150b399],
13	antagonism	NN	O	antagonism	dep	9	SENT_471	[p21l117t409r445b479],
14	and	CC	O	and	_	0	SENT_471	[p21l473t407r575b460],
15	atherothrombosis	NN	O	atherothrombosis	conj_and	3	SENT_471	[p21l603t407r1116b460],
16	.	.	O	.	_	0	SENT_471	[p21l603t407r1116b460],

1	Eur	NNP	O	Eur	nn	2	SENT_472	[p21l1147t408r1254b460],
2	Heart	NNP	O	Heart	_	0	SENT_472	[p21l1280t408r1493b475],
3	]	CD	NUMBER	]	num	4	SENT_472	[p21l1280t408r1493b475],
4	2010	CD	DATE	2010	dep	2	SENT_472	[p21l1518t408r1961b472],
5	;	:	O	;	_	0	SENT_472	[p21l1518t408r1961b472],
6	31:17	CD	NUMBER	31:17	num	7	SENT_472	[p21l1518t408r1961b472],
7	-28	CD	NUMBER	-28	dep	2	SENT_472	[p21l1518t408r1961b472],
8	.	.	O	.	_	0	SENT_472	[p21l1518t408r1961b472],

1	25	CD	NUMBER	25	_	0	SENT_473	[p21l7t487r92b541],
2	.	.	O	.	_	0	SENT_473	[p21l7t487r92b541],

1	Price	NN	O	price	nn	3	SENT_474	[p21l116t488r260b540],
2	M	NN	O	m	nn	3	SENT_474	[p21l298t488r406b555],
3	]	NN	O	]	_	0	SENT_474	[p21l298t488r406b555],
4	,	,	O	,	_	0	SENT_474	[p21l298t488r406b555],
5	Berger	NNP	PERSON	Berger	nn	6	SENT_474	[p21l447t488r637b559],
6	PB	NN	O	pb	appos	3	SENT_474	[p21l675t488r779b552],
7	,	,	O	,	_	0	SENT_474	[p21l675t488r779b552],
8	Teirstein	NNP	PERSON	Teirstein	nn	9	SENT_474	[p21l818t486r1077b540],
9	PS	NNP	O	PS	appos	3	SENT_474	[p21l1116t487r1211b552],
10	,	,	O	,	_	0	SENT_474	[p21l1116t487r1211b552],
11	et	FW	O	et	nn	12	SENT_474	[p21l1253t501r1305b540],
12	al.	FW	O	al.	appos	3	SENT_474	[p21l1344t487r1403b540],
13	.	.	O	.	_	0	SENT_474	[p21l1344t487r1403b540],

1	Standard	NNP	O	Standard	_	0	SENT_475	[p21l1448t487r1729b540],
2	—	CD	NUMBER	—	nn	7	SENT_475	[p21l1448t487r1729b540],
3	vs	CC	O	vs	_	0	SENT_475	[p21l1767t508r1823b540],
4	high	JJ	O	high	amod	6	SENT_475	[p21l1863t487r2148b559],
5	—	NN	O	—	nn	6	SENT_475	[p21l1863t487r2148b559],
6	dose	NN	O	dose	conj_vs	2	SENT_475	[p21l1863t487r2148b559],
7	clopidogrel	NN	O	clopidogrel	dobj	1	SENT_475	[p21l117t567r434b639],
8	based	VBN	O	base	_	0	SENT_475	[p21l456t567r615b620],
9	on	IN	O	on	_	0	SENT_475	[p21l640t588r711b620],
10	platelet	NN	O	platelet	nn	12	SENT_475	[p21l735t567r945b639],
11	function	NN	O	function	nn	12	SENT_475	[p21l968t567r1207b620],
12	testing	NN	O	testing	prep_based_on	1	SENT_475	[p21l1231t569r1424b639],
13	after	IN	O	after	mark	16	SENT_475	[p21l1448t567r1576b620],
14	percutaneous	JJ	O	percutaneous	amod	16	SENT_475	[p21l1599t581r1971b639],
15	coronary	JJ	O	coronary	amod	16	SENT_475	[p21l1998t587r2147b620, p21l117t667r241b719],
16	intervention	NN	O	intervention	dep	12	SENT_475	[p21l256t649r618b700],
17	:	:	O	:	_	0	SENT_475	[p21l256t649r618b700],
18	the	DT	O	the	det	19	SENT_475	[p21l639t647r728b700],
19	GRAVITAS	NNP	O	GRAVITAS	nsubj	20	SENT_475	[p21l749t646r1123b701],
20	randomized	VBD	O	randomize	dep	16	SENT_475	[p21l1144t647r1483b700],
21	trial	NN	O	trial	dobj	20	SENT_475	[p21l1500t647r1627b700],
22	.	.	O	.	_	0	SENT_475	[p21l1500t647r1627b700],
23	]	SYM	O	]	dep	1	SENT_475	[p21l1642t646r1848b715],

1	AMA	NNP	O	AMA	_	0	SENT_476	[p21l1642t646r1848b715],
2	2011	CD	DATE	2011	num	1	SENT_476	[p21l1864t647r2128b712],
3	;	:	O	;	_	0	SENT_476	[p21l1864t647r2128b712],
4	305	CD	NUMBER	305	num	6	SENT_476	[p21l1864t647r2128b712],
5	:	:	O	:	_	0	SENT_476	[p21l2137t668r2146b700],
6	1097-105	CD	NUMBER	1097-105	dep	1	SENT_476	[p21l119t727r414b781],
7	.	.	O	.	_	0	SENT_476	[p21l119t727r414b781],

1	26	CD	NUMBER	26	_	0	SENT_477	[p21l7t810r92b861],
2	.	.	O	.	_	0	SENT_477	[p21l7t810r92b861],

1	Angiolillo	NN	O	angiolillo	nn	2	SENT_478	[p21l114t806r402b879],
2	D	NN	O	d	_	0	SENT_478	[p21l436t808r531b875],
3	]	CD	NUMBER	]	dep	2	SENT_478	[p21l436t808r531b875],
4	,	,	O	,	_	0	SENT_478	[p21l436t808r531b875],
5	Bernardo	NNP	PERSON	Bernardo	nn	6	SENT_478	[p21l567t807r830b860],
6	E	NNP	PERSON	E	appos	3	SENT_478	[p21l866t808r927b872],
7	,	,	O	,	_	0	SENT_478	[p21l866t808r927b872],
8	Capodanno	NNP	O	Capodanno	nn	9	SENT_478	[p21l964t807r1294b879],
9	D	NNP	O	D	appos	3	SENT_478	[p21l1328t808r1399b872],
10	,	,	O	,	_	0	SENT_478	[p21l1328t808r1399b872],
11	et	FW	O	et	nn	12	SENT_478	[p21l1435t821r1487b860],
12	al.	FW	O	al.	appos	3	SENT_478	[p21l1520t807r1579b860],
13	.	.	O	.	_	0	SENT_478	[p21l1520t807r1579b860],

1	Impact	NN	O	impact	_	0	SENT_479	[p21l1615t808r1818b879],
2	of	IN	O	of	advmod	3	SENT_479	[p21l1850t807r1914b860],
3	chronic	JJ	O	chronic	amod	4	SENT_479	[p21l1938t807r2149b860],
4	kidney	NN	O	kidney	dobj	5	SENT_479	[p21l116t887r308b959],
5	disease	NN	O	disease	dep	1	SENT_479	[p21l327t887r521b940],
6	on	IN	O	on	_	0	SENT_479	[p21l544t908r614b940],
7	platelet	NN	O	platelet	nn	9	SENT_479	[p21l635t887r845b959],
8	function	NN	O	function	nn	9	SENT_479	[p21l865t887r1103b940],
9	proﬁles	NNS	O	proﬁles	prep_on	5	SENT_479	[p21l1123t887r1330b959],
10	in	IN	O	in	_	0	SENT_479	[p21l1353t889r1407b940],
11	diabetes	NN	O	diabetes	nn	13	SENT_479	[p21l1430t887r1657b940],
12	mellitus	NN	O	mellitus	nn	13	SENT_479	[p21l1680t887r1903b940],
13	patients	NNS	O	patient	prep_in	9	SENT_479	[p21l1925t889r2148b959],
14	with	IN	O	with	prep	5	SENT_479	[p21l113t967r243b1020],
15	coronary	JJ	O	coronary	amod	17	SENT_479	[p21l264t987r513b1039],
16	artery	NN	O	artery	nn	17	SENT_479	[p21l532t981r694b1039],
17	disease	NN	O	disease	dep	14	SENT_479	[p21l712t967r907b1020],
18	taking	VBG	O	take	rcmod	17	SENT_479	[p21l928t967r1108b1039],
19	dual	JJ	O	dual	amod	21	SENT_479	[p21l1127t967r1247b1020],
20	antiplatelet	JJ	O	antiplatelet	amod	21	SENT_479	[p21l1268t967r1586b1039],
21	therapy	NN	O	therapy	dobj	18	SENT_479	[p21l1605t967r1832b1039],
22	.	.	O	.	_	0	SENT_479	[p21l1605t967r1832b1039],
23	]	SYM	O	]	dep	1	SENT_479	[p21l1849t968r1877b1035],

1	Am	VBP	O	be	dep	2	SENT_480	[p21l1895t966r2005b1020],
2	Coll	NN	PERSON	coll	_	0	SENT_480	[p21l2028t967r2150b1020],

1	Cardiol	NNP	O	Cardiol	_	0	SENT_481	[p21l118t1063r333b1116],
2	2010	CD	DATE	2010	num	1	SENT_481	[p21l357t1063r888b1127],
3	;	:	O	;	_	0	SENT_481	[p21l357t1063r888b1127],
4	55:1139	CD	NUMBER	55:1139	number	5	SENT_481	[p21l357t1063r888b1127],
5	—	CD	NUMBER	—	dep	1	SENT_481	[p21l357t1063r888b1127],
6	46	CD	NUMBER	46	dep	5	SENT_481	[p21l357t1063r888b1127],
7	.	.	O	.	_	0	SENT_481	[p21l357t1063r888b1127],

1	27	CD	NUMBER	27	_	0	SENT_482	[p21l7t1143r92b1196],
2	.	.	O	.	_	0	SENT_482	[p21l7t1143r92b1196],

1	Silvain	NNP	O	Silvain	nn	2	SENT_483	[p21l119t1142r308b1195],
2	G	NNP	O	G	_	0	SENT_483	[p21l339t1142r409b1207],
3	,	,	O	,	_	0	SENT_483	[p21l339t1142r409b1207],
4	Cayla	NNP	PERSON	Cayla	nn	5	SENT_483	[p21l442t1142r602b1214],
5	G	NNP	PERSON	G	appos	2	SENT_483	[p21l632t1142r702b1207],
6	,	,	O	,	_	0	SENT_483	[p21l632t1142r702b1207],
7	Hulot	NNP	PERSON	Hulot	nn	9	SENT_483	[p21l733t1142r905b1195],
8	]	CD	NUMBER	]	num	9	SENT_483	[p21l925t1142r1009b1210],
9	S	NN	O	s	appos	2	SENT_483	[p21l925t1142r1009b1210],
10	,	,	O	,	_	0	SENT_483	[p21l925t1142r1009b1210],
11	et	FW	O	et	nn	12	SENT_483	[p21l1041t1156r1092b1195],
12	al.	FW	O	al.	appos	2	SENT_483	[p21l1121t1142r1180b1195],
13	.	.	O	.	_	0	SENT_483	[p21l1121t1142r1180b1195],

1	High	JJ	O	high	_	0	SENT_484	[p21l1213t1142r1363b1214],
2	on	IN	O	on	_	0	SENT_484	[p21l1392t1142r1912b1214],
3	—	NN	O	—	nn	6	SENT_484	[p21l1392t1142r1912b1214],
4	thienopyridine	NN	O	thienopyridine	nn	6	SENT_484	[p21l1392t1142r1912b1214],
5	platelet	NN	O	platelet	nn	6	SENT_484	[p21l1940t1142r2150b1214],
6	reactivity	NN	O	reactivity	prep_on	1	SENT_484	[p21l116t1224r377b1294],
7	in	IN	O	in	_	0	SENT_484	[p21l416t1224r470b1275],
8	elderly	JJ	O	elderly	amod	10	SENT_484	[p21l513t1222r702b1294],
9	coronary	JJ	O	coronary	amod	10	SENT_484	[p21l742t1242r990b1294],
10	patients	NNS	O	patient	prep_in	6	SENT_484	[p21l1028t1224r1267b1294],
11	:	:	O	:	_	0	SENT_484	[p21l1028t1224r1267b1294],
12	the	DT	O	the	det	15	SENT_484	[p21l1312t1222r1400b1275],
13	SENIOR	JJ	O	senior	amod	15	SENT_484	[p21l1446t1222r1722b1275],
14	PLATELET	NN	O	platelet	nn	15	SENT_484	[p21l1762t1221r2150b1275],
15	study	NN	O	study	dep	1	SENT_484	[p21l117t1302r281b1374],
16	.	.	O	.	_	0	SENT_484	[p21l117t1302r281b1374],

1	Eur	NNP	O	Eur	nn	2	SENT_485	[p21l312t1303r419b1355],
2	Heart	NNP	O	Heart	_	0	SENT_485	[p21l445t1303r659b1370],
3	]	CD	NUMBER	]	num	4	SENT_485	[p21l445t1303r659b1370],
4	2012	CD	DATE	2012	dep	2	SENT_485	[p21l683t1305r1161b1367],
5	;	:	O	;	_	0	SENT_485	[p21l683t1305r1161b1367],
6	33:1241	CD	NUMBER	33:1241	number	7	SENT_485	[p21l683t1305r1161b1367],
7	—	CD	NUMBER	—	dep	2	SENT_485	[p21l683t1305r1161b1367],
8	9	CD	NUMBER	9	dep	7	SENT_485	[p21l683t1305r1161b1367],
9	.	.	O	.	_	0	SENT_485	[p21l683t1305r1161b1367],

1	28	CD	NUMBER	28	_	0	SENT_486	[p21l7t1385r92b1436],
2	.	.	O	.	_	0	SENT_486	[p21l7t1385r92b1436],

1	Park	NNP	O	Park	nn	2	SENT_487	[p21l116t1382r250b1435],
2	Y	NN	O	y	_	0	SENT_487	[p21l267t1383r331b1447],
3	,	,	O	,	_	0	SENT_487	[p21l267t1383r331b1447],
4	]	NN	O	]	nn	6	SENT_487	[p21l349t1383r517b1454],
5	eong	NN	O	eong	nn	6	SENT_487	[p21l349t1383r517b1454],
6	YH	NN	O	yh	appos	2	SENT_487	[p21l535t1383r660b1447],
7	,	,	O	,	_	0	SENT_487	[p21l535t1383r660b1447],
8	Tantry	NNP	LOCATION	Tantry	nn	9	SENT_487	[p21l682t1381r882b1454],
9	US	NNP	LOCATION	US	appos	2	SENT_487	[p21l900t1382r1007b1447],
10	,	,	O	,	_	0	SENT_487	[p21l900t1382r1007b1447],
11	et	FW	O	et	nn	12	SENT_487	[p21l1033t1396r1084b1435],
12	al.	FW	O	al.	appos	2	SENT_487	[p21l1107t1382r1166b1435],
13	.	.	O	.	_	0	SENT_487	[p21l1107t1382r1166b1435],

1	Accelerated	VBN	O	accelerate	_	0	SENT_488	[p21l1191t1381r1527b1435],
2	platelet	NN	O	platelet	nn	3	SENT_488	[p21l1548t1382r1758b1454],
3	inhibition	NN	O	inhibition	dobj	1	SENT_488	[p21l1779t1382r2062b1435],
4	by	IN	O	by	_	0	SENT_488	[p21l2083t1382r2152b1454],
5	switching	VBG	O	switch	prepc_by	1	SENT_488	[p21l117t1462r391b1534],
6	from	IN	O	from	_	0	SENT_488	[p21l420t1462r557b1515],
7	atorvastatin	NN	O	atorvastatin	prep_from	5	SENT_488	[p21l589t1464r918b1515],
8	to	TO	O	to	_	0	SENT_488	[p21l949t1476r1003b1515],
9	a	DT	O	a	det	10	SENT_488	[p21l1036t1483r1064b1515],
10	non	JJ	O	non	prep_to	5	SENT_488	[p21l1094t1461r1878b1515],
11	.	.	O	.	_	0	SENT_488	[p21l1094t1461r1878b1515],

1	—	NN	O	—	_	0	SENT_489	[p21l1094t1461r1878b1515],
2	.	.	O	.	_	0	SENT_489	[p21l1094t1461r1878b1515],

1	CYP3A4	NN	O	cyp3a4	_	0	SENT_490	[p21l1094t1461r1878b1515],
2	.	.	O	.	_	0	SENT_490	[p21l1094t1461r1878b1515],

1	—	NN	O	—	_	0	SENT_491	[p21l1094t1461r1878b1515],
2	.	.	O	.	_	0	SENT_491	[p21l1094t1461r1878b1515],

1	metabolized	VBN	O	metabolize	_	0	SENT_492	[p21l1094t1461r1878b1515],
2	statin	NN	O	statin	dobj	1	SENT_492	[p21l1910t1464r2064b1515],
3	in	IN	O	in	_	0	SENT_492	[p21l2095t1464r2149b1515],
4	patients	NNS	O	patient	prep_in	1	SENT_492	[p21l115t1544r338b1613],
5	with	IN	O	with	_	0	SENT_492	[p21l366t1541r496b1594],
6	high	JJ	O	high	amod	7	SENT_492	[p21l526t1541r654b1613],
7	platelet	NN	O	platelet	prep_with	1	SENT_492	[p21l683t1541r892b1613],
8	reactivity	NN	O	reactivity	nn	10	SENT_492	[p21l921t1543r1182b1613],
9	(	CD	NUMBER	(	num	10	SENT_492	[p21l1211t1540r1811b1606],
10	ACCEL	NNP	ORGANIZATION	ACCEL	dep	7	SENT_492	[p21l1211t1540r1811b1606],
11	.	.	O	.	_	0	SENT_492	[p21l1211t1540r1811b1606],

1	—	NN	O	—	_	0	SENT_493	[p21l1211t1540r1811b1606],
2	.	.	O	.	_	0	SENT_493	[p21l1211t1540r1811b1606],

1	STATIN	JJ	O	statin	amod	2	SENT_494	[p21l1211t1540r1811b1606],
2	)	NN	O	)	_	0	SENT_494	[p21l1211t1540r1811b1606],
3	study	NN	O	study	dep	2	SENT_494	[p21l1845t1541r2009b1613],
4	.	.	O	.	_	0	SENT_494	[p21l1845t1541r2009b1613],

1	Eur	NNP	O	Eur	nn	2	SENT_495	[p21l2043t1542r2151b1594],
2	Heart	NNP	O	Heart	_	0	SENT_495	[p21l117t1622r330b1689],
3	]	CD	NUMBER	]	num	4	SENT_495	[p21l117t1622r330b1689],
4	2012	CD	DATE	2012	dep	2	SENT_495	[p21l355t1621r784b1686],
5	;	:	O	;	_	0	SENT_495	[p21l355t1621r784b1686],
6	33:2151	CD	NUMBER	33:2151	num	8	SENT_495	[p21l355t1621r784b1686],
7	-	:	O	-	_	0	SENT_495	[p21l355t1621r784b1686],
8	62	CD	DATE	62	dep	2	SENT_495	[p21l795t1624r878b1675],
9	.	.	O	.	_	0	SENT_495	[p21l795t1624r878b1675],

1	29	CD	NUMBER	29	_	0	SENT_496	[p21l7t1704r92b1755],
2	.	.	O	.	_	0	SENT_496	[p21l7t1704r92b1755],

1	Patti	NNP	PERSON	Patti	nn	2	SENT_497	[p21l116t1702r252b1754],
2	G	NNP	PERSON	G	_	0	SENT_497	[p21l282t1701r352b1765],
3	,	,	O	,	_	0	SENT_497	[p21l282t1701r352b1765],
4	Greco	NNP	PERSON	Greco	nn	5	SENT_497	[p21l384t1701r556b1754],
5	D	NNP	O	D	appos	2	SENT_497	[p21l586t1702r657b1765],
6	,	,	O	,	_	0	SENT_497	[p21l586t1702r657b1765],
7	Dicuonzo	NNP	O	Dicuonzo	nn	8	SENT_497	[p21l687t1702r966b1754],
8	G	NNP	O	G	appos	2	SENT_497	[p21l997t1701r1067b1765],
9	,	,	O	,	_	0	SENT_497	[p21l997t1701r1067b1765],
10	Pasceri	NNP	O	Pasceri	nn	11	SENT_497	[p21l1098t1702r1297b1754],
11	V	NNP	O	V	appos	2	SENT_497	[p21l1326t1702r1389b1765],
12	,	,	O	,	_	0	SENT_497	[p21l1326t1702r1389b1765],
13	Nusca	NNP	O	Nusca	nn	14	SENT_497	[p21l1419t1702r1596b1754],
14	A	NNP	O	A	appos	2	SENT_497	[p21l1621t1700r1689b1765],
15	,	,	O	,	_	0	SENT_497	[p21l1621t1700r1689b1765],
16	Di	NNP	PERSON	Di	nn	19	SENT_497	[p21l1720t1702r1794b1753],
17	Sciascio	NNP	PERSON	Sciascio	nn	19	SENT_497	[p21l1825t1701r2046b1754],
18	G.	NNP	PERSON	G.	nn	19	SENT_497	[p21l2077t1701r2146b1754],
19	High	NNP	PERSON	High	appos	2	SENT_497	[p21l117t1781r267b1853],
20	versus	CC	O	versus	prep	19	SENT_497	[p21l287t1801r458b1834],
21	standard	JJ	O	standard	amod	24	SENT_497	[p21l485t1781r727b1834],
22	clopidogrel	NN	O	clopidogrel	nn	24	SENT_497	[p21l751t1781r1068b1853],
23	maintenance	NN	O	maintenance	nn	24	SENT_497	[p21l1091t1783r1452b1834],
24	dose	NN	O	dose	dep	20	SENT_497	[p21l1476t1781r1601b1834],
25	after	IN	O	after	dep	2	SENT_497	[p21l1626t1781r1754b1834],
26	percutaneous	JJ	O	percutaneous	amod	28	SENT_497	[p21l1775t1795r2147b1853],
27	coronary	JJ	O	coronary	amod	28	SENT_497	[p21l117t1881r365b1933],
28	intervention	NN	O	intervention	pobj	25	SENT_497	[p21l383t1863r729b1914],
29	and	CC	O	and	_	0	SENT_497	[p21l751t1861r854b1914],
30	effects	NNS	O	effect	conj_and	28	SENT_497	[p21l875t1861r1046b1914],
31	on	IN	O	on	dep	2	SENT_497	[p21l1069t1882r1139b1914],
32	platelet	NN	O	platelet	nn	33	SENT_497	[p21l1159t1861r1368b1933],
33	inhibition	NN	O	inhibition	pobj	31	SENT_497	[p21l1388t1861r1686b1926],
34	,	,	O	,	_	0	SENT_497	[p21l1388t1861r1686b1926],
35	endothelial	JJ	O	endothelial	pobj	31	SENT_497	[p21l1710t1861r2027b1914],
36	and	CC	O	and	_	0	SENT_497	[p21l2047t1861r2150b1914],
37	inﬂammation	NN	O	inﬂammation	pobj	31	SENT_497	[p21l116t1940r516b1993],
38	:	:	O	:	_	0	SENT_497	[p21l116t1940r516b1993],
39	results	NNS	O	result	dep	47	SENT_497	[p21l540t1940r719b1993],
40	of	IN	O	of	_	0	SENT_497	[p21l742t1940r806b1993],
41	the	DT	O	the	det	42	SENT_497	[p21l818t1940r906b1993],
42	ARMYDA-150	NN	O	armyda-150	prep_of	39	SENT_497	[p21l926t1939r1392b1993],
43	mg	NN	O	mg	dep	47	SENT_497	[p21l1415t1961r1505b2012],
44	(	CD	NUMBER	(	num	43	SENT_497	[p21l1527t1939r1890b2012],
45	Antiplatelet	JJ	O	antiplatelet	amod	47	SENT_497	[p21l1527t1939r1890b2012],
46	Therapy	NN	O	therapy	nn	47	SENT_497	[p21l1907t1939r2152b2012],
47	Leoncini	NNP	O	Leoncini	dep	50	SENT_497	[p21l1441t2033r1657b2076],
48	et	FW	O	et	nn	49	SENT_497	[p21l1686t2035r1737b2076],
49	al.	FW	O	al.	dep	47	SENT_497	[p21l1760t2033r1818b2076],
50	179	CD	NUMBER	179	dep	2	SENT_497	[p21l2037t2032r2141b2076],

1	High-Dose	JJ	O	high-dose	amod	2	SENT_498	[p21l587t2115r852b2168],
2	Atorvastatin	NN	O	atorvastatin	_	0	SENT_498	[p21l873t2115r1193b2157],
3	and	CC	O	and	_	0	SENT_498	[p21l1218t2115r1313b2157],
4	Platelet	NN	O	platelet	conj_and	2	SENT_498	[p21l1340t2115r1542b2157],
5	Reactivity	NN	O	reactivity	dobj	9	SENT_498	[p21l1566t2115r1823b2168],
6	for	IN	O	for	_	0	SENT_498	[p21l116t2330r203b2383],
7	Reduction	NN	O	reduction	prep_for	5	SENT_498	[p21l259t2330r577b2383],
8	of	IN	O	of	prep	7	SENT_498	[p21l634t2330r701b2383],
9	Myocardial	JJ	O	myocardial	dep	2	SENT_498	[p21l746t2330r1099b2402],
10	Damage	NN	O	damage	nsubj	14	SENT_498	[p21l1154t2331r1408b2402],
11	During	IN	O	during	_	0	SENT_498	[p21l1464t2331r1688b2402],
12	Angioplasty	JJ	O	angioplasty	amod	13	SENT_498	[p21l1741t2328r2139b2402],
13	)	NN	O	)	prep_during	10	SENT_498	[p21l1741t2328r2139b2402],
14	randomized	VBN	O	randomize	ccomp	9	SENT_498	[p21l116t2412r454b2465],
15	study	NN	O	study	dobj	14	SENT_498	[p21l481t2412r644b2483],
16	.	.	O	.	_	0	SENT_498	[p21l481t2412r644b2483],
17	]	SYM	O	]	dep	2	SENT_498	[p21l666t2413r695b2480],

1	Am	VBP	O	be	dep	3	SENT_499	[p21l719t2411r828b2465],
2	Coll	NNP	O	Coll	nn	3	SENT_499	[p21l856t2412r978b2465],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_499	[p21l1005t2412r1220b2465],
4	2011	CD	DATE	2011	num	3	SENT_499	[p21l1244t2412r1693b2477],
5	;	:	O	;	_	0	SENT_499	[p21l1244t2412r1693b2477],
6	57:771	CD	NUMBER	57:771	dep	3	SENT_499	[p21l1244t2412r1693b2477],
7	—	CD	NUMBER	—	num	8	SENT_499	[p21l1244t2412r1693b2477],
8	8	CD	NUMBER	8	dep	6	SENT_499	[p21l1244t2412r1693b2477],
9	.	.	O	.	_	0	SENT_499	[p21l1244t2412r1693b2477],

1	30	CD	NUMBER	30	_	0	SENT_500	[p21l9t2497r92b2548],
2	.	.	O	.	_	0	SENT_500	[p21l9t2497r92b2548],

1	Campo	NNP	O	Campo	nn	2	SENT_501	[p21l117t2495r325b2567],
2	G	NNP	O	G	_	0	SENT_501	[p21l358t2495r428b2560],
3	,	,	O	,	_	0	SENT_501	[p21l358t2495r428b2560],
4	Parrinello	NNP	PERSON	Parrinello	nn	5	SENT_501	[p21l460t2495r738b2548],
5	G	NNP	PERSON	G	appos	2	SENT_501	[p21l770t2495r840b2560],
6	,	,	O	,	_	0	SENT_501	[p21l770t2495r840b2560],
7	Ferraresi	NNP	PERSON	Ferraresi	nn	8	SENT_501	[p21l873t2495r1121b2548],
8	P	NN	PERSON	p	appos	2	SENT_501	[p21l1151t2495r1207b2560],
9	,	,	O	,	_	0	SENT_501	[p21l1151t2495r1207b2560],
10	et	FW	O	et	nn	11	SENT_501	[p21l1241t2509r1291b2548],
11	al.	FW	O	al.	appos	2	SENT_501	[p21l1321t2495r1381b2548],
12	.	.	O	.	_	0	SENT_501	[p21l1321t2495r1381b2548],

1	Prospective	JJ	O	prospective	amod	2	SENT_502	[p21l1415t2495r1739b2567],
2	evaluation	NN	O	evaluation	_	0	SENT_502	[p21l1770t2495r2058b2548],
3	of	IN	O	of	advmod	11	SENT_502	[p21l2089t2495r2152b2548],
4	on-clopidogrel	JJ	O	on-clopidogrel	amod	6	SENT_502	[p21l117t2577r535b2649],
5	platelet	NN	O	platelet	nn	6	SENT_502	[p21l571t2578r780b2649],
6	reactivity	NN	O	reactivity	pobj	3	SENT_502	[p21l816t2580r1076b2649],
7	over	IN	O	over	_	0	SENT_502	[p21l1111t2598r1230b2631],
8	time	NN	O	time	prep_over	6	SENT_502	[p21l1266t2580r1393b2631],
9	in	IN	O	in	_	0	SENT_502	[p21l1431t2580r1486b2630],
10	patients	NNS	O	patient	prep_in	8	SENT_502	[p21l1523t2580r1744b2649],
11	treated	VBN	O	treat	partmod	2	SENT_502	[p21l1783t2578r1979b2631],
12	with	IN	O	with	prep	11	SENT_502	[p21l2013t2578r2143b2631],
13	percutaneous	JJ	O	percutaneous	amod	15	SENT_502	[p21l115t2700r487b2758],
14	coronary	JJ	O	coronary	amod	15	SENT_502	[p21l517t2707r765b2758],
15	intervention	NN	O	intervention	dep	12	SENT_502	[p21l790t2689r1150b2739],
16	:	:	O	:	_	0	SENT_502	[p21l790t2689r1150b2739],
17	relationship	NN	O	relationship	nn	19	SENT_502	[p21l1182t2686r1516b2758],
18	gene	NN	O	gene	nn	19	SENT_502	[p21l1545t2707r1676b2758],
19	polymorphisms	NNS	O	polymorphism	dep	15	SENT_502	[p21l1703t2686r2141b2758],
20	clinical	JJ	O	clinical	amod	21	SENT_502	[p21l117t2768r316b2820],
21	outcomes	NNS	O	outcome	dep	19	SENT_502	[p21l341t2782r625b2820],
22	.	.	O	.	_	0	SENT_502	[p21l341t2782r625b2820],
23	]	SYM	O	]	dep	2	SENT_502	[p21l648t2769r676b2835],

1	Am	VBP	O	be	dep	3	SENT_503	[p21l700t2767r809b2820],
2	Coll	NNP	O	Coll	nn	3	SENT_503	[p21l838t2768r960b2821],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_503	[p21l986t2768r1201b2821],
4	2011	CD	DATE	2011	num	3	SENT_503	[p21l1225t2768r1754b2832],
5	;	:	O	;	_	0	SENT_503	[p21l1225t2768r1754b2832],
6	57:2474	CD	NUMBER	57:2474	dep	3	SENT_503	[p21l1225t2768r1754b2832],
7	—	CD	NUMBER	—	num	8	SENT_503	[p21l1225t2768r1754b2832],
8	83	CD	NUMBER	83	dep	6	SENT_503	[p21l1225t2768r1754b2832],
9	.	.	O	.	_	0	SENT_503	[p21l1225t2768r1754b2832],

1	31	CD	NUMBER	31	_	0	SENT_504	[p21l9t2852r92b2902],
2	.	.	O	.	_	0	SENT_504	[p21l9t2852r92b2902],

1	Mega	JJ	O	mega	amod	3	SENT_505	[p21l115t2850r279b2921],
2	]	NN	O	]	nn	3	SENT_505	[p21l308t2850r399b2917],
3	L	NN	O	l	_	0	SENT_505	[p21l308t2850r399b2917],
4	,	,	O	,	_	0	SENT_505	[p21l308t2850r399b2917],
5	Hochholzer	NNP	PERSON	Hochholzer	nn	6	SENT_505	[p21l440t2849r780b2902],
6	W	NNP	PERSON	W	appos	3	SENT_505	[p21l812t2850r903b2914],
7	,	,	O	,	_	0	SENT_505	[p21l812t2850r903b2914],
8	Frelinger	NNP	ORGANIZATION	Frelinger	nn	9	SENT_505	[p21l944t2849r1204b2921],
9	AL	NNP	ORGANIZATION	AL	appos	3	SENT_505	[p21l1237t2848r1353b2914],
10	,	,	O	,	_	0	SENT_505	[p21l1237t2848r1353b2914],
11	et	FW	O	et	nn	12	SENT_505	[p21l1393t2863r1444b2902],
12	al.	FW	O	al.	appos	3	SENT_505	[p21l1482t2849r1541b2902],
13	.	.	O	.	_	0	SENT_505	[p21l1482t2849r1541b2902],

1	Dosing	NN	O	dosing	nn	2	SENT_506	[p21l1582t2850r1791b2921],
2	clopidogrel	NN	O	clopidogrel	_	0	SENT_506	[p21l1828t2849r2144b2921],
3	based	VBN	O	base	partmod	2	SENT_506	[p21l114t2932r273b2985],
4	on	IN	O	on	_	0	SENT_506	[p21l304t2952r375b2985],
5	CYP2C19	NN	O	cyp2c19	nn	6	SENT_506	[p21l407t2932r705b2986],
6	genotype	NN	O	genotype	prep_on	3	SENT_506	[p21l737t2945r994b3004],
7	and	CC	O	and	_	0	SENT_506	[p21l1027t2932r1129b2985],
8	the	DT	O	the	det	9	SENT_506	[p21l1160t2932r1248b2985],
9	effect	NN	O	effect	prep_on	3	SENT_506	[p21l1281t2932r1429b2985],
10	on	IN	O	on	_	0	SENT_506	[p21l1460t2952r1530b2985],
11	platelet	NN	O	platelet	nn	12	SENT_506	[p21l1561t2932r1770b3004],
12	reactivity	NN	O	reactivity	prep_on	3	SENT_506	[p21l1800t2934r2060b3003],
13	in	IN	O	in	_	0	SENT_506	[p21l2089t2934r2143b2984],
14	patients	NNS	O	patient	prep_in	12	SENT_506	[p21l115t3016r337b3085],
15	with	IN	O	with	_	0	SENT_506	[p21l361t3014r491b3067],
16	stable	JJ	O	stable	amod	18	SENT_506	[p21l518t3014r677b3067],
17	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_506	[p21l705t3014r1103b3067],
18	disease	NN	O	disease	prep_with	14	SENT_506	[p21l1129t3014r1338b3067],
19	.	.	O	.	_	0	SENT_506	[p21l1129t3014r1338b3067],
20	]	SYM	O	]	dep	2	SENT_506	[p21l1360t3012r1566b3081],

1	AMA	NNP	O	AMA	_	0	SENT_507	[p21l1360t3012r1566b3081],
2	2011	CD	DATE	2011	num	1	SENT_507	[p21l1589t3016r2110b3078],
3	;	:	O	;	_	0	SENT_507	[p21l1589t3016r2110b3078],
4	306:2221	CD	NUMBER	306:2221	number	5	SENT_507	[p21l1589t3016r2110b3078],
5	—	CD	NUMBER	—	dep	1	SENT_507	[p21l1589t3016r2110b3078],
6	8	CD	NUMBER	8	dep	5	SENT_507	[p21l1589t3016r2110b3078],
7	.	.	O	.	_	0	SENT_507	[p21l1589t3016r2110b3078],

1	32	CD	NUMBER	32	_	0	SENT_508	[p21l9t3098r92b3149],
2	.	.	O	.	_	0	SENT_508	[p21l9t3098r92b3149],

1	Athyros	NNP	O	Athyros	nn	2	SENT_509	[p21l114t3094r342b3167],
2	VG	NNP	O	VG	_	0	SENT_509	[p21l372t3095r494b3160],
3	,	,	O	,	_	0	SENT_509	[p21l372t3095r494b3160],
4	Kakaﬁka	NNP	PERSON	Kakaﬁka	nn	5	SENT_509	[p21l527t3095r775b3149],
5	AI	NNP	O	AI	appos	2	SENT_509	[p21l801t3094r896b3160],
6	,	,	O	,	_	0	SENT_509	[p21l801t3094r896b3160],
7	Tziomalos	NNP	ORGANIZATION	Tziomalos	nn	8	SENT_509	[p21l925t3094r1225b3148],
8	K	NNP	ORGANIZATION	K	appos	2	SENT_509	[p21l1258t3096r1319b3160],
9	,	,	O	,	_	0	SENT_509	[p21l1258t3096r1319b3160],
10	Karagiannis	NNP	PERSON	Karagiannis	nn	11	SENT_509	[p21l1353t3096r1686b3167],
11	A	NNP	O	A	appos	2	SENT_509	[p21l1715t3094r1783b3160],
12	,	,	O	,	_	0	SENT_509	[p21l1715t3094r1783b3160],
13	Mikhailidis	NNP	O	Mikhailidis	nn	14	SENT_509	[p21l1813t3095r2141b3149],
14	DP	NN	O	dp	appos	2	SENT_509	[p21l116t3178r229b3230],
15	.	.	O	.	_	0	SENT_509	[p21l116t3178r229b3230],

1	Pleiotropic	JJ	O	pleiotropic	amod	2	SENT_510	[p21l259t3177r570b3249],
2	effects	NNS	O	effect	_	0	SENT_510	[p21l597t3177r768b3230],
3	of	IN	O	of	_	0	SENT_510	[p21l796t3177r861b3230],
4	statins	NNS	O	statin	prep_of	2	SENT_510	[p21l878t3179r1131b3230],
5	—	CD	NUMBER	—	num	7	SENT_510	[p21l878t3179r1131b3230],
6	clinical	JJ	O	clinical	amod	7	SENT_510	[p21l1141t3177r1340b3230],
7	evidence	NN	O	evidence	dep	4	SENT_510	[p21l1366t3177r1622b3230],
8	.	.	O	.	_	0	SENT_510	[p21l1366t3177r1622b3230],

1	Curr	NNP	MISC	Curr	nn	3	SENT_511	[p21l1654t3177r1789b3230],
2	Pharm	NNP	MISC	Pharm	nn	3	SENT_511	[p21l1814t3177r2005b3230],
3	Des	NNP	MISC	Des	_	0	SENT_511	[p21l2031t3178r2141b3230],
4	2009	CD	DATE	2009	num	3	SENT_511	[p21l114t3260r608b3324],
5	;	:	O	;	_	0	SENT_511	[p21l114t3260r608b3324],
6	15:479	CD	NUMBER	15:479	number	7	SENT_511	[p21l114t3260r608b3324],
7	—	CD	NUMBER	—	dep	3	SENT_511	[p21l114t3260r608b3324],
8	89	CD	NUMBER	89	dep	7	SENT_511	[p21l114t3260r608b3324],
9	.	.	O	.	_	0	SENT_511	[p21l114t3260r608b3324],

1	33	CD	NUMBER	33	_	0	SENT_512	[p21l9t3344r92b3395],
2	.	.	O	.	_	0	SENT_512	[p21l9t3344r92b3395],

1	Werner	NNP	PERSON	Werner	nn	2	SENT_513	[p21l113t3342r336b3395],
2	N	NNP	PERSON	N	_	0	SENT_513	[p21l366t3342r436b3407],
3	,	,	O	,	_	0	SENT_513	[p21l366t3342r436b3407],
4	Nickenig	NNP	O	Nickenig	nn	5	SENT_513	[p21l468t3342r730b3413],
5	G	NNP	O	G	appos	2	SENT_513	[p21l761t3342r831b3407],
6	,	,	O	,	_	0	SENT_513	[p21l761t3342r831b3407],
7	Laufs	NNP	O	Laufs	nn	8	SENT_513	[p21l865t3342r1022b3395],
8	U.	NNP	O	U.	appos	2	SENT_513	[p21l1053t3342r1119b3395],
9	Pleiotropic	JJ	O	pleiotropic	amod	10	SENT_513	[p21l1154t3342r1465b3414],
10	effects	NNS	O	effect	dep	2	SENT_513	[p21l1497t3342r1667b3395],
11	of	IN	O	of	_	0	SENT_513	[p21l1701t3342r1765b3395],
12	HMG-CoA	NN	O	hmg-coa	prep_of	10	SENT_513	[p21l1787t3340r2144b3395],

1	reductase	NN	O	reductase	nn	2	SENT_514	[p21l116t3423r378b3476],
2	inhibitors	NNS	O	inhibitor	_	0	SENT_514	[p21l405t3424r694b3476],
3	.	.	O	.	_	0	SENT_514	[p21l405t3424r694b3476],

1	Basic	JJ	O	basic	amod	3	SENT_515	[p21l725t3424r873b3476],
2	Res	NNP	O	Res	nn	3	SENT_515	[p21l901t3424r1000b3476],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_515	[p21l1030t3423r1244b3476],
4	2002	CD	DATE	2002	dep	3	SENT_515	[p21l1268t3423r1745b3488],
5	;	:	O	;	_	0	SENT_515	[p21l1268t3423r1745b3488],
6	97:105	CD	NUMBER	97:105	num	7	SENT_515	[p21l1268t3423r1745b3488],
7	-16	CD	NUMBER	-16	dep	3	SENT_515	[p21l1268t3423r1745b3488],
8	.	.	O	.	_	0	SENT_515	[p21l1268t3423r1745b3488],

1	34	CD	NUMBER	34	_	0	SENT_516	[p21l9t3507r92b3558],
2	.	.	O	.	_	0	SENT_516	[p21l9t3507r92b3558],

1	Angiolillo	NN	O	angiolillo	_	0	SENT_517	[p21l114t3503r401b3576],
2	D	NN	O	d	nn	3	SENT_517	[p21l445t3505r539b3572],
3	]	NN	O	]	dep	1	SENT_517	[p21l445t3505r539b3572],
4	,	,	O	,	_	0	SENT_517	[p21l445t3505r539b3572],
5	Alfonso	NNP	PERSON	Alfonso	nn	7	SENT_517	[p21l583t3503r808b3557],
6	F.	NNP	PERSON	F.	nn	7	SENT_517	[p21l853t3505r907b3557],
7	Clopidogrel-statin	NNP	PERSON	Clopidogrel-statin	appos	3	SENT_517	[p21l954t3504r1486b3576],
8	interaction	NN	O	interaction	rcmod	7	SENT_517	[p21l1529t3507r1850b3557],
9	:	:	O	:	_	0	SENT_517	[p21l1529t3507r1850b3557],
10	myth	NN	O	myth	dep	8	SENT_517	[p21l1897t3504r2043b3576],
11	or	CC	O	or	_	0	SENT_517	[p21l2086t3525r2144b3557],
12	reality	NN	O	reality	conj_or	10	SENT_517	[p21l116t3586r315b3658],
13	?	.	O	?	_	0	SENT_517	[p21l116t3586r315b3658],
14	]	SYM	O	]	dep	8	SENT_517	[p21l335t3587r363b3654],

1	Am	VBP	O	be	dep	3	SENT_518	[p21l387t3585r496b3639],
2	Coll	NNP	O	Coll	nn	3	SENT_518	[p21l525t3586r647b3639],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_518	[p21l674t3586r888b3639],
4	2007	CD	DATE	2007	num	3	SENT_518	[p21l912t3586r1370b3651],
5	;	:	O	;	_	0	SENT_518	[p21l912t3586r1370b3651],
6	50:296	CD	NUMBER	50:296	num	7	SENT_518	[p21l912t3586r1370b3651],
7	-8	CD	NUMBER	-8	dep	3	SENT_518	[p21l912t3586r1370b3651],
8	.	.	O	.	_	0	SENT_518	[p21l912t3586r1370b3651],

1	35	CD	NUMBER	35	_	0	SENT_519	[p21l9t3668r92b3721],
2	.	.	O	.	_	0	SENT_519	[p21l9t3668r92b3721],

1	Marin	NNP	O	Marin	nn	2	SENT_520	[p21l115t3669r295b3721],
2	F	NN	O	f	_	0	SENT_520	[p21l322t3669r378b3733],
3	,	,	O	,	_	0	SENT_520	[p21l322t3669r378b3733],
4	Gonzalez-Conejero	NNP	PERSON	Gonzalez-Conejero	nn	5	SENT_520	[p21l408t3668r969b3739],
5	R	NNP	PERSON	R	appos	2	SENT_520	[p21l998t3669r1059b3733],
6	,	,	O	,	_	0	SENT_520	[p21l998t3669r1059b3733],
7	Capranzano	NNP	O	Capranzano	nn	8	SENT_520	[p21l1090t3668r1432b3740],
8	P	NN	O	p	appos	2	SENT_520	[p21l1461t3669r1517b3733],
9	,	,	O	,	_	0	SENT_520	[p21l1461t3669r1517b3733],
10	Bass	NNP	ORGANIZATION	Bass	nn	11	SENT_520	[p21l1546t3669r1670b3721],
11	TA	NNP	ORGANIZATION	TA	appos	2	SENT_520	[p21l1696t3666r1815b3733],
12	,	,	O	,	_	0	SENT_520	[p21l1696t3666r1815b3733],
13	Roldan	NNP	PERSON	Roldan	nn	14	SENT_520	[p21l1846t3668r2050b3721],
14	V	NNP	PERSON	V	appos	2	SENT_520	[p21l2077t3669r2140b3733],
15	,	,	O	,	_	0	SENT_520	[p21l2077t3669r2140b3733],
16	Angiolillo	NNP	O	Angiolillo	nn	17	SENT_520	[p21l114t3750r401b3822],
17	D	NNP	O	D	appos	2	SENT_520	[p21l452t3751r545b3819],
18	]	NN	O	]	dep	17	SENT_520	[p21l452t3751r545b3819],
19	.	.	O	.	_	0	SENT_520	[p21l452t3751r545b3819],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_521	[p21l599t3751r1113b3822],
2	in	IN	O	in	_	0	SENT_521	[p21l1164t3753r1218b3803],
3	cardiovascular	JJ	O	cardiovascular	amod	5	SENT_521	[p21l1268t3751r1666b3804],
4	antithrombotic	JJ	O	antithrombotic	amod	5	SENT_521	[p21l1716t3751r2143b3804],
5	therapy	NN	O	therapy	prep_in	1	SENT_521	[p22l116t12r341b84],
6	.	.	O	.	_	0	SENT_521	[p22l116t12r341b84],

1	J	NNP	O	J	nn	4	SENT_522	[p22l364t13r393b80],
2	Am	NNP	O	Am	nn	4	SENT_522	[p22l417t11r526b65],
3	Coll	NNP	O	Coll	nn	4	SENT_522	[p22l554t12r676b66],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_522	[p22l703t12r917b66],
5	2009	CD	DATE	2009	num	4	SENT_522	[p22l942t12r1454b78],
6	;	:	O	;	_	0	SENT_522	[p22l942t12r1454b78],
7	54:1041	CD	NUMBER	54:1041	number	8	SENT_522	[p22l942t12r1454b78],
8	—	CD	NUMBER	—	dep	4	SENT_522	[p22l942t12r1454b78],
9	57	CD	NUMBER	57	dep	8	SENT_522	[p22l942t12r1454b78],
10	.	.	O	.	_	0	SENT_522	[p22l942t12r1454b78],

1	Key	NN	O	key	nn	2	SENT_523	[p22l11t256r155b344],
2	words	NNS	O	word	_	0	SENT_523	[p22l183t254r427b322],
3	:	:	O	:	_	0	SENT_523	[p22l183t254r427b322],
4	clopidogrel	NN	O	clopidogrel	nn	7	SENT_523	[p22l500t255r896b345],
5	I	PRP	O	I	dep	4	SENT_523	[p22l931t267r976b313],
6	high-dose	JJ	O	high-dose	amod	7	SENT_523	[p22l1012t255r1368b344],
7	statins	NNS	O	statin	dep	2	SENT_523	[p22l1406t258r1629b321],
8	I	PRP	O	I	nsubj	9	SENT_523	[p22l1666t267r1712b312],
9	VerifyNoW	VBP	O	verifynow	rcmod	7	SENT_523	[p22l1748t255r2146b344],
10	assay	NN	O	assay	dobj	9	SENT_523	[p22l10t387r202b449],
11	.	.	O	.	_	0	SENT_523	[p22l10t387r202b449],

